	#SentenceID	Sentence	TF	TG	TF Id	TG Id	TF offset	Gene offset	TRI score	Valid	MoR scores	MoR	PMID	TF Symbol	TF TaxID	TG Symbol	TG TaxID	TF_type	renormalisation	Error
26	PMID:16474426:pubtator_title_and_abstract:215da416f644aaf6eb02eaf3ac2a2f45:4:IRF7:NF-kappaB:461:441	The TLR pathway induces interferon production through several signaling proteins that ultimately lead to the activation of the transcription factors [TG], IRF3 and [TF].	IRF7	NF-kappaB	3665	4790	461	441	0.0013226747170055	Non valid	0.049966948587590564;0.9475040135914433;0.0025290378209661644	ACTIVATION	16474426	IRF7	9606	NFKB1	9606	dbTF		NFKB
63	PMID:32668392:pubtator_title_and_abstract:db7682dd91cea546bd7424c63519ef93:7:signal transducer and activator of transcription 3:NF-kappaB:789:774	Proliferation of DLBCL following CA1 knockdown was investigated both in vitro and in vivo, along with the effects on nuclear factor kappaB ([TG]) and [TF] (STAT3) pathways.	signal transducer and activator of transcription 3	NF-kappaB	6774	4790	789	774	0.0011120579462292	Non valid	0.9903858313054731;0.007931812300983634;0.001682356393543373	UNDEFINED	32668392	STAT3	9606	NFKB1	9606	dbTF		NFKB
163	PMID:27092478:pubtator_title_and_abstract:3167806e339a436ed28ad4f87f85be8c:10:NF-kappaB:NF-kappaB:1304:1435	By in silico molecular docking studies, we found that scopoletin bound to [TF] and its regulator IkappaB. Scopoletin activated NF-kappaB in a SEAP-driven NF-kappaB reporter cell line, indicating that [TG] might be a resistance factor for scopoletin.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1304	1435	0.0071493219680282	Non valid	0.75902066784561;0.15940787802790515;0.081571454126485	UNDEFINED	27092478	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
184	PMID:19095738:pubtator_title_and_abstract:62009ee84e72963d010bdd2e91208393:7:p65:NF-kappaB:1000:1027	Chromatin immunoprecipitation assays revealed that recombinant [TF] bound to the predicted [TG]-binding sites.	p65	NF-kappaB	5970	4790	1000	1027	0.0016644166234262	Non valid	0.9975059499252938;0.001134953968977419;0.0013590961057287788	UNDEFINED	19095738	RELA	9606	NFKB1	9606	dbTF		NFKB
244	PMID:29315574:pubtator_title_and_abstract:ba81ad047b431744f40c6032e6e7cb20:0:C/EBP homologous protein:NF-kappaB:18:63	Palmitate-induced [TF] activation leads to [TG]-mediated increase in BACE1 activity and amyloid beta genesis.	C/EBP homologous protein	NF-kappaB	13198	18033	18	63	0.0011478093230238	Non valid	0.005917693092419291;0.9931531764064904;0.0009291305010903282	ACTIVATION	29315574	Ddit3	10090	Nfkb1	10090	dbTF		NFKB
302	PMID:37131693:pubtator_title_and_abstract:eb060bfa1a051182c35a4406356fc3f5:12:MYD88:NF-kappaB:1345:1355	Results In vitro, BMSCs and inhibitors of TLR4, [TF] and [TG] showed decreased ROS content, decreased inflammatory factor protein level, decreased apoptotic protein level and increased mRNA expression compared with NaCl group.	MYD88	NF-kappaB	17874	18033	1345	1355	0.0011412041376856	Non valid	0.007326397111155657;0.008866970317020998;0.9838066325718233	REPRESSION	37131693	Myd88	10090	Nfkb1	10090	coTF		NFKB
330	PMID:25632270:pubtator_title_and_abstract:07d47a2a34959df5f3a1668c2ecc1c60:9:PPAR-gamma:NF-kappaB:1491:1566	The specific [TF] inhibitor, GW9662 blocked the effects of the hydrolysate on the [TG]-mediated chemokines and adhesion molecules expression in endothelial cells.	PPAR-gamma	NF-kappaB	5468	4790	1491	1566	0.0012445777342031	Non valid	0.5760553641652104;0.4200371439475954;0.003907491887194115	UNDEFINED	25632270	PPARG	9606	NFKB1	9606	dbTF		NFKB
368	PMID:36998478:pubtator_title_and_abstract:91ed42c6acc0643408a87fb93c6316c7:3:nuclear factor-kappaB:NF-kappaB:200:223	The [TF] ([TG]) pathway plays an important role in inflammatory activity and inhibiting NF-kappaB-mediated inflammation can be a potential strategy for treating OA.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	200	223	0.0010891304134084	Non valid	0.47325014324473963;0.5194603291447768;0.007289527610483608	ACTIVATION	36998478	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
404	PMID:36288961:pubtator_title_and_abstract:f3a63cbd237e6702989278cff0fe1e75:6:c-Jun N-terminal kinase:nuclear factor-kappaB:920:882	In addition, vitamin K3 inhibited the pro-inflammatory signaling pathways including [TG] (NF-kappaB) and [TF] (JNK).	c-Jun N-terminal kinase	nuclear factor-kappaB	5599	4790	920	882	0.0011678712862328	Non valid	0.18352556095366168;0.8132383048190204;0.003236134227317898	ACTIVATION	36288961	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
410	PMID:33356390:pubtator_title_and_abstract:26c39c1d9126b2eec9ed22054c25b129:10:Akt:nuclear factor kappa-light-chain-enhancer of activated B cells:1343:1210	Simultaneously, Cx43 downregulation reduced the phosphorylation of NF-kappaB ([TG]) and Akt (protein kinase B) pathway and reactivation of NF-kappaB and [TF] using betulinic acid, and SC79 could restore the secretion of growth factors and cytokines.	Akt	nuclear factor kappa-light-chain-enhancer of activated B cells	207	4790	1343	1210	0.0011130541917288	Non valid	0.014465202400599234;0.9820619897614876;0.003472807837913151	ACTIVATION	33356390	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
413	PMID:26513078:pubtator_title_and_abstract:a8e74bd5fc3509b8085a09f6ad5705c7:6:IKK2:NFkappaB:803:698	Involvement of the nuclear factor kappa B ([TG]) signaling pathway was investigated by adenoviral overexpression of a dominant-negative form of [TF].	IKK2	NFkappaB	3551	4790	803	698	0.0019017784053429	Non valid	0.3752874761072736;0.6200487153662559;0.00466380852647059	ACTIVATION	26513078	IKBKB	9606	NFKB1	9606	coTF		NFKB
470	PMID:32539239:pubtator_title_and_abstract:5e7eb351d16161d3b4080fb7baad9880:7:c-Myc:NF-kappabeta:1242:1249	Here, we present detailed protocols on how to perform multiplex hextuple luciferase assaying to monitor pathway fluxes through transcriptional response elements for five specific signaling pathways (i.e., [TF], [TG], TGF-beta, p53, and MAPK/JNK) using the constitutive CMV promoter as normalization control.	c-Myc	NF-kappabeta	4609	4790	1242	1249	0.0011827484477198	Non valid	0.9928025925189851;0.006481806160390549;0.0007156013206244213	UNDEFINED	32539239	MYC	9606	NFKB1	9606	dbTF		NFKB
522	PMID:36428266:pubtator_title_and_abstract:cd2f7748b985e87a8777213e5864241f:7:CREB:NF-kappaB:946:967	Furthermore, in vivo and in vitro experiments indicated that 4-GDB could activate cAMP/PKA/[TF] and inhibit the [TG] pathway.	CREB	NF-kappaB	12912	18033	946	967	0.0012370295495398	Non valid	0.28020879579426794;0.4012631714076525;0.3185280327980795	ACTIVATION	36428266	Creb1	10090	Nfkb1	10090	dbTF		NFKB
551	PMID:37623434:pubtator_title_and_abstract:752dbaf4e2f64582606f7c42a8cbe25c:3:NF-kappaB:NF-kappaB:799:713	Although MALT1 scaffolding induces [TG]-dependent survival signaling, MALT1 protease function is thought to augment [TF] activation by cleaving signaling mediators and transcriptional regulators in B-cell lymphomas.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	799	713	0.0011069479605143	Non valid	0.011459964845019101;0.9796395340596576;0.008900501095323263	ACTIVATION	37623434	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
556	PMID:30841931:pubtator_title_and_abstract:f9021bf9fb50a2b50de1451f4783017a:12:Erk1/2:NF-kappaB:1355:1434	Mechanistically, PKD2/3 interacted with [TF] and activated Erk1/2 or NF-kappaB signaling pathway, leading to AP-1 or [TG] binding to the promoter of scf, ccl5 and ccl11.	Erk1/2	NF-kappaB	26417;26413	18033	1355	1434	0.0010847222624774	Non valid	0.6411351183797671;0.3563721574067056;0.002492724213527341	UNDEFINED	30841931	Mapk3;Mapk1	10090;10090	Nfkb1	10090	ll_coTF;ll_coTF		NFKB
595	PMID:19706766:pubtator_title_and_abstract:3db3c270702586db9204e0568901ce99:11:NF-kappaB p65:NF-kappaB:1423:1519	These findings indicate that MUC1-C is a direct activator of [TF] and that an inhibitor of MUC1 function is effective in blocking activation of the [TG] pathway.	NF-kappaB p65	NF-kappaB	5970	4790	1423	1519	0.0027791026776032	Non valid	0.004649259652099569;0.9919578430638226;0.0033928972840777563	ACTIVATION	19706766	RELA	9606	NFKB1	9606	dbTF		NFKB
625	PMID:24027435:pubtator_title_and_abstract:3b24fa51da70360872139775256a2347:4:IkappaB-zeta:NF-kappaB.:774:808	Here, we show that NF-kappaB-binding cofactor inhibitor of NF-kappaB-zeta (IkappaB-zeta) is constitutively expressed in HTLV-I-infected T cell lines and ATL cells, and Tax transactivates the [TF] gene, mainly through [TG] Microarray analysis of IkappaB-zeta-expressing uninfected T cells demonstrated that IkappaB-zeta induced the expression of NF-kappaB. and interferon-regulatory genes such as B cell CLL/lymphoma 3 (Bcl3), guanylate-binding protein 1, and signal transducer and activator of transcription 1.	IkappaB-zeta	NF-kappaB.	64332	4790	774	808	0.0023397968417101	Non valid	0.004202635735866455;0.9948588903899513;0.0009384738741821623	ACTIVATION	24027435	NFKBIZ	9606	NFKB1	9606	coTF		NFKB
637	PMID:18723484:pubtator_title_and_abstract:36ca571b1ee6c5ac44f05c993c4110d5:2:nuclear factor-kappaB:NF-kappaB:165:188	The activation of [TF] ([TG]) is thought to protect cancer cells against therapy-induced cytotoxicity.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	165	188	0.00122715813067	Non valid	0.00673278184412565;0.9921220780636207;0.0011451400922537034	ACTIVATION	18723484	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
683	PMID:32114385:pubtator_title_and_abstract:14561584ba1ad7e47faa5d8ee0788b0b:9:p65:NF-kappaB:1071:1121	Mutations of IKKbeta (S733A) and [TF] (T352A) abrogated the O-GlcNAc in IKKbeta and [TG] and inhibited AIEC LF82-induced activation of NF-kappaB. Application of 6-diazO-5-oxO-L-norleucine, an agent that blocks the production of UDP-GlcNAc and inhibits O-GlcNAc, inactivated NF-kappaB in AIEC LF82-infected cells, enhanced the formation of autophagy, promoted the removal of cell-associated AIEC LF82, alleviated intestinal epithelial inflammation, and improved the survival of the colitis mice.	p65	NF-kappaB	5970	4790	1071	1121	0.0029190372799274	Non valid	0.03498201653386178;0.9507713165608696;0.014246666905268619	ACTIVATION	32114385	RELA	9606	NFKB1	9606	dbTF		NFKB
700	PMID:32048261:pubtator_title_and_abstract:b0ff2ebe65ae228cfb00588a4e98f26b:11:HO-1:NF-kappaB:1918:1899	CONCLUSION: The observed ameliorative effect of MMF against Con A-induce ALI may be contributed to its anti-inflammatory, anti-oxidant and anti-apoptotic potentials taking into consideration that TLR4/[TG] and Nrf2/[TF] are the main implicated pathways.	HO-1	NF-kappaB	15368	18033	1918	1899	0.0011471933686257	Non valid	0.6543876705773419;0.3422536479633843;0.003358681459273739	UNDEFINED	32048261	Hmox1	10090	Nfkb1	10090	ll_coTF		NFKB
861	PMID:32044659:pubtator_title_and_abstract:24c8f5ac95a559cb45e2046a4b869526:0:TXNIP:NF-kappaB:96:112	NecroX-5 alleviate lipopolysaccharide-induced acute respiratory distress syndrome by inhibiting [TF]/NLRP3 and [TG].	TXNIP	NF-kappaB	56338	18033	96	112	0.0011658364079916	Non valid	0.005528137809866949;0.9815276618931569;0.012944200296976169	ACTIVATION	32044659	Txnip	10090	Nfkb1	10090	coTF		NFKB
951	PMID:24357803:pubtator_title_and_abstract:ba578d9650607282a57ee404cc270858:2:nuclear factor kappa-light-chain-enhancer of activated B-cell:NF-kappaB:176:239	The zinc-finger protein A20 is a key player in the negative feedback regulation of the [TF] ([TG]) pathway in response to multiple stimuli.	nuclear factor kappa-light-chain-enhancer of activated B-cell	NF-kappaB	Complex:NFKB	4790	176	239	0.0011416115992004	Non valid	0.017270771478623704;0.021348736717233932;0.9613804918041423	REPRESSION	24357803	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
1078	PMID:33937399:pubtator_title_and_abstract:6c871ebc91420bd812d2ad8873fa01de:15:Bcl-2:NF-kappaB:1812:1794	Additionally, Bax was significantly increased, whereas [TG]-p65 and [TF] were downregulated after knockdown of gastrin.	Bcl-2	NF-kappaB	596	4790	1812	1794	0.0012054165543136	Non valid	0.018156170388862178;0.6826599466413006;0.2991838829698373	ACTIVATION	33937399	BCL2	9606	NFKB1	9606	coTF		NFKB
1112	PMID:14760889:pubtator_title_and_abstract:88bf829508b5299ed6300461d4e37f5e:10:NF-kappaB p50:NF-kappaB:2285:2193	Suppression of HCMV replication could be correlated with an increased cytosolic accumulation of IkappaB as well as a reduced [TG] binding activity in nuclear extracts of MG132-treated cells, which mainly regards [TF].	NF-kappaB p50	NF-kappaB	4790	4790	2285	2193	0.0012163697367049	Non valid	0.9859796427110169;0.010186507727132334;0.003833849561850742	UNDEFINED	14760889	NFKB1	9606	NFKB1	9606	dbTF		NFKB
1120	PMID:33189893:pubtator_title_and_abstract:6d5ff29c9cffea674d570d86fcfd35c7:2:AKT:nuclear factor-kappaB:352:223	BACKGROUND & AIMS: p21-activated kinase-1 (PAK1) belongs to a family of serine-threonine kinases and contributes to cellular pathways such as [TG] (NF-kappaB), mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase/protein kinase B (PI3K/[TF]), and Wingless-related integration site(Wnt)/beta-catenin, all of which are involved in intestinal homeostasis.	AKT	nuclear factor-kappaB	11651	18033	352	223	0.0011244424621497	Non valid	0.8373882759107601;0.15996998796262812;0.002641736126611745	UNDEFINED	33189893	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
1153	PMID:20696864:pubtator_title_and_abstract:746fdd9edb57c97af4f4c245835a2be4:6:p65:NF-kappaB:1088:1105	Analysis of in vivo recruitment of [TF] NF-kappaB to [TG]-regulated promoters by chromatin immunoprecipitation in U937 cells and human PBMCs indicated that although the p65 recruitment to TNF-alpha, IL-1beta, and IL-6 promoters was inhibited by the nuclear IkappaBalpha, p65 recruitment to IL-8 promoter was not repressed.	p65	NF-kappaB	5970	4790	1088	1105	0.0020403535084312	Non valid	0.9981262164368767;0.0010804561159293092;0.0007933274471939605	UNDEFINED	20696864	RELA	9606	NFKB1	9606	dbTF		NFKB
1207	PMID:32873150:pubtator_title_and_abstract:9c9e682620944386ac53655d1d786474:4:TAK1:NF-kappabeta:551:644	Within the TNF intracellular inflammatory signalling cascade, transforming growth factor-beta-activated kinase 1 ([TF]) has been shown to play a critical role in mediating signal transduction and downstream [TG] activation.	TAK1	NF-kappabeta	6885	4790	551	644	0.1396650823658787	Non valid	0.008479397492184801;0.9906118813235089;0.0009087211843063647	ACTIVATION	32873150	MAP3K7	9606	NFKB1	9606	ll_coTF		NFKB
1321	PMID:30639961:pubtator_title_and_abstract:fc2b4a91846d7447b10b22c172074d29:8:NF-kappaB:nuclear factor kappa-B:1216:1192	EsB remarkably suppressed nuclear translocation of [TG] ([TF]) from cytosolic space.	NF-kappaB	nuclear factor kappa-B	Complex:NFKB	18033	1216	1192	0.0011891239261322	Non valid	0.008143257171386807;0.9892362502186886;0.0026204926099246445	ACTIVATION	30639961	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
1341	PMID:25664004:pubtator_title_and_abstract:6bc6256b740f7adcaaba6408be680f4a:3:STAT3:NF-kappaB:287:322	Previous reports have documented the crosstalk between SIRT1 with signal transducer and activator of transcription 3 ([TF]) and nuclear factor kappa-B ([TG]) signaling in leukemia, lymphoma and myeloma.	STAT3	NF-kappaB	6774	4790	287	322	0.0011314709470967	Non valid	0.9940699121636082;0.004852913979617965;0.0010771738567739177	UNDEFINED	25664004	STAT3	9606	NFKB1	9606	dbTF		NFKB
1393	PMID:30059682:pubtator_title_and_abstract:12e3c9c47388b28bd8a7879b2ed73861:6:NF-kB:NF-kB:1010:1023	Nuclear factor kappa-B (NF-kB-p65) was estimated using real time PCR technique, while phosphorylated [TF]-p65 (p-[TG]-p65), phosphorylated and non-phosphorylated protein kinase B (p-Akt and Akt) and phosphorylated inhibitor of kappa-B (p-IkBa) were estimated by western blot analysis.	NF-kB	NF-kB	Complex:NFKB	309165	1010	1023	0.0012077786785356	Non valid	0.9238689991761293;0.06970615477989504;0.006424846043975628	UNDEFINED	30059682	NFKB	10116	Rela	10116	dbTF	NFKB	NFKB
1542	PMID:21392794:pubtator_title_and_abstract:2111d4809e13b342c00a5e6cff9b8cf7:10:p38 MAPK:NF-kappaB:1813:1840	Following intestinal I/R, phosporylation of [TF] and activation of [TG] and AP-1 were significantly inhibited in lung tissue from TLR4 mutant mice compared with WT controls.	p38 MAPK	NF-kappaB	26416	18033	1813	1840	0.0015694664388775	Non valid	0.00559923871066765;0.9923416692082812;0.0020590920810511257	ACTIVATION	21392794	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
1568	PMID:31426492:pubtator_title_and_abstract:ba872ca2757d8285f85a8c54705fb40a:9:heme oxygenase (HO)-1:nuclear factor (NF)-kappaB:1338:1237	ARAE markedly attenuated the transcriptional activities of [TG] and mitogen-activated protein kinases (MAPK) phosphorylation, and induced [TF] expression.	heme oxygenase (HO)-1	nuclear factor (NF)-kappaB	15368	18033	1338	1237	0.0011588386293596	Non valid	0.04580812425600335;0.060153170191192706;0.894038705552804	REPRESSION	31426492	Hmox1	10090	Nfkb1	10090	ll_coTF		NFKB
1619	PMID:31621446:pubtator_title_and_abstract:b07576be72c6a2fadf45c9acc068ec85:7:NF-kB:NF-kB:1435:1219	Additionally, these agents decreased the activity of MPO (p   .001), TNF-alpha (p   .001) and the expression level of p-[TG] (p   .001) in rat colon tissue compared with the acetic acid group.Conclusion: It is proposed that the anti-inflammatory activity of dapsone on acetic acid-induced colitis in rats may involve the inhibition of [TF] pathway.	NF-kB	NF-kB	Complex:NFKB	309165	1435	1219	0.0021595458403722	Non valid	0.040375619470627906;0.9419957802030932;0.017628600326278842	ACTIVATION	31621446	NFKB	10116	Rela	10116	dbTF	NFKB	NFKB
1642	PMID:20669221:pubtator_title_and_abstract:391d979a0f357c9bbd11cf597f69f569:5:JNK:NFkappaB:896:930	DMAPT generated ROS with subsequent [TF] activation and also decreased [TG] DNA binding and antiapoptotic proteins, TRAF-2 and XIAP.	JNK	NFkappaB	5599	4790	896	930	0.0016782871714793	Non valid	0.20886263677143166;0.7631791494332565;0.027958213795311795	ACTIVATION	20669221	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
1761	PMID:33827262:pubtator_title_and_abstract:3f2ec6ad36a1bfc24c5c2eb6d767084c:9:IkappaBalpha:nuclear factor-kappaB:1406:1317	Moreover, AOPPs markedly activated the phosphorylation of [TG] (NF-kappaB) p65 protein, which triggered inhibitory kappa B-alpha ([TF]) degradation, NF-kappaB p65 protein phosphorylation, and NF-kappaB p65 translocation into the nucleus.	IkappaBalpha	nuclear factor-kappaB	4792	4790	1406	1317	0.0011582628260644	Non valid	0.11101515031005918;0.16210225077476978;0.7268825989151709	REPRESSION	33827262	NFKBIA	9606	NFKB1	9606	coTF		NFKB
1769	PMID:24592135:pubtator_title_and_abstract:4f05ddd6c7e1e72e1082f2c68c2b5cd2:6:CD34:NF-kappaB:689:608	CD9, VEGF, and [TG] immunohistochemistry were applied to GIST cases positive for CD117 and [TF], which are used to evaluate GISTs immunohistochemically.	CD34	NF-kappaB	947	4790	689	608	0.0012537463352824	Non valid	0.7527225728915983;0.2380458627520406;0.009231564356361209	UNDEFINED	24592135	CD34	9606	NFKB1	9606	ll_coTF		NFKB
1865	PMID:19160540:pubtator_title_and_abstract:a4648fc92b448bc2a74d510cd7cabcfa:2:interferon regulatory factor (IRF)-3:NF-kappaB:287:334	Over the past four years, the field of the innate immune response has been highly influenced by the discovery of the IkappaB kinase (IKK)-related kinases, TANK Binding Kinase 1 (TBK1) and IKKi, which regulate the activity of [TF]/IRF-7 and [TG] transcription factors.	interferon regulatory factor (IRF)-3	NF-kappaB	3661	4790	287	334	0.0011000244829775	Non valid	0.9758377629218022;0.02169687932367219;0.002465357754525678	UNDEFINED	19160540	IRF3	9606	NFKB1	9606	dbTF		NFKB
1927	PMID:20955423:pubtator_title_and_abstract:3e5de42f45837635866b3bd3a5ab2961:5:NF-kappaB:nuclear factor-kappa B:573:549	A central regulator of inflammatory response is the transcription factor, [TG] ([TF]).	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	4790	573	549	0.0011459482591366	Non valid	0.9877092417360283;0.010809902225419374;0.001480856038552339	UNDEFINED	20955423	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
2065	PMID:33414422:pubtator_title_and_abstract:b9971781a4018988db1c156dde6a748d:0:p53:NF-kappaB:69:139	Snai1-induced partial epithelial-mesenchymal transition orchestrates [TF]-p21-mediated G2/M arrest in the progression of renal fibrosis via [TG]-mediated inflammation.	p53	NF-kappaB	7157	18033	69	139	0.0032166157844978	Non valid	0.035972226539959004;0.9581245988347564;0.005903174625284618	ACTIVATION	33414422	TP53	9606	Nfkb1	10090	dbTF		NFKB
2067	PMID:32183436:pubtator_title_and_abstract:9a4c31c80f50a478354ee6274bf85ef8:11:Nrf2:NF-kappaB:1584:1489	Collectively, these results indicated that ALDE not only exerts anti-inflammatory effects via the suppression of the [TG] and MAPK pathways but also has an antioxidative effect through the activation of the [TF]/HO-1 pathway.	Nrf2	NF-kappaB	18024	18033	1584	1489	0.0011159087495355	Non valid	0.1295510968553805;0.19731397641090986;0.6731349267337097	REPRESSION	32183436	Nfe2l2	10090	Nfkb1	10090	dbTF		NFKB
2083	PMID:31737131:pubtator_title_and_abstract:950f273ac4d91727d05b0725eed5e912:9:SATB1:NF-kappaB:1520:1703	HER2 expression was not significantly correlated with that of other proteins, but a positive correlation was found between the expression of [TF] and NF-kappaB. Further studies with a larger group of patients combined with in vitro mechanistic experiments are required to fully elucidate the role and relationship of HER2, [TG], and SATB1 expression in gastric cancer progression.	SATB1	NF-kappaB	6304	4790	1520	1703	0.001542313021088	Non valid	0.11845738046076809;0.8790187315639709;0.0025238879752610254	ACTIVATION	31737131	SATB1	9606	NFKB1	9606	dbTF		NFKB
2103	PMID:31912662:pubtator_title_and_abstract:6c4ec780ac821c9a901a0859c5084964:7:NF-kappaB:nuclear factor-kappaB:1400:1233	We further show activation of the canonical [TG] (NF-kappaB) pathway in response to C. t. infection, including phosphorylation of the inhibitor of kappaB (IkappaB), the nuclear translocation of [TF] subunit (NF-kappaB-P65 ) and the recruitment of NF-kappaB-P65 and RNA polymerase to the NF-kappaB response elements at the promoter region of the inflammatory genes.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	1400	1233	0.0011231682522013	Non valid	0.012275265792635413;0.9868759616613616;0.0008487725460030327	ACTIVATION	31912662	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
2200	PMID:24238405:pubtator_title_and_abstract:779b4a333597e9565abf6b653e3e9ac5:11:JNK:NF-kappaB:1642:1675	The inhibitory effects of SOCS1 were mediated by blocking p38, c-Jun N-terminal kinase ([TF]), and nuclear factor kappaB ([TG]) activation, and by downregulating transforming growth factor-beta-activated kinase 1 (TAK1) expression.	JNK	NF-kappaB	5599	4790	1642	1675	0.0011109937966125	Non valid	0.0033810262829032144;0.9947046556787263;0.0019143180383704105	ACTIVATION	24238405	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
2253	PMID:29670828:pubtator_title_and_abstract:fd4be403a5b9ffe7ba6d9d6619521840:4:MyD88:NF-kappaB:957:964	In addition, their correlations with the key downstream factors of the HMGB1-TLR4 axis ([TF], [TG], and TNF-alpha) were analyzed.	MyD88	NF-kappaB	4615	4790	957	964	0.0013259300807338	Non valid	0.9878087686610526;0.0111254545389013;0.001065776800046192	UNDEFINED	29670828	MYD88	9606	NFKB1	9606	coTF		NFKB
2285	PMID:26054669:pubtator_title_and_abstract:95443dd19f2f13b924dc8f06154f5973:7:NFkappaB:NFkappaB:825:1011	[TF] activation was not affected by EP in the cells during the short exposures, thus implying that the observed effect of EP on cytokine and nitric oxide generation was performed in [TG] independent way.	NFkappaB	NFkappaB	Complex:NFKB	18033	825	1011	0.0018046385049532	Non valid	0.10700340935350319;0.8865030782875403;0.006493512358956496	ACTIVATION	26054669	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
2333	PMID:31266264:pubtator_title_and_abstract:f684974408a8af53d3b8a504381214e2:3:NF-kappaB:nuclear factor-kappaB:406:383	"Enteric glia-derived S100B protein has been proposed as an ""ideal bridge"", linking colonic inflammation and cancer, given its dual ability to up-regulate [TG] ([TF]) transcription via receptor for advanced glycation end products (RAGE) signaling and to sequestrate wild type pro-apoptotic wild type (wt)p53."	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	406	383	0.0016606738799524	Non valid	0.004657942359878838;0.9895183231181156;0.005823734522005522	ACTIVATION	31266264	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
2334	PMID:26400473:pubtator_title_and_abstract:4a54548dd73b88fc43c06efd1daaba33:0:Akt:NF-kappaB:122:76	The human parasite Leishmania amazonensis downregulates iNOS expression via [TG] p50/p50 homodimer: role of the PI3K/[TF] pathway.	Akt	NF-kappaB	207	4790	122	76	0.0019056589548128	Non valid	0.010027478978025011;0.014957512538908634;0.9750150084830664	REPRESSION	26400473	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
2382	PMID:22271508:pubtator_title_and_abstract:abc224a3f41f9a7a10e9285b82845e75:8:Trib2:nuclear factor kappa B:686:695	Involvement of [TF] in [TG] (NF-kappaB) pathways was assessed in epithelial cells by NF-kappaB reporter assay.	Trib2	nuclear factor kappa B	28951	4790	686	695	0.0013974539630842	Non valid	0.5950308870877058;0.401954179618757;0.003014933293537169	UNDEFINED	22271508	TRIB2	9606	NFKB1	9606	coTF		NFKB
2403	PMID:32627006:pubtator_title_and_abstract:3a55bedf68ebdd8de7034ee0c8fe4f28:8:NF-kappaB:NF-kappaB:1147:953	[TG] and Wnt/beta-catenin pathways were activated in TNF-alpha-induced inflammatory responses, leading to the nuclear translocation of p65 and beta-catenin, as well as promoter activity of [TF] and TCF/LEF transcription factors.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1147	953	0.0011467377640163	Non valid	0.011877493232644136;0.98616120611058;0.0019613006567758455	ACTIVATION	32627006	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
2447	PMID:23300960:pubtator_title_and_abstract:47113b521d728bf791919b00e2ee66b9:5:JAK2:NF-kappaB:504:645	Similar to [TF] kinase inhibitors, QM56 inhibited Tweak-induced NF-kappaB transcriptional activity and chemokine expression, despite failing to inhibit [TG]-p65 nuclear translocation and NF-kappaB DNA binding.	JAK2	NF-kappaB	16452	18033	504	645	0.0011221520072624	Non valid	0.029661679406624314;0.9677983586743858;0.002539961918989867	ACTIVATION	23300960	Jak2	10090	Nfkb1	10090	coTF		NFKB
2509	PMID:26401561:pubtator_title_and_abstract:1a397f6d2e34df3f8effa7d4d9da26b7:6:NEMO:NF-kappaB:707:890	It has been shown that peptides corresponding to the NF-kappaB essential modifier ([TF])-binding domain (NBD) of IkappaB kinase alpha (IKKalpha) or IkappaB kinase beta (IKKbeta) specifically inhibit the induction of NF-kappaB activation without inhibiting the basal [TG] activity.	NEMO	NF-kappaB	16151	18033	707	890	0.0011459815536961	Non valid	0.008641460494437177;0.9856786960302738;0.005679843475289007	ACTIVATION	26401561	Ikbkg	10090	Nfkb1	10090	coTF		NFKB
2675	PMID:21188975:pubtator_title_and_abstract:e7b4c960d48bae520d004f6021102f21:8:IkappaB-alpha:NF-kappaB:1205:1319	The results showed that exposure of human melanoma cells to 1 inhibited [TF] degradation and constitutive NF-kappaB DNA-binding activity as well as the expression, regulated by [TG], of two antiapoptotic genes, XIAP and c-FLIP.	IkappaB-alpha	NF-kappaB	4792	4790	1205	1319	0.0011856217177369	Non valid	0.965757644466952;0.02770169160659639;0.0065406639264515894	UNDEFINED	21188975	NFKBIA	9606	NFKB1	9606	coTF		NFKB
2791	PMID:33827262:pubtator_title_and_abstract:3f2ec6ad36a1bfc24c5c2eb6d767084c:9:NF-kappaB p65:nuclear factor-kappaB:1433:1317	Moreover, AOPPs markedly activated the phosphorylation of [TG] (NF-kappaB) p65 protein, which triggered inhibitory kappa B-alpha (IkappaBalpha) degradation, [TF] protein phosphorylation, and NF-kappaB p65 translocation into the nucleus.	NF-kappaB p65	nuclear factor-kappaB	5970	4790	1433	1317	0.0011512183344048	Non valid	0.040691936095576094;0.9577276618707891;0.0015804020336348816	ACTIVATION	33827262	RELA	9606	NFKB1	9606	dbTF		NFKB
2838	PMID:16159934:pubtator_title_and_abstract:36b190dbf1bb2e4d4bcf119102bb4068:2:nuclear factor-kappaB:NF-kappaB:165:188	CONTEXT: The [TF] ([TG]) pathway is a critical mediator of RANTES (regulated on activation, normal T cell expressed and secreted) gene regulation and therefore represents a potential target for therapy of endometriosis-associated symptoms.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	165	188	0.001088286179241	Non valid	0.9959287613633572;0.0033267156742992406;0.0007445229623436279	UNDEFINED	16159934	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
2956	PMID:26463447:pubtator_title_and_abstract:73924f2e961332aab8266033cdd2a2b0:6:NF-kappaB:NF-kappaB:1247:1091	We found that inducible phosphorylation of RelA is accomplished in an IKK-complex-dependent manner within the [TG]/RelA-IkappaBalpha-complex contemporaneous with the phosphorylation of IkappaBalpha, and that RelA phosphorylation is not sufficient to dissociate [TF]/RelA from IkappaBalpha.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1247	1091	0.001110771300967	Non valid	0.9748610665987046;0.01335391317688908;0.011785020224406225	UNDEFINED	26463447	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
3030	PMID:35418179:pubtator_title_and_abstract:ec1e250db1dc8bf63d52ce0380144b9c:12:TGF-beta:NF-kappaB:1371:1396	In summary, our findings indicated that the [TF]/CLDN4/TNF-alpha/[TG] signal axis plays a key role in the biological progression of glioma.	TGF-beta	NF-kappaB	7040	4790	1371	1396	0.0011096475981173	Non valid	0.973586507509796;0.025453540365526446;0.0009599521246775016	UNDEFINED	35418179	TGFB1	9606	NFKB1	9606	ll_coTF		NFKB
3036	PMID:23566884:pubtator_title_and_abstract:8f52c893f073cac6bb9a3eb0cd5d0157:10:nuclear factor kappa B:NF-kappaB:1236:1260	In addition, tomatidine significantly decreases the nuclear level of [TF] ([TG]), which suggests that tomatidine inhibits NF-kappaB activity.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	4790	1236	1260	0.0011950205316729	Non valid	0.015894011032980583;0.9794399510388944;0.004666037928124991	ACTIVATION	23566884	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
3093	PMID:25394713:pubtator_title_and_abstract:4ad710ce903923afcbffd825dab6c9cf:5:HIF-1alpha:nuclear factor-kappaB:860:660	Elevated GAPDH expression was found to promote [TG] (NF-kappaB) activation via binding to tumor necrosis factor receptor-associated factor-2 (TRAF2), enhancing the transcription and the activity of hypoxia-inducing factor-1alpha ([TF]).	HIF-1alpha	nuclear factor-kappaB	3091	4790	860	660	0.0012135783742922	Non valid	0.007135754639696772;0.9917368232761261;0.0011274220841771111	ACTIVATION	25394713	HIF1A	9606	NFKB1	9606	dbTF		NFKB
3152	PMID:19686049:pubtator_title_and_abstract:ee61f7beb378627076dfc36dd070a035:0:NOTCH1:NF-kappaB:20:28	Increased levels of [TF], [TG], and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells.	NOTCH1	NF-kappaB	4851	4790	20	28	0.0011981178599754	Non valid	0.265970022074567;0.7290617355535536;0.004968242371879424	ACTIVATION	19686049	NOTCH1	9606	NFKB1	9606	dbTF		NFKB
3196	PMID:35372108:pubtator_title_and_abstract:7b25718d766b2eef61986fcbc51202b5:10:MyD88:NF-kappaB:1580:1586	Conclusion: We concluded that TLR2 regulates M. pneumoniae-mediated lung inflammation and TNF-alpha release through the TLR2-[TF]-[TG] signaling pathway.	MyD88	NF-kappaB	17874	18033	1580	1586	0.0010649071271126	Non valid	0.9934384294710584;0.005261529552412046;0.0013000409765295028	UNDEFINED	35372108	Myd88	10090	Nfkb1	10090	coTF		NFKB
3202	PMID:23146919:pubtator_title_and_abstract:409771f535e1059f35f201a7354b4428:7:AKT:NFkappaB:699:704	The proliferation, apoptosis, cytokines, and activities of [TF], [TG], and caspases 3, 8, and 9 of T cells were determined.	AKT	NFkappaB	11651	18033	699	704	0.0011698030123745	Non valid	0.6979122698990462;0.28840114797046;0.013686582130493785	UNDEFINED	23146919	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
3240	PMID:25839117:pubtator_title_and_abstract:2eb45b1cbcba4109cd1276624f0c9728:13:p65:NF-kappaB:2242:2301	The effects of the isolated compounds, Sen, Int, N-oxide senecionine and DCQs, were also analyzed for their ability to inhibit [TF] phosphorylation (p-p65) in the nuclear factor-kappa B ([TG]) pathway in the lung tissue.	p65	NF-kappaB	19697	18033	2242	2301	0.0012962312213637	Non valid	0.34098301797790836;0.6101786294422004;0.048838352579891144	ACTIVATION	25839117	Rela	10090	Nfkb1	10090	dbTF		NFKB
3355	PMID:38043934:pubtator_title_and_abstract:d05504469501b338302ea83fa8b42b90:12:TRAF6:NF-kappaB:1437:1444	In addition, acacetin down-regulated the expression [TF], [TG], and Cyclooxygenase-2 (COX2) by western blot.	TRAF6	NF-kappaB	22034	18033	1437	1444	0.0013957940431031	Non valid	0.05239078194417444;0.9261405809410627;0.02146863711476292	ACTIVATION	38043934	Traf6	10090	Nfkb1	10090	coTF		NFKB
3388	PMID:37000125:pubtator_title_and_abstract:8aff455214e13aad7f1740cb48f89c22:10:Akt:NF-kappaB:1579:1567	Results: In vitro, LiCl exerted no obvious toxic effects on microglia and significantly decreased proinflammatory factor (inducible nitric oxide synthase, tumor necrosis factor alpha, interleukin 6) production, inhibited microglial activation in morphology, and suppressed nuclear factor kappa B ([TG]), [TF], and phosphatidylinositol 3-kinase (PI3K) phosphorylation.	Akt	NF-kappaB	11651	18033	1579	1567	0.0011315488232701	Non valid	0.02009840003139046;0.9764588880197116;0.0034427119488979526	ACTIVATION	37000125	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
3397	PMID:35432559:pubtator_title_and_abstract:9c4609e1eb34ee5073f8124df58e8dce:13:TRAF6:NF-kappaB:1483:1560	Western blot results showed that the expression of protein [TF], p-p38, p-ERK, p-p65, and NFATc1 decreased in the MAPK pathway and the [TG] pathway affected by AEO.	TRAF6	NF-kappaB	22034	18033	1483	1560	0.0012941837437956	Non valid	0.9207287384936162;0.06167931434040173;0.017591947165982044	UNDEFINED	35432559	Traf6	10090	Nfkb1	10090	coTF		NFKB
3405	PMID:34220318:pubtator_title_and_abstract:20949c20405e9a32667648ecf2c6e2ff:8:cyclinD1:NF-kappaB:1211:1303	The mechanism may be associated with down-regulated p-IkappaB-alpha and [TF] expression and up-regulated IkappaB-alpha expression in the nuclear factor-kappaB ([TG]) pathway.	cyclinD1	NF-kappaB	595	4790	1211	1303	0.0011376965852208	Non valid	0.1968829855580331;0.2174515476734402;0.5856654667685267	REPRESSION	34220318	CCND1	9606	NFKB1	9606	coTF		NFKB
3503	PMID:33972147:pubtator_title_and_abstract:2e913f7fb6906427cbe61c909f4025da:11:NF-kappaB:NF-kappaB:1723:2149	The hesperidin/naringin hydrogel suppressed [TF] and COX-2 expression on days 6 and 12. CONCLUSIONS: Application of 5% hesperidin hydrogel was more effective than 5% naringin or combination of hesperidin and naringin gels (1:1, 2:1 or 1:2) indicated by a greater wound contraction, reduced mean wound healing time, elevated collagen and DNA syntheses, rise in glutathione concentration, and superoxide dismutase activity followed by reduced lipid peroxidation, and [TG], and COX-2 expression.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1723	2149	0.0020168628593719	Non valid	0.033037909057981284;0.6563339246977968;0.31062816624422196	ACTIVATION	33972147	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
3532	PMID:10187771:pubtator_title_and_abstract:c86deaad9bcaccc00199eca9fa8b68bb:7:JNK:NF-kappaB:1175:1250	c-CARMEN or truncated versions thereof do not appear to induce [TF] and NF-kappaB activation by themselves, nor do they affect the JNK and [TG] activating potential of v-CARMEN.	JNK	NF-kappaB	5599	4790	1175	1250	0.0024406698096659	Non valid	0.0789100583793004;0.9174972434189542;0.0035926982017453132	ACTIVATION	10187771	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
3729	PMID:22419549:pubtator_title_and_abstract:90f62b32242434f38c37ced1b067ef1a:2:NF-kappaB:nuclear factor-kappaB:139:116	The [TG] ([TF]) is a DNA sequence-specific regulator of many important biological processes, whose activity is modulated by enzymatic acetylation.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	139	116	0.0011901760920087	Non valid	0.9823373860729446;0.015501476965636404;0.002161136961418974	UNDEFINED	22419549	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
3758	PMID:23806004:pubtator_title_and_abstract:b8a828961f0c60ca32c23f887093e13d:12:AP-1:NF-kappaB.:2028:2033	Treatment with CSP-AU1 also induced phosphorylation of a number of MAPKs in human PBMC and activated [TF]/[TG] In vivo treatment of mice with CSP-AU1 and CSP-NU1 resulted in increased serum IL-6, IL-10, TNF, monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1alpha/CCL3, and MIP-1beta/CCL4.	AP-1	NF-kappaB.	3726	4790	2028	2033	0.002971493724431	Non valid	0.07778730181429777;0.9115878020986014;0.010624896087100995	ACTIVATION	23806004	JUNB	9606	NFKB1	9606	dbTF		NFKB
3776	PMID:32982435:pubtator_title_and_abstract:03f8d522304d17894e154c18bfe9912b:8:NLRP3:NF-kappaB.:1266:1188	In addition, ursolic acid inhibited the LPS-induced activation of [TG] Furthermore, the NF-kappaB pathway regulated the activation of the [TF] inflammasome.	NLRP3	NF-kappaB.	114548	4790	1266	1188	0.0023379465007506	Non valid	0.34171247588846543;0.6459766788834193;0.012310845228115345	ACTIVATION	32982435	NLRP3	9606	NFKB1	9606	coTF		NFKB
3876	PMID:29142418:pubtator_title_and_abstract:4a49b3f5964844dae83e5c1c26c4f517:19:NLRP3:NF-kappaB:3202:3143	pumila, MSU: Monosodium urate, MTT: Methylthiazole tetrazolium, [TG]: Nuclear factor-kappa B, NLR: NOD-like receptor, [TF]: NLR family pyrin domain containing protein 3, NO: Nitric oxide, NOD: Nucleotide-binding oligomerization domain, NSAID: Nonsteroidal anti-inflammatory drug, PAMP: Pathogen-associated molecular pattern, PBMC: Peripheral blood mononuclear cell, PBS: Phosphate buffered saline, PGE2: Prostaglandin E2, PMACI: Phorbol-12-myristate 13-acetate and calcium ionosphere A23187, PRR: Pathogen recognition receptor, PTFE: Polytetrafluoroethylene, RIA: Radioimmunoassay, RIG: Retinoic acid-inducible gene I, RLR: RIG I-like receptor, RP-HPLC: Reversed-phase high-performance liquid chromatography, RPMI-1640: Roswell Park Memorial Institute-1640, TLR: Toll-like receptor, TNF: Tumor necrosis factor, VCAM: Vascular cell adhesion molecule.	NLRP3	NF-kappaB	114548	4790	3202	3143	0.0011431685747148	Non valid	0.8018802655392515;0.18164610795136257;0.016473626509385938	UNDEFINED	29142418	NLRP3	9606	NFKB1	9606	coTF		NFKB
3949	PMID:29699604:pubtator_title_and_abstract:b6eb93024c56c89338ce33584a8ad52c:8:AP-1:NF-kappaB:1018:1003	Furthermore, hindsiipropane B inhibited HIV-1 Tat-mediated signaling cascades including MAPK, [TG], and [TF].	AP-1	NF-kappaB	3727	4790	1018	1003	0.0012288936706423	Non valid	0.034666511222188424;0.9638435975232923;0.001489891254519333	ACTIVATION	29699604	JUND	9606	NFKB1	9606	dbTF		NFKB
3974	PMID:32038638:pubtator_title_and_abstract:fe800d8ddb49b288244a7a5d82640337:7:NF-kappaB:NF-kappaB.:1109:1041	Here, we systematically depleted all predicted substrate adaptors for the CRL5 family (the so-called SOCS-box proteins) and assessed the impact on the activation of the inflammatory transcription factor [TG] Depletion of SPSB1 resulted in a significant increase in [TF] activation, indicating the importance of SPSB1 as an NF-kappaB negative regulator.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	1109	1041	0.0012159220164268	Non valid	0.004171795467668452;0.011231327920524285;0.9845968766118072	REPRESSION	32038638	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
4187	PMID:34676048:pubtator_title_and_abstract:76d9ea9930d2502459d77c0217a9a84c:3:Transforming growth factor-beta activated kinase 1:nuclear factor kappa-light-chain-enhancer of activated B cells:195:285	[TF] (MAP3K7, TAK1) is a major regulator of [TG] (NF-kappaB) and mitogen-activated protein kinase (MAPK) signaling.	Transforming growth factor-beta activated kinase 1	nuclear factor kappa-light-chain-enhancer of activated B cells	6885	4790	195	285	0.0089504005497359	Non valid	0.9830210015869345;0.015956596363679864;0.0010224020493857387	UNDEFINED	34676048	MAP3K7	9606	NFKB1	9606	ll_coTF		NFKB
4226	PMID:31189689:pubtator_title_and_abstract:f5418c74e2dbca6e0921733800bfb6ab:0:RhoA:NF-kappaB:101:106	Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through [TF]-[TG].	RhoA	NF-kappaB	11848	18033	101	106	0.0025128412084745	Non valid	0.9727882552293268;0.017565739271143493;0.009646005499529707	UNDEFINED	31189689	Rhoa	10090	Nfkb1	10090	ll_coTF		NFKB
4270	PMID:27011900:pubtator_title_and_abstract:7a51df42c4d7c0aeacb243534d59d513:8:STAT3:nuclear factor kappa B:1193:1102	In addition, it activates [TG] (NF-kappaB) and signal transducer and activator of transcription 3 ([TF]), two transcriptional regulators that serve as master switches in inflammation and carcinogenesis.	STAT3	nuclear factor kappa B	6774	4790	1193	1102	0.0012091997265362	Non valid	0.009367374406021312;0.9893159098495619;0.0013167157444169209	ACTIVATION	27011900	STAT3	9606	NFKB1	9606	dbTF		NFKB
4359	PMID:23606689:pubtator_title_and_abstract:432d4d20270b9ca9f25a76251c68cb0f:6:NF-kappaB:NF-kappaB:1280:1410	Simultaneous molecular imaging of the temporal change of [TF] activity and of viable cells in the same Huh7/NF-kappaB-tk-luc2/rfp tumors of the animal may reflect the real status of [TG] activity and the viable tumor cells at the time of imaging.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1280	1410	0.0012761324051554	Non valid	0.9795680218525047;0.016557154808020676;0.0038748233394746375	UNDEFINED	23606689	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
4474	PMID:29410396:pubtator_title_and_abstract:8aef326c1da81948ed2d573caa6d381b:5:p65:NF-kappaB:734:724	In this study, we validated that Notch1 and [TG]([TF]) are highly expressed in the classical and proneural subtypes of GBM using the data set from The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA).	p65	NF-kappaB	5970	4790	734	724	0.0014291998566452	Non valid	0.3888472196621129;0.6066621885717063;0.004490591766180875	ACTIVATION	29410396	RELA	9606	NFKB1	9606	dbTF		NFKB
4500	PMID:10397459:pubtator_title_and_abstract:b902edae791e98968fe78daa68f79063:3:IkappaB-alpha:NF-kappaB:652:699	This result was consistent with the findings that PMA-stimulated activities of NF-kappaB were markedly increased in the NF-kappaB subunit-transfected cells in comparison with their parental cells and PMA-induced differentiation was enhanced by pretreatment with [TF] antisense oligonucleotide in the [TG] subunit-transfected cells.	IkappaB-alpha	NF-kappaB	4792	4790	652	699	0.0015153270686638	Non valid	0.03823031581474172;0.08385620331253701;0.8779134808727214	REPRESSION	10397459	NFKBIA	9606	NFKB1	9606	coTF		NFKB
4612	PMID:20693316:pubtator_title_and_abstract:f2b59529df60f005e4bd8ccd661329bd:11:c-Jun:NF-kappaB:1168:1125	Nuclear [TG] (p50 subunit) and phosphorylated [TF] were comparable in cells from both groups, although nuclear c-Fos (part of the AP-1 complex) levels were lower in ASMA than ASMNA cells.	c-Jun	NF-kappaB	3725	4790	1168	1125	0.0011671486834577	Non valid	0.9799030600514143;0.012967931072095578;0.007129008876490127	UNDEFINED	20693316	JUN	9606	NFKB1	9606	dbTF		NFKB
4625	PMID:29487338:pubtator_title_and_abstract:ea0a120843405be6c57418cae078240c:5:STAT3:NF-kappaB:619:648	SMYD2 executes this activity via methylation and activation of its novel non-histone substrates, including [TF] and the p65 subunit of [TG], leading to increased TNBC cell proliferation and survival.	STAT3	NF-kappaB	6774	4790	619	648	0.0012186537573441	Non valid	0.19836533223624175;0.797424262927132;0.004210404836626364	ACTIVATION	29487338	STAT3	9606	NFKB1	9606	dbTF		NFKB
4762	PMID:15121507:pubtator_title_and_abstract:2f8a4ad629107c4cd33e2d266b1954d0:13:nuclear factor-kappa-B:NF-kappa-B:1788:1812	californicus and trichodermin together was studied by analyzing for the presence of [TF] ([TG]) in nuclear extracts of the exposed cells.	nuclear factor-kappa-B	NF-kappa-B	Complex:NFKB	18033	1788	1812	0.0011713459488213	Non valid	0.9891197252978594;0.00903378507443417;0.0018464896277065167	UNDEFINED	15121507	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
4955	PMID:24681962:pubtator_title_and_abstract:9f201e85ed70f653cfaaf657190dfe21:9:nuclear factor kappa-light-chain-enhancer of activated B cells:NF-kappaB:1187:1320	[TF] (NF-kappaB) was the major activator of C7ORF41 that in turn repressed [TG] activity by inhibiting its phosphorylation at serine 536, while MAPK/ERK was the potent repressor of C7ORF41.	nuclear factor kappa-light-chain-enhancer of activated B cells	NF-kappaB	Complex:NFKB	4790	1187	1320	0.0159123659713475	Non valid	0.012304712544433957;0.0718483719403105;0.9158469155152555	REPRESSION	24681962	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
4990	PMID:27863449:pubtator_title_and_abstract:d36b239c12ec5bcd82ee345c24990619:8:NFkappaB:nuclear factor kappa B:1376:1352	IL6 beta2SP+/- LSCs not only exhibited nuclear localization of Twist and Slug, markers of epithelial-mesenchymal transition (EMT), but also constitutive activation of [TG] ([TF]; RELA).	NFkappaB	nuclear factor kappa B	Complex:NFKB	18033	1376	1352	0.0013335420507788	Non valid	0.003997490072304639;0.9944932554541601;0.0015092544735353483	ACTIVATION	27863449	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
5002	PMID:12237297:pubtator_title_and_abstract:4707b9fb117448b4bda393bfc7f47a7e:13:p38:NF-kappaB:2017:2125	Therefore, these studies indicate that [TF] stimulates COX-2 expression in cTALH and macula densa by transcriptional regulation predominantly via a [TG]-dependent pathway and by post-transcriptional increases in mRNA stability.	p38	NF-kappaB	1432	4790	2017	2125	0.001133846015335	Non valid	0.002665733247191917;0.9964003092007339;0.0009339575520743099	ACTIVATION	12237297	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
5008	PMID:36138855:pubtator_title_and_abstract:cb2281d32027ed01502a5c2e50f08f35:5:nuclear factor kappa B:NF-kappaB:753:777	The astrocytic CD24 expression was determined by quantitative real-time polymerase chain reaction (qPCR), Western blot analysis and immunofluorescence, [TF] ([TG]) binding activity was detected by electrophoretic mobility shift assay (EMSA), and the proinflammatory factors, tumor necrosis factor-alpha (TNF-alpha), and interleukin 1beta (IL-1beta), were measured by qPCR.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	4790	753	777	0.0010957533801744	Non valid	0.9949342490925889;0.004334295161815314;0.0007314557455957619	UNDEFINED	36138855	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
5137	PMID:37127183:pubtator_title_and_abstract:34a401a1a215e36435bab8daa10e9de4:10:NRF-2:NFKB:1670:1677	The combination therapy up-regulated the [TF], [TG], and acetylcholine esterase gene expression.	NRF-2	NFKB	83619	81736	1670	1677	0.0014161417159191	Non valid	0.004009328748482949;0.9897312082155484;0.006259463035968655	ACTIVATION	37127183	Nfe2l2	10116	Nfkb1	10116	dbTF		NFKB
5164	PMID:16740746:pubtator_title_and_abstract:6f38eb26477475b1ef1434bbf0985b49:9:NFkappaB:NFkappaB:1896:1860	In marked contrast, host response tumors, which have up-regulation of multiple [TG] target genes and increased [TF] activity, express significantly higher levels of cFLIP(long).	NFkappaB	NFkappaB	Complex:NFKB	4790	1896	1860	0.0012978733247952	Non valid	0.9454930246495172;0.05118092007192673;0.0033260552785560884	UNDEFINED	16740746	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
5246	PMID:27009840:pubtator_title_and_abstract:88457b742b130cda1f4b1f56423a5619:4:TAK1:NF-kappaB:692:747	In this study, we have determined that the TAK1 binding protein 3 (TAB3) was O-GlcNAcylated at Ser408 by OGT in the TNBC, which was required for its Thr404 phosphorylation, [TF] activation and downstream nuclear factor kappa B ([TG]) activation in TNBC.	TAK1	NF-kappaB	6885	4790	692	747	0.0735247047448864	Non valid	0.009905074478338658;0.9888883377360765;0.0012065877855847716	ACTIVATION	27009840	MAP3K7	9606	NFKB1	9606	ll_coTF		NFKB
5373	PMID:33382900:pubtator_title_and_abstract:44b563bf165df1c2cab9a2f917eb467c:7:interferon regulatory factor-7:NFkappaB:1287:1330	RESULTS: We demonstrated the distribution of protein expression and localization associated with the significantly increased androgen receptor, TLR2, and TLR4-mediated activation of [TF] (IRF-7) and [TG] signaling, cytokine production, and endometrial inflammation in PCOS patients compared to non-PCOS patients with and without endometrial hyperplasia.	interferon regulatory factor-7	NFkappaB	3665	4790	1287	1330	0.0011388304887967	Non valid	0.11468112821110381;0.8826818343722216;0.002637037416674614	ACTIVATION	33382900	IRF7	9606	NFKB1	9606	dbTF		NFKB
5405	PMID:34341712:pubtator_title_and_abstract:b62e4789aa41eae91dc4cbd6bc2992ff:9:Nrf2:NF-kappaB:1433:1413	[TG] and Keap1/[TF] are the main molecular targets on which a list of nutraceuticals can modulate the altered processes.	Nrf2	NF-kappaB	4780	4790	1433	1413	0.0015970933437732	Non valid	0.9948600521480465;0.003146329885111101;0.0019936179668423684	UNDEFINED	34341712	NFE2L2	9606	NFKB1	9606	dbTF		NFKB
5512	PMID:21459945:pubtator_title_and_abstract:c063bab8d66d633b7734e54c66eb3f38:5:NF-kappaB:nuclear factor-kappaB:856:833	METHODS: We investigated mechanisms downregulating the TNF-induced inflammatory response such as (1) receptor shedding, producing a secreted form acting as a TNF inhibitor; (2) receptor internalization with subsequent induction of apoptosis; and (3) negative regulation of [TG] ([TF]) transcription.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	856	833	0.0015249700717138	Non valid	0.004493454478750156;0.024411551591258546;0.9710949939299913	REPRESSION	21459945	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
5516	PMID:32934775:pubtator_title_and_abstract:df2bdfb1929149be5ca67fe62b33d37e:6:NF-kappaB:NF-kappaB:1438:1248	We thus provide novel evidence that topical administration of a pharmacological [TG] inhibitor, either before or after acidic bile exposure can successfully prevent its oncogenic mRNA and miRNA phenotypes in HM, supporting the observation that co-administration of [TF] inhibitor may not be essential in preventing early bile-related oncogenic events and encouraging a capacity for further translational exploration.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1438	1248	0.0011073846092148	Non valid	0.04309577258356974;0.8706321463047463;0.08627208111168402	ACTIVATION	32934775	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
5556	PMID:37235964:pubtator_title_and_abstract:bd8376d3dbe224a559c543f370fb79f9:11:AKT:NFkappaB:1789:1802	Moreover, the protection of fucoxanthin on endothelial cell pyroptosis was abrogated when PI3K/AKT was inhibited or TLR4 was overexpressed, which further suggested the anti-pyroptosis effect of fucoxanthin was mediated through regulations of PI3K/[TF] and TLR4/[TG] signaling.	AKT	NFkappaB	11651	18033	1789	1802	0.0011590663257009	Non valid	0.9725883717477217;0.025111954706103147;0.0022996735461751723	UNDEFINED	37235964	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
5670	PMID:35886440:pubtator_title_and_abstract:fdd01066332b9ff967726a81960e3d5c:3:Nuclear Factor Kappa B:NF-kappaB:524:548	The pro-inflammatory potential of Polycyclic Aromatic Hydrocarbons (PAHs) as potential inducers of inflammation bound to the Toll-like Receptor 4 (TLR4) and the anti-inflammatory capacity of A. paniculata (AP) phytocompounds as prospective inhibitors of the [TF] ([TG]) p50 transcription factor are investigated via in silico techniques.	Nuclear Factor Kappa B	NF-kappaB	Complex:NFKB	4790	524	548	0.0011508301950743	Non valid	0.6420484889094648;0.31732220327766203;0.040629307812873196	UNDEFINED	35886440	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
5694	PMID:15814628:pubtator_title_and_abstract:f8d3f79f98219ab5eee39804d2433e62:3:RelA:NF-kappaB:423:413	EXPERIMENTAL DESIGN: Immunohistochemistry for [TG]/[TF] was done on 290 human gastric carcinoma specimens placed on tissue array slides.	RelA	NF-kappaB	5970	4790	423	413	0.0011782572551609	Non valid	0.9801144339554446;0.015953041726903157;0.003932524317652298	UNDEFINED	15814628	RELA	9606	NFKB1	9606	dbTF		NFKB
5745	PMID:35281910:pubtator_title_and_abstract:d0cea8253d1d022e21fee49709c7428b:5:Myd88:NF-kappaB:972:921	Further, the in vivo results indicated that EcN-MT strain could reduce 26.3% Cd in the liver and increase 24.7% Cd in the feces, which greatly decreased malondialdehyde (MDA) levels and increased catalase (CAT), glutathione (GSH), and superoxide dismutase (SOD) levels in liver, and reduced the expression of toll-like receptor4 (TLR4), nuclear factor-kappaB ([TG]), the myeloid differentiation factor 88 ([TF]) andincreased B-cell lymphoma 2 (Bcl-2)/Bcl-2-Associated X (Bax).	Myd88	NF-kappaB	17874	18033	972	921	0.0011865964699717	Non valid	0.07796754597557494;0.6023043328542373;0.31972812117018773	ACTIVATION	35281910	Myd88	10090	Nfkb1	10090	coTF		NFKB
5830	PMID:36733419:pubtator_title_and_abstract:98887ee82300048ef27a3a094273d079:6:ERK:NF-kappaB:1058:1118	Western blot analysis showed that the significant inhibition of phosphorylation of IkappaB and P65 and P38, [TF] and JNK suggested that the effects were exerted through [TG] pathway and MAPK pathway.	ERK	NF-kappaB	26413	18033	1058	1118	0.0010967217142668	Non valid	0.04933803906576841;0.07400246804575523;0.8766594928884764	REPRESSION	36733419	Mapk1	10090	Nfkb1	10090	ll_coTF		NFKB
5939	PMID:25542736:pubtator_title_and_abstract:5a55e6efcae1a0bbc7adfcc1d7428467:4:MyD88:NF-kappaB:989:1069	Wild-type male Balb/c mice and matched genetically-deficient TLR2, TLR4, and [TF] strains were utilized, together with pharmacological manipulation of MOR, [TG], TLR4 and Interleukin-1beta.	MyD88	NF-kappaB	17874	18033	989	1069	0.0011672707077487	Non valid	0.9502357911208025;0.04073164388600987;0.009032564993187669	UNDEFINED	25542736	Myd88	10090	Nfkb1	10090	coTF		NFKB
5979	PMID:19136257:pubtator_title_and_abstract:83a9d5349dd6127c58cf21d8cbf73ec2:3:IKKbeta:NF-kappaB:337:294	These studies suggested a noncanonical [TG] signaling pathway independent of [TF] in HUVEC cells.	IKKbeta	NF-kappaB	3551	4790	337	294	0.0011145507626536	Non valid	0.8292315546135544;0.16650876812911916;0.004259677257326395	UNDEFINED	19136257	IKBKB	9606	NFKB1	9606	coTF		NFKB
5996	PMID:31885716:pubtator_title_and_abstract:47a858767e5e01a7134da25e2426dc88:8:AKT:NF-kappaB:1133:1146	In addition, the results demonstrated that the regulatory effects of NRSN2 on breast cancer cells were associated with PI3K/[TF]/mTOR and [TG] signaling pathway dysregulation.	AKT	NF-kappaB	11651	18033	1133	1146	0.0011154961059386	Non valid	0.994824074894422;0.003575898129956529;0.0016000269756214012	UNDEFINED	31885716	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
6003	PMID:34463194:pubtator_title_and_abstract:d8abdf5b4bf944826633e905d0364915:0:IKKbeta:NF-kappaB:65:24	miRNA-451 regulates the [TG] signaling pathway by targeting [TF] to inhibit glioma cell growth.	IKKbeta	NF-kappaB	16150	18033	65	24	0.0020053477715992	Non valid	0.924165306252494;0.06714209928091626;0.008692594466589643	UNDEFINED	34463194	Ikbkb	10090	Nfkb1	10090	coTF		NFKB
6006	PMID:29551587:pubtator_title_and_abstract:ae033f464bbaa46691b3326d76d6ecf9:11:p62:nuclear factor kappa B:1428:1453	CAN-induced increase in [TF] was dependent on the [TG] (NFkappaB) signaling pathway.	p62	nuclear factor kappa B	8878	18033	1428	1453	0.001273436927442	Non valid	0.003915305124309889;0.9946527140419604;0.0014319808337297493	ACTIVATION	29551587	SQSTM1	9606	Nfkb1	10090	coTF		NFKB
6067	PMID:37954847:pubtator_title_and_abstract:525a6029918bf8f61b541fc676235f3a:13:NLRP3:NF-kappaB:2346:2336	Specifically, ECS reduced the expression of inflammatory factors in the hippocampus, inhibited M1 microglial cell polarization, and alleviated depression through the regulation of the [TG]-[TF] inflammation pathway.| Conclusion: Based on experimental and network analysis, this study revealed for the first time that ECS exerted antidepression effect via anti-neuroinflammation.	NLRP3	NF-kappaB	216799	18033	2346	2336	0.0010838427216432	Non valid	0.9760889692543968;0.016885758085242904;0.00702527266036027	UNDEFINED	37954847	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
6125	PMID:8655581:pubtator_title_and_abstract:5af7b328984a02fb4cc120b60f50e110:5:p65:NF-kappa B:796:775	The cellular contents of the two [TG] subunits ([TF] and p50) and of the inhibitory subunit I kappa B-alpha were unaffected by GSHPx overexpression, suggesting that increased GSHPx activity interfered with the activation, but not the synthesis or stability, of Nf-kappa B. Nuclear translocation of NF-kappa B as well as I kappa B-alpha degradation were inhabited in GSHPx-overexpressing cells exposed to oxidative stress.	p65	NF-kappa B	5970	4790	796	775	0.0012355546527943	Non valid	0.06067247330105627;0.935701149335496;0.0036263773634477906	ACTIVATION	8655581	RELA	9606	NFKB1	9606	dbTF		NFKB
6352	PMID:23521863:pubtator_title_and_abstract:3e906ce63a9e744c15dac8ec48e4c4bf:4:IKKalpha/beta:NF-kappaB.:698:558	Bioinformatic analysis of genes downregulated by metformin suggests that the drug blocks the activity of the transcription factor [TG] In agreement, metformin prevented the translocation of NF-kappaB to the nucleus and inhibited the phosphorylation of IkappaB and [TF], events required for activation of the NF-kappaB pathway.	IKKalpha/beta	NF-kappaB.	1147;3551	4790	698	558	0.0012717472687479	Non valid	0.009858835497640953;0.9890330537338317;0.001108110768527359	ACTIVATION	23521863	CHUK;IKBKB	9606;9606	NFKB1	9606	coTF;coTF		NFKB
6359	PMID:23585913:pubtator_title_and_abstract:582af899fd069678d424fdf6698bd448:6:CD274:NF-kappaB:757:883	Firstly, [TF] expression levels in human primary monocytes after lipopolysaccharide (LPS) treatment were observed and correlated with [TG] activation.	CD274	NF-kappaB	29126	4790	757	883	0.0012021698319136	Non valid	0.8222580364678022;0.17291536153117087;0.004826602001026966	UNDEFINED	23585913	CD274	9606	NFKB1	9606	ll_coTF		NFKB
6367	PMID:15146413:pubtator_title_and_abstract:e89d352542f9c7345c823de83f8ecb38:10:AP-1:NF-kappaB:1431:1458	The mRNA up-regulation of IL-8 and IL-1beta by MIF was inhibited by 2 tyrosine kinase inhibitors, a protein kinase C (PKC) inhibitor, an activator protein 1 ([TF]) inhibitor, and by an [TG] inhibitor.	AP-1	NF-kappaB	3726	4790	1431	1458	0.0011360017667385	Non valid	0.0021444919797101378;0.9919348564611395;0.005920651559150325	ACTIVATION	15146413	JUNB	9606	NFKB1	9606	dbTF		NFKB
6443	PMID:36720498:pubtator_title_and_abstract:167740f40e2631cc4319bd0334af37c2:6:NEMO:NF-kappaB:897:1114	Supporting the functional relevance of [TF] phase separation in signaling, a pathogenic NEMO mutant, which is impaired in both binding and linkage to linear ubiquitin chains, does not undergo phase separation and is defective in mediating IL-1beta-induced [TG] activation.	NEMO	NF-kappaB	8517	4790	897	1114	0.0429590700591974	Non valid	0.0038825960512732516;0.9948720823833994;0.0012453215653272758	ACTIVATION	36720498	IKBKG	9606	NFKB1	9606	coTF		NFKB
6566	PMID:33255947:pubtator_title_and_abstract:54f9be420638ce0252684cb3dc245b09:5:NF-kappaB:nuclear factor-kappa B:1059:1035	In vitro experiments demonstrated that LJPS significantly inhibited the generation of nitric oxide (NO) and prostaglandin E2 (PGE2) via the downregulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression and suppressed pro-inflammatory cytokines tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta production via the [TG] ([TF]) and mitogen-activated protein kinase (MAPK) signal pathways in LPS-induced RAW 264.7 cells.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	18033	1059	1035	0.0011000134799659	Non valid	0.1726585198159592;0.5459316269298522;0.2814098532541885	ACTIVATION	33255947	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
6657	PMID:36550750:pubtator_title_and_abstract:40b439ff3a90f6f04c666fc7569309ca:9:NF-kappaB:NF-kappaB:1577:1423	Second, STAT3 and STAT6 affected Bcl-XL transcription by binding to its promoter without disrupting the DNA-binding activity of NF-kappaB. Third, in situ proximity ligation assays (isPLAs) indicated crosstalk between JAK-STAT signalling and NF-kappaB, in which STAT3 inhibited canonical [TG] by accelerating nuclear export, and STAT6 promoted non-canonical NF-kappaB. Finally, NF-kappaB inducing kinase (NIK) inhibition interrupted the [TF]/STAT crosstalk and resensitized CLL cells to venetoclax.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1577	1423	0.0012125090097308	Non valid	0.7777305414202907;0.2146486404585596;0.007620818121149711	UNDEFINED	36550750	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
6675	PMID:28279768:pubtator_title_and_abstract:69812b2c03ec8b04e0ce3c801a6e27bd:7:IkappaBalpha:NF-kappaB:1117:1027	In fact, PAP prevented the activation of TLR/[TG] pathway, by inhibiting the expression of TLR2, TLR4 MyD88, p-NF-kappaBp65 and p-[TF].	IkappaBalpha	NF-kappaB	18035	18033	1117	1027	0.0011640273665191	Non valid	0.002764711225436909;0.9938399411251253;0.003395347649437694	ACTIVATION	28279768	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
6687	PMID:34506597:pubtator_title_and_abstract:39ef6cf958a01d9b7415ae96c1a4e71c:7:NLRP3:nuclear factor kappa B:950:1037	24 hours following the final injury, rmTBI causes an upregulation in mRNA levels of [TF], caspase-1, the apoptosis-associated speck-like protein containing a CARD (ASC), [TG] (NF-kappaB), interleukin-1Beta (IL-1beta), interleukin 18 (IL-18), nuclear factor erythroid 2-related factor 2 (NRF2) and heme oxygenase 1 (HMOX1).	NLRP3	nuclear factor kappa B	216799	18033	950	1037	0.0011892672198422	Non valid	0.008025924337144297;0.988053778792459;0.003920296870396728	ACTIVATION	34506597	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
6787	PMID:32945357:pubtator_title_and_abstract:69e34afbfd29a65697e25ee19ea237a9:7:vascular endothelial growth factor A:NF-kappaB:1022:1228	Western blotting, reverse transcription, quantitative PCR, immunofluorescence and immunohistochemistry were used to detect the expression of the angiogenesis-related factors angiopoietin-2 (Ang2), TEK receptor tyrosine kinase 2 (tie2), [TF] (VEGFA), CD31 and alpha-smooth muscle actin (alpha-SMA) and the Notch/NF-kappaB pathways-related factors NOTCH1 intracellular domain (N1ICD), Notch receptor 3 (Notch3), [TG] and p65 in HUVEC or CLI mice muscle tissues.	vascular endothelial growth factor A	NF-kappaB	22339	18033	1022	1228	0.0011902262588238	Non valid	0.9754030025913735;0.023052534826511203;0.001544462582115247	UNDEFINED	32945357	Vegfa	10090	Nfkb1	10090	ll_coTF		NFKB
6832	PMID:20564628:pubtator_title_and_abstract:713afe5e6b1f874fbbc43e0e0a9f1a05:9:NF-kappaB:NF-kappaB:1425:1383	Coexpression of the [TG] machinery suggested activity of [TF] signaling in these ovarian tumors.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1425	1383	0.0011398797370253	Non valid	0.7280552020390877;0.26980688314260076;0.002137914818311536	UNDEFINED	20564628	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
6862	PMID:30277087:pubtator_title_and_abstract:ecf360d826f4a1ea220998101b464438:9:OSI:NFKB:1208:1213	RESULTS: MDA, TOS, [TF], [TG] and TNF-alpha levels were significantly higher, while TGSH and TAS levels were significantly lower in CG compared with HG (p < 0.001).	OSI	NFKB	113894	81736	1208	1213	0.0012531419339798	Non valid	0.1519688427335185;0.8115258153933511;0.03650534187313044	ACTIVATION	30277087	Sqstm1	10116	Nfkb1	10116	coTF		NFKB
6894	PMID:30396745:pubtator_title_and_abstract:39ce80169956415e76eaa1fd6e294ac1:5:STAT1:NF-kappaB:533:543	[TF] and [TG] also exhibit crosstalk with the aryl hydrocarbon receptor (AHR).	STAT1	NF-kappaB	6772	4790	533	543	0.0011315911319477	Non valid	0.9943830419499516;0.00478261301189724;0.0008343450381510943	UNDEFINED	30396745	STAT1	9606	NFKB1	9606	dbTF		NFKB
6950	PMID:15778123:pubtator_title_and_abstract:5b342ccf4093fd5a18dbe257fe0a7bd5:7:ERK:NF-kappa B:978:852	Treatment with chemical inhibitors of [TG] and p38 mitogen-activated protein kinases (MAPKs) in vitro inhibited LPS-induced IL-12 production, whereas JNK and [TF] inhibitors increased IL-12 production.	ERK	NF-kappa B	26413	18033	978	852	0.0011052151925766	Non valid	0.005340473617551488;0.02829439362771412;0.9663651327547345	REPRESSION	15778123	Mapk1	10090	Nfkb1	10090	ll_coTF		NFKB
6978	PMID:34733352:pubtator_title_and_abstract:27a56067c4ae3abe1da67e607c72ba51:14:AP-1:NF-kappaB:1450:1496	Chromatin immunoprecipitation (ChIP) assays were used to the association between [TF] transcription and nuclear factor-kappaB ([TG]) with COX-2 and cyclin D1 promoters.	AP-1	NF-kappaB	16476	18033	1450	1496	0.001152471084568	Non valid	0.9980938547290027;0.0010770785942822276;0.0008290666767151059	UNDEFINED	34733352	Jun	10090	Nfkb1	10090	dbTF		NFKB
7001	PMID:33961996:pubtator_title_and_abstract:387ec7f205f0d261a773043e33342beb:14:mTOR:NF-kappaB:2188:2208	Moreover, we demonstrated that RC induced obviously apoptotic and autophagic cell death, activated MAPK signaling pathway and inhibited [TF]/Akt/p70S6K and [TG] signaling pathways.	mTOR	NF-kappaB	56717	18033	2188	2208	0.0011326361454603	Non valid	0.020894858127722057;0.9634950307557391;0.015610111116538868	ACTIVATION	33961996	Mtor	10090	Nfkb1	10090	ll_coTF		NFKB
7112	PMID:28515148:pubtator_title_and_abstract:29840622a7dbcf1acea1ab0b4a7b8b58:6:NEMO:NFkappaB:906:957	Accordingly, E+P treatment of breast cancer cells increased ER binding to the [TF] promoter, thereby increasing NEMO expression, [TG] activation, and IL6 secretion.	NEMO	NFkappaB	8517	4790	906	957	0.033249784036435	Non valid	0.01731628242885194;0.9815254025171664;0.0011583150539817898	ACTIVATION	28515148	IKBKG	9606	NFKB1	9606	coTF		NFKB
7220	PMID:23956783:pubtator_title_and_abstract:d6f35da33f6f9bcddaa252f5a91c0b41:12:XIAP:NF kappa B:1480:1447	The rapid NF kappa B activation by S-[6]-gingerol was associated with an increase in mRNA levels of [TG]-target genes: cIAP-2, [TF], and Bcl-2 that encode antiapoptotic proteins.	XIAP	NF kappa B	331	4790	1480	1447	0.0013538857452772	Non valid	0.6277095940289452;0.3687714607229352;0.0035189452481196207	UNDEFINED	23956783	XIAP	9606	NFKB1	9606	coTF		NFKB
7244	PMID:37298614:pubtator_title_and_abstract:18c305286f721a64d93866303c14a7c0:7:myeloid differentiation factor 88:NFkappaB:1351:1463	In addition, ZEA and DON inhibited Lipoteichoic acid (LTA)-induced expression of TLR2 and [TF] (MyD88) in Buffalo Rat Liver (BRL 3A) cells in vitro, downregulating the TLR2/[TG] signaling pathway and resulting in the decreased expression levels of NO, causing immunosuppressive effects.	myeloid differentiation factor 88	NFkappaB	301059	18033	1351	1463	0.0011169313166927	Non valid	0.005661909622468032;0.989429835508441;0.00490825486909087	ACTIVATION	37298614	Myd88	10116	Nfkb1	10090	coTF		NFKB
7299	PMID:22382990:pubtator_title_and_abstract:e3a63af5f75bbe9e8ca982dcc0eda00a:7:p65:NF-kappaB:832:841	DK-139 blocked LPS-induced phosphorylation of IkappaB and [TF]/RelA [TG], resulting in inhibition of the nuclear translocation and trans-acting activity of NF-kappaB in BV2 microglial cells.	p65	NF-kappaB	19697	18033	832	841	0.0011431563239329	Non valid	0.005172869060695541;0.9925945827744459;0.002232548164858522	ACTIVATION	22382990	Rela	10090	Nfkb1	10090	dbTF		NFKB
7432	PMID:22798961:pubtator_title_and_abstract:0aa232a00e9ba45b951bcaeafa872a89:3:AP-1:NF-kappaB:495:484	The signals delivered from T cell receptor (TCR) and CD28 costimulatory molecules trigger PKC-theta catalytic activation and membrane translocation to the immunological synapse, leading to activation of [TG], [TF], and NF-AT.	AP-1	NF-kappaB	3725	4790	495	484	0.0012448747234612	Non valid	0.011672672140729054;0.9869156503846318;0.0014116774746390883	ACTIVATION	22798961	JUN	9606	NFKB1	9606	dbTF		NFKB
7457	PMID:31095741:pubtator_title_and_abstract:639e8f1f074cbf73e00a223ae7e05012:16:p65:NF-kappaB:2240:2170	Downregulation of LPS-induced MCP-1 by LL-37 was not mediated by reduction in [TG] activity as shown by unaltered expression of phosphorylated [TF], phosphorylated p105, and IkappaBalpha NF-kappaB proteins in the presence of LL-37.	p65	NF-kappaB	5970	4790	2240	2170	0.0011903195123573	Non valid	0.2122264717741673;0.7461695341772845;0.04160399404854818	ACTIVATION	31095741	RELA	9606	NFKB1	9606	dbTF		NFKB
7489	PMID:30471562:pubtator_title_and_abstract:66cd3339546e4acbbc876bf8379f3cf2:5:NF-kappaB:NF-kappaB.:1166:862	deltaTE potently inhibited TNF-alpha-induced phosphorylation of transforming growth factor beta-activated kinase 1 (TAK1), an upstream kinase essential for the activation of [TG] Interestingly, deltaTE significantly increased the expression of A20 and to a less extent, cylindromatosis (CYLD), both of which are inhibitors of NF-kappaB. The importance of induction of A20 in deltaTE's anti-NF-kappaB effect is validated in A20 knockout cells where deltaTE's inhibition of [TF] was largely diminished.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	1166	862	0.0013723735912984	Non valid	0.04745499191645812;0.6613030791837676;0.2912419288997743	ACTIVATION	30471562	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
7499	PMID:37258145:pubtator_title_and_abstract:02ecd960dd204eada47795d3cd9b1d96:8:PARP:NF-kappaB:1186:1346	In addition, PON significantly activates the expression of pro-apoptotic proteins, including cleaved-poly(ADP-ribose)polymerase ([TF]) (cl.PARP), Bak and Bim proteins, and also inhibits the expression of anti-apoptotic protein Mcl-1 and nuclear transcription factor nuclear factor-kappaB ([TG]) in melanoma cells.	PARP	NF-kappaB	11545	18033	1186	1346	0.0011851477650312	Non valid	0.046414825621185735;0.2749459012777224;0.6786392731010918	REPRESSION	37258145	Parp1	10090	Nfkb1	10090	coTF		NFKB
7581	PMID:36111043:pubtator_title_and_abstract:fcfeedc0a739675ef23d13e2694573ff:0:NLRP3:NF-kappaB:122:112	Itaconic acid facilitates inflammation abatement and alleviates liver ischemia-reperfusion injury by inhibiting [TG]/[TF]/caspase-1 inflammasome axis.	NLRP3	NF-kappaB	216799	18033	122	112	0.0011568219506285	Non valid	0.012904013346052937;0.9823878035249242;0.00470818312902286	ACTIVATION	36111043	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
7645	PMID:17607667:pubtator_title_and_abstract:a7ee0fe58937cc33cdfa8fec3f9bca41:10:GSK-3beta:NF-kappaB:1636:1567	These findings provide evidence that a shift from [TG] to beta-catenin signalling pathways through alterations in [TF] expression may be essential for the induction of trans-differentiation of endometrial carcinoma cells, leading to a shut-down of mesenchymal markers.	GSK-3beta	NF-kappaB	2932	4790	1636	1567	0.0011312987762228	Non valid	0.84808424708994;0.13916189963087716;0.012753853279182756	UNDEFINED	17607667	GSK3B	9606	NFKB1	9606	ll_coTF		NFKB
7675	PMID:19519322:pubtator_title_and_abstract:c46937e4e01d302d8758107de44b75d9:2:p65:Nuclear factor-kappaB:264:89	[TG] (NF-kappaB) is a key transcriptional factor family that consists of five members in mammalian cells, including NF-kappaB1 (p50), NF-kappaB2 (p52), RelA ([TF]), RelB and c-Rel.	p65	Nuclear factor-kappaB	5970	4790	264	89	0.0012841063015978	Non valid	0.6765370163492443;0.3203339603152276;0.0031290233355280323	UNDEFINED	19519322	RELA	9606	NFKB1	9606	dbTF		NFKB
7899	PMID:31846625:pubtator_title_and_abstract:1dafc4b365b7e02e914a243d9d8bc2b6:8:NLRP3:NF-kappaB:994:1022	[TF] inhibitor inactivated [TG] and IL-4/STAT6 signaling, suppressed M1 and M2 macrophage infiltration and attenuated renal damage and fibrosis in UUO mice.	NLRP3	NF-kappaB	216799	18033	994	1022	0.0025608586626257	Non valid	0.0035681497882269035;0.9937391493989323;0.0026927008128409444	ACTIVATION	31846625	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
7978	PMID:11728884:pubtator_title_and_abstract:6c7e510155a3d71fe7b78f527696f23c:5:nuclear factor (NF)-kappaB.:NF-kappaB:679:743	This inhibition is associated with effects on specific cell-cycle regulatory molecules, and may proceed via downregulation of the transcription factor, [TF] High-dose salicylates and selective [TG] inhibitors may, therefore, play an important role in the management of vascular proliferative disorders.	nuclear factor (NF)-kappaB.	NF-kappaB	Complex:NFKB	4790	679	743	0.0033661293584367	Non valid	0.17751113260724907;0.7700739150135348;0.05241495237921606	ACTIVATION	11728884	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
8015	PMID:31475196:pubtator_title_and_abstract:387abb2735c68b1e4e9f18b8aa174f2b:5:PPARalpha:NF-kappaB:1098:953	RESULTS: Compared to group C, the apoptosis rate was markedly increased, the adiponectin level was decreased, the expression of APPL1, p-AMPK and PPARalpha was down-regulated and that of [TG] was up-regulated in group D (P<0.05); in group DE, the apoptosis rate was significantly decreased, the expression of APPL1, p-AMPK and [TF] was up-regulated and that of NF-kappaB was down-regulated, as compared with group D (P<0.05).	PPARalpha	NF-kappaB	5465	4790	1098	953	0.0011615421259832	Non valid	0.03999347313658086;0.7876854467380406;0.17232108012537858	ACTIVATION	31475196	PPARA	9606	NFKB1	9606	dbTF		NFKB
8041	PMID:27863501:pubtator_title_and_abstract:003f76fa85605c658798efcd18907d32:10:alpha-synuclein:NF-kappaB:1308:1294	We next tested whether [TG] and [TF] pathways converged and found that TNFalpha modulated alpha-synuclein levels, although we could not detect an effect of LRRK2 mutations, partly because of the individual variability.	alpha-synuclein	NF-kappaB	6622	4790	1308	1294	0.0069076265628639	Non valid	0.9908548118916275;0.008265081634866805;0.000880106473505727	UNDEFINED	27863501	SNCA	9606	NFKB1	9606	coTF		NFKB
8045	PMID:23647456:pubtator_title_and_abstract:e98a310d1271eed992471850719ad873:0:RFP2:NF Kappa B:8:100	TRIM13 ([TF]) downregulation decreases tumour cell growth in multiple myeloma through inhibition of [TG] pathway and proteasome activity.	RFP2	NF Kappa B	10206	4790	8	100	0.0057292549912237	Non valid	0.009016103685603474;0.974801378842784;0.01618251747161265	ACTIVATION	23647456	TRIM13	9606	NFKB1	9606	coTF		NFKB
8051	PMID:26069697:pubtator_title_and_abstract:8cef918f12e18ce623ee58cd49969e6f:0:TCF4:NFkappaB:19:31	Distinct Effect of [TF] on the [TG] Pathway in Human Primary Chondrocytes and the C20/A4 Chondrocyte Cell Line.	TCF4	NFkappaB	6925	4790	19	31	0.0415482391068783	Non valid	0.9960283086896271;0.0028784378836526087;0.0010932534267202691	UNDEFINED	26069697	TCF4	9606	NFKB1	9606	dbTF		NFKB
8117	PMID:23322372:pubtator_title_and_abstract:74ffb66e4407d10ee6dc1b7c9655dcd8:10:p38:NF-kappaB.:1455:1380	Ellagic acid dose-dependently lowered caspase-3 activity and cleaved caspase-3 formation, and at 0.5 and 1% declined activity and protein level of [TG] Doxorubicin treatment also up-regulated cardiac expression of p-[TF], p-ERK 1/2 and p-JNK, and ellagic acid at 0.5 and 1% suppressed p-p38 expression and at 1% down-regulated p-ERK 1/2 expression.	p38	NF-kappaB.	26416	18033	1455	1380	0.0012665062323415	Non valid	0.03844102771672496;0.7737485935467029;0.1878103787365721	ACTIVATION	23322372	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
8125	PMID:30206627:pubtator_title_and_abstract:de96ccf66f67fd5bea4b6cef87d417e5:7:STAT3:NF-kappaB:769:746	Western blotting and ELISA showed that the combined treatment reduced the expression levels of pro-inflammatory proteins involving [TG] pathway, and [TF] activation, which regulated expression of other inflammatory proteins such as iNOS, COX-2, IL-6, and IL-1beta.	STAT3	NF-kappaB	6774	4790	769	746	0.0011147225113061	Non valid	0.12249803326031694;0.8706283504696938;0.006873616269989184	ACTIVATION	30206627	STAT3	9606	NFKB1	9606	dbTF		NFKB
8130	PMID:23131831:pubtator_title_and_abstract:011e4c414aa1d5f0c49ba87a79809dd1:3:NEMO:NF-kappaB:514:448	Furthermore, Kaposi's sarcoma-associated herpesvirus (KSHV) FADD-like interleukin-1beta (IL-1beta) converting enzyme (FLICE) inhibitory protein (vFLIP) activates the [TG] signaling pathway by directly interacting with IKKgamma/[TF].	NEMO	NF-kappaB	8517	4790	514	448	0.0012878972085464	Non valid	0.031672965658734904;0.9664299879271074;0.001897046414157699	ACTIVATION	23131831	IKBKG	9606	NFKB1	9606	coTF		NFKB
8139	PMID:10799556:pubtator_title_and_abstract:7d474bbddbc36faa0d91bf30418c56a5:5:p65:NF-kappaB:752:729	Supershift assays revealed the presence of [TG] heterodimers [TF]/p50 and p50/p52, whereas nuclear c-Jun levels correlated with the DNA binding of AP-1.	p65	NF-kappaB	5970	4790	752	729	0.0011215474021291	Non valid	0.9931942920423288;0.005446731063739;0.001358976893932245	UNDEFINED	10799556	RELA	9606	NFKB1	9606	dbTF		NFKB
8167	PMID:36181744:pubtator_title_and_abstract:d096d9fe57c7e9ff2a64f22bea30d294:6:p65:NF-kappaB:1107:833	Subsequently, we showed here that deleting the AP-1 and [TG] binding motif in porcine IL-8 promoter abrogated its activation, suggesting that IL-8 expression was dependent on AP-1 and NF-kappaB. Furthermore, PDCoV E induced IL-8 production, which was also dependent on the NF-kappaB pathway through activating nuclear factor [TF] phosphorylation and NF-kappaB inhibitor alpha (IkappaBalpha) protein phosphorylation, as well as inducing the nuclear translocation of p65, eventually resulting in the promotion of IL-8 production.	p65	NF-kappaB	5970	4790	1107	833	0.0011217031309676	Non valid	0.0018090024874595663;0.996848884187755;0.0013421133247855212	ACTIVATION	36181744	RELA	9606	NFKB1	9606	dbTF		NFKB
8174	PMID:29436586:pubtator_title_and_abstract:d14d345a2b5d8617775e1e4e5b7b5978:7:ERK1/2:NF-kappaB:1182:1166	SCRT (1 mg/ml) inhibited the LPS-induced changes in the protein expression of [TG], JNK, [TF], iNOS and COX-2, as well as the production of NO, PGE2 and cytokines.	ERK1/2	NF-kappaB	26417;26413	18033	1182	1166	0.0011841832253198	Non valid	0.939763133685542;0.05276685140915197;0.0074700149053061	UNDEFINED	29436586	Mapk3;Mapk1	10090;10090	Nfkb1	10090	ll_coTF;ll_coTF		NFKB
8193	PMID:15814588:pubtator_title_and_abstract:46146ea3d64e0687aa4ef73d432145ad:7:C/EBPbeta:NF-kappaB:1029:995	MG-132 did not affect mRNA levels of NF-kappaB and C/EBPbeta, or the nuclear presence of [TG], but markedly increased [TF] isoforms, including liver-enriched transcriptional activating protein and liver-enriched transcriptional inhibitory protein.	C/EBPbeta	NF-kappaB	1051	4790	1029	995	0.0011621198343581	Non valid	0.7764752490080774;0.17878961683901579;0.044735134152906864	UNDEFINED	15814588	CEBPB	9606	NFKB1	9606	dbTF		NFKB
8236	PMID:19789307:pubtator_title_and_abstract:0623e0ad1d5a853450eba453200bb4cc:2:NF-kappaB:NF-kappaB:374:210	PURPOSE: Aberrant nuclear activation and phosphorylation of the canonical [TG] subunit RELA/p65 at Serine-536 by inhibitor kappaB kinase is prevalent in head and neck squamous cell carcinoma (HNSCC), but the role of other kinases in [TF] activation has not been well defined.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	374	210	0.0014062745946715	Non valid	0.11331521174989934;0.8816427507807889;0.005042037469311706	ACTIVATION	19789307	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
8297	PMID:33891947:pubtator_title_and_abstract:af5cecdc66307a6f2c2588141d687970:8:GR:NF-kappaB:1286:1293	Within this framework, emerging data indicate that the gene set regulated through the cooperative convergence of [TF] and [TG] signaling is central to the broad clinical effectiveness of glucocorticoids in terminating inflammation and promoting tissue repair.	GR	NF-kappaB	2908	4790	1286	1293	0.0010874643536875	Non valid	0.9895557322727171;0.009829405039009914;0.0006148626882730102	UNDEFINED	33891947	NR3C1	9606	NFKB1	9606	dbTF		NFKB
8313	PMID:16436136:pubtator_title_and_abstract:b84bfcd10aef7863628fa718fe71aefc:6:ERK:NF-kappaB:1803:1811	Using various selective inhibitors for signaling molecules, we found that the inductions of IL-8, MCP-1, and I-309 were mediated by either SCF-activated ERK or TNF-alpha-activated p38 MAPK, while the induction of IP-10 by TNF-alpha was mediated by both activated p38 MAPK and NF-kappaB. The induction of RANTES by SCF or TNF-alpha was mediated by [TF] and [TG], respectively, and SCF induced MIP-1beta release was mediated by ERK.	ERK	NF-kappaB	5594	4790	1803	1811	0.0011832400388969	Non valid	0.0026267190116592023;0.9965341340001053;0.0008391469882356191	ACTIVATION	16436136	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
8349	PMID:34833849:pubtator_title_and_abstract:8a80a25e69429a42d89166f72dfac09b:9:JNK:NF-kappaB:1477:1463	The results demonstrated that PSO and RA-RF act as antioxidants to scavenge TNF-alpha induced ROS levels, resulting in decreased the expression of MnSOD, FOXO1, [TG] and [TF] signaling pathway in a human lung cell culture exposed to TNF-alpha.	JNK	NF-kappaB	5599	4790	1477	1463	0.0012663274102739	Non valid	0.013887791604228778;0.9750133412539581;0.011098867141813107	ACTIVATION	34833849	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
8448	PMID:34929480:pubtator_title_and_abstract:6815f9dcd0c59bde4973d826f872e032:4:STAT3:NF-kappaB:662:648	Perillyl alcohol (POH) is one such natural molecule having anti proliferative, anti-inflammatory and anti-oxidant properties by inhibiting farnesyltransferase enzyme which further down regulates [TG] and [TF] via Ras/Raf/MAPK pathway.	STAT3	NF-kappaB	6774	4790	662	648	0.0012457370452384	Non valid	0.004886291281386943;0.9647990177474712;0.030314690971141908	ACTIVATION	34929480	STAT3	9606	NFKB1	9606	dbTF		NFKB
8511	PMID:33584642:pubtator_title_and_abstract:e9158671f322b2e89d11196fe7d6b730:9:VEGF:NFkappaB:1765:1662	Our data reveals that BMP2 and high glucose upregulates BMP components of the BMP signaling pathway (SMAD effectors, BMP receptors, and TGFbeta ligand itself) and induces phosphorylation of p38 MAPK and [TG] with nuclear translocation of NFkappaB. Inhibition of p38 or NFkappaB attenuated BMP2-induced [TF] expression and barrier dysfunction in HRECs.	VEGF	NFkappaB	7422	4790	1765	1662	0.0012070345752503	Non valid	0.002605142277015601;0.9954955233052738;0.0018993344177105772	ACTIVATION	33584642	VEGFA	9606	NFKB1	9606	ll_coTF		NFKB
8544	PMID:25210319:pubtator_title_and_abstract:05b98cd3bcbc35655e4c651e4a27993a:4:nuclear factor kappa-light-chain-enhancer of activated B cells:NF-kappaB:389:453	Compounds (0.1-10 muM) were tested for inhibition of tumor necrosis factor-alpha (TNF)-induced [TF] ([TG]) luciferase reporter activity using a human kidney 293T cell-based assay.	nuclear factor kappa-light-chain-enhancer of activated B cells	NF-kappaB	Complex:NFKB	4790	389	453	0.0017821114940928	Non valid	0.004752049571979791;0.986290881551093;0.008957068876927158	ACTIVATION	25210319	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
8565	PMID:35396527:pubtator_title_and_abstract:7da16d8496c4c70c48a7ec24da633a5d:14:RelA:NFkappaB:2116:2106	Thus, results of the present study for the first time convincingly demonstrate [TG] ([TF]) mediated transcriptional upregulation of hnRNPD expression in oral cancer.	RelA	NFkappaB	5970	4790	2116	2106	0.0012387218079038	Non valid	0.0036732417483133295;0.9955006385865232;0.000826119665163481	ACTIVATION	35396527	RELA	9606	NFKB1	9606	dbTF		NFKB
8578	PMID:33017381:pubtator_title_and_abstract:578f137a8706e6633be618ed91cf3c49:0:Protein Kinase R:NF-kappaB:4:107	The [TF] Inhibitor C16 Alleviates Sepsis-Induced Acute Kidney Injury Through Modulation of the [TG] and NLR Family Pyrin Domain-Containing 3 (NLPR3) Pyroptosis Signal Pathways.	Protein Kinase R	NF-kappaB	19106	18033	4	107	0.0022128230520747	Non valid	0.9861935385032792;0.008921088264264203;0.004885373232456581	UNDEFINED	33017381	Eif2ak2	10090	Nfkb1	10090	ll_coTF		NFKB
8615	PMID:26571498:pubtator_title_and_abstract:1223da95a516898724f9d0956ea053be:0:p65:NF-kappaB:47:16	TDP-43 Inhibits [TG] Activity by Blocking [TF] Nuclear Translocation.	p65	NF-kappaB	5970	4790	47	16	0.0950723100071116	Non valid	0.004387805112360966;0.9921077834679094;0.003504411419729669	ACTIVATION	26571498	RELA	9606	NFKB1	9606	dbTF		NFKB
8910	PMID:35004844:pubtator_title_and_abstract:fd1b371f5db66915b125e93b3e2afd69:6:STAT3:NF-kappaB:631:669	miR-1290 can also regulate activity of JAK/[TF], PI3K/AKT, Wnt/beta-catenin and [TG] molecular pathways.	STAT3	NF-kappaB	6774	4790	631	669	0.0011696793309349	Non valid	0.9780970146079127;0.018503233754224722;0.0033997516378626498	UNDEFINED	35004844	STAT3	9606	NFKB1	9606	dbTF		NFKB
8924	PMID:20423679:pubtator_title_and_abstract:b510d9b3e16ee95c50248fd3ff309441:3:nuclear factor kappa-light-chain-enhancer of activated B cells:NF-kappaB:363:427	In CF, elevated levels of interleukin-8 (IL-8) signaling mediated by the [TF] ([TG]) result in chronic infection, neutrophilic inflammation, and progressive airway destruction.	nuclear factor kappa-light-chain-enhancer of activated B cells	NF-kappaB	Complex:NFKB	4790	363	427	0.0012003510706292	Non valid	0.11553657524842677;0.8827148084198121;0.0017486163317611708	ACTIVATION	20423679	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
9035	PMID:22830352:pubtator_title_and_abstract:028f93ed1b2a1d52bd0d258e4863f241:5:AP-1:NF-kappaB:661:627	Activation of PKC-theta leads to the activation of various transcription factors in the nuclei of T-cells, e.g. [TG], NFAT, c-Jun, c-Fos and [TF] that further control the proliferation and differentiation of T-cells.	AP-1	NF-kappaB	3725	4790	661	627	0.0013094993266695	Non valid	0.8781136155901372;0.11952587115926998;0.0023605132505927894	UNDEFINED	22830352	JUN	9606	NFKB1	9606	dbTF		NFKB
9063	PMID:37127183:pubtator_title_and_abstract:34a401a1a215e36435bab8daa10e9de4:0:NRF2:NFKB:138:143	Synergistic action of carvedilol and clomiphene in mitigating the behavioral phenotypes of letrozole-model of PCOS rats by modulating the [TF]/[TG] pathway.	NRF2	NFKB	83619	81736	138	143	0.0010975743148433	Non valid	0.9886842487459157;0.007461037903403054;0.003854713350681287	UNDEFINED	37127183	Nfe2l2	10116	Nfkb1	10116	dbTF		NFKB
9123	PMID:19955102:pubtator_title_and_abstract:59275de7d4ab3f5111dd4d29a47e9c2a:7:ERalpha:NFkappaB:1051:981	E2 and IL-1beta treatment of TERT-EECs enhances ERE activity by a [TG] and ER dependent mechanism; this effect could be mediated by [TF] or ERbeta.	ERalpha	NFkappaB	2099	4790	1051	981	0.0011201284074315	Non valid	0.01578146152599512;0.9821709144101366;0.002047624063868352	ACTIVATION	19955102	ESR1	9606	NFKB1	9606	dbTF		NFKB
9156	PMID:30082413:pubtator_title_and_abstract:43348a3d3ddcd515aa376c255f368079:6:MAEL:nuclear factor kappa B:881:969	These results prompted us to investigate the factors affecting the tumorigenicity of MAEL Further experimentation demonstrated that [TF] enhanced the expression of phosphorylated Akt1, with subsequent phosphorylation of [TG] (NF-kappaB) subunit RelA in tumor cells, and chemoattracted myeloid-derived suppressor cells (MDSCs) by upregulating interleukin-8 (IL8) to accelerate tumor progression in the tumor microenvironment.	MAEL	nuclear factor kappa B	84944	4790	881	969	0.001183236094087	Non valid	0.017615753126999915;0.9810316764089457;0.0013525704640542976	ACTIVATION	30082413	MAEL	9606	NFKB1	9606	coTF		NFKB
9159	PMID:36544647:pubtator_title_and_abstract:de8bbd124742920c52346b9f5807617c:12:nuclear factor-kappaB:NF-kappaB:1533:1556	The protein levels of nuclear factor erythroid 2 related factor 2 (Nrf2) and [TF] ([TG]) signaling from lung tissue as well as cell lysate were determined by Western blot.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1533	1556	0.0011790277191434	Non valid	0.8928856509500541;0.10471715491276057;0.0023971941371852346	UNDEFINED	36544647	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
9290	PMID:27087131:pubtator_title_and_abstract:ffc2e62990fff60cd2e6fc7d65f47f86:10:AP-1:NFkappaB:1539:1522	A chromosome conformation capture assay showed that EGF induced a chromosomal loop formation in the MMP-9 promoter via [TG]/p65 and [TF]/c-Jun activation.	AP-1	NFkappaB	3725	4790	1539	1522	0.0011969056145394	Non valid	0.49822443150756146;0.4959652710495939;0.005810297442844604	UNDEFINED	27087131	JUN	9606	NFKB1	9606	dbTF		NFKB
9455	PMID:23451236:pubtator_title_and_abstract:055b0eb5704ff511cbf4e13a0a18d99b:11:RelB:NF-kappaB:1563:1710	Thus, our findings demonstrate that [TF] is an oncogenic driver of mesenchymal glioma tumor growth and invasion, highlighting the therapeutic potential of inhibiting the noncanonical [TG] (RelB-mediated) pathway to treat these deadly tumors.	RelB	NF-kappaB	5971	4790	1563	1710	0.0014991598180568	Non valid	0.06602544642781992;0.9314186578688125;0.0025558957033674913	ACTIVATION	23451236	RELB	9606	NFKB1	9606	dbTF		NFKB
9526	PMID:31555126:pubtator_title_and_abstract:fb510eb320f4917bf09e16512a1add1f:12:NF-kappaB:NF-kappaB:1717:1877	Meanwhile, FX significantly inhibits phosphorylation of the [TF] signaling pathway induced by LPS at the cellular level and reduces the nuclear translocation of NF-kappaB. The IC50 for suppressing the expression of [TG] was 11.08 +- 0.78 muM in the THP1-Lucia  NF-kappaB cells.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1717	1877	0.0052792977022646	Non valid	0.0036957943626223892;0.9897686994165699;0.006535506220807804	ACTIVATION	31555126	NFKB	10090	NFKB1	9606	dbTF	NFKB	NFKB
9540	PMID:29042957:pubtator_title_and_abstract:d88c2ebc3d79af53d0016d2af1ddcabc:0:AKT:NF-kappaB:158:166	Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K/[TF] and [TG] signaling pathways in vitro.	AKT	NF-kappaB	207	4790	158	166	0.0010991396157716	Non valid	0.8576947970780651;0.134351491869631;0.007953711052303934	UNDEFINED	29042957	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
9564	PMID:9312025:pubtator_title_and_abstract:ca52e42ec2167fa87cfc335518cff3f1:0:protein kinase C zeta:NF-kappaB:50:134	Protein phosphatase 2A is a critical regulator of [TF] signaling targeted by SV40 small t to promote cell growth and [TG] activation.	protein kinase C zeta	NF-kappaB	18762	18033	50	134	0.408769544351956	Non valid	0.2267482587022866;0.7634531198408372;0.009798621456876246	ACTIVATION	9312025	Prkcz	10090	Nfkb1	10090	ll_coTF		NFKB
9567	PMID:28912140:pubtator_title_and_abstract:8aa6a6f43e822fb9c1ef9cb879ad2cdc:8:SAFB:NF-kappaB:1779:1789	Furthermore, the expression of SAFB in CRC tissues was negatively correlated with the expression of TAK1- and NF-kappaB-related genes.Conclusions: Our results show that SAFB regulated the activity of NF-kappaB signaling in CRC by targeting TAK1 This novel mechanism provides a comprehensive understanding of both SAFB and the NF-kappaB signaling pathway in the progression of CRC and indicates that the [TF]-TAK1-[TG] axis is a potential target for early therapeutic intervention in CRC progression.	SAFB	NF-kappaB	6294	4790	1779	1789	0.001257403712882	Non valid	0.9760643549128615;0.009404405085314859;0.014531240001823759	UNDEFINED	28912140	SAFB	9606	NFKB1	9606	dbTF		NFKB
9583	PMID:34444996:pubtator_title_and_abstract:1bb55f096c5ed12d7aeee44303ed36c3:12:p65:NF-kappaB:1816:1820	Furthermore, KrO deactivated hepatic REL-A/[TF]-[TG] signaling, consistent with increased PPARalpha protein expression and a trend towards an increase in IkBalpha.	p65	NF-kappaB	5970	4790	1816	1820	0.0014024579142917	Non valid	0.10148425731560767;0.7075305106652735;0.19098523201911893	ACTIVATION	34444996	RELA	9606	NFKB1	9606	dbTF		NFKB
9637	PMID:37628826:pubtator_title_and_abstract:6283d182f5efa89c16d61249311f25f1:6:nuclear factor kappa B:NF-kappaB:870:894	Moreover, we provide evidence indicating that Scopoletin-induced HIV-1 reactivation involves the [TF] ([TG]) signaling pathway.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	4790	870	894	0.0011421557419429	Non valid	0.009652927147046585;0.9887430396023513;0.001604033250602107	ACTIVATION	37628826	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
9685	PMID:23244239:pubtator_title_and_abstract:bbc5ebe3ef82e8f982c0ff747e9bb05b:9:PINK1:NF-kappaB:1276:1307	To confirm the effect of [TF] on NF-kappaB activation, [TG]-dependent firefly luciferase reporter assay was conducted.	PINK1	NF-kappaB	68943	4790	1276	1307	0.0011343826787375	Non valid	0.07856808950469092;0.9194562058808026;0.0019757046145064323	ACTIVATION	23244239	Pink1	10090	NFKB1	9606	ll_coTF		NFKB
9901	PMID:17935800:pubtator_title_and_abstract:75c1ad859b97bf31dd67422eee99ff2f:4:nuclear factor kappa B:NFkappaB:633:657	The human renal proximal tubular reabsorption of excessive light chains by endocytosis causes cellular protein overload and activates the transcription factor [TF] ([TG]).	nuclear factor kappa B	NFkappaB	Complex:NFKB	4790	633	657	0.0012126227763192	Non valid	0.08123797969512545;0.9157982033543312;0.0029638169505433985	ACTIVATION	17935800	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
9996	PMID:21801811:pubtator_title_and_abstract:1c9647727ada19d0acaf26cc0ac860d7:8:Bcl-2:NF-kappaB:1538:1459	Consistent with the hypothesis that inhibition of autophagy could induce apoptosis, we noticed inhibition of autophagy and induction of apoptosis in the serum-starved SH-SY5Y cells with the suppression of the survival factor [TG], upregulation of pro-apoptotic Bax, downregulation of anti-apoptotic [TF], activation of caspase-3, and degradation of poly(ADP-ribose) polymerase (PARP) after combination therapy.	Bcl-2	NF-kappaB	596	4790	1538	1459	0.001166825477957	Non valid	0.03399841602226807;0.10860306404628711;0.8573985199314449	REPRESSION	21801811	BCL2	9606	NFKB1	9606	coTF		NFKB
10016	PMID:32747017:pubtator_title_and_abstract:3941d0bad9847f40d0a0241ffcfac78e:9:JNK:NF-kappaB:1653:1667	Moreover, MerTK-/- mice lung tissues and silencing MerTK in RAW 264.7 inhibited the S. aureus-induced activation of MerTK, which significantly upregulated the phosphorylation of crucial protein in MAPKs (ERK, [TF], p38) and [TG] (IkBalpha, p65) signalling pathways, as well as the production of pro-inflammatory cytokines.	JNK	NF-kappaB	26419	18033	1653	1667	0.001128934952457	Non valid	0.2032144411130148;0.30753158887069687;0.4892539700162883	REPRESSION	32747017	Mapk8	10090	Nfkb1	10090	ll_coTF		NFKB
10056	PMID:33182361:pubtator_title_and_abstract:33ef03dd0c41140fa95f2d098dde18b9:7:p38:NF-kappaB:1277:1157	However, this downregulation of DC-STAMP expression following letrozole treatment was not related to the inhibition of major osteoclastogenesis pathways, such as the nuclear factor-kappaB ([TG]), c-Fos, and nuclear factor of activated T cell c1 (NFATc1) pathways, but was attributed to the inhibition of [TF], which is known to reside upstream of DC-STAMP expression.	p38	NF-kappaB	1432	4790	1277	1157	0.001121236009237	Non valid	0.016443148012023543;0.9758724336750743;0.007684418312902231	ACTIVATION	33182361	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
10142	PMID:9224203:pubtator_title_and_abstract:6eeba82f6ffa24f9f71719e3f7fd7b12:6:NF-kappa B:NF-kappa B:824:980	The activation of [TF] initiates both extracellular and intracellular regulatory events that result in autoregulation of the inflammatory cascade through modulation of [TG] activation.	NF-kappa B	NF-kappa B	Complex:NFKB	4790	824	980	0.2402575338701961	Non valid	0.6977335553967382;0.28915721539851585;0.013109229204745899	UNDEFINED	9224203	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
10201	PMID:17462862:pubtator_title_and_abstract:31b5bb4db0d9cd1631bd55bf6a8d5c97:8:Akt1:NF-kappaB:1375:1246	In MRC5CV1 cells, however, Akt1 level could be reduced only when CPT and [TG] inhibitors were co-treated to the cells, and this reversed by DEVD-cho treatment, demonstrating the caspase-3-mediated [TF] degradation.	Akt1	NF-kappaB	207	4790	1375	1246	0.0010941115951433	Non valid	0.02777399569716165;0.7342047519927231;0.23802125231011534	ACTIVATION	17462862	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
10277	PMID:36406192:pubtator_title_and_abstract:86a5a738e5934d34ec5a54ed55e421aa:15:Akt:NF-kappaB:1945:2070	In addition, metformin suppressed EGF-induced phosphorylation of [TF] and NF-kappaB. ROS is involved in EGF-induced cancer invasion and activation of phosphatidylinositol 3-kinase (PI3K)/Akt/[TG] pathway.	Akt	NF-kappaB	207	4790	1945	2070	0.0013104294443963	Non valid	0.013422774061983323;0.9830849519493204;0.0034922739886962197	ACTIVATION	36406192	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
10360	PMID:31787755:pubtator_title_and_abstract:84ee71f064d5e9eace09623acf20b396:0:NLRP3:NF-kappaB:20:87	NEK7 interacts with [TF] to modulate the pyroptosis in inflammatory bowel disease via [TG] signaling.	NLRP3	NF-kappaB	216799	18033	20	87	0.0012636535193964	Non valid	0.99001330754764;0.007631220982426438;0.0023554714699335066	UNDEFINED	31787755	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
10428	PMID:28444734:pubtator_title_and_abstract:e368601fba47df279b199969d91a6a84:11:Akt:NF-kappaB.:1663:1672	These effects were markedly disrupted by the application of signaling pathway inhibitors, thus demonstrating that L5 interacts with Toll-like receptor 4 to modulate multiple pathways, including MAPKs, PI3K/[TF], and [TG] Decreased N2a cell viability in a transwell co-culture was mainly ascribed to L5-induced BV-2 cell activation.	Akt	NF-kappaB.	11651	18033	1663	1672	0.0018381135996611	Non valid	0.9368411302181182;0.046580159934274654;0.01657870984760719	UNDEFINED	28444734	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
10462	PMID:15479861:pubtator_title_and_abstract:5c63705328af8a28090f913f3ec3b12e:4:IkappaBalpha:NF-kappaB:373:472	Some IkappaB proteins, including [TF] and IkappaBbeta, can regulate transcription by modulating the concentration of active [TG] complexes within the nucleus.	IkappaBalpha	NF-kappaB	4792	4790	373	472	0.0010893291212752	Non valid	0.9725956690746406;0.024736618757053692;0.0026677121683057383	UNDEFINED	15479861	NFKBIA	9606	NFKB1	9606	coTF		NFKB
10542	PMID:35158743:pubtator_title_and_abstract:06421c2b0858d6fd70b656bafa8425e2:7:NTRK3:NF-kappaB:1345:1095	It will cover adenoid cystic carcinoma (NFIB, MYB, and MYBL1 fusion), cutaneous mixed tumor (PLAG1 fusion), cylindroma and spiradenoma and their carcinomas thereof ([TG] activation through CYLD inactivation or ALKP1 hotspot mutation), hidradenoma and hidradenocarcinoma (MAML2 fusion), myoepithelioma (EWSR1 and FUS fusion), poroma and porocarcinoma (YAP1, MAML2, and NUTM1 fusion), secretory carcinoma (ETV6, [TF] fusion), tubular adenoma and syringo-cystadenoma papilliferum (HRAS and BRAF activating mutations).	NTRK3	NF-kappaB	4916	4790	1345	1095	0.0011608179059306	Non valid	0.009872164753683547;0.988439045610681;0.0016887896356354056	ACTIVATION	35158743	NTRK3	9606	NFKB1	9606	ll_coTF		NFKB
10605	PMID:35241643:pubtator_title_and_abstract:91ed6843350cbfc58afa357bac258038:10:NF-kappaB:nuclear factor-kappaB:1390:1367	AMPK activators metformin and 5-aminoimidazole-4-carboxamide (AICAR) hindered miR-146a expression at the transcriptional level by promoting IkappaB kinase (IKK) phosphorylation to attenuate [TG] ([TF]) activity.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	1390	1367	0.00119969838372	Non valid	0.014974859226491857;0.9092842207474485;0.0757409200260595	ACTIVATION	35241643	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
10634	PMID:26255828:pubtator_title_and_abstract:8587951c0e9ca133ec8e180aa84d8e74:9:B-cell lymphoma 2:NF-kappa B:1692:1677	The possible mechanisms related to its anti-cancer activity as illustrated by different experimental studies include its potential action as modulator of specific receptors such as topoisomerase I, [TG] and [TF] (Bcl2).	B-cell lymphoma 2	NF-kappa B	596	4790	1692	1677	0.0011855627103316	Non valid	0.9919627845908803;0.006413698396121926;0.001623517012997822	UNDEFINED	26255828	BCL2	9606	NFKB1	9606	coTF		NFKB
10785	PMID:22993301:pubtator_title_and_abstract:8dfb546ae6818df12bd25400a2812e7c:4:mammalian target of rapamycin:NF-kappaB:735:723	Here, the effects of caffeine on the proliferation of HOS osteosarcoma cells were assessed by WST-8 assay, and the effects on the nuclear factor kappa-light-chain-enhancer of activated B cells ([TG]), [TF] (mTOR) and mitogen-activated protein kinase (MAPK) pathways were assessed by western blot analyses.	mammalian target of rapamycin	NF-kappaB	2475	4790	735	723	0.0011400399089118	Non valid	0.9947945195789205;0.003912588171162611;0.0012928922499168942	UNDEFINED	22993301	MTOR	9606	NFKB1	9606	ll_coTF		NFKB
10911	PMID:20709826:pubtator_title_and_abstract:63d6c88dcd415073f0e4bb5dbe26714c:11:nuclear factor-kappaB:NF-kappaB:1402:1425	Moreover, inhibition of [TF] ([TG]) by helenalin and inhibition of the JNK pathway by JNK inhibitor II inhibited R-PC-induced IL-12 p70 production.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1402	1425	0.0011149970454919	Non valid	0.004055063696460586;0.9831099839611923;0.012834952342347074	ACTIVATION	20709826	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
10938	PMID:20004765:pubtator_title_and_abstract:eb42eebf92bfd152313647852f348b2f:10:IKK-beta:NF-kappaB:1516:1460	This gene encodes NIK- and IKK-beta-binding protein (NIBP), which is involved in the [TG] signaling pathway and directly interacts with [TF] and MAP3K14.	IKK-beta	NF-kappaB	3551	4790	1516	1460	0.0012626729728312	Non valid	0.9619710835585619;0.03682137387473473;0.0012075425667034702	UNDEFINED	20004765	IKBKB	9606	NFKB1	9606	coTF		NFKB
11010	PMID:34678206:pubtator_title_and_abstract:d2e66d4a5c9d75d29400e7754dad69fa:5:nuclear factor kappa b:NF-kappaB:937:961	This shift in astrocyte homeostasis triggers a reactive astrocyte phenotype and increased release of toxic cytokines, which accumulate in [TF] ([TG]) pathway activation with increased production of CHF, LCN2, and C3 causing neurodegeneration.	nuclear factor kappa b	NF-kappaB	Complex:NFKB	4790	937	961	0.0010990707731332	Non valid	0.030357713736639553;0.9669955560215472;0.002646730241813222	ACTIVATION	34678206	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
11244	PMID:30092810:pubtator_title_and_abstract:b4067f1631d3bff0967587b63039c4ce:11:alpha-synuclein:NFkappaB:2129:2183	Moreover, in vitro studies with neuronal and astroglial cells showed that the neuroprotective effects of anti-TLR2 antibody were mediated by blocking the neuron-to-neuron and neuron-to-astrocyte [TF] transmission which otherwise promotes [TG] dependent pro-inflammatory responses.	alpha-synuclein	NFkappaB	20617	4790	2129	2183	0.0011058154801024	Non valid	0.026903514279673715;0.957755438224754;0.015341047495572392	ACTIVATION	30092810	Snca	10090	NFKB1	9606	coTF		NFKB
11257	PMID:32472095:pubtator_title_and_abstract:83e4da76ac5d652f01d663374a84b07f:10:c-jun n-terminal kinases:NF-kappaB:1880:1944	The multiple factorial analysis demonstrated that the most important variables linked to moderate, spontaneous physical activity were the increase in growth factor (epithelial growth factor (EGF), hepatocyte growth factor (HGF)) and the activation of the signalling pathways (STAT3, [TF] (JNK), EKR1/2, nuclear factor-kappa B ([TG])) in the gastrocnemius (G).	c-jun n-terminal kinases	NF-kappaB	26419	18033	1880	1944	0.0011113280205548	Non valid	0.056844380004801943;0.9407674063500842;0.0023882136451139277	ACTIVATION	32472095	Mapk8	10090	Nfkb1	10090	ll_coTF		NFKB
11333	PMID:33357114:pubtator_title_and_abstract:22ad17f4acce6c0e5401c38109a91a32:9:STAT1:nuclear factor (NF)-KappaB:1575:1387	RESULTS: Anti-IL17 or Rho-kinase inhibitor reduced the number of CD4+, CD8+, dendritic cells, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17, Rho-kinase 1 and 2, transforming growth factor (TGF-beta), vascular endothelial growth factor (VEGF), [TG], iNOS, metalloproteinase (MMP)-9, MMP-12, metalloproteinase inhibitor-1 (TIMP-1), FOXP-3, signal transducer and activator of transcription 1 (STAT1) and phospho-[TF]-positive cells, and actin, endothelin-1, isoprostane, biglycan, decorin, fibronectin and the collagen fibers volume fraction compared with the ovalbumin group (p < 0.05).	STAT1	nuclear factor (NF)-KappaB	20846	18033	1575	1387	0.0014836450814926	Non valid	0.13980418495210406;0.8382804873829914;0.021915327664904616	ACTIVATION	33357114	Stat1	10090	Nfkb1	10090	dbTF		NFKB
11335	PMID:36010610:pubtator_title_and_abstract:38d380aa0f4fcf06ac5e04143db9b1fb:7:nuclear factor-kappaB:NF-kappaB:994:1017	We introduce the mechanisms of Ginsenoside Rg1 in neurological diseases, including apoptosis, neuroinflammation, the microRNA (miRNA) family, the mitogen-activated protein kinase (MAPK) family, oxidative stress, [TF] ([TG]), and learning and memory of Rg1 in neurological diseases.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	994	1017	0.0011870907893727	Non valid	0.9717718361704671;0.022500993410138424;0.005727170419394381	UNDEFINED	36010610	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
11371	PMID:32323797:pubtator_title_and_abstract:7a113f3ae3e54e39d1fafca123c4a857:0:EGFR:NF-kappaB:87:96	AREG mediates the epithelial-mesenchymal transition in pancreatic cancer cells via the [TF]/ERK/[TG] signalling pathway.	EGFR	NF-kappaB	1956	4790	87	96	0.0010743807156919	Non valid	0.3909104326026168;0.6055577196659806;0.0035318477314025365	ACTIVATION	32323797	EGFR	9606	NFKB1	9606	ll_coTF		NFKB
11381	PMID:37377974:pubtator_title_and_abstract:39e0f5ac0f0151be9761d3ce2cac9fda:5:IkappaBalpha:NF-kappaB:660:691	Under high glucose conditions, HK2 acts as a protein kinase and phosphorylates IkappaBalpha at T291 in breast cancer cells, leading to the rapid degradation of [TF] and activation of [TG], which enters the nucleus and promotes PD-L1 expression.	IkappaBalpha	NF-kappaB	4792	4790	660	691	0.0077381464626609	Non valid	0.03285957702839606;0.06413881596177537;0.9030016070098286	REPRESSION	37377974	NFKBIA	9606	NFKB1	9606	coTF		NFKB
11468	PMID:18486909:pubtator_title_and_abstract:eac18f607e8df8fed88e3bbf414d889a:9:NF-kappaB:nuclear factor-kappaB:1133:1110	Further studies revealed that florfenicol prevented the LPS-induced [TG] ([TF]) translocation from cytoplasm into nuclear in RAW 264.7 macrophages.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	18033	1133	1110	0.0012276652339684	Non valid	0.09439905726307266;0.90133391361817;0.004267029118757367	ACTIVATION	18486909	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
11599	PMID:23302996:pubtator_title_and_abstract:3e78bdb6ce47c76f7ba4102358ff8df3:8:Her2/neu:NF-kappaB:970:931	The highest levels of [TG], Ki-67 and p53 were found in [TF]+ and basal-like tumor subtypes.	Her2/neu	NF-kappaB	2064	4790	970	931	0.0204453689252064	Non valid	0.1907307204711052;0.8018824314175983;0.007386848111296539	ACTIVATION	23302996	ERBB2	9606	NFKB1	9606	ll_coTF		NFKB
11697	PMID:35078487:pubtator_title_and_abstract:7413e9379c22bb9ad04c5192d850e371:4:NLRP3:NF-kappaB:778:768	METHODS: Using a mouse model of high-fat diet (HFD) feeding and a cellular model of HepG2 cells challenged by lipopolysaccharide (LPS) and palmitic acid (PA), the possible molecular mechanisms were exploited in the aspects of [TG]/[TF] inflammasome and mTORC1-SREBPs signaling pathways by examining the relevant gene/protein expressions.	NLRP3	NF-kappaB	114548	18033	778	768	0.0011289470510059	Non valid	0.9563569299596044;0.041574375689239426;0.002068694351156203	UNDEFINED	35078487	NLRP3	9606	Nfkb1	10090	coTF		NFKB
11774	PMID:21967852:pubtator_title_and_abstract:78a8fdd1037ee4c90bc37748b1a90e5a:4:TNIP1:NF-kappaB:447:516	[TF]'s complex nomenclature parallels its additional function as an [TG] inhibitor.	TNIP1	NF-kappaB	10318	4790	447	516	0.1704850203749497	Non valid	0.002823345464156912;0.005138969216799267;0.9920376853190438	REPRESSION	21967852	TNIP1	9606	NFKB1	9606	coTF		NFKB
11834	PMID:17567906:pubtator_title_and_abstract:afce32d0257f5227d63f6e1494bd8ef4:0:JNK1:NF-kappaB:138:127	Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of [TG], [TF], p53 and WOX1 during stress response.	JNK1	NF-kappaB	5599	4790	138	127	0.0012376895531442	Non valid	0.005113723646958571;0.9897422887471488;0.0051439876058926625	ACTIVATION	17567906	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
11978	PMID:26797516:pubtator_title_and_abstract:3b2c85f15b3b8cdcf14e776911c918ef:5:yin yang 1:NF-kappaB:685:671	Our findings revealed that the human TGF-alpha promoter contains consensus sites for several transcription factors, such as [TG] and [TF] (YY1).	yin yang 1	NF-kappaB	7528	4790	685	671	0.0011958839578868	Non valid	0.994561314534376;0.004990198058621986;0.0004484874070019757	UNDEFINED	26797516	YY1	9606	NFKB1	9606	dbTF		NFKB
12061	PMID:23359692:pubtator_title_and_abstract:c0492f41a8bc13adb5f69ec3c736c074:8:androgen receptor:NF-kappabeta:1233:1193	Significant reduction in levels of proliferating cell nuclear antigen, [TG]/p50, cyclooxygenase-2, and [TF] was also seen.	androgen receptor	NF-kappabeta	367	4790	1233	1193	0.0011868315922645	Non valid	0.013882022677679216;0.9687477696871651;0.01737020763515559	ACTIVATION	23359692	AR	9606	NFKB1	9606	dbTF		NFKB
12123	PMID:23223635:pubtator_title_and_abstract:69ad0341d0c1c3a5840cfea1b0dddb88:6:p65:NF-kappaB:937:913	Interestingly, PGC-1alpha and PGC-1beta both reduced phoshorylation of the [TG] family member [TF] and thereby its transcriptional activation potential.	p65	NF-kappaB	5970	4790	937	913	0.0028653685247447	Non valid	0.012683284997934216;0.9774037759515485;0.009912939050517308	ACTIVATION	23223635	RELA	9606	NFKB1	9606	dbTF		NFKB
12126	PMID:16177093:pubtator_title_and_abstract:8ce0c30564d6f01fa6b59bd7f2516d83:5:CREB:NF-kappaB:852:839	Our data suggest a cohesive protein complex regulating Igamma1 promoter activity because disruption of any individual [TG] or [TF]/ATF site markedly lowers the overall inducible activity of the promoter.	CREB	NF-kappaB	1385	4790	852	839	0.0011838355740615	Non valid	0.0017625568111539927;0.9951056382654703;0.0031318049233756	ACTIVATION	16177093	CREB1	9606	NFKB1	9606	dbTF		NFKB
12270	PMID:30881601:pubtator_title_and_abstract:ec84e2f6af8b00e4a2c05fa984f61738:7:p65:nuclear factor-kappaB:1008:974	YQHX also decreases the phosphorylation of [TG] (NF-kappaB) [TF] and IkappaB following LPS stimulation, and it effectively suppresses PAI-1 and TF via a NF-kappaB-dependent mechanism.	p65	nuclear factor-kappaB	5970	4790	1008	974	0.0011777994253475	Non valid	0.04711125202807769;0.9474624062987359;0.005426341673186399	ACTIVATION	30881601	RELA	9606	NFKB1	9606	dbTF		NFKB
12281	PMID:12438279:pubtator_title_and_abstract:74b7d81fc480548691ff08aeef169227:7:CK2alpha:NF-kappaB.:1125:1057	Here, we report that the inhibition of CK2 blocks Her-2/neu-mediated activation of [TG] NF639 breast cancer cells, stably expressing CK2alpha or [TF]' kinase-inactive mutants, displayed decreased NF-kappaB binding and reduced ability to grow in soft agar, as well as increased sensitivity to tumor necrosis factor (TNF)-alpha killing.	CK2alpha	NF-kappaB.	1459	18033	1125	1057	0.0019128687863873	Non valid	0.07984290109164684;0.9100164727754837;0.010140626132869387	ACTIVATION	12438279	CSNK2A2	9606	Nfkb1	10090	coTF		NFKB
12483	PMID:16984731:pubtator_title_and_abstract:4b3c0e9622150750ffd36ef594e98a0f:4:EGFR:nuclear factor kappaB:449:620	However, [TF]-independent mechanisms also contribute to the activation of key intracellular signaling routes, including signal transducer and activator of transcription-3 (STAT3), [TG] (NFkappaB), and Akt.	EGFR	nuclear factor kappaB	1956	4790	449	620	0.0698161589294736	Non valid	0.016660773064522686;0.9817306454794337;0.0016085814560436497	ACTIVATION	16984731	EGFR	9606	NFKB1	9606	ll_coTF		NFKB
12595	PMID:32519392:pubtator_title_and_abstract:c13c48b9fca79b6104020c1cbc3b7353:0:JNK:NF-kappaB:65:100	Hinokiflavone induces apoptosis via activating mitochondrial ROS/[TF]/caspase pathway and inhibiting [TG] activity in hepatocellular carcinoma.	JNK	NF-kappaB	5599	4790	65	100	0.0011605453687545	Non valid	0.08087648818224114;0.5143317985448217;0.40479171327293717	ACTIVATION	32519392	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
12603	PMID:29676038:pubtator_title_and_abstract:82fd95cba012e263638c7a99238ceb69:3:NFkappaB:nuclear factor kappa B:504:480	Using various approaches, we found that the effects of TLR3 upon cardiomyocyte maturation were dependent upon the RelA subunit of [TG] ([TF]).	NFkappaB	nuclear factor kappa B	Complex:NFKB	4790	504	480	0.0012255759117705	Non valid	0.9782150811958316;0.0190451702212137;0.002739748582954686	UNDEFINED	29676038	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
12647	PMID:23688403:pubtator_title_and_abstract:3679ec81721a71e6548ce3796c92cef9:10:IkappaBalpha:NF-kappaB:1049:981	RESULTS: Poly I:C plus IL-4 increased the secretion and mRNA levels of TSLP, which was suppressed by an NF-kappaB inhibitor, and also enhanced [TG] transcriptional activities and induced the degradation of [TF] in keratinocytes.	IkappaBalpha	NF-kappaB	4792	4790	1049	981	0.001267570941409	Non valid	0.05062547429165069;0.2387048482408268;0.7106696774675225	REPRESSION	23688403	NFKBIA	9606	NFKB1	9606	coTF		NFKB
12756	PMID:35646156:pubtator_title_and_abstract:cb2382020ddcb9878e42738ff1b9874e:5:VEGF:NF-kappa B:811:835	Results: 36 active compounds were identified from XNJ, and the effect of XNJ against IS was related to the [TF] signaling pathway, [TG] signaling pathway, and gap junction.	VEGF	NF-kappa B	22339	18033	811	835	0.0012137931117173	Non valid	0.9903299343351335;0.007956369691899081;0.0017136959729673604	UNDEFINED	35646156	Vegfa	10090	Nfkb1	10090	ll_coTF		NFKB
12771	PMID:28528205:pubtator_title_and_abstract:8fe039849a2ad2be83758fd1332d721c:4:STAT1:NF-kappaB:591:519	These mediators are downstream targets for the transcription factors; activator protein-1 (AP1), nuclear factor kappa-light-chain-enhancer ([TG]), signal transducers and activators of transcription factors ([TF]), as well as interferon regulatory factors (IRFs), which control the expression of most immunomodulatory genes.	STAT1	NF-kappaB	6772	4790	591	519	0.0011425385101726	Non valid	0.9585940101585112;0.03967031388713453;0.0017356759543541984	UNDEFINED	28528205	STAT1	9606	NFKB1	9606	dbTF		NFKB
12795	PMID:33154638:pubtator_title_and_abstract:af669e9d75ac723de469671b3ebfc004:8:NF-kappaB:NF-kappaB:1204:1290	The [TF] activity was distinctly observed by highly-specific DNA-based ELISA, and by [TG]-specific inhibitor, Bay 11-7082.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1204	1290	0.0025062838981101	Non valid	0.7130999212283323;0.27114836115493157;0.01575171761673607	UNDEFINED	33154638	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
12854	PMID:31844427:pubtator_title_and_abstract:58fa3d7384666a3e68997a150a7d43ea:8:Nrf2:NF-kB:1043:1052	Examination of [TF] and [TG] levels was carried out by ELISA.	Nrf2	NF-kB	83619	81736	1043	1052	0.0014773716888826	Non valid	0.9509304703539322;0.04320114219062766;0.00586838745544017	UNDEFINED	31844427	Nfe2l2	10116	Nfkb1	10116	dbTF		NFKB
12868	PMID:15041463:pubtator_title_and_abstract:b3964284542f2622819a64bec34f6515:3:p73:NF-kappaB:504:489	To elucidate the mechanisms of CP-induced apoptosis in Hep3B cells, which are Fas- and p53-negative, we investigated mitochondria associated pathways, the involvement of [TG], and [TF] activation.	p73	NF-kappaB	7161	4790	504	489	0.0011631101866799	Non valid	0.18858377004216156;0.8077818824281037;0.003634347529734798	ACTIVATION	15041463	TP73	9606	NFKB1	9606	dbTF		NFKB
12958	PMID:23355795:pubtator_title_and_abstract:4f5a2894eaa45937e3b487b23cf6b11e:11:nuclear factor-kappaB:NF-kappaB:1319:1342	AGE-LDL stimulation led to phosphorylation of JNK, p38, Akt and the p65 subunit of [TF] ([TG]).	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	1319	1342	0.0011800133547487	Non valid	0.49373890423969563;0.49994737261112115;0.006313723149183238	ACTIVATION	23355795	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
13063	PMID:20804734:pubtator_title_and_abstract:07143f1e9cf91a5be54feb532a19e389:4:zinc-finger protein 91:NF-kappaB:521:621	In this report we demonstrate that a novel [TF] (ZFP91) is a critical regulator in LIGHT-induced activation of non-canonical [TG] pathway.	zinc-finger protein 91	NF-kappaB	7644	4790	521	621	0.0371808386056532	Non valid	0.015349148329972319;0.9835156962299922;0.001135155440035414	ACTIVATION	20804734	ZNF91	9606	NFKB1	9606	dbTF		NFKB
13287	PMID:36012159:pubtator_title_and_abstract:1cfed74bd8c325d38a14a6ca5914c089:6:mTOR:NF-kappa B:1354:1370	The recent literature published on the topic has highlighted the role of triterpenic acids in several signaling pathways including PI3/AKT/[TF], TNF-alpha/[TG], JNK-p38, HIF-alpha/AMPK, and Grb2/Sos/Ras/MAPK, which trigger their various biological activities.	mTOR	NF-kappa B	2475	4790	1354	1370	0.0011503378081437	Non valid	0.9166353201733958;0.08120215698965888;0.0021625228369452614	UNDEFINED	36012159	MTOR	9606	NFKB1	9606	ll_coTF		NFKB
13290	PMID:38022581:pubtator_title_and_abstract:552d786ae52f07a4e5764e38eaa746ed:3:HMGB1:NF-kappaB:696:860	This was further confirmed in vitro that overexpression of SARS-CoV-2 N protein caused the release of [TF] from injured tubular cells under high AGE conditions, which resulted in M1 macrophage activation and production of proinflammatory cytokines via a Mincle-Syk/[TG]-dependent mechanism.	HMGB1	NF-kappaB	15289	18033	696	860	0.0011508271803794	Non valid	0.018290487240220605;0.9798973637891232;0.0018121489706562916	ACTIVATION	38022581	Hmgb1	10090	Nfkb1	10090	coTF		NFKB
13309	PMID:36359766:pubtator_title_and_abstract:52c5760a31799af0228ac91cbe90044d:6:STAT3:NF-kappaB:799:789	When upregulated by ectopic expression, OPG activated BSFs through the [TG]/[TF]/AUF1 signaling pathway and promoted their paracrine pro-carcinogenic effects in an IL-6-dependent manner.	STAT3	NF-kappaB	20848	18033	799	789	0.0011849948081986	Non valid	0.008300559509256357;0.9906179581999193;0.001081482290824284	ACTIVATION	36359766	Stat3	10090	Nfkb1	10090	dbTF		NFKB
13416	PMID:16105982:pubtator_title_and_abstract:f0831fab22013910eb7278a790506197:5:XIAP:NF-kappaB:1050:797	Treatment with arsenic trioxide (ATO; 2-200 microM) inhibited [TG] activity in normal marrow, primary MDS, and ML1 cells, even in the presence of exogenous TNF-alpha (20 ng/mL), and down-regulated NF-kappaB-dependent antiapoptotic proteins, B-cell leukemia XL (Bcl-XL), Bcl-2, X-linked inhibitor of apoptosis ([TF]), and Fas-associated death domain (FADD)-like interleukin-1beta-converting enzyme (FLICE) inhibitory protein (FLIP), leading to apoptosis.	XIAP	NF-kappaB	331	4790	1050	797	0.001174679589944	Non valid	0.01735384528694629;0.9757612327815967;0.0068849219314570725	ACTIVATION	16105982	XIAP	9606	NFKB1	9606	coTF		NFKB
13494	PMID:31926936:pubtator_title_and_abstract:29431d7482b4abfd83057348426673d6:7:STAT1:nuclear factor (NF)-kappaB.:1355:1125	Luciferase assay and immunoblotting analysis with nuclear fractions showed that activator protein-1 (AP-1), signal transducer and activator of transcription 1 (STAT1), and interferon regulatory factor 3 (IRF3) are targeted by BX795 rather than [TG] Moreover, TBK1 and AKT, transforming growth factor activated kinase (TAK)-1/c-Jun N-terminal kinase (JNK)/mitogen-activated protein kinase kinase 4 (MKK4) for AP-1 activation, and Janus kinase 2 (JAK2)/[TF] were inhibited by BX795.	STAT1	nuclear factor (NF)-kappaB.	20846	18033	1355	1125	0.001248638556984	Non valid	0.28556560045584173;0.701011958351549;0.01342244119260937	ACTIVATION	31926936	Stat1	10090	Nfkb1	10090	dbTF		NFKB
13495	PMID:36660689:pubtator_title_and_abstract:717e942e8e55b293100e655da4314784:12:nuclear factor kappa B:NF-kappaB:2312:2336	Interestingly, melatonin significantly mitigated adenomyosis-induced changes by inhibiting the [TF] ([TG]) signaling pathway, increasing the vascular endothelial growth factor (VEGF) expression, decreasing the endometrial cells apoptosis, and improving pregnancy outcomes.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	18033	2312	2336	0.0011619659721053	Non valid	0.5143270496564655;0.38319129245557787;0.10248165788795675	UNDEFINED	36660689	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
13578	PMID:38115079:pubtator_title_and_abstract:a535d7d08f00d4037de1df9e994f7c62:11:P52:NF-kappaB:1600:1618	Eldecalcitol (10 nM) significantly inhibited the expression of MuRF-1 (P < 0.001) and Atrogin-1 (P < 0.01), increased the diameter of myotubes (P < 0.05), inhibited the expression of P65 and [TF] components of [TG] and P65 nuclear location, thereby inhibiting NF-kappaB signaling.	P52	NF-kappaB	18034	18033	1600	1618	0.0016829934324998	Non valid	0.10574885150736185;0.8828706352887629;0.01138051320387521	ACTIVATION	38115079	Nfkb2	10090	Nfkb1	10090	dbTF		NFKB
13598	PMID:18436581:pubtator_title_and_abstract:7b37a3e8f7648d9c7b73f8f8da4c7f3d:8:NF-kappaB:NF-kappaB:1047:976	The thrombin-induced CX3CL1 expression was [TG]-dependent, as shown by EMSA, ELISA, and by inhibition of the [TF] signaling pathway by the IkappaB kinase inhibitor acety-11-keto-beta-boswellic acid or by transient overexpression of a transdominant-negative form of IkappaBalpha.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1047	976	0.0011110324270264	Non valid	0.00856667697347353;0.9901488542390501;0.0012844687874764373	ACTIVATION	18436581	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
13766	PMID:30672111:pubtator_title_and_abstract:69a2737110fd5e055c2101cf5a339a36:7:nuclear factor kappa-light-chain-enhancer of activated B cells:NF-kappaB:719:783	The modification of MDP maintained the ability to stimulate a [TF] ([TG]) immune response dependent on the expression of nucleotide-binding oligomerization domain-containing protein 2 (Nod2).	nuclear factor kappa-light-chain-enhancer of activated B cells	NF-kappaB	Complex:NFKB	4790	719	783	0.0013489931946849	Non valid	0.07996088417807388;0.9149933121850975;0.005045803636828651	ACTIVATION	30672111	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
13779	PMID:35638868:pubtator_title_and_abstract:37587798a3b0e265822afffab89848d4:10:FGFR1:NF-kappaB:1494:1522	The potential of BGF1 to suppress tumor invasion was indicated by quantitative analysis of the metastasis-related proteins, including [TF], pFGFR1, NF-kappaB, p-[TG], MMP-9, E-cadherin, N-cadherin, and Vimentin, and supported by small animal positron emission tomography (PET) used 18Fluorodeoxyglucose (18F-FDG).	FGFR1	NF-kappaB	14182	18033	1494	1522	0.0011507912787095	Non valid	0.976907096982513;0.020306017232596167;0.0027868857848908227	UNDEFINED	35638868	Fgfr1	10090	Nfkb1	10090	ll_coTF		NFKB
13897	PMID:29576246:pubtator_title_and_abstract:184183378b7e8cb28e901ae1dbc8adb4:9:MyD88:NF-kappaB:1368:1426	Two clusters of novel autoantigens revealed distinctive networks of interacting proteins: SMAD2, SMAD5 and proteins linked to TGF-beta signalling; and [TF] and proteins involved in TLR signalling, apoptosis, [TG] regulation and lymphocyte development.	MyD88	NF-kappaB	4615	4790	1368	1426	0.0151478697680484	Non valid	0.9980057443918444;0.0012808411940975902;0.0007134144140579731	UNDEFINED	29576246	MYD88	9606	NFKB1	9606	coTF		NFKB
13980	PMID:22111071:pubtator_title_and_abstract:a791bed3615c583acb08f4f4a846df63:3:protein kinase C (PKC) alpha/betaII:nuclear factor-kappaB:379:420	In the present study, we investigated whether EGCG plays a role in the expression of transforming growth factor-beta1 (TGF-beta1), [TF], and [TG] (NF-kappaB) in glomerular epithelial cells (GECs) against high-glucose injury.	protein kinase C (PKC) alpha/betaII	nuclear factor-kappaB	5578	4790	379	420	0.0013844652650444	Non valid	0.99490990964955;0.003391957205056563;0.0016981331453935005	UNDEFINED	22111071	PRKCA	9606	NFKB1	9606	ll_coTF		NFKB
14105	PMID:21813505:pubtator_title_and_abstract:a9f4bce4da282f4b87ae32195f3bbb99:0:C/EBP:NF-kappaB:141:70	C/EBPalpha, C/EBPalpha oncoproteins, or C/EBPbeta preferentially bind [TG] p50 compared with p65, focusing therapeutic targeting on the [TF]:p50 interaction.	C/EBP	NF-kappaB	1050	4790	141	70	0.0011947035575439	Non valid	0.9915593515749994;0.007104359044274855;0.0013362893807257884	UNDEFINED	21813505	CEBPA	9606	NFKB1	9606	dbTF		NFKB
14107	PMID:24489901:pubtator_title_and_abstract:ea7f86e3d0779e90afbbba6484bd4a7d:4:PPARgamma:NF-kappaB:622:632	AIM: To assess the expression of peroxisome proliferator-activated receptorgamma (PPARgamma) and nuclear factor kappa B (NF-kappaB) in placenta and HTR-8/SVneo cell, and evaluate the serum levels of cytokines, bile acids, hepatic function and lipids in control and ICP patients and the fetal outcome, in order to explore the role of [TF]/[TG] signaling pathway in the possible mechanism of ICP.	PPARgamma	NF-kappaB	5468	4790	622	632	0.0011079826434047	Non valid	0.9927080378705885;0.00651958067589555;0.0007723814535160163	UNDEFINED	24489901	PPARG	9606	NFKB1	9606	dbTF		NFKB
14126	PMID:17214582:pubtator_title_and_abstract:fe39abae08c13732040fa50f56555552:8:NF-kappaB:NF-kappaB:1052:961	In this review, I have attempted to overview the pathologic involvement of [TG] in rheumatic diseases and discuss the feasibility of a therapeutic strategy with [TF] and its signaling cascade as novel molecular targets.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1052	961	0.0011738817725819	Non valid	0.9893247001232125;0.0090499026888352;0.001625397187952221	UNDEFINED	17214582	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
14142	PMID:26349982:pubtator_title_and_abstract:201aa3ba47f94cc52c826809986e99c0:5:NF-kappaB:NF-kappaB:990:933	Mechanistic studies revealed that BDMC-A might have exerted its activity by inhibiting metastatic and angiogenic pathways by modulating the expression of proteins upstream to [TG] (TGF-beta, TNF-alpha, IL-1beta and c-Src), and [TF] signaling cascade (c-Rel, COX-2, MMP-9, VEGF, IL-8) and by upregulating TIMP-2 levels.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	990	933	0.001180764157912	Non valid	0.9734156585414127;0.02461100995685638;0.0019733315017310643	UNDEFINED	26349982	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
14194	PMID:12418963:pubtator_title_and_abstract:9f677bba17c5df1c5560238f2d3153e9:0:JNK:NF-kappaB:157:117	A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB ([TG]) and c-Jun N-terminal kinase ([TF]).	JNK	NF-kappaB	5599	4790	157	117	0.0012007321590544	Non valid	0.011785753241069244;0.9855272489301761;0.0026869978287547597	ACTIVATION	12418963	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
14258	PMID:23335792:pubtator_title_and_abstract:5bd3c7c2ce8c44c545b1bb0376534ac2:2:MyD88:NF-kappaB:141:152	Myeloid differentiation factor 88 ([TF]) and [TG] play central roles in mediating signal transduction of the Toll-like receptor (TLR) superfamily in human macrophages.	MyD88	NF-kappaB	4615	4790	141	152	0.0011124364675372	Non valid	0.37570318484486925;0.6215954753630109;0.0027013397921197666	ACTIVATION	23335792	MYD88	9606	NFKB1	9606	coTF		NFKB
14280	PMID:20335611:pubtator_title_and_abstract:c0f8efd3cadf2382bf7d41b81bc6f7f1:10:JNK:NF-kappaB:1375:1295	Tranilast inhibited the cytokine-induced phosphorylation of the [TG] inhibitor IkappaBalpha and of mitogen-activated protein kinases (ERK, [TF], p38), without affecting that of STAT6, in corneal fibroblasts.	JNK	NF-kappaB	5599	4790	1375	1295	0.0011539513395618	Non valid	0.11313568059057878;0.836956049764572;0.04990826964484917	ACTIVATION	20335611	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
14291	PMID:32461184:pubtator_title_and_abstract:a8a822c7d9ca3ca2c4cfa612e96e77eb:2:NF-kappaB:nuclear factor kappa B:113:89	BACKGROUND: The [TG] ([TF]) is composed of a series of transcription factors, which are involved in the expression of a plethora of target genes, many of these genes contributing to the regulation of inflammatory responses.	NF-kappaB	nuclear factor kappa B	Complex:NFKB	4790	113	89	0.0011415411868608	Non valid	0.8329263440492284;0.1646008318797956;0.0024728240709760434	UNDEFINED	32461184	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
14372	PMID:24413684:pubtator_title_and_abstract:8dfd4fc80a9e130c71ed6d7719f4a9b0:9:IkappaBalpha:NF-kappaB:1237:1152	PDCD4 does not inhibit pathways upstream of [TG] including the activation of IKKalpha and IKKbeta kinases or degradation of [TF], events needed for nuclear transport of p65 and p50.	IkappaBalpha	NF-kappaB	4792	4790	1237	1152	0.0013089849573684	Non valid	0.1566820036172116;0.8159824348058666;0.02733556157692175	ACTIVATION	24413684	NFKBIA	9606	NFKB1	9606	coTF		NFKB
14461	PMID:24992458:pubtator_title_and_abstract:57492b3f5e4eda8a7b7d0908d0273ce4:8:NF-kappaB:NF-kappaB:1499:1443	The SNMM model thus provides a new alternative model for scoring the relative binding affinities of [TG] to the 10-bp DNA sequences and predicting the [TF] DNA-binding sites.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1499	1443	0.0013529096850471	Non valid	0.996908835129229;0.002159194322425449;0.0009319705483454785	UNDEFINED	24992458	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
14474	PMID:31684202:pubtator_title_and_abstract:4699d2d195303fb9c896c6c9a7a84f9d:8:NF-kappaB:NF-kappaB.:1486:1415	This finding suggested that PCV2-induced overexpression of IL-1beta was associated with the downregulation of SIGIRR and the activation of NF-kappaB. Furthermore, the excessive activity of NF-kappaB in SIGIRR-knockout PAMs cell line, indicating that SIGIRR negatively regulated IL-1beta production by inhibiting the activation of [TG] Overall, PCV2-induced downregulation of SIGIRR induction of [TF] activation is a critical process in enhancing IL-1beta production in PAMs.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	1486	1415	0.00129910201236	Non valid	0.015443249434451729;0.9541103877008725;0.030446362864675742	ACTIVATION	31684202	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
14570	PMID:36772833:pubtator_title_and_abstract:9340cc478ca6eb68ef9fb1ab939d64fa:0:NLRP3:NF-kappaB:123:113	Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/[TG]/[TF] signalling pathway.	NLRP3	NF-kappaB	216799	18033	123	113	0.0011319248060521	Non valid	0.15490531963547968;0.8297379228016915;0.015356757562828949	ACTIVATION	36772833	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
14627	PMID:34851237:pubtator_title_and_abstract:6156d99472a2b9bbc61748025bf4d2b8:11:NF-kappaB:nuclear factor kappa B:1452:1428	Mechanistically, the expression of [TG] ([TF]) pathway decreased after Src inhibition.	NF-kappaB	nuclear factor kappa B	Complex:NFKB	18033	1452	1428	0.0016234017267587	Non valid	0.06106950037267755;0.3357245409951314;0.6032059586321911	REPRESSION	34851237	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
14650	PMID:36317732:pubtator_title_and_abstract:ff6626a41a5526cc790cd6a9e1e3c960:8:NF-kappaB:nuclear factor-kappaB:1105:1082	Furthermore, IRW showed LPS-neutralizing activity and could significantly inhibit LPS-induced activation of [TG] ([TF]) and mitogen-activated protein kinase (MAPK) signaling pathways.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	1105	1082	0.0011263614474442	Non valid	0.002615249221569608;0.9956067952131681;0.0017779555652623759	ACTIVATION	36317732	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
14732	PMID:20100315:pubtator_title_and_abstract:6971931590501c8a163e625a0355b39e:4:Tak1:NF-kappaB:422:619	RESULTS: Herein we report that NRAGE, via the same XIAP-[TF]-Tab1 complex, is required for the phosphorylation of IKK -alpha/beta and subsequent transcriptional activation of the p65 subunit of NF-kappaB. Ablation of endogenous NRAGE by siRNA inhibited [TG] pathway activation, while ablation of Tak1 and Tab1 by morpholino inhibited overexpression of NRAGE from activating NF-kappaB. Finally, cytokine profiling of an NRAGE over-expressing stable line revealed the expression of macrophage migration inhibitory factor.	Tak1	NF-kappaB	6885	4790	422	619	0.0012252873140209	Non valid	0.003997679904323287;0.9951584818414512;0.0008438382542255776	ACTIVATION	20100315	MAP3K7	9606	NFKB1	9606	ll_coTF		NFKB
14786	PMID:15164793:pubtator_title_and_abstract:98f90b6d7b03ca57f40ef9d25b9b2332:4:TGF-beta1:NF-kappaB:789:695	As the transcription factor nuclear factor kappa B (NF-kappaB) is crucially involved in mediating an inflammatory response by inducing the expression of cytokines and adhesion molecules, [TG] DNA binding and transcriptional activity as well as its impact on the expression of [TF] in EA.hy.926 endothelial cells were analysed subsequently to low-dose radiotherapy.	TGF-beta1	NF-kappaB	7040	4790	789	695	0.0023325679015829	Non valid	0.893378011456426;0.10378991705855675;0.0028320714850171495	UNDEFINED	15164793	TGFB1	9606	NFKB1	9606	ll_coTF		NFKB
14904	PMID:34572779:pubtator_title_and_abstract:8fdb24e45cd806ccaa799d988d0c4d3e:7:CAF:NFkappaB:824:1006	MT2A knockdown in the [TF]-like cells suppressed expression and secretion of insulin-like growth factor binding protein 2 (IGFBP2); recombinant IGFBP2 promoted migration and invasiveness of ESCC cells via [TG], Akt, and Erk signaling pathways.	CAF	NFkappaB	8850	4790	824	1006	0.0011908686940599	Non valid	0.07296866953358234;0.9221297709956682;0.004901559470749397	ACTIVATION	34572779	KAT2B	9606	NFKB1	9606	coTF		NFKB
15016	PMID:20388792:pubtator_title_and_abstract:13914dbc3fc13fba65a5ac6617d2b14d:4:AR:NF-kappaB:422:345	In the present study, we showed that [TG]/p52 can activate the AR, resulting in increased transactivation of [TF]-responsive genes, such as PSA and NKX3.1, in a ligand-independent manner.	AR	NF-kappaB	367	4790	422	345	0.0010709576769127	Non valid	0.007428028965125884;0.991592713968176;0.0009792570666980395	ACTIVATION	20388792	AR	9606	NFKB1	9606	dbTF		NFKB
15027	PMID:12490536:pubtator_title_and_abstract:44f6974466d86df3a7f99e1afdbd8f79:5:NF-kappaB:NF-kappaB:921:1004	Inhibition of AR attenuated TNF-alpha and hyperglycemia-induced activation of protein kinase C (PKC), phosphorylation of the inhibitory subunit of nuclear factor-kappaB ([TF]), and stimulation of NF-kappaB, but it did not prevent the activation of [TG] and PKC by phorbol ester.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	921	1004	0.001253167596463	Non valid	0.016194955768615574;0.9237675574141232;0.06003748681726115	ACTIVATION	12490536	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
15077	PMID:9510476:pubtator_title_and_abstract:9cf28e401febd850f2e7acf12f1fad04:0:IkappaB alpha:NF-kappaB:39:57	Characterization of mRNA expression of [TF] and [TG] subfamilies in primary adult T-cell leukemia cells.	IkappaB alpha	NF-kappaB	4792	4790	39	57	0.0011979897620368	Non valid	0.9858743390853009;0.012640314936239044;0.0014853459784600694	UNDEFINED	9510476	NFKBIA	9606	NFKB1	9606	coTF		NFKB
15219	PMID:28808068:pubtator_title_and_abstract:3bc8f30f9285b6fa84fcdc37a62bedf1:5:Smurf2:NF-kappaB:1039:1179	Mechanistic studies revealed that worsening kidney injury in ACE2 knockout mice was associated with an increase in Smurf2 (Smad-specific E3 ubiquitin protein ligase 2), a decrease in renal Smad7, and marked activation of TGF-beta (transforming growth factor beta)/Smad3 and NF-kappaB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling, suggesting that [TF]-dependent Smad7 ubiquitin degradation may be a key mechanism whereby loss of ACE2 promotes angiotensin II-induced TGF-beta/Smad3 and [TG]-mediated hypertensive nephropathy.	Smurf2	NF-kappaB	66313	18033	1039	1179	0.0013070910142405	Non valid	0.02576796679638225;0.07550168920138038;0.8987303440022375	REPRESSION	28808068	Smurf2	10090	Nfkb1	10090	coTF		NFKB
15287	PMID:11818506:pubtator_title_and_abstract:ec951487cf11b5672bf4cd2661306b9b:6:NF-kappaB:nuclear factor-kappaB:998:815	Analysis of [TG] (NF-kappaB) nuclear accumulation and binding to corresponding DNA consensus sequences indicated that in NGF-secreting responder cells, but not in nonresponders, [TF] is constitutively activated.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	998	815	0.0012458402791389	Non valid	0.3426501217672749;0.6541733301019034;0.0031765481308217553	ACTIVATION	11818506	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
15357	PMID:34964782:pubtator_title_and_abstract:ef1d96c4067541d48d7e29c4d8346396:9:HIF-1:NF-kappa B:1878:1904	AGE- Receptor of Advanced Glycation Endproducts (RAGE) signaling pathway in diabetic complications, IL-17 signaling pathway, hypoxia-inducible factor-1 ([TF]) signaling pathway, [TG] signaling pathway might serve as the principal pathways for RP treatment.	HIF-1	NF-kappa B	3091	4790	1878	1904	0.0011534960758132	Non valid	0.9522271620910155;0.04616242078043236;0.001610417128552119	UNDEFINED	34964782	HIF1A	9606	NFKB1	9606	dbTF		NFKB
15389	PMID:11429707:pubtator_title_and_abstract:7c2a82953914b3b0f967ced4215a83db:0:p53:NF-kappaB:59:21	Contrasting roles of [TG] and JNK in arsenite-induced [TF]-independent expression of GADD45alpha.	p53	NF-kappaB	7157	4790	59	21	0.0012184149497236	Non valid	0.4618532031796247;0.5087132339665669;0.029433562853808326	ACTIVATION	11429707	TP53	9606	NFKB1	9606	dbTF		NFKB
15410	PMID:31480226:pubtator_title_and_abstract:696bcbd814853a7d39e5c94314da95e4:7:nuclear factor kappa-light-chain-enhancer of activated B cells:NF-kappaB:1218:1282	Furthermore, the Western blot method was used to investigate the mechanism of compounds 6, 7, 10, and 16 by analysing the level of inflammation related proteins, such as inducible nitric oxide synthase (iNOS), interleukin-6 (IL-6), and [TF] ([TG]) in LPS-stimulated RAW264.7 cells.	nuclear factor kappa-light-chain-enhancer of activated B cells	NF-kappaB	Complex:NFKB	18033	1218	1282	0.001224029249446	Non valid	0.9908415500919754;0.0072091834630652885;0.001949266444959269	UNDEFINED	31480226	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
15652	PMID:24634836:pubtator_title_and_abstract:f171023ed27aa6be89eb567b3c54a968:2:Yap1:NF-kappaB:233:320	The regulatory mechanisms by which hydrogen peroxide (H2O2) modulates the activity of transcription factors in bacteria (OxyR and PerR), lower eukaryotes ([TF], Maf1, Hsf1 and Msn2/4) and mammalian cells (AP-1, NRF2, CREB, HSF1, HIF-1, TP53, [TG], NOTCH, SP1 and SCREB-1) are reviewed.	Yap1	NF-kappaB	10413	4790	233	320	0.0011909872393624	Non valid	0.9951300248406689;0.003206035918925702;0.0016639392404052783	UNDEFINED	24634836	YAP1	9606	NFKB1	9606	coTF		NFKB
15775	PMID:18452655:pubtator_title_and_abstract:0092b381a71deb1c7413615b413f381e:2:AP-1:NF-kappaB:344:330	A variety of anti-inflammatory agents have been shown to exert chemopreventive activity via targeting of transcription factors such as [TG] and [TF].	AP-1	NF-kappaB	16476	18033	344	330	0.00127562808813	Non valid	0.9273028406922791;0.06840749282686663;0.004289666480854354	UNDEFINED	18452655	Jun	10090	Nfkb1	10090	dbTF		NFKB
15816	PMID:17483545:pubtator_title_and_abstract:7ec958a99122a6032dde2fbb20c2feac:5:p65:NF-kappaB:662:693	Furthermore, [TF] and p50 subunits of active [TG] dimers were evaluated in endometriotic lesions to gain some insight into NF-kappaB-implicated pathways.	p65	NF-kappaB	5970	4790	662	693	0.0011473105767373	Non valid	0.5192085169550914;0.47793319716971616;0.0028582858751924722	UNDEFINED	17483545	RELA	9606	NFKB1	9606	dbTF		NFKB
15848	PMID:26202948:pubtator_title_and_abstract:483ea1668bf538738a5e17cac526398e:7:AKT:NF-kappaB:1020:1034	Antitumor activity was associated with PF-03084014-induced inhibition of Notch pathway signaling; decreased survival signals (cyclin E; MEK/ERK, PI3K/[TF], EGFR and [TG] pathway; BCL-2, BCL-XL); increased apoptotic signals (BAK, BAX; cleaved caspase-3); reduced microvessel density; reduced epithelial-mesenchymal transition; and reduced cancer stem-like cells in the tumor.	AKT	NF-kappaB	11651	18033	1020	1034	0.0012387336066982	Non valid	0.021728194654229926;0.9407483595992459;0.03752344574652414	ACTIVATION	26202948	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
15903	PMID:26555174:pubtator_title_and_abstract:3ecbe550cbc7ff1a3de1ab9f79e88c28:4:RelB:NF-kappaB:556:636	Here, we show that complete NF-kappaB inhibition by combined LPC-specific ablation of RelA, c-Rel, and [TF] did not phenocopy NEMO deficiency, but constitutively active IKK2-mediated [TG] activation prevented hepatocellular damage and HCC in NEMO(LPC-KO) mice.	RelB	NF-kappaB	19698	18033	556	636	0.0011555485156011	Non valid	0.013459579984491933;0.9277803290293947;0.05876009098611342	ACTIVATION	26555174	Relb	10090	Nfkb1	10090	dbTF		NFKB
15926	PMID:29104724:pubtator_title_and_abstract:0fba2ce8badfeff3bb63e19131540978:7:IkappaB-alpha:NF-kappaB:766:723	[TG], dihydroethidium (DHE), COX-2, p-[TF], TNFalpha, and CD45 expression were evaluated through immunohistochemistry, Western blot analysis, and qPCR.	IkappaB-alpha	NF-kappaB	18035	18033	766	723	0.0011926503838014	Non valid	0.9771887884283941;0.02011445696992519;0.002696754601680792	UNDEFINED	29104724	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
15950	PMID:29042497:pubtator_title_and_abstract:b448352b3cbdbd97f4c22129aa3ab7e7:9:NF-kappaB:NF-kappaB:1530:1480	To define the role of ldcA in pathogenesis, we demonstrate that ldcA disruption results in both loss of NOD1-dependent [TG] activation and decreased NOD2-dependent [TF] activation while not affecting Toll-like receptor (TLR) agonist release.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1530	1480	0.0011409329396602	Non valid	0.0021581132751148347;0.9955377630895194;0.002304123635365864	ACTIVATION	29042497	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
15952	PMID:20818435:pubtator_title_and_abstract:688f08df3c3709c922e62c9695fe69cc:4:IkappaB kinase (IKK)beta:NF-kappaB:726:713	In wild-type MEFs, RP3 upregulated CCL2, CXCL1, granulocyte-macrophage colony-stimulating factor and tumor necrosis factor expression and activated classical but not noncanonical NF-kappaB. RP3-activated [TG] in [TF](-/-) MEFs but not IKKalpha- or NF-kappaB essential modulator (NEMO)-deficient cells and activation was inhibited by a peptide that blocks NEMO binding to the IKKs.	IkappaB kinase (IKK)beta	NF-kappaB	16150	18033	726	713	0.0014590441061292	Non valid	0.032663575493548695;0.09839458729537362;0.8689418372110778	REPRESSION	20818435	Ikbkb	10090	Nfkb1	10090	coTF		NFKB
15985	PMID:26544695:pubtator_title_and_abstract:abf39d6d202a264c281bf6fe54346fd0:6:AP-1:NF-kappaB:663:652	IL-16 induced MMP-9 expression via the binding activity of transcription factors [TG], [TF], and Sp-1 motifs in VSMCs.	AP-1	NF-kappaB	3726	4790	663	652	0.0012065529350396	Non valid	0.06915210713768945;0.9292880251561628;0.0015598677061476425	ACTIVATION	26544695	JUNB	9606	NFKB1	9606	dbTF		NFKB
15995	PMID:29148232:pubtator_title_and_abstract:cdfeb2d2ebe0a4639159ed0e0e467f42:0:TGF-beta:NF-kappaB:144:130	Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the [TG] and [TF] pathways.	TGF-beta	NF-kappaB	7040	4790	144	130	0.0011389511832491	Non valid	0.9270569383860459;0.03678144150031657;0.036161620113637494	UNDEFINED	29148232	TGFB1	9606	NFKB1	9606	ll_coTF		NFKB
16068	PMID:26802647:pubtator_title_and_abstract:23bb59c4adc76f5543f4eeeec868dcb0:7:NF-kappaB:NF-kappaB:678:561	In the present study, we examined whether [TG] is involved in the chemoresistance of CCA and whether dehydroxymethylepoxyquinomicin (DHMEQ), an effective [TF] inhibitor, can overcome the drug resistance of CCA.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	678	561	0.001263549713926	Non valid	0.9663320410565258;0.025424408329754705;0.008243550613719468	UNDEFINED	26802647	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
16070	PMID:31870117:pubtator_title_and_abstract:0c738c68272029bf2cd8a285d6eb601c:3:XPO1:NF-kappaB:280:290	This study aimed to evaluate the association between the overexpression of [TF] with [TG], Ki67 and clinicopathological characteristics in colorectal cancer (CRC) tissue samples and to explore the anti-proliferative effect of KPT-330, as XPO1 inhibitor, in colorectal cancer cell line.	XPO1	NF-kappaB	7514	4790	280	290	0.0012216606908699	Non valid	0.9929701324250453;0.005398985179949527;0.001630882395005119	UNDEFINED	31870117	XPO1	9606	NFKB1	9606	coTF		NFKB
16087	PMID:35439615:pubtator_title_and_abstract:a7a814f5ad45dd139672eed7a7a40f44:11:ERK:NF-kappaB:1642:1646	Collectively, our studies indicate that blockage of TRPV4 prevents AF in SP mice by inhibiting NLRP3-inflammasome through the [TF]/[TG] signaling pathway.	ERK	NF-kappaB	26413	18033	1642	1646	0.0010877303686637	Non valid	0.2908866495905989;0.13415773545823054;0.5749556149511706	REPRESSION	35439615	Mapk1	10090	Nfkb1	10090	ll_coTF		NFKB
16232	PMID:24205328:pubtator_title_and_abstract:2e03a392acc2833fcfd25d3ad84aa6ea:9:ERK:NF-kappaB:1392:1405	GW843682X also inhibited LPS-induced activation of [TF], p38 and [TG], which contributed to LPS-induced up-regulation of TNF-alpha.	ERK	NF-kappaB	5594	4790	1392	1405	0.0011685854306464	Non valid	0.0026330256580936544;0.9953400661902005;0.002026908151705775	ACTIVATION	24205328	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
16435	PMID:37243262:pubtator_title_and_abstract:5469d154879bb92a2d83837e5883be74:6:STAT1:NF-kappaB:818:721	Our data generated in vitro suggest that multiple viral proteins can suppress host type I interferon production and signaling, including N, M, and P/C/V/W. The P gene products disrupt both IRF3 and [TG] dependent type I IFN production and block type I IFN signaling pathway by sequestering [TF] in the cytoplasm.	STAT1	NF-kappaB	6772	4790	818	721	0.0011170776261218	Non valid	0.009429513879461497;0.9861036119266088;0.004466874193929749	ACTIVATION	37243262	STAT1	9606	NFKB1	9606	dbTF		NFKB
16496	PMID:21169469:pubtator_title_and_abstract:a70a7542838e5704f9e798f70b213c64:9:TGF-beta:NF-kappaB:999:1077	[TF]-induced YY1 expression was dramatically decreased by an inhibitor of [TG], which blocked I-kappaB degradation.	TGF-beta	NF-kappaB	21803	18033	999	1077	0.001136231204617	Non valid	0.0014494132069399368;0.9962990271133342;0.002251559679725895	ACTIVATION	21169469	Tgfb1	10090	Nfkb1	10090	ll_coTF		NFKB
16497	PMID:23055050:pubtator_title_and_abstract:b084565acd98553c9723e412924ec497:8:cyclic AMP response element binding protein:nuclear factor-kappaB:1135:1294	A dramatic PKC-dependent increase of the phosphorylation of [TF] (CREB) and signal transducer and activator of transcription (STAT)-1 was observed, along with an activation of the [TG] (NF-kappaB) pathway, as reflected by a reduction of the inhibitory protein-kappa-Balpha (IkappaBalpha).	cyclic AMP response element binding protein	nuclear factor-kappaB	12912	18033	1135	1294	0.0011057801910399	Non valid	0.040271910151248126;0.9562354237819647;0.003492666066787285	ACTIVATION	23055050	Creb1	10090	Nfkb1	10090	dbTF		NFKB
16527	PMID:9378980:pubtator_title_and_abstract:3a7d62ac16f60097f1fb9eb74b8054f0:5:NF-IL-6:NF-kappa B:758:741	IL-6 induction paralleled increased DNA binding activity to the nuclear factor-kappa B ([TG])- and [TF]-recognized sites in the IL-6 promoter.	NF-IL-6	NF-kappa B	1051	4790	758	741	0.0012442565201222	Non valid	0.9499210295226325;0.048878342828221774;0.0012006276491457846	UNDEFINED	9378980	CEBPB	9606	NFKB1	9606	dbTF		NFKB
16571	PMID:20955770:pubtator_title_and_abstract:766109d0b29fc8c2c22a0fbfeafa9bdf:3:NF-kappaB:nuclear factor-kappa B:541:517	Here we demonstrate that TWEAK induces a dose-dependent increase in neuronal death and that this effect is independent of tumor necrosis factor alpha (TNF-alpha) and mediated by [TG] ([TF]) pathway activation.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	18033	541	517	0.0011040221670592	Non valid	0.012628654189217003;0.9862547128229078;0.001116632987875149	ACTIVATION	20955770	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
16606	PMID:25902734:pubtator_title_and_abstract:e5eddcb6b79ca6369bcd788d5d35c16d:8:nuclear factor kappa B:NF-kappaB:1076:1274	Using chromatin immunoprecipitation assays and expression analyses, CD47 expression was found to be regulated by [TF] (NF-kappaB) through a specific response element in the promoter of CD47, and the site occupancy and expression were increased and decreased upon stimulation and inhibition of [TG], respectively.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	4790	1076	1274	0.0010690586331719	Non valid	0.9645690763211764;0.013968317129718428;0.02146260654910516	UNDEFINED	25902734	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
16612	PMID:20574001:pubtator_title_and_abstract:4757e539860dd6d75957d6baaf3970f2:5:HIF-2alpha:NF-kappaB:1183:1298	siRNA-mediated knockdown of hypoxia inducible factor (HIF)-1alpha, [TF], and the NF-kappaB family member p65 revealed that hypoxic upregulation of ICAM-1 resulted from hypoxic [TG] induction but not from activation of HIFs.	HIF-2alpha	NF-kappaB	2034	4790	1183	1298	0.0016892512871631	Non valid	0.003901655888384829;0.9930557896353663;0.003042554476248801	ACTIVATION	20574001	EPAS1	9606	NFKB1	9606	dbTF		NFKB
16758	PMID:38001739:pubtator_title_and_abstract:3bb259acb3ef6575a5cf1d7491cfc5ea:7:NF-kappaB:nuclear factor-kappa B:1435:1411	The unique mechanism of action of EF24 involves modulation of the [TG] ([TF]) and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathways, disrupting cancer-promoting inflammation and oxidative stress.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	4790	1435	1411	0.0011160838967888	Non valid	0.9784903879627416;0.019344191045983;0.002165420991275498	UNDEFINED	38001739	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
16779	PMID:38165941:pubtator_title_and_abstract:8a7e91d81ae0736fc0761ad9de7db781:5:NCoR:nuclear factor kappa-B:1119:1425	Recent studies provide evidence that [TF]/HDAC3 complexes can also exert coactivator functions in brown adipocytes by deacetylating and activating PPARgamma coactivator 1alpha (PGC1alpha) and that signaling via receptor activator of nuclear factor kappa-B (RANK) promotes the formation of a stable NCoR/HDAC3/PGC1beta complex that coactivates [TG] (NFkappaB)- and activator protein 1 (AP-1)-dependent genes required for osteoclast differentiation.	NCoR	nuclear factor kappa-B	9611	4790	1119	1425	0.0010694217699887	Non valid	0.004676074815727015;0.9922980271245481;0.003025898059725015	ACTIVATION	38165941	NCOR1	9606	NFKB1	9606	dbTF		NFKB
16856	PMID:24023754:pubtator_title_and_abstract:09ce9115e8123c23e380ef0b05f0dece:7:p65:NF-kappaB:1255:1245	The analysis demonstrated that for both human and canine DLBCL there is activation of the [TG]/[TF] canonical pathway, indicating that canine lymphoma could be used as a model to study NF-kappaB-targeted therapeutics for human lymphoma.	p65	NF-kappaB	5970	4790	1255	1245	0.0011997106683339	Non valid	0.027191997039114072;0.9713036945506979;0.0015043084101881024	ACTIVATION	24023754	RELA	9606	NFKB1	9606	dbTF		NFKB
16887	PMID:32410941:pubtator_title_and_abstract:682ffe29062f6663df2192e3bc2adcc9:4:nuclear factor-kappaB:NF-kappaB:549:572	Engagement of RAGE contributed to neuroinflammation by upregulating [TF] ([TG]) as well as cytokines.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	549	572	0.0012256838980448	Non valid	0.02011982738987992;0.9700382359590047;0.009841936651115355	ACTIVATION	32410941	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
16954	PMID:15104118:pubtator_title_and_abstract:c74d50937cf5de4cadefb5c083076c98:10:NF-kappaB:NF-kappaB:1382:1234	The transient expression and electrophoretic mobility shift assays with the [TG] binding sites revealed that the o,p'-DDT-induced increase in the iNOS and proinflammatory cytokines expression level were mediated by the [TF] transcription factor.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1382	1234	0.0011484874185148	Non valid	0.14861068034540245;0.8475888098902141;0.003800509764383367	ACTIVATION	15104118	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
16957	PMID:30647194:pubtator_title_and_abstract:bef693a21795648128279b95a9c0e9a0:12:beta-catenin:NF-kappaB:1698:1664	PPAR gamma agonists induce the inhibition of several signaling pathways such as [TG], STAT, PI3K/Akt and WNT/[TF] pathway.	beta-catenin	NF-kappaB	1499	4790	1698	1664	0.00115293280831	Non valid	0.44455576079148873;0.5303196982605334;0.025124540947977867	ACTIVATION	30647194	CTNNB1	9606	NFKB1	9606	coTF		NFKB
16999	PMID:26843885:pubtator_title_and_abstract:45c0f1bcdf3316a878e72d9051360ef2:5:nuclear factor kappa B:NF-kappaB:475:499	Moreover, protein expression of [TF] ([TG]), insulin receptor substrate 1(IRS1), and glucose transporter 4 (GLUT4) in cells treated with OA were measured by Western blot analysis.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	4790	475	499	0.0011989138572076	Non valid	0.9594987041818915;0.03638837848833481;0.004112917329773597	UNDEFINED	26843885	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
17013	PMID:21765633:pubtator_title_and_abstract:df7afed66e6e7e57f39df90352c670c5:3:NF-kappaB.:NF-kappaB:340:652	To seek interactions between intestinal epithelial cells (IEC) and commensal bacteria, we screened 49 commensal strains for their capacity to modulate [TF] We used HT-29/kb-seap-25 and Caco-2/kb-seap-7 intestinal epithelial cells and monocyte-like THP-1 blue reporter cells to measure effects of commensal bacteria on cellular expression of a reporter system for NF-kappaB. Bacteria conditioned media (CM) were tested alone or together with an activator of [TG] to explore its inhibitory potentials.	NF-kappaB.	NF-kappaB	Complex:NFKB	4790	340	652	0.0026387448322566	Non valid	0.8801354658120968;0.05236460566190391;0.06749992852599943	UNDEFINED	21765633	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
17033	PMID:34028920:pubtator_title_and_abstract:c5c854835914d061dfa184af9e8dfe0d:4:NF-kappaB:Nuclear factor-kappaB:454:431	[TG] ([TF]) transcription factor has long been regarded as a pathogenic factor of IDD.	NF-kappaB	Nuclear factor-kappaB	Complex:NFKB	4790	454	431	0.0012553872961899	Non valid	0.9750746216442178;0.021787882476932762;0.003137495878849407	UNDEFINED	34028920	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
17136	PMID:30886640:pubtator_title_and_abstract:1d453c900c6f31c60ffba388a2528507:3:NF-kappaB:nuclear factor-kappaB:336:313	The c-Jun NH2-terminal kinase (JNK) activation and the transcription factor [TG] ([TF]) nuclear translocation have been found in I/R injury.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	336	313	0.0011864297648096	Non valid	0.17602800476732489;0.8191119692262002;0.004860026006474931	ACTIVATION	30886640	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
17168	PMID:12934082:pubtator_title_and_abstract:210169feebfca189507335537f3a969f:9:IkappaBalpha:NF-kappaB:1420:1530	However, unlike SS, dominant-negative [TF] (IkappaBdn) does not block apoptosis, suggesting that SS inhibits CD95L-mediated apoptosis in an [TG]-independent manner.	IkappaBalpha	NF-kappaB	4792	4790	1420	1530	0.0019080629970473	Non valid	0.05061873236979166;0.9107446582116042;0.038636609418604154	ACTIVATION	12934082	NFKBIA	9606	NFKB1	9606	coTF		NFKB
17353	PMID:32594651:pubtator_title_and_abstract:3f136dccb433fb24a2c5c316f9dfb9db:3:NF-kappaB:nuclear factor-kappa B:377:353	PTX-induced apoptosis is associated with p38 mitogen-activated protein kinase (p38 MAPK), extracellular signal-regulated kinase (ERK), [TG] ([TF]) and c-Jun N-terminal kinase or stress-activated protein kinase (JNK/ SAPK) pathways.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	4790	377	353	0.0011438436593119	Non valid	0.799816375548556;0.17336095929443876;0.02682266515700522	UNDEFINED	32594651	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
17379	PMID:22102915:pubtator_title_and_abstract:8ef1768cdb32bf6f83bcd9f8c4f656f9:14:erbB2:NFkappaB:2193:2203	Thus, [TF] and [TG] overexpression are relevant to chemoradiation resistance and are putative targets aimed at overcoming chemoradiation resistance in MIBC.	erbB2	NFkappaB	2064	4790	2193	2203	0.0019065520631409	Non valid	0.06056309761378348;0.9331010375022021;0.006335864884014505	ACTIVATION	22102915	ERBB2	9606	NFKB1	9606	ll_coTF		NFKB
17467	PMID:22579587:pubtator_title_and_abstract:c5fbc454da99869f6a27fd289df3d32f:10:BCL10:NF-kappaB:1878:1868	These results indicate that NF-kappaB binding to the BCL10 promoter can lead to prolonged activation of the carrageenan-induced inflammatory cascade by a transcriptional mechanism involving an [TG]-[TF] loop.	BCL10	NF-kappaB	8915	4790	1878	1868	0.0012336302183907	Non valid	0.04265059792634049;0.9558957467968174;0.001453655276842024	ACTIVATION	22579587	BCL10	9606	NFKB1	9606	coTF		NFKB
17488	PMID:20731882:pubtator_title_and_abstract:45a7c53ce33a6c9505e7646993ae583f:8:nuclear factor kappa B:NFkappaB:928:952	The expression of TLR5, the activation state of [TF] ([TG]) and mitogen-activated protein kinases (MAPKs) [extracellular related kinase (ERK) and c-jun-NH2 terminal kinase (JNK)], the production of cytokines [tumor necrosis alpha (TNFalpha), interleukin-1beta (IL-1beta), interleukin-6 (IL-6), macrophage inhibitory protein-2 (MIP-2) and soluble triggering receptor expressed on myeloid cells (TREM-1)], and the apoptotic cleavage of caspase-3 and its substrate Poly(ADP-ribose) polymerase (PARP) were determined in lung, liver, gut and kidney at different time-points.	nuclear factor kappa B	NFkappaB	Complex:NFKB	18033	928	952	0.0011046567963765	Non valid	0.12394917194048607;0.8728722635542759;0.0031785645052379973	ACTIVATION	20731882	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
17669	PMID:31351099:pubtator_title_and_abstract:cc73a9448f8a8e3ebc2e3274970575d6:10:p38:NF-kappaB:1205:1244	Inhibition of MAPK and transcriptional factor NF-kappaB was also validated by western blotting analysis of p-ERK, p-[TF], IKKalpha, IKKgamma, IkappaBalpha, [TG]-p65.	p38	NF-kappaB	26416	18033	1205	1244	0.0011531151329939	Non valid	0.8269147493897827;0.05338793429466951;0.11969731631554777	UNDEFINED	31351099	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
17726	PMID:34305604:pubtator_title_and_abstract:e1eca2d84d4a3773585f2d8ab2003394:0:Nrf2:NF-kappaB:148:116	Phenylethanoid Glycosides From Callicarpa kwangtungensis Chun Attenuate TNF-alpha-Induced Cell Damage by Inhibiting [TG] Pathway and Enhancing [TF] Pathway in A549 Cells.	Nrf2	NF-kappaB	4780	4790	148	116	0.0011553393932379	Non valid	0.054183955630902565;0.04475919158831229;0.9010568527807852	REPRESSION	34305604	NFE2L2	9606	NFKB1	9606	dbTF		NFKB
17785	PMID:25862169:pubtator_title_and_abstract:49649d530f673d360faf58d052e86cc1:7:NF-kappaB:NF-kappaB:1539:1613	Moreover, these reversible effects are attributable, at least in part, to downregulation of ATM-dependent [TF] signaling in MDA-MB-231 cells as RNAi-mediated knockdown of the [TG] subunit RelA or its upstream activator TG2 produced similar alterations in phenotype.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1539	1613	0.0011566384896298	Non valid	0.46167474809582126;0.5248426680736619;0.01348258383051683	ACTIVATION	25862169	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
17819	PMID:38004214:pubtator_title_and_abstract:f6d9a863d19922fabf77843142bf4da8:6:Stat3:NFkappaB:1157:1131	In addition, AFE elicited its anticancer activity through regulation of [TG]/IL-6/Stat3, JAK2/[TF], MAPKs, PI3K/AKT, and Wnt/beta-catenin signal transductions in AOM/DSS mice, which was consistent with a vitro model of CT26 cells, while APE treatment exhibited anticancer activity through regulation of Nrf2/IL-6, MAPKs, PI3K/AKT, and Wnt/beta-catenin signal transductions in the AOM/DSS mouse model.	Stat3	NFkappaB	20848	18033	1157	1131	0.0011566541901096	Non valid	0.9895723828327276;0.007403413464981848;0.0030242037022905647	UNDEFINED	38004214	Stat3	10090	Nfkb1	10090	dbTF		NFKB
17871	PMID:35588785:pubtator_title_and_abstract:c9174f7520fb6823132366313f9d0357:11:SGK1:NF-kappaB:1871:1890	Altogether, we demonstrated for the first time that SGK1 acts as a rheostat to limit P. gingivalis-induced inflammatory immune responses and mapped out a novel [TF]-TRAF2/3-c-Jun-[TG] signaling axis.	SGK1	NF-kappaB	20393	18033	1871	1890	0.001046960840311	Non valid	0.9906050801335337;0.008533791155229268;0.0008611287112369555	UNDEFINED	35588785	Sgk1	10090	Nfkb1	10090	ll_coTF		NFKB
17932	PMID:16928771:pubtator_title_and_abstract:d905a25344b8e65b5bf941356abd3eed:5:NF-kappaB:NF-kappaB:966:989	LPA induced a striking increase in IL-8 production and stimulated NF-kappaB activation, as measured by [TF]-DNA binding, [TG]-driven luciferase reporter activity, and IkappaBalpha phosphorylation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	966	989	0.0206530232495963	Non valid	0.02000739146397991;0.9789071262330183;0.0010854823030017199	ACTIVATION	16928771	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
17982	PMID:15272146:pubtator_title_and_abstract:f63319e690ce6e074335206b0ead9b52:5:NF-kappaB:NF-kappaB:1303:1074	RESULTS: We discovered a candidate [TG] site in promoter 3 of bdnf and showned that activation of N-methyl-D-aspartate (NMDA) inotropic glutamate receptors increased bdnf expression through an NF-kappaB-dependent pathway and extended the finding to show that [TF] was required for NMDA neuroprotection in vitro.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1303	1074	0.0011693239587781	Non valid	0.021478465167628462;0.9723823756799307;0.006139159152440789	ACTIVATION	15272146	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
18109	PMID:35792753:pubtator_title_and_abstract:35c511e01dab0be1e09bb33439cc6f51:8:TCF7:NFkappaB:959:999	[TF] and XCL1 were regulated by AKT and [TG], respectively through protein-protein network analysis.	TCF7	NFkappaB	21414	18033	959	999	0.0014172567929928	Non valid	0.9978949929603783;0.0012529459574042467;0.0008520610822175626	UNDEFINED	35792753	Tcf7	10090	Nfkb1	10090	dbTF		NFKB
18199	PMID:23072591:pubtator_title_and_abstract:c7b5f3ffc3262c45a8c6c3aa62fbac7b:10:p38:NF-kappaB:1623:1695	Similarly, CD40L-induced p-ERK and p-[TF] were also significantly reduced in lymphoma B cells, whereas p-p65 ([TG]) was equal to that of normal B cells.	p38	NF-kappaB	1432	4790	1623	1695	0.0011896073990641	Non valid	0.008033376194288991;0.9820928193282158;0.009873804477495257	ACTIVATION	23072591	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
18311	PMID:33240279:pubtator_title_and_abstract:2cc70a23aaa3690ce17d853621a7a220:6:HO-1:NF-kappaB:1070:1122	Exploration of the specific mechanism of action indicated that triptolide reduced the production of ROS, inhibited macrophage infiltration and M1-type polarization by activating the NRF2/[TF] signaling pathway, and inhibited the PDE4B/AKT/[TG] signaling cascade, which may help weaken the intestinal inflammatory response.	HO-1	NF-kappaB	15368	18033	1070	1122	0.0011866156849516	Non valid	0.11995260373602125;0.2743889677515799;0.6056584285123988	REPRESSION	33240279	Hmox1	10090	Nfkb1	10090	ll_coTF		NFKB
18318	PMID:19109151:pubtator_title_and_abstract:7c05ad933212122acb9ef7828882b050:10:p38:NF-kappaB:1314:1267	Whereas LPS-induced activation of [TG] and Erk1/2 appears to be unaffected, [TF] and Jnk were spontaneously activated and hyperinduced in cFLIP-deficient B cells.	p38	NF-kappaB	26416	18033	1314	1267	0.0012427076182202	Non valid	0.02400592681084247;0.9683908870693618;0.007603186119795739	ACTIVATION	19109151	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
18321	PMID:34309775:pubtator_title_and_abstract:b91783dcd132e011ff99beabb1975ecc:5:NF-kappaB:nuclear factor-kappaB:892:869	Abeta25-35-induced upregulation of Toll-like receptor 4 (TLR4) expression and nuclear translocation of [TG] ([TF]) p65 subunit were inhibited by pretreatment with SIN.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	892	869	0.0012560804113815	Non valid	0.023673304970805716;0.9742303458090772;0.002096349220117104	ACTIVATION	34309775	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
18337	PMID:19889580:pubtator_title_and_abstract:7914d9eed7bdddae3687dbe0d6258280:8:NF-kappaB:nuclear factor-kappaB:1258:1235	Using a luciferase reporter assay, we also showed that hsa-miR-601 specifically repressed [TG] ([TF]) transcription factor-dependent reporter expression, a key component of the immune-oncogenesis pathway.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	1258	1235	0.0011382600075517	Non valid	0.006276514743093423;0.9919021226502622;0.001821362606644411	ACTIVATION	19889580	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
18394	PMID:32020859:pubtator_title_and_abstract:9365cce0fbbb35f7360bb6a36195c9d1:2:NF-kappaB:nuclear factor kappa B:315:291	BACKGROUND: Cordyceps militaris (L.) Fr. (C. militaris) exhibits pharmacological activities, including antitumor properties, through the regulation of the [TG] ([TF]) signaling.	NF-kappaB	nuclear factor kappa B	Complex:NFKB	4790	315	291	0.0011173753584052	Non valid	0.9941088132611794;0.004673873995150377;0.001217312743670213	UNDEFINED	32020859	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
18504	PMID:21426659:pubtator_title_and_abstract:9817364f1944729014e74e4c3f275f17:3:Raf-1:NFkappaB:256:295	RKIP is an endogenous inhibitor of the [TF]-MEK1/2-ERK1/2 signaling pathway, [TG] signaling pathway and G protein coupled receptors signaling pathway.	Raf-1	NFkappaB	5894	4790	256	295	0.0012404078126617	Non valid	0.15639750268631236;0.8367227116386536;0.006879785675033929	ACTIVATION	21426659	RAF1	9606	NFKB1	9606	ll_coTF		NFKB
18576	PMID:33266352:pubtator_title_and_abstract:071caa2e75e6d21a4e9a998f6b1190ad:4:cRel:NF-kappaB:453:370	However, existing [TG] inhibitors do not discriminate between its subunits, namely, RelA, RelB, [TF], p50, and p52.	cRel	NF-kappaB	5966	4790	453	370	0.0011313095529745	Non valid	0.9283983809611239;0.06283237202968886;0.00876924700918721	UNDEFINED	33266352	REL	9606	NFKB1	9606	dbTF		NFKB
18580	PMID:23331079:pubtator_title_and_abstract:3a3981f97d71c3c213deda2fb677ff28:7:AP-1:NF-kappaB:1339:1347	Treatment of IL-1beta-stimulated human CEC with either [TF] or [TG] antagonists decreased FGF2 expression and resulted in reduced IL-1beta-enhanced cell migration.	AP-1	NF-kappaB	3726	4790	1339	1347	0.0011183545222614	Non valid	0.00513311181347373;0.9817383465709515;0.013128541615574732	ACTIVATION	23331079	JUNB	9606	NFKB1	9606	dbTF		NFKB
18619	PMID:25296760:pubtator_title_and_abstract:a690c1a8ab7452b87aa94dc7e58d7ca4:4:NF-kappaB Essential Modulator:NF-kappaB:379:443	NEMO ([TF]) is a central player in canonical [TG] signaling whose major function is to bind to Lys-63- and/or M1- (or linear) linked polyubiquitin chains generated in response to cell stimulation.	NF-kappaB Essential Modulator	NF-kappaB	8517	4790	379	443	0.0012004945721174	Non valid	0.4400794324611653;0.5575422875750551;0.002378279963779625	ACTIVATION	25296760	IKBKG	9606	NFKB1	9606	coTF		NFKB
18657	PMID:18448428:pubtator_title_and_abstract:592efbbae4d1bb1737a9f9e683f01caf:9:NF-kappaB:NF-kappaB:1533:1504	Taken together, our data suggest SDF-1alpha/CXCR4 may promote HNSCC invasion and metastasis by activating [TG] and that targeting [TF] may provide therapeutic opportunities in preventing HNSCC metastasis mediated by SDF-1alpha.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1533	1504	0.0011434046320492	Non valid	0.02714380165566723;0.963512086419728;0.009344111924604817	ACTIVATION	18448428	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
18662	PMID:18662246:pubtator_title_and_abstract:d68fe9128de26bdd64610d34fe6c9f55:8:NFkappaB.:NFkappaB:1671:1751	The activation of NFkappaB was associated with increased iNOS protein expression and NO generation, and these changes were blocked by BAY 11-7082, an inhibitor of [TF] Additionally, ammonia-induced astrocyte swelling was inhibited by the [TG] inhibitors, BAY 11-7082 and SN-50, thereby implicating NFkappaB in the mechanism of astrocyte swelling.	NFkappaB.	NFkappaB	Complex:NFKB	4790	1671	1751	0.0012764156391012	Non valid	0.03315860604566165;0.9568019580370383;0.010039435917300124	ACTIVATION	18662246	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
18747	PMID:19752240:pubtator_title_and_abstract:f29dcb522480248a2e1a8e1331ccd85b:3:NF-kappaB:NF-kappaB:545:741	At variance to skin from patients with atopic dermatitis or from healthy subjects, human psoriatic skin lesions exhibit strong activation of transcription factor NF-kappaB that is mainly confined to dermal macrophages, whereas only a few dendritic cells but no CD3+ lymphocytes show activated NF-kappaB. Since [TF] signaling is required for the induction and/or function of many cytokines and aberrant cytokine expression has been proposed as an underlying cause of psoriasis, we investigated whether [TG] targeting would affect the course of the disease in the CD18 hypomorphic (CD18(hypo)) mouse model of psoriasis.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	545	741	0.0010650671754096	Non valid	0.9743575506504294;0.023358866411031468;0.0022835829385390955	UNDEFINED	19752240	NFKB	9606	Nfkb1	10090	dbTF	NFKB	NFKB
18758	PMID:28858735:pubtator_title_and_abstract:2f74c75ae4870c2c0167199d4b46123c:9:NF-kappaB:Nuclear factor kappa-B:1329:1305	Also, we found that linarin-reduced cellular proliferation of glioma was dependent on p53 up-regulation and [TG] ([TF])/p65-down-regulation, thereby inhibiting glioma cell growth.	NF-kappaB	Nuclear factor kappa-B	Complex:NFKB	4790	1329	1305	0.0011441904791054	Non valid	0.024710568755805264;0.03630129126936856;0.9389881399748262	REPRESSION	28858735	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
18906	PMID:12151316:pubtator_title_and_abstract:8d9a17f7f1e3dd6574391cd273ce79e5:4:activator protein (AP)-1:NF-kappaB:648:753	Mutational analysis of the 5' flanking region of the IL-8 gene revealed that [TF]-binding element, but not that element responsive to nuclear factor (NF)-IL-6 or [TG], was necessary for MG132 stimulation.	activator protein (AP)-1	NF-kappaB	3726	4790	648	753	0.0011297079065055	Non valid	0.07071728183425251;0.9278173402955122;0.0014653778702353143	ACTIVATION	12151316	JUNB	9606	NFKB1	9606	dbTF		NFKB
18928	PMID:34201243:pubtator_title_and_abstract:0298b03bb1e8c9f004eff9511ab63a59:8:STAT1:NF-kappaB.:1248:1270	These results were associated with the regulation of the expression of several genes, including those encoding for [TF], STAT2, p53 and [TG] Irinotecan did not modulate these responses in both untreated cells and cells stimulated with ONNV.	STAT1	NF-kappaB.	6772	4790	1248	1270	0.0011530668031643	Non valid	0.9363351350159989;0.060927783711185006;0.0027370812728161457	UNDEFINED	34201243	STAT1	9606	NFKB1	9606	dbTF		NFKB
18945	PMID:31332287:pubtator_title_and_abstract:b153499f13e565c3833b4dddfcca3c07:6:YAP:NFkappaB:809:1042	Luciferase activity from a synthetic TEAD-dependent [TF]/TAZ-responsive reporter, as a direct readout of the Hippo signaling pathway, was decreased by 92% in cells with USP39 knockdown, whereas the luciferase activities from the other six cancer pathways, including MAPK/ERK, MAPK/JNK, [TG], Notch, TGFbeta, and Wnt, remained unchanged.	YAP	NFkappaB	10413	4790	809	1042	0.001349588493058	Non valid	0.5176271990526204;0.4719119364719158;0.01046086447546373	UNDEFINED	31332287	YAP1	9606	NFKB1	9606	coTF		NFKB
19036	PMID:31998441:pubtator_title_and_abstract:9f07d07adfba341ad5e6d3899bff2c24:10:NF-kappaB:nuclear factor kappa B:1739:1715	More importantly, serotonin activated [TG] ([TF]) and upregulated the hepatic expressions of high mobility group protein B1 (HMGB1), toll-like receptor-4 (TLR4), and downstream molecules in Con A-mediated liver injury.	NF-kappaB	nuclear factor kappa B	Complex:NFKB	18033	1739	1715	0.0011671464598986	Non valid	0.0038716203122522346;0.9943994158165137;0.0017289638712341877	ACTIVATION	31998441	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
19144	PMID:29956762:pubtator_title_and_abstract:0699a431f61f6ba25ee7abcf5a40df72:10:NF-kappaB:NF-kappaB:1390:1323	Additionally, rCC16 treatment inhibited the DNA binding of [TG]/p65 in lung tissues and reduced nuclear translocation of [TF]/p65 in BALF and epithelial cells.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1390	1323	0.0012245257303844	Non valid	0.05141812601609056;0.9459419161642895;0.0026399578196200694	ACTIVATION	29956762	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
19183	PMID:32454852:pubtator_title_and_abstract:36ba6e2df7da82cd4318a3f2ae53901e:5:Nrf2:NF-kappaB:1108:889	AVEE was found to suppress the [TG] signaling pathway, thus, to reduce proinflammatory cytokine, nitric oxide, and prostaglandin levels in peritoneal macrophages and Raw 264.7 cells treated with LPS, and to enhance HO-1 expression by activating [TF] signaling.	Nrf2	NF-kappaB	18024	18033	1108	889	0.0011729643790577	Non valid	0.045723134443878835;0.6098382016964992;0.344438663859622	ACTIVATION	32454852	Nfe2l2	10090	Nfkb1	10090	dbTF		NFKB
19187	PMID:21777697:pubtator_title_and_abstract:86542e4066f99066e9a8404f331da8ed:6:NF-kappaB:NF-kappaB:1257:1166	A further analysis indicated that ZLJ-6 attenuated TNF-alpha-induced nuclear translocation of [TG], IkappaB phosphorylation, IkappaB kinase beta (IKKbeta) activity, and subsequent [TF]-DNA complex formation, suggesting that NF-kappaB pathway was involved in TNF-alpha-induced inflammation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1257	1166	0.0011344748040002	Non valid	0.5406632314872171;0.45634110661662197;0.0029956618961609113	UNDEFINED	21777697	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
19198	PMID:36605523:pubtator_title_and_abstract:8f7193c99bbdd5aa5e1cd3759be2a16f:17:PPARgamma:NF-kappaB:2179:2189	Overall, the present study suggested that FX could ameliorate oxidative damage as well as inflammation in CSE-treated human bronchial epithelial in patients with COPD via modulating the [TF]/[TG] signaling pathway.	PPARgamma	NF-kappaB	5468	4790	2179	2189	0.0011047709788908	Non valid	0.9897858932992643;0.007879300110062059;0.002334806590673806	UNDEFINED	36605523	PPARG	9606	NFKB1	9606	dbTF		NFKB
19203	PMID:26114112:pubtator_title_and_abstract:9bd53b457a7d931a66c33066cfd482d5:7:NF-kappaB:NF-kappaB:905:1020	AGEs significantly increased RAGE expression in macrophages and activated [TF] pathway, and the aforementioned effects were partly abolished by administration of anti-RAGE antibody or [TG] inhibitor PDTC.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	905	1020	0.0011551204056084	Non valid	0.012784644185344553;0.9855575225855558;0.0016578332290996033	ACTIVATION	26114112	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
19285	PMID:27071417:pubtator_title_and_abstract:25fc05fd3434736bfd4b3b83eae4f2f4:4:MALT1:NF-kappaB:654:716	We investigated the mechanism by which CARD14 mutation in psoriasis activates NF-kappaB. In contrast with wild-type CARD14, CARD14(E138A) and CARD14(G117S) psoriasis mutants interacted constitutively with BCL10 and [TF], and triggered BCL10- and MALT1-dependent activation of [TG] in keratinocytes.	MALT1	NF-kappaB	10892	4790	654	716	0.0073670825856691	Non valid	0.017431405442496762;0.9742756779595851;0.008292916597918112	ACTIVATION	27071417	MALT1	9606	NFKB1	9606	coTF		NFKB
19432	PMID:26378077:pubtator_title_and_abstract:17903f92747578dd8ae666c9266b3792:8:IKKalpha:NF-kappaB:1041:1108	In addition, phosphorylation of DBC1 at its C terminus by IKKalpha facilitates its interaction with RelB and [TF], indicating that DBC1-mediated suppression of alternative [TG] is regulated by IKKalpha.	IKKalpha	NF-kappaB	12675	18033	1041	1108	0.1054254336453307	Non valid	0.5266724341814999;0.27407788840920205;0.19924967740929797	UNDEFINED	26378077	Chuk	10090	Nfkb1	10090	coTF		NFKB
19504	PMID:24502419:pubtator_title_and_abstract:51b5b2dcdd82b759392c7b98143aceee:12:nuclear factor-kappaB:NF-kappaB:1840:1863	Further mechanism assays suggested that miR-21 regulated lipid accumulation by Toll-like receptor 4 (TLR4) and [TF] ([TG]) pathway as pretreatment with anti-TLR4 antibody or a specific inhibitor of NF-kappaB (PDTC) strikingly dampened miR-21 silence-induced lipid deposition.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	1840	1863	0.0011006581274646	Non valid	0.9496052701575349;0.040586649830343484;0.009808080012121655	UNDEFINED	24502419	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
19534	PMID:19351843:pubtator_title_and_abstract:a93a3fee2c29fad5836d201a95748435:8:TbetaRII:NF-kappaB:1519:1632	Finally, experiments with [TF] conditional knockout mice show that abrogation of TGFbeta signaling promotes the sustained induction of [TG] and its proinflammatory target genes during HNSCC tumorigenesis and progression.	TbetaRII	NF-kappaB	21813	18033	1519	1632	0.1640986602668152	Non valid	0.009463161619943795;0.011684574238232286;0.9788522641418239	REPRESSION	19351843	Tgfbr2	10090	Nfkb1	10090	ll_coTF		NFKB
19537	PMID:23533581:pubtator_title_and_abstract:ef74fe6fc3a512cff7052a1e678cbaf1:3:MyD88:NF-kappaB:312:361	CpG-ODN activates the TLR9/[TF]/TRAF6 cascade leading to activation of IKK-[TG] and JNK, which are critical for production of pro-inflammatory cytokines.	MyD88	NF-kappaB	4615	4790	312	361	0.0090059243913085	Non valid	0.004055184015780926;0.9950779623922652;0.0008668535919539729	ACTIVATION	23533581	MYD88	9606	NFKB1	9606	coTF		NFKB
19557	PMID:26358194:pubtator_title_and_abstract:83523b95d04504e88be53ed80372e296:4:nuclear factor erythroid 2-related factor 2:nuclear factor-kappaB:632:724	The present study aimed to evaluate the potential involvement of di-O-demethylcurcumin, an analog of curcuminoid, on Abeta-induced neurotoxicity in culture neuroblastoma cells (SK-N-SH cells) through the activation of [TF] (Nrf2) signaling pathway and the suppression of [TG] (NF-kappaB) signaling pathway and their downstream targets.	nuclear factor erythroid 2-related factor 2	nuclear factor-kappaB	4780	4790	632	724	0.001311014926952	Non valid	0.07742430230862019;0.028753930061238483;0.8938217676301413	REPRESSION	26358194	NFE2L2	9606	NFKB1	9606	dbTF		NFKB
19597	PMID:31688605:pubtator_title_and_abstract:a50421dc57a0ce51b07fe6e2c30893da:6:p65:NF-kappaB:706:736	The expression levels of p65 and p-[TF] were detected to evaluate [TG] activity.	p65	NF-kappaB	5970	4790	706	736	0.0016934440168899	Non valid	0.8761841227775913;0.11691325345865661;0.006902623763752069	UNDEFINED	31688605	RELA	9606	NFKB1	9606	dbTF		NFKB
19600	PMID:29180720:pubtator_title_and_abstract:8431ba38c45ae73f335db22186b71e51:5:activator protein 1:NF-kappaB:606:661	SNX27 silencing in human T cells enhanced T cell receptor (TCR)-stimulated [TF] (AP-1)- and nuclear factor kappaB ([TG])-mediated transcription.	activator protein 1	NF-kappaB	3726	4790	606	661	0.0011232498376016	Non valid	0.00353627726851333;0.9932231450703741;0.0032405776611124796	ACTIVATION	29180720	JUNB	9606	NFKB1	9606	dbTF		NFKB
19647	PMID:28400607:pubtator_title_and_abstract:cb95d0ea43db311045500920993a5f5a:6:PID1:NFkappaB:961:1000	Etoposide and cisplatin increased NFkappaB promoter reporter activity and etoposide induced nuclear translocation of NFkappaB. Etoposide also increased PID1 promoter reporter activity, PID1 mRNA, and [TF] protein, which were diminished by [TG] inhibitors JSH-23 and Bay117082.	PID1	NFkappaB	55022	4790	961	1000	0.0011507551041126	Non valid	0.004634336790276776;0.9865774865520552;0.00878817665766797	ACTIVATION	28400607	PID1	9606	NFKB1	9606	coTF		NFKB
19662	PMID:20685965:pubtator_title_and_abstract:a9aef66aeaf1320cc168d9651ed3d369:8:p65:NF-kappaB:1178:1257	Rather, we reveal a tonicity-dependent interaction between TonEBP and [TF] and show that NF-kappaB activity is considerably enhanced after binding of [TG]-TonEBP complexes to kappaB elements of NF-kappaB-responsive genes.	p65	NF-kappaB	5970	4790	1178	1257	0.0011094610412575	Non valid	0.08769683822212646;0.9100375326531873;0.002265629124686289	ACTIVATION	20685965	RELA	9606	NFKB1	9606	dbTF		NFKB
19694	PMID:25084093:pubtator_title_and_abstract:af2ac3d89de3e5223609d30bbd1104d9:7:NF-kappaB:NF-kappaB:971:822	By detecting the [TG] signaling pathway, we discover that the protective effect of ginsenoside Rb3 on the OGD-Rep injury is closely related to the inhibition of [TF] activity.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	971	822	0.0011975584949536	Non valid	0.14749884526334064;0.7987347031831561;0.05376645155350331	ACTIVATION	25084093	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
19751	PMID:10713122:pubtator_title_and_abstract:ba84607ffb9f7d7bdcf4319f7ed733e5:5:HER-2/neu:NF-kappaB:527:642	Blocking of the Akt pathway by a dominant-negative Akt sensitizes the [TF]-overexpressing cells to TNF-induced apoptosis and inhibits IkappaB kinases, IkappaB phosphorylation, and [TG] activation.	HER-2/neu	NF-kappaB	2064	4790	527	642	0.0015521847569125	Non valid	0.0038863431275785168;0.9929538212516777;0.003159835620743791	ACTIVATION	10713122	ERBB2	9606	NFKB1	9606	ll_coTF		NFKB
19810	PMID:27295129:pubtator_title_and_abstract:feb8603bd08ea024ff0e9fa772022769:8:HIST1H2AJ:NFkappaB:1440:1526	We found that dysregulation of miR-29C, miR-34A, miR-98, and miR-215; and methylation of ANKRD1, ARID5B, CDCA2, PIF1, STAMBPL1, TROAP, ZNF165, and [TF] in HeLa cells could result in cell proliferation and anti-apoptosis through [TG], TGF-beta, and PI3K pathways.	HIST1H2AJ	NFkappaB	8331	4790	1440	1526	0.0011580027461098	Non valid	0.9969254568412838;0.0017288167762938835;0.0013457263824223878	UNDEFINED	27295129	H2AC14	9606	NFKB1	9606	coTF		NFKB
19893	PMID:33473265:pubtator_title_and_abstract:abc4ceb16e9546a4f5191a8592651c69:6:ERK1/2:NF-kappaB:919:971	Further, fisetin also suppresses the activation of the PKCalpha/ROS/[TF] and p38 MAPK signaling pathways, reduces the [TG] activation, and down-regulates the level of the oncoprotein securin.	ERK1/2	NF-kappaB	5595;5594	4790	919	971	0.0015452655137761	Non valid	0.0021260160325207596;0.9958701873436896;0.0020037966237896865	ACTIVATION	33473265	MAPK3;MAPK1	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
19898	PMID:10405163:pubtator_title_and_abstract:1e3a6a95de0264b0dae6d38f9078575b:3:NF-kappaB:nuclear factor-kappaB:343:320	IKK proteins play a central role in cell signaling by regulating [TG] ([TF]) activation.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	343	320	0.0011989646773968	Non valid	0.41230002059521254;0.5744381126619504;0.013261866742837011	ACTIVATION	10405163	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
19932	PMID:30655862:pubtator_title_and_abstract:bd1d038191cc521ec3e7bf91bcb89052:9:NF-kappaB:NF-kappaB:1423:1349	The RT-qPCR results showed that NF-kappaB and MDR1 mRNA expression in HepG-2 cells was very low, while NF-kappaB and MDR1 mRNA expression in HepG-2/ADM cells was significantly increased, and western blot results showed that [TG] and MDR1 protein expression in HepG-2 cells was very low, while [TF] and MDR1 protein expression in HepG-2/ADM cells was increased significantly.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1423	1349	0.0013166179577063	Non valid	0.04493678715290502;0.9332049859014946;0.021858226945600332	ACTIVATION	30655862	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
19971	PMID:29277893:pubtator_title_and_abstract:29294b52daf8d1a4483f3b3afcff2a95:0:Akt:NF-kappaB:62:66	DCLK1 promotes epithelial-mesenchymal transition via the PI3K/[TF]/[TG] pathway in colorectal cancer.	Akt	NF-kappaB	207	4790	62	66	0.0010871960733611	Non valid	0.35708852386229545;0.6337009117552406;0.009210564382464018	ACTIVATION	29277893	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
20096	PMID:21843371:pubtator_title_and_abstract:8ea52fabbdbd2d9c6660e4f5578c3380:12:NF-kappaB:NF-kappaB:1700:1811	These results suggest that lung cancer cells become resistant to gemcitabine via [TF] activation and the subsequent overexpression of Bfl-1, and that BC, which has both pro-apoptotic and [TG] inhibitory effects, could be harnessed as a gene therapy to complement gemcitabine chemotherapy in non-small cell lung cancer.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1700	1811	0.0012977679479609	Non valid	0.003617077805173256;0.004796786399288425;0.9915861357955383	REPRESSION	21843371	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
20158	PMID:23870485:pubtator_title_and_abstract:30a44d99fd4964c42a43414cb0de7d9c:10:SIRT1:NFkappaB.:1641:1690	Further investigations indicated enhanced expression of [TF] on the mRNA levels in cells overexpressing [TG] A functional assay showed that acetylation of one of the main target proteins of SIRT1 is reduced in these cells.	SIRT1	NFkappaB.	23411	4790	1641	1690	0.0012054722427693	Non valid	0.020157050334905106;0.974111089126137;0.0057318605389578775	ACTIVATION	23870485	SIRT1	9606	NFKB1	9606	coTF		NFKB
20166	PMID:22683888:pubtator_title_and_abstract:26a5d90c93931020aa7a7dac95e6e3aa:9:PPARbeta/delta:NF-kappaB:1468:1256	Consistent with a role for [TG] in the changes caused by TNF-alpha, treatment with the NF-kappaB inhibitor parthenolide restored PPAR DNA-binding activity, the expression of PPARbeta/delta-target genes and the expression of SIRT1 and [TF].	PPARbeta/delta	NF-kappaB	5467	4790	1468	1256	0.0019105696309096	Non valid	0.9291536306510847;0.04909354621961293;0.02175282312930245	UNDEFINED	22683888	PPARD	9606	NFKB1	9606	dbTF		NFKB
20189	PMID:16707452:pubtator_title_and_abstract:d766c502d1b77c10e9cf073604d398d8:7:IkappaB kinase gamma:NF-kappaB:1044:1101	Polyubiquitination of [TF] (IKKgamma), indicative for enhanced [TG] activation, was increased in splenic lymphocytes and promoted the survival of B cells ex vivo.	IkappaB kinase gamma	NF-kappaB	16151	18033	1044	1101	0.0225888904112813	Non valid	0.02261659876604826;0.9753967789918141;0.0019866222421376025	ACTIVATION	16707452	Ikbkg	10090	Nfkb1	10090	coTF		NFKB
20210	PMID:15670752:pubtator_title_and_abstract:d9b11d97382a7f17db05d3b7584ccfe5:8:nuclear factor-kappaB:NF-kappaB:1252:1275	In addition, TPA induced [TF] ([TG]) activation, which was shown by increased nuclear translocation of p65 NF-kappaB and degradation of IkappaB-alpha, a NF-kappaB inhibitory protein.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	1252	1275	0.0011510475479574	Non valid	0.0033778279794036874;0.9957732600737557;0.0008489119468406773	ACTIVATION	15670752	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
20334	PMID:25386046:pubtator_title_and_abstract:d679b9a49c395f6d86273c8aae3ffdd2:0:AP-1:NF-kappaB:10:0	[TG]/[TF]-targeted inhibition of macrophage-mediated inflammatory responses by depigmenting compound AP736 derived from natural 1,3-diphenylpropane skeleton.	AP-1	NF-kappaB	16476	18033	10	0	0.0011607651072262	Non valid	0.13489211482257404;0.032048197373402344;0.8330596878040237	REPRESSION	25386046	Jun	10090	Nfkb1	10090	dbTF		NFKB
20476	PMID:28924147:pubtator_title_and_abstract:ba4d98c3463d6d4941898368321d80f1:3:DPF2:NF-kappaB:333:385	We previously reported that the d4-family proteins (DPF1, [TF], DPF3a/b) function as adaptor proteins linking [TG] with the SWI/SNF complex.	DPF2	NF-kappaB	19708	18033	333	385	0.0012724078960871	Non valid	0.9944901718141645;0.00419934870504982;0.0013104794807856407	UNDEFINED	28924147	Dpf2	10090	Nfkb1	10090	coTF		NFKB
20639	PMID:26032013:pubtator_title_and_abstract:ea5e20c0b7e43de2d69a4278a98c97ed:7:IRF3:nuclear factor-kappaB:1201:1131	Results showed that FC-98 blocked activation of the c-Jun N-terminal kinase (JNK), [TG] (NF-kappaB) and interferon regulatory factor 3 ([TF]) signaling pathways.	IRF3	nuclear factor-kappaB	54131	18033	1201	1131	0.0011593771688268	Non valid	0.0026859151878589637;0.9957805791075511;0.0015335057045898404	ACTIVATION	26032013	Irf3	10090	Nfkb1	10090	dbTF		NFKB
20941	PMID:35885510:pubtator_title_and_abstract:eab93873959f7d5ee7b49899ed673103:5:TGFbeta:NFkappaB:874:968	Gene expression of 20 stroma-derived factors, including the androgen receptor (AR), chaperones (HSPA1A and HSF1), growth factors (FGF2, FGF7, FGF10, HGF, PDGFB, and [TF]), proteins implicated in invasion (MMP2, MMP9, and MMP11), inflammation (IL6, IL17RB, [TG], and STAT3), and in-stroma/epithelium interaction (CDH11, CXCL12, CXCL14, and FAP), was evaluated.	TGFbeta	NFkappaB	7040	4790	874	968	0.0011438303117094	Non valid	0.9340473272587393;0.06287720594026577;0.0030754668009949165	UNDEFINED	35885510	TGFB1	9606	NFKB1	9606	ll_coTF		NFKB
20969	PMID:20388715:pubtator_title_and_abstract:0f84ec0a4ab78b5d52b6e9e94fa3e674:4:MyD88:NF-kappaB:626:780	Likely contributing to this unique functional profile, intestinal macrophages expressed markedly down-regulated adapter proteins [TF] and Toll interleukin receptor 1 domain-containing adapter-inducing interferon beta, which together mediate all TLR MyD88-dependent and -independent [TG] signaling, did not phosphorylate NF-kappaB p65 or Smad-induced IkappaBalpha, and did not translocate NF-kappaB into the nucleus.	MyD88	NF-kappaB	4615	4790	626	780	0.0011447254903676	Non valid	0.08446622656985538;0.9115484304268251;0.003985343003319535	ACTIVATION	20388715	MYD88	9606	NFKB1	9606	coTF		NFKB
21073	PMID:18262561:pubtator_title_and_abstract:9d38b81f83867a1bed5847451ee939d3:11:NF-kappaB:NF-kappaB:1469:1505	Clonidine also significantly enhanced LPS-induced NF-kappaB activation by enhancing the nuclear translocation of [TF] as well as increasing the [TG]-DNA binding activity.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1469	1505	0.0011550893215293	Non valid	0.0707168436677774;0.926071202809002;0.003211953523220662	ACTIVATION	18262561	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
21151	PMID:8657113:pubtator_title_and_abstract:f2e427a3d03c0ad8c08c5d0375fcf2d2:3:IkappaBalpha:NF-kappaB:532:317	[TG]/Rel proteins are coupled to inhibitory molecules, collectively termed IkappaB, which are responsible for cytoplasmic retention of NF-kappaB. Cell activation leads to the phosphorylation and degradation of [TF], permitting NG-kappaB/Rel translocation to the nucleus and target gene activation.	IkappaBalpha	NF-kappaB	4792	4790	532	317	0.0012461900919883	Non valid	0.06413789696586678;0.6806948211018911;0.2551672819322423	ACTIVATION	8657113	NFKBIA	9606	NFKB1	9606	coTF		NFKB
21237	PMID:30756140:pubtator_title_and_abstract:feacd7483bf81128841dd08ee8e193b5:5:nuclear factor kappa B:NFkappaB:716:740	The mutations interfere with normal processing of RANK and cause osteoclast activation through activation of [TF] ([TG]) independent of RANK ligand stimulation.	nuclear factor kappa B	NFkappaB	Complex:NFKB	4790	716	740	0.001100726545131	Non valid	0.04219082101289911;0.9321596843408609;0.02564949464623984	ACTIVATION	30756140	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
21262	PMID:25265386:pubtator_title_and_abstract:0f2924b859516d2adb9ff6eb39e323aa:3:Trx1:NF-kappaB:450:579	Thioredoxin-1 (Trx1) is a thiol antioxidant protecting against non-radical oxidants by controlling protein thiol/disulfide status; [TF] translocates from cytoplasm to cell nuclei due to stress signaling, facilitates DNA binding of transcription factors, e.g., [TG], and potentiates inflammatory signaling.	Trx1	NF-kappaB	7295	4790	450	579	0.0016708123042771	Non valid	0.9632480881493541;0.03559468185942845;0.001157229991217479	UNDEFINED	25265386	TXN	9606	NFKB1	9606	ll_coTF		NFKB
21321	PMID:15090542:pubtator_title_and_abstract:ba332b2608eeb4f582414ee34b0bf4ee:9:IAP2:NF-kappaB.:1769:1667	SCH 66336 also inhibited the NF-kappaB-dependent reporter gene expression activated by TNF, TNFR1, TRADD, TRAF2, NIK, and IKK but not that activated by the p65 subunit of [TG] The TNF-induced NF-kappaB-regulated gene products cyclin D1, COX-2, MMP-9, survivin, IAP1, [TF], XIAP, Bcl-2, Bfl-1/A1, TRAF1, and FLIP were all down-regulated by SCH 66336, which potentiated apoptosis induced by TNF and doxorubicin.	IAP2	NF-kappaB.	329	4790	1769	1667	0.0013142244204814	Non valid	0.466283150056008;0.5252963925902109;0.008420457353781064	ACTIVATION	15090542	BIRC2	9606	NFKB1	9606	coTF		NFKB
21322	PMID:22880094:pubtator_title_and_abstract:42a44e44fcc1b0ebc389a6caa5d3fd9d:11:NF-kappaB:NF-kappaB:1780:1980	Moreover, alternative [TF] signaling strongly synergized both in vitro and in vivo with classical NF-kappaB activation, thereby extending the number of genes under the control of the p100 inhibitor of the alternative [TG] signaling pathway.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1780	1980	0.0010872626193603	Non valid	0.09005902140534686;0.9042952238029698;0.005645754791683285	ACTIVATION	22880094	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
21438	PMID:33809574:pubtator_title_and_abstract:00e74b0129be2df70d8e25b5a8c4bb8c:3:NF-kappaB:nuclear factor kappa of activated B-cells:327:284	An important feature of curcumin is the inhibition of [TG] ([TF]).	NF-kappaB	nuclear factor kappa of activated B-cells	Complex:NFKB	4790	327	284	0.0012650775666076	Non valid	0.00896317557775159;0.9833843897337768;0.007652434688471519	ACTIVATION	33809574	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
21488	PMID:20483743:pubtator_title_and_abstract:f2a696415164c0674d3472a46bd4d969:5:NF-kappaB:NF-kappaB.:894:771	A human monocyte cell line and ex vivo healthy monocytes were treated with 100 microg/ml IgG for 6 h, and cell extracts were examined by immunoblot using Abs to p38 MAPK and [TG] To further investigate intracellular signaling pathways induced by these IgGs, specific inhibitors of p38 MAPK, [TF], TLR4, and TLR2 were used to determine their effect on TF activity.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	894	771	0.0011076887301033	Non valid	0.4307413058477346;0.5657199473708273;0.003538746781438068	ACTIVATION	20483743	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
21610	PMID:18947405:pubtator_title_and_abstract:871ef8542967b2bdb2508b4bdfcabea7:9:p65:NF-kappaB:1285:1328	Upregulation of NF-kappaB and IkappaB family genes (REL, RELA, and RELB, NFKBIA, NFKBIE and NFKB1) at 48 to 96 hours, supported by the increase of phosphorylated RELA ([TF]), suggests that the involvement of the [TG] complex in the process of T-cell proliferation is not only regulated at the protein level but also at the transcriptional level.	p65	NF-kappaB	5970	4790	1285	1328	0.0011395819856559	Non valid	0.051690516711759525;0.9456524218498898;0.002657061438350622	ACTIVATION	18947405	RELA	9606	NFKB1	9606	dbTF		NFKB
21620	PMID:24473196:pubtator_title_and_abstract:d369608e9fe5b69eddb0c33c2158f7b6:8:STAT3:NF-kappaB:1318:1283	Our results identify an epigenetic mechanism of crosstalk between STAT3 and [TG] relevant to constitutive [TF] activation in malignancy and the role of inflammation in oncogenesis.	STAT3	NF-kappaB	6774	4790	1318	1283	0.0012747575466554	Non valid	0.2791975371459234;0.7159025626013887;0.0048999002526879	ACTIVATION	24473196	STAT3	9606	NFKB1	9606	dbTF		NFKB
21746	PMID:22524476:pubtator_title_and_abstract:6087b35f0873c93016eff5fb03ff0d37:9:Smad 7:NF-kappaB:1680:1666	These results, therefore, suggest that probiotic, La, prebiotic inulin, or synbiotic may promote host-protective immunity and attenuate Cr-induced intestinal inflammation through mechanisms affecting [TG] and [TF] signaling.	Smad 7	NF-kappaB	17131	18033	1680	1666	0.0010916654831803	Non valid	0.990810238413424;0.007205958769876795;0.0019838028166991916	UNDEFINED	22524476	Smad7	10090	Nfkb1	10090	dbTF		NFKB
21941	PMID:23652462:pubtator_title_and_abstract:4356ddb6960df1670ac7bf7e8018f821:6:SIRT1:NF-kappaB:710:759	To explore the possible mechanisms, the expression of [TF] and the association between SIRT1, LXR and [TG] in the process of foam cell formation was investigated in an in vitro human mononuclear U937 cell line.	SIRT1	NF-kappaB	23411	4790	710	759	0.0014200378424501	Non valid	0.9964696675500867;0.0026074602741176737;0.0009228721757955789	UNDEFINED	23652462	SIRT1	9606	NFKB1	9606	coTF		NFKB
22002	PMID:15090542:pubtator_title_and_abstract:ba332b2608eeb4f582414ee34b0bf4ee:9:Bcl-2:NF-kappaB:1781:1525	SCH 66336 also inhibited the [TG]-dependent reporter gene expression activated by TNF, TNFR1, TRADD, TRAF2, NIK, and IKK but not that activated by the p65 subunit of NF-kappaB. The TNF-induced NF-kappaB-regulated gene products cyclin D1, COX-2, MMP-9, survivin, IAP1, IAP2, XIAP, [TF], Bfl-1/A1, TRAF1, and FLIP were all down-regulated by SCH 66336, which potentiated apoptosis induced by TNF and doxorubicin.	Bcl-2	NF-kappaB	596	4790	1781	1525	0.0011529830545577	Non valid	0.1322793175926896;0.8646481697836651;0.0030725126236453037	ACTIVATION	15090542	BCL2	9606	NFKB1	9606	coTF		NFKB
22081	PMID:36017888:pubtator_title_and_abstract:8c7922357b950f71f17fc1d77bffc980:8:NLRP3:NF-kappaB:1445:1431	Western blot analysis show that NADD inhibits the protein levels of Toll-like receptor 4 (TLR4), nuclear factor kappa-B (NF-kappaB), NOD-like receptor thermal protein domain associated protein 3 (NLRP3), ASC and cysteinyl aspartate specific proteinase (Caspase)-1, indicating that NADD may inhibit neuroinflammation through the TLR4/[TG] and [TF]/Caspase-1 signaling pathways.	NLRP3	NF-kappaB	216799	18033	1445	1431	0.0011257524320723	Non valid	0.5518744736691464;0.35968478423111155;0.088440742099742	UNDEFINED	36017888	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
22109	PMID:28295231:pubtator_title_and_abstract:58cf1d7d706339af71339e094f718105:6:p65:NF-kappaB:857:884	Lupus development in BXSB mice expressing the Y chromosome autoimmunity accelerator (Yaa) increased basal and Toll-like receptor (TLR) 4/7-induced phosphorylation of mitogen-activated protein kinases, [TF] nuclear factor-kappaB ([TG]), enhanced tumor necrosis factor (TNF)-alpha and C-C motif chemokine ligand (CCL) 5 gene expression in splenic macrophages, but decreased levels of Toll-interacting protein and IRAK-M, without affecting IRAK4 or IRAK1 expression.	p65	NF-kappaB	19697	18033	857	884	0.0011220988274299	Non valid	0.08088869215733815;0.9097979803951806;0.00931332744748121	ACTIVATION	28295231	Rela	10090	Nfkb1	10090	dbTF		NFKB
22178	PMID:19635561:pubtator_title_and_abstract:274748ec2466c8404a00bd3a5c70914a:10:FRA2:NFkappaB:1288:1111	Indeed, both HDACi impair [TG]-dependent IkappaBalpha resynthesis in glial cells exposed to LPS, and, among various AP1 subunits and NFkappaB p65, affect the DNA binding activity of c-FOS, c-JUN and [TF].	FRA2	NFkappaB	14284	18033	1288	1111	0.0010883126164592	Non valid	0.972989273854346;0.02440014066511977;0.0026105854805342755	UNDEFINED	19635561	Fosl2	10090	Nfkb1	10090	dbTF		NFKB
22224	PMID:8628301:pubtator_title_and_abstract:fbe9a0354e6b0b6ded281d7be8230f1d:7:NF-kappaB.:NF-kappaB:1045:1267	Treatment of wild-type cells with tumor necrosis factor alpha (TNF-alpha) resulted in rapid, transient nuclear localization of [TF] IkappaBalpha-deficient fibroblasts are also TNF-alpha responsive, but nuclear localization of NF-kappaB is prolonged, thus demonstrating that a major irreplaceable function Of IkappaBalpha is termination of the [TG] response.	NF-kappaB.	NF-kappaB	Complex:NFKB	18033	1045	1267	0.0026361603093274	Non valid	0.13499641277465352;0.7893839005050798;0.0756196867202668	ACTIVATION	8628301	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
22289	PMID:18720533:pubtator_title_and_abstract:ae11bbf0e00c455b3d14420078a8f3f3:9:p65:NF-kappaB:1029:1019	A survival difference was found in [TG]-[TF] positive and negative patients.	p65	NF-kappaB	5970	4790	1029	1019	0.0016960530443057	Non valid	0.9635119466313126;0.015124100963197634;0.02136395240548974	UNDEFINED	18720533	RELA	9606	NFKB1	9606	dbTF		NFKB
22301	PMID:33456749:pubtator_title_and_abstract:3fc62235c34a16ec15d452bc1022796e:8:NF-kappaB:nuclear factor kappa-light-chain-enhancer of activated B cells:967:903	It could significantly attenuate the interferon-gamma-induced upregulation of proinflammatory cytokines, including inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and [TG] ([TF]).	NF-kappaB	nuclear factor kappa-light-chain-enhancer of activated B cells	Complex:NFKB	18033	967	903	0.0025634097818131	Non valid	0.006247451324380613;0.9825986449888996;0.011153903686719814	ACTIVATION	33456749	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
22327	PMID:29609268:pubtator_title_and_abstract:4541626a36f670076c1f245ad90c60a6:4:P65:NF-kappaB:620:610	Results: The positive expression rates of Id2 and [TG]/[TF] were 71.4% (240/336) and 56.3% (189/336) in cancer tissues, and 26.7%(16/60) and 15.0%(9/60)in normal tissues, respectively.Id2 and NF-kappaB/P65 were all related to tumor size, differentiation degree, infiltrative depth, lymphatic invasion, distant metastasis and clinical TNM stage (P<0.05).	P65	NF-kappaB	5970	4790	620	610	0.0012211996841866	Non valid	0.023717123358329838;0.9741608275997413;0.0021220490419287846	ACTIVATION	29609268	RELA	9606	NFKB1	9606	dbTF		NFKB
22328	PMID:33545204:pubtator_title_and_abstract:481e4e173de04ab8b0ff909f984a58f0:4:nuclear factor-kappaB:NF-kappaB:802:825	Renal toxicity markers, serum level of cystatin-c, complete blood count (CBC), prothrombin time (Pt) and tissue expression of CXCL16, ADAM10, cluster of differentiation 3 (CD3), fibrinogen, tissue factor (TF), [TF] ([TG]) and tumour necrosis factor alpha (TNF-alpha) were measured.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	802	825	0.0012244452535828	Non valid	0.8129869419702488;0.18016554634665277;0.006847511683098472	UNDEFINED	33545204	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
22338	PMID:21061471:pubtator_title_and_abstract:60f20f7d8473bb5a1256418f472e1ded:4:Akt:NF-kappaB:633:505	Hirsutenoxime, a cell signaling Akt inhibitor, and Bay 11-7085, an inhibitor of [TG] activation, attenuated the lipopolysaccharide-induced expression of Toll-like receptor 4, activation of NF-kappaB and [TF], and the production of chemokines and reactive oxygen/nitrogen species.	Akt	NF-kappaB	207	4790	633	505	0.0011486479778979	Non valid	0.002735527024554001;0.9958797355145862;0.0013847374608597785	ACTIVATION	21061471	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
22355	PMID:28060845:pubtator_title_and_abstract:cd505b9fd610514b017ef34360b5cd8f:5:nuclear factor (NF)-kappaB:NF-kappaB:815:923	Moreover, PNAP-6 and PNAP-8 inhibited [TF] activation by decreasing the degradation of IkappaB and nuclear translocation of [TG] subunit (p65).	nuclear factor (NF)-kappaB	NF-kappaB	Complex:NFKB	18033	815	923	0.0011742262245634	Non valid	0.0030483472966021706;0.9937443175296196;0.0032073351737782387	ACTIVATION	28060845	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
22391	PMID:30227591:pubtator_title_and_abstract:73c17d5be7374768b25caa392f62923d:7:NF-kappaB:NF-kappaB:1385:1517	Moreover, these compounds were shown to inhibit the activation of the [TF] signaling pathway in LPS-stimulated BV2 microglial cells by suppressing the phosphorylation of IkappaB-alpha and blocking [TG] translocation.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1385	1517	0.0010972985778348	Non valid	0.007898235415897393;0.99011597994247;0.0019857846416326233	ACTIVATION	30227591	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
22504	PMID:30647762:pubtator_title_and_abstract:15618789f170269f15364eee14d0eb76:11:IkappaBalpha:NF-kappaB:1622:1593	Protein analyses indicated that expression of [TG] and degradation of [TF] were suppressed by SSM treatment.	IkappaBalpha	NF-kappaB	18035	18033	1622	1593	0.0025386774721927	Non valid	0.04171656269381969;0.14965672612757527;0.8086267111786052	REPRESSION	30647762	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
22594	PMID:35573793:pubtator_title_and_abstract:4a19cb339a73104e8e9aa7490cbecef8:11:p38:NF-kappaB:1834:1884	Coaggregation enhanced the phosphorylation of p65, [TF], and JNK proteins and therefore activated the [TG] and MAPK signaling pathways.	p38	NF-kappaB	1432	4790	1834	1884	0.0037536194622476	Non valid	0.01441839401103802;0.9843201912241077;0.0012614147648543036	ACTIVATION	35573793	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
22704	PMID:18538010:pubtator_title_and_abstract:68d320d0f6b73a1d5f2a50ac3d3a6e26:14:ERK1/2:NF-kappaB.:1745:1925	HIV-1 Tat protein also induced activation of [TF] and NF-kappaB. HIV-1 Tat protein induced barrier destruction, changes in expression of TJs, and activation of ERK1/2 and NF-kappaB were abrogated by inhibitor of ERK1/2 and [TG] CONCLUSION: HIV-1 Tat protein causes increases in the paracellular permeability of RPE cells in vitro concomitant with changes in expression of certain transmembrane proteins associated with the tight junction.	ERK1/2	NF-kappaB.	5595;5594	4790	1745	1925	0.0011016982197343	Non valid	0.1895483777149341;0.7803928129796326;0.030058809305433292	ACTIVATION	18538010	MAPK3;MAPK1	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
22710	PMID:36760245:pubtator_title_and_abstract:cc56c5bf9174d3f241e38dc42592d9cb:13:AMPK-alpha1:NF-kappaB:2136:1999	In addition, rhACE2 partly inhibited activation of nuclear factor kappaB ([TG]), the p38 mitogen-activated protein kinase (MAPK) pathway, and promoted activation of the AMP-activated protein kinase-alpha1 ([TF]) pathway in heart tissue.	AMPK-alpha1	NF-kappaB	105787	18033	2136	1999	0.0011461534999961	Non valid	0.041210804237042896;0.7019982635475464;0.2567909322154108	ACTIVATION	36760245	Prkaa1	10090	Nfkb1	10090	ll_coTF		NFKB
22737	PMID:23244491:pubtator_title_and_abstract:c46afad3c612e7980e57525a8e903ebf:8:p38:NFkappaB:1188:1228	To evaluate the antiviral efficacy of GUE, fecal consistency score, fecal virus shedding and histological changes of the small intestine, mRNA expression levels of inflammation-related cytokines (IL8, IL10, IFN-beta, IFN-gamma and TNF-alpha), signaling molecules ([TF] and JNK), and transcription factor ([TG]) in the small intestine and spleen were determined.	p38	NFkappaB	1432	4790	1188	1228	0.001148269181234	Non valid	0.9851556658847235;0.013526136405795842;0.0013181977094806584	UNDEFINED	23244491	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
22781	PMID:19720604:pubtator_title_and_abstract:0cebc5879a8b231e9ea073bc56726c69:11:NF-kappaB:nuclear factor-kappaB:1596:1393	Increased [TG] (NF-kappaB) and inhibitor of apoptosis protein-1 (IAP-1) and reduced bax levels associated with the anti-flt-1-induced increase of intimal SMC survival; the latter was prevented by [TF] activity inhibitor and IAP-1 interfering RNA (RNAi).	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	1596	1393	0.0012035206625423	Non valid	0.004168768495557911;0.9870030475357953;0.00882818396864679	ACTIVATION	19720604	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
22841	PMID:11741913:pubtator_title_and_abstract:7a09d548a607423e248dc8f5db1396b1:0:STAT5:NF-kappa B:47:72	Cytokine receptor common beta subunit-mediated [TF] activation confers [TG] activation in murine proB cell line Ba/F3 cells.	STAT5	NF-kappa B	20850	18033	47	72	0.2598068563689341	Non valid	0.0025778082677152584;0.9963408246786044;0.0010813670536803342	ACTIVATION	11741913	Stat5a	10090	Nfkb1	10090	dbTF		NFKB
22861	PMID:10393859:pubtator_title_and_abstract:8b94b26ccd0b9a6969a9cf2833d5ab5c:7:NF-kappaB:NF-kappaB:1051:1239	Although a putative [TF] binding site was identified in the -74 GGAGAGCCCCC -64 region of the NOS-3 gene promoter, gel mobility shift assays and site-directed mutation analyses suggest that the putative [TG] site is not of primary importance.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1051	1239	0.0012097025865313	Non valid	0.9966492326138033;0.0027678122153691957;0.000582955170827402	UNDEFINED	10393859	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
22910	PMID:21752354:pubtator_title_and_abstract:598384f20b7ced22364a9ab5d637717a:6:NF-kappaB:NF-kappaB.:892:1154	Utilization of various signaling inhibitors and ELISA-based [TF] DNA binding assay demonstrated that the signaling initiated from Fas is mediated by mitogen activated protein kinases (MAPKs) including extracellular-signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) which induce subsequent activation of [TG] Furthermore, mixed cell culture experiment demonstrated that Fas can be activated through interaction with membrane-bound form of FasL during cell-to-cell interaction.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	892	1154	0.001134739874658	Non valid	0.06527551499110702;0.9322505051402671;0.0024739798686257922	ACTIVATION	21752354	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
22971	PMID:32578930:pubtator_title_and_abstract:21718438f309d945192115421f34bc80:7:p65:NF-kappaB:1130:1105	The protein expression changes (caspase-3, caspase-8, Bax, Bcl-2, beta-tubulin, nuclear factor-kappaB [[TG]/p50, NF-kappaB/[TF]], vascular endothelial growth factor, WNT1-inducible signaling pathway protein-1 [WISP1], transforming growth factor beta [TGF-beta]) in response to drug treatment were screened via western blotting.	p65	NF-kappaB	5970	4790	1130	1105	0.0011785973761448	Non valid	0.9834420307043676;0.014276993504380723;0.002280975791251624	UNDEFINED	32578930	RELA	9606	NFKB1	9606	dbTF		NFKB
23074	PMID:23570504:pubtator_title_and_abstract:3e0ef8ee335c31790a0a37ca101e6323:18:NF-kB:NF-kB:2682:2735	The parallelism between enhanced cytoplasmic NF-kB immunolabeling in the damaged muscular tissue and muscle cell apoptosis suggests that this drug may avoid the translocation of [TF] to the nucleus and interfere in the control of [TG]-mediated smooth muscle cell apoptosis.	NF-kB	NF-kB	Complex:NFKB	81736	2682	2735	0.0012286835795027	Non valid	0.6892699289154518;0.29533591010243093;0.015394160982117282	UNDEFINED	23570504	NFKB	10116	Nfkb1	10116	dbTF	NFKB	NFKB
23088	PMID:36482204:pubtator_title_and_abstract:653e0086558f08d3d68a4de122e0a2cf:0:PARP-1:NF-kappaB:61:15	Correction to: [TG] mediates radio-sensitization by the [TF] inhibitor, AG-014699.	PARP-1	NF-kappaB	142	4790	61	15	0.0043329160767079	Non valid	0.20272685380041636;0.6030809276676607;0.1941922185319229	ACTIVATION	36482204	PARP1	9606	NFKB1	9606	coTF		NFKB
23116	PMID:33035580:pubtator_title_and_abstract:e99b3e4a5b75152dd91bbf77d3b86273:8:MyD88:NF-kappaB:1179:1185	In summary, TAR could inhibit the inflammatory response and oxidative stress, which was related to the regulation of TAR on TLR-4/[TF]/[TG] and Nrf2/HO-1 pathways.	MyD88	NF-kappaB	4615	4790	1179	1185	0.0012015141544132	Non valid	0.9960380868699658;0.0028402597593544083;0.001121653370679849	UNDEFINED	33035580	MYD88	9606	NFKB1	9606	coTF		NFKB
23145	PMID:24752613:pubtator_title_and_abstract:181d1a368148b19a7607773c37293a3a:9:IkappaB-alpha:NF-kappaB:1214:1265	Intriguingly, SH-11052 blocked TNF-alpha induced [TF] degradation, and therefore decreased [TG] nuclear translocation.	IkappaB-alpha	NF-kappaB	4792	4790	1214	1265	0.0013705707862992	Non valid	0.004110338254914122;0.9894723930748319;0.006417268670253912	ACTIVATION	24752613	NFKBIA	9606	NFKB1	9606	coTF		NFKB
23146	PMID:34988179:pubtator_title_and_abstract:291e87a6256041fa400c66923dbc22e1:10:nuclear factor-kappa B:NF-kappaB:1464:1488	The expressions of cluster of differentiation 81, tumor susceptibility gene 101, [TF] ([TG]) p65, and Phospho-NF-kappaB p65 were detected by western blotting.	nuclear factor-kappa B	NF-kappaB	Complex:NFKB	4790	1464	1488	0.0011612890539528	Non valid	0.9120117309297542;0.08457098916039422;0.0034172799098515913	UNDEFINED	34988179	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
23350	PMID:8127864:pubtator_title_and_abstract:6a65c8e8dc4d7fa04965e7b6700c8234:0:AP-1:NF-kappa B:107:92	Distinct effects of thioredoxin and antioxidants on the activation of transcription factors [TG] and [TF].	AP-1	NF-kappa B	2353	4790	107	92	0.001218453538797	Non valid	0.19402555771559782;0.7975943310750648;0.008380111209337456	ACTIVATION	8127864	FOS	9606	NFKB1	9606	dbTF		NFKB
23363	PMID:35945910:pubtator_title_and_abstract:323683cc6990a2381a95e0fb711e2d2b:5:p65:NF-kappaB:737:724	Mammaglobin 1 (MGB1), cyclin D1, E1, A2, and phosphorylated [TG] (p-[TF]) were upregulated in resistant cells.	p65	NF-kappaB	5970	4790	737	724	0.0012943634124333	Non valid	0.6661813398876616;0.2603340482161839;0.07348461189615456	UNDEFINED	35945910	RELA	9606	NFKB1	9606	dbTF		NFKB
23404	PMID:19850960:pubtator_title_and_abstract:2be31fcca2d8284e37fd094043e2d1d5:12:nuclear factor-kappaB:NF-kappaB:1501:1524	From its preferred niche in the intestinal mucus layer, H hepaticus activated [TF] ([TG])-regulated networks associated with innate and T helper 1 (Th1)-type adaptive immunity both in the lower bowel and liver.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1501	1524	0.00115798426969	Non valid	0.9956117745000028;0.0033852760831312822;0.0010029494168659842	UNDEFINED	19850960	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
23511	PMID:35205759:pubtator_title_and_abstract:30895f0d9586e4d50ad65066dc90c661:4:MEK1:NF-kappaB:528:613	TRIB1 directly interacts with transcription factors such as FOXP3 and C/EBPalpha, with several signaling molecules such as [TF] and MALT1 and directly acts on key cell signaling pathways such as the MAPK and [TG] pathways.	MEK1	NF-kappaB	5604	4790	528	613	0.0011938077206159	Non valid	0.9477139772979556;0.050634950737592936;0.001651071964451405	UNDEFINED	35205759	MAP2K1	9606	NFKB1	9606	ll_coTF		NFKB
23546	PMID:28338974:pubtator_title_and_abstract:749db7ba846581b3bfb3b6998d41a3bd:5:activator protein (AP)-1:nuclear factor (NF)-kappaB:1088:1053	Such suppressive effects were accompanied by the inhibition of transcriptional activity and the deoxyribonucleic acid binding activity of [TG] but not [TF].	activator protein (AP)-1	nuclear factor (NF)-kappaB	16476	18033	1088	1053	0.0012787696360323	Non valid	0.8981405660603411;0.09590267323380676;0.005956760705852223	UNDEFINED	28338974	Jun	10090	Nfkb1	10090	dbTF		NFKB
23638	PMID:29085224:pubtator_title_and_abstract:c21b9583b03b4c606c77f5ba1de7bc51:6:ERbeta:NF-kappaB:891:946	The expression of ERalpha and [TF] was correlated with the expression of activated [TG], activated IKK and cyclin D1 by Spearman's correlation.	ERbeta	NF-kappaB	2100	4790	891	946	0.0011657422941966	Non valid	0.08955345592236229;0.9079335465864653;0.002512997491172486	ACTIVATION	29085224	ESR2	9606	NFKB1	9606	dbTF		NFKB
23666	PMID:34831483:pubtator_title_and_abstract:bc0e541adaa4efae048550dbd341cab4:6:beta-catenin:NF-kappaB:857:874	By the age of 6 months, the number and function of the microglia increased, accompanied by progressive amyloid-beta deposition, synaptic dysfunction, neuroinflammation, and dysregulation of [TF] and [TG] signaling pathways.	beta-catenin	NF-kappaB	12387	18033	857	874	0.0011271278097992	Non valid	0.9937839682646665;0.004776872207853621;0.0014391595274798048	UNDEFINED	34831483	Ctnnb1	10090	Nfkb1	10090	coTF		NFKB
23674	PMID:25700379:pubtator_title_and_abstract:90d2f951bcc9ab5a87f1ade92ec61de0:9:nuclear factor-kappaB:NF-kappaB:1168:1191	These changes were associated with increased [TF] ([TG]) activation in CC16(-/-) lungs.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1168	1191	0.0011523124611455	Non valid	0.08408303150846555;0.4994190035120134;0.4164979649795211	ACTIVATION	25700379	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
23718	PMID:35053345:pubtator_title_and_abstract:cd0c08b80afebf938fdc3695fc977727:7:IRF3:NF-kappaB:1436:1590	Despite TLR4-MyD88 complex-associated activations of IKKalpha/beta, NF-kappaB and [TF] being well-known as involved in macrophage M1-activation, our results demonstrated that the CD91-TLR4-MyD88 complex-associated IRAK1/4-IKKalpha/beta-[TG]/IRF3 pathway was not only directly involved in M2-associated CD163, CD204, and IL-10 gene expressions but also required for downregulation of M1 inflammatory cytokines.	IRF3	NF-kappaB	3661	4790	1436	1590	0.0011266973377171	Non valid	0.05232603423888659;0.9288966661624809;0.018777299598632453	ACTIVATION	35053345	IRF3	9606	NFKB1	9606	dbTF		NFKB
23808	PMID:37858201:pubtator_title_and_abstract:387aa1bac0e14f0cebd25451d3edd246:12:p65:NF-kappaB:1928:2495	p65 can directly bind to the INHBB promoter and increase the INHBB transcription of GC cells, thus establishing a positive regulatory feedback loop to promote the progression of GC.|Conclusions|GC cells p65/INHBB/activin B and fibroblasts [TF]/IL-1beta signal loop led to the formation of a whole tumor-promoting inflammatory microenvironment, which might be a promising therapeutic target for GC.|Supplementary Information|The online version contains supplementary material available at 10.1186/s13046-023-02861-4.|Highlights|Tumor-secreted activin B promotes gastric cancer via fibroblast reprogramming.|Activin B activates the NF-kappaB pathway by inducing auto-ubiquitination of TRAF6 in fibroblasts.|Activin B stimulates the production of a pro-tumorigenic secretome and matrisome.|Activin B activates [TG] pathway of fibroblasts to up-regulate IL-1beta secretion.|IL-1beta activates transcription factor p65 of gastric cancer to up-regulate INHBB expression.|Supplementary Information|The online version contains supplementary material available at 10.1186/s13046-023-02861-4.	p65	NF-kappaB	5970	4790	1928	2495	0.0011306316256217	Non valid	0.06912237167100771;0.9284894376106095;0.0023881907183827835	ACTIVATION	37858201	RELA	9606	NFKB1	9606	dbTF		NFKB
23919	PMID:37597762:pubtator_title_and_abstract:c95284451d6afd38d02c37d0c9fcaea9:6:p65:NF-kappaB:939:928	In addition, we found H2O2-induced upregulation of phosphoinositide 3-kinase (PI3K), protein kinase B (AKT), phosphorylation of nuclear factor-kappaB ([TG]) [TF] and nuclear translocation of NF-kappaB decreased by AFYRW.	p65	NF-kappaB	5970	4790	939	928	0.0012046128026617	Non valid	0.07274510454381038;0.9216892903108751;0.005565605145314543	ACTIVATION	37597762	RELA	9606	NFKB1	9606	dbTF		NFKB
23947	PMID:17708800:pubtator_title_and_abstract:3c011b599931a6ccba507dab6f5c5f0f:8:NF-kappaB:NF-kappaB:1427:1350	It is concluded that [TG] P65 protein expresses in cells of childhood ALL, the inhibition of [TF] transduction pathway may have significant value in childhood ALL treatment.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1427	1350	0.0011789412449396	Non valid	0.1149201765768227;0.8552477493374148;0.029832074085762474	ACTIVATION	17708800	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
23970	PMID:9719433:pubtator_title_and_abstract:2f5e27719e1f1b83a35fdbbebb9e8582:2:NF-kappaB:nuclear factor kappa B:288:264	In murine peritoneal macrophages cisplatin (cis-dichlorodiammine platinum (II)), a potent chemoimmunotherapeutic drug modulates the expression of several cytokines which contain [TG] ([TF]) binding site suggesting the involvement of NF-kappaB in the activation process of macrophages by cisplatin.	NF-kappaB	nuclear factor kappa B	Complex:NFKB	18033	288	264	0.0011431380841229	Non valid	0.8937644311881582;0.10355792347097727;0.0026776453408645607	UNDEFINED	9719433	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
24006	PMID:8019435:pubtator_title_and_abstract:e38a12d609437588740cecf293d7d6f6:7:NF-kappa B:NF-kappa B.:976:924	The observed effects may, at least in part, be due to the ability of the two compounds to directly inhibit DNA binding activity of activated [TG] The inhibitory capability of OR-1246 on [TF] DNA binding does not appear to be a sole mechanism, as it did not inhibit NF-kappa B activation induced by okadaic acid.	NF-kappa B	NF-kappa B.	Complex:NFKB	4790	976	924	0.001109587875373	Non valid	0.6642160951313648;0.33048856592966486;0.005295338938970391	UNDEFINED	8019435	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
24147	PMID:12910267:pubtator_title_and_abstract:2a28fcbe9725bdd25dc1f6cc85e7b51b:5:Bcl10:NF-kappaB:582:648	However, both Bcl10-deficient follicular and marginal zone B cells failed to proliferate normally, although [TF]-deficient marginal zone B cells uniquely failed to activate [TG] efficiently after stimulation with lipopolysaccharide.	Bcl10	NF-kappaB	12042	18033	582	648	0.016727644257955	Non valid	0.005572959712247382;0.9911199392109277;0.0033071010768250227	ACTIVATION	12910267	Bcl10	10090	Nfkb1	10090	coTF		NFKB
24212	PMID:33554730:pubtator_title_and_abstract:d39943ac4a2c8fe255f22cde4d580031:12:TRAF6:NF-kappaB:1291:1361	The potential mechanisms were associated with dysregulated interleukin 1beta, tumor necrosis factor alpha (TNF-alpha), IRAK1 (interleukin-1 receptor-associated kinase 1), [TF] (TNF receptor-associated factor 6), and nuclear factor kappa B ([TG]) signaling induced by miR-146a KO.	TRAF6	NF-kappaB	22034	18033	1291	1361	0.0011235714219651	Non valid	0.8902725772136079;0.10705917721655867;0.002668245569833416	UNDEFINED	33554730	Traf6	10090	Nfkb1	10090	coTF		NFKB
24262	PMID:37872562:pubtator_title_and_abstract:ff9f5e097ba787ad87c53d3447d09824:7:AKT:NF-kappaB:763:1010	They also increased [TF] activation, PGC1alpha, SIRT1, and myosin heavy chain (MyHC) expression, MyHC-positive cell population, and cell size in the gastrocnemius (GA) muscle, while FOXO3a and NF-kappaB activation, MuRF1, muscle atrophy F-box, and p16 expression, and [TG]+CD11c+ cell population decreased.	AKT	NF-kappaB	11651	18033	763	1010	0.001434119275853	Non valid	0.020314602420258038;0.049076732797012586;0.9306086647827293	REPRESSION	37872562	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
24332	PMID:36445678:pubtator_title_and_abstract:6f012443bb7bd3223d4cc6938b820e25:8:NF-kappaB:nuclear factor-kappa B:1177:1153	Medicarpin treatment also suppressed CUMS-induced inflammation and hindered [TG] ([TF]) signaling activation.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	18033	1177	1153	0.0011100538508153	Non valid	0.0027462190750801433;0.9953873800687196;0.0018664008562003127	ACTIVATION	36445678	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
24357	PMID:10464245:pubtator_title_and_abstract:2d1d96bfd81fc576430725237a635cdd:0:Rac:nuclear factor-kappaB:15:77	Integration of [TF]-dependent regulation of cyclin D1 transcription through a [TG]-dependent pathway.	Rac	nuclear factor-kappaB	11651	18033	15	77	0.0011652110684022	Non valid	0.9953765882141001;0.004013048572955093;0.0006103632129447614	UNDEFINED	10464245	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
24388	PMID:37546685:pubtator_title_and_abstract:868558504a2b5d29864ff16ca4af46e2:5:AKT:NF-kappaB:576:534	These molecules affect several cellular signaling cascades, including p53, [TG], STAT3, RAS, MAPK/ERK, Wnt, and [TF]/PI3K, and are thus implicated in the therapeutic management of cancers.	AKT	NF-kappaB	207	4790	576	534	0.001160286987368	Non valid	0.9784832669443052;0.019901791474606155;0.001614941581088553	UNDEFINED	37546685	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
24412	PMID:PMC7764792:pubtator_title_and_abstract:a876381e56da8f3d2242fae5e0c10851:0:Akt:NF-kappaB:130:111	Novel Small Molecular Compound AE-848 Potently Induces Human Multiple Myeloma Cell Apoptosis by Modulating the [TG] and PI3K/[TF]/mTOR Signaling Pathways	Akt	NF-kappaB	207	4790	130	111	0.0011148143691931	Non valid	0.9903534665076487;0.007857450647115065;0.0017890828452363353	UNDEFINED	PMC7764792	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
24457	PMID:28033581:pubtator_title_and_abstract:2f256283bf7145b13005a92c7f6573dc:9:NF-kappaB.:NF-kappaB:1394:1265	iRhom2 silence significantly suppress pro-inflammatory cytokines releases, and inactivated Toll-like receptor-4/Nuclear Factor kappa-B (TLR-4/[TG]) signaling pathway in cells after LPS administration, suggesting its possible relationship with heart injury via TLR-4/[TF] It is concluded that iRhom2 may be a promising therapeutic target for LPS-induced cardiac injury by regulating inflammatory response.	NF-kappaB.	NF-kappaB	Complex:NFKB	4790	1394	1265	0.0011201073335672	Non valid	0.32918338844138706;0.6655780372994131;0.005238574259199762	ACTIVATION	28033581	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
24471	PMID:27371876:pubtator_title_and_abstract:7780e370beb0c1c09d1e8d095c1b9346:10:NF-kappaB:NF-kappaB:1181:1144	This review focuses on the role of HDAC 3 in ([TG]-mediated) inflammation and [TF] lysine acetylation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1181	1144	0.0011424057373842	Non valid	0.9303798553113745;0.06698466012319915;0.002635484565426461	UNDEFINED	27371876	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
24553	PMID:36966253:pubtator_title_and_abstract:091c964a7abd15cec181e0e003c7caa6:3:NF-kappaB inhibitor alpha:NF-kappaB:251:290	[TF] (IKBA) is an [TG] inhibitory mediator in the cytoplasm that modulates the nuclear translocation and DNA binding activities of NF-kappaB proteins.	NF-kappaB inhibitor alpha	NF-kappaB	4792	4790	251	290	0.0057274109391565	Non valid	0.01836287041208051;0.005245983085652238;0.9763911465022673	REPRESSION	36966253	NFKBIA	9606	NFKB1	9606	coTF		NFKB
24584	PMID:35205759:pubtator_title_and_abstract:30895f0d9586e4d50ad65066dc90c661:4:TRIB1:NF-kappaB:405:613	[TF] directly interacts with transcription factors such as FOXP3 and C/EBPalpha, with several signaling molecules such as MEK1 and MALT1 and directly acts on key cell signaling pathways such as the MAPK and [TG] pathways.	TRIB1	NF-kappaB	10221	4790	405	613	0.0040073327189916	Non valid	0.9490938875669606;0.04924867255120382;0.0016574398818355418	UNDEFINED	35205759	TRIB1	9606	NFKB1	9606	coTF		NFKB
24809	PMID:34746569:pubtator_title_and_abstract:72e007a6d44a6e5aaf36e07caeef8cad:8:EGFR:NF-kappaB:1325:1355	Antioxidant enzymes and proinflammatory cytokines (TNF-alpha, IL-1beta, IL-6) were inhibited by CS-PLGA-TA-E. CS-PLGA-TA-E inhibited markers for tumor growth ([TF]-PI3K-AKT), inflammation ([TG]/Stat3), beta-catenin signaling (beta-catenin, c-myc, cyclin D1), EMT (E-cadherin, N-cadherin, vimentin), and apoptosis (Bcl-2) in a significantly greater way as compared with PLGA-TA-E, TA, or E. CS-PLGA-TA-E NPs can be considered promising anticancer drugs for colon cancer.	EGFR	NF-kappaB	1956	4790	1325	1355	0.0012421295319274	Non valid	0.0516249934076241;0.7372046505271352;0.21117035606524062	ACTIVATION	34746569	EGFR	9606	NFKB1	9606	ll_coTF		NFKB
24838	PMID:20195534:pubtator_title_and_abstract:b244d11d73a4f5447e0c83a07e4e328a:6:IkappaB alpha:NF-kappaB:1092:950	METHODOLOGY: Analysis of [TG] activation in response to TNF in MEFs reveals that IKKbeta is essential for efficient phosphorylation and subsequent degradation of [TF], yet IKKalpha contributes to the NF-kappaB activation response in these cells as measured via DNA binding assays.	IkappaB alpha	NF-kappaB	18035	18033	1092	950	0.0056544779521399	Non valid	0.10015204901868201;0.8760504794756273;0.023797471505690535	ACTIVATION	20195534	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
24963	PMID:26408225:pubtator_title_and_abstract:fe7e9b1355f7aee65d499f6ab0717c08:9:NF-kappaB:NF-kappaB.:1372:1473	MALDI-TOF analysis using a synthetic [TF]-p50 peptide containing Cys-62 residue suggested that WA can modify the cysteine residue of [TG] The pharmacokinetic studies for WA were also carried out and in vivo efficacy of WA was studied using mouse model of Graft-versus-host disease.	NF-kappaB	NF-kappaB.	Complex:NFKB	18033	1372	1473	0.0011780855481538	Non valid	0.9951074627353345;0.003399543047882482;0.0014929942167830328	UNDEFINED	26408225	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
25000	PMID:10628751:pubtator_title_and_abstract:349e528f9e813f2a66e109e286917076:5:Stat5b:NFkappaB:733:1116	Further, PRL-inducible [TF] inhibits tumor necrosis factor-alpha signaling presumably by inhibiting endogenous NFkappaB. This Stat5b-mediated inhibitory effect on NFkappaB signaling is independent of Stat5b-DNA interactions but requires the carboxyl terminus of Stat5b as well as Stat5b nuclear translocation and/or accumulation, suggesting that Stat5b is competing for a nuclear factor(s) necessary for [TG]-mediated activation of target promoters.	Stat5b	NFkappaB	6777	4790	733	1116	0.0011226328779042	Non valid	0.010187076119846634;0.9244380572234615;0.06537486665669187	ACTIVATION	10628751	STAT5B	9606	NFKB1	9606	dbTF		NFKB
25084	PMID:9632806:pubtator_title_and_abstract:931cbb6d9d6ab61fab64f697fbad319d:10:DNA-PK:NF-kappaB:1593:1664	These results suggest that [TF] phosphorylation of IkappaB alpha increases its interaction with [TG] to reduce NF-kappaB DNA binding properties.	DNA-PK	NF-kappaB	5591	18033	1593	1664	0.0011241125974906	Non valid	0.12679003636522318;0.012293346018903407;0.8609166176158733	REPRESSION	9632806	PRKDC	9606	Nfkb1	10090	ll_coTF		NFKB
25213	PMID:36126189:pubtator_title_and_abstract:b5b18215ffed7e0acf2555d7df0c81ac:13:Nrf2:NF-kappaB:1830:1764	The expression level of [TG] significantly increased, while the expression levels of [TF] and Nrf2-dependent antioxidant enzymes significantly decreased after miR-450b-5p agomir injection.	Nrf2	NF-kappaB	83619	4790	1830	1764	0.0012127743854227	Non valid	0.2625852488564525;0.48384338180691583;0.2535713693366317	ACTIVATION	36126189	Nfe2l2	10116	NFKB1	9606	dbTF		NFKB
25370	PMID:28319891:pubtator_title_and_abstract:e4952795d6952e48b54a9bdd0f6054b6:0:Nrf2:NF-kappaB:52:66	Time- and cell-resolved dynamics of redox-sensitive [TF], HIF and [TG] activities in 3D spheroids enriched for cancer stem cells.	Nrf2	NF-kappaB	4780	4790	52	66	0.0011404029578953	Non valid	0.9680510700829918;0.027728741277771824;0.004220188639236252	UNDEFINED	28319891	NFE2L2	9606	NFKB1	9606	dbTF		NFKB
25396	PMID:15765103:pubtator_title_and_abstract:73e13166c14db7bd0b0babde34417ec1:4:AP-1:NF-kappaB:827:604	The effects of [TG] and AP-1 were studied by the administration of the thioredoxin inhibitor, MOL-294 (methyl 4-hydroxy-4-(8-methyl-1,3-dioxo-2-phenyl-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazin-5-yl)but-2-ynoate), and the [TF] inhibitor, PNRI-299 (N-benzyl-2-(3-cyanophenyl)-1,3,7-trioxo-2,3,7,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazine-5-carboxamide).	AP-1	NF-kappaB	16476	18033	827	604	0.0011718967126098	Non valid	0.978661500901319;0.015804287478062454;0.0055342116206184705	UNDEFINED	15765103	Jun	10090	Nfkb1	10090	dbTF		NFKB
25398	PMID:26874514:pubtator_title_and_abstract:eac2634a50b5888bc2c7ac83ee0de4c3:10:Bcr-Abl:NF-kappaB:1250:1282	The results also showed that co-treatment with deferasirox and imatinib reduced the expression of BcrAbl, phosphorylated [TF], nuclear factor-kappaB ([TG]) and beta-catenin.	Bcr-Abl	NF-kappaB	25	4790	1250	1282	0.0012125127632806	Non valid	0.03433375358047773;0.9511067065485633;0.01455953987095903	ACTIVATION	26874514	ABL1	9606	NFKB1	9606	ll_coTF		NFKB
25440	PMID:26862037:pubtator_title_and_abstract:76aa6c498d1c3855e61917e24fa2887f:5:NF-kappaB:nuclear factor-kappaB:837:814	We investigated whether diminazene aceturate (DIZE), an angiotensin-converting enzyme 2 (ACE2) activator, prevented lipopolysaccharide (LPS)-induced inflammatory response by activating the protective axis and whether the effect was mediated by inhibiting the mitogen-activated protein kinase (MAPK) and the [TG] ([TF]) pathways.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	837	814	0.0011291107974386	Non valid	0.09708402318155764;0.8791799195233849;0.023736057295057525	ACTIVATION	26862037	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
25465	PMID:24529193:pubtator_title_and_abstract:a4ed28fcf73c465b4bff911de9c74bff:10:p65:NF-kappaB:1377:1350	EMSA results indicate that [TG] subunits p50 and [TF] bind to human Mcl-1-kappaB probe in vitro.	p65	NF-kappaB	5970	4790	1377	1350	0.0011629337608947	Non valid	0.9967787027542795;0.0025434278864983166;0.0006778693592222194	UNDEFINED	24529193	RELA	9606	NFKB1	9606	dbTF		NFKB
25484	PMID:28507170:pubtator_title_and_abstract:2672f60a1d40846bd458b7e24c4ba250:10:PPARgamma:NF-kappaB:1570:1725	Transgenic mice expressing WT-PPARgamma or DN-[TF] specifically in SMC (S-WT or S-DN) were bred with mice expressing luciferase controlled by an NF-kappaB-responsive promoter to assess effects on [TG] activity in whole tissue.	PPARgamma	NF-kappaB	19016	18033	1570	1725	0.121279364678948	Non valid	0.9866038618923418;0.009741569129131693;0.003654568978526505	UNDEFINED	28507170	Pparg	10090	Nfkb1	10090	dbTF		NFKB
25732	PMID:19197368:pubtator_title_and_abstract:aa40af4e9c9021283c83d47f35e4b0f5:2:ERK:NF-kappaB:269:223	Transcription of the mast cell growth factor SCF (stem cell factor) is upregulated in inflammatory conditions, and this is dependent upon [TG], as well as the MAP kinases p38 and [TF] activation.	ERK	NF-kappaB	5594	4790	269	223	0.0011401677910801	Non valid	0.0031515080399584896;0.9961162393450459;0.0007322526149956235	ACTIVATION	19197368	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
25838	PMID:29165402:pubtator_title_and_abstract:2cddbdb10758c5434b687e68e048edba:5:VEGF:NF-kappaB:759:850	[TF]-induced degradation of limiting membrane and translocation of nuclear factor kappa B ([TG]) were analyzed by immunocytochemistry.	VEGF	NF-kappaB	22339	18033	759	850	0.0016252951309052	Non valid	0.1885946961266264;0.807702924440793;0.0037023794325806124	ACTIVATION	29165402	Vegfa	10090	Nfkb1	10090	ll_coTF		NFKB
25879	PMID:29907126:pubtator_title_and_abstract:beb88204644d9f6e2708f6b630bfa7ef:7:NF-kappaB:NF-kappaB:1400:1550	However, mantle cell lymphoma cells often acquire resistance to such targeted agents and continue to survive by activating alternate signaling pathways such as the PI3K-Akt pathway or the [TF] pathways.NF-kappaB is a transcription factor family that regulates the growth and survival of B cells; mantle cell lymphoma cells depend on [TG] signaling for continued growth and proliferation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1400	1550	0.0010934176535829	Non valid	0.11945713079039759;0.8762056606123956;0.004337208597206937	ACTIVATION	29907126	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
25979	PMID:15632193:pubtator_title_and_abstract:a8930fb2de5eaf6a44441ffa71181ce5:3:SIR2:NFkappaB:396:496	SIRT1, the closest mammalian ortholog of the yeast [TF] (silent information regulator 2) gene, represses several transcription factors, including p53, [TG] and forkhead proteins.	SIR2	NFkappaB	23411	4790	396	496	0.0150850532077939	Non valid	0.0018457737059614772;0.0027571878111037024;0.9953970384829348	REPRESSION	15632193	SIRT1	9606	NFKB1	9606	coTF		NFKB
26031	PMID:36518665:pubtator_title_and_abstract:994b98796678465c1ba12fe6c9d1af0f:8:NF-kappaB:nuclear factor kappa-light-chain-enhancer of activated B cells:1054:990	This review comprehensively covers the role and the mechanisms that involve the [TG] ([TF]) in lung adenocarcinoma and methods of treating it by altering the tumor microenvironment.	NF-kappaB	nuclear factor kappa-light-chain-enhancer of activated B cells	Complex:NFKB	4790	1054	990	0.0011630550680611	Non valid	0.9791778361061466;0.019289576553490593;0.0015325873403628416	UNDEFINED	36518665	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
26396	PMID:27500631:pubtator_title_and_abstract:8852f91d70159e7858995b63594bddf0:6:Oct-2:NF-kappaB:739:663	Demethylation occurred first at binding motifs for the transcription factors [TG] and AP-1 and later at those for the transcription factors IRF and [TF] and was coincident with activation and differentiation gene-expression programs in a cell-division-dependent manner.	Oct-2	NF-kappaB	5452	4790	739	663	0.0013742356948019	Non valid	0.7983239121503584;0.14198818785625847;0.059687899993383246	UNDEFINED	27500631	POU2F2	9606	NFKB1	9606	dbTF		NFKB
26462	PMID:34861244:pubtator_title_and_abstract:0c37a57be8bc6829a138c1b26251be6c:9:NF-kappaB:nuclear factor-kappa B:1351:1327	Upon exploring the mechanisms underlying the protective role of MaR1, we found MaR1 markedly upregulated the nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1), and considerably reduced the phosphorylation of p38, ERK, and [TG] ([TF])-p65.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	18033	1351	1327	0.0011164635210262	Non valid	0.2220460913026126;0.7550442270816922;0.022909681615695166	ACTIVATION	34861244	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
26493	PMID:32547316:pubtator_title_and_abstract:c25a734accf40bc21279bb72c3d32976:9:ERK:NF-kappaB:886:894	S1P also facilitated PI3K, MEK/[TF] and [TG] signaling cascades.	ERK	NF-kappaB	5594	4790	886	894	0.0012158609237737	Non valid	0.11216510943738418;0.8855688694218735;0.0022660211407422603	ACTIVATION	32547316	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
26546	PMID:33222690:pubtator_title_and_abstract:5b002aeaae9723ef3fd7b44d2b62bdfe:7:ERK:NF-kappaB:1362:1370	K284-6111 treatment also selectively inactivated [TF] and [TG] pathways, which were activated when CHI3L1 was overexpressed, in the mouse brain and in BV-2 cells.	ERK	NF-kappaB	26413	18033	1362	1370	0.0011659399696975	Non valid	0.03632495846442231;0.9556587163219845;0.008016325213593228	ACTIVATION	33222690	Mapk1	10090	Nfkb1	10090	ll_coTF		NFKB
26653	PMID:34147108:pubtator_title_and_abstract:096ebe422bb1ffc16635d150adb6c4b1:5:SNF2H:NF-kappaB:1230:1033	This review summarizes the functional domains of RSF1, the overexpression status of RSF1 and SNF2H in cancer based on the TCGA and GTEX databases, the cancer-related functions of RSF1 in interacting with H2Aub, HDAC1, CENP-A, PLK1, ATM, CENP-S, SNF2H, HBX, BubR1, cyclin E1, CBP and [TG] and the potential clinical value of RSF1, which will lay a theoretical foundation for the structural biology study of RSF1 and application of RSF1 inhibitors, truncated RSF1 proteins and [TF] inhibitors in the treatment of RSF1-overexpressing tumours.	SNF2H	NF-kappaB	8467	4790	1230	1033	0.0011051314941334	Non valid	0.9832186694396895;0.013758824434782798;0.0030225061255276697	UNDEFINED	34147108	SMARCA5	9606	NFKB1	9606	dbTF		NFKB
26815	PMID:36909374:pubtator_title_and_abstract:6fefa53a775631ec5a0849314557e0ec:3:Smad2:NF-kappaB:514:485	Furthermore, KIN17 is associated with cancer cell proliferation, migration, invasion and cell cycle regulation by regulating pathways including the p38 MAPK, [TG]-Snail and TGF-beta/[TF] signaling pathways.	Smad2	NF-kappaB	4087	4790	514	485	0.0011179620084244	Non valid	0.9910968976484971;0.007930063801126616;0.0009730385503763347	UNDEFINED	36909374	SMAD2	9606	NFKB1	9606	dbTF		NFKB
26850	PMID:33174138:pubtator_title_and_abstract:64a0e53197fda14e93bbb599c5923ee3:0:MyD88:NF-kappaB:15:21	Silencing TLR4/[TF]/[TG] Signaling Pathway Alleviated Inflammation of Corneal Epithelial Cells Infected by ISE.	MyD88	NF-kappaB	17874	18033	15	21	0.0010760175264633	Non valid	0.01244415534102416;0.8850239516663135;0.10253189299266234	ACTIVATION	33174138	Myd88	10090	Nfkb1	10090	coTF		NFKB
26916	PMID:11136976:pubtator_title_and_abstract:509c7fd6d7856e1e156b8bbeb6ac50f6:6:DNA-PKcs:NF-kappaB.:875:827	ISS-ODN and bacterial DNA activate DNA-PK, which in turn contributes to activation of IKK and [TG] These results reveal a novel role of [TF] in innate immune responses and a link between DNA repair and innate immunity.	DNA-PKcs	NF-kappaB.	19090	18033	875	827	0.0014437119014682	Non valid	0.03488581383341202;0.9632435244336964;0.0018706617328915678	ACTIVATION	11136976	Prkdc	10090	Nfkb1	10090	ll_coTF		NFKB
27042	PMID:29057467:pubtator_title_and_abstract:6f3f657858fe02489b438565ec5f7672:6:PPARgamma:NF-kappaB:803:833	This included oxy-radical and TNFalpha production, TNFalpha and [TF] gene expression and [TG] translocation.	PPARgamma	NF-kappaB	5468	4790	803	833	0.0011465130328903	Non valid	0.5646571875611787;0.43293458676516017;0.0024082256736611468	UNDEFINED	29057467	PPARG	9606	NFKB1	9606	dbTF		NFKB
27047	PMID:20511288:pubtator_title_and_abstract:e9b06f7f1de812d6339a025a528a5a40:8:nuclear factor-kappa B:NF-kappaB:1074:1098	Gyp decreased the abundance of several proteins, including [TF] ([TG]), cyclooxygenase-2 (COX-2), extracellular signal-regulated kinase 1/2 (ERK1/ 2), matrix metalloproteinase-9, -2 (MMP-9, -2), sevenless homolog (SOS), Ras, urokinase-type plasminogen activator (uPA), focal adhesion kinase (FAK) and RAC-alpha serine/threonine-protein kinase (Akt), in a time-dependent manner.	nuclear factor-kappa B	NF-kappaB	Complex:NFKB	4790	1074	1098	0.0011940050314896	Non valid	0.4663327791205592;0.5194101815604695;0.014257039318971236	ACTIVATION	20511288	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
27093	PMID:32515468:pubtator_title_and_abstract:2d38b9615592f2ebb3d869c51a8f7417:9:JNK:NF-kappaB:1305:1267	Mechanically, we noticed that cimifugin inhibited IMQ-activated phosphorylation of [TG] (IkappaB and p65) and MAPK ([TF], ERK, and p38) signaling pathways.	JNK	NF-kappaB	5599	18033	1305	1267	0.0012002613194442	Non valid	0.05209215072394012;0.938643330916345;0.009264518359714839	ACTIVATION	32515468	MAPK8	9606	Nfkb1	10090	ll_coTF		NFKB
27181	PMID:26968836:pubtator_title_and_abstract:dba3b3abe9acd72bcd3b3a2f91c5ea8b:15:p38:NF-kappaB:2131:2175	In BV2 microglial cultures, TO901317 attenuated LPS- and thrombin-stimulated nitric oxide production and reduced LPS-induced [TF], JNK, MAPK, and nuclear factor-kappa B ([TG]) signaling.	p38	NF-kappaB	26416	18033	2131	2175	0.0011396112959252	Non valid	0.0037864596735587073;0.9945378295008837;0.0016757108255576782	ACTIVATION	26968836	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
27204	PMID:28753650:pubtator_title_and_abstract:2acb8ef3eb94bc422a3868d2874ec337:8:NF-kappaB:NF-kappaB:1222:1060	Patients with high [TG] activity had higher frequency of ileocolonic involvement (P = 0.028) and lower frequency of perianal involvement (P = 0.042) relative to those with low [TF] activity.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1222	1060	0.0011366512391091	Non valid	0.2891143993443321;0.47652595568610046;0.23435964496956743	ACTIVATION	28753650	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
27205	PMID:33859619:pubtator_title_and_abstract:63fcb5471139895b4b6f10f21c9bcf37:6:RELA:NFkappaB:867:845	However, whether ERbeta impacts the chromatin interaction (cistrome) of the main [TG] subunit p65 ([TF]) is not known.	RELA	NFkappaB	5970	4790	867	845	0.0050660526184175	Non valid	0.9979247456532218;0.0012133448753340193;0.0008619094714442309	UNDEFINED	33859619	RELA	9606	NFKB1	9606	dbTF		NFKB
27284	PMID:7896875:pubtator_title_and_abstract:a5963b3209356929e5f22e135ebe46ab:6:NF-kappa B:NF-kappa B:786:1255	In nonstimulated cells, the majority of [TF] resides in the cytosplasm as a complex with its inhibitor I kappa B. Upon cell stimulation, NF-kappa B translocates to the nucleus with concomitant degradation of I kappa B. We show that cold-induced depolymerization of microtubules also leads to I kappa B degradation and activation of NF-kappa B. However, the activated factor remains in the cytoplasm and translocates to the nucleus only upon warming to 37 degrees C, thus revealing two distinct steps in [TG] activation.	NF-kappa B	NF-kappa B	Complex:NFKB	4790	786	1255	0.0019347918692915	Non valid	0.01903281050242852;0.978916118587352;0.0020510709102195867	ACTIVATION	7896875	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
27593	PMID:27811358:pubtator_title_and_abstract:b9e22b99dc03c0d6c3a04918a93dcfec:6:cyclin D1:NF-kappaB:932:882	We found that overexpression of Sphk1 induced [TG]-p65 activation, increased expression of [TF], shortened the cell division cycle, and thus promoted proliferation of breast epithelial cells.	cyclin D1	NF-kappaB	595	4790	932	882	0.0011424791958337	Non valid	0.008441934791278126;0.9868747002137049;0.004683364995016822	ACTIVATION	27811358	CCND1	9606	NFKB1	9606	coTF		NFKB
27614	PMID:37249279:pubtator_title_and_abstract:ffd3ede539a9adbf42fb641b8b9f326c:12:p65:NF-kappaB:1663:1652	Furthermore, we found that the loss of TMUB1 suppressed the phosphorylation of IkappaB kinase (IKK) alpha/beta and attenuated cytoplasmic-nuclear translocation of nuclear factor-kappaB ([TG]) [TF] in LPS-induced cells.	p65	NF-kappaB	19697	18033	1663	1652	0.0011239613526034	Non valid	0.012543592431769281;0.9856966937102105;0.0017597138580202458	ACTIVATION	37249279	Rela	10090	Nfkb1	10090	dbTF		NFKB
27662	PMID:12893773:pubtator_title_and_abstract:db7fdc0723a3e647a70f80d373987998:6:nuclear factor kappa B:NF-kappa B:1362:1386	Coadministration of bortezomib and SAHA resulted in increased reactive oxygen species (ROS) generation and diminished [TF] ([TG]) activation; moreover, the free radical scavenger L-N-acetylcyteine (LNAC) blocked bortezomib/SAHA-related ROS generation, induction of JNK and p21CIP1, and apoptosis.	nuclear factor kappa B	NF-kappa B	Complex:NFKB	4790	1362	1386	0.0010674720564712	Non valid	0.015462718114543438;0.9612534633600949;0.02328381852536168	ACTIVATION	12893773	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
27700	PMID:22319003:pubtator_title_and_abstract:4e0c5950bcd05e38013514a86ed856e6:11:p300:NF-kappaB:1406:1331	Combined stimulation with IL-6, sIL-6R, and IL-17 increased the recruitment of phosphorylated [TG] to the CCL20 promoter, increased binding of coactivators such as [TF] and CBP, and enhanced H3 and H4 histone acetylation, consistent with a transcriptionally active gene.	p300	NF-kappaB	328572	18033	1406	1331	0.0011874170567039	Non valid	0.17864362891158841;0.8156662358698111;0.005690135218600408	ACTIVATION	22319003	Ep300	10090	Nfkb1	10090	coTF		NFKB
27705	PMID:37714273:pubtator_title_and_abstract:829813b80d6c1fc083aa72b06d4dd1cd:9:NLRP3:NF-kappaB:1650:1625	Additionally, Corilagin interrupted the TLR4-MyD88 interaction through targeting TIR domain of MyD88, leading to the inhibition of [TG] activation and [TF] production.	NLRP3	NF-kappaB	216799	18033	1650	1625	0.001155632725544	Non valid	0.002104945652395687;0.9931330202060273;0.004762034141576979	ACTIVATION	37714273	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
27741	PMID:36378417:pubtator_title_and_abstract:ba5637c7e697a58e3f85c266f13d8f34:9:NF-kappaB:NF-kappaB:1464:1405	Mechanistically, ENOPH1 activated the [TG] pathway, as evidenced by increased expression of [TF] downstream genes and enhanced NF-kappaB p65 nuclear translocation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1464	1405	0.0010887880774943	Non valid	0.1413104876309451;0.8549342368090256;0.0037552755600292805	ACTIVATION	36378417	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
28102	PMID:28430599:pubtator_title_and_abstract:1a5fac773d64d69672063269cbd79669:2:nuclear factor-kappaB:NF-kappaB:115:138	Aberrant activation of [TF] ([TG]) allows cancer cells to escape chemotherapy-induced cell death and acts as one of the major mechanisms of acquired chemoresistance in cervical cancer.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	115	138	0.0012026328277093	Non valid	0.05074267726955707;0.945931073338189;0.0033262493922539263	ACTIVATION	28430599	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
28154	PMID:34630646:pubtator_title_and_abstract:d080f22a54648ce945cff38fb81e219e:11:JAK2:NF-kappaB:1055:1079	IL-17 promoted the progression of cervical cancer via the activation of [TF]/STAT3 and PI3K/Akt/[TG] signaling.	JAK2	NF-kappaB	3717	4790	1055	1079	0.0010989697419274	Non valid	0.03660462052233381;0.961646493766044;0.0017488857116221756	ACTIVATION	34630646	JAK2	9606	NFKB1	9606	coTF		NFKB
28218	PMID:19734906:pubtator_title_and_abstract:b0392b6cdfadb159ab29fa9b129916f9:4:NF-kappaB:NF-kappaB:537:498	Peli1 was required for TLR3-induced activation of IkappaB kinase (IKK) and its 'downstream' target, transcription factor [TG], but was dispensable for IKK-[TF] activation induced by several other TLRs and the interleukin 1 (IL-1) receptor.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	537	498	0.0013435004605461	Non valid	0.021147971375629366;0.977251046261665;0.0016009823627055031	ACTIVATION	19734906	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
28225	PMID:22607974:pubtator_title_and_abstract:ac52f31711bb2cc57a803a27048c2e8f:6:NOD2:NF-kappaB:862:792	We further show that LUBAC activity is required for efficient [TG] activation and secretion of proinflammatory cytokines after [TF] stimulation.	NOD2	NF-kappaB	257632	18033	862	792	0.0535536960046596	Non valid	0.004086800656112103;0.9950944468482986;0.0008187524955892826	ACTIVATION	22607974	Nod2	10090	Nfkb1	10090	coTF		NFKB
28272	PMID:27144453:pubtator_title_and_abstract:806ce487a019621e8f5bb5ae72bd0a23:10:STAT1/2:NFkappaB:1472:1462	Major upstream factors predicted by IPA  for gene down-regulation included [TG], [TF], IRF3/4 and SP1 but no major factors controlling gene up-regulation were identified.	STAT1/2	NFkappaB	6772;6773	4790	1472	1462	0.001192887556437	Non valid	0.0014292631341758933;0.005487330738098527;0.9930834061277256	REPRESSION	27144453	STAT1;STAT2	9606;9606	NFKB1	9606	dbTF;dbTF		NFKB
28429	PMID:15107419:pubtator_title_and_abstract:561164fde5a7184076ed588e59eeda7b:4:NEMO:NF-kappaB:574:698	Using purified truncation mutants, we showed that the minimal oligomerization domain of [TF] is the CC2-LZ segment and that both CC2 and LZ subdomains are necessary to restore the LPS-dependent activation of the [TG] pathway in a NEMO-deficient cell line.	NEMO	NF-kappaB	8517	4790	574	698	0.010988367613045	Non valid	0.011007236037618304;0.9854318580408384;0.0035609059215432584	ACTIVATION	15107419	IKBKG	9606	NFKB1	9606	coTF		NFKB
28576	PMID:23138939:pubtator_title_and_abstract:dab58b50e8ae46b914a4e9e69c8d45c3:8:p65:nuclear factor-kappaB:983:949	Whereas docetaxel stimulated the expression of [TG] (NF-kappaB) [TF] protein in B88 cells, gamma-tocotrienol slightly inhibited the expression of constitutive nuclear p65 protein.	p65	nuclear factor-kappaB	5970	4790	983	949	0.0012642882719507	Non valid	0.009191700161932437;0.9781647912592024;0.01264350857886521	ACTIVATION	23138939	RELA	9606	NFKB1	9606	dbTF		NFKB
28622	PMID:18641332:pubtator_title_and_abstract:46be8000ee95ca74cb5d2157f6bae7a4:7:NFkappaB:NF-kappaB:960:1052	Chemical inhibition of the [TF] pathway abolished cytokine production and PAP facilitated nuclear translocation of [TG] and phosphorylation of IkappaB alpha inhibitory protein suggesting that PAP2 signaling involves this pathway.	NFkappaB	NF-kappaB	Complex:NFKB	4790	960	1052	0.0010960720606923	Non valid	0.04812695896848616;0.9257606455541124;0.02611239547740141	ACTIVATION	18641332	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
28703	PMID:25490314:pubtator_title_and_abstract:10b7819efd090558085157a8ef81e8e9:6:ERK:NF-kappaB:922:868	We concluded that NUP is anti-inflammatory by inhibiting the [TG] pathway, modulating cytokine production and [TF] phosphorylation.	ERK	NF-kappaB	26413	18033	922	868	0.0011232533151436	Non valid	0.9721503933102099;0.023860878942812424;0.00398872774697766	UNDEFINED	25490314	Mapk1	10090	Nfkb1	10090	ll_coTF		NFKB
28726	PMID:33375283:pubtator_title_and_abstract:a6e344893988cd05bcf606c84464c53e:5:NF-kappaB:NF-kappaB:647:791	The differential site-specific phosphorylation of NF-kappaB itself or some [TF] regulators can result in dysregulated NF-kappaB signaling, often culminating in events that induce cancer progression and other hyper [TG] related diseases, such as inflammation, cardiovascular diseases, diabetes, as well as neurodegenerative diseases, etc.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	647	791	0.0013642940276375	Non valid	0.3303900854906089;0.6530560032279307;0.016553911281460332	ACTIVATION	33375283	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
28730	PMID:32973783:pubtator_title_and_abstract:a1549a74c9d9b20a0360966939e0f80a:8:p50:NF-kappaB:1195:1082	The acute hepatic innate immune response to LPS was associated by the degradation of the [TG] inhibitory proteins (IkappaBalpha and IkappaBbeta), and nuclear translocation of the NF-kappaB subunit [TF] in all ages, whereas nuclear translocation of the NF-kappaB subunit p65 was only observed in the p35 and adult mouse.	p50	NF-kappaB	18033	18033	1195	1082	0.0011224262306734	Non valid	0.050685049371614624;0.060897159180407515;0.888417791447978	REPRESSION	32973783	Nfkb1	10090	Nfkb1	10090	dbTF		NFKB
28814	PMID:21506136:pubtator_title_and_abstract:63a5b19ca8a9d0c9ab54bb86d19443f2:6:nuclear factor kappa B:NF-kappaB:1106:1130	Further investigation indicated that [TF] ([TG]) is the responsible transcription factor involved in the TNF-alpha-induced upregulation of ASB4, placing ASB4 downstream of NF-kappaB in the TNF-alpha signalling cascade and identifying it as a potential regulator for TNF-alpha's numerous functions associated with inflammation, angiogenesis and apoptosis.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	18033	1106	1130	0.0011318210277291	Non valid	0.011071606085858292;0.987731184127442;0.0011972097866997618	ACTIVATION	21506136	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
28833	PMID:22140508:pubtator_title_and_abstract:e4f7503d604845b2c36593c5cc94eafd:6:nuclear factor-kappaB:NF-kappaB:813:836	DHA pretreatment also attenuated UVB-induced DNA binding of [TF] ([TG]) through the inhibition of phosphorylation of IkappaB kinase-alpha/beta, phosphorylation and degradation of IkappaBalpha and nuclear translocation of p50 and p65.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	813	836	0.0011846728731094	Non valid	0.9138858754516167;0.08346178652102203;0.0026523380273612155	UNDEFINED	22140508	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
29020	PMID:11960379:pubtator_title_and_abstract:4a389cd23a84a97afe22d126e9422c26:7:Heregulin:NF-kappaB:995:1014	[TF]-mediated [TG] activation correlated with phosphorylation of epidermal growth factor receptor (EGFR) and ErbB3 but not her2/neu.	Heregulin	NF-kappaB	211323	18033	995	1014	0.1794775541248186	Non valid	0.004551992070310054;0.994658020590794;0.0007899873388960017	ACTIVATION	11960379	Nrg1	10090	Nfkb1	10090	ll_coTF		NFKB
29023	PMID:25190035:pubtator_title_and_abstract:941f1b2258e1b5baadcc892f50e8ec56:8:NF-kappaB:nuclear factor-kappaB:1075:1052	Cell viability and parameters associated with [TG] ([TF]) activation were assayed.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	1075	1052	0.0011334075819549	Non valid	0.035804220785139916;0.9624389757572991;0.001756803457560986	ACTIVATION	25190035	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
29036	PMID:25115881:pubtator_title_and_abstract:e549a67c4e195b0a7abcf61a789f47c9:4:HIF-1alpha:NF-kB:796:874	The aim of the study was to analyse the effects of hyperoxia in the liver tissue (hepatocytes and haemopoietic cells) and to investigate possible changes in the expression of Vascular Endothelial Growth Factor (VEGF), Matrix Metalloproteinase 9 (MMP-9), Hypoxia-Inducible Factor-1alpha ([TF]), endothelial Nitric Oxide Synthase (eNOS), and Nuclear Factor-kB ([TG]).	HIF-1alpha	NF-kB	29560	309165	796	874	0.0012287584825346	Non valid	0.9894337705481108;0.007508246996882838;0.003057982455006326	UNDEFINED	25115881	Hif1a	10116	Rela	10116	dbTF		NFKB
29057	PMID:36552584:pubtator_title_and_abstract:baaba3fbbb5b5d57f9fc2a5fcf5add49:7:HO-1:NF-kappaB:983:968	During cerebral ischemia, Nrf2 participates in signaling pathways such as Keap1, PI3K/AKT, MAPK, [TG], and [TF], and then alleviates cerebral ischemia injury or CIRI by inhibiting oxidative stress, anti-inflammation, maintaining mitochondrial homeostasis, protecting the blood-brain barrier, and inhibiting ferroptosis.	HO-1	NF-kappaB	3162	4790	983	968	0.0011219040343695	Non valid	0.8971394519460343;0.10075312167894993;0.0021074263750156742	UNDEFINED	36552584	HMOX1	9606	NFKB1	9606	ll_coTF		NFKB
29062	PMID:23431343:pubtator_title_and_abstract:1cd69b0b84a66b29cf61a33a27758dde:5:IkappaB-alpha:NF-kappaB:814:737	Additionally, MAB suppressed the Hp-induced inflammatory response by attenuation of [TG] activation, translocation of p65 NF-kappaB, and phosphorylation of [TF], indicating that MAB modulates CagA-mediated signaling pathway.	IkappaB-alpha	NF-kappaB	4792	4790	814	737	0.0011445545757645	Non valid	0.0036497513415854506;0.9944785030276876;0.0018717456307270008	ACTIVATION	23431343	NFKBIA	9606	NFKB1	9606	coTF		NFKB
29109	PMID:8530143:pubtator_title_and_abstract:5f8219f213966573a6583ed269b33b32:1:NF-kappa B:NF-kappa B:347:195	Tumor Necrosis Factor (TNF) is one of the most potent physiological inducers of the nuclear transcription factor NF-kappa B. In light of the pivotal role of [TG] in the development of immune responses and activation of HIV replication, the identification of TNF signal transduction pathways involved in [TF] activation is of particular interest.	NF-kappa B	NF-kappa B	Complex:NFKB	4790	347	195	0.0013180799581065	Non valid	0.03286233953991287;0.9660168209704179;0.0011208394896692936	ACTIVATION	8530143	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
29125	PMID:37210624:pubtator_title_and_abstract:b95f33ac3582d8b23fe904008262534f:8:nuclear factor kappa B:NF-kappaB:1030:1054	Therefore, this narrative review aims to find the potential link between T2DM and PD by investigating the role of inflammatory signalling pathways, mainly the [TF] ([TG]) and the nod-like receptor pyrin 3 (NLRP3) inflammasome.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	4790	1030	1054	0.0011210245463372	Non valid	0.9513271706715855;0.04600971856629938;0.002663110762115073	UNDEFINED	37210624	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
29163	PMID:10915750:pubtator_title_and_abstract:0dba855744a3bd40ed40a637d91773e8:4:serum response factor:NF-kappaB:938:894	Viral protein-expression vectors were cotransfected into mammalian cells with reporter vectors having a luciferase gene driven by the following inducible cis-enhancer elements: the cyclic adenosine monophosphate response element, the serum response element (SRE), and the binding sites for nuclear factor kappaB ([TG]), activator protein 1 (AP-1), and [TF] (SRF).	serum response factor	NF-kappaB	6722	4790	938	894	0.0011952940391376	Non valid	0.1628339715891587;0.8332220532117637;0.0039439751990776005	ACTIVATION	10915750	SRF	9606	NFKB1	9606	dbTF		NFKB
29212	PMID:24231956:pubtator_title_and_abstract:a28c054b7f62d7dfbc654a5d75d10b03:9:NFkappaB:NFkappaB:936:986	DETT inhibited [TF] transcription activity and downregulated [TG]-targeted genes, including Bcl-2, Bcl-XL, and XIAP as measured by their protein expression.	NFkappaB	NFkappaB	Complex:NFKB	18033	936	986	0.0011068006040393	Non valid	0.21955346098783707;0.7725947256705987;0.007851813341564212	ACTIVATION	24231956	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
29244	PMID:27695001:pubtator_title_and_abstract:6b79c54cbd46a95cd684868053735b7f:5:TRIM29:NF-kappaB:935:886	Mechanistically, we demonstrated that TRIM29 inhibited interferon-regulatory factors and signaling via the transcription factor [TG] by degrading the adaptor NEMO and that [TF] directly bound NEMO and subsequently induced its ubiquitination and proteolytic degradation.	TRIM29	NF-kappaB	72169	18033	935	886	0.0011199560935294	Non valid	0.06304034310070922;0.3657499828384481;0.5712096740608427	REPRESSION	27695001	Trim29	10090	Nfkb1	10090	coTF		NFKB
29311	PMID:11051346:pubtator_title_and_abstract:f25ffcbeb23afa7fb47a3c39785d8700:5:NF-kappaB:NF-kappaB:492:679	Expression of activated [TF] was studied in situ by immunohistochemistry using alpha-p65 mouse monoclonal antibody (alpha-p65 mAb), which recognizes activated NF-kappaB. To identify the cell types in which [TG] was activated, we performed immunohistochemical analysis using antibodies against vascular endothelial cells, macrophages, and B and T lymphocytes.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	492	679	0.0011682426314215	Non valid	0.08115684947329241;0.9167526513481182;0.002090499178589289	ACTIVATION	11051346	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
29324	PMID:37204068:pubtator_title_and_abstract:6b9c7bdfedc7c4e0a94aa6b1fd8a32d1:8:HMGB1:NF-kappaB:1215:1118	[TG] signaling is confirmed to be the converging downstream pathway of TDSCs in response to [TF]-containing EVs and IL-1beta.	HMGB1	NF-kappaB	15289	18033	1215	1118	0.0126831605966405	Non valid	0.7767639752542569;0.22131314523567272;0.0019228795100703854	UNDEFINED	37204068	Hmgb1	10090	Nfkb1	10090	coTF		NFKB
29383	PMID:28009484:pubtator_title_and_abstract:1bd239d8d9ca5eb2f66923ddc6daadb7:10:NF-kappaB:NF-kappaB:1109:1162	Further, the translocation of [TF] was promoted by HSP90, while inhibition of [TG] significantly reduced MMP-8 production, which is upregulated by HSP90.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1109	1162	0.0011625303254773	Non valid	0.005638055496811119;0.9627322880628228;0.03162965644036594	ACTIVATION	28009484	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
29433	PMID:31346357:pubtator_title_and_abstract:6a26f915a828ac9d7996e001c922a521:12:Smad2:NF-kappaB:1580:1566	Furthermore, miR-200c inhibition repressed the production of proinflammatory cytokines (TGF-beta, TNF-alpha, and IL-1alpha) via inhibiting [TG] and [TF] activation in NHKs exposed to IR.	Smad2	NF-kappaB	4087	4790	1580	1566	0.0011845600331115	Non valid	0.0021087959363006825;0.9953916488441775;0.0024995552195218496	ACTIVATION	31346357	SMAD2	9606	NFKB1	9606	dbTF		NFKB
29441	PMID:24347921:pubtator_title_and_abstract:6d345deed6f5ad11f4d85dd3cef1673f:5:NF-kappaB:nuclear factor kappa-light-chain-enhancer of activated B chain:526:462	Oleandrin (a toxic cardiac glycoside of N. oleander L.) inhibits the activity of [TG] ([TF]) in various cultured cell lines (U937, CaOV3, human epithelial cells and T cells) as well as it induces programmed cell death in PC3 cell line culture.	NF-kappaB	nuclear factor kappa-light-chain-enhancer of activated B chain	Complex:NFKB	4790	526	462	0.0011804079518295	Non valid	0.012212727524917047;0.9761496450867913;0.011637627388291721	ACTIVATION	24347921	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
29449	PMID:17911635:pubtator_title_and_abstract:289101aa269a7aa9183d01ca83f24746:0:p38:NF-kappa B:97:106	Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, [TF], and [TG] pathway.	p38	NF-kappa B	1432	4790	97	106	0.001086154912644	Non valid	0.006233986686790021;0.9929420320435565;0.0008239812696534096	ACTIVATION	17911635	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
29516	PMID:24957606:pubtator_title_and_abstract:c6a0639cc3da57ff6988c9fbce0395d4:9:ATM:NF-kappaB:1295:1240	We further observed decreased binding and recruitment of the transcriptional elongation complex containing cyclin dependent kinase-9 (CDK9; a kinase necessary for triggering transcriptional elongation) to promoters of [TG]-dependent immediate-early cytokine genes, in [TF] knockdown cells.	ATM	NF-kappaB	472	4790	1295	1240	0.0011022682475446	Non valid	0.9653449169718226;0.031617806412035154;0.0030372766161423028	UNDEFINED	24957606	ATM	9606	NFKB1	9606	coTF		NFKB
29521	PMID:33113766:pubtator_title_and_abstract:1385322dcf6617235d59b6526c6401db:5:nuclear factor erythroid 2-related factor 2:NF-kappaB:701:790	EGCG has the ability to regulate many pathways, including the activation of [TF] (Nrf2), inhibition of nuclear factor-kappaB ([TG]), and protection against epithelial-mesenchymal transition (EMT).	nuclear factor erythroid 2-related factor 2	NF-kappaB	4780	4790	701	790	0.0011370351433252	Non valid	0.13618148971566066;0.055608095555481;0.8082104147288582	REPRESSION	33113766	NFE2L2	9606	NFKB1	9606	dbTF		NFKB
29532	PMID:36443670:pubtator_title_and_abstract:19a8cc006e1ae233c6e835ee1cb257f1:8:HOXB5:NF-kappaB:879:982	HOXB5 bound to the CARD9 promoter, and [TF] overexpression reversed the regulation by CARD9 knockdown in cells, as well as the activation of [TG] signaling.	HOXB5	NF-kappaB	3215	4790	879	982	0.0048527003814926	Non valid	0.06645596557841417;0.13689869442086375;0.7966453400007221	REPRESSION	36443670	HOXB5	9606	NFKB1	9606	dbTF		NFKB
29558	PMID:25040843:pubtator_title_and_abstract:c739d319b637664e4ad340041179e636:5:activator protein-1:nuclear factor-kappaB:971:868	In silico analysis of the Fk promoter indicated the presence of binding sites for various inflammatory modulators, such as [TG] (NF-kappaB), signal transducer and activator of transcription (STAT)1/STAT3, and [TF].	activator protein-1	nuclear factor-kappaB	3725	4790	971	868	0.0011907439222631	Non valid	0.994500583113017;0.004380563254215776;0.0011188536327672444	UNDEFINED	25040843	JUN	9606	NFKB1	9606	dbTF		NFKB
29729	PMID:36465385:pubtator_title_and_abstract:b73ef3b203b117c319175f9c048b1f8b:3:nuclear factor kappa-B:NF-kappaB:265:254	The activation of the [TG] ([TF]) is the oncogenic hallmark of PCNSL, and it was driven by B cell receptor (BCR) and Toll-like receptor (TLR) signaling pathways.	nuclear factor kappa-B	NF-kappaB	Complex:NFKB	4790	265	254	0.0015206948919674	Non valid	0.006009893894881198;0.9926921120448104;0.0012979940603083553	ACTIVATION	36465385	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
29818	PMID:26707483:pubtator_title_and_abstract:c397e0e0ef103092725e3863ad5cc5eb:12:NF-kappaB:nuclear factor-kappaB:1984:1961	Furthermore, transduced Tat-SOD hindered nuclear transactivation of [TG] ([TF]), modulating the induction of paracellular junction proteins and matrix-degrading MMP in TNF-alpha-stimulated HUVECs.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	1984	1961	0.0012642157212885	Non valid	0.004946497474969801;0.9923546227268604;0.002698879798169823	ACTIVATION	26707483	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
29969	PMID:33898464:pubtator_title_and_abstract:3134b6030e05c2932439c94e5efbc443:7:SOX9:NF-kappaB:1455:1394	We further discuss underlying molecular regulators determining fate specifications of NCSCs, suggesting a regulatory network including [TG] and NC-related transcription factors like SLUG and [TF] accompanied by Wnt- and MAPK-signaling to orchestrate NCSC stemness and differentiation.	SOX9	NF-kappaB	6662	4790	1455	1394	0.0011716162762387	Non valid	0.971928075122253;0.027125646657020212;0.0009462782207268542	UNDEFINED	33898464	SOX9	9606	NFKB1	9606	dbTF		NFKB
30058	PMID:23243426:pubtator_title_and_abstract:101f59b67a49bd1d254cc21f8562517d:8:IKK alpha/beta:NF-kappaB:1301:1333	A notable [TF] mediated hepatic [TG] inactivation was associated with a significant hepatic TNFalpha downregulation among mice-bearing hepatocarcinogenic changes subjected to decoction treatment.	IKK alpha/beta	NF-kappaB	12675;16150	18033	1301	1333	0.187686675657568	Non valid	0.0016039075387583644;0.023571355173284087;0.9748247372879576	REPRESSION	23243426	Chuk;Ikbkb	10090;10090	Nfkb1	10090	coTF;coTF		NFKB
30102	PMID:34163463:pubtator_title_and_abstract:b6e45ae99e9f3af1141d8043768578ab:0:MYD88:NF-kappaB:37:105	Absence of Non-Canonical, Inhibitory [TF] Splice Variants in B Cell Lymphomas Correlates With Sustained [TG] Signaling.	MYD88	NF-kappaB	4615	4790	37	105	0.0010896955027472	Non valid	0.0643500806010433;0.23187620295722486;0.7037737164417319	REPRESSION	34163463	MYD88	9606	NFKB1	9606	coTF		NFKB
30176	PMID:24137201:pubtator_title_and_abstract:0ac4d6bbbc83b851f5a89d4f2c4e1307:9:NF-kappaB:NF-kappaB:1414:1744	Furthermore, we investigated the function of [TF] with regard to the anti-inflammatory effect exerted by escin in lipopolysaccharide (LPS)-treated mice, and demonstrated that escin significantly inhibited the expression of NF-kappaB. These results suggest that escin has a GC-like anti-inflammatory effect, and that its mechanisms may be correlated with the GC receptor/[TG] signaling pathway, but not the COX/PGF2alpha signaling pathway.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1414	1744	0.0015846017513868	Non valid	0.9157926623307926;0.07792093033501755;0.006286407334189831	UNDEFINED	24137201	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
30452	PMID:25294957:pubtator_title_and_abstract:1bc36f090b8e69a3efe096bce685692d:5:IRF3:NF-kappaB:722:660	Protein content of markers involved in the TLR4-mediated activation of several nuclear transcription factors, such as nuclear factor kappaB ([TG]), and interferon regulatory transcription factor 3 ([TF]), was analyzed.	IRF3	NF-kappaB	3661	4790	722	660	0.0012362892319831	Non valid	0.023689264844496;0.9748783846847083;0.0014323504707957043	ACTIVATION	25294957	IRF3	9606	NFKB1	9606	dbTF		NFKB
30600	PMID:30235753:pubtator_title_and_abstract:f3f985fd4f240c8ada9bbdb74121dcbe:4:AP-1:NF-kappaB:981:828	However, the interaction relationship between the 2 molecules in labor initiation has not yet been reported.This study aimed to investigate the interaction between NF-kappaB and AP-1 and their intracellular translocation during labor in human late pregnant myometrial cells (HLPMCs).Co-immunoprecipitation (Co-IP), Western blot analysis, immunohistochemistry (IHC), and immunocytofluorescence (ICF) techniques were applied to explore the interaction between [TG] and AP-1 and the alteration in their intracellular localization before and after labor onset.The protein expression levels of NF-kappaBp65 and [TF](c-jun) in the natural labor group were observed significantly higher than that in the non-labor group.	AP-1	NF-kappaB	3725	4790	981	828	0.0011428950051573	Non valid	0.9833373367859226;0.01491499658513631;0.0017476666289410966	UNDEFINED	30235753	JUN	9606	NFKB1	9606	dbTF		NFKB
30607	PMID:27862450:pubtator_title_and_abstract:bb6443220ee9701dfd9996e32e236973:5:PDX1:NF-kB:746:756	Expression of [TF], P65 [TG] and IKB in RIN5F cells and Nrf2, GLUT2, COX2, iNOS protein levels in the pancreatic tissue and plasma glucose, insulin and tumor necrosis factor-alpha and antioxidants, lipid peroxides and nitric oxide were measured.	PDX1	NF-kB	29535	309165	746	756	0.0011741350691692	Non valid	0.6614575986020881;0.3329252646773486;0.005617136720563358	UNDEFINED	27862450	Pdx1	10116	Rela	10116	dbTF		NFKB
30694	PMID:28122624:pubtator_title_and_abstract:bf0d3590aa591fa2843d3a1192215f57:9:NF-kappaB:NF-kappaB:1466:1394	The relevance of [TG] regulation to C3 induction was confirmed through detection of [TF] translocation into nuclei and inhibition through overexpression of the physiological NF-kappaB inhibitor, I-kappaBalpha.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1466	1394	0.00273099476185	Non valid	0.14056664284716622;0.8554694687235319;0.003963888429301936	ACTIVATION	28122624	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
30716	PMID:19906234:pubtator_title_and_abstract:67570227bbd66ad765763daa50b78c7c:9:GR:Nuclear factor-kappaB:1387:1279	[TG] (NF-kappaB) also has been shown to lead to GR suppression through mutually inhibitory [TF]-NF-kappaB nuclear interactions.	GR	Nuclear factor-kappaB	2908	4790	1387	1279	0.0012160798291732	Non valid	0.0066442399106158975;0.022040112457164845;0.9713156476322192	REPRESSION	19906234	NR3C1	9606	NFKB1	9606	dbTF		NFKB
30833	PMID:10551882:pubtator_title_and_abstract:da49b9238ec1d0d8864b5c69bd09880b:3:p52:NF-kappaB:310:386	The binding of NF-kappaB [TF] to DNA-DNA, DNA-PNA, PNA-DNA, and PNA-PNA hybrid molecules carrying the [TG] binding sites of human immunodeficiency type 1 long terminal repeat was studied by (i) biospecific interaction analysis (BIA) using surface plasmon resonance technology, (ii) electrophoretic mobility shift, (iii) DNase I footprinting, and (iv) UV cross-linking assays.	p52	NF-kappaB	4791	4790	310	386	0.0014322078562614	Non valid	0.9973053837811519;0.0018246836810668786;0.0008699325377812534	UNDEFINED	10551882	NFKB2	9606	NFKB1	9606	dbTF		NFKB
30853	PMID:21266552:pubtator_title_and_abstract:4fbdc86ec9176c1333b22c16c2d2d527:9:NF-kappaB:NF-kappaB:1601:1534	In addition, SAM did not affect LPS-inducible inhibitor of nuclear factor-kappaB degradation or nuclear factor-kappaB ([TG])-p65 translocation into the nucleus but rather inhibited [TF] transcriptional activity.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1601	1534	0.0011070078049637	Non valid	0.005003670548007444;0.9901891735065933;0.004807155945399255	ACTIVATION	21266552	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
30895	PMID:10075662:pubtator_title_and_abstract:55b896476bb9dd94f0990e4f8e4c33c7:10:NF-kappaB:NF-kappaB:1628:1539	Thus, our results indicate that RANK interacts with various TRAFs through distinct motifs and activates [TG] via a novel TRAF6 interaction motif, which then activates NIK, thus leading to [TF] activation, whereas RANK most likely activates JNK through a TRAF2-interacting region in RANK.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1628	1539	0.0011402060770636	Non valid	0.007031734366098738;0.9917554347821147;0.001212830851786588	ACTIVATION	10075662	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
30961	PMID:20927568:pubtator_title_and_abstract:a82664cea0575607799116a6b319d193:6:NF-kappaB:nuclear factor-kappaB:694:671	The activation of the [TG] ([TF]) signaling pathway was then analyzed.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	694	671	0.0011603538570386	Non valid	0.09463586695318896;0.9012713631594989;0.004092769887312157	ACTIVATION	20927568	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
31044	PMID:30177620:pubtator_title_and_abstract:7e9c99a30216cb1a8dcbac3ed23ed588:7:p65:NF-kappaB:935:1033	Mechanistically, ACE inhibits TNFalpha-induced phosphorylation of inhibitor of kappaB (IkappaB) kinase (IKK), IkappaB and [TF]/RelA, leading to the suppression of nuclear translocation of p65/RelA nuclear factor kappa-B ([TG]).	p65	NF-kappaB	5970	4790	935	1033	0.0011194473085943	Non valid	0.004126132310677943;0.9937713041118145;0.002102563577507516	ACTIVATION	30177620	RELA	9606	NFKB1	9606	dbTF		NFKB
31093	PMID:7489503:pubtator_title_and_abstract:2e9ce13139fba85c2b35a9aa5326ee72:4:CREB:NF-kappa B:724:731	Tax does not normally bind to nucleic acids, but instead stimulates transcription by interacting with a variety of cellular transcription factors, including the cyclic AMP-response element binding protein ([TF]), [TG], and the serum response factor (SRF).	CREB	NF-kappa B	1385	4790	724	731	0.0012291895561827	Non valid	0.008372871001526663;0.9907733849127657;0.0008537440857076352	ACTIVATION	7489503	CREB1	9606	NFKB1	9606	dbTF		NFKB
31147	PMID:36081452:pubtator_title_and_abstract:96a5789782816cf53343749d64f3b557:0:Nrf2:NF-kappaB:88:102	Trametenolic Acid Ameliorates the Progression of Diabetic Nephropathy in db/db Mice via [TF]/HO-1 and [TG]-Mediated Pathways.	Nrf2	NF-kappaB	18024	18033	88	102	0.0011856620929149	Non valid	0.07317588363040992;0.9241978589028346;0.0026262574667555555	ACTIVATION	36081452	Nfe2l2	10090	Nfkb1	10090	dbTF		NFKB
31170	PMID:17002883:pubtator_title_and_abstract:4446fb209bc242aa6fb004ad91a3c1e4:5:NF-kappaB:NF-kappaB:771:1203	We observed that (1) UVB induced protein and mRNA expression of ICAM-1 in a dose- and time-dependent manner in human keratinocyte cell HaCaT; (2) UVB induced the translocation of NF-kappaB and inhibition of [TF] by NF-kappaB inhibitors suppressed UVB-induced mRNA and protein expression of ICAM-1; (3) UVB increased the intracellular level of reactive oxygen species (ROS) by HaCaT cells; (4) UVB-induced increase of intracellular ROS level was suppressed by pretreatment with diphenyl iodonium (DPI) and N-acetyl cysteine (NAC); and (5) inhibition of UVB-induced ROS production by DPI or NAC suppressed UVB-mediated translocation of [TG], expression of ICAM-1 and subsequent monocyte adhesion in HaCaT cells.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	771	1203	0.0011432001551127	Non valid	0.004709379842055711;0.9938791256861921;0.0014114944717521492	ACTIVATION	17002883	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
31225	PMID:27166260:pubtator_title_and_abstract:e77f1070362783ce726eb368a9defee4:7:NF-kappaB:NF-kappaB:840:944	Interestingly, miR-K12-1 activates STAT3 indirectly through inducing NF-kappaB activation and [TF]-dependent expression of the cytokine interleukin-6 (IL-6) by repressing the expression of the [TG] inhibitor IkappaBalpha.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	840	944	0.0023358481380235	Non valid	0.01611753391091148;0.9711925019187159;0.012689964170372724	ACTIVATION	27166260	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
31294	PMID:36075565:pubtator_title_and_abstract:4850713187d77c48eafc90f9d1d43749:7:AKT:NF-kappaB:1046:1059	It is reasonable that LMP1 expression derived from initial viral infection is enough to assure the constant potentiation of [TF]/mTOR and [TG] signalings.	AKT	NF-kappaB	207	4790	1046	1059	0.0011048204441002	Non valid	0.06631000054936194;0.9270467664795843;0.006643232971053708	ACTIVATION	36075565	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
31352	PMID:35364376:pubtator_title_and_abstract:14dc5c5c5d9ea826e5c2bffe9c97ba43:0:AMPK:NF-kappaB:140:152	The enhanced mitochondrial dysfunction by cantleyoside confines inflammatory response and promotes apoptosis of human HFLS-RA cell line via [TF]/Sirt 1/[TG] pathway activation.	AMPK	NF-kappaB	5562	4790	140	152	0.0010931434803662	Non valid	0.016858468167856737;0.974972014933526;0.00816951689861719	ACTIVATION	35364376	PRKAA1	9606	NFKB1	9606	ll_coTF		NFKB
31466	PMID:28262619:pubtator_title_and_abstract:11d8c5d6f11f0b87257e2c7d9e12fff1:12:MyD88:NF-kappaB:1651:1666	These results suggest that kaempferol exhibits a protective effect on H9N2 virus-induced inflammation via suppression of TLR4/[TF]-mediated [TG] and MAPKs pathways, and kaempferol may be considered as an effective drug for the potential treatment of influenza virus-induced ALI.	MyD88	NF-kappaB	17874	18033	1651	1666	0.0142100415357644	Non valid	0.01266713737469687;0.985057941866796;0.002274920758507179	ACTIVATION	28262619	Myd88	10090	Nfkb1	10090	coTF		NFKB
31526	PMID:25009775:pubtator_title_and_abstract:6782a54d25ac929ff49ccd8225a7fd5f:10:IkappaBalpha:NFkappaB:1557:1495	[TG] was inhibited by both rac-1 and rac-8 independent of [TF] degradation.	IkappaBalpha	NFkappaB	4792	4790	1557	1495	0.0017941984026288	Non valid	0.049210794415890415;0.6076545800706795;0.34313462551343016	ACTIVATION	25009775	NFKBIA	9606	NFKB1	9606	coTF		NFKB
31530	PMID:36765977:pubtator_title_and_abstract:ba9f4c3d1de959836a998ee8a7318294:10:MyD88:NF-kappaB:1541:1547	Overall, HSP-W has beneficial effects on LPS-induced inflammation; it protects the intestinal barrier from injury in Caco-2 cells through inhibiting the TLR4/[TF]/[TG] and p38 MAPK signaling pathways.	MyD88	NF-kappaB	4615	4790	1541	1547	0.0010910466241788	Non valid	0.058532087447528726;0.9106921976948852;0.030775714857586036	ACTIVATION	36765977	MYD88	9606	NFKB1	9606	coTF		NFKB
31590	PMID:21327328:pubtator_title_and_abstract:65aeadd6f1e1318fdecd8e1e9d2eadc1:11:NF-kappaB:NF-kappaB:1373:1552	Using the p38 inhibitor, SB203580, the ERK1/2 inhibitor PD98059, the [TF] inhibitor, pyrrolidine dithiocarbamate and the NAMPT inhibitor FK866, we demonstrated that the visfatin pro-inflammatory action was through the NAMPT-MAPK (p38, ERK1/2)-[TG] pathway.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1373	1552	0.0011278812626813	Non valid	0.16907662628491718;0.826842997696741;0.00408037601834185	ACTIVATION	21327328	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
31591	PMID:28159925:pubtator_title_and_abstract:94190fe9b2e558c9e237f6e90be2a46f:6:p65:NF-kappaB:651:776	Functionally, miR-1246 led to a [TF]-dependent increase in transcription and release of pro-inflammatory mediators IL-6, CCL2 and CCL5 in MSCs, and increased [TG] activity.	p65	NF-kappaB	5970	4790	651	776	0.055228264977126	Non valid	0.022040760316047285;0.9700526898846462;0.00790654979930651	ACTIVATION	28159925	RELA	9606	NFKB1	9606	dbTF		NFKB
31762	PMID:36068919:pubtator_title_and_abstract:78e8b476a12fd6a222e74e8f451f747e:6:p300:NF-kappaB:1276:1220	Genetic inhibition of NLRC3 disrupted the NLRC3-mTOR-p300 complex and enhanced [TG] binding to the NFAT5 promoter in concert with [TF].	p300	NF-kappaB	328572	18033	1276	1220	0.0011421494859571	Non valid	0.9964698533581353;0.0023685906724632104;0.0011615559694014006	UNDEFINED	36068919	Ep300	10090	Nfkb1	10090	coTF		NFKB
31792	PMID:19176382:pubtator_title_and_abstract:28df7a067e5b1d498202d8682b6c725f:3:AKT:nuclear factor-kappaB:219:227	Increased activation of the [TF] and [TG] (NF-kappaB) pathways have been identified as critical steps in cancer initiation and progression in a variety of human cancers.	AKT	nuclear factor-kappaB	207	4790	219	227	0.0011379453347537	Non valid	0.007110737747720663;0.9904852781978842;0.0024039840543950155	ACTIVATION	19176382	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
31854	PMID:30125551:pubtator_title_and_abstract:81d2f72992b7065fe4f29ff58cee01bc:9:p38 MAPK:NF-kappaB:1284:1405	Further, TNFalpha challenge induced activation of mitogen-activated protein kinases (MAPKs), such as [TF] (38.0 +- 3.08 fold), JNK (51.6 +- 2.26 fold), and ERK (14.1 +- 0.77 fold); expression of nuclear factor-kappaB ([TG];   4-fold) and TNF receptor 1 (TNFR1; 2.7 +- 0.198 fold) were also increased.	p38 MAPK	NF-kappaB	26416	18033	1284	1405	0.0011818750740324	Non valid	0.0052772968073443085;0.9935090852948298;0.0012136178978258984	ACTIVATION	30125551	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
31998	PMID:25144719:pubtator_title_and_abstract:62ee1a49df7c72b5d87f7cc63f84ca33:9:RIP3:nuclear factor-kappaB:1262:1287	The expression of [TF]-KD induced p65/RelA [TG] (NF-kappaB) subunit caspase-dependent cleavage, and a non-cleavable p65/RelA D361E mutant rescued these cells from apoptosis.	RIP3	nuclear factor-kappaB	11035	4790	1262	1287	0.0013604324031176	Non valid	0.015703387883165193;0.038059939510483566;0.9462366726063512	REPRESSION	25144719	RIPK3	9606	NFKB1	9606	ll_coTF		NFKB
32237	PMID:32187449:pubtator_title_and_abstract:800e9d02cd7021955e873c4b6791b7dd:9:nuclear factor-kappa B:NF-kappaB:1170:1194	Furthermore, we demonstrated that CXCL1-overexpression induced radioresistance through mesenchymal transition of GBM via the activation of [TF] ([TG]) signaling.	nuclear factor-kappa B	NF-kappaB	Complex:NFKB	4790	1170	1194	0.001194290535992	Non valid	0.09706215190702683;0.8967835230959113;0.00615432499706192	ACTIVATION	32187449	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
32243	PMID:28629477:pubtator_title_and_abstract:bf0a3897344604586608979c54dee9dc:3:epidermal growth factor receptor:nuclear factor-kappaB:239:283	Expression of the [TF] (EGFR) and [TG] (NF-kappaB) is well-known to be upregulated in BLBC.	epidermal growth factor receptor	nuclear factor-kappaB	1956	4790	239	283	0.0016041755489924	Non valid	0.009655228630858796;0.9880673958167911;0.002277375552350009	ACTIVATION	28629477	EGFR	9606	NFKB1	9606	ll_coTF		NFKB
32256	PMID:24274545:pubtator_title_and_abstract:6b38915ff19f01c2ed218aece22eb02e:5:NF-kappaB:NF-kappaB:677:649	LPS enhanced O-GlcNAc modification of [TG]/p65 and activated [TF] pathway, which could be prevented either by siRNA knockdown of O-GlcNAc transferase (OGT) or pretreatment with COS.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	677	649	0.0011895615074374	Non valid	0.11357123906809408;0.8840096801085014;0.0024190808234045005	ACTIVATION	24274545	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
32311	PMID:35818417:pubtator_title_and_abstract:58ff3859faaf1d1bd33f014f9d567105:0:Nrf2:NF-kappaB:59:88	Effects of G-Rh2 on mast cell-mediated anaphylaxis via AKT-[TF]/NF-kappaB and MAPK-Nrf2/[TG] pathways.	Nrf2	NF-kappaB	18024	18033	59	88	0.0012033664835728	Non valid	0.981991263518949;0.014820502992623231;0.003188233488427687	UNDEFINED	35818417	Nfe2l2	10090	Nfkb1	10090	dbTF		NFKB
32441	PMID:35288557:pubtator_title_and_abstract:583da3e7d0701cfe8d4cb7c1a9f75fed:6:RelA:NF-kappaB:829:819	Mechanistically, activation of [TG]/[TF] in monocytes induces PRMT7 transcription and consequential mono-methylation of histones at the regulatory elements of RAP1A, which leads to increased transcription of this gene that is responsible for adhesion and migration of monocytes.	RelA	NF-kappaB	19697	18033	829	819	0.0012315694677952	Non valid	0.0069234387061277505;0.9915829528945651;0.001493608399307203	ACTIVATION	35288557	Rela	10090	Nfkb1	10090	dbTF		NFKB
32611	PMID:24204969:pubtator_title_and_abstract:9731246dc39fe3f97a609a3297be74ea:10:NLRP3:NF-kappaB:2021:2003	Our data also confirm that ROS generation and activation of [TG] and the [TF] inflammasome are crucial mechanistic events involved in the progression of the renal disorder.	NLRP3	NF-kappaB	216799	18033	2021	2003	0.0011661160179159	Non valid	0.0118389867373933;0.9867943138260377;0.0013666994365691455	ACTIVATION	24204969	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
32780	PMID:18832723:pubtator_title_and_abstract:ae399649ae3d8d91123d1058bfcd9f2f:10:PPARgamma:NF-kappaB.:1948:2040	We conclude that AC induce [TF] sumoylation to attenuate the removal of NCoR, thereby blocking transactivation of [TG] This contributes to an antiinflammatory phenotype shift in macrophages responding to AC by lowering proinflammatory cytokine production.	PPARgamma	NF-kappaB.	19016	18033	1948	2040	0.3404267859220919	Non valid	0.03372409233057597;0.23377789260147736;0.7324980150679467	REPRESSION	18832723	Pparg	10090	Nfkb1	10090	dbTF		NFKB
32799	PMID:20367496:pubtator_title_and_abstract:09c6cb897cef8f9ddbaac0b1d7893855:6:p53:NF-kappaB:1061:1050	This review highlights recent observations on the molecular interactions and their functional consequences between NRF2 and the arylhydrocarbon receptor (AhR), [TG], [TF], and Notch1 signaling pathways.	p53	NF-kappaB	7157	4790	1061	1050	0.0011566679626355	Non valid	0.9964888291687968;0.002749520442548548;0.0007616503886546302	UNDEFINED	20367496	TP53	9606	NFKB1	9606	dbTF		NFKB
32807	PMID:26492598:pubtator_title_and_abstract:a73dcc3b6cf75d9060dd043a309079d1:6:NF-kappaB:NF-kappaB:1137:1399	TNF-alpha strongly activates the [TF] pathway, therefore, we propose that TNF-alpha-induced neurite regrowth occurs primarily through EphB2 signaling via stimulation of NF-kappaB. EphB2 promoter activity increased with TNF-alpha treatment and overexpression of NF-kappaB. Direct binding of [TG] to the EphB2 promoter occurred in the ChIP assay, and site-directed mutagenesis identified binding sites involved in TNF-alpha-induced EphB2 activation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1137	1399	0.0010619797759746	Non valid	0.24198275225899565;0.7521142725605218;0.005902975180482659	ACTIVATION	26492598	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
32955	PMID:16990795:pubtator_title_and_abstract:a14927d75c423786f1b03f290071fff3:2:p52:nuclear factor kappa B:93:102	The [TF]/p100 [TG] (NF-kappaB) subunit (NF-kappaB2) is aberrantly expressed in many tumour types and has been implicated as a regulator of cell proliferation.	p52	nuclear factor kappa B	4791	4790	93	102	0.0011305468122746	Non valid	0.9491055575339815;0.04088996113026453;0.010004481335753912	UNDEFINED	16990795	NFKB2	9606	NFKB1	9606	dbTF		NFKB
33014	PMID:9022022:pubtator_title_and_abstract:063a00f0810ef91d00c87a612542c2fb:5:NF-kappaB:NF-kappaB:571:724	The possible link between the JNK cascade and [TF] activation was demonstrated by the fact that the active form of MAP kinase kinase kinase (deltaMEKK), a constitutive activator of JNK, induced [TG] but not AP-1, Oct, and NF-AT in T cells.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	571	724	0.0014292437509618	Non valid	0.04556422318733823;0.9525351490726929;0.0019006277399689815	ACTIVATION	9022022	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
33047	PMID:26246742:pubtator_title_and_abstract:4a76ccb17bbbde79c2c3f73c177d677e:10:nuclear factor-kappaB:NF-kappaB:1556:1579	This inhibition was associated with suppression of Ikappa-B-alpha degradation and subsequent inhibition of [TF] ([TG]) p65 translocation to the nucleus.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1556	1579	0.001114717732779	Non valid	0.00846033450996838;0.9890183447856793;0.0025213207043523634	ACTIVATION	26246742	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
33048	PMID:31684930:pubtator_title_and_abstract:a6f43d166d53a980c010c5ad085b2182:6:vitamin D receptor:NF-kappaB:951:1064	Expression of [TF] (VDR), and activation of AhR was examined using western blot analysis, and phosphorylation of [TG] was detected using cell-based protein phosphorylation ELISA.	vitamin D receptor	NF-kappaB	7421	4790	951	1064	0.001103987461003	Non valid	0.6298576930449808;0.3618610071605756;0.008281299794443515	UNDEFINED	31684930	VDR	9606	NFKB1	9606	dbTF		NFKB
33128	PMID:22112782:pubtator_title_and_abstract:bc046dd4a053298cb41a6450b3f2c95c:16:HIF-1alpha:NFkappaB:2567:2554	This finding was subsequently confirmed by finding that hypoxic HUVEC-CM resulted in higher expression of [TG] and [TF] in the nuclear fraction of HRPC and corresponding decrease in cytoplasmic NFkappaB and HIF-1alpha.	HIF-1alpha	NFkappaB	3091	4790	2567	2554	0.0011912759946952	Non valid	0.0919418174399239;0.8689882534738911;0.03906992908618506	ACTIVATION	22112782	HIF1A	9606	NFKB1	9606	dbTF		NFKB
33214	PMID:17110449:pubtator_title_and_abstract:ea75341f41c040206c637a75606a6080:0:TAK1:NF-kappaB:156:118	Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting [TG]-regulated gene products and [TF]-mediated NF-kappaB activation.	TAK1	NF-kappaB	6885	4790	156	118	0.0011563914416908	Non valid	0.014019206583821506;0.9838171115252679;0.0021636818909107043	ACTIVATION	17110449	MAP3K7	9606	NFKB1	9606	ll_coTF		NFKB
33229	PMID:25597356:pubtator_title_and_abstract:3bde322b92edd3736434bd565a86c58c:9:STAT3:NF-kappaB:1244:1254	Loss of RKIP in AGS cells results in increased expression of the Cag A virulence factor after H. pylori infection and RKIP overexpression inhibits H. pylori-mediated STAT3 phosphorylation and [TF] and [TG] transcriptional activity.	STAT3	NF-kappaB	20848	18033	1244	1254	0.0012286835795027	Non valid	0.011390250407581824;0.9824437076367449;0.006166041955673268	ACTIVATION	25597356	Stat3	10090	Nfkb1	10090	dbTF		NFKB
33312	PMID:27121155:pubtator_title_and_abstract:710f8de965347a027d6160fc0156fffa:7:p65:NF-kappaB:1481:1531	Further analyses revealed that LNT activated the NF-kappaB and MAPK signalling pathways and promoted the nuclear import of [TF] and that BAY 11-7082 (a specific inhibitor of [TG]) suppressed the release of G-CSF, GM-CSF and M-CSF.	p65	NF-kappaB	19697	18033	1481	1531	0.001933441992664	Non valid	0.03505546112499593;0.9558806708099459;0.009063868065058102	ACTIVATION	27121155	Rela	10090	Nfkb1	10090	dbTF		NFKB
33326	PMID:35874059:pubtator_title_and_abstract:8b4912ba5cc48473d0e5ea1aadf3ee0d:10:IkappaBalpha:nuclear factor-kappa-B:1284:1303	Cyclooxygenase-2 and inducible nitric oxide synthase proteins, phosphorylation of mitogen-activated protein kinase (MAPK) subgroups, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), p38, I-kappa-B-alpha ([TF]), and [TG] (NF-kappaB), and activation in extracts were detected via western blotting.	IkappaBalpha	nuclear factor-kappa-B	18035	18033	1284	1303	0.0011559872450578	Non valid	0.192563106879764;0.8028482791215535;0.004588613998682417	ACTIVATION	35874059	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
33339	PMID:31963866:pubtator_title_and_abstract:eb5af47bb56ead7fefca463101bcd390:5:Nrf2:NF-kappaB:904:844	Cell viability and death were evaluated using proapoptotic and antiapoptotic markers such as cleaved caspase-3 (c-caspase-3), cleaved poly(ADP-ribose) polymerase N-acetylcysteine (c-PARP), Bcl-XL, and transcription factors associated with redox and inflammation regulation, including nuclear factor kappa B ([TG]) and nuclear factor (erythroid-derived 2)-like 2 ([TF]).	Nrf2	NF-kappaB	4780	4790	904	844	0.0012150033445191	Non valid	0.9644479379189116;0.03094081553858976;0.004611246542498641	UNDEFINED	31963866	NFE2L2	9606	NFKB1	9606	dbTF		NFKB
33367	PMID:26045547:pubtator_title_and_abstract:5cd733f19efeb649e05129b0d7a78808:7:RORalpha:NF-kappaB:1101:1039	In an important finding, the inhibition of [TG] by melatonin, but not that of NLRP3, was blunted in [TF] (sg/sg) mice, indicating that functional RORalpha transcription factor is necessary for the initiation of the innate immune response against inflammation.	RORalpha	NF-kappaB	19883	18033	1101	1039	0.2703220519619087	Non valid	0.016940456955032532;0.33498283983690164;0.6480767032080658	REPRESSION	26045547	Rora	10090	Nfkb1	10090	dbTF		NFKB
33563	PMID:25776492:pubtator_title_and_abstract:e29b5f253e0d8f15204115899473d210:3:nuclear factor-kappaB:NF-kappaB:204:227	The [TF] ([TG]) transcription factors play critical roles in development and progression of cancer.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	204	227	0.0010929391319088	Non valid	0.979170543503422;0.018495894508179365;0.002333561988398663	UNDEFINED	25776492	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
33722	PMID:23161884:pubtator_title_and_abstract:aa4a5390cb728bd16b4ef588468cf2cb:6:Smad3:NF-kappaB.:735:995	Consistently, [TF] knockout lung at postnatal day 28 had reduced SIRT1 expression, which in turn resulted in increased histone acetylation at the binding sites of the transcription factors AP-1, NF-kappaB, and Pea3 on the MMP9 promoter, as well as increased acetylation of [TG] Thus, upon TGF-beta activation, phosphorylated Smad3 can be translocated into the nucleus with Smad4, whereat Smad3 in turn collaborates with c-Jun to activate SIRT1 transcription.	Smad3	NF-kappaB.	17127	18033	735	995	0.0017765043952989	Non valid	0.2966489460870979;0.10447382146096035;0.5988772324519418	REPRESSION	23161884	Smad3	10090	Nfkb1	10090	dbTF		NFKB
33727	PMID:35624762:pubtator_title_and_abstract:6f8c16ba303bdd741381d4a54a3cd3e4:6:PGC-1alpha:NF-kappaB:1038:1080	Mechanistically, PL-EA markedly upregulated the pgc-1alpha, sirt1 genes and adiponectin, downregulated gck and srebp-1c; upregulated proteins PPARgamma, pAMPK, and [TF], and downregulated SREBP-1 and [TG] in the liver of HFD-fed mice.	PGC-1alpha	NF-kappaB	10891	18033	1038	1080	0.0012091740995179	Non valid	0.1350749199322466;0.4049068060453972;0.46001827402235623	REPRESSION	35624762	PPARGC1A	9606	Nfkb1	10090	coTF		NFKB
33747	PMID:28629477:pubtator_title_and_abstract:bf0a3897344604586608979c54dee9dc:10:EGFR:NF-kappaB:1273:1278	CONCLUSION: Collectively, our findings reveal a novel [TF]-[TG]-FOXC1 signaling axis that is critical for BLBC cell function, supporting the notion that intervention in the FOXC1 pathway may provide potential modalities for BLBC treatment.	EGFR	NF-kappaB	1956	4790	1273	1278	0.0011643339930403	Non valid	0.9862003906934015;0.013031737192476148;0.0007678721141223657	UNDEFINED	28629477	EGFR	9606	NFKB1	9606	ll_coTF		NFKB
33777	PMID:32272583:pubtator_title_and_abstract:f7a5f060a12791b66d7564ae24b98efc:3:IFN regulatory factor 3:nuclear factor-kappa B:604:564	Once engaged, these nucleotide-sensing receptors use distinct signaling modules for the rapid and robust activation of mitogen-activated protein kinases (MAPKs), the IkappaB kinase (IKK) complex, and the IKK-related kinases IKKepsilon and TANK-binding kinase 1 (TBK1), leading to the subsequent activation of the activator protein 1 (AP1), [TG] (NF-kappaB), and [TF] (IRF3) transcription factors, respectively.	IFN regulatory factor 3	nuclear factor-kappa B	3661	4790	604	564	0.0011384150721029	Non valid	0.00636377312975081;0.9927929292298321;0.00084329764041717	ACTIVATION	32272583	IRF3	9606	NFKB1	9606	dbTF		NFKB
33912	PMID:22787206:pubtator_title_and_abstract:712daa951c3e1a7e09b21da9feecbf3c:3:p52:NF-kappaB:544:639	Since almost nothing is known so far about a function of noncanonical NF-kappaB signaling after IAV infection, we tested infected cells for activation of [TF] and RelB. We show that the viral NS1 protein strongly inhibits RIG-I-mediated noncanonical [TG] activation and expression of the noncanonical target gene CCL19.	p52	NF-kappaB	4791	4790	544	639	0.0015692041916742	Non valid	0.012605613088429408;0.9845303924751782;0.0028639944363923263	ACTIVATION	22787206	NFKB2	9606	NFKB1	9606	dbTF		NFKB
34017	PMID:22952582:pubtator_title_and_abstract:8b27ab488ccaf79a68dee3d37a41bace:5:IkappaBalpha:NF-kappaB:677:502	Results showed CD40-induced [TG] signaling was constitutively activated in B cells from active lupus patients, including decreased CD40 in raft portion, increased phosphorylation and degradation of [TF], phosphorylation of P65, as well as increased nuclear translocation of P65, P50, c-Rel, which could be blocked by anti-CD154.	IkappaBalpha	NF-kappaB	4792	4790	677	502	0.0011053504921286	Non valid	0.019216541699305124;0.9765966711492895;0.004186787151405388	ACTIVATION	22952582	NFKBIA	9606	NFKB1	9606	coTF		NFKB
34120	PMID:30983127:pubtator_title_and_abstract:524c0275b1814f8c6837b28383b69457:7:NF-kappaB p65:NF-kappaB:858:735	Using lentiviral pLVX-[TG]-puro and Lentivirus-delivered NF-kappaB short hairpin RNA (shRNA), we created ovarian cancer cell lines in which [TF] was stably up-regulated and down-regulated.	NF-kappaB p65	NF-kappaB	5970	4790	858	735	0.0011188708048902	Non valid	0.057574871266922595;0.056249857235571216;0.8861752714975062	REPRESSION	30983127	RELA	9606	NFKB1	9606	dbTF		NFKB
34190	PMID:36199696:pubtator_title_and_abstract:09da87710a4442372e201ca95f98e2d4:10:Akt:NF kappa B:1364:1369	In addition, the combination of luteolin and erlotinib reduced the phosphorylation of downstream EGFR cell signaling molecules such as [TF], [TG], and STAT3 in a concentration-dependent manner.	Akt	NF kappa B	207	4790	1364	1369	0.0012177852209375	Non valid	0.2411461984600707;0.7532213590347134;0.005632442505215842	ACTIVATION	36199696	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
34220	PMID:26539482:pubtator_title_and_abstract:baf7ff3b21a4ddfa72ba9f0b569ebf6c:5:NF-kappaB:NF-kappaB:1009:1047	Results show that curcumin not only significantly enhances radiation-induced cytotoxicity and depletion of MMP but inhibits radiation-induced [TF] activity and expressions of [TG] downstream proteins in HCC cells.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1009	1047	0.0011651694465053	Non valid	0.013365005324588956;0.9832005483446528;0.003434446330758354	ACTIVATION	26539482	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
34223	PMID:35490778:pubtator_title_and_abstract:eb6f895d2ebcea6d6c5570489f0b875a:7:NF-kappaB:nuclear factor Kappa B:1356:1332	Furthermore, PPI (protein-protein interaction) network analysis, GO (gene ontology) and KEGG (Kyoto encyclopedia of genes and genomes) pathway enrichment analyses show that the molecular mechanisms underlying the enhancing effect of trans-UCA on spatial memory are mainly associated with the regulation of insulin, mitogen-activated protein kinase (MAPK) and [TG] ([TF]) signaling pathways, serotonergic synapse and arginine and proline metabolism.	NF-kappaB	nuclear factor Kappa B	Complex:NFKB	4790	1356	1332	0.0011158465642483	Non valid	0.9703880897424261;0.027282193254466368;0.0023297170031074854	UNDEFINED	35490778	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
34228	PMID:33191401:pubtator_title_and_abstract:7530a370b90173e551e14a1c880edf58:6:STAT3:NF-kappaB:1219:1226	Moreover, the disabled c-Myc, [TF], [TG], and eIF4F were associated with the broadly decreased levels of anti-apoptosis proteins and pro-stemness proteins.	STAT3	NF-kappaB	6774	4790	1219	1226	0.0012346135222743	Non valid	0.07262061914845278;0.8847135428239575;0.042665838027589685	ACTIVATION	33191401	STAT3	9606	NFKB1	9606	dbTF		NFKB
34283	PMID:26225825:pubtator_title_and_abstract:7d4afc7601e99d317285e9b8d4990439:6:nuclear factor-kappaB:NF-kappaB:1142:1165	Hemodynamics, lung mechanics, gas exchange, and acid-base status were measured together with blood and tissue cytokine and chemokine concentrations, heme oxygenase-1 (HO-1), activated caspase-3, and hypoxia-inducible factor 1-alpha (HIF-1alpha) expression, [TF] ([TG]) activation, nitrotyrosine formation, purinergic receptor 2X4 (P2XR4) and 2X7 (P2XR7) expression, and histological scoring.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1142	1165	0.0012665930892568	Non valid	0.016950783908681672;0.98166102229201;0.0013881937993082253	ACTIVATION	26225825	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
34402	PMID:35399843:pubtator_title_and_abstract:8eb3b37386fb37a3aa7af8bc08920f40:6:MyD88:NF-kappaB:1796:1803	Conclusion: LSeA will increase the inflammatory reactions in child patients, and its pathogenesis may be related to the upregulation of TLR4, [TF], [TG] expression and thus activation of TLR4/MyD88/NF-kappaB signaling pathways.	MyD88	NF-kappaB	4615	4790	1796	1803	0.001385707849517	Non valid	0.019404573417972828;0.9783378899921563;0.0022575365898707895	ACTIVATION	35399843	MYD88	9606	NFKB1	9606	coTF		NFKB
34423	PMID:33767151:pubtator_title_and_abstract:a7e4dd45bee28370c7d4e52480989f25:6:IRF3:NFkappaB:774:798	Despite priming equivalent antitumor T cell quantities, MDA5-orchestrated TBK1-[TF] signaling, but not [TG]-polarized TLR activation, culminates in polyfunctional and Th1-differentiated antitumor T cell phenotypes.	IRF3	NFkappaB	3661	4790	774	798	0.0011306329719165	Non valid	0.21882847087471935;0.7772381035445831;0.003933425580697492	ACTIVATION	33767151	IRF3	9606	NFKB1	9606	dbTF		NFKB
34454	PMID:20932499:pubtator_title_and_abstract:653960d9e9022845b06ea95fa6d48272:6:NF-kappaB:NF-kappaB:882:789	IL-6 expression and [TG] transcriptional activation were inhibited by astaxanthin, as well as inhibitors of [TF] and MAPK in LPS-stimulated BV-2 microglial cells.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	882	789	0.0020773287588033	Non valid	0.002022162671920471;0.995710717431553;0.0022671198965265103	ACTIVATION	20932499	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
34662	PMID:24613819:pubtator_title_and_abstract:e432a2d235b63f512309920580ce1057:7:Akt:NF-kappaB:1337:1431	Furthermore, phosphorylation of TNF-alpha-induced phosphatidyl-inositol 3 kinase (PI3K)/[TF] was significantly downregulated in the presence of GA accompanying with the inhibition of [TG] activity, and as presumed, the specific PI3K/Akt inhibitor LY294002 significantly decreased MMP-9 and VEGF expression as well as activity.	Akt	NF-kappaB	207	4790	1337	1431	0.0020348562173569	Non valid	0.0040626062283454206;0.9930761657305405;0.002861228041114069	ACTIVATION	24613819	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
34673	PMID:31999475:pubtator_title_and_abstract:2f2fe26e0eb48fcd3b56d80f5a4a1b27:7:NF-kappaB:NF-kappaB:742:862	The [TF] inhibitor, pyrrolidine dithiocarbamate (PDTC), alleviated UVB-induced apoptosis in HLECs; while activation of [TG] suppressed the effects of the ROS inhibitor, N-acetyl-L-cysteine (NAC), on UVB-treated HLECs.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	742	862	0.0014519423660039	Non valid	0.01821771786542029;0.9543417669646842;0.027440515169895544	ACTIVATION	31999475	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
34783	PMID:23646170:pubtator_title_and_abstract:8f62beb40c60c2c78ef89f3cd9dfb7f0:6:TAB1:NFkappaB.:1005:1118	Consistent with these findings, PPARbeta/delta physically interacts with both the endogenous cytoplasmic TAK1/[TF] complex and HSP27, and PPARbeta/delta overexpression increases the TAK1-induced transcriptional activity of [TG] These observations suggest that PPARbeta/delta plays a role in the assembly of a cytoplasmic multi-protein complex containing TAK1, TAB1, HSP27 and PPARbeta/delta, and thereby participates in the NFkappaB response to IL-1beta.	TAB1	NFkappaB.	10454	4790	1005	1118	0.006911456393206	Non valid	0.008009439424180897;0.99048289106738;0.0015076695084391186	ACTIVATION	23646170	TAB1	9606	NFKB1	9606	ll_coTF		NFKB
34804	PMID:28730076:pubtator_title_and_abstract:6bb05c5da6715c6dc1bceb1ecb4ab561:12:p65:NFkappaB:1390:1380	SE reduced the increased phosphorylation of nuclear factor kappa B ([TG]) [TF] and its subsequent nuclear translocation in retinas from STZ-induced diabetic mice.	p65	NFkappaB	19697	18033	1390	1380	0.0011322213679227	Non valid	0.03759423669391951;0.9580830350527936;0.004322728253286986	ACTIVATION	28730076	Rela	10090	Nfkb1	10090	dbTF		NFKB
34890	PMID:11856733:pubtator_title_and_abstract:c4e63cf03e2c301cac2baa6171e17046:5:Egr-1:NFkappaB:723:812	Binding of [TF] to the TNFalpha promoter was increased by 2.5-fold after ethanol exposure, whereas [TG] binding was decreased to 30% of control.	Egr-1	NFkappaB	1958	4790	723	812	0.0011119988883799	Non valid	0.893533033412095;0.017545405351155473;0.08892156123674946	UNDEFINED	11856733	EGR1	9606	NFKB1	9606	dbTF		NFKB
35003	PMID:37254541:pubtator_title_and_abstract:9787e09327bbb183a64e01881fc1a54c:8:ERK:NF-kappaB:812:831	Apigenin is non-toxic in nature and acts through various pathways (JAK/STAT, Wnt/beta-catenin, MAPK/[TF], PI3K/Akt, and [TG]) to exert its therapeutic efficacy.	ERK	NF-kappaB	5594	4790	812	831	0.0011258596764317	Non valid	0.663485824763648;0.3321832017752154;0.0043309734611365	UNDEFINED	37254541	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
35025	PMID:28561752:pubtator_title_and_abstract:86ba9ce1312087c8e62a4a110545d6c7:0:NF-kappaB:Nuclear Factor-Kappa B:94:70	Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced [TG] ([TF]) Activation and NF-kappaB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant Prostate Cancer (CRPC) Therapy.	NF-kappaB	Nuclear Factor-Kappa B	Complex:NFKB	4790	94	70	0.0011156621547353	Non valid	0.003983283013456078;0.993411554865635;0.0026051621209088865	ACTIVATION	28561752	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
35066	PMID:20124446:pubtator_title_and_abstract:5828b32f9169189c948d769ae5d53cd2:0:NF-kappaB:NF-kappaB:134:34	The novel, proteasome-independent [TG] inhibitor V1810 induces apoptosis and cell cycle arrest in multiple myeloma and overcomes [TF]-mediated drug resistance.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	134	34	0.0011719371791129	Non valid	0.48884713874594393;0.2453265448900781;0.2658263163639779	UNDEFINED	20124446	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
35215	PMID:8496188:pubtator_title_and_abstract:01ef2a0c5d9400c268c3e4812bb05c0e:4:NF kappa B:NF kappa B.:677:813	We demonstrate evidence suggesting that redox regulation of [TF] by Trx might be exerted at a step after dissociation of the inhibitory molecule I kappa B, a cytosolic-anchoring protein for [TG] To examine the effect of Trx in intact cells, we performed transient assay with a chloramphenicol acetyltransferase-expressing plasmid under the control of human immunodeficiency virus (HIV) long terminal repeat and an effector plasmid expressing human Trx.	NF kappa B	NF kappa B.	Complex:NFKB	4790	677	813	0.0011382711216165	Non valid	0.9936215818768944;0.0033438828786280794;0.0030345352444774644	UNDEFINED	8496188	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
35254	PMID:15013838:pubtator_title_and_abstract:80eb3163627fc3b4eb497f93fc68ccb0:8:NF-kappaBp65:NF-kappaB:1303:1255	Site-directed mutagenesis of the [TG] site strongly inhibited TNFalpha- and [TF]-induced promoter activation.	NF-kappaBp65	NF-kappaB	5970	4790	1303	1255	0.0011060053756384	Non valid	0.0019167709295241997;0.9964702794236832;0.0016129496467925638	ACTIVATION	15013838	RELA	9606	NFKB1	9606	dbTF		NFKB
35323	PMID:35449863:pubtator_title_and_abstract:a7bf2f4608d2aa4024a85dd87d138ee0:4:NF-kappaB:NF-kappaB.:613:532	Objective: The study's goal was to figure out what was causing the problem HMGB1 involved in regulating the autoimmune encephalomyelitis by regulating [TG] Materials and Methods: The expressions of HMGB1, miR-129-5p, and TLR4/[TF] signalling pathway-related proteins were measured by qRT-PCR.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	613	532	0.0014196274693585	Non valid	0.9953678383723576;0.003535261131830838;0.0010969004958114722	UNDEFINED	35449863	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
35353	PMID:34306206:pubtator_title_and_abstract:2a01438aee51745484daf6cd3d05eef5:9:phosphatidylinositol-3-kinase:nuclear factor-kappaB:1212:1174	Additionally, the protein and mRNA expression levels of [TG] (NF-kappaB) and [TF] (PI3K)/protein kinase B (AKT) signaling pathway-related factors were determined using western blot analysis and reverse transcription-quantitative PCR, respectively.	phosphatidylinositol-3-kinase	nuclear factor-kappaB	5295	4790	1212	1174	0.0011420559222533	Non valid	0.9812293393938213;0.017454957745623258;0.001315702860555436	UNDEFINED	34306206	PIK3R1	9606	NFKB1	9606	ll_coTF		NFKB
35446	PMID:34560519:pubtator_title_and_abstract:acb5c46d95afa94b9ee6ea115b63f9df:14:nuclear factor kappa-light-chain-enhancer of activated B cells:NF-kappaB:1837:1901	RESULTS: Our data demonstrated that asiatic acid induced cell death in multiple ways, including reactive oxygen species production, adenosine triphosphate (ATP) content reduction, and adaptive immunity balance via intrinsic apoptosis, AMP-activated protein kinase (AMPK), programmed death-ligand 1 (PD-L1), and indirect [TF] ([TG]) transcriptional pathways, using experimental validation and in silico analysis.	nuclear factor kappa-light-chain-enhancer of activated B cells	NF-kappaB	Complex:NFKB	4790	1837	1901	0.0012028106860402	Non valid	0.21769631605895967;0.7190125860692044;0.0632910978718361	ACTIVATION	34560519	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
35648	PMID:15147574:pubtator_title_and_abstract:09dc59a687efdb8e92799816e4a399ba:5:IkappaBalpha:NF-kappaB:1338:1367	However, B. vulgatus failed to trigger [TF] degradation and [TG] transcriptional activity in the presence of PBMC.	IkappaBalpha	NF-kappaB	4792	4790	1338	1367	0.0300330607389131	Non valid	0.017955505600794154;0.0595430307933012;0.9225014636059047	REPRESSION	15147574	NFKBIA	9606	NFKB1	9606	coTF		NFKB
35695	PMID:15029150:pubtator_title_and_abstract:762627392f86b1ca8bd871bef005c802:2:peroxisome proliferator activated receptors:NFkappaB:143:223	Two families of gene transcription factors - these review deals with [TF] (PP AR) and nuclear factor kappa B ([TG]).	peroxisome proliferator activated receptors	NFkappaB	5465	4790	143	223	0.0011882489628184	Non valid	0.9885930571223737;0.009543800541539969;0.0018631423360864808	UNDEFINED	15029150	PPARA	9606	NFKB1	9606	dbTF		NFKB
35718	PMID:25004881:pubtator_title_and_abstract:b9fa75c189b6a6f3e0b6e8fb69846fd2:7:JNK:nuclear factor (NF)-kappaB:939:996	The action mechanism of LRC underlies the blocking of LPS-mediated p38 and Jun N-terminal kinase ([TF]), mitogen-activated protein kinases (MAPKs), and the [TG] signaling pathway.	JNK	nuclear factor (NF)-kappaB	26419	18033	939	996	0.0011958113411934	Non valid	0.06660032897240953;0.9296155510158528;0.003784120011737705	ACTIVATION	25004881	Mapk8	10090	Nfkb1	10090	ll_coTF		NFKB
35798	PMID:27347072:pubtator_title_and_abstract:27a2cc8805c4585ef4d01d07a36e6a37:8:Bcl-2:NF-kappaB:1373:1354	In addition, the mRNA levels of K-ras, [TG], Fas and [TF] were markedly reduced, while P53 mRNA level was notably enhanced, in the pGenesil-PLCepsilon group, and these changes were accompanied by similar changes in the corresponding protein levels.	Bcl-2	NF-kappaB	12043	18033	1373	1354	0.0012290932611898	Non valid	0.0556133918537383;0.5173928353735943;0.42699377277266753	ACTIVATION	27347072	Bcl2	10090	Nfkb1	10090	coTF		NFKB
35802	PMID:22323467:pubtator_title_and_abstract:5725ff3e4f1d86abf0baba173d42fddc:2:nuclear factor-kappaB:NF-kappaB:144:167	PURPOSE: To determine the role of [TF] ([TG]) during FGF-2-mediated endothelial mesenchymal transformation (EMT) in response to interleukin (IL)-1beta stimulation in corneal endothelial cells (CECs).	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	144	167	0.001363729915684	Non valid	0.9815918759811403;0.016782739846660004;0.0016253841721997181	UNDEFINED	22323467	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
35834	PMID:33377310:pubtator_title_and_abstract:e80179d1558dc2465b89fa274a671a53:6:p65:NF-kappaB:883:873	This effect is not due to modulation of the inhibitor of NF-kappaB kinases (IKK) alpha/beta/gamma and NF-kappaB inhibitor alpha, and [TG]/[TF] DNA binding activity.	p65	NF-kappaB	19697	18033	883	873	0.0011500447227828	Non valid	0.9965958937212366;0.002282815940167123;0.0011212903385962526	UNDEFINED	33377310	Rela	10090	Nfkb1	10090	dbTF		NFKB
35911	PMID:36519789:pubtator_title_and_abstract:3421e3ac52bca7ae26c2c5565e2b6b15:13:NF-kappaB:nuclear factor kappa-B:1298:1274	Furthermore, [TG] ([TF]) inhibitor PS-341 could attenuate tumorigenesis, metastasis, and drug resistance ability induced by HKDC1 overexpression in GC cells.	NF-kappaB	nuclear factor kappa-B	Complex:NFKB	4790	1298	1274	0.0011990349155817	Non valid	0.13993193520344732;0.791836325230446;0.06823173956610679	ACTIVATION	36519789	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
35972	PMID:31766169:pubtator_title_and_abstract:d3b521e88f0dd3d338834b6c16ee90c3:6:p16:NFkappaB:1253:1163	Univariate analysis revealed that the high expression of [TG] is associated with significantly worse LPFS, DMFS, and OS, and low expression of [TF] is associated with significantly lower LPFS.	p16	NFkappaB	1029	4790	1253	1163	0.001311508857813	Non valid	0.08619154029015633;0.649300571046992;0.26450788866285174	ACTIVATION	31766169	CDKN2A	9606	NFKB1	9606	coTF		NFKB
35990	PMID:12875694:pubtator_title_and_abstract:f8cfd522784356ed2726b5569e54eb2d:2:NF-kappaB:NF-kappaB:377:115	OBJECTIVE: To evaluate the role of nuclear factor-kappa B ([TG]) and inhibitory kappaB alpha (IkappaBalpha) in hepatocellular cacinoma (HCC) SMMC7721 cells, the consequence of NF-kappaB inhibition in SMMC7721 cells transfected with mutated IkappaBalpha (mIkappaBalpha) plasmid and the effect of stable inhibition of [TF] activity in combination with Doxorubicin.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	377	115	0.0011161756009144	Non valid	0.8649459392892386;0.10855409219911397;0.026499968511647508	UNDEFINED	12875694	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
36220	PMID:9058790:pubtator_title_and_abstract:6fc9fd15529ca269a832c0d6cfe78755:5:p50:NF-kappa B:646:579	In the present report, we identified [TG] proteins extracted from human thymocyte nuclei as being [TF]/p65 and p50/c-Rel complexes.	p50	NF-kappa B	4790	4790	646	579	0.0011494661667341	Non valid	0.9711055067578611;0.02708247045468176;0.0018120227874571357	UNDEFINED	9058790	NFKB1	9606	NFKB1	9606	dbTF		NFKB
36246	PMID:22020376:pubtator_title_and_abstract:690d503b1ddeae62e3314257b0e30a8b:8:Nuclear factor Kappa B:NF-kappaB:1029:1187	(c) [TF] (NF-kappaB) was activated following exposure to DEDC, and suppressing NF-kappaB pathway by pyrrolidine dithiocarbamate (PDTC, a potent [TG] inhibitor) significantly increased neuroblastoma cell sensitivity to the pro-apoptotic effect of DEDC.	Nuclear factor Kappa B	NF-kappaB	Complex:NFKB	4790	1029	1187	0.002834361923492	Non valid	0.07259359141393222;0.6282078946627974;0.2991985139232704	ACTIVATION	22020376	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
36332	PMID:26242746:pubtator_title_and_abstract:be42acf736d98d48813f716f8b9108b8:5:NF-kappaB:nuclear factor-kappaB:810:787	Here we show that during ischaemia, soluble CD163 functions as a decoy receptor for TWEAK, a secreted pro-inflammatory cytokine of the tumour necrosis factor family, to regulate TWEAK-induced activation of canonical [TG] ([TF]) and Notch signalling necessary for myogenic progenitor cell proliferation.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	18033	810	787	0.0011514500193921	Non valid	0.03837473385538657;0.951415939018745;0.010209327125868367	ACTIVATION	26242746	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
36399	PMID:8496188:pubtator_title_and_abstract:01ef2a0c5d9400c268c3e4812bb05c0e:3:NF kappa B:NF kappa B:579:517	We show that a cellular reducing catalyst thioredoxin (Trx) plays a major role in activation of the DNA binding of [TG] in vitro and stimulation of transcription from the [TF]-dependent gene expression.	NF kappa B	NF kappa B	Complex:NFKB	4790	579	517	0.001221612109735	Non valid	0.007892254914228415;0.9908560494433174;0.0012516956424541497	ACTIVATION	8496188	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
36440	PMID:31009059:pubtator_title_and_abstract:d110d7d131a08f260ab41a627fae9749:7:NF-kappaB p65:nuclear factor kappa B:1704:1649	Stimulation of PBMCs with TLR-9 ligand (ODN2006) triggered significantly greater up-regulation of proinflammatory signalling intermediates [TNF receptor-associated factor (TRAF 3), IL-1 receptor-associated kinase-like 2 (IRAK2), Toll interacting protein (TOLLIP), TRAF6, phosphorylated transforming growth factor-beta-activated kinase 1 (pTAK), transforming growth factor-beta-activated kinase-binding protein 2 (TAB2), phosphorylated TAK 2 (pTAB2), IFN-regulatory factor 7 (IRF7), receptor interacting protein (RIP), [TG] (NF-kappaB) p65, phosphorylated [TF] (pNF-kappaB p65) and mitogen-activated protein kinase kinase (MEK1/2)] in TRAPS patients' PBMCs.	NF-kappaB p65	nuclear factor kappa B	5970	4790	1704	1649	0.0011915574424065	Non valid	0.28364013965321144;0.7070322459676308;0.009327614379157698	ACTIVATION	31009059	RELA	9606	NFKB1	9606	dbTF		NFKB
36510	PMID:16753019:pubtator_title_and_abstract:d1569df4acc593dc8ceafc71d8e90529:6:RXR:NF-kappaB:1395:1320	Patient's fibroblasts and COS-7 cells transfected with wildtype or mutant VDRs were studied for ligand-binding capacity, transactivation activity using two gene promoters [CYP-24, a classical 1,25(OH)2D3-responsive gene, and relB, a critical [TG] component for regulation of dendritic cell differentiation], VDR-[TF] heterodimers association to CYP 24 VDREs by gel mobility shift assays, and co-activator binding by Glutathione-S-transferase pull-down assays.	RXR	NF-kappaB	6256	4790	1395	1320	0.0011927847285045	Non valid	0.2497679743070394;0.7460533630235758;0.0041786626693847825	ACTIVATION	16753019	RXRA	9606	NFKB1	9606	dbTF		NFKB
36571	PMID:30848228:pubtator_title_and_abstract:f3df87757b2924d142f346070e0ef0aa:8:Nuclear Factor-Kappa B:NF-kappaB:1054:1078	5-ASA inhibits TNF-alpha-dependent [TF] ([TG]) activation, which was dampened by AMPK inhibition.	Nuclear Factor-Kappa B	NF-kappaB	Complex:NFKB	4790	1054	1078	0.0011575502964127	Non valid	0.00208022224685101;0.9965537994656029;0.0013659782875461632	ACTIVATION	30848228	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
36598	PMID:36534970:pubtator_title_and_abstract:10b3e65eff796d52aeb7b3e63b4599c8:6:NFkappaB.:NFkappaB:1367:1047	ERRalpha expression significantly decreased [TG] reporter activities in a dose-dependent manner with unaltered IkappaBalpha phosphorylation levels but with a significant increase in the mRNA levels of PDZ and LIM domain protein 2 (PDLIM2) and copper metabolism gene MURR1 domain-containing protein (COMMD1), which enhance the ubiquitination and degradation of [TF] Also, PDLIM2 and COMMD1 mRNA levels were upregulated in BAIBA-treated HAECs.	NFkappaB.	NFkappaB	Complex:NFKB	4790	1367	1047	0.001679337688593	Non valid	0.1019231833597696;0.1420673851288876;0.7560094315113427	REPRESSION	36534970	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
36701	PMID:27938563:pubtator_title_and_abstract:17cce1bdb15749dbc71eeb7c6a4b5f3b:7:NF-kappaB:NF-kappaB:1628:1649	The results of Western blot showed that compared with the endotoxin+nicotine group of C57 NASH mice, the endotoxin+nicotine group of gene knockout NASH mice had significantly higher relative protein expression of phosphorylated [TF] and TLR-4 ([TG]: 69 425+-600 vs 51 133+-200, P < 0.05; TLR-4: 93 387+-684 vs 64 198+-630, P < 0.05).	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1628	1649	0.0024163187319686	Non valid	0.029914945572145257;0.013033509560285176;0.9570515448675696	REPRESSION	27938563	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
36756	PMID:30558163:pubtator_title_and_abstract:1916e7caad05345155cc64719f750175:12:ERK:NF-kappaB:1283:1298	SCL also decreased the phosphorylation of IKKalpha/beta, IkappaB-alpha, Akt, TBK1, [TF], p38, JNK, [TG] (p65), AP-1 (c-Jun), and IRF3 in RAW264.7 macrophages activated with LPS.	ERK	NF-kappaB	26413	18033	1283	1298	0.0011740637715636	Non valid	0.03495470627964461;0.9580706849996475;0.006974608720707869	ACTIVATION	30558163	Mapk1	10090	Nfkb1	10090	ll_coTF		NFKB
36903	PMID:12875694:pubtator_title_and_abstract:f8cfd522784356ed2726b5569e54eb2d:2:IkappaBalpha:nuclear factor-kappa B:301:91	OBJECTIVE: To evaluate the role of [TG] (NF-kappaB) and inhibitory kappaB alpha (IkappaBalpha) in hepatocellular cacinoma (HCC) SMMC7721 cells, the consequence of NF-kappaB inhibition in SMMC7721 cells transfected with mutated [TF] (mIkappaBalpha) plasmid and the effect of stable inhibition of NF-kappaB activity in combination with Doxorubicin.	IkappaBalpha	nuclear factor-kappa B	4792	4790	301	91	0.001106452193162	Non valid	0.8342687247412405;0.14540186768800606;0.020329407570753508	UNDEFINED	12875694	NFKBIA	9606	NFKB1	9606	coTF		NFKB
36949	PMID:16637061:pubtator_title_and_abstract:7571de088ee86ffc1e8ef7070d29b5db:7:EGFR:nuclear factor-kappa B:1156:1225	Here, we provide evidence that a naturally occurring nontoxic flavanoid, silibinin, targets the epidermal growth factor receptor ([TF]), insulin-like growth factor-1 receptor (IGF-1R) and NF-kappaB ([TG]) pathways in PCA.	EGFR	nuclear factor-kappa B	1956	4790	1156	1225	0.0011409057690579	Non valid	0.988279776662174;0.010308211133863243;0.0014120122039626597	UNDEFINED	16637061	EGFR	9606	NFKB1	9606	ll_coTF		NFKB
36965	PMID:31434493:pubtator_title_and_abstract:c16d5f7604a2178f8c35d0ad6a2d60b8:8:GLP:NFkappaB:1162:1331	Inhibition of G9A/[TF] (G9A-like protein), the primary enzymes responsible for H3K9me2, significantly potentiated inflammation-induced gene induction in vitro and in vivo without altering [TG] (nuclear factor kappa-light-chain-enhancer of activated B cell) and MAPK (mitogen-activated protein kinase) signaling.	GLP	NFkappaB	79813	4790	1162	1331	0.0012304529180177	Non valid	0.681072410156423;0.2827267663768459;0.03620082346673106	UNDEFINED	31434493	EHMT1	9606	NFKB1	9606	coTF		NFKB
37070	PMID:31766169:pubtator_title_and_abstract:d3b521e88f0dd3d338834b6c16ee90c3:3:nuclear factor-kappa B:NFkappaB:601:625	Pretreatment biopsy samples from patients with muscle-invasive bladder cancer receiving trimodality bladder-preserving therapy were analyzed for expression levels of p53, p16, human epidermal growth factor receptor-2 (Her-2), epidermal growth factor receptor (EGFR), [TF] ([TG]; p65), E-cadherin, matrix metalloproteinase-9 (MMP9), meiotic recombination 11 homolog (MRE11), programmed death-1 ligand (PD-L1), and mismatch repair proteins (MLH1, PMS2, MSH2, and MSH6) by immunohistochemical (IHC) staining.	nuclear factor-kappa B	NFkappaB	Complex:NFKB	4790	601	625	0.0011476207304792	Non valid	0.9380179743619055;0.059143632878242765;0.002838392759851771	UNDEFINED	31766169	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
37182	PMID:23684722:pubtator_title_and_abstract:2040671532b52a10dc7f2fe1e15cbd72:0:p38:NF-kappaB:131:135	Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through [TF]-[TG] survival pathway in A375-S2 cells.	p38	NF-kappaB	1432	4790	131	135	0.0011747436513361	Non valid	0.3111557818287348;0.6629474977010048;0.025896720470260298	ACTIVATION	23684722	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
37189	PMID:33876201:pubtator_title_and_abstract:a9c724b0b9bec6351cd407806044a2b6:6:STAT3:NF-kappaB:946:932	In ABC DLBCL cells, which are addicted to [TG] and [TF] survival signaling, DMF treatment efficiently inhibits the activity of the IKK complex and Janus kinases.	STAT3	NF-kappaB	6774	4790	946	932	0.0010771254234751	Non valid	0.07208837090490615;0.9236735355376469;0.004238093557446955	ACTIVATION	33876201	STAT3	9606	NFKB1	9606	dbTF		NFKB
37243	PMID:9467376:pubtator_title_and_abstract:6bc8f7847c1e8955e26e73f1ee60471e:4:p50:NF-kappa B:491:464	Nuclear factor kappa B ([TG]; heterodimer of [TF] and p65) proteins have been suggested to play an important role in gene transcription of inflammatory mediators when monocytes are stimulated with lipopolysaccharide.	p50	NF-kappa B	4790	4790	491	464	0.0011706814147805	Non valid	0.5900266683213508;0.3950196434187566;0.014953688259892602	UNDEFINED	9467376	NFKB1	9606	NFKB1	9606	dbTF		NFKB
37326	PMID:15827332:pubtator_title_and_abstract:24de0e88a058b6488dfea4ea2af441f9:11:NF-kappa B:NF-kappa B:1850:1668	Similarly, decreased [TG] DNA binding and transcriptional activities were detected in cells treated with the combination compared with the single agents, demonstrating cooperative targeting of the [TF] pathway.	NF-kappa B	NF-kappa B	Complex:NFKB	4790	1850	1668	0.0012054438241126	Non valid	0.34777582340930446;0.5502150729508728;0.10200910363982278	ACTIVATION	15827332	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
37332	PMID:29233887:pubtator_title_and_abstract:e5d80f5121583dc3f46a5331c76e7219:5:c-Jun N-terminal kinase:NF-kappaB:781:770	Using pancreatic and ovarian cancer cells with ST6Gal-I knockdown or overexpression, we determined that alpha2-6 sialylation of TNFR1 had no effect on early TNF-induced signaling events, including the rapid activation of [TG], [TF] (JNK), extracellular signal-regulated kinase (ERK), and Akt (occurring within 15 min).	c-Jun N-terminal kinase	NF-kappaB	5599	4790	781	770	0.0010929170072954	Non valid	0.06830239088351246;0.913972224820566;0.01772538429592146	ACTIVATION	29233887	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
37334	PMID:23224146:pubtator_title_and_abstract:0772346a93b63a24ea6d308148cfe2e7:4:TG2:NF-kappaB:495:663	Our group has recently documented that the [TF] gene (termed TGM2) is a direct transcriptional target of NF-kappaB. These developments uncover a novel self-reinforcing molecular feedback loop where TG2 activates [TG] and, in turn, NF-kappaB directly upregulates the transcription of TGM2.	TG2	NF-kappaB	7052	4790	495	663	0.0180576261523635	Non valid	0.019802754001551664;0.9787572127477888;0.0014400332506595492	ACTIVATION	23224146	TGM2	9606	NFKB1	9606	ll_coTF		NFKB
37388	PMID:20043264:pubtator_title_and_abstract:97957aee90c8a001e3002cfd41a70a17:3:NFkappa B.:NFkappa B:303:398	Also, studies have demonstrated that RSE inhibits transcriptional regulators including [TF] Accordingly, we investigated the effect of RSE in inhibiting radiation (IR) induced [TG] mediated radioprotection in breast adenocarcinoma cells.	NFkappa B.	NFkappa B	Complex:NFKB	4790	303	398	0.0021395831888603	Non valid	0.0843581635939527;0.9092326508184927;0.006409185587554569	ACTIVATION	20043264	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
37397	PMID:22721959:pubtator_title_and_abstract:ed6648428bc4caea4a748bec55a3c339:7:nuclear factor kappa B:NF-kappaB:1202:1226	PD98059, an ERK1/2 inhibitor, depressed phosphorylation of ERK1/2 and nuclear translocation of [TF] ([TG]) p65, but SB203580, a p38 MAPK inhibitor, did not.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	18033	1202	1226	0.0011310732962149	Non valid	0.01970872725368285;0.9788097936879321;0.0014814790583850604	ACTIVATION	22721959	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
37402	PMID:32874130:pubtator_title_and_abstract:5c79f58b24d4a304a25eb96bc3d2d263:10:NOD2:NF-kappaB:1292:1301	Moreover, low expression of ANGPT2 affected the protein levels of NOD1, [TF] and [TG] in the NOD_LIKE_RECEPTOR pathway, thus weakening the abilities of cell proliferation, migration and invasion.	NOD2	NF-kappaB	64127	4790	1292	1301	0.0012014866872925	Non valid	0.9886973660809706;0.008933397645502553;0.0023692362735269366	UNDEFINED	32874130	NOD2	9606	NFKB1	9606	coTF		NFKB
37528	PMID:34206763:pubtator_title_and_abstract:cc34760fbf4bc2729a9802348dfbcef0:10:Ikappa-Balpha:nuclear factor-kappa B:1208:1238	In addition, mice that were pretreated with BA showed a reduction in [TF] degradation and [TG] (NF-kappaB) binding activity in the pancreas.	Ikappa-Balpha	nuclear factor-kappa B	18035	18033	1208	1238	0.0011453191190815	Non valid	0.34225082623403585;0.13454236611666093;0.5232068076493033	REPRESSION	34206763	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
37604	PMID:16987412:pubtator_title_and_abstract:cdcd6ee15f0391080c6a681de3fbeef0:17:IKK-beta:NF-kappaB:2203:2238	CONCLUSION: TNF-mediated activation of [TF] resulted in activation of [TG] and was followed by up-regulation of the bona-fide target gene cyclin D1.	IKK-beta	NF-kappaB	3551	4790	2203	2238	0.0213069241454628	Non valid	0.004758492097662507;0.9943372094271454;0.0009042984751920501	ACTIVATION	16987412	IKBKB	9606	NFKB1	9606	coTF		NFKB
37758	PMID:14642780:pubtator_title_and_abstract:0f7041f93273c01be2c6acfcfcb31950:0:Akt:nuclear factor-kappa B:29:131	Lipopolysaccharide activates [TF] in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through [TG] activation.	Akt	nuclear factor-kappa B	207	4790	29	131	0.003051721237352	Non valid	0.0029071148410362664;0.9961657503066524;0.0009271348523113368	ACTIVATION	14642780	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
37782	PMID:30393173:pubtator_title_and_abstract:e1a299e77bc9c23d22b20d776fcbbacc:9:NF-kappaB:NF-kappaB:1184:1149	EcTRAF2-1 and EcTRAF2-2 increased the activity of [TG], while EcTRAF2-3 reduced [TF] activation mediated by EcTRAF2-1 implying that EcTRAF2-3 might be a negative regulator of EcTRAF2-1.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1184	1149	0.0012668494724827	Non valid	0.0034321522047382528;0.9944093423323321;0.0021585054629295517	ACTIVATION	30393173	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
37809	PMID:29148169:pubtator_title_and_abstract:875d0cd15e69429af6d5ec862f221a1e:7:p38:NF-kappaB:896:833	Meanwhile, RPS raised the content of SOD and CAT enzymes and thereby inhibited the aberrantly active [TG], and phosphorylation of PI3K/Akt and MAPK (including [TF], Erk1/2, and JNK) signaling pathways.	p38	NF-kappaB	26416	18033	896	833	0.0011236094188702	Non valid	0.2624181281693895;0.6955512590586598;0.04203061277195067	ACTIVATION	29148169	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
37939	PMID:15784698:pubtator_title_and_abstract:168e584ae0cc9146390c5f0361f45be3:10:TRAF6:NF-kappaB:1297:1312	Greater activation of downstream signal molecules (i.e., MYD88, [TF], IRAK-1, [TG], MAPK, AP-1) was observed in OuJ mice than in HeJ mice before the development of ROFA-induced pulmonary injury.	TRAF6	NF-kappaB	22034	18033	1297	1312	0.0011612246192722	Non valid	0.10632981842080542;0.8899327253767904;0.003737456202404248	ACTIVATION	15784698	Traf6	10090	Nfkb1	10090	coTF		NFKB
37966	PMID:35795373:pubtator_title_and_abstract:ab7174d3dad02632b5f01ad9b23b97aa:3:CREB:nuclear factor-kappa B:258:178	Melatonin inhibits [TG] (NF-kappaB)/cyclic AMP response element-binding protein ([TF]), contributing to CAVD progression.	CREB	nuclear factor-kappa B	1385	4790	258	178	0.0012038196196111	Non valid	0.010522068270122304;0.9718426973981575;0.01763523433172013	ACTIVATION	35795373	CREB1	9606	NFKB1	9606	dbTF		NFKB
38157	PMID:10541287:pubtator_title_and_abstract:4bb6bf2714241ad1343a71827e59cc90:10:AP-1:NF-kappaB:1594:1493	These results suggest that: (1) quercetin has the ability to attenuate activation of [TG]; and (2) it inhibits IL-1-triggered MCP-1 expression via suppression of NF-kappaB, but not [TF], in glomerular cells.	AP-1	NF-kappaB	16476	18033	1594	1493	0.0012191344159367	Non valid	0.0033111359309548134;0.9924189525798681;0.004269911489177031	ACTIVATION	10541287	Jun	10090	Nfkb1	10090	dbTF		NFKB
38187	PMID:22683306:pubtator_title_and_abstract:3b42e179ca5763e6ad61273ff0fb828f:9:p65:NF-kappaB:1227:1214	Moreover, inhibition of [TG] by [TF] RNAi significantly reduced foam cell formation in macrophages from WT mice relative to MKP5-deficient mice.	p65	NF-kappaB	19697	18033	1227	1214	0.0026917717752568	Non valid	0.003204304133357269;0.9782063956311313;0.01858930023551137	ACTIVATION	22683306	Rela	10090	Nfkb1	10090	dbTF		NFKB
38190	PMID:24759106:pubtator_title_and_abstract:1a0ddb84323b0106918b6a8ede80bc04:8:NF-kappaB:NF-kappaB:1368:1217	Moreover, we found that RAC1 acts through [TG] to induce NRF2 because either expression of a dominant negative mutant of IkappaBalpha that leads to NF-kappaB degradation or the use of p65-[TF]-deficient cells demonstrated lower NRF2 protein levels and basally impaired NRF2 signature compared with control cells.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1368	1217	0.0010763220141224	Non valid	0.00435661238109517;0.9929131330860107;0.0027302545328941634	ACTIVATION	24759106	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
38244	PMID:7729908:pubtator_title_and_abstract:8b8f5cd0a2d80137f81aa00cbfa6687e:4:NF-kappa B:NF-kappa B.:960:1163	A critical component in the regulation of many genes central to immune function is the transcription factor NF-kappa B. Lipopolysaccharide (LPS)-mediated induction of TNF-alpha expression in murine macrophages has been demonstrated to be regulated in part by NF-kappa B. In this study, we demonstrate that AraLAM is capable of rapid activation of [TF]- and KBF1-binding activities in C3H/HeN bone marrow-derived macrophages and the J774.A and RAW264.7 murine macrophagelike cell lines, whereas ManLAM is considerably less potent at stimulating [TG] Treatment of RAW264.7 cells with AraLAM or LPS results in the stimulation of DNA binding of both forms within 7.5 min, which peaks within 30 min and 1 h, respectively.	NF-kappa B	NF-kappa B.	Complex:NFKB	18033	960	1163	0.00113699019439	Non valid	0.43977929930380655;0.5567190079959597;0.0035016927002336027	ACTIVATION	7729908	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
38251	PMID:31918264:pubtator_title_and_abstract:eaebba427afba8c74a32cc285d6603b5:8:nuclear factor-kappaB:NF-kappaB:1418:1441	Additionally, DOX-induced apoptosis and inflammatory response in cardiomyocytes were diminished by CAR through reducing the Caspase-3 and [TF] ([TG]) signaling pathways, respectively.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1418	1441	0.0011163553096617	Non valid	0.019617840761479245;0.9754077345848325;0.004974424653688213	ACTIVATION	31918264	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
38288	PMID:15147726:pubtator_title_and_abstract:1dc1a33c8aaf0c8b8aa1696d34a5ff4b:11:EGFR:NF-kappaB:1665:1531	CONCLUSIONS: EGCG inhibited not only the dose-dependent survival rate of NPC cells, but also the dose-dependent activation of NF-kappaB. This inhibition of LMP1-caused [TG] activation was mediated via the phosphorylative degradation of its inhibitory protein IkappaBalpha, and then EGCG inhibited [TF] activity which was a downstream gene from NF-kappaB. This study suggests that interference effect of EGCG on targets of signal transduction pathway plays an important role in the anticancer function.	EGFR	NF-kappaB	1956	4790	1665	1531	0.0013306430947991	Non valid	0.006245527027581788;0.9820009470667902;0.011753525905627962	ACTIVATION	15147726	EGFR	9606	NFKB1	9606	ll_coTF		NFKB
38295	PMID:12126643:pubtator_title_and_abstract:7e8d76e50d3b63b60dcc458a16599934:9:AP-1:NF-kappaB:1290:1327	SB203580, a specific P38 MAPK inhibitor, partially blocked IL-1beta induction of IL-8 mRNA, IL-8 promoter activity, and [TF] nuclear extract binding but not [TG] DNA binding.	AP-1	NF-kappaB	3726	4790	1290	1327	0.0011390846400777	Non valid	0.693990113859164;0.30296519664229876;0.0030446894985371926	UNDEFINED	12126643	JUNB	9606	NFKB1	9606	dbTF		NFKB
38301	PMID:17661372:pubtator_title_and_abstract:beb43391120ac63a8ef1af3ed75567f9:5:IRF3:nuclear factor (NF)-kappaB:889:826	Stimulation with polyinosinic-polycytidylic acid [poly(I:C), a synthetic analog of viral dsRNA] induced the activation of transcription factors [[TG] and interferon regulatory factor 3 ([TF])] and the production of interferon-beta1 (IFN-beta1) and MxA as potent antiviral responses.	IRF3	nuclear factor (NF)-kappaB	3661	4790	889	826	0.0011752904131875	Non valid	0.07116799114014234;0.9260376569239295;0.002794351935928176	ACTIVATION	17661372	IRF3	9606	NFKB1	9606	dbTF		NFKB
38358	PMID:31024544:pubtator_title_and_abstract:32f3de30fc27278a4583fcb52931b166:5:NF-kappaB:NF-kappaB:564:788	The dynamics by which [TF] proteins shuttle between the cytoplasm and the nucleus to initiate transcription have been studied rigorously in fibroblasts and other non-hematopoietic cells, but many questions remain as to how current models of [TG] signaling and dynamics can be translated to innate immune cells such as macrophages.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	564	788	0.0010670999234469	Non valid	0.07303465458263671;0.9245975029734331;0.0023678424439301437	ACTIVATION	31024544	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
38362	PMID:17070520:pubtator_title_and_abstract:82cdacc75f8662a8f5ac73855c736991:3:STAT3:NF-kappaB:410:391	Sodium arsenite is known to suppress both the IKK-[TG] and JAK2-[TF] signaling pathways and to activate the MAPK/JNK-cJun pathways, thereby committing some cancers to undergo apoptosis.	STAT3	NF-kappaB	6774	4790	410	391	0.0011317601129327	Non valid	0.09137897101297755;0.8532850486764654;0.055335980310557024	ACTIVATION	17070520	STAT3	9606	NFKB1	9606	dbTF		NFKB
38479	PMID:22590514:pubtator_title_and_abstract:6ed8a15b572653be538de1bbcecf3fce:5:p38:nuclear factor-kappaB:703:713	Inotilone was tested in the inhibitor of mitogen-activated protein kinase (MAPK) [extracellular signal-regulated protein kinase (ERK), c-Jun NH(2)-terminal kinase (JNK), [TF]], and [TG] (NF-kappaB), matrix-metalloproteinase (MMP)-9 protein expressions in LPS-stimulated RAW264.7 cells.	p38	nuclear factor-kappaB	26416	18033	703	713	0.0013035447222318	Non valid	0.1062605056074718;0.8592247550326902;0.03451473935983799	ACTIVATION	22590514	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
38526	PMID:27713146:pubtator_title_and_abstract:792f807f3b6958f2f897394ca7108109:8:NF-kappaB:nuclear factor-kappaB:1168:1145	Both genetic and pharmacological approaches revealed that blocking [TG] ([TF]) signaling not only inhibited the production of inflammatory factors, but also rescued the senescent phenotype induced by TGF-beta in HCECs.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	1168	1145	0.001113251161662	Non valid	0.02142990239541282;0.9171173214443064;0.06145277616028075	ACTIVATION	27713146	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
38641	PMID:17464322:pubtator_title_and_abstract:086d0a248d1fc0458faa147d5765c387:7:NF-kappaB:NF-kappaB:971:1026	Inhibition of p53 activity resulted in the concomitant increase in [TF] transcriptional activity and upregulation of [TG]-target proteins, for example X-chromosomal-linked inhibitor of apoptosis (XIAP).	NF-kappaB	NF-kappaB	Complex:NFKB	18033	971	1026	0.0010753061093518	Non valid	0.20404443205817002;0.7833545946783362;0.012600973263493648	ACTIVATION	17464322	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
38705	PMID:16505114:pubtator_title_and_abstract:e2b068029be2c4130dba9873036841c8:3:nuclear factor-kappaB:NF-kappaB:481:504	Part of the chemoresistance of NSCLCs results from the constitutive or anticancer drug-induced activation of the [TF] ([TG]) signaling pathways.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	481	504	0.001100035486099	Non valid	0.020470807462747948;0.9765141541197745;0.0030150384174775662	ACTIVATION	16505114	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
38813	PMID:9500529:pubtator_title_and_abstract:143fcd23b259b4f834e6064ec4b2b51f:2:nuclear factor-kappaB:NF-kappaB:314:337	We investigated the effect of proteasome inhibitors on the lipopolysaccharide (LPS)-induced expression of several monocytic cytokines, which may be dependent on the transcription factor, [TF] ([TG]).	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	314	337	0.0011406881558547	Non valid	0.08988588081358813;0.9065484598654139;0.003565659320997979	ACTIVATION	9500529	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
39027	PMID:35795373:pubtator_title_and_abstract:ab7174d3dad02632b5f01ad9b23b97aa:3:NF-kappaB:nuclear factor-kappa B:202:178	Melatonin inhibits [TG] ([TF])/cyclic AMP response element-binding protein (CREB), contributing to CAVD progression.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	4790	202	178	0.0012482529834478	Non valid	0.010777796897301326;0.976306859284653;0.012915343818045653	ACTIVATION	35795373	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
39092	PMID:20381234:pubtator_title_and_abstract:92dfa26c943e42a0cbda6052d4b2354e:9:ERK:NF-kappaB:1317:1325	Furthermore, DA inhibited the expression of pro-inflammatory cytokines and MMP-9 through suppression of PI3K, [TF] and [TG] activation.	ERK	NF-kappaB	5594	4790	1317	1325	0.0011391052567529	Non valid	0.001821455904701259;0.9958429238146378;0.0023356202806608765	ACTIVATION	20381234	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
39102	PMID:23317035:pubtator_title_and_abstract:5fa3842b7856ec93cbe29f96d87621a1:11:IkappaBalpha:NF-kappaB:1655:1726	PGE2, dbcAMP and 8-Cpt-cAMP induced the phosphorylation of Akt, IkappaB kinase and [TF] and the translocation of p65 to the nucleus and increased [TG] dependent reporter gene activity, which was diminished by Akti.	IkappaBalpha	NF-kappaB	18035	18033	1655	1726	0.0011863266453625	Non valid	0.006326629211773809;0.9922593283107914;0.0014140424774346672	ACTIVATION	23317035	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
39114	PMID:12365017:pubtator_title_and_abstract:4e7129fddfab34dfdaebedb6e39eaef5:6:IkappaB(alpha):NF-kappaB:1139:1528	RESULTS: The current study data demonstrate that 1) RelA/NF-kappaB activity is activated constitutively in Hep3B cells, as determined by electrophoretic mobility shift assays; 2) RelA/NF-kappaB reporter gene activity is inhibited specifically by dominant-negative mutants of IkappaB(alpha), IKK1, IKK2, MEKK1, and MEKK3 and it is activated by overexpression of wild-type MEKK3, suggesting that upstream kinase cascades induce phosphorylation of [TF] and activate RelA/NF-kappaB in Hep3B cells; 3) overexpression of the HBV x gene fails to activate NF-kappaB in HepG2 and Chang cell lines; 4) The NF-kappaB-inducible gene, bcl-xl, is overexpressed in Hep3B cells and is inhibited by the proteosome inhibitor PS341, which prevents IkappaBalpha degradation and RelA/NF-kappaB activation; and 5) inhibition of constitutive RelA/[TG] activity by PS341 sensitizes Hep3B cells to doxorubicin-induced apoptosis.	IkappaB(alpha)	NF-kappaB	4792	4790	1139	1528	0.0018235307019566	Non valid	0.027612026825395763;0.9244386966578227;0.04794927651678149	ACTIVATION	12365017	NFKBIA	9606	NFKB1	9606	coTF		NFKB
39134	PMID:8871623:pubtator_title_and_abstract:e6e15e9f86984a367b63eec18a489c48:5:AP-1:NF-kappaB:1022:1055	However, subsequent analysis of transcription factor generation revealed that B7 stimulation induced both activator protein-1 ([TF]) and nuclear factor-kappaB ([TG]) complexes, but not NF-AT.	AP-1	NF-kappaB	3726	4790	1022	1055	0.0011021188885805	Non valid	0.48805671882520346;0.5089281611638502;0.0030151200109463715	ACTIVATION	8871623	JUNB	9606	NFKB1	9606	dbTF		NFKB
39182	PMID:36403167:pubtator_title_and_abstract:6c6421d96c43c1c12b5373b61393f299:11:Blimp-1:NF-kappaB.:1202:1387	CONCLUSION: [TF] represses the production of multiple pro-inflammatory cytokines by directly binding the genomic region and restricting the nuclear translocation and transcriptional activity of [TG] This finding may provide potential therapeutic strategies for the cytokine storm-related diseases.	Blimp-1	NF-kappaB.	639	4790	1202	1387	0.0115411840949606	Non valid	0.010014629829485876;0.007770138430921625;0.9822152317395926	REPRESSION	36403167	PRDM1	9606	NFKB1	9606	dbTF		NFKB
39189	PMID:11589757:pubtator_title_and_abstract:c37eb4189a8c610d25fe6156a9ccb0de:2:nuclear factor-kappa B:NF-kappa B:202:226	We have recently demonstrated that the pineal secretory product melatonin inhibits the key transcriptional regulator [TF] ([TG]).	nuclear factor-kappa B	NF-kappa B	Complex:NFKB	4790	202	226	0.001445340632546	Non valid	0.9878109137503569;0.008370869992892261;0.0038182162567507267	UNDEFINED	11589757	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
39230	PMID:19665994:pubtator_title_and_abstract:592975895fcd0bfa829a16e921af79c5:4:IKK-alpha:NF-kappaB:862:892	Our data also provide evidence that HPV16E7 inhibits TNF-alpha-induced up-regulation of MHC class I transcription by impaired nuclear translocation of NF-kappaB. More importantly, CaSki tumor cells treated with TSA and transfected with the constitutively active mutant form of [TF] (which can activate [TG] directly) showed a maximal level of up-regulation of MHC-I expression.	IKK-alpha	NF-kappaB	1147	4790	862	892	0.0110963000965425	Non valid	0.04954964674398553;0.356421004615276;0.5940293486407384	REPRESSION	19665994	CHUK	9606	NFKB1	9606	coTF		NFKB
39239	PMID:20721970:pubtator_title_and_abstract:7253da89af0887b7d98ba5bbe0e04913:5:AR:NF-kappaB:686:652	In the present study, we assessed the effect of one such botanical agent, namely isosilybin A, on apoptotic machinery and key members of cell survival signaling [Akt, [TG], and androgen receptor ([TF])] in different PCA cells.	AR	NF-kappaB	367	4790	686	652	0.0012218012088461	Non valid	0.992781273732536;0.005909349104424097;0.0013093771630398653	UNDEFINED	20721970	AR	9606	NFKB1	9606	dbTF		NFKB
39245	PMID:28396116:pubtator_title_and_abstract:5c3f7adc449273761d30f6516403cd61:8:NF-kappaB.:NF-kappaB:1289:1384	This subsequently enhanced phosphorylation of IkappaBalpha and activation of NF-kappaB. The beta2AR agonists enhanced beta-arrestin2 and its interaction with IkappaBalpha, leading to downregulation of [TF] A siRNA specific for beta-arrestin2 reversed beta2AR agonist-mediated inhibition of [TG] activation and inflammatory cytokine production.	NF-kappaB.	NF-kappaB	Complex:NFKB	4790	1289	1384	0.1164991958955576	Non valid	0.013406845281837828;0.8419119203675003;0.14468123435066188	ACTIVATION	28396116	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
39267	PMID:29420126:pubtator_title_and_abstract:6c0dd826e4b2e809f0548284808da842:7:NF-kappaB:NF-kappaB:1214:1114	We identified nuclear factor kappaB (NF-kappaB) as the central signaling pathway that mediated LDR-enhanced expression of IL-12 and CCR7 based on findings that 0.2 Gy X-ray irradiation activated [TG], showing increased nuclear p65 translocation and NF-kappaB DNA-binding activity, while an [TF] inhibitor blocked LDR-enhanced expression of IL-12 and CCR7, as well as DC migration.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1214	1114	0.0010782899288939	Non valid	0.004913235704654371;0.9933610095246305;0.00172575477071524	ACTIVATION	29420126	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
39353	PMID:27648362:pubtator_title_and_abstract:0ef8a09e88bedbd4030dae540c5ccf43:8:ERK:NF-kappaB:1003:1007	Furthermore, the anti-metastatic effect of DEC2 was mediated by inhibiting [TF]/[TG]/EMT axis.	ERK	NF-kappaB	5594	4790	1003	1007	0.00115359552065	Non valid	0.07555174627536934;0.9182308648934681;0.006217388831162528	ACTIVATION	27648362	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
39381	PMID:10190904:pubtator_title_and_abstract:d5c0eeb36e22ba2f12565ce3de041af1:2:IRAK:nuclear factor (NF)-kappaB.:520:480	Interleukin (IL)-18 is functionally similar to IL-12 in mediating T helper cell type 1 (Th1) response and natural killer (NK) cell activity but is related to IL-1 in protein structure and signaling, including recruitment of IL-1 receptor-associated kinase (IRAK) to the receptor and activation of c-Jun NH2-terminal kinase (JNK) and [TG] The role of [TF] in IL-18-induced responses was studied in IRAK-deficient mice.	IRAK	nuclear factor (NF)-kappaB.	16179	18033	520	480	0.0014935595938503	Non valid	0.21056961639272256;0.7868681624745507;0.002562221132726701	ACTIVATION	10190904	Irak1	10090	Nfkb1	10090	coTF		NFKB
39453	PMID:34923337:pubtator_title_and_abstract:5fa17b7c8e25057dd7c5f946d07e2b1c:7:nuclear factor-kappaB:NF-kappaB:1111:1134	Besides, OA-GP11d reduced the phosphorylation of [TF] ([TG]) and inhibitor of NF-kappaB (I-kappaB) induced by lipopolysaccharide stimulation in mouse macrophages, and inhibited the release of associated inflammatory factors tumor necrosis factor (TNF)-alpha and interleukin (IL)-6.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1111	1134	0.0011380315155607	Non valid	0.11801953032123658;0.8723846415991746;0.009595828079588838	ACTIVATION	34923337	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
39512	PMID:22629832:pubtator_title_and_abstract:e6195f58b99274d825bb55ee5bdc2c99:7:estrogen receptor:NF-kappaB:1333:1289	In general, the results obtained demonstrate that direct inhibition of [TG] and Snail1 partially restores the [TF] machinery, and show that Snail1 and NF-kappaB may serve as an important targets in the treatment of breast cancer.	estrogen receptor	NF-kappaB	2099	4790	1333	1289	0.0011557813462789	Non valid	0.13495543269149163;0.09003170743021734;0.775012859878291	REPRESSION	22629832	ESR1	9606	NFKB1	9606	dbTF		NFKB
39520	PMID:10965913:pubtator_title_and_abstract:5f0f1e1b68e734753884bd9dfb9c060d:0:estrogen receptor:nuclear factor-kappaB:19:53	The role of CBP in [TF] cross-talk with [TG] in HepG2 cells.	estrogen receptor	nuclear factor-kappaB	2099	4790	19	53	0.0011867883511398	Non valid	0.9964891846025563;0.0027266360369811314;0.0007841793604624288	UNDEFINED	10965913	ESR1	9606	NFKB1	9606	dbTF		NFKB
39619	PMID:20920357:pubtator_title_and_abstract:ad10d6991caf18b119284a85b0480917:2:beta-catenin:NF-kappaB:221:235	BACKGROUND: Glycogen Synthase Kinase-3 (GSK-3) alpha and beta are two serine-threonine kinases controlling insulin, Wnt/[TF], [TG] signaling and other cancer-associated transduction pathways.	beta-catenin	NF-kappaB	1499	4790	221	235	0.0011194571727733	Non valid	0.9752854680891742;0.022314296237580234;0.0024002356732455805	UNDEFINED	20920357	CTNNB1	9606	NFKB1	9606	coTF		NFKB
39679	PMID:31735662:pubtator_title_and_abstract:4d135579f296b37d71b4ea46c4e0bbc2:11:NLRP3:NF-kappaB:1281:1309	Besides, [TF] inflammasome and TLR4/[TG] pathway were inactivated under the treatment of propofol according to the expression of pathways-related proteins.	NLRP3	NF-kappaB	216799	18033	1281	1309	0.0012852209800045	Non valid	0.08042868015868011;0.16001404125329233;0.7595572785880276	REPRESSION	31735662	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
39787	PMID:19997048:pubtator_title_and_abstract:df7dfb6db86ab077886d6a45c41a4177:9:p38 MAPK:NF-kappaB:1499:1485	To go inside the mechanisms by which 15dPGJ2 exerts inhibitory effects, cells were preincubated with specific chemical inhibitors of [TG] and [TF], and we found that these signaling cascades are implicated in 15dPGJ2 action as well as PPARgamma.	p38 MAPK	NF-kappaB	26416	18033	1499	1485	0.0012613924899668	Non valid	0.2704765467299993;0.6811504276020346;0.04837302566796609	ACTIVATION	19997048	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
39832	PMID:37728854:pubtator_title_and_abstract:9a176704ae2fcea572116d3a1241ea9b:8:NF-kappaB:NF-kappaB:1133:1045	To investigate whether [TG]/p65 signaling pathway modulates CD40 expression in PF4-treated HAECs, PDTC, a [TF] inhibitor, and p65-shRNA were introduced.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1133	1045	0.0011433398271488	Non valid	0.997558301582162;0.001534461440599626;0.0009072369772383876	UNDEFINED	37728854	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
39856	PMID:19139021:pubtator_title_and_abstract:3af8626a6e1fad32712b59b96a230b44:8:nuclear factor-kappaB:NF-kappaB:1417:1440	Cytokines secreted by tumor cells and tumor-associated macrophages regulate angiogenesis by activating [TF] ([TG]) and signal transducers and activators of transcription (STAT).	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1417	1440	0.0011370283737937	Non valid	0.31047076623575043;0.6847952680739466;0.004733965690302957	ACTIVATION	19139021	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
39863	PMID:22965301:pubtator_title_and_abstract:17618efdb33d61f8940ea8cab67505d6:8:NF-kappaB:NF-kappaB:936:1086	In siRNA experiments, DDX6 appeared not to be involved in [TF] activation as frequently observed for genes promoting lymphomagenesis but was found to interfere with the expression of BCL6 and BCL2 in an [TG] independent manner.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	936	1086	0.0017377848406426	Non valid	0.0474680398689099;0.9454528110886317;0.007079149042458597	ACTIVATION	22965301	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
39904	PMID:22740410:pubtator_title_and_abstract:50ce0d726732b2e675aa17cb8e0a71a3:6:NF-kappaB:NF-kappaB:1105:1052	Consistent with a critical role of IKKalpha in the transcriptional activity of [TG], IKKalpha deficiency drastically decreased [TF] trans-activation by Tax, although it only modestly reduced Tax-mediated I-kappaBalpha degradation and NF-kappaB nuclear localization.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1105	1052	0.0012093546519736	Non valid	0.002577477457438365;0.9961786437812526;0.0012438787613090368	ACTIVATION	22740410	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
39928	PMID:21921982:pubtator_title_and_abstract:64e7aa114962aa205bd3cf99d3617b1e:11:JNK:NF-kappaB.:1590:1514	Cis-UCA inhibited the binding of c-Jun and c-Fos but not that of [TG] Moreover, UV-B increased the levels of phospho-c-Jun and phospho-[TF], and the expression of both was attenuated by cis-UCA.	JNK	NF-kappaB.	5599	4790	1590	1514	0.0012716794382983	Non valid	0.9430482697078634;0.05189557739646706;0.005056152895669634	UNDEFINED	21921982	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
40010	PMID:15211107:pubtator_title_and_abstract:e00b55acd7b2c07c5e0f97cebb64b17b:3:NF-kappaB:nuclear factor-kappaB:387:364	We researched whether the signaling pathway activated by GDNF correlates with the [TG] ([TF]) in human pancreatic cancer cell lines and whether the inhibition of NF-kappaB activity is associated with suppression of invasive potential.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	387	364	0.0013307682476928	Non valid	0.8468956173643736;0.14401517425691904;0.009089208378707391	UNDEFINED	15211107	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
40012	PMID:15226414:pubtator_title_and_abstract:e94f52a518aa51f038cdad1983dc7302:1:PKD:NF-kappaB.:283:320	Activation of the inducible transcription factor nuclear factor kappaB (NF-kappaB) occurs in cells exposed to oxidative stress, and the serine/threonine kinase protein kinase D ([TF]) is critical for signal relay to [TG] We have recently delineated two coordinated events that control PKD activation in response to oxidative stress: phosphorylation at Tyr463 by the tyrosine kinase Abl, and phosphorylation at the activation loop Ser738/Ser742 by the protein kinase C (PKC) isoform PKCdelta.	PKD	NF-kappaB.	5587	4790	283	320	0.0011107207760538	Non valid	0.28425675409882;0.7130524018462712;0.002690844054908822	ACTIVATION	15226414	PRKD1	9606	NFKB1	9606	ll_coTF		NFKB
40053	PMID:29203240:pubtator_title_and_abstract:14f8ef11a5c8a6f8c886012cb8dab4ee:5:NF-kappaB:NF-kappaB:617:755	Attenuation of the nuclear factor (NF)-kappaB-signaling pathway using an [TF]-subunit p65-specific small-interfering RNA (siRNA), reduced IL-1beta-induced IL-17C expression, demonstrating the importance of [TG] signaling in IL-17C regulation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	617	755	0.0010704499672249	Non valid	0.004908007874201538;0.990999196672646;0.004092795453152494	ACTIVATION	29203240	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
40159	PMID:16271621:pubtator_title_and_abstract:6930edbccf5a4f6cf8fe37801bb7b62f:5:activator protein-1:NF-kappaB:789:843	Our study demonstrated that arsenite pretreatment potentiated the TNF-alpha-induced VCAM-1 expression with up-regulations of both [TF] (AP-1) and nuclear factor-kappaB ([TG]).	activator protein-1	NF-kappaB	3726	4790	789	843	0.0012623239494453	Non valid	0.006223883140917026;0.9921594418925553;0.0016166749665276357	ACTIVATION	16271621	JUNB	9606	NFKB1	9606	dbTF		NFKB
40167	PMID:9605420:pubtator_title_and_abstract:7b4deac9d94a839d502dc0810c193698:11:NFkappaB:NFkappaB:1736:1653	Furthermore, curcumin and nordihydroguaiaritic acid inhibit [TG] by interfering with IkappaBalpha degradation and reacting with p50 in the [TF] complex.	NFkappaB	NFkappaB	Complex:NFKB	4790	1736	1653	0.0322287101409429	Non valid	0.04251998037361217;0.9418832580871572;0.015596761539230642	ACTIVATION	9605420	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
40373	PMID:28906110:pubtator_title_and_abstract:90441a0f8d914543f729691d3890206d:8:IkappaBalpha:NF-kappaB:923:819	Furthermore, CAVAO inhibited nuclear factor-kappaB ([TG]) activation, which was justified by the inhibitory effect on NF-kappaB nuclear translocation, [TF] phosphorylation and degradation, and phosphorylation-dependent IkappaB kinase activation in RAW264.7 cells stimulated with lipopolysaccharides.	IkappaBalpha	NF-kappaB	18035	18033	923	819	0.0011466219796673	Non valid	0.03818465567332091;0.8464589240062933;0.11535642032038579	ACTIVATION	28906110	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
40381	PMID:18055877:pubtator_title_and_abstract:c16215afa13ea5bfb913135aeba353de:5:NF-kappaB:nuclear factor (NF)-kappaB:854:730	In addition, DNA binding of [TG], a proinflammatory transcription factor that regulates both TNFalpha and IFNgamma synthesis, and [TF]-dependent reporter gene expression were reduced.	NF-kappaB	nuclear factor (NF)-kappaB	Complex:NFKB	4790	854	730	0.0011609105167816	Non valid	0.05357779596826297;0.9442430018729918;0.0021792021587452278	ACTIVATION	18055877	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
40541	PMID:10224051:pubtator_title_and_abstract:abbaeb2f9b50470f2ec8d7ee0a2d2f14:7:NF-kappaB:NF-kappaB:1250:1132	In addition, co-transfection studies with an [TG]-dependent reporter construct demonstrated that IkappaBbeta co-expression partially alleviated inhibition of [TF]-mediated gene expression by IkappaBalpha, implying that IkappaBbeta can maintain transcriptionally active NF-kappaB.DNA complexes.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1250	1132	0.0012623597191585	Non valid	0.01022288044843513;0.9589531870777146;0.030823932473850204	ACTIVATION	10224051	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
40562	PMID:19821485:pubtator_title_and_abstract:581fa12aaa929a56c3f1660579318dfc:4:Ikappa B kinase beta:NF-kappaB:464:549	To explore the role of [TF] (IKKbeta), which is the critical kinase of the IKK complex, and [TG] activation in metastasis, we injected LLC cells into hepatocyte-specific IKKbeta knockout mice (Ikkbeta(Deltahep)), whole-liver knockout (Ikkbeta(DeltaL+H)) mice, and control (Ikkbeta(F/F)) mice.	Ikappa B kinase beta	NF-kappaB	16150	18033	464	549	0.0015272075908464	Non valid	0.08874524614341558;0.9086413027057;0.0026134511508844917	ACTIVATION	19821485	Ikbkb	10090	Nfkb1	10090	coTF		NFKB
40662	PMID:26851278:pubtator_title_and_abstract:1cbc349def4c23504bf3ee2a22c470d6:3:HIF-1alpha:NF-kappaB:598:611	CBP and p300 contain a number of small structured domains that provide scaffolds for the interaction of disordered transactivation domains from a wide variety of partners, including p53, hypoxia-inducible factor 1alpha ([TF]), [TG], and STAT proteins, and are the targets for the interactions of disordered viral proteins that compete with cellular factors to disrupt signaling and subvert the cell cycle.	HIF-1alpha	NF-kappaB	3091	4790	598	611	0.0011459414366003	Non valid	0.41527943637236353;0.5799864109362121;0.0047341526914243875	ACTIVATION	26851278	HIF1A	9606	NFKB1	9606	dbTF		NFKB
40685	PMID:35791892:pubtator_title_and_abstract:be4f1893e8036020c8c2babb94b14565:5:PARP-1:NF-kappaB:1174:1303	METHODS: We targeted PARP-1 and NF-kappaB(p65), using pharmacologic inhibitors, 1.0 muM Rucaparib (AG014699) and 10 muM BAY 11-7082 {3-[4=methylphenyl)sulfonyl]-(2E)-propenenitrile}, respectively, or silencing their gene expression (siRNAs) and used immunofluorescence, luciferase, cell viability, direct enzyme-linked immunosorbent assays, and qPCR analysis to detect the effect of targeting [TF] or NF-kappaB in acidic bile-induced DNA damage, PARP-1, p-NF-kappaB, and B-cell lymphoma 2 (Bcl-2) expression, as well as [TG] transcriptional activity, cell survival, and mRNA oncogenic phenotype in HCs.	PARP-1	NF-kappaB	142	4790	1174	1303	0.043226675005934	Non valid	0.8526936286925686;0.13088522911728384;0.016421142190147578	UNDEFINED	35791892	PARP1	9606	NFKB1	9606	coTF		NFKB
40934	PMID:32672964:pubtator_title_and_abstract:81b6f75c236d80854873f2e8ce238006:9:NF-KappaB:NF-kappaB:984:878	To elucidate the influence of CA on the [TG] pathway, RAW 264.7 macrophages were pretreated with CA and then stimulated with LPS, evaluating [TF] activation, IKK phosphorylation, IKappaB-alpha, p65, cytokine expression, and COX-2 release and activity.	NF-KappaB	NF-kappaB	Complex:NFKB	18033	984	878	0.0011396300223248	Non valid	0.24177509596325336;0.752111965390701;0.00611293864604551	ACTIVATION	32672964	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
40971	PMID:32361811:pubtator_title_and_abstract:ef374d3d250270b94f04ae85e9fac1e0:8:nuclear factor kappa-B:NF-kappaB:979:1003	The levels of NOD-like receptor 3 (NLRP3) inflammasome, interleukin-18 (IL-18) and [TF] ([TG]) in the serum were measured.	nuclear factor kappa-B	NF-kappaB	Complex:NFKB	4790	979	1003	0.0011539106689957	Non valid	0.9295584939101738;0.06612389660604287;0.004317609483783317	UNDEFINED	32361811	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
41044	PMID:16806824:pubtator_title_and_abstract:4a1ee0a18114808d28f8ed953c7b871d:4:p65:NFkappaB:605:520	We show that chronic cholesterol depletion achieved with lipoprotein-deficient serum (LPDS) and 25-hydroxycholesterol (25-HC) treatment resulted in a significant increase in [TG]-dependent transcription, NFkappaB-DNA binding, IkappaBalpha degradation and [TF]/NFkappaB translocation to the nucleus, and the addition of exogenous cholesterol reversed these effects.	p65	NFkappaB	19697	18033	605	520	0.0011442308074676	Non valid	0.059794011374522366;0.9210413966936317;0.019164591931845994	ACTIVATION	16806824	Rela	10090	Nfkb1	10090	dbTF		NFKB
41084	PMID:16517719:pubtator_title_and_abstract:b65a9e27d3ee03c97f79658efb71836c:6:p65:NF-kappaB:787:769	GITR engagement using DTA-1, an agonistic mAb against GITR, in the presence of TCR signals, augmented IL-2 production, the expression of activation markers, cell cycle progression, and the nuclear translocations of [TG] p50 and [TF].	p65	NF-kappaB	19697	18033	787	769	0.0011853142902734	Non valid	0.041674923343088144;0.9567136431400113;0.0016114335169004888	ACTIVATION	16517719	Rela	10090	Nfkb1	10090	dbTF		NFKB
41106	PMID:33150340:pubtator_title_and_abstract:e843c7d64b48fd86dea5761ed5b3dac5:10:N-WASP:NF-kappaB:1602:1588	Furthermore, this combination treatment impeded the migration of HepG2 and MDA-MB-231 cancer cells via Cdc42 regulating JNK/[TG] and [TF] signaling pathways, and knockdown of DLC1 obviously increased the levels of Cdc42 and the molecules related to both signaling pathways in MDA-MB-231 cells.	N-WASP	NF-kappaB	8976	4790	1602	1588	0.0011263292587416	Non valid	0.9892580614056918;0.008398116955143186;0.0023438216391650757	UNDEFINED	33150340	WASL	9606	NFKB1	9606	coTF		NFKB
41203	PMID:15155785:pubtator_title_and_abstract:445baa58bef5e089f9267b87741c650d:13:ERbeta:NF-kappaB:1590:1649	The inhibition of [TF] in combination with the antiapoptotic properties of [TG] may therefore contribute to pathogenesis of GCT.	ERbeta	NF-kappaB	2100	4790	1590	1649	0.0011511380095362	Non valid	0.6087763174512788;0.23134423516132974;0.15987944738739143	UNDEFINED	15155785	ESR2	9606	NFKB1	9606	dbTF		NFKB
41218	PMID:11562449:pubtator_title_and_abstract:86532b1fb21712c5992907eb1c56219a:11:Akt:NF-kappa B:1814:1818	All these indicate that distinct mechanisms mediate ERK and [TF]/[TG] activation by D(4) dopamine receptor stimulation.	Akt	NF-kappa B	11651	18033	1814	1818	0.0014799262691549	Non valid	0.015504958565504776;0.9826010632647568;0.001893978169738274	ACTIVATION	11562449	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
41229	PMID:20147408:pubtator_title_and_abstract:bcefb342b2afe4e50e38cce3cd811b04:4:NF-kappaB:NF-kappaB:924:862	We have shown previously that the [TG] binding sites within the MIEP enhancer and cellular [TF] activity induced by HCMV infection are required for efficient MIEP activity and viral replication in quiescent cells (P. Caposio, A. Luganini, G. Hahn, S. Landolfo, and G. Gribaudo, Cell.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	924	862	0.0018043700980759	Non valid	0.05692898073259765;0.9416974479058433;0.0013735713615590688	ACTIVATION	20147408	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
41283	PMID:37858757:pubtator_title_and_abstract:025a7ed3debaf2de4b5779367050de64:2:NLRP3:NF-kappaB:455:381	Erhuang Quzhi Granules (EQG), the Chinese herbal compound, has demonstrated significant clinical efficacy in treating Non-alcoholic fatty liver disease (NAFLD). And the mechanism of this treatment has been shown to involve the nuclear factor kappa B ([TG])/Nod-like receptor thermal protein domain associated protein 3 ([TF]) pathway.	NLRP3	NF-kappaB	114548	4790	455	381	0.0011022787480566	Non valid	0.9303226519927883;0.06574644920333404;0.00393089880387762	UNDEFINED	37858757	NLRP3	9606	NFKB1	9606	coTF		NFKB
41328	PMID:26547583:pubtator_title_and_abstract:0dca9de498ae194407502cfd86b59a73:14:p65:NF-kappaB:2244:2234	Moreover, treating cells with SZC014 resulted in a decrease in phosphorylation of IkappaBalpha and [TG]/[TF] and NF-kappaB/p65 nuclear translocation.	p65	NF-kappaB	5970	4790	2244	2234	0.0011499088879551	Non valid	0.011506601222498072;0.9847190406046485;0.003774358172853464	ACTIVATION	26547583	RELA	9606	NFKB1	9606	dbTF		NFKB
41360	PMID:15195516:pubtator_title_and_abstract:60dbd48602b1866a113f8111af015476:5:NF-kappa B:NF-kappa B.:1201:898	The hypothesis is proposed that exposure to thermal stress and/or IR might alter metabolic processes impacting upon cellular redox state and thereby modify the activity of redox-sensitive transcription factors such as AP-1 and [TG] Gel electromobility shift assays (EMSA) demonstrated that heat shock-induced AP-1 DNA-binding activity but inhibited IR-induced activation of NF-kappa B. A time course showed that activation of the AP-1 complex occurs between 4 and 5 h following thermal stress, and inhibition of IR-induced [TF] activation also occurs during this time interval.	NF-kappa B	NF-kappa B.	Complex:NFKB	4790	1201	898	0.0011562465975158	Non valid	0.08562861095589269;0.8892078627015698;0.02516352634253748	ACTIVATION	15195516	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
41367	PMID:31358843:pubtator_title_and_abstract:6c4cd977757803dbed1d3e4885f72ae2:11:NFKB1:NF-kappaB:1496:1473	Taken together, these data suggest that increased activation of [TG] and MAPK via [TF] deletion enhance macrophage and myofibroblast content at the repair, driving increased collagen deposition and biomechanical properties.	NFKB1	NF-kappaB	4790	4790	1496	1473	0.0094699803203257	Non valid	0.0030526366077868253;0.00913189124289276;0.9878154721493203	REPRESSION	31358843	NFKB1	9606	NFKB1	9606	dbTF		NFKB
41376	PMID:17008051:pubtator_title_and_abstract:5f0b67d1707bc9323aa76219bead6171:9:IKKalpha/beta:NF-kappaB:1343:1281	Pharmacological inhibition of IKKalpha/beta activity reduced both Zn2+-induced p65/RelA phosphorylation at Ser 536 and [TG]-dependent transcriptional activity, suggesting that [TF] is necessary for these Zn2+-induced effects.	IKKalpha/beta	NF-kappaB	1147;3551	4790	1343	1281	0.0011620379195467	Non valid	0.010792076778898999;0.988065226512822;0.0011426967082789905	ACTIVATION	17008051	CHUK;IKBKB	9606;9606	NFKB1	9606	coTF;coTF		NFKB
41598	PMID:30764712:pubtator_title_and_abstract:ed031a3beae8fc0b13739e097af2dd07:7:NF-kappaB:nuclear factor-kappaB:786:763	In this study, we tested the hypothesis that perioperative use of a nonspecific beta-blocker and/or a [TG] ([TF]) inhibitor can retard the growth of residual endometriotic lesions that are left intact in the primary surgery.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	18033	786	763	0.00112833099624	Non valid	0.1772643199421717;0.37957317058907547;0.4431625094687528	REPRESSION	30764712	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
41694	PMID:24924589:pubtator_title_and_abstract:6a6830eb5f7502cbe9d18803e6a62726:6:BRD2:NF-kB:898:1022	SiRNA studies indicate that [TF] is the main BET protein involved in regulation of NF-kB and that I-BET151 caused transcriptional downregulation of the [TG] subunit p105/p50.	BRD2	NF-kB	6046	4790	898	1022	0.0079025590845179	Non valid	0.04447974848417485;0.9084152517633829;0.047104999752442214	ACTIVATION	24924589	BRD2	9606	NFKB1	9606	coTF		NFKB
41708	PMID:15280531:pubtator_title_and_abstract:9b152d6aa1b74e05e1d74161cc4e7011:6:NF-kappaB.:NF-kappaB:980:1000	METHODS: Biopsy specimens from 11 patients with type 2 diabeties and overt nephropathy were studied by southwestern histochemistry for the in situ detection of activated NF-kappaB. In addition, by immunohistochemistry and/or in situ hybridization, we studied the expression of MCP-1 and RANTES, whose genes are regulated by [TF] RESULTS: [TG] was detected mainly in cortical tubular epithelial cells and, to a lesser extent, in some glomerular and interstitial cells.	NF-kappaB.	NF-kappaB	Complex:NFKB	4790	980	1000	0.0011664551382681	Non valid	0.9905021188183298;0.008669822537843057;0.0008280586438270624	UNDEFINED	15280531	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
41729	PMID:16271621:pubtator_title_and_abstract:6930edbccf5a4f6cf8fe37801bb7b62f:7:AP-1:NF-kappaB:1237:1264	Our investigation revealed that, by depleting GSH, arsenite attenuated the TNF-alpha-induced VCAM-1 expression as well as a potentiation of [TF] and an attenuation of [TG] activations by TNF-alpha.	AP-1	NF-kappaB	3726	4790	1237	1264	0.0014211827127666	Non valid	0.02551251825402904;0.8837237593600717;0.09076372238589925	ACTIVATION	16271621	JUNB	9606	NFKB1	9606	dbTF		NFKB
41887	PMID:15829306:pubtator_title_and_abstract:f7dba950481abd9b1bac77188a108ea4:2:NF-kappaB:NF-kappaB.:356:310	Pyrrolidine dithiocarbamate (PDTC) is a stable compound that acts as antioxidant or prooxidant, and is widely used to inhibit the activation of [TG] PDTC was also reported to activate [TF] depending on its dose and metal ions in PC12 cells.	NF-kappaB	NF-kappaB.	Complex:NFKB	18033	356	310	0.0011430803720123	Non valid	0.04361963371522862;0.9488137993145036;0.007566566970267808	ACTIVATION	15829306	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
41947	PMID:9186501:pubtator_title_and_abstract:0dded126a5fea8a74d303fde150631b2:8:I kappa B alpha:NF-kappa B:1255:1287	This suggests that calpain contributes to silica-induced [TF] degradation and [TG] activation but not to LPS-induced I kappa B alpha degradation and NF-kappa B activation.	I kappa B alpha	NF-kappa B	18035	18033	1255	1287	0.0016019291597477	Non valid	0.054424616545403086;0.8280172621217456;0.11755812133285128	ACTIVATION	9186501	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
41949	PMID:16267831:pubtator_title_and_abstract:6d072669943042be5f9da10c1f024544:2:activator protein-1:NF-kappaB:285:269	The roles of the mitogen-activated kinase protein (MAPK) pathway, nuclear factor-kappa B ([TG]), and [TF] (AP-1) in cellular responses to growth factors and mitogen are well established.	activator protein-1	NF-kappaB	3726	4790	285	269	0.0011762743287625	Non valid	0.9764143202781922;0.02241131878586195;0.0011743609359458752	UNDEFINED	16267831	JUNB	9606	NFKB1	9606	dbTF		NFKB
41983	PMID:9681829:pubtator_title_and_abstract:0cae3e85fd3a990e2dd5bceed65c6ea1:5:IkappaB-alpha:NF-kappaB:853:951	Stable transfection of a unresponsive mutated [TF] Ser 32-36 expression vector showed that TNF-alpha induced MHC Cl I expression in an [TG]-dependent way while IFN-gamma did it independently of any NF-kappaB activation.	IkappaB-alpha	NF-kappaB	4792	4790	853	951	0.001081803363047	Non valid	0.04409339262658146;0.8445568700213555;0.11134973735206304	ACTIVATION	9681829	NFKBIA	9606	NFKB1	9606	coTF		NFKB
42084	PMID:30660646:pubtator_title_and_abstract:0e148e2ac77569251c8f4efe099743df:5:p65:NF-kappaB:776:766	Mechanical exploration revealed that IL-17 stimulation could increase the phosphorylation levels of Akt1 and [TG]-[TF] in glioma cells, and knockdown or inhibition of PI3K, Akt1 and NF-kappaB-p65 could also reduce the IL-17-induced proliferation and migration of the glioma cells.	p65	NF-kappaB	5970	4790	776	766	0.0011315156780851	Non valid	0.12490683314476893;0.8694078020730259;0.0056853647822050195	ACTIVATION	30660646	RELA	9606	NFKB1	9606	dbTF		NFKB
42141	PMID:33744777:pubtator_title_and_abstract:594d818e27f7e0302461e6310afa3d0e:11:ERK:NF-kappaB:1665:1673	Taken together, the anti-inflammatory effect of loganin in sepsis-induced ALI was associated with the [TF] and [TG] pathway-mediated macrophage polarization and NLRP3 inflammasome activation.	ERK	NF-kappaB	26413	18033	1665	1673	0.0011031926752032	Non valid	0.05566559771016864;0.9355674321901247;0.008766970099706624	ACTIVATION	33744777	Mapk1	10090	Nfkb1	10090	ll_coTF		NFKB
42170	PMID:25676613:pubtator_title_and_abstract:e6eeed69f32d9f9a9b8b72658c130cc6:6:PPARgamma:NF-kappaB:1040:1133	In addition, AOM induced downregulation of peroxisome proliferator activated receptor gamma ([TF]) and p53 mRNA expression, with concomitant upregulation of nuclear factor-kappa B ([TG]) in colon tissue.	PPARgamma	NF-kappaB	19016	18033	1040	1133	0.0014086832700316	Non valid	0.005191603591048414;0.013820452077165774;0.9809879443317859	REPRESSION	25676613	Pparg	10090	Nfkb1	10090	dbTF		NFKB
42255	PMID:33168409:pubtator_title_and_abstract:680a4e68172e8838cb372036a965c869:8:CHOP:NF-kappaB:1172:1226	Moreover, limonin attenuated DSS-induced chronic colitis by inhibiting PERK-ATF4-[TF] pathway of endoplasmic reticulum (ER) stress and [TG] signaling.	CHOP	NF-kappaB	13198	18033	1172	1226	0.0013508905173818	Non valid	0.03971744479527833;0.9557426031492466;0.004539952055475082	ACTIVATION	33168409	Ddit3	10090	Nfkb1	10090	dbTF		NFKB
42315	PMID:15722346:pubtator_title_and_abstract:28363619a51b4ef5f51bd6aad9f58307:3:ABIN-1:nuclear factor-kappaB:422:369	Using a murine model of allergen-induced asthma, we have demonstrated that adenovirus-mediated delivery of the [TG] (NF-kappaB) inhibitory protein [TF] to the lung epithelium results in a considerable reduction of allergen-induced eosinophil infiltration into the lungs.	ABIN-1	nuclear factor-kappaB	57783	18033	422	369	0.0012158719260157	Non valid	0.007491188810404854;0.0044193410549172064;0.988089470134678	REPRESSION	15722346	Tnip1	10090	Nfkb1	10090	coTF		NFKB
42415	PMID:12870650:pubtator_title_and_abstract:646f9545c676d4205afba69e48baf604:0:I(kappa)B-alpha:NF-kappaB:129:197	Phosphoinositide 3-kinase activity leads to silica-induced NF-kappaB activation through interacting with tyrosine-phosphorylated [TF] and contributing to tyrosine phosphorylation of p65 [TG].	I(kappa)B-alpha	NF-kappaB	18035	18033	129	197	0.0012817214347878	Non valid	0.017276882012215097;0.9812335806879918;0.0014895372997930255	ACTIVATION	12870650	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
42441	PMID:18345001:pubtator_title_and_abstract:db54a0bf012c8365a9c72ceb0d426027:4:TAK1:NF-kappaB:445:603	Here we report that the tripartite-motif protein TRIM30alpha, a RING protein, was induced by TLR agonists and interacted with the TAB2-TAB3-[TF] adaptor-kinase complex involved in the activation of transcription factor NF-kappaB. TRIM30alpha promoted the degradation of TAB2 and TAB3 and inhibited [TG] activation induced by TLR signaling.	TAK1	NF-kappaB	26409	18033	445	603	0.0014817866269949	Non valid	0.011216956405212088;0.9832318511807688;0.005551192414019003	ACTIVATION	18345001	Map3k7	10090	Nfkb1	10090	ll_coTF		NFKB
42464	PMID:33787460:pubtator_title_and_abstract:cb24e06e3da4dcbf1d01b8219d9384fd:13:SIRT1:NFkappaB:1332:1338	Our study demonstrated that remarkable effects of rosmarinic acid on the mice with NASH might be due to activation of SIRT1/Nrf2, [TF]/[TG] and SIRT1/PPARalpha pathways, which alleviate hepatic steatosis, oxidative stress, inflammation and apoptosis.	SIRT1	NFkappaB	93759	18033	1332	1338	0.0011338241436468	Non valid	0.2825705045387838;0.6951071002268765;0.022322395234339702	ACTIVATION	33787460	Sirt1	10090	Nfkb1	10090	coTF		NFKB
42489	PMID:32214070:pubtator_title_and_abstract:82c4e4b2c7201133489240956b775275:0:MyD88:NF-kappaB:86:92	Cotinine aggravates inflammatory response in thromboangiitis obliterans through TLR-4/[TF]/[TG] inflammatory signaling pathway.	MyD88	NF-kappaB	4615	4790	86	92	0.0010877560152169	Non valid	0.03575625741812714;0.961322272281859;0.002921470300013885	ACTIVATION	32214070	MYD88	9606	NFKB1	9606	coTF		NFKB
42575	PMID:21692687:pubtator_title_and_abstract:c0f944d3b7066d732673d19e293aa6ea:5:Bmi-1:NF-kappaB:1024:939	This review article gives a brief overview of some transcription factors ([TG], Hes, STAT3, AP-1, CREB, HIF1, Pax6, Tcf/Lef, Gli, Sox2, Olig2, Dlx2, TLX, [TF]) in ischemia-induced neurogenesis.	Bmi-1	NF-kappaB	648	4790	1024	939	0.0012712873643322	Non valid	0.5394729559797418;0.45655282853969337;0.0039742154805648845	UNDEFINED	21692687	BMI1	9606	NFKB1	9606	coTF		NFKB
42611	PMID:32322927:pubtator_title_and_abstract:2a272ca17317e7c6fefeac7c2fe5731c:7:p53:NF-kappaB:953:917	This review analyzes the various mechanisms by which [TG] regulates the activity of [TF] and the role of p53 on NF-kappaB activity.	p53	NF-kappaB	7157	4790	953	917	0.0012653688957281	Non valid	0.9969070482209572;0.00204368078153002;0.0010492709975128763	UNDEFINED	32322927	TP53	9606	NFKB1	9606	dbTF		NFKB
42749	PMID:36371018:pubtator_title_and_abstract:0e7084575d2e79510c0dbeb203e23f71:4:nuclear factor-kappa B:NF-kappaB:872:896	In addition, 7y inhibited the expression of iNOS, COX-2 and pro-inflammatory cytokines and attenuated LPS-induced activation of [TF] ([TG]) and ERK MAPK phosphorylation in BV2 cells.	nuclear factor-kappa B	NF-kappaB	Complex:NFKB	18033	872	896	0.0011214314876507	Non valid	0.0024074367406857356;0.9962666711052204;0.0013258921540939108	ACTIVATION	36371018	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
42800	PMID:15195516:pubtator_title_and_abstract:60dbd48602b1866a113f8111af015476:5:AP-1:NF-kappa B:889:1201	The hypothesis is proposed that exposure to thermal stress and/or IR might alter metabolic processes impacting upon cellular redox state and thereby modify the activity of redox-sensitive transcription factors such as [TF] and NF-kappa B. Gel electromobility shift assays (EMSA) demonstrated that heat shock-induced AP-1 DNA-binding activity but inhibited IR-induced activation of NF-kappa B. A time course showed that activation of the AP-1 complex occurs between 4 and 5 h following thermal stress, and inhibition of IR-induced [TG] activation also occurs during this time interval.	AP-1	NF-kappa B	3726	4790	889	1201	0.0014380356904821	Non valid	0.10746651994604572;0.837082533862871;0.05545094619108313	ACTIVATION	15195516	JUNB	9606	NFKB1	9606	dbTF		NFKB
42822	PMID:9721103:pubtator_title_and_abstract:185c7636b01f29bcd4fdd9f194eb5be1:6:IKKbeta:NF-kappaB:663:703	Both IKKalpha and [TF] phosphorylated IkappaB bound to [TG] more efficiently than they phosphorylated free IkappaB. This result explains how free IkappaB can accumulate in cells in which IKK is still active and thus can contribute to the termination of NF-kappaB activation.	IKKbeta	NF-kappaB	3551	4790	663	703	0.0017426651197337	Non valid	0.3996720266485757;0.5877287121105702;0.012599261240854151	ACTIVATION	9721103	IKBKB	9606	NFKB1	9606	coTF		NFKB
42829	PMID:32377752:pubtator_title_and_abstract:afc1342c823d0643db3c6764550e12e3:13:ERK:nuclear factor (NF)-kappaB:1637:1648	The activation of phosphorylated (p-) extracellular signal-regulated kinase ([TF]) and p-[TG] were measured by western blot analysis.	ERK	nuclear factor (NF)-kappaB	5594	4790	1637	1648	0.001168238736553	Non valid	0.0127171385161135;0.9857391743996785;0.0015436870842080103	ACTIVATION	32377752	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
42861	PMID:10807870:pubtator_title_and_abstract:8f6dbdb08936eb8d5f8080b52e02efe6:10:bcl-2:NF-kappaB:1636:1578	bcl-2 mRNA was also decreased by hypoxia, whereas transfection of [TG] decoy ODNs significantly attenuated decrease in [TF] mRNA.	bcl-2	NF-kappaB	24224	4790	1636	1578	0.001445823138348	Non valid	0.009181802902713662;0.44821421433876696;0.5426039827585194	REPRESSION	10807870	Bcl2	10116	NFKB1	9606	coTF		NFKB
42872	PMID:27299588:pubtator_title_and_abstract:f2ebfeed8355d8c59da2be420b846a7b:11:Trx-1:NF-kappaB:1225:1261	More importantly, the overexpression of [TF] in transgenic mice suppressed [TG] inflammatory signal pathway by inhibiting the activation of molecules involved in ER stress.	Trx-1	NF-kappaB	22166	18033	1225	1261	0.0070906517584708	Non valid	0.0020711359564039955;0.0017252460063034208;0.9962036180372926	REPRESSION	27299588	Txn1	10090	Nfkb1	10090	ll_coTF		NFKB
42905	PMID:11007787:pubtator_title_and_abstract:f6db4b33635481b8b44e7677df69ec66:5:amphoterin:NF-kappaB.:729:806	Here we show that two S100 family proteins, S100B and S100A1, activate RAGE in concert with [TF] inducing neurite outgrowth and activation of transcription factor [TG] Furthermore, activation of RAGE by amphoterin and S100B promotes cell survival through increased expression of the anti-apoptotic protein Bcl-2.	amphoterin	NF-kappaB.	3146	4790	729	806	0.4467730985377856	Non valid	0.010715641332205745;0.9880262812263818;0.0012580774414125012	ACTIVATION	11007787	HMGB1	9606	NFKB1	9606	coTF		NFKB
42927	PMID:35149130:pubtator_title_and_abstract:331ddc44632db33ada5bd4ae4dca4436:8:NF-kappaB:NF-kappaB:1357:1394	The [TF] transcription activity and [TG] nuclear translocation were observed.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1357	1394	0.0012968820081484	Non valid	0.16871145873174148;0.8284966279734861;0.0027919132947724135	ACTIVATION	35149130	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
42929	PMID:27348973:pubtator_title_and_abstract:4f5fc8c5db0306c38b6eb9bc6ff683e5:9:NF-kappaB:NF-kappaB.:1001:905	In addition, RRM2 time-dependently induced activation of AKT, IKBalpha, and [TG] These effects of RRM2 were prevented by AKT selective inhibitor GSK690693 as well as [TF] selective inhibitor BAY117082.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	1001	905	0.0066274632519382	Non valid	0.009294697663650436;0.9878307095868617;0.0028745927494878715	ACTIVATION	27348973	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
42951	PMID:26447839:pubtator_title_and_abstract:af69aa4370828ae96ea847260ac9210b:7:NF-kappaB:NF-kappaB:1288:1405	Quantitative reverse transcription polymerase chain reaction confirmed the microarray data by showing transcriptional alternation of selected [TF] target genes in cells treated with (111)In-trastuzumab-NLS-L. Interestingly, bortezomib, a drug known as a [TG] modulator, significantly enhanced the cytotoxicity of (111)In-trastuzumab-NLS-L in SKBR3 cells.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1288	1405	0.0015184972648162	Non valid	0.993925282730877;0.004284399562792741;0.0017903177063302567	UNDEFINED	26447839	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
42981	PMID:34544028:pubtator_title_and_abstract:b8973272daab9dd3649bee58978468c5:12:Bcl-2:Nf-kappaB:1409:1433	Significant upregulation (p < 0.05) of p53, Bax, Cas3, Cas7 and PTEN and significant downregulation (p < 0.05) of [TF], Cyclin-D1, Rac1, [TG], HIF-1a, VEGF and MMP9 were observed.	Bcl-2	Nf-kappaB	596	4790	1409	1433	0.0012159208582438	Non valid	0.0037551418959521276;0.04596598661115307;0.9502788714928949	REPRESSION	34544028	BCL2	9606	NFKB1	9606	coTF		NFKB
42993	PMID:10202024:pubtator_title_and_abstract:ef76eb832c90efeddb9848049109d8f8:3:p50:NF-kappaB:399:384	First, we showed that viral binding induced a number of immunoregulatory genes (IL-1beta, A20, [TG]-p105/[TF], and IkappaBalpha) in unactivated monocytes and that neutralizing Abs to the major HCMV glycoproteins, gB (UL55) and gH (UL75), inhibited the induction of these genes.	p50	NF-kappaB	4790	4790	399	384	0.0011891103339486	Non valid	0.06552583522736338;0.9294555133708124;0.005018651401824203	ACTIVATION	10202024	NFKB1	9606	NFKB1	9606	dbTF		NFKB
43030	PMID:18996094:pubtator_title_and_abstract:e29541286b7eecc7753c7fe8e05121a7:6:p65:NF-kappaB:827:854	Remicade, a clinically used anti-TNFalpha antibody, small interfering RNA (siRNA) against p50 and [TF] nuclear factor-kappaB ([TG]) isoforms, curcumin, a well characterized natural NF-kappaB inhibitor, as well as a dominant negative inhibitor of kappaB alpha (IkappaBalpha), prevented GGT activation at various levels, illustrating the involvement of this signaling pathway in TNFalpha-induced stimulation.	p65	NF-kappaB	5970	4790	827	854	0.0011128951566241	Non valid	0.004274433639931563;0.9933732440494032;0.002352322310665187	ACTIVATION	18996094	RELA	9606	NFKB1	9606	dbTF		NFKB
43037	PMID:11238525:pubtator_title_and_abstract:f18c07bf965249336572f849a6945efb:2:NFkappaB:nuclear factor kappaB:334:311	To elucidate whether troglitazone exerts an antiinflammatory effect in humans, in vivo, we investigated the suppression of [TG] ([TF]) in mononuclear cells (MNC) by this drug.	NFkappaB	nuclear factor kappaB	Complex:NFKB	4790	334	311	0.0015340855405432	Non valid	0.11084379541550615;0.5384330463123282;0.3507231582721656	ACTIVATION	11238525	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
43113	PMID:34752597:pubtator_title_and_abstract:c73445df340589bfd7644d2bf1ce0420:4:HDAC:NF-kappaB:459:520	Butyrate enters the cells through the Solute Carrier Family 5 Member 8 (SLC5A8) transporters, then works as a histone deacetylase inhibitor ([TF]) that inhibits the activation of Nuclear factor-kappaB ([TG]), which down-regulates the expression of IL-1beta, IL-6, TNF-alpha.	HDAC	NF-kappaB	9734	4790	459	520	0.0050875835998358	Non valid	0.00857315260775621;0.8964307535306225;0.09499609386162126	ACTIVATION	34752597	HDAC9	9606	NFKB1	9606	coTF		NFKB
43168	PMID:23898080:pubtator_title_and_abstract:aee10854ebc9053faf81b948bede9aff:6:NF-kappaB:nuclear factor-kappaB:653:630	Electrophoretic mobility shift assay (EMSA) and quantitative real-time polymerase chain reaction (qRT-PCR) were used to evaluate changes in [TG] ([TF]) activity and gene expression, respectively.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	653	630	0.0012183641764867	Non valid	0.9899376914424597;0.007288644735382712;0.002773663822157648	UNDEFINED	23898080	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
43246	PMID:15955104:pubtator_title_and_abstract:0d6b2003fc90036e26b50332b006475c:0:RelA:NF-kappaB:52:42	Differential expression of phosphorylated [TG]/[TF] in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.	RelA	NF-kappaB	5970	4790	52	42	0.0012312832720129	Non valid	0.9687271400738127;0.01906049278855858;0.012212367137628787	UNDEFINED	15955104	RELA	9606	NFKB1	9606	dbTF		NFKB
43383	PMID:23463347:pubtator_title_and_abstract:0ebaa9363ac11f16b51adb39a78ee3af:3:cyclinD1:NF-kappaB:377:366	The epidermal growth factor receptor (EGFR)/Akt/nuclear factor-kappa B ([TG])/[TF] signaling pathway is one of the most important pathways in regulating cell survival and proliferation.	cyclinD1	NF-kappaB	595	4790	377	366	0.0012380727522235	Non valid	0.9407967468052632;0.05797239436670991;0.0012308588280269199	UNDEFINED	23463347	CCND1	9606	NFKB1	9606	coTF		NFKB
43385	PMID:18295546:pubtator_title_and_abstract:5b0f74043e6725de0bd7d0e74bde8427:3:NF-kappaB:nuclear factor-kappaB:894:871	In the present study, we found that reinioside C, the main component extracted from Polygala fallax Hemsl., dose-dependently inhibited tumor necrosis factor-alpha (TNF-alpha) production induced by ADMA in monocytes, Furthermore, reinioside C attenuated ADMA-induced generation of reactive oxygen species and activation of [TG] ([TF]) activity in monocytes in a dose-dependent manner, this effect was inhibited by l-arginine (NOS substrate) and PDTC (inhibitor of NF-kappaB).	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	894	871	0.0012090914632775	Non valid	0.010250597214496905;0.9757156636641746;0.014033739121328426	ACTIVATION	18295546	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
43483	PMID:36127053:pubtator_title_and_abstract:3bae230b67457abeffd27d5cc81010bb:7:c-Jun N-terminal kinase:NF-kappaB:905:871	While combined MB and PQ elevated the expression of COX-2 protein, activation of nuclear factor-kappa B ([TG]) and phosphorylation of [TF] (JNK), release of mitochondrial cytochrome c and levels of procaspase-3/9 were attenuated in the PMNs.	c-Jun N-terminal kinase	NF-kappaB	116554	4790	905	871	0.0011259878468254	Non valid	0.054134035284967026;0.9391029552337246;0.006763009481308417	ACTIVATION	36127053	Mapk8	10116	NFKB1	9606	ll_coTF		NFKB
43493	PMID:15277220:pubtator_title_and_abstract:a208e0d98018ce6bd8699f51abd12b7d:8:VEGF:NF-kappaB:1228:1271	In conclusion, IGF-I participates in the pathophysiology of diabetic retinopathy by inducing retinal [TF] expression via PI-3K/Akt, HIF-1alpha, [TG], and secondarily, JNK/AP-1 activation.	VEGF	NF-kappaB	7422	4790	1228	1271	0.0011543413550369	Non valid	0.002782477537144742;0.9961688706671772;0.0010486517956780315	ACTIVATION	15277220	VEGFA	9606	NFKB1	9606	ll_coTF		NFKB
43551	PMID:19010537:pubtator_title_and_abstract:ee1db7fd63ca4c78941d7f21662cf86e:5:PRB:nuclear factor-kappaB:911:708	There is now compelling evidence implicating NRs, including the [TG] (NF-kappaB) family of nuclear TFs, the nuclear hormone receptor superfamily of peroxisome proliferator activated receptors (PPARs), and the steroid receptors for progesterone (PRA, [TF] and PRC), as candidate upstream regulators of labour-associated processes.	PRB	nuclear factor-kappaB	5925	4790	911	708	0.0011508959722005	Non valid	0.9916425265504197;0.006989341639610454;0.0013681318099698575	UNDEFINED	19010537	RB1	9606	NFKB1	9606	coTF		NFKB
43689	PMID:30989475:pubtator_title_and_abstract:2e78406f6e8b9d12ed3dcfa11765d3e8:8:SIRT6:nuclear transcription factor-kappa B:940:1011	Moreover, it was found that [TF] knockdown upregulated TLR4 and reinforced phosphorylation of the [TG] (NF-kappaB) subunit p65 as well as inhibitor of nuclear factor kappa-B kinase.	SIRT6	nuclear transcription factor-kappa B	51548	4790	940	1011	0.0021858378907452	Non valid	0.0024345638704454334;0.0027361145128791294;0.9948293216166755	REPRESSION	30989475	SIRT6	9606	NFKB1	9606	coTF		NFKB
43917	PMID:15991283:pubtator_title_and_abstract:15c13bcdd57373a2faa82cdbf53c6f72:4:NF-kappaB:NF-kappaB:640:807	RESULTS: Twenty-two (55%) and 25 (62.5%) of 40 cases for [TF] and AP-1 were presented for nuclear or both nuclear and cytoplastic staining respectively, while less cases were presented for only cytoplastic staining for [TG] (18%) and AP-1 (10%) in adjacent nontumoral tissues and negative staining in normal liver tissues.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	640	807	0.0011424838211532	Non valid	0.4228037968980709;0.5558586293896254;0.02133757371230378	ACTIVATION	15991283	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
43918	PMID:17880928:pubtator_title_and_abstract:416c308661b5563ab2e8599d8a8d20e3:9:AP-1:NF-kappaB:1231:1217	Furthermore, Rh2 significantly repressed the PMA-mediated activation of p38 MAPK, ERK and JNK, which are upstream modulators of [TG] and [TF].	AP-1	NF-kappaB	2354	4790	1231	1217	0.0013088833543382	Non valid	0.5693379965619642;0.40966814989298284;0.020993853545053044	UNDEFINED	17880928	FOSB	9606	NFKB1	9606	dbTF		NFKB
43942	PMID:19799035:pubtator_title_and_abstract:042fcdfff821156befe9ec13bd8949ae:4:nuclear factor-kappaB:NF-kappaB:810:833	After culture for 4 hours, TF activity, TF protein expression, [TF] ([TG]) activity were examined.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	810	833	0.0011345172219562	Non valid	0.766830590160647;0.22479457586297644;0.008374833976376637	UNDEFINED	19799035	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
44028	PMID:11562449:pubtator_title_and_abstract:86532b1fb21712c5992907eb1c56219a:10:Akt:NF-kappa B:1727:1731	However, PP2 and the mitogen activated protein kinase kinase inhibitor PD98059 did not change D(4) receptor-mediated [TF]/[TG] activation.	Akt	NF-kappa B	11651	18033	1727	1731	0.0012951363023141	Non valid	0.06789249149277997;0.9261153402815434;0.005992168225676612	ACTIVATION	11562449	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
44221	PMID:35738472:pubtator_title_and_abstract:95c22ca2e14f0844a02066a04d20f42c:19:HO-1:NF-kappaB:2567:2548	CONCLUSION: Ethanol extracts of LLF ameliorated LPS-induced acute lung injury by suppressing inflammatory response and enhancing antioxidation capacity, which correlated with the MAPK/[TG] and Nfr2/[TF] signaling pathways.	HO-1	NF-kappaB	15368	18033	2567	2548	0.001112535820897	Non valid	0.9531259300369297;0.03974029179400013;0.007133778169070148	UNDEFINED	35738472	Hmox1	10090	Nfkb1	10090	ll_coTF		NFKB
44286	PMID:11238525:pubtator_title_and_abstract:f18c07bf965249336572f849a6945efb:6:NFkappaB:NFkappaB:1272:1247	MNC were separated; and the levels of intranuclear [TG], total cellular [TF], IkappaBalpha, and p47 (phox) subunit and ROS generation were determined.	NFkappaB	NFkappaB	Complex:NFKB	4790	1272	1247	0.0011338106428151	Non valid	0.7257122014675355;0.2620819665276342;0.012205832004830382	UNDEFINED	11238525	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
44468	PMID:12620799:pubtator_title_and_abstract:410598253eea270e6aa14d897ee8b8dc:3:HDAC:NF-kappaB.:496:538	Previous in vitro studies with class I enhancer sequences have indicated that there is an increased binding of repressor COUP-TFII and its associated [TF] and a decreased binding of activator [TG] In this study, we used chromatin immunoprecipitation (ChIP) assay in order to determine in vivo whether these proteins regulate class I transcription by affecting chromatin.	HDAC	NF-kappaB.	9734	4790	496	538	0.0011310770673154	Non valid	0.35830956723487534;0.11703863276584586;0.5246517999992788	REPRESSION	12620799	HDAC9	9606	NFKB1	9606	coTF		NFKB
44496	PMID:24278135:pubtator_title_and_abstract:836ec0eaf9d1f31462848afa1ccbadf3:3:beta-catenin:NF-kappaB:431:464	Herein, we test the hypothesis that [TF] and not necessarily [TG] regulates colonic crypt hyperplasia or tumorigenesis in response to CR infection.	beta-catenin	NF-kappaB	12387	18033	431	464	0.0011998569506004	Non valid	0.996869313785319;0.0020936326130897324;0.0010370536015911957	UNDEFINED	24278135	Ctnnb1	10090	Nfkb1	10090	coTF		NFKB
44501	PMID:28257048:pubtator_title_and_abstract:c16762aaca0f468cf65f878012be3849:7:nuclear factor-kappaB:NF-kappaB:1273:1296	Consequently, it was found that vanillin causes inhibition of promoter occupancy by signal transducer and activator of transcription 3 (STAT3), but not [TF] ([TG]), on HIF1A.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	1273	1296	0.0011242962602021	Non valid	0.9940341256847284;0.004893224031958726;0.0010726502833129433	UNDEFINED	28257048	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
44582	PMID:12960395:pubtator_title_and_abstract:07c08844bc8c9cfb3c69223d0f74929c:4:NF-kappaB:NF-kappaB:673:595	Human parainfluenza virus type 3, a mildly cytopathic virus that induced [TG] very early during infection was converted to a virulent virus after [TF] inhibition.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	673	595	0.0012249296520828	Non valid	0.012020914030560362;0.19126320602610378;0.7967158799433358	REPRESSION	12960395	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
44589	PMID:24720748:pubtator_title_and_abstract:db62e3381091352e893c8f81c0aa7cbc:0:PSMD9:NF-kappaB:43:103	A novel role for the proteasomal chaperone [TF] and hnRNPA1 in enhancing IkappaBalpha degradation and [TG] activation - functional relevance of predicted PDZ domain-motif interaction.	PSMD9	NF-kappaB	5715	4790	43	103	0.208232702895681	Non valid	0.008042083329706032;0.9902102693455088;0.001747647324785208	ACTIVATION	24720748	PSMD9	9606	NFKB1	9606	coTF		NFKB
44725	PMID:15722553:pubtator_title_and_abstract:7640dd4a0112ef910ebd8bd15ade4727:8:IkappaBepsilon:NF-kappaB:1124:1015	Quantitative real-time PCR assays of eight characterized [TG]-dependent genes and five genes not previously known to be NF-kappaB-dependent (Gro-beta and-gamma, [TF], interleukin (IL)-7R, and Naf-1) were used to determine whether they were directly or indirectly NF-kappaB regulated.	IkappaBepsilon	NF-kappaB	4794	4790	1124	1015	0.0012272142378568	Non valid	0.7914190060113239;0.20614268881491543;0.002438305173760743	UNDEFINED	15722553	NFKBIE	9606	NFKB1	9606	dbTF		NFKB
44733	PMID:22207895:pubtator_title_and_abstract:666d8a6bb33e37584aa8afe5b1903505:3:c-Rel:NF-kappaB:306:160	Unlike other [TG] proteins that are expressed in a variety of cell types, high levels of c-Rel expression are found primarily in B and T cells, with many [TF] target genes involved in lymphoid cell growth and survival.	c-Rel	NF-kappaB	5966	4790	306	160	0.0011368328870937	Non valid	0.9965180155686633;0.0026018898798205936;0.0008800945515161045	UNDEFINED	22207895	REL	9606	NFKB1	9606	dbTF		NFKB
44772	PMID:15004509:pubtator_title_and_abstract:d5c330a9723e47cfb7813c40f4c3382c:2:NF-kappaB:NF-kappaB:243:200	Inflammatory conditions are characterized by activation of the transcription factor nuclear factor kappa B ([TG]), resulting in the expression of [TF]-regulated, inflammation-related genes, such as inducible nitric oxide synthase (iNOS) and cyclo-oxygenase-2 (COX-2).	NF-kappaB	NF-kappaB	Complex:NFKB	4790	243	200	0.0010967974625781	Non valid	0.9840937936176647;0.014781141206644735;0.0011250651756905812	UNDEFINED	15004509	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
44796	PMID:34663388:pubtator_title_and_abstract:2b81e60ab80f8a364e315179682b48d1:7:nuclear factor-kappa B:NF-kappaB:909:933	The activity of the [TF] ([TG]) pathway was examined by western blotting and immunofluorescence.	nuclear factor-kappa B	NF-kappaB	Complex:NFKB	4790	909	933	0.0011204128099512	Non valid	0.9136788927312277;0.08278694425712663;0.0035341630116456075	UNDEFINED	34663388	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
44910	PMID:33157101:pubtator_title_and_abstract:5ae93fb751806959731331f1906485f8:7:p65:nuclear factor-kappaB:1044:960	Our data showed that neferine suppressed [TG] (NF-kappaB) nuclear translocation and inhibited the NF-kappaB-[TF]-induced transcriptional activity of ICAM1 and VCAM1.	p65	nuclear factor-kappaB	5970	4790	1044	960	0.0011158128155629	Non valid	0.0021407478741128478;0.9967690271747078;0.0010902249511792353	ACTIVATION	33157101	RELA	9606	NFKB1	9606	dbTF		NFKB
44971	PMID:12460196:pubtator_title_and_abstract:3bdc47d5c12879dcb90a6452ed43801f:7:AP-1:NF-kappaB:1340:1361	Electrophoretic mobility shift assays demonstrated that nuclear extract prepared from A. laidlawii-treated THP-1 cells generated a specific binding to oligonucleotides, including [TF], C/EBPbeta, and [TG] element.	AP-1	NF-kappaB	3726	4790	1340	1361	0.0011379464187485	Non valid	0.9977292107660719;0.0011113342813084562;0.0011594549526196603	UNDEFINED	12460196	JUNB	9606	NFKB1	9606	dbTF		NFKB
44987	PMID:23811270:pubtator_title_and_abstract:a8c31fec9234c03ae66786f21089ecbc:4:STAT3:NF-kappaB:900:574	DATS significantly inhibited the DSS-induced DNA binding of [TG], phosphorylation of IkappaBalpha and the expression of pro-inflammatory proteins, such as cyclooxygenase-2 and inducible nitric oxide synthase, which are major target proteins of NF-kappaB. The DSS-induced DNA binding and phosphorylation at the Tyr 705 residue of signal transducer and activator of transcription 3 ([TF]), and expression of its major target protein cyclin D1 in mouse colonic mucosa were also attenuated by DATS administration.	STAT3	NF-kappaB	20848	18033	900	574	0.0010929425157126	Non valid	0.14242905824160626;0.8502799058056527;0.007291035952741016	ACTIVATION	23811270	Stat3	10090	Nfkb1	10090	dbTF		NFKB
45075	PMID:26823762:pubtator_title_and_abstract:9f95807444546da973991b280fc0c598:10:TAK1:nuclear factor-kappaB:1493:1672	In vitro, 5Z-7-oxozeaenol, a selective [TF] inhibitor, significantly inhibited the proliferation and invasion and promoted the apoptosis of thyroid cancer cells, possibly due to its inhibition of the activation of the [TG] (NF-kappaB) signaling pathway.	TAK1	nuclear factor-kappaB	6885	4790	1493	1672	0.0011922599326926	Non valid	0.004210510353647795;0.9923344892661432;0.003455000380209024	ACTIVATION	26823762	MAP3K7	9606	NFKB1	9606	ll_coTF		NFKB
45187	PMID:14615419:pubtator_title_and_abstract:6ecb4aa34ae38770f0471695a5522c09:4:NF-kappaB:nuclear factor (NF)-kappaB:772:690	Intracellular signalings after Toll-like receptors activation by lipopolysaccharide was examined by analysis of [TG] activation and inhibition studies using inhibitors for [TF] and mitogen-activated protein kinase and blocking antibody.	NF-kappaB	nuclear factor (NF)-kappaB	Complex:NFKB	18033	772	690	0.0011119890898469	Non valid	0.5638463095778643;0.3870816664204091;0.04907202400172665	UNDEFINED	14615419	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
45265	PMID:18239058:pubtator_title_and_abstract:2fd5983375ce077ff7f246f81f715ef9:13:phosphatidylinositol 3-kinase:NF-kappaB:1869:1919	IL-32alpha mRNA expression is dependent on interactions between the [TF]/Akt-pathway and the [TG]/AP-1 system.	phosphatidylinositol 3-kinase	NF-kappaB	5295	4790	1869	1919	0.0010965681440748	Non valid	0.042745404397080626;0.9557950660429874;0.0014595295599320547	ACTIVATION	18239058	PIK3R1	9606	NFKB1	9606	ll_coTF		NFKB
45276	PMID:19850345:pubtator_title_and_abstract:9d5d7d719ce404ab83049ae1317b7682:11:RelA:NF-kappaB:2132:2121	Furthermore, thymulin/Zn(2+) reduced, in a dose-dependent manner, the DNA-binding activity of [TG] ([TF]/p65).	RelA	NF-kappaB	5970	4790	2132	2121	0.0013372653585791	Non valid	0.8211530000794176;0.17475145479405857;0.00409554512652386	UNDEFINED	19850345	RELA	9606	NFKB1	9606	dbTF		NFKB
45417	PMID:28695925:pubtator_title_and_abstract:158971aa84938ef27bcfef060d3bbaaa:8:nuclear factor-kappaB:NF-kappaB:1176:1199	Administration with AG suppressed the activation of [TF] ([TG]) including the nuclear translocation of the p65 NF-kappaB subunit, phosphorylation and degradation of IkappaB-alpha.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1176	1199	0.0012179070224206	Non valid	0.002097980782541358;0.9965449260593564;0.0013570931581023131	ACTIVATION	28695925	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
45491	PMID:16484540:pubtator_title_and_abstract:018295e7e44b132b6be5930d2eed541b:5:NF-kappaB:NF-kappaB:1358:1332	In addition to the compound-specific inhibition of TNF-induced [TG] DNA binding and [TF] transcriptional activity, apigenin and luteolin selectively blocked Akt phosphorylation/activity.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1358	1332	0.001209318078568	Non valid	0.08831025262566965;0.9065938821294974;0.0050958652448329055	ACTIVATION	16484540	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
45537	PMID:15489888:pubtator_title_and_abstract:af73db72c37651282bf2a5aee4ed19c5:8:IkappaBalpha:NF-kappaB:1458:1487	All drugs inhibited IkappaBalpha kinase and suppressed [TF] degradation and [TG]-regulated reporter gene expression.	IkappaBalpha	NF-kappaB	4792	4790	1458	1487	0.0011125209835656	Non valid	0.021940969346223783;0.0475534957292579;0.9305055349245184	REPRESSION	15489888	NFKBIA	9606	NFKB1	9606	coTF		NFKB
45589	PMID:17970697:pubtator_title_and_abstract:1f57ef094aacb3a7990fd3f899ede36f:6:NF-kappaB:NF-kappaB:1222:1020	Although the IFN-gamma-induced expression of the IKKbeta-dependent gene ip-10 is sensitive to the superrepressor (SR) of IkappaBalpha and requires the p65 subunit of [TG], IFN-gamma does not activate NF-kappaB. In summary, a distinct subset of IFN-gamma-dependent genes requires some components of the normal pathway of NF-kappaB activation without activation of [TF] signaling by IFN-gamma.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1222	1020	0.0011494147049388	Non valid	0.04262314604081321;0.9535358733952097;0.003840980563977095	ACTIVATION	17970697	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
45739	PMID:20930376:pubtator_title_and_abstract:a7be28ceb39d93d480f81f33c0de01d0:9:NF-kappaB:NF-kappaB:1242:1295	In addition, alpha-solanine significantly decreased the nuclear level of nuclear factor kappa B ([TF]), suggesting that alpha-solanine inhibited [TG] activity.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1242	1295	0.001529421809533	Non valid	0.00610666508535699;0.987833746594757;0.006059588319886062	ACTIVATION	20930376	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
45743	PMID:19573522:pubtator_title_and_abstract:8b8971d4deb2597fce7f586b4ed52a52:9:ERK1/2:NFkappaB.:1359:1292	Analyses by an electrophoretic mobility shift and reporter gene further showed that propofol could alleviate LTA-induced transactivation of [TG] Sequentially, propofol decreased phosphorylation of IKK, [TF], MEK1/2, and Raf in LTA-stimulated macrophages.	ERK1/2	NFkappaB.	5595;5594	4790	1359	1292	0.0014435111882923	Non valid	0.13760704706815607;0.8305234676878244;0.03186948524401952	ACTIVATION	19573522	MAPK3;MAPK1	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
45766	PMID:18425350:pubtator_title_and_abstract:ed8f6d0dd5892126a977698bf449ea2e:12:p53:NF-kappaB:2250:2293	Our results suggested that the PTL-induced apoptosis of A549 cells was due to the direct suppression of NF-kappaB activity in a [TF]- and hsp72-independent manner based on [TG] signaling.	p53	NF-kappaB	7157	4790	2250	2293	0.0011021506486361	Non valid	0.3319766424845078;0.2232438841151087;0.4447794734003835	REPRESSION	18425350	TP53	9606	NFKB1	9606	dbTF		NFKB
45805	PMID:16495340:pubtator_title_and_abstract:0c107a27973627fc14a2184e35c55aec:3:Bcl10:NF-kappaB:710:676	We have previously described TCR-induced cytoplasmic structures called POLKADOTS (punctate and oligomeric killing or activating domains transducing signals) that are enriched in the [TG] signaling intermediate, [TF].	Bcl10	NF-kappaB	8915	4790	710	676	0.0011930091434263	Non valid	0.4980049107106014;0.4983709822166045;0.0036241070727941857	ACTIVATION	16495340	BCL10	9606	NFKB1	9606	coTF		NFKB
45837	PMID:37758314:pubtator_title_and_abstract:4d75128057648c1310382588c04f9478:7:JNK:NF-kappaB:1066:1047	Addition of endotoxin caused activation of the [TG] and SAPK/[TF] signaling cascades, while in the presence of PRDX6, activity of these signaling cascades decreases.	JNK	NF-kappaB	26419	18033	1066	1047	0.0011289013460561	Non valid	0.011682282571469096;0.9811019819425781;0.007215735485952782	ACTIVATION	37758314	Mapk8	10090	Nfkb1	10090	ll_coTF		NFKB
45849	PMID:22083490:pubtator_title_and_abstract:d79736bebfb74f249cdc9103354f5bb0:9:STAT3:NF-kappaB:1276:1262	Taken together, the results suggest that pyranocoumarins may exert anti-inflammatory effects in LPS-stimulated RAW 264.7 macrophages through the inhibition of [TG] and [TF] activation.	STAT3	NF-kappaB	20848	18033	1276	1262	0.0011770258389473	Non valid	0.004624876720785701;0.9917713058968862;0.003603817382328044	ACTIVATION	22083490	Stat3	10090	Nfkb1	10090	dbTF		NFKB
45911	PMID:25083991:pubtator_title_and_abstract:a7f845f2f366a2d1b8f4b522329f5743:5:DP103:NF-kappaB:719:855	Furthermore, [TF] enhanced TGF-beta-activated kinase-1 (TAK1) phosphorylation of NF-kappaB-activating IkappaB kinase 2 (IKK2), leading to increased [TG] activity.	DP103	NF-kappaB	11218	4790	719	855	0.0716998650258036	Non valid	0.00353264854001417;0.9951518402386119;0.0013155112213739748	ACTIVATION	25083991	DDX20	9606	NFKB1	9606	coTF		NFKB
45981	PMID:30291461:pubtator_title_and_abstract:94696ce8c421588a712b3f181f3f5c9e:7:NF-kappaB.:NF-kappaB:1116:1360	We found treatment of MM cells with RANKL-induced c-Src phosphorylation and activation of the downstream signaling molecules Akt, mTOR, STAT3, JNK, and [TF] In addition, treatment with dasatinib, a c-Src inhibitor, overcame RANKL- and bone marrow stromal cell-induced drug resistance to adriamycin, vincristine, dexamethasone, and melphalan by suppressing c-Src, Akt, mTOR, STAT3, JNK, and [TG] activation and enhancing expression of Bim.	NF-kappaB.	NF-kappaB	Complex:NFKB	4790	1116	1360	0.0011719154107516	Non valid	0.007461413077337773;0.9886890581257254;0.003849528796936933	ACTIVATION	30291461	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
46307	PMID:16675347:pubtator_title_and_abstract:bd72de01d531de3d4adb08a0c569cc2f:5:NF-kappaB:nuclear factor-kappaB:746:723	METHODS: We challenged CF knockout (KO) and WT mice intratracheally with P aeruginosa in suspension and evaluated bacteria counts, [TG] ([TF]), and inhibitor of NF-kappaB alpha protein (I-kappaBalpha) in lung tissue, cytokines, and PMN in bronchoalveolar lavage (BAL).	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	18033	746	723	0.0012162350557909	Non valid	0.9817984662066027;0.015445204236673265;0.00275632955672407	UNDEFINED	16675347	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
46340	PMID:14675038:pubtator_title_and_abstract:d880ae320a2a0f5ccc2171004514d482:3:JNK:nuclear factor-kappaB:424:367	Neutrophil proteinase 3 (PR3) is a caspase-like protease that enters endothelial cells, cleaves [TG] (NF-kappaB), and induces sustained [TF] activation, implying that the major cell cycle inhibitor p21 may be inactivated.	JNK	nuclear factor-kappaB	5599	4790	424	367	0.0011454317714429	Non valid	0.0038243888182224158;0.9947454475395408;0.0014301636422369157	ACTIVATION	14675038	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
46349	PMID:10801793:pubtator_title_and_abstract:23aa3b9494f7a1b23cead570b6fd0aa2:3:NF-kappaB:nuclear factor-kappaB:293:270	The O(2) and redox-sensitive transcription factors hypoxia inducible factor-1alpha (HIF-1alpha) and [TG] ([TF]) are differentially regulated in the alveolar epithelium over fetal to neonatal oxygen tensions.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	293	270	0.0011908462908892	Non valid	0.9882258404636459;0.01060197340117246;0.0011721861351817126	UNDEFINED	10801793	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
46385	PMID:24498923:pubtator_title_and_abstract:278a81f2a64b0f54e34ddba90156d079:6:Akt:nuclear factor kappaB:1357:1297	Owing to such pleiotropic actions of the KKS by local modulatory events and the probable fine-tuning of associated signalling cascades involved in skeletal muscle catabolic disorders [for example, NF-kappaB ([TG]) and PI3K (phosphoinositide 3-kinase)/[TF] pathways], we hypothesized that KKS might contribute to the modulation of intracellular responses in atrophying skeletal muscle.	Akt	nuclear factor kappaB	11651	18033	1357	1297	0.001126812454123	Non valid	0.9773718873342649;0.020632023605330476;0.0019960890604046456	UNDEFINED	24498923	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
46453	PMID:35647928:pubtator_title_and_abstract:89509efbbc78d55f11178c2d0e0728d7:7:VEGF:NF-kappabeta:1477:1244	RESULTS: It was observed that BM-MSCs therapy provided a valuable tissue repair as evidenced by a reduction in inflammatory mediators including tumor necrosis factor alpha (TNF-alpha), interleukin-1beta (IL-1beta), nuclear factor kappa (NF-kappabeta), phosphorylated [TG]-p65 (P-NF-kappabeta-p65), interferon-gamma (IFNgamma) and monocyte chemoattractant protein-1 (MCP-1) associated with decreased levels of transforming growth factor-beta (TGF-beta) and vascular endothelial growth factor ([TF]) in brain tissues of irradiated mice.	VEGF	NF-kappabeta	22339	18033	1477	1244	0.0011612608460566	Non valid	0.07518686377120953;0.8935930753752649;0.031220060853525564	ACTIVATION	35647928	Vegfa	10090	Nfkb1	10090	ll_coTF		NFKB
46496	PMID:17085450:pubtator_title_and_abstract:def8988a9b375be3b4c233e8c4146415:9:NFkappaB:NFkappaB:1415:1148	The effect on [TG] likely explains the inhibition of COX-2 as well as that of HAS1, as both are genes that depend on the activation of NFkappaB. Interestingly, AuTM does not interfere with IL-1beta-induced IkappaB alpha degradation, in most cases a prerequisite for subsequent [TF] activation.	NFkappaB	NFkappaB	Complex:NFKB	4790	1415	1148	0.0023645216869244	Non valid	0.01980169937195455;0.9739665507282704;0.006231749899774968	ACTIVATION	17085450	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
46528	PMID:25083991:pubtator_title_and_abstract:a7f845f2f366a2d1b8f4b522329f5743:6:DP103:NF-kappaB:888:980	Reduction of [TF] expression in invasive breast cancer cells reduced phosphorylation of IKK2, abrogated [TG]-mediated MMP9 expression, and impeded metastasis in a murine xenograft model.	DP103	NF-kappaB	11218	4790	888	980	0.0011855884021906	Non valid	0.0014091841617016989;0.9955841363710034;0.0030066794672949262	ACTIVATION	25083991	DDX20	9606	NFKB1	9606	coTF		NFKB
46569	PMID:21631396:pubtator_title_and_abstract:e0128121f03707939f554a8a0db024b6:0:AP-1:NF-kappaB:76:56	Pseudoephedrine inhibits T-cell activation by targeting [TG], NFAT and [TF] signaling pathways.	AP-1	NF-kappaB	3725	4790	76	56	0.0012181509519669	Non valid	0.027453636466504117;0.9680426002334646;0.004503763300031314	ACTIVATION	21631396	JUN	9606	NFKB1	9606	dbTF		NFKB
46577	PMID:15854663:pubtator_title_and_abstract:7afb1b16e78cc79992611e943b785753:15:NFkappaB:NFkappaB:1597:1575	In addition, hyperglycemia also reduces [TG] activity and [TF]-dependent cytokines production.	NFkappaB	NFkappaB	Complex:NFKB	18033	1597	1575	0.0011202332491232	Non valid	0.005016715420882398;0.993559637776942;0.0014236468021756451	ACTIVATION	15854663	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
46595	PMID:23224876:pubtator_title_and_abstract:595f4c68bc9e206e52f6e67617351229:4:cAMP response element-binding protein:NF-kappaB:541:611	Here, we reviewed our recent findings on several transcription factors including [TF] (CREB), nuclear factor kappa B ([TG]), and hypoxia-inducible factor-1 (HIF-1) in the control of the ncx1 gene expression in neuronal cells.	cAMP response element-binding protein	NF-kappaB	1385	4790	541	611	0.0011947701322154	Non valid	0.997281677075775;0.001978042719194107;0.0007402802050308844	UNDEFINED	23224876	CREB1	9606	NFKB1	9606	dbTF		NFKB
46656	PMID:17495961:pubtator_title_and_abstract:59c11a135b7c8df8d020ec422536e4b2:6:MSK1:NF-kappaB:1029:966	In addition, DMF decreased phosphorylation of [TG]/p65 (Ser276), which is known to be transactivated by [TF].	MSK1	NF-kappaB	9252	4790	1029	966	0.0024529906678072	Non valid	0.0023678263808250676;0.9967701656153034;0.0008620080038715818	ACTIVATION	17495961	RPS6KA5	9606	NFKB1	9606	coTF		NFKB
46659	PMID:23560633:pubtator_title_and_abstract:96dac5f8945042e8542376c41fb21bcd:7:activator protein-1:nuclear factor kappa B:1065:1026	Repeated low-dose irradiation reduced OVA-specific IgE levels, the number of inflammatory cells including mast cells, goblet cell hyperplasia, collagen deposition, airway hyperresponsiveness, expression of inflammatory cytokines, CCL2/CCR2, as well as [TG] (NF-kappaB) and [TF] activities.	activator protein-1	nuclear factor kappa B	16476	18033	1065	1026	0.0011004542103511	Non valid	0.019762593537332836;0.9597401429602888;0.020497263502378505	ACTIVATION	23560633	Jun	10090	Nfkb1	10090	dbTF		NFKB
46680	PMID:1427600:pubtator_title_and_abstract:af113ef414f3945a1fcce5dac72dea65:9:p65:NF-kappa B:1434:1418	These results indicate that there is a synergistic effect between NF-IL6 and [TG] (p50/[TF]) in IL-6 gene regulation.	p65	NF-kappa B	5970	4790	1434	1418	0.00113885489788	Non valid	0.9964384223991153;0.003021843063690547;0.0005397345371942739	UNDEFINED	1427600	RELA	9606	NFKB1	9606	dbTF		NFKB
46707	PMID:24320144:pubtator_title_and_abstract:88728c6807350e35b0a1d8cc0a35b42d:9:nuclear factor-kappa B:NF-kappaB:947:971	The results indicated that the [TF] ([TG])-binding site proximal to the translation initiation site was indispensable for dsRNA-stimulated hBD-2 expression, but not in the case of FW.	nuclear factor-kappa B	NF-kappaB	Complex:NFKB	4790	947	971	0.0012231819357956	Non valid	0.033264771743300656;0.9636783551205246;0.003056873136174737	ACTIVATION	24320144	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
46832	PMID:34008261:pubtator_title_and_abstract:f08898b44fa1ecff747b1aab509085e2:8:p38:NF-kappaB:1265:1279	Adv-Mfn2 treatment not only increased the expression of Mfn-2 but also reduced the levels of phosphorylated ERK1/2, [TF], JNK, and [TG], followed by a decrease in the concentrations of IL-6, TNF-alpha, PAI-1, and MMP-9 in the supernatant.	p38	NF-kappaB	26416	18033	1265	1279	0.0011220167911183	Non valid	0.25626041444687664;0.6849379506010861;0.05880163495203726	ACTIVATION	34008261	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
46837	PMID:19552846:pubtator_title_and_abstract:072d9d3099cc5cca127e89cf0981de4d:10:ERK:NF-kappaB:1986:2061	The [TF] activation and nuclear translocation of transcription factors SP-1 and [TG] induced by TNF-alpha were abolished or markedly inhibited by alpha-ZAL pretreatment.	ERK	NF-kappaB	5594	4790	1986	2061	0.0013197861556399	Non valid	0.008543970160048155;0.9905271288214489;0.0009289010185029373	ACTIVATION	19552846	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
47161	PMID:29432919:pubtator_title_and_abstract:fdda0b1663dccac0c7d2f96532d236d4:9:YAP1:NF-kappaB:1317:1421	Mechanistically, the interaction of [TF]/TEADs with AP-1 and cooperation on downstream gene transcription were confirmed, and RANKL-induced [TG] signaling was also impaired in the YAP1-inhibited condition.	YAP1	NF-kappaB	10413	4790	1317	1421	0.0019322222519939	Non valid	0.1923868822333883;0.799182447532;0.0084306702346118	ACTIVATION	29432919	YAP1	9606	NFKB1	9606	coTF		NFKB
47190	PMID:24211200:pubtator_title_and_abstract:aee4c17d27a14911bf0bd11e104479a7:10:NF-kappaB:NF-kappaB:1083:1144	Mechanically, Sirt2 deacetylated p65 subunit of nuclear factor-kappa B ([TF]) at lysine 310, resulting in reduced expression of [TG]-dependent genes, including interleukin 1beta (IL-1beta), IL-6, monocyte chemoattractant protein 1(MCP-1), RANTES, matrix metalloproteinase 9 (MMP-9) and MMP-13.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1083	1144	0.0010871520568425	Non valid	0.0037850531857967985;0.9937227748429822;0.0024921719712210156	ACTIVATION	24211200	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
47210	PMID:17638883:pubtator_title_and_abstract:179e4c0e9a744151ab5265161ef42533:6:nuclear factor-kappaB:NF-kappaB:835:858	Both BEX1 and NGFRAP1 interact with p75NTR and modulate nerve growth factor (NGF) signaling through [TF] ([TG]) to regulate cell cycle, apoptosis, and differentiation in neural tissues.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	835	858	0.0011218666294178	Non valid	0.9952465498950961;0.003543175172129831;0.0012102749327740367	UNDEFINED	17638883	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
47218	PMID:29795356:pubtator_title_and_abstract:44aa72d737007cdca4ff5284097d92ff:7:GSK3beta:NF-kappaB:1084:1120	Furthermore, AS-IV administration significantly reduced the levels of TNF-alpha and IL-1beta, increased PPARgamma expression and [TF] phosphorylation, decreased [TG] phosphorylation, and reduced NOD-, LRR- and pyrin domain-containingprotein 3 (NLRP3) inflammasome and caspase-1 p20 generation in the hippocampus of the mice.	GSK3beta	NF-kappaB	56637	18033	1084	1120	0.001269983338842	Non valid	0.07724274926410367;0.5227391445685982;0.4000181061672981	ACTIVATION	29795356	Gsk3b	10090	Nfkb1	10090	ll_coTF		NFKB
47229	PMID:11733000:pubtator_title_and_abstract:487e3ae6409ac95c29f2b470595ac033:2:NF-kappaB:NF-kappaB:190:312	The decoy approach against nuclear factor kappaB ([TF]) is a useful tool to alter NF-kappaB dependent gene expression using synthetic oligonucleotides (ODNs) carrying [TG] specific cis-elements.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	190	312	0.0011056595846771	Non valid	0.9725646900799171;0.024031153438483884;0.0034041564815989905	UNDEFINED	11733000	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
47260	PMID:34894936:pubtator_title_and_abstract:c4f42e5f747f622ae7b5da51d749cfaa:10:androgen receptor:NF-kappaB:1529:1671	However, the detailed molecular mechanism of their role in spermatogenesis still needs to be further studied.Abbreviations: AR: androgen receptor; Pebp1: phosphatidyl ethanolamine binding protein 1; ARKO: androgen receptor knockout; WT: wild type; SCARKO: Sertoli cell-selective [TF] knockout; ChIP: chromatin immunoprecipitation; RKIP: Raf kinase inhibitory protein; MAPK: mitogen-activated protein kinase; [TG]: nuclear factor kappa-light-chain-enhancer of activated B cells; GSK-3: glycogen synthase kinase-3; RT-PCR: reverse transcriptase polymerase chain reaction; SEM: standard error of the mean.	androgen receptor	NF-kappaB	11835	18033	1529	1671	0.0011754312021252	Non valid	0.19514252461756237;0.7186880418078603;0.0861694335745773	ACTIVATION	34894936	Ar	10090	Nfkb1	10090	dbTF		NFKB
47302	PMID:20225658:pubtator_title_and_abstract:3bd9d25eb61e8f1199312439bfec2219:3:NF-kappaB:nuclear factor-kappaB:517:494	The aim of the present study was to investigate the effect of antioxidants genistein and puerarin on the activation of [TG] ([TF]) and the production of tumor necrosis factor-alpha (TNF-alpha) in peripheral blood mononuclear cells (PBMCs) in asthma patients.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	517	494	0.001177470469926	Non valid	0.16546654610970554;0.8279988458581125;0.006534608032182003	ACTIVATION	20225658	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
47387	PMID:16288051:pubtator_title_and_abstract:f4040ca4abe57b1b8cb651044185e6ca:7:NFkappaB:NFkappaB:1097:963	The constitutive expressions of [TG] p50, c-rel, p65, and C/EBPalpha and beta, as well as the lipopolysaccharide-induced nuclear translocation and DNA binding of [TF] components and C/EBPalpha and beta, are profoundly impaired in macrophages from mice bearing D1-DMBA-3 tumors.	NFkappaB	NFkappaB	Complex:NFKB	18033	1097	963	0.0011588113088013	Non valid	0.67863412777429;0.3173698607651585;0.003996011460551475	UNDEFINED	16288051	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
47446	PMID:26859114:pubtator_title_and_abstract:2058ba85b34b8c5619674ca48300816b:7:Akt:NF-kappaB.:1169:1127	Furthermore, Icariside II suppressed TNF-alpha-triggered nuclear translocation of NF-kappaB and phosphorylation of IkappaBalpha, and repressed the DNA-binding activity of [TG] Further data demonstrated that [TF]/GSK-3beta, other than MAPK signaling pathway was taking a part in the inhibitory potential of Icariside II on NF-kappaB activation.	Akt	NF-kappaB.	207	4790	1169	1127	0.0011942419044118	Non valid	0.30259918795788177;0.6062320724830694;0.0911687395590488	ACTIVATION	26859114	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
47454	PMID:30423555:pubtator_title_and_abstract:88033c121aabed32b00e3643ff613683:10:IkappaB-alpha:NFkappaB:1544:1534	RESULTS: Our study documented an increase in the expression of the major components of the NFkappaB complex ([TG], [TF], and IkappaB-beta) following injury.	IkappaB-alpha	NFkappaB	4792	4790	1544	1534	0.0012104742748197	Non valid	0.117049700970445;0.8788664431332563;0.00408385589629871	ACTIVATION	30423555	NFKBIA	9606	NFKB1	9606	coTF		NFKB
47497	PMID:20430889:pubtator_title_and_abstract:262c3747eedb442a5aa1d34107afe0de:7:IkappaB kinase beta:NF-kappaB:1423:1352	Conversely, Muc1 overexpression was correlated with decreased [TG] activation, reduced interleulin-8 production, and diminished [TF] (IKKbeta)/IKKgamma coimmunoprecipitation compared with cells expressing Muc1 endogenously.	IkappaB kinase beta	NF-kappaB	3551	4790	1423	1352	0.0010827666030541	Non valid	0.04969714951801789;0.9354913092921204;0.014811541189861598	ACTIVATION	20430889	IKBKB	9606	NFKB1	9606	coTF		NFKB
47608	PMID:23869088:pubtator_title_and_abstract:5a32351959ad5bdbf17eb135342e6dd3:0:IkappaB-zeta:NF-kappaB:0:39	[TF] controls the constitutive [TG] target gene network and survival of ABC DLBCL.	IkappaB-zeta	NF-kappaB	64332	4790	0	39	0.0023414314294803	Non valid	0.9938938613239308;0.005095833443430352;0.00101030523263884	UNDEFINED	23869088	NFKBIZ	9606	NFKB1	9606	coTF		NFKB
47609	PMID:34482064:pubtator_title_and_abstract:68390a49cd6bb7459a214f8d434a3638:0:Nrf2:NF-kappaB:148:94	Betulinic acid attenuates cyclophosphamide-induced intestinal mucosa injury by inhibiting the [TG]/MAPK signalling pathways and activating the [TF] signalling pathway.	Nrf2	NF-kappaB	18024	18033	148	94	0.0011499685875788	Non valid	0.11417414777024532;0.07215579510196093;0.8136700571277937	REPRESSION	34482064	Nfe2l2	10090	Nfkb1	10090	dbTF		NFKB
47641	PMID:36977287:pubtator_title_and_abstract:3804e5a14e4f2aafc1ecc14fdb33f098:11:PGC1alpha:NF-kappaB:1275:1509	Chrysin administration elevated discrimination ratio in object recognition, Y Maze percentage alternation, locomotor activity and brain contents of AMPK, LKB1, [TF], NAD (P)H quinone oxidoreductase 1 (NQO1), Heme oxygenase 1 (HO-1), nerve growth factor (neurotrophin-3; NT-3), seretonin as well as reduced brain contents of tumor necrosis factor-alpha (TNF-alpha), nuclear factor kabba B ([TG]), advanced glycation endproducts (AGEs) and glial fibrillary acidic protein (GFAP) compared to D-gal-treated mice.	PGC1alpha	NF-kappaB	19017	18033	1275	1509	0.0011652135657632	Non valid	0.37427499479786613;0.24590688988325152;0.3798181153188824	REPRESSION	36977287	Ppargc1a	10090	Nfkb1	10090	coTF		NFKB
47684	PMID:27720842:pubtator_title_and_abstract:94b923b1ddc5fb25392288963962c7aa:4:NF-kappaB:NF-kappaB:313:540	Here, we show that the [TF]-activating signaling adapter myeloid differentiation primary response gene 88 (MyD88) is highly sensitive to oxidation by H2O2 and may be redox-regulated in its function, thus facilitating an influence of H2O2 on the [TG] signaling pathway.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	313	540	0.0017256110978489	Non valid	0.40382955424888456;0.5926261744609574;0.003544271290158	ACTIVATION	27720842	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
47699	PMID:21716324:pubtator_title_and_abstract:a068dbb28c76319143950f5a7fc19042:7:RelA:NF-kappaB:1011:1315	The dsRNA-induced gene expression of TSLP depended on [TF], a component of NF-kappaB, but not IRF3, similar to IL-8 but different from IFN-beta, which depended on both IRF3 and RelA. The results indicate that endosomal acidification and the subsequent activation of NF-kappaB are necessary to sense extracellular dsRNA, suggesting the importance of the TLR3-[TG] axis to trigger production of TSLP against the self dsRNA released from damaged cells or viral dsRNA, in the epidermis, relating to skin inflammation including atopic dermatitis (AD).	RelA	NF-kappaB	5970	4790	1011	1315	0.0011346253003414	Non valid	0.006219662831413956;0.9930145688122463;0.0007657683563398896	ACTIVATION	21716324	RELA	9606	NFKB1	9606	dbTF		NFKB
47708	PMID:32193100:pubtator_title_and_abstract:9b6b57a4b41e931761cc9ae7a19a6b66:9:RelA:NF-kappaB:1635:1689	In addition, Sirt1 activators significantly inhibited the phosphorylated and acetylated levels of the [TF]/p65 subunit of the nuclear transcription factor ([TG]) but not the interferon regulatory factor (IRF) 3 in poly I:C-injured mice livers.	RelA	NF-kappaB	19697	18033	1635	1689	0.0012308499995265	Non valid	0.9155296475360981;0.06244843007797;0.02202192238593199	UNDEFINED	32193100	Rela	10090	Nfkb1	10090	dbTF		NFKB
47833	PMID:21854107:pubtator_title_and_abstract:c46f2150ac834079526ad294e0a79e5d:7:p65:nuclear factor-kappaB:989:851	Particularly, EAPS suppressed the level of [TG] (NF-kappaB) activity, which was linked with the suppression of LPS-induced phosphorylation of p65 at serine 276 and [TF] translocation into nuclei, but not MAPK signaling.	p65	nuclear factor-kappaB	19697	18033	989	851	0.001139042865326	Non valid	0.008240350441008883;0.9894855837995139;0.0022740657594771583	ACTIVATION	21854107	Rela	10090	Nfkb1	10090	dbTF		NFKB
47841	PMID:25350220:pubtator_title_and_abstract:4edf31c551888bbd1c790af084283cc7:3:p38:nuclear factor-kappa B:422:351	Transforming growth factor-activated kinase-1 (TAK1) mediates the activation of [TG] (NF-kappaB), c-Jun N-terminal kinase (JNK), and [TF] pathways in response to TNF-alpha.	p38	nuclear factor-kappa B	5594	4790	422	351	0.0011549391394315	Non valid	0.0067113636424089625;0.991490276462131;0.001798359895460136	ACTIVATION	25350220	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
47890	PMID:19528508:pubtator_title_and_abstract:7fb86d526eae33bbeaacdc80f1eccdda:5:nuclear factor kappa-B:NF-kappaB:903:927	We also investigated tThe inhibitory effects of these compounds on lipopolysaccharide (LPS)-stimulated cyclooxygenase-2 (COX-2) mRNA and protein expression and on binding of activator-protein-1 (AP-1) and [TF] ([TG]) to their respective consensus sequences were also investigated in RAW 264.7 cells.	nuclear factor kappa-B	NF-kappaB	Complex:NFKB	18033	903	927	0.0012725524255907	Non valid	0.9964619033979726;0.002670642552974477;0.0008674540490528963	UNDEFINED	19528508	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
47898	PMID:12116367:pubtator_title_and_abstract:4126c332ff82e15e95708c7aa11e0649:4:NF-kappaB:NF-kappaB:553:610	Stimulation of cells by various reagents such as bacterial endotoxin or cytokines leads to a dissociation of [TF] from IkappaB and a rapid translocation of free [TG] to the nucleus.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	553	610	0.0011119522799126	Non valid	0.893382457098938;0.05479038600328613;0.05182715689777588	UNDEFINED	12116367	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
48085	PMID:22562244:pubtator_title_and_abstract:23f65b47f4c8bf33792229f5ebe26ade:6:STAT3:NF-kappaB:888:863	TROP2 upregulation was shown to subsequently drive the expression and activation of CREB1 (cyclic AMP-responsive-element binding protein), Jun, [TG], Rb, STAT1 and [TF] through induction of the cyclin D1 and ERK (extracellular signal regulated kinase)/MEK (MAPK/ERK kinase) pathways.	STAT3	NF-kappaB	6774	4790	888	863	0.0011987962367084	Non valid	0.0030373310445749803;0.9957820779883224;0.001180590967102631	ACTIVATION	22562244	STAT3	9606	NFKB1	9606	dbTF		NFKB
48216	PMID:17911169:pubtator_title_and_abstract:8cea926b7ddd5b96bfaaaf01eda609ee:6:NF-kappaB:NF-kappaB:1152:1292	We also observed that acini expressing elevated levels of Pak1 can activate p65 and survive death treatments, even in the absence of activated Rac, yet will die if activation of [TF] is simultaneously inhibited through expression of IkappaBalphaM. Thus, mammary tissues can resist apoptotic stimuli by activating [TG] through alpha6beta4 integrin-dependent Rac-Pak1 signaling.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1152	1292	0.0014487060322645	Non valid	0.03354934462168435;0.4595986469715917;0.506852008406724	REPRESSION	17911169	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
48380	PMID:10636889:pubtator_title_and_abstract:ea37dff837df5f5747da5e79b7e99a3e:7:NF-kappaB:NF-kappaB:1722:1913	Moreover, cadmium- and ROS-associated mdr1 up-regulation was linked to activation of the transcription factor [TF]; N-acetylcysteine, pyrrolidine dithiocarbamate, and the IkappaB-alpha kinase inhibitor Bay 11-7082 (20 microM) prevented both, mdr1 overexpression and degradation of the inhibitory [TG] subunit, IkappaB-alpha, induced by cadmium.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1722	1913	0.0011658472357291	Non valid	0.07783491245886312;0.212761293292413;0.7094037942487238	REPRESSION	10636889	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
48395	PMID:21551466:pubtator_title_and_abstract:0991a8bcbbd10e7612cfa8b1ca5d59a0:8:RelB.:NF-kappaB:1194:1347	Furthermore, expression of c-Rel correlated positively with the MIB-1 LI in retinoblastoma, and RelA/c-Rel revealed positive correlation with RelA/[TF] CONCLUSIONS: This study demonstrated that expression of RelA and c-Rel proteins represents a reliable prognostic marker of retinoblastoma and that [TG] is related to retinoblastoma tumorigenesis and progression through a non-conventional pathway.	RelB.	NF-kappaB	5971	4790	1194	1347	0.001367923284791	Non valid	0.02651470352814242;0.9716956699259238;0.0017896265459337013	ACTIVATION	21551466	RELB	9606	NFKB1	9606	dbTF		NFKB
48490	PMID:12527815:pubtator_title_and_abstract:2ff66c50c8bc085b04c9718dd6de8efc:3:NF-kappaB:NF-kappaB.:902:524	Because of the central role of nuclear factor-kappaB (NF-kappaB) in the inflammatory process and the immune response, we postulated that AEA might owe some of its effects to the suppression of [TG] This study shows that AEA inhibits tumor necrosis factor-alpha (TNFalpha)-induced NF-kappaB activation by direct inhibition of the IkappaB kinase (IKK)beta and, to a lesser extent, the IKKalpha subunits of kappaB inhibitor (IkappaB) kinase complex, and that IKKs inhibition by AEA correlates with inhibition of IkappaBalpha degradation, NF-kappaB binding to DNA, and [TF]-dependent transcription in TNFalpha-stimulated cells.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	902	524	0.0011035179846601	Non valid	0.005128513896946476;0.993449514359382;0.0014219717436715655	ACTIVATION	12527815	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
48520	PMID:33424246:pubtator_title_and_abstract:e53e1c317b5149207bba43a8484e9cbd:15:glucocorticoid receptor:NFkappab:2108:2095	Molecular docking showed hydrogen bonding interactions (binding energies: -11.3 to -7.8 kcal/mol) with arachidonate 5 lipoxygenase, [TG] and [TF].	glucocorticoid receptor	NFkappab	2908	4790	2108	2095	0.0012532618956761	Non valid	0.9965273914060924;0.002227961759914221;0.0012446468339934588	UNDEFINED	33424246	NR3C1	9606	NFKB1	9606	dbTF		NFKB
48543	PMID:31830547:pubtator_title_and_abstract:3945b8b2f6a4fe649a000773d248c1a1:7:NF-kappaB:nuclear factor-kappaB:1008:985	HsA reduced the phosphorylation of IKKepsilon and the transactivation of [TG] ([TF]).	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	1008	985	0.0013596953808947	Non valid	0.0039916287272618;0.9868045268412907;0.009203844431447483	ACTIVATION	31830547	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
48720	PMID:29925918:pubtator_title_and_abstract:88b81cc99af2f6403a9fae8a2fff5673:8:NF-kappaB:NF-kappaB:1117:1104	CoCl2-activated HIF1alpha expression could slightly rescue the GLUT1 expression inhibited by aspirin or PDTC, suggesting that aspirin depressed GLUT1 through targeting [TG] or [TF]/HIF1alpha signaling.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1117	1104	0.0011064698482636	Non valid	0.03491507054620602;0.9491168064688033;0.01596812298499082	ACTIVATION	29925918	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
48728	PMID:16702955:pubtator_title_and_abstract:b19cd729d6d76b1090f9321526669913:2:AP-1:NF-kappaB:375:339	The tumor necrosis factor receptor (TNFR)-associated factor (TRAF) family of six adaptor proteins (TRAF1-6) links the TNFR superfamily to the nuclear factor kappa B ([TG]) and activator protein-1 ([TF]) transcriptional activators.	AP-1	NF-kappaB	16476	18033	375	339	0.0011443016580285	Non valid	0.0713212510048972;0.9265041427665291;0.0021746062285736122	ACTIVATION	16702955	Jun	10090	Nfkb1	10090	dbTF		NFKB
48816	PMID:16044419:pubtator_title_and_abstract:57f71e1d14bac2891b9d35eb6df49f9e:10:NF-kappaB:NF-kappaB:1516:1682	These results suggest that [TF] may contribute to the resistance of human cervical cancer cells to cisplatin and highlight the potential use of combination therapy involving cisplatin and [TG] inhibitors.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1516	1682	0.0013681760452505	Non valid	0.47767429599744493;0.06747157587169803;0.454854128130857	UNDEFINED	16044419	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
48819	PMID:9442376:pubtator_title_and_abstract:9de399b5b7c857deb5420c31bfbf900f:9:p38:NF-kappa B:1009:1056	Here, we will review very recent data demonstrating that both the JNK and the [TF] pathways are involved in the activation of [TG] in the cytoplasm as well as in modulation of its transactivating potential in the nucleus.	p38	NF-kappa B	1432	4790	1009	1056	0.0638103687265242	Non valid	0.006756095259033346;0.992405709573847;0.0008381951671196105	ACTIVATION	9442376	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
49072	PMID:19552846:pubtator_title_and_abstract:072d9d3099cc5cca127e89cf0981de4d:6:activator protein (AP)-1:NF-kappaB:1357:1313	The activation of extracellular signal-regulated kinase (ERK) and nuclear translocation of nuclear factor-kappaB ([TG]), stimulatory protein (SP)-1, and [TF] were assessed with Western blotting.	activator protein (AP)-1	NF-kappaB	3726	4790	1357	1313	0.0012503130332139	Non valid	0.031395953532589775;0.9664099904374259;0.002194056029984252	ACTIVATION	19552846	JUNB	9606	NFKB1	9606	dbTF		NFKB
49106	PMID:14572449:pubtator_title_and_abstract:82d2dc4b6743d39a528bc942b2af5479:6:NF-kappaB:nuclear factor kappa B:1159:1135	Expression of molecules involved in ICAM-1 activation and cytokine signaling were increased in tubers, including tumor necrosis factor alpha (TNF-alpha), mitogen activated protein kinase (MAPK), and [TG] ([TF]).	NF-kappaB	nuclear factor kappa B	Complex:NFKB	18033	1159	1135	0.0013406638350445	Non valid	0.012548080465262262;0.9852457998072832;0.002206119727454431	ACTIVATION	14572449	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
49116	PMID:34232730:pubtator_title_and_abstract:6ffae06495a958ba15652b2062809aae:6:NF-kappaB:NF-kappaB:1147:1260	Inhibition of HIV-1 gp120-induced upregulation of mitogen-activated protein kinase (MAPK) and [TF] signaling in tonsil epithelial cells, reduces HCMV infection, indicating that HIV-1-activated MAPK and [TG] signaling may play a critical role in HCMV infection of tonsil epithelium.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1147	1260	0.0013057114481005	Non valid	0.008249002128572738;0.9885626235647709;0.0031883743066564484	ACTIVATION	34232730	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
49118	PMID:19710092:pubtator_title_and_abstract:1ac6a761e42a2360e0e5f679b6af3945:5:NF-kappaB:Nuclear factor-kappaB:564:541	[TG] ([TF]) activity, expression of adhesion molecules, and cytokine secretion were quantified.	NF-kappaB	Nuclear factor-kappaB	Complex:NFKB	4790	564	541	0.001177285420264	Non valid	0.20483747610769748;0.7842906586513626;0.010871865240939882	ACTIVATION	19710092	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
49189	PMID:10229820:pubtator_title_and_abstract:442d6d1dde1be75c00bb600d8ea89832:9:p65:NF-kappaB:1307:1241	This [TG] binding complex is composed of transcriptionally active [TF](RelA)/p50 heterodimers and results primarily from the targeted degradation of IkappaB-alpha, an inhibitor that sequesters Rel/kappaB in the cytoplasm.	p65	NF-kappaB	5970	4790	1307	1241	0.0011859190580441	Non valid	0.18073526656122213;0.8174272561195709;0.0018374773192070658	ACTIVATION	10229820	RELA	9606	NFKB1	9606	dbTF		NFKB
49210	PMID:8796372:pubtator_title_and_abstract:7e28141d6c614604b33eb78d14d68c85:4:NF kappa B:NF kappa B:696:550	The age-related decline in induction of [TG] could not be attributed to alteration in the composition of subunits, p50 and p65 were found to be the predominant subunits of induced [TF] in T cells from young as well as elderly donors.	NF kappa B	NF kappa B	Complex:NFKB	4790	696	550	0.0014261849232889	Non valid	0.0051481921958569385;0.9924052652511026;0.002446542553040377	ACTIVATION	8796372	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
49238	PMID:11380692:pubtator_title_and_abstract:e9c2f9f9e055c1cba4471c89d7462341:2:nuclear factor kappaB:NFkappaB:403:426	Synthetic lipopeptides based on bacterial lipoprotein are efficient activators for monocytes/macrophages inducing the release of interleukin (IL)-1, IL-6, tumour necrosis factor-alpha (TNF-alpha), reactive oxygen/nitrogen intermediates, and the translocation of [TF] ([TG]).	nuclear factor kappaB	NFkappaB	Complex:NFKB	18033	403	426	0.0011398493340532	Non valid	0.27972478176149523;0.7178894661059221;0.002385752132582562	ACTIVATION	11380692	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
49320	PMID:30839135:pubtator_title_and_abstract:53e59e6dc68b64aa351eddc461e0b44a:0:STAT-6:NF-kappaB:95:81	TNF-alpha mediated MEK-ERK signaling in invasion with putative network involving [TG] and [TF]: a new perspective in glioma.	STAT-6	NF-kappaB	6778	4790	95	81	0.001231790611256	Non valid	0.9084010125811212;0.08940994055951186;0.002189046859366891	UNDEFINED	30839135	STAT6	9606	NFKB1	9606	dbTF		NFKB
49398	PMID:20427526:pubtator_title_and_abstract:a19c9528b2aaf54487edb40fb346ca92:4:IRF-3:NF-kappaB.:681:691	We show that MHV infection activated both transcription factors, the IFN regulatory factor 3 (IRF-3) and nuclear factor kappaB (NF-kappaB), as evidenced by phosphorylation and nuclear translocation of IRF-3 and an increased promoter binding activity for [TF] and [TG] Furthermore, the cytoplasmic pattern recognition receptor retinoic acid-inducible gene I (RIG-I) was induced by MHV infection.	IRF-3	NF-kappaB.	54131	18033	681	691	0.0011101453244124	Non valid	0.9638570677832123;0.03505389455267231;0.0010890376641152946	UNDEFINED	20427526	Irf3	10090	Nfkb1	10090	dbTF		NFKB
49436	PMID:8063696:pubtator_title_and_abstract:3534aac62171e0fac3226e0f8fe5ea31:3:p65:NF-kappa B:388:488	In this study, we examined the binding of c-Rel-[TF] heterodimers to non-consensus kappa B-like sites from several genes that do not bind prototypic [TG](p50-p65).	p65	NF-kappa B	5970	4790	388	488	0.0011870017458235	Non valid	0.9970452701603539;0.0020956935475534653;0.0008590362920926789	UNDEFINED	8063696	RELA	9606	NFKB1	9606	dbTF		NFKB
49459	PMID:20651334:pubtator_title_and_abstract:8f78f72c7bc1665c177ee6b017c88013:6:NF-kappaB:NF-kappaB:870:749	The results proposed alpha terpineol as an NF-kappaB inhibitor, which was confirmed by the observed dose-dependent inhibition of [TG] translocation and activity using two NF-kappaB assays, and by the down-regulation of the expression of several [TF]-related genes such as IL-1 beta and IL1R1.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	870	749	0.0010898270875997	Non valid	0.03644978412050391;0.9346458743642246;0.028904341515271534	ACTIVATION	20651334	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
49493	PMID:30106136:pubtator_title_and_abstract:ad95b799a3268d9cf5def6a0ba82c7d6:12:ZBTB7:NF-kappaB:1462:1514	Collectively, the findings demonstrated that [TF] mediated 5-FU resistance in CRC cells through [TG] signaling.	ZBTB7	NF-kappaB	51341	4790	1462	1514	0.0016839162243681	Non valid	0.8217117749037388;0.12736620819619657;0.05092201690006451	UNDEFINED	30106136	ZBTB7A	9606	NFKB1	9606	dbTF		NFKB
49610	PMID:32474900:pubtator_title_and_abstract:1f2e2e52b35136de6336999cde2e370b:0:NOD:NF-kappaB:88:97	Inhibition of IL-32 Expression Ameliorates Cerebral Ischemia-Reperfusion Injury via the [TF]/MAPK/[TG] Signaling Pathway.	NOD	NF-kappaB	1822	4790	88	97	0.0010952613168029	Non valid	0.39312556241918634;0.3527315924724583;0.2541428451083554	UNDEFINED	32474900	ATN1	9606	NFKB1	9606	coTF		NFKB
49614	PMID:29117513:pubtator_title_and_abstract:9bbc9cb3af96a72dc0e50073733645b6:5:CREB:NF-kappaB:830:904	This review discusses potential mechanisms of flavonoid action in the brain, with a focus on two critical transcription factors: cAMP response element-binding protein ([TF]) and nuclear factor kappa-light-chain-enhancer of activated B cells ([TG]).	CREB	NF-kappaB	1385	4790	830	904	0.0011457815279694	Non valid	0.9759051330602733;0.022796827570171044;0.001298039369555732	UNDEFINED	29117513	CREB1	9606	NFKB1	9606	dbTF		NFKB
49615	PMID:26171782:pubtator_title_and_abstract:1feb0394a576ccb467acb3eccb814cf3:8:extracellular signal-regulated kinase:nuclear factor (NF)-kappaB:1167:1057	We studied the inhibitory effects of saxifragin on the nuclear translocation of [TG], activation of caspase-1, and phosphorylation of c-Jun N-terminal kinase (JNK) and [TF] (ERK).	extracellular signal-regulated kinase	nuclear factor (NF)-kappaB	26413	18033	1167	1057	0.0011073780160171	Non valid	0.4166052916968528;0.5729879561619087;0.010406752141238576	ACTIVATION	26171782	Mapk1	10090	Nfkb1	10090	ll_coTF		NFKB
49838	PMID:23199342:pubtator_title_and_abstract:2b27c923f6b609c582b501c77c666d70:9:p38:NF-kappaB:1507:1555	Resveratrol and Ad-SIRT1 inhibited nicotine and LPS-mediated protein kinase C (PKC), phosphatidylinositol 3-kinase (PI3K), [TF], ERK, JNK, MAPK and nuclear factor-kappa B ([TG]) activation.	p38	NF-kappaB	1432	4790	1507	1555	0.0011729241564464	Non valid	0.0027339859178463414;0.9947372309117261;0.0025287831704276374	ACTIVATION	23199342	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
49855	PMID:24748189:pubtator_title_and_abstract:07508801fef39a0561b6a603601ec965:5:IkappaBalpha:NF-kappaB:774:734	The mRNA expressions of p38, nuclear factor kappaB ([TG]) p65, inhibitory kappaBalpha ([TF]) and MUC5AC were detected by real-time PCR.	IkappaBalpha	NF-kappaB	4792	4790	774	734	0.0012235064564423	Non valid	0.8841189714573425;0.03818040336047977;0.07770062518217771	UNDEFINED	24748189	NFKBIA	9606	NFKB1	9606	coTF		NFKB
49992	PMID:30324762:pubtator_title_and_abstract:0c56ff1e1f83fd7d04bf2422d04cf5ce:14:Akt:NF-kappaB:2014:1999	AS-6 protected against microglial-mediated neurotoxicity in SH-SY5Y and BV2 cocultured cells from LPS-induced neuroinflammation and death via inhibiting MAPK, [TG], and [TF] pathways.	Akt	NF-kappaB	207	4790	2014	1999	0.001146277972442	Non valid	0.034997787613669756;0.9069306401123156;0.05807157227401474	ACTIVATION	30324762	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
50170	PMID:25872797:pubtator_title_and_abstract:a140185da4af7f9e4547d30a83ee4c06:11:IkappaBalpha:NF-kappaB:1576:1589	In addition, H2S inhibited the activation of the extracellular signal-regulated kinase (ERK)/[TF]/[TG] pathway which was induced by IL-1beta.	IkappaBalpha	NF-kappaB	4792	4790	1576	1589	0.0011562595391287	Non valid	0.0026260359951290006;0.994800680161681;0.002573283843189865	ACTIVATION	25872797	NFKBIA	9606	NFKB1	9606	coTF		NFKB
50177	PMID:26524020:pubtator_title_and_abstract:dc0070636d5e1147bd773ec163be8cd4:2:BCL-2:NF-kappaB:378:385	OBJECTIVE: To investigate the effect of Emodin combined with 3'-azido-3'-deoxythymidine (AZT) on the proliferation and apoptosis of concentrated leukemia stem cells (CLSC)-human acute myeloid leukemia KG-la cells and expression of [TF], [TG] and TGF-beta.	BCL-2	NF-kappaB	596	4790	378	385	0.0012014231719777	Non valid	0.9948720871254494;0.0038056430016002573;0.0013222698729502737	UNDEFINED	26524020	BCL2	9606	NFKB1	9606	coTF		NFKB
50232	PMID:12676746:pubtator_title_and_abstract:bf286d2cd28478a74dd2f0aee524d3c3:6:NF-kappaB:NF-kappaB:1186:979	[TG] DNA binding activity was determined by electrophoretic mobility shift assay and by transfecting myocytes with a luciferase reporter plasmid containing a promoter construct with multiple repeats of [TF] binding site.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1186	979	0.0011720513300803	Non valid	0.9963767563352747;0.003015338827761107;0.0006079048369642572	UNDEFINED	12676746	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
50274	PMID:22451523:pubtator_title_and_abstract:fb1e69ad558d678636690f7b49b43551:6:IkappaBalpha:NF-kappaB:984:932	NleH1, but not NleH2, inhibited [TG] activity without altering the kinetics of [TF] phosphorylation/degradation.	IkappaBalpha	NF-kappaB	4792	4790	984	932	0.0012068241932612	Non valid	0.3557276477730998;0.21668895288677445;0.4275833993401258	REPRESSION	22451523	NFKBIA	9606	NFKB1	9606	coTF		NFKB
50290	PMID:21332403:pubtator_title_and_abstract:2d78f120dd6a3fb0a369e14c7815bc7c:4:p53:NF-kappaB:563:732	In order to understand the mechanism by which GA induces apoptosis, we examined the gene expression of [TF], nuclear factor kappaB (NF-kappaB), and inhibitor of NF-kappaB (I-kappaB) after treating the cells with GA and found that expression levels of the genes for p53 and [TG] increased and that for I-kappaB decreased.	p53	NF-kappaB	7157	4790	563	732	0.0012446888745906	Non valid	0.03884182891736744;0.957418965678124;0.0037392054045084725	ACTIVATION	21332403	TP53	9606	NFKB1	9606	dbTF		NFKB
50370	PMID:1498089:pubtator_title_and_abstract:753a38098a3e617b24b20f39118cf821:3:ADF:NF kappa B:913:624	Using electrophoretic mobility shift assay (EMSA), which demonstrates specific DNA-protein interaction in vitro, we could demonstrate that reducto-oxidative modulation of [TG] dramatically changes its DNA binding activity and that a cellular physiological reducing catalyst, thioredoxin (TRX) also known as adult T cell leukemia derived factor (ADF), fully restored the DNA-binding activity of the oxidized NF kappa B. We also observed that purified TRX/[TF] protein could augment gene expression from HIV LTR as demonstrated by transient chloramphenicol acetyltransferase (CAT) assay.	ADF	NF kappa B	7295	4790	913	624	0.0011204048051416	Non valid	0.10030598263768577;0.8959783043165019;0.0037157130458123073	ACTIVATION	1498089	TXN	9606	NFKB1	9606	ll_coTF		NFKB
50381	PMID:36426684:pubtator_title_and_abstract:8283a9bf8b0d0927f849759c4d1adcde:8:Hmox:NFkappaB:1191:1052	Furthermore, we interrogated the hepatic expression of [TG] inflammatory (Cxcl1, Tnf, Il1b, Il6, Ptgs2, and Ccl2), anti-inflammatory (Il10, Tnfaip3, and Nfkbia), and Nrf2/antioxidant (Gclc, [TF], and Nqo1) target genes previously demonstrated to play a role in APAP-induced injury.	Hmox	NFkappaB	15368	18033	1191	1052	0.0011286502706551	Non valid	0.9964807582775822;0.0027464084243241198;0.000772833298093619	UNDEFINED	36426684	Hmox1	10090	Nfkb1	10090	ll_coTF		NFKB
50537	PMID:36541122:pubtator_title_and_abstract:b7661e8071382905ca2ac568c3b88b73:10:MyD88:NF-kappaB:1433:1439	The [TF]/[TG] signaling pathway was subsequently proved to be positively regulated by lncRNA AGAP2-AS1, and the promotive role of lncRNA AGAP2-AS1 in LC and activating CAFs was confirmed in vivo.	MyD88	NF-kappaB	4615	4790	1433	1439	0.0011041070963233	Non valid	0.5499020132800656;0.4402780393777701;0.009819947342164294	UNDEFINED	36541122	MYD88	9606	NFKB1	9606	coTF		NFKB
50549	PMID:15705788:pubtator_title_and_abstract:40c213379ca879acc1061255d454994b:7:p65:NFkappaB:1320:1310	Azaspirane inhibits signal transducer activator of transcription 3 (STAT3) and a PI3-K (phosphatidylinositol 3-kinase) target (Akt), but not extracellular signal-regulated kinase 1 and 2 (ERK1/2), inhibits phosphorylation triggered by IL-6, and also inhibits inhibitorkappaBalpha (IkappaBalpha) and nuclear factor kappaB ([TG]) [TF] phosphorylation triggered by tumor necrosis factor alpha (TNF-alpha).	p65	NFkappaB	5970	4790	1320	1310	0.0011350063586759	Non valid	0.0027324109367770385;0.9951030213622897;0.002164567700933219	ACTIVATION	15705788	RELA	9606	NFKB1	9606	dbTF		NFKB
50567	PMID:26524020:pubtator_title_and_abstract:dc0070636d5e1147bd773ec163be8cd4:7:BCL-2:NF-kappaB:1152:1141	RESULTS: As compared with cells treated with mentioned above drugs alone, the inhibition of proliferation potential and apoptosis rate of cells in combination group markedly increase with time and concentration dependent member (P < 0.01), the expression of [TG], [TF] and TGF-beta mRNA and proteins decreased.	BCL-2	NF-kappaB	596	4790	1152	1141	0.0012496186331178	Non valid	0.0028376344561408242;0.019431944582292547;0.9777304209615666	REPRESSION	26524020	BCL2	9606	NFKB1	9606	coTF		NFKB
50572	PMID:31589911:pubtator_title_and_abstract:db740898fff20e4b83d82824f7134693:8:AKT:NF-kappaB:1391:1549	Hypothalamic [TF] and IKK phosphorylation and IkappaB degradation were significantly increased in Prip-KO rather than WT mice, indicating further promotion of AKT-mediated [TG] signaling.	AKT	NF-kappaB	11651	18033	1391	1549	0.0012299153768972	Non valid	0.17705899017602603;0.6233026702721783;0.1996383395517956	ACTIVATION	31589911	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
50653	PMID:28502904:pubtator_title_and_abstract:0bbbffcf88610b4b94bb6118cf32e881:2:Nuclear factor-kappa B:NF-kappaB:132:156	ETHNOPHARMACOLOGICAL RELEVANCE: [TF] ([TG]) plays pivotal roles in inflammation.	Nuclear factor-kappa B	NF-kappaB	Complex:NFKB	4790	132	156	0.0012737216869402	Non valid	0.9451907503516314;0.05152075188561769;0.003288497762751002	UNDEFINED	28502904	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
50766	PMID:18040287:pubtator_title_and_abstract:c7c01c09fd2e6dd8c9af15d838adabba:5:RelA:NF-kappaB:924:1048	As a nuclear-cytoplasmic shuttling protein, p28(GANK) directly binds to NF-kappaB/RelA and exports RelA from nucleus through a chromosomal region maintenance-1 (CRM-1) dependent pathway, which results in the cytoplasmic retention of NF-kappaB/RelA. We demonstrate that all the ankyrin repeats of p28(GANK) are required for the interaction with [TF] and that the N terminus of p28(GANK), which contains the nuclear export sequence (NES), is responsible for suppressing [TG]/RelA nuclear translocation.	RelA	NF-kappaB	5970	4790	924	1048	0.0011167267816	Non valid	0.16288318942571037;0.6868992788332433;0.15021753174104638	ACTIVATION	18040287	RELA	9606	NFKB1	9606	dbTF		NFKB
50776	PMID:11422736:pubtator_title_and_abstract:54f94bac5800f45bf9f6733d4caa3954:14:AP-1:NF-kappaB.:1713:1676	EMSA revealed that glucose increased the AP-1 binding activity in a time- and dose-dependent manner, but not [TG] Curcumin, an inhibitor of [TF], dose-dependently suppressed the induction of MCP-1 mRNA by high glucose.	AP-1	NF-kappaB.	3726	4790	1713	1676	0.0011197040721272	Non valid	0.03150917684514293;0.9631230260032455;0.0053677971516115875	ACTIVATION	11422736	JUNB	9606	NFKB1	9606	dbTF		NFKB
50825	PMID:37866242:pubtator_title_and_abstract:52da8601d8f770424cffc06b2eefe419:8:nodular receptor protein 3:NF-kappaB:1018:1108	In the liver, A. muciniphila and Amuc_1100 significantly reduced the mRNA expression levels of [TF] (NLRP3) and Toll-like receptor 4 (TLR4)/nuclear factor kappaB ([TG]), and the protein and mRNA expression levels inflammatory cytokines.	nodular receptor protein 3	NF-kappaB	216799	18033	1018	1108	0.0013562803726588	Non valid	0.030740705400828947;0.9395805052523153;0.02967878934685581	ACTIVATION	37866242	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
50880	PMID:18034190:pubtator_title_and_abstract:0acec2e3af8dcb9095192546f34f80f9:8:Bcl-2:NF-kappaB:1225:1144	These findings identify RelA/[TG] as a critical regulator of T-cell survival by affecting the balance of [TF] family members.	Bcl-2	NF-kappaB	596	4790	1225	1144	0.0011495242008811	Non valid	0.99518184703449;0.0033196306589389087;0.0014985223065711194	UNDEFINED	18034190	BCL2	9606	NFKB1	9606	coTF		NFKB
50952	PMID:29525378:pubtator_title_and_abstract:ff5509d586226d227c2b0e70f9198926:7:STAT3:NF-kappaB:1123:1139	Over-expression of L1CAM activated the STAT3/NF-kappaB signaling pathway in Panc-1 and Bxpc-3 pancreatic cancer cells and celecoxib inhibited their viability and the expressions of [TF], p-STAT3, [TG], p-NF-kappaB as well as full length L1CAM in a concentration dependent manner.	STAT3	NF-kappaB	6774	4790	1123	1139	0.0012838773065056	Non valid	0.3359104954008128;0.5322784867878619;0.1318110178113253	ACTIVATION	29525378	STAT3	9606	NFKB1	9606	dbTF		NFKB
51024	PMID:24488495:pubtator_title_and_abstract:1b1849397091f587ddab9e7e57da7379:9:RelB:NF-kappaB:1225:1321	Analysis of the Cot promoter demonstrated that p65 and [TF] bound to the distal NF-kappaB-binding site and that RelB but not p65 bound to the proximal [TG]-binding site in the Cot promoter.	RelB	NF-kappaB	19698	18033	1225	1321	0.0010674064662428	Non valid	0.996867588065799;0.002454744242526902;0.0006776676916741105	UNDEFINED	24488495	Relb	10090	Nfkb1	10090	dbTF		NFKB
51034	PMID:11181838:pubtator_title_and_abstract:9b9f55cbbe59ba9df46622548895b3bb:14:NF-kappaB:NF-kappaB:2135:1811	Besides being necessary for high potassium-mediated neuronal survival, [TG] is also involved in the survival-promoting effects of IGF-1 and cAMP as judged by the ability of SN-50 to inhibit the actions of these survival factors and the ability of these factors to inhibit the low potassium-induced alterations in the DNA-binding activity of NF-kappaB. Taken together, our results show that [TF] may represent a point of convergence in the signaling pathways activated by different survival factors and that uncommon mechanisms might be involved in NF-kappaB-mediated survival of cerebellar granule neurons.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	2135	1811	0.0012552859623578	Non valid	0.8880635318609424;0.10898719132153624;0.0029492768175212697	UNDEFINED	11181838	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
51214	PMID:27657826:pubtator_title_and_abstract:818845f4d118b36b536ad21df8d0d722:8:AMPK:NF-kappaB:1186:1203	AICAR-induced [TF] activation, [TG] activation and tumor necrosis factor (TNF)-alpha release were reduced by fenoterol.	AMPK	NF-kappaB	5562	4790	1186	1203	0.0013655786813895	Non valid	0.0034593498568120246;0.9953192726283784;0.0012213775148096537	ACTIVATION	27657826	PRKAA1	9606	NFKB1	9606	ll_coTF		NFKB
51268	PMID:19244329:pubtator_title_and_abstract:9c1efda0d92ec815e06951a4498fc464:9:RBP-Jkappa:NF-kappaB.:1649:1569	Many K-Rta-responsive promoters modulated by NF-kappaB contain the sequence of the RBP-Jkappa binding site, a major coactivator which anchors K-Rta to target promoters via consensus motifs which overlap with that of [TG] Gel shift assays demonstrated that NF-kappaB inhibits the binding of [TF] and forms a complex with RBP-Jkappa.	RBP-Jkappa	NF-kappaB.	3516	4790	1649	1569	0.0011303362872452	Non valid	0.9965742992447465;0.0017632556786774391;0.001662445076576083	UNDEFINED	19244329	RBPJ	9606	NFKB1	9606	dbTF		NFKB
51286	PMID:27866306:pubtator_title_and_abstract:b2da193bf04ec59122ab17336ff35cca:7:Akt:NF-kappaB:946:859	The inhibitor of [TG] (BAY 11-7082), but not PD98059 (PD, ERK1/2 inhibitor) or LY294002 (LY, PI3 K/[TF] inhibitor), attenuated BPA-induced IL-6 expression and cell proliferation and invasion.	Akt	NF-kappaB	207	4790	946	859	0.0011229454605935	Non valid	0.0030411655906865463;0.992040576685597;0.004918257723716566	ACTIVATION	27866306	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
51303	PMID:21423202:pubtator_title_and_abstract:8e047c44796027b62a73e59504734f98:7:cyclin D1:NFkappaB:1131:1110	This effect was partly mediated by reduced levels of the [TG] target gene [TF], because its downregulation by RNA interference reproduced a similar phenotype.	cyclin D1	NFkappaB	595	4790	1131	1110	0.0012691211776458	Non valid	0.9624338135831088;0.03515867379439797;0.002407512622493304	UNDEFINED	21423202	CCND1	9606	NFKB1	9606	coTF		NFKB
51320	PMID:29395328:pubtator_title_and_abstract:623ee65de8a81e78b6fa8f9fcb84f4f2:5:p65:NF-kappaB:695:670	Mechanistically, CD10+GPR77+ CAFs are driven by persistent [TG] activation via [TF] phosphorylation and acetylation, which is maintained by complement signaling via GPR77, a C5a receptor.	p65	NF-kappaB	5970	4790	695	670	0.0039035595734705	Non valid	0.017753260681610764;0.9798364346441998;0.0024103046741894606	ACTIVATION	29395328	RELA	9606	NFKB1	9606	dbTF		NFKB
51325	PMID:14715080:pubtator_title_and_abstract:228854617fd1c0c500d1ad870ab93bc8:4:NF-kappaB:NF-kappaB.:661:932	We observed that activation of [TF] by TNFalpha (tumour necrosis factor alpha) inhibited both basal and androgen-stimulated PSA expression, and that this down-regulation occurred at the promoter level, as confirmed by the super-repressor IkappaBalpha (S32A/S36A), a dominant negative inhibitor of [TG] Using a linker-scanning mutagenesis approach, we identified a cis -element, designated XBE (X-factor-binding element), in the AREc (androgen response element enhancer core) of the PSA promoter, which negatively regulated several AR-responsive promoters, including that of PSA.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	661	932	0.0015031125913961	Non valid	0.0023902013165625425;0.01081299742622682;0.9867968012572106	REPRESSION	14715080	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
51360	PMID:29588164:pubtator_title_and_abstract:5dad3f0232cb6f556cb4a4f80bbbeed0:8:hem oxygenase-1:NF-kappaB:1252:1226	NO2-FAs undergo reversible covalent binding to cysteine residues and by virtue of these posttranslational protein modifications act as potent anti-inflammatory signaling mediators via modulation of various critical pathways like nuclear factor E2-related factor 2 (Nrf2)- and peroxisome proliferator-activated receptor gamma (PPARgamma) activation, nuclear factor-kappa B ([TG]) inhibition and [TF] (HO-1)- and heat shock protein (HSP) induction.	hem oxygenase-1	NF-kappaB	15368	18033	1252	1226	0.0012250384566267	Non valid	0.03562146922990896;0.028252520025647505;0.9361260107444436	REPRESSION	29588164	Hmox1	10090	Nfkb1	10090	ll_coTF		NFKB
51431	PMID:25376195:pubtator_title_and_abstract:54f393fcd32a8b2c61ee0cdfcd01a171:9:AhR:NF-kappaB:1030:1062	IS induced activation of aryl hydrocarbon receptor ([TF]) and nuclear factor-kappaB ([TG]) subunit p65 in HUVECs and HASMCs.	AhR	NF-kappaB	196	4790	1030	1062	0.0011485046495382	Non valid	0.00804814894933622;0.9897924991977197;0.0021593518529439393	ACTIVATION	25376195	AHR	9606	NFKB1	9606	dbTF		NFKB
51496	PMID:10477716:pubtator_title_and_abstract:0f7cf7fa20e5bf8b427db8ba60815ed4:10:NF-kappaB:NF-kappaB:1367:1577	Similar selective effects on [TF] transcription are seen with the unrelated antioxidants, N-acetylcysteine (NAC) and vitamin C. These data indicate that TNFalpha induces a delayed ROS-dependent signalling pathway that is required for [TG] transcriptional activation and is separable from that required for its nuclear translocation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1367	1577	0.0014366080668583	Non valid	0.0453870575614616;0.952976007327273;0.0016369351112654215	ACTIVATION	10477716	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
51619	PMID:30575942:pubtator_title_and_abstract:c1a2bf80e5a6019dcad5d233222ce8e9:12:NF-kappaB:nuclear factor-kappaB:1625:1602	In addition, the expression of [TG] ([TF]) was also detected via Western blotting.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	18033	1625	1602	0.0014669538853881	Non valid	0.8759302166984982;0.11906467127760255;0.005005112023899261	UNDEFINED	30575942	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
51624	PMID:24041930:pubtator_title_and_abstract:7ae29d23284e35f761ddffeba5e6240b:8:ERK1/2:NF-kappaB:1002:1014	The exposure of atrial tissue to FXa resulted in the 1.7 fold upregulation of PAR2-mRNA, activation of MAP kinases ([TF]) and [TG] signalling.	ERK1/2	NF-kappaB	5595;5594	4790	1002	1014	0.001128314873663	Non valid	0.08575037813948745;0.9115023891656336;0.002747232694878803	ACTIVATION	24041930	MAPK3;MAPK1	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
51670	PMID:15811576:pubtator_title_and_abstract:031ed86104b3c6743a9982c71ef3a588:6:NF-kappaB:NF-kappaB.:737:845	Interestingly, G-120 (100 microg/ml) completely suppressed the binding of [TF] to DNA and increased the cytosolic level of IkappaBalpha which prevented nuclear translocation of [TG] In addition, G-120 increased the expression of c-Jun, Fra-1, and Fra-2, but did not affect the expression of c-Fos.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	737	845	0.0011408413773115	Non valid	0.151264696870584;0.8443137052911807;0.0044215978382353876	ACTIVATION	15811576	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
51809	PMID:22668720:pubtator_title_and_abstract:bfaedbd8a6da5c3d8555fdda7f5a0774:5:c-maf:NF-kappaB:663:680	This review encompasses a wide range of molecular events during IgE mediated reactions like primary exposure of allergens, processing of allergens by antigen presenting cells, role of transcription factors like GATA-3, STAT-6, NF-AT, [TF], c-kit and [TG], Treg cells, toll like receptors, cytokines and chemokines, class switch to IgE, FcepsilonR1 receptor, priming of IgE on mast cells or basophils, signaling events followed by secondary exposure of allergens, degranulation and release of mediators like leukotrienes, histamines, prostaglandins, beta-hexosaminidase and ultimately anaphylaxis.	c-maf	NF-kappaB	4094	4790	663	680	0.0011434906812002	Non valid	0.7104101334518574;0.2841482431316516;0.005441623416490838	UNDEFINED	22668720	MAF	9606	NFKB1	9606	dbTF		NFKB
51816	PMID:34489184:pubtator_title_and_abstract:c4c5ae1bd1794fc1cc48123d9f8d7464:8:AKT:NF-kbeta:1402:1372	The exposure of rats to PD promoted oxidative stress and inflammation via an increase in MDA and a decrease in GSH brain contents with an increase in brain contents of TNF-alpha, IL-6, and [TG] and reduced AMPK and [TF] brain contents as compared to the control group.	AKT	NF-kbeta	24185	81736	1402	1372	0.0011485598999578	Non valid	0.08143783227020994;0.5122072331362033;0.40635493459358674	ACTIVATION	34489184	Akt1	10116	Nfkb1	10116	ll_coTF		NFKB
51819	PMID:29775759:pubtator_title_and_abstract:8abde8c78179c344f237b723ae2840b5:5:NF-kappaB:NF-kappaB:786:601	Here, we show that maybe the stability of [TG] is controlled by proteasome-mediated degradation and ubiquitin-specific protease 48 (USP48), also known as synaptic ubiquitin-specific protease (synUSP) or USP31, can enhance [TF] stability through proteasome-dependent regulation in the nucleus.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	786	601	0.0012835175394732	Non valid	0.4536989576610878;0.38994948885997444;0.15635155347893773	UNDEFINED	29775759	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
51822	PMID:27584057:pubtator_title_and_abstract:07434fabf9b7d8d3a91b3ee168180cd7:7:activator protein 1:NF-kappaB:1024:1012	Signaling pathways via TLR4 activate various transcription factors like Nuclear factor kappa-light-chain-enhancer ([TG]), [TF] (AP1), Signal Transducers and Activators of Transcription family of transcription factors (STAT1) and Interferon regulatory factors (IRF's), which are the key players regulating the inflammatory response.	activator protein 1	NF-kappaB	3726	4790	1024	1012	0.0012631096131779	Non valid	0.6915130266945282;0.3060174366762057;0.0024695366292660503	UNDEFINED	27584057	JUNB	9606	NFKB1	9606	dbTF		NFKB
51885	PMID:20380796:pubtator_title_and_abstract:6eb91d3fdafc667c55cfea2923b882e4:7:TGFbeta1:NF-kB:785:874	The mRNA levels of NF-kB, [TF], FN from rats liver were assayed by semi-quantity RT-PCR, the protein levels of [TG], TGFbeta1, FN was detected by IHC.	TGFbeta1	NF-kB	59086	309165	785	874	0.0012697559520529	Non valid	0.9684464623063228;0.027779223038092434;0.0037743146555847583	UNDEFINED	20380796	Tgfb1	10116	Rela	10116	ll_coTF		NFKB
51919	PMID:16911361:pubtator_title_and_abstract:592b00b3dcc67c2432a6f104e6dff7ff:14:IRF3:NF-kappaB:2020:2003	These signals may increase expression of inflammatory cytokines, chemokines and ICAM-1 through activation of transcription factors [TG] and/or [TF] in airway epithelial cells.	IRF3	NF-kappaB	3661	4790	2020	2003	0.0012839913403517	Non valid	0.00599810051495492;0.9926924234794821;0.001309476005562973	ACTIVATION	16911361	IRF3	9606	NFKB1	9606	dbTF		NFKB
52027	PMID:26836460:pubtator_title_and_abstract:7fa2f43abc239d1a493c6f2cdbbe481d:6:p38:NF-kappaB.:1043:1114	GA inhibited UV-B-mediated activation of [TF] and JNK MAP kinases, COX-2 expression and nuclear translocation of [TG] Furthermore, GA inhibited UV-B-mediated apoptosis by attenuating translocation of Bax from the cytosol to mitochondria, thus preserving mitochondrial integrity.	p38	NF-kappaB.	1432	4790	1043	1114	0.001126973207407	Non valid	0.004002766814362424;0.9936000975509187;0.002397135634718795	ACTIVATION	26836460	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
52099	PMID:37886658:pubtator_title_and_abstract:7380ab27ab078af88879de2264a2a6df:6:IkappaBalpha:NF-kappaB:1075:1027	To test our hypothesis that the mechanism of DMA's effects in in vitro and in vivo models of IBD is inhibition of the NF-kappaB pathway, we used western blotting to track levels of the nuclear factor kappa B ([TG]) inhibitory molecule I kappa B alpha ([TF]) in THP-1 human monocytes in the absence or presence of DMA.	IkappaBalpha	NF-kappaB	4792	4790	1075	1027	0.001271546815984	Non valid	0.660857861047053;0.017950322735991536;0.32119181621695536	UNDEFINED	37886658	NFKBIA	9606	NFKB1	9606	coTF		NFKB
52106	PMID:25873394:pubtator_title_and_abstract:1a51438dd2a914994ff374f960a2ce91:8:NF-kappaB:NF-kappaB:852:1125	Mechanistically, we identified three [TF] binding sites on paxillin promoter and confirmed that paxillin was a direct transcriptional target of NF-kappaB. Our findings reveal a novel mechanism by which PTEN inhibits the progression of colon cancer by inhibiting paxillin expression downstream of PI3K/AKT/[TG] pathway.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	852	1125	0.0010723249191528	Non valid	0.16170097293466743;0.8321782570488301;0.006120770016502534	ACTIVATION	25873394	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
52190	PMID:23690471:pubtator_title_and_abstract:b4750938ccb3b76d897bfe537dc20edd:8:NF-kappaB:NF-kappaB:1936:1882	These results suggest that, in addition to its known effect on nuclear translocation of [TG], DHMEQ interferes with the cytokine-induced [TF] signaling via generation of ROS at both upstream and downstream of the IkappaB kinase-IkappaB level.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1936	1882	0.0011026121912681	Non valid	0.17816096529449307;0.8164088934775209;0.005430141227986111	ACTIVATION	23690471	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
52244	PMID:37843712:pubtator_title_and_abstract:8e1cfa5ec4c261762ecb191ad6289ec8:10:CREB:NF-kappaB:1420:1400	Furthermore, the activation of the key regulators in the inflammatory response [TG], Akt, and [TF] was suppressed by myricetin under hypoxic conditions.	CREB	NF-kappaB	1385	4790	1420	1400	0.0012384053471306	Non valid	0.05207512357169406;0.9393910705643457;0.008533805863960171	ACTIVATION	37843712	CREB1	9606	NFKB1	9606	dbTF		NFKB
52395	PMID:23807739:pubtator_title_and_abstract:7705d47406c37062e127ff088490e1eb:3:P53:NF-kappaB:273:278	Effects of ghrelin signaling on CDK6, [TF], [TG]/P65 and MMP2 mRNA and/or protein expression were determined by real-time PCR and western blot.	P53	NF-kappaB	7157	4790	273	278	0.0012733890188879	Non valid	0.9928350214254336;0.005492865350067514;0.0016721132244990188	UNDEFINED	23807739	TP53	9606	NFKB1	9606	dbTF		NFKB
52438	PMID:31022702:pubtator_title_and_abstract:57525e51c8f989651ac4ff723f13a071:7:ERK1/2:NF-kappaB:1045:1032	In TIPE2-deficient myometrial cells treated with inhibitors of [TG] or [TF], the secretion of pro-labor mediators was reduced back to control levels.	ERK1/2	NF-kappaB	5595;5594	4790	1045	1032	0.0011239541254805	Non valid	0.0050020395380131885;0.9826339936251731;0.012363966836813699	ACTIVATION	31022702	MAPK3;MAPK1	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
52482	PMID:10473604:pubtator_title_and_abstract:5ffe81ab888394815c3111c662ccb2dc:5:RelA:NF-kappaB:1371:1135	In this report, we demonstrate that mesalamine, an anti-inflammatory aminosalicylate, dose-dependently inhibits IL-1-stimulated [TG]-dependent transcription without preventing IkappaB degradation or nuclear translocation and DNA binding of the transcriptionally active NF-kappaB proteins, RelA, c-Rel, or RelB. Mesalamine was found to inhibit IL-1-stimulated [TF] phosphorylation.	RelA	NF-kappaB	5970	4790	1371	1135	0.0011209393850348	Non valid	0.00476251757026378;0.9940897868745611;0.001147695555175109	ACTIVATION	10473604	RELA	9606	NFKB1	9606	dbTF		NFKB
52599	PMID:19349371:pubtator_title_and_abstract:2fb48d92fd5148ae14b4af1d17292155:10:NF-kappaB:NF-kappaB:1859:1775	Thus, the divergent role of [TG] activation in selective liver cell populations underlies the dichotomy of [TF] in hepatic I/R injury, illustrating the relevance of specifically maintaining NF-kappaB activation in parenchymal cells.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1859	1775	0.0011086200748562	Non valid	0.3647960103320268;0.6231922511080785;0.012011738559894647	ACTIVATION	19349371	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
52782	PMID:25873394:pubtator_title_and_abstract:1a51438dd2a914994ff374f960a2ce91:8:AKT:NF-kappaB:1121:1125	Mechanistically, we identified three NF-kappaB binding sites on paxillin promoter and confirmed that paxillin was a direct transcriptional target of NF-kappaB. Our findings reveal a novel mechanism by which PTEN inhibits the progression of colon cancer by inhibiting paxillin expression downstream of PI3K/[TF]/[TG] pathway.	AKT	NF-kappaB	207	4790	1121	1125	0.0010583819235488	Non valid	0.0409909753615452;0.9546394993625024;0.0043695252759523556	ACTIVATION	25873394	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
52787	PMID:14962100:pubtator_title_and_abstract:5f35c4c43efa10687d1e1b7716da7698:4:NF-kappa B:nuclear factor-kappa B:439:415	The transcription factors [TG] ([TF]) and activator protein-1 (AP-1) functionally regulate cell proliferation, transformation, and apoptosis.	NF-kappa B	nuclear factor-kappa B	Complex:NFKB	4790	439	415	0.0012122921897431	Non valid	0.979683374746145;0.017720777986494626;0.0025958472673603687	UNDEFINED	14962100	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
52928	PMID:27485202:pubtator_title_and_abstract:ead7499d4443220353f378ecc15bf7d9:5:Bcl-2:NF-kappaB:652:800	The results indicated that evodiamine significantly inhibited proliferation, induced apoptosis and the expression of reactive oxygen species, arrested the cell cycle, regulated the expression of Survivin, [TF] and Cyclin B1, regulated the activity of caspase-3/8 and glutathione in tumor cells, and decreased the activity of AKT/nuclear factor-kappaB ([TG]) and Sonic hedgehog/GLI family zinc finger 1 (SHH/GLI1) signaling pathways in A549 cells.	Bcl-2	NF-kappaB	596	4790	652	800	0.0011232102478812	Non valid	0.8244314926682854;0.15205706571725514;0.023511441614459443	UNDEFINED	27485202	BCL2	9606	NFKB1	9606	coTF		NFKB
52956	PMID:26296466:pubtator_title_and_abstract:43d6f7af20411a647ecc6077d6730bed:6:SIRT1:NF-kappaB:783:909	In this model, administration of the [TF] agonist SRT1720 substantially attenuated AngII-accelerated atherosclerosis with decreasing blood pressure and inhibited [TG] and STAT3 activation, which was associated with suppression of inflammatory factor and atherogenic gene expression in the artery.	SIRT1	NF-kappaB	93759	18033	783	909	0.0098135163028923	Non valid	0.025988062124613832;0.5571015890261104;0.4169103488492757	ACTIVATION	26296466	Sirt1	10090	Nfkb1	10090	coTF		NFKB
53051	PMID:21467650:pubtator_title_and_abstract:04f688f6773116341f8321d530adf24c:10:nuclear factor kappa B:NFkappaB:1256:1280	We further demonstrated that costunolide inhibited the activation of Akt and [TF] ([TG]) and the expression of anti-apoptotic factors B-cell lymphoma-extra lage (Bcl-xL) and X-linked inhibitor of apoptosis protein (XIAP) in 11Z cells.	nuclear factor kappa B	NFkappaB	Complex:NFKB	4790	1256	1280	0.0011457190441348	Non valid	0.003179334393032595;0.995451058986133;0.001369606620834382	ACTIVATION	21467650	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
53075	PMID:15811958:pubtator_title_and_abstract:c1c99aed31235f0b0e8d32552d394bd0:6:IAP2:NF-kappaB:1452:1294	The [TG]-regulated gene products cyclin D1, cyclooxygenase-2 (COX-2), matrix metalloproteinase-9 (MMP-9), survivin, inhibitor-of-apoptosis protein-1 (IAP1), [TF], X chromosome-linked IAP (XIAP), Bcl-2, Bfl-1/A1, TNF receptor-associated factor-1 (TRAF1), and Fas-associated death domain protein-like interleukin-1beta-converting enzyme inhibitory protein (FLIP) were all down-regulated by indole-3-carbinol.	IAP2	NF-kappaB	329	4790	1452	1294	0.0013837715774884	Non valid	0.9928135324582229;0.005358697598559435;0.001827769943217672	UNDEFINED	15811958	BIRC2	9606	NFKB1	9606	coTF		NFKB
53186	PMID:11470802:pubtator_title_and_abstract:b655dee1903c6f695209bfb401fb5b49:5:histone H4:NF-kappaB:1560:1245	We demonstrated that: (i) inducible RelA expression down-regulated aryl hydrocarbon receptor (AhR) activated reporter gene; (ii) the suppressive effects of LPS and TNF-alpha on the AhR-activated reporter gene could be blocked by pyrrolidine dithiocarbamate, which is known to inhibit NF-kappaB action; and (iii) TNF-alpha and LPS-imposed repression could be reversed by the NF-kappaB super repressor (SRIkappaBalpha), thus demonstrating the specific involvement of NF-kappaB. Furthermore, nuclear receptor coactivators p300/CBP and steroid receptor coactivator-1 act individually as well as cooperatively to reverse the suppressive effects by [TG] on the AhR-activated reporter gene, suggesting that these transcriptional coactivators serve as the common integrators for the two pathways, thereby mediating the cross-interactions between AhR and NF-kappaB. Finally, using the chromatin immunoprecipitation assay, we demonstrated that AhR ligand induces [TF] acetylation at the cyp1a1 promoter region containing the TATA box, whereas TNF-alpha inhibits this acetylation, suggesting that AhR/NF-kappaB interaction converges at level of transcription involving chromatin remodeling.	histone H4	NF-kappaB	8361	4790	1560	1245	0.0010848206934922	Non valid	0.16652843606721965;0.16374632179627532;0.6697252421365051	REPRESSION	11470802	H4C6	9606	NFKB1	9606	coTF		NFKB
53485	PMID:23159616:pubtator_title_and_abstract:386fad73c26c8f9cfa53db854ca27960:9:Akt:NFkappaB:1608:1705	Although [TF] phosphorylation was reduced, GW3965 seemed to act independently of MAPKs (p38, ERK, JNK) and [TG], and had no inhibitory effect on cytokine expression (Tnfalpha, Il6, or Il1beta).	Akt	NFkappaB	11651	18033	1608	1705	0.0011973343657861	Non valid	0.19901335656300623;0.7882329442230066;0.012753699213987104	ACTIVATION	23159616	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
53585	PMID:33665657:pubtator_title_and_abstract:b238697504369cd196b45e138bae294e:9:Hif-1alpha:NF-kappaB:1276:1332	Cell viability was determined by the CCK-8 kit, lactate dehydrogenase (LDH) content in cell supernatant was determined by LDH kit, oxidative stress level was detected by the reactive oxygen species (ROS) probe, and protein expression levels of hypoxia inducible factor-1alpha ([TF]) and phosphorylated nuclear factor kappaB (p-[TG]) were detected by Western blot.	Hif-1alpha	NF-kappaB	15251	18033	1276	1332	0.0011397540585571	Non valid	0.9874775833038557;0.010385698326308626;0.00213671836983571	UNDEFINED	33665657	Hif1a	10090	Nfkb1	10090	dbTF		NFKB
53669	PMID:15256061:pubtator_title_and_abstract:87d1f8ece85bdf3d9bb0dd5ea37f5811:4:IkappaBalpha:NF-kappaB:706:647	Using tissue samples obtained during transurethral prostatic resection and paraffin-embedded sections of benign and cancer specimens, we determined the nuclear expression of [TG]/p65 and NF-kappaB/p50, cytoplasmic expression of [TF], its phosphorylation, and expression of NF-kappaB-regulated genes, specifically Bcl2, cyclin D1, matrix metalloproteinase-9 (MMP-9), and vascular endothelial growth factor (VEGF).	IkappaBalpha	NF-kappaB	4792	4790	706	647	0.001163492765162	Non valid	0.9762090963589369;0.021553049954579753;0.0022378536864833313	UNDEFINED	15256061	NFKBIA	9606	NFKB1	9606	coTF		NFKB
53738	PMID:8878392:pubtator_title_and_abstract:43ff953d7c917598560cd1b292ffbed4:3:I(kappa)B(alpha):NF-kappaB.:694:641	The transcription of genes associated with EC activation, such as E-selectin and interleukin (IL)-8, is regulated by the transcription factor NF-kappaB. In resting EC, NF-kappaB is complexed within the cytoplasm to I(kappa)B(alpha), and EC activation leads to dissociation of the I(kappa)B(alpha)-NF-kappaB complex and nuclear translocation of [TG] We investigated whether overexpression of [TF] in EC, using adenoviral gene transfer, could block NF-kappaB translocation, thereby inhibiting NK cell-mediated EC activation.	I(kappa)B(alpha)	NF-kappaB.	4792	4790	694	641	0.001100744108972	Non valid	0.3942116630611644;0.10404515540197055;0.501743181536865	REPRESSION	8878392	NFKBIA	9606	NFKB1	9606	coTF		NFKB
53797	PMID:31242482:pubtator_title_and_abstract:dc4623ec6a988f6162a545978358b604:8:SIRT1:NF-kappaB:1039:1049	The expression of [TF] and [TG] was analyzed by western blotting.	SIRT1	NF-kappaB	23411	4790	1039	1049	0.0012804594659007	Non valid	0.9867393037937673;0.011658326275176822;0.001602369931055897	UNDEFINED	31242482	SIRT1	9606	NFKB1	9606	coTF		NFKB
53968	PMID:12686591:pubtator_title_and_abstract:f545d0541767b50ab37f3917feba1e7a:4:AP-1:nuclear factor-kappaB:803:744	We now report that differential activation of two transcription factors, [TG] (NF-kappaB) and activator protein-1 ([TF]), in primary human hepatocytes or IHEC, is associated with and may explain, in part, the different responses of these cell types to CD40 ligation.	AP-1	nuclear factor-kappaB	3725	4790	803	744	0.001222736369816	Non valid	0.6069409073722558;0.38448532884504905;0.008573763782695148	UNDEFINED	12686591	JUN	9606	NFKB1	9606	dbTF		NFKB
53970	PMID:27252847:pubtator_title_and_abstract:65b67bc0b1fc993754fa922cef02670f:2:PPARgamma:NF-kappaB:595:464	Hypoxia stimulates pulmonary hypertension (PH), in part by increasing the proliferation of human pulmonary artery smooth muscle cells (HPASMCs) via sustained activation of mitogen-activated protein kinase, extracellular signal-regulated kinases 1 and 2 (ERK 1/2), and nuclear factor-kappa B ([TG]); elevated expression of NADPH oxidase 4 (Nox4); and downregulation of peroxisome proliferator-activated receptor gamma ([TF]) levels.	PPARgamma	NF-kappaB	5468	4790	595	464	0.0011337744613779	Non valid	0.015401979843664256;0.22196678530557468;0.762631234850761	REPRESSION	27252847	PPARG	9606	NFKB1	9606	dbTF		NFKB
53996	PMID:16890260:pubtator_title_and_abstract:03216b7a5db9908bb5c04816408564a2:10:NF-kappaB.:NF-kappaB:1218:1380	AEMD decreased PMA and A23187-induced degradation of IkappaBalpha and nuclear translocation of [TF] Our findings provide evidence that AEMD inhibits mast cell-derived immediate-type allergic reactions and involvement of pro-inflammatory cytokines and [TG] in these effects.	NF-kappaB.	NF-kappaB	Complex:NFKB	4790	1218	1380	0.0011098304859583	Non valid	0.3437898591422083;0.6493131162518918;0.006897024605899877	ACTIVATION	16890260	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
54005	PMID:34974060:pubtator_title_and_abstract:989bac2eb629dcb7d4c497261cb2ade5:11:Akt:NFkappaB.:1755:1781	Conversely, knockdown of GALNT4 decreased VVL binding and attenuated the activation of [TF]/mTOR and IkappaBalpha/[TG] Additionally, mTOR inhibitor rapamycin blocked these effects of GALNT4 overexpression on monocytes.	Akt	NFkappaB.	11651	18033	1755	1781	0.0011873718149845	Non valid	0.002665673641829915;0.99592855835974;0.0014057679984301062	ACTIVATION	34974060	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
54131	PMID:30471852:pubtator_title_and_abstract:0d2ffcac644498881d8ccfc5a44131d8:7:c-Jun:NFkappaB:930:940	Further studies show that LPS-induced TLR4 endosomal traffic and downstream [TF] and [TG] (nuclear factor-kappa B) activation were significantly inhibited by Rab21 shRNA, but intensified with Rab21 overexpression in BMDMs.	c-Jun	NFkappaB	16476	4790	930	940	0.0011959286691788	Non valid	0.009143830662701007;0.9892328025273233;0.0016233668099757618	ACTIVATION	30471852	Jun	10090	NFKB1	9606	dbTF		NFKB
54155	PMID:25451575:pubtator_title_and_abstract:1d1a25cccb8bf3eeeff2544f96fec451:6:p65:NF-kappaB:1227:1201	Furthermore, 7-HMIA mediated attenuation of inducible NO synthase (iNOS), TNF-alpha, and IL-6 was closely associated with suppression of transcriptional activities of nuclear factor-kappa B ([TG]), by decreasing [TF] nuclear translocation and Akt phosphorylation.	p65	NF-kappaB	5970	4790	1227	1201	0.0029936143652356	Non valid	0.003389270125954313;0.9919156767447307;0.004695053129315096	ACTIVATION	25451575	RELA	9606	NFKB1	9606	dbTF		NFKB
54259	PMID:11123332:pubtator_title_and_abstract:6113b2b70211416a0debaf7323e5f7dc:8:NF-kappa B.:NF-kappa B.:1764:1880	Alpha-adrenergic blockade before hemorrhage resulted in increased activation in lung neutrophils of MEK1/2, ERK1, ERK2, and CREB, but decreased activation of NF-kappa B. In contrast, alpha-adrenergic blockade before endotoxemia was associated with decreased activation of MEK1/2, ERK2, and CREB, but increased activation of NF-kappa B. Beta-adrenergic blockade before hemorrhage did not alter MEK1/2 or ERK1 activation in lung neutrophils, but decreased activation of ERK2 and CREB, while increasing activation of [TF] Beta-adrenergic inhibition before endotoxemia did not affect activation of MEK1/2, ERK1, ERK2, CREB, or [TG] These data indicate that the pathways leading to lung neutrophil activation after hemorrhage are different from those induced by endotoxemia.	NF-kappa B.	NF-kappa B.	Complex:NFKB	4790	1764	1880	0.0014019464679209	Non valid	0.029507533755338676;0.9475922611651852;0.022900205079476123	ACTIVATION	11123332	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
54410	PMID:32504709:pubtator_title_and_abstract:a5cb81d96a92d924eab2dd6ce4183063:5:IKKalpha/beta:NFkappaB:1080:1136	Furthermore, Western Blot and quantitative real-time polymerase chain reaction (qRT-PCR) assays demonstrated that 80 mug/mL CCP activated macrophages, significantly increased mRNA expression of cytokines (IL-8, IL-1beta, IFN-alpha and TNF-alpha) and upregulated the protein expression of cell membrane receptor TLR4, as well as its downstream protein kinase products (MyD88, TAK1, P-[TF] and P-MEK) through activation of the TLR4-[TG] pathway in peritoneal macrophages.	IKKalpha/beta	NFkappaB	12675;16150	18033	1080	1136	0.0011385533467514	Non valid	0.048783220298825834;0.9495290566386795;0.0016877230624947107	ACTIVATION	32504709	Chuk;Ikbkb	10090;10090	Nfkb1	10090	coTF;coTF		NFKB
54442	PMID:31150368:pubtator_title_and_abstract:4a4245fe5bf937d45c1cd8f2152bee5e:10:IKKbeta:NF-kappaB:1437:1445	RESULTS: Triptolide promoted locomotion recovery of SCI rats, upregulated the expression of miR-96, decreased microglia activation marker Iba-1 and [TF]/[TG]-related proteins, and inhibited inflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta levels in spinal cord tissues and lipopolysaccharide -induced microglia.	IKKbeta	NF-kappaB	16150	18033	1437	1445	0.0011736207049797	Non valid	0.5760297539330524;0.3726067485187932;0.05136349754815431	UNDEFINED	31150368	Ikbkb	10090	Nfkb1	10090	coTF		NFKB
54521	PMID:16230421:pubtator_title_and_abstract:4ce97bbbac529b9305ef01208ec0b1e6:3:NF-kappaB:NF-kappaB:648:662	Because the nuclear factor-kappaB (NF-kappaB) has also been shown to regulate proliferation, invasion, and metastasis of tumor cells, we postulated that 4-HPR modulates the activity of NF-kappaB. To test this postulate, we examined the effect of this retinoid on [TF] and [TG]-regulated gene products.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	648	662	0.001242058547016	Non valid	0.9978470843385613;0.0014202577855945274;0.0007326578758442199	UNDEFINED	16230421	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
54533	PMID:36103108:pubtator_title_and_abstract:b34819a7e547679cba409288527cca66:5:ERK:NF-kappaB:1154:1013	It has been proposed that exosomes could improve cognition function, inhibit apoptosis, suppress inflammation, regulate autophagy, and protect blood brain barrier (BBB) in CNS injuries via different molecules and pathways including microRNA (miRNA), nuclear factor kappa-light-chain-enhancer of activated B cells ([TG]), phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B (PI3K/AKT), Notch1, and extracellular regulated protein kinases ([TF]).	ERK	NF-kappaB	5594	4790	1154	1013	0.0011461109204167	Non valid	0.9621281389087174;0.03491044596730272;0.0029614151239799056	UNDEFINED	36103108	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
54560	PMID:27991921:pubtator_title_and_abstract:293b7825b9bf227d3d5506aec4266c5a:7:Mypt1:NF-kappaB:1674:1680	Novel papilloma outgrowths appeared expressing intense, basal layer p21 that confined endogenous ROCK2/p-[TF]/[TG] to supra-basal layers, and was paralleled by restored basal layer p53.	Mypt1	NF-kappaB	17931	18033	1674	1680	0.0012575465402454	Non valid	0.7320020756601887;0.24698579766070655;0.021012126679104813	UNDEFINED	27991921	Ppp1r12a	10090	Nfkb1	10090	ll_coTF		NFKB
54677	PMID:8878392:pubtator_title_and_abstract:43ff953d7c917598560cd1b292ffbed4:3:NF-kappaB:NF-kappaB:465:594	The transcription of genes associated with EC activation, such as E-selectin and interleukin (IL)-8, is regulated by the transcription factor NF-kappaB. In resting EC, [TF] is complexed within the cytoplasm to I(kappa)B(alpha), and EC activation leads to dissociation of the I(kappa)B(alpha)-[TG] complex and nuclear translocation of NF-kappaB. We investigated whether overexpression of I(kappa)B(alpha) in EC, using adenoviral gene transfer, could block NF-kappaB translocation, thereby inhibiting NK cell-mediated EC activation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	465	594	0.0011036104972505	Non valid	0.5885726697509754;0.2772907787059708;0.13413655154305373	UNDEFINED	8878392	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
54765	PMID:23484696:pubtator_title_and_abstract:48748387107b9681c522a4df7f4a3ade:5:BCL-2:NF-kappaB:717:727	Treated with HHT 10 ng/ml for 48 h, K562 cell apoptosis significantly increased, cell cycle was blocked at G0/G1, the expression level of [TF] and [TG] proteins was lower than that in control group (P < 0.05).	BCL-2	NF-kappaB	596	4790	717	727	0.00124055343833	Non valid	0.005952718617450514;0.017651093423125395;0.9763961879594242	REPRESSION	23484696	BCL2	9606	NFKB1	9606	coTF		NFKB
54800	PMID:18369406:pubtator_title_and_abstract:bcc6fabbdb87227e15268da96708daa7:7:activator protein (AP)-1:NF-kappaB:961:1010	In this case, ER modulates the activities of transcription factors such as the [TF], nuclear factor-kappaB ([TG]) and stimulating protein-1 (Sp-1), by stabilizing DNA-protein complexes and/or recruiting co-activators.	activator protein (AP)-1	NF-kappaB	3726	4790	961	1010	0.001185640916951	Non valid	0.9338556589532354;0.06157604391877859;0.004568297127985902	UNDEFINED	18369406	JUNB	9606	NFKB1	9606	dbTF		NFKB
54822	PMID:22623725:pubtator_title_and_abstract:761807141f2f501f858cc63691f1a85d:9:MLL1:NF-kappaB.:1179:1052	The MLL1 complex is found both in the nucleus and cytoplasm and is associated with [TG] CHIP assays proved that the translocation of MLL1 to chromatin was dependent on NF-kappaB. Our results suggest that [TF] is recruited to its target genes by activated NF-kappaB and regulates their transcription.	MLL1	NF-kappaB.	4297	4790	1179	1052	0.0011437970795791	Non valid	0.9980195049455498;0.0012700236243084412;0.00071047143014172	UNDEFINED	22623725	KMT2A	9606	NFKB1	9606	dbTF		NFKB
54850	PMID:34116185:pubtator_title_and_abstract:7d58231fe640f9fd1bf4b112171cc699:9:NF-kappaB:nuclear factor-kappa B:1420:1396	The expressions of target proteins in [TG] ([TF]) and mitogen-activated protein kinase (MAPK) were determined by western blot analysis.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	18033	1420	1396	0.0011933668741145	Non valid	0.9953004331456055;0.003703763080191013;0.0009958037742034782	UNDEFINED	34116185	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
54856	PMID:30292843:pubtator_title_and_abstract:d304530c795bbc8ec266298fdd6b449b:16:TRAF6:NF-kappaB:1842:1848	TLR4 activation results in increased proliferation due to the TLR4-MyD88-[TF]-[TG] signaling pathway, and inhibition of NF-kappaB leads to decreased esophageal cell growth.	TRAF6	NF-kappaB	7189	4790	1842	1848	0.0011107347958258	Non valid	0.12579206711780427;0.8718934509715347;0.002314481910661021	ACTIVATION	30292843	TRAF6	9606	NFKB1	9606	coTF		NFKB
54869	PMID:26684801:pubtator_title_and_abstract:46b2fb598881a480cc7225017e71d96c:11:STAT-3:NF-kappaB:1261:1250	In addition, [TG], [TF], and HIF-1 play a crucial role in radiation-induced inflammatory responses embedded in a complex inflammatory network.	STAT-3	NF-kappaB	6774	4790	1261	1250	0.0011579442844166	Non valid	0.8259972848942385;0.16953320068380387;0.0044695144219576415	UNDEFINED	26684801	STAT3	9606	NFKB1	9606	dbTF		NFKB
54893	PMID:35986876:pubtator_title_and_abstract:972239b2ed76e484bb1aa6d85d658f47:14:HMGB1:NF-kappaB:1368:1377	Treatment with polydatin increased the expression of the Sirt1 but decreased the expression of the [TF], p-[TG], IL-1b, and TNF-alpha in the LPS-induced depression mice.	HMGB1	NF-kappaB	15289	18033	1368	1377	0.00118358497878	Non valid	0.05779088448737522;0.8927557852654273;0.04945333024719746	ACTIVATION	35986876	Hmgb1	10090	Nfkb1	10090	coTF		NFKB
54924	PMID:7520524:pubtator_title_and_abstract:304482832edaba475997261f12733ba9:9:HMG-I(Y):NF-kappa B:1392:1296	We demonstrate that the binding affinity of the p50 subunit of [TG] to both NF-kappa B sites within the E-selectin promoter is significantly enhanced by [TF].	HMG-I(Y)	NF-kappa B	3159	4790	1392	1296	0.0011996203936373	Non valid	0.9735438249085656;0.02513551554692255;0.0013206595445118229	UNDEFINED	7520524	HMGA1	9606	NFKB1	9606	dbTF		NFKB
54927	PMID:26626357:pubtator_title_and_abstract:c2268058056e477b699bee4689469824:9:MyD88:NF-kappaB:1660:1671	Taken together, the present data indicate that the TLR2, [TF], and [TG] pathways, Dectin-1 signaling, and intracellular ROS generation contribute to the Mch-mediated expression of chemokine genes in BMDMs.	MyD88	NF-kappaB	17874	18033	1660	1671	0.0011145773063133	Non valid	0.012331423371764013;0.9865992305885937;0.001069346039642393	ACTIVATION	26626357	Myd88	10090	Nfkb1	10090	coTF		NFKB
55032	PMID:25038279:pubtator_title_and_abstract:5a81ce37b6d4fe99a96e1b584cc04412:5:NF-kappaB:NF-kappaB:611:685	Over-expression of CgSIMPL does not activate the [TF] reporter in the HEK293 cell line, but can enhance Rel-dependent [TG] transactivation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	611	685	0.0016466636890548	Non valid	0.005964363566781155;0.9906397484457725;0.003395887987446316	ACTIVATION	25038279	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
55100	PMID:9488049:pubtator_title_and_abstract:439fa390e6d884141aaceb65588f2e5e:7:IkappaBalpha:NF-kappaB:1181:1059	Our results imply that T cells need to maintain a certain level of [TG] transcriptional activity in order to survive; up- or down-regulation of nuclear NF kappaB through modulation of [TF] expression by cytokines or DEX may lead to cell survival or cell death, respectively.	IkappaBalpha	NF-kappaB	4792	4790	1181	1059	0.0028606952125094	Non valid	0.41379044621643973;0.47744192727450663;0.1087676265090536	ACTIVATION	9488049	NFKBIA	9606	NFKB1	9606	coTF		NFKB
55304	PMID:14769342:pubtator_title_and_abstract:981966bce053d6e059abef7edcc29648:2:IKKbeta:NF-kappaB:228:395	In response to diverse stimuli, the transcription factor NF-kappaB is activated by the IKK kinase complex containing two kinases (IKKalpha and [TF]) that phosphorylate IkappaB, an inhibitory protein of NF-kappaB. The phosphorylation of IkappaB results in ubiquitination and degradation of IkappaB, allowing [TG] to translocate to the nucleus where it regulates its target genes.	IKKbeta	NF-kappaB	3551	4790	228	395	0.0011119649911193	Non valid	0.011077093251369406;0.9877466000008153;0.0011763067478153188	ACTIVATION	14769342	IKBKB	9606	NFKB1	9606	coTF		NFKB
55381	PMID:19273191:pubtator_title_and_abstract:f821db0185f05fbe08a3df07a6a40b00:8:GR:NF-kappaB:1058:1065	In view of this observation, possible reciprocal relationship between [TF] and [TG] activation might be an important regulatory factor in 2-ME mediated demise of a subpopulation of pancreatic cancer cells.	GR	NF-kappaB	2908	4790	1058	1065	0.0015233725010655	Non valid	0.44537335951058177;0.548573055226106;0.00605358526331234	ACTIVATION	19273191	NR3C1	9606	NFKB1	9606	dbTF		NFKB
55413	PMID:9890939:pubtator_title_and_abstract:a71789c2a873986148f300af8e4536c6:6:p53:NF-kappaB:658:608	Increased levels of the coactivator relieve p53-mediated repression of [TG] activity and p65-mediated repression of [TF]-dependent gene expression.	p53	NF-kappaB	7157	4790	658	608	0.0013158626562891	Non valid	0.021268762484425854;0.3496809773614135;0.6290502601541607	REPRESSION	9890939	TP53	9606	NFKB1	9606	dbTF		NFKB
55474	PMID:19240648:pubtator_title_and_abstract:e288132a59ac1880a1d254a5e439e4cf:4:peroxisome proliferator-activated receptor-gamma:nuclear factor-kappaB:642:497	Intracellular effects of PGD2 and 15d-PGJ2 that may suppress inflammation include inhibition of [TG] (NF-kappaB) by multiple mechanisms (IkappaB kinase inhibition and blockade of NF-kappaB nuclear binding) and activation of [TF] (PPAR-gamma).	peroxisome proliferator-activated receptor-gamma	nuclear factor-kappaB	5468	4790	642	497	0.00117375654234	Non valid	0.06802954154069296;0.14587061488753464;0.7860998435717725	REPRESSION	19240648	PPARG	9606	NFKB1	9606	dbTF		NFKB
55520	PMID:28068095:pubtator_title_and_abstract:a95f3fb90a934307ff5b329cfd94ab20:6:ERK:NF-kappaB:738:723	Furthermore, 7a remarkably down-regulated AKT, [TG], and [TF] activation and HIF-1alpha expression in K562/A02 cells, which are associated with the tumor cell proliferation and drug resistance.	ERK	NF-kappaB	5594	4790	738	723	0.001213795424036	Non valid	0.002315410559148131;0.995188309093645;0.002496280347206861	ACTIVATION	28068095	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
55560	PMID:10905518:pubtator_title_and_abstract:eb38ccdfc242dc4660a208bb2798590a:7:AP-1:NF-kappaB:1068:1101	These include genotoxicity, DNA damage, lipid peroxidation, activation of transcription factors activator protein-1 ([TF]) or nuclear factor kappa B ([TG]), and p53 or k-ras gene alterations.	AP-1	NF-kappaB	3726	4790	1068	1101	0.0011823423698699	Non valid	0.05992171606566438;0.934622717724126;0.005455566210209655	ACTIVATION	10905518	JUNB	9606	NFKB1	9606	dbTF		NFKB
55639	PMID:20192578:pubtator_title_and_abstract:90502f34a24ae5713f1ffac1d6db46dc:6:NF-kappaBp50:NF-kappaB:689:808	The inhibited nuclear translocation of NF-kappaBp65, [TF], NF-kappaB-c-Rel, c-Fos, ATF-2 and CREB-1 in Punarnavine treated B16 F-10 cells pointed to suppression of [TG] signaling by Punarnavine.	NF-kappaBp50	NF-kappaB	18033	18033	689	808	0.0011813989599206	Non valid	0.05120419563933125;0.9451649597567859;0.0036308446038828593	ACTIVATION	20192578	Nfkb1	10090	Nfkb1	10090	dbTF		NFKB
55676	PMID:15048722:pubtator_title_and_abstract:8190f409ace9f039bb5bdbab60985569:5:NF-IL6:NF-kappa B:593:607	In this study, we show that the IL-4 promoter is synergistically activated by NF-kappa B, NF-AT and [TF] at the [TG]/NF-AT/NF-IL6 composite sites.	NF-IL6	NF-kappa B	1051	4790	593	607	0.0011605442632572	Non valid	0.009097779361222096;0.9899972565329006;0.0009049641058773215	ACTIVATION	15048722	CEBPB	9606	NFKB1	9606	dbTF		NFKB
55757	PMID:21592969:pubtator_title_and_abstract:8889c9747693691551bd07bcfeee09ea:0:Nuclear factor-kappaB:NF-kappaB:0:23	[TF] ([TG]) p65 interacts with Stat5b in growth plate chondrocytes and mediates the effects of growth hormone on chondrogenesis and on the expression of insulin-like growth factor-1 and bone morphogenetic protein-2.	Nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	0	23	0.0011621566425533	Non valid	0.9497692390831837;0.04612959782656287;0.004101163090253391	UNDEFINED	21592969	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
55836	PMID:10753918:pubtator_title_and_abstract:757375f2ff76e224a5608cb3074e841f:7:p65:NF-kappaB:1260:1246	By contrast, truncation at Gly(359) created a dominant-negative mutant that inhibited ligand-induced cell death and activation of [TG] p50/[TF] heterodimers.	p65	NF-kappaB	5970	4790	1260	1246	0.0012471219210932	Non valid	0.0019301146856908805;0.995705176356973;0.0023647089573361263	ACTIVATION	10753918	RELA	9606	NFKB1	9606	dbTF		NFKB
55857	PMID:34818056:pubtator_title_and_abstract:594bfea7e137f160d1d4c1b15d49a391:10:S100A9:NF-kappaB:1232:1263	In silico analyses identified a potential miR-21/special AT-rich sequence-binding protein 1 (SATB1)/S100 calcium binding protein A9 ([TF])/nuclear factor kappaB ([TG]) axis, which was further investigated.	S100A9	NF-kappaB	20202	18033	1232	1263	0.0011656398603728	Non valid	0.9927334597174778;0.006614957060818445;0.0006515832217036424	UNDEFINED	34818056	S100a9	10090	Nfkb1	10090	ll_coTF		NFKB
55902	PMID:11884428:pubtator_title_and_abstract:628a48bb2003c701bde310c86594a348:8:NF-kappaB:NF-kappaB:1734:1469	Thalidomide abolished the [TG]-dependent reporter gene expression activated by overexpression of TNFR1, TNFR-associated factor-2, and NF-kappaB-inducing kinase, but not that activated by the p65 subunit of NF-kappaB. Overall, our results clearly demonstrate that thalidomide suppresses [TF] activation specifically induced by TNF and H(2)O(2) and that this may contribute to its role in suppression of proliferation, inflammation, angiogenesis, and the immune system.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1734	1469	0.0011205043356676	Non valid	0.002531536856315434;0.9963507419037531;0.0011177212399315418	ACTIVATION	11884428	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
55927	PMID:22762947:pubtator_title_and_abstract:f610709000062a4fa95f7a2d29aac1c9:4:NF-kappaB:NF-kappaB:709:658	In patients with sALS or OPTN-ALS, the expression pattern of [TG] was altered when compared to that of NC; [TF] immunoreactivity tended to be absent from neuronal nucleus and was increased in microglia.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	709	658	0.0012141585126542	Non valid	0.9432546385283754;0.024760074568124454;0.031985286903500054	UNDEFINED	22762947	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
55935	PMID:16513841:pubtator_title_and_abstract:7a1ea27dcc4c11a4626240487e3aab3b:6:p65:NF-kappaB:771:716	An initial [TG] activation event enhances the recruitment of [TF] and ELF1 to the NFKB1 promoter, leading to p65- and ELF1-dependent synthesis of p105/p50, which promotes an exchange of NF-kappaB complexes to p50-containing complexes with an increased DNA-binding activity to certain NF-kappaB target elements.	p65	NF-kappaB	5970	4790	771	716	0.0012159228850649	Non valid	0.420745027717114;0.5762427518769323;0.003012220405953828	ACTIVATION	16513841	RELA	9606	NFKB1	9606	dbTF		NFKB
56001	PMID:16608838:pubtator_title_and_abstract:8cd2b72260682205bf5c49c196f200aa:5:NF-kappaB:NF-kappaB:783:796	Inhibition of [TF] by [TG]-specific suppressor SRIkappaBalpha reversed the suppressive effects of lipopolysaccharide and tumor necrosis factor-alpha.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	783	796	0.0031484596403588	Non valid	0.010338284710516267;0.2076802382546169;0.7819814770348669	REPRESSION	16608838	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
56147	PMID:27673475:pubtator_title_and_abstract:1cb8f6a6424f8cf602224dbb35da721c:8:p65:NF-kappa-B:896:861	Moreover, miR-155 deficiency aberrantly activated [TG] signaling via enhancing [TF] and IKKepsilon expression.	p65	NF-kappa-B	19697	18033	896	861	0.0012716927618514	Non valid	0.3404157145998129;0.4068017609612079;0.25278252443897925	ACTIVATION	27673475	Rela	10090	Nfkb1	10090	dbTF		NFKB
56152	PMID:23298677:pubtator_title_and_abstract:aa0dd6323e2f0e63112611a511ce4d12:8:IkappaBalpha:NF-kappaB:991:941	Furthermore, EIH not only inhibited [TG] luciferase activity, phosphorylation of [TF] in LPS-activated cells but also significantly suppressed expression of adhesion molecules (ICAM-1 and VCAM-1) in TNF-alpha activated human umbilical vein endothelial cells.	IkappaBalpha	NF-kappaB	4792	4790	991	941	0.013534809614387	Non valid	0.011159683106464653;0.9858989980171992;0.002941318876336246	ACTIVATION	23298677	NFKBIA	9606	NFKB1	9606	coTF		NFKB
56191	PMID:33419223:pubtator_title_and_abstract:a927e8685338d51f73f5bc8060bc39bd:8:nucleus factor-kappa-light-chain-enhancer of activated B cells:NFkappaB:908:972	In addition, an increase in [TF] ([TG]), as well as of microglia/macrophages and T-cells could be observed.	nucleus factor-kappa-light-chain-enhancer of activated B cells	NFkappaB	Complex:NFKB	4790	908	972	0.0013001897537108	Non valid	0.018177628146945613;0.9740007747305475;0.00782159712250688	ACTIVATION	33419223	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
56201	PMID:17785853:pubtator_title_and_abstract:62337438bade7f520beef1ef4bf0fd77:9:NF-kappaB:NF-kappaB:1890:1590	Involvement of [TG] activation in LPS-, Abeta-, PrP-, poly IC-, Tat-, and MPP+-, but not IFN-gamma-, induced microglial expression of iNOS and stimulation of IkappaBalpha expression and inhibition of NF-kappaB activation by gemfibrozil via the PI3K pathway suggests that gemfibrozil inhibits the activation of [TF] and the expression of proinflammatory molecules in microglia via PI3K-mediated up-regulation of IkappaBalpha.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1890	1590	0.0012796618054363	Non valid	0.008100262417815543;0.9905099654323338;0.0013897721498506263	ACTIVATION	17785853	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
56257	PMID:26492645:pubtator_title_and_abstract:c9f2854ca91c8fedc2aab34e2fdbf7c6:8:p65:nuclear factor-kappaB:1085:1051	In addition, we demonstrated that Sch B blocked the phosphorylation of IkappaBalpha, [TG] (NF-kappaB) [TF], p38 mitogen-activated protein kinase (MAPK), c-Jun NH2-terminal kinase, and extracellular signal regulated kinase in DSS-induced acute colitis.	p65	nuclear factor-kappaB	19697	18033	1085	1051	0.0011706094903418	Non valid	0.07359392671123233;0.9203802999097338;0.006025773379033962	ACTIVATION	26492645	Rela	10090	Nfkb1	10090	dbTF		NFKB
56324	PMID:21715489:pubtator_title_and_abstract:236ffe72d498aea309a760f09b3f98c5:6:xIAP:NF-kappaB:959:890	Accordingly, inhibition of NF-kappaB signaling resulted in the downregulation of [TG]-regulated antiapoptotic genes, including cIAP1, cIAP2, and [TF] genes.	xIAP	NF-kappaB	331	4790	959	890	0.0012479522176062	Non valid	0.9474644452021094;0.04986348468683081;0.002672070111059724	UNDEFINED	21715489	XIAP	9606	NFKB1	9606	coTF		NFKB
56400	PMID:19816657:pubtator_title_and_abstract:2eac067e81d003b232203346d1300c68:8:JNK1/2:NFkappaB:1303:1218	RL90 and RL91 also modulated the expression of key cell signaling proteins, specifically, in SKBr3 cells, protein levels of Her-2, Akt, and [TG] were decreased in a time-dependent manner, while activity of stress kinases [TF] and P38 MAPK were increased.	JNK1/2	NFkappaB	5599;5601	4790	1303	1218	0.0011935427952872	Non valid	0.06026772979741786;0.7320863446092706;0.20764592559331152	ACTIVATION	19816657	MAPK8;MAPK9	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
56450	PMID:12614893:pubtator_title_and_abstract:38cdfe01018bea28b1c38717b25bb5c2:2:Egr-1:NF-kappaB:219:226	Curcumin, the yellow pigment of the rhizome of Curcuma longa is known to inhibit the transcription factors AP-1, [TF], [TG], c-myc and several important signaling kinases.	Egr-1	NF-kappaB	1958	4790	219	226	0.0012256722233948	Non valid	0.012970901569174824;0.9795836638733233;0.0074454345575020045	ACTIVATION	12614893	EGR1	9606	NFKB1	9606	dbTF		NFKB
56502	PMID:23426622:pubtator_title_and_abstract:71edb7bb9c066c2cc11d678fa2879120:10:NF-kappaB:NF-kappaB:1136:1042	Three different [TG] reporter cell lines including NF-kappaB/293/GFP-Luc , NF-kappaB/Jurkat/GFP  and RAW/[TF]/SEAPorter  were stimulated with the 23 fractions.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1136	1042	0.0019582243441592	Non valid	0.30488292655773747;0.6909264062092982;0.004190667232964195	ACTIVATION	23426622	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
56551	PMID:16630544:pubtator_title_and_abstract:836ceb0a1beee43b235475426534a031:11:Bcl-2:NF-kappaB:1233:1243	HGF significantly promoted the expression of [TF] and [TG], while decreasing the activities of caspase-3 and -9 without affecting Bax level.	Bcl-2	NF-kappaB	596	4790	1233	1243	0.0013151403539095	Non valid	0.006398643529168301;0.9883607028774122;0.005240653593419425	ACTIVATION	16630544	BCL2	9606	NFKB1	9606	coTF		NFKB
56612	PMID:11180173:pubtator_title_and_abstract:6063d684e96146566f1ca4ec12aa9392:7:c-jun:nuclear factor kappa B:1179:1274	In contrast to the massive activation of [TF] and p38, only a small population of the suprabasal cells showed nuclear translocation of [TG] (NFkappaB), and a few scattered cells became apoptotic, as determined by TUNEL (TdT mediated dUTP nick end labelling) staining.	c-jun	nuclear factor kappa B	3725	4790	1179	1274	0.0011186472663205	Non valid	0.06132307242301345;0.9318866094591244;0.006790318117862203	ACTIVATION	11180173	JUN	9606	NFKB1	9606	dbTF		NFKB
56613	PMID:16079150:pubtator_title_and_abstract:76f0e6188fcdd25f3dbbad8786b53312:10:IKKalpha:NF-kappaB:1560:1621	At the same time, peroxynitrite activated phosphorylation of NF-kappaB-inducing kinase and [TF], considered as part of an alternative, noncanonical [TG] activation pathway.	IKKalpha	NF-kappaB	1147	4790	1560	1621	0.0310220080559552	Non valid	0.011588978039055613;0.9867468689760219;0.001664152984922358	ACTIVATION	16079150	CHUK	9606	NFKB1	9606	coTF		NFKB
56639	PMID:24953853:pubtator_title_and_abstract:fbc76feb2825fb31910213d234912998:5:Akt:NF-kappaB:717:808	Dieckol (12.5-50 muM) inhibited nitric oxide production and attenuated inducible nitric oxide synthase, phospho (p)-PI-3K, p-[TF], p-IKK-alpha/beta, p-IkappaB-alpha and nuclear p-NF-kappaBp65 protein expressions, and [TG] transcriptional activity in LPS (0.1 mug/ml) stimulated murine macrophages.	Akt	NF-kappaB	11651	18033	717	808	0.0013216811609342	Non valid	0.002703065705668246;0.9940224235925357;0.0032745107017959985	ACTIVATION	24953853	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
56695	PMID:8943328:pubtator_title_and_abstract:f1c147b3d69b4d2153dca603bc560b89:6:IkappaBalpha:NF-kappaB:1003:911	Interestingly, activation of these [TG]/Rel complexes by the CD28 signal is associated with the rapid degradation of both [TF] and IkappaBbeta, two major cytoplasmic inhibitors of NF-kappaB/Rel.	IkappaBalpha	NF-kappaB	4792	4790	1003	911	0.001167782014075	Non valid	0.01704984771103197;0.04516685469435077;0.9377832975946173	REPRESSION	8943328	NFKBIA	9606	NFKB1	9606	coTF		NFKB
56761	PMID:33210684:pubtator_title_and_abstract:2e218a3c84cb54b19d47a8f808216089:9:HMGB-1:NF-kappaB:1197:1209	Moreover, the pathological changes in the liver and kidney were mainly mediated by reducing gluconeogenesis and increasing glycogenesis via stimulation of the PI3K/AKT signaling pathway and regulation of the [TF]/TLR4/[TG] signaling pathway, which simultaneously interrelated to ten main pathological pathways.	HMGB-1	NF-kappaB	15289	18033	1197	1209	0.0011015945861047	Non valid	0.9940929609924036;0.0041906466812425954;0.0017163923263537853	UNDEFINED	33210684	Hmgb1	10090	Nfkb1	10090	coTF		NFKB
56773	PMID:12065326:pubtator_title_and_abstract:166828c7bb190ef7b7e0d5f05aae60e4:0:c-Jun:NF-kappaB:127:137	Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced [TF] and [TG] activation and adhesion molecule expression.	c-Jun	NF-kappaB	3725	4790	127	137	0.001329768936704	Non valid	0.1346673860222117;0.8594008243537841;0.00593178962400423	ACTIVATION	12065326	JUN	9606	NFKB1	9606	dbTF		NFKB
56792	PMID:17053833:pubtator_title_and_abstract:1784baa64f76899a27a70489adbe5aaf:5:NFATc1:NF-kappaB.:819:781	PLCgamma2, independent of PLCgamma1, was required for receptor activator of NF-kappaB ligand-induced (RANKL-induced) osteoclastogenesis by differentially regulating nuclear factor of activated T cells c1 (NFATc1), activator protein-1 (AP1), and [TG] Specifically, we show that [TF] upregulation is dependent on RANKL-mediated phosphorylation of PLCgamma2 downstream of Dap12/Fc receptor gamma (Dap12/FcRgamma) receptors and is blocked by the PLCgamma inhibitor U73122.	NFATc1	NF-kappaB.	18018	18033	819	781	0.0012625945018125	Non valid	0.10774793579870547;0.8858698679452721;0.006382196256022415	ACTIVATION	17053833	Nfatc1	10090	Nfkb1	10090	dbTF		NFKB
56801	PMID:21790943:pubtator_title_and_abstract:4d96f88aa638daccacf2e9e89b344c67:7:AP-1:NF-kappaB:1121:1106	Luciferase reporters and chromatin immunoprecipitation assays suggest that J96-1 invasion increases [TG]- and [TF]-DNA-binding activities in 5637 cells.	AP-1	NF-kappaB	3725	4790	1121	1106	0.001241058386493	Non valid	0.9064161754152409;0.08936916394484835;0.004214660639910805	UNDEFINED	21790943	JUN	9606	NFKB1	9606	dbTF		NFKB
57086	PMID:22367622:pubtator_title_and_abstract:07ec2c0a4585a50e754db222e5865c09:8:Keap1:NF-kappaB:1406:1700	In order to inhibit the NF-kappaB activity, EGCG can promote the             dissociation of the nuclear factor E2-related factor 2 (Nrf2)-Kelch-like ECH-associated             protein 1 ([TF]) complex; when the released Nrf2 translocates to the nucleus             and activates the transcription of genes containing an ARE element inhibition             of NF-kappaB occurs and Keap1 is separated from the complex to directly interact with             IKKbeta and thus represses [TG] function.	Keap1	NF-kappaB	9817	4790	1406	1700	0.0067778546603228	Non valid	0.015132808142150905;0.07844903343726894;0.90641815842058	REPRESSION	22367622	KEAP1	9606	NFKB1	9606	coTF		NFKB
57097	PMID:10841980:pubtator_title_and_abstract:6a78b535fbf1d5be9d6cb91bfb4f1cba:4:RelA:NF-kB:535:460	Supershift analysis of [TG] DNA-binding activity in nuclear extracts of spinal cords showed that [TF]/p65 and p50 subunits but not c-Rel/p75, RelB/p68 and p52 subunits were involved in DNA binding.	RelA	NF-kB	309165	309165	535	460	0.001185302999688	Non valid	0.9971705296787321;0.0019807444930371836;0.0008487258282307765	UNDEFINED	10841980	Rela	10116	Rela	10116	dbTF		NFKB
57142	PMID:27911816:pubtator_title_and_abstract:90c1c9d7cb9958cf0e5a6e294a597658:6:filamin-A:NF-kappaB:946:1155	Specifically, we identified (i) a frame-shift insertion in the [TF] gene, which regulates the influx and efflux of topoisomerase II poisons; (ii) the overexpression of aldo-keto reductase enzymes, which convert doxorubicin into doxorubicinol; and (iii) activation of [TG] via alterations in the nucleotide-binding oligomerization domain (NOD)-like receptor signaling pathway from mutations in three genes (CARD6, NSD1, and NLRP13) and the overexpression of inflammatory cytokines.	filamin-A	NF-kappaB	2316	4790	946	1155	0.0018666009230066	Non valid	0.01260736426247008;0.9806661501807511;0.006726485556778806	ACTIVATION	27911816	FLNA	9606	NFKB1	9606	coTF		NFKB
57221	PMID:19662631:pubtator_title_and_abstract:c569c7fbb91f737289a3eb6cc182e666:6:IkappaB kinase alpha/beta:NF-kappaB:769:830	We show that Notch1 signaling promotes NF-kappaB translocation to the nucleus and DNA binding by increasing both phosphorylation of the [TF] complex and the expression of some [TG] family members.	IkappaB kinase alpha/beta	NF-kappaB	1147;3551	4790	769	830	0.0289272582047305	Non valid	0.24718970148185918;0.7478759482871004;0.004934350231040548	ACTIVATION	19662631	CHUK;IKBKB	9606;9606	NFKB1	9606	coTF;coTF		NFKB
57248	PMID:28843855:pubtator_title_and_abstract:395e798ac92ed566d0319b1a2320560e:9:NF-kappaB:NF-kappaB.:1643:1704	Notably, metformin attenuated the increases in protein levels; reduced co-localization of TUNEL-positive ganglion cells and OGT, ChREBP, TXNIP, or [TF]; and reduced interaction between OGT and ChREBP or [TG] Our results indicate that OGT inhibition might be one of the mechanisms by which metformin decreases retinal cell death.	NF-kappaB	NF-kappaB.	Complex:NFKB	18033	1643	1704	0.0011250772951496	Non valid	0.9850962790503663;0.013328621191023739;0.0015750997586097858	UNDEFINED	28843855	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
57332	PMID:23566060:pubtator_title_and_abstract:c421d5e7c0b769d8b7c5e20209cf306e:2:vascular endothelial growth factor:NFkappaB:360:346	Enterolactone and enterodiol, mammalian lignans derived from dietary sources such as flaxseed, sesame seeds, kale, broccoli, and apricots, may impede tumor proliferation by inhibiting activation of nuclear factor kappa B ([TG]) and [TF] (VEGF).	vascular endothelial growth factor	NFkappaB	7422	4790	360	346	0.0011752218441589	Non valid	0.0043964475291742395;0.990880718325247;0.004722834145578682	ACTIVATION	23566060	VEGFA	9606	NFKB1	9606	ll_coTF		NFKB
57355	PMID:23178654:pubtator_title_and_abstract:9e3cf90de5c609e0c69d0bbf6d742b63:2:ERK-2:NFkappaB:371:377	Previously, our in vivo studies demonstrated that folic acid (FA) could inhibit angiogenesis and in vitro studies showed that FA reduced vascular endothelial cell proliferation through activating the cSrc/[TF]/[TG]/p53 pathway mediated by FA receptor (FR).	ERK-2	NFkappaB	5594	4790	371	377	0.0011093997432931	Non valid	0.11530746001512103;0.7540408312151945;0.13065170876968454	ACTIVATION	23178654	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
57437	PMID:36083478:pubtator_title_and_abstract:517973f2325fe0ec2d8db3f24dad284c:7:Nuclear factor-kappaB:NF-kappaB:645:668	[TF] ([TG]) pathway and nuclear factor-erythroid 2-related factor 2 (Nrf2) family members were evaluated by Western blotting.	Nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	645	668	0.0011663748625552	Non valid	0.9839307646009846;0.014947635293433117;0.0011216001055822783	UNDEFINED	36083478	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
57494	PMID:21513709:pubtator_title_and_abstract:f01e3cf19b777fa80dc3156c71726a89:8:Akt:NF-kappaB:1347:1333	These results suggest that luteolin plays a central role in ameliorating LPS-induced inflammatory cascades via inactivation of the [TG] and [TF] pathways, and that chicoric acid strengthens the anti-inflammatory activity of luteolin through NF-kappaB attenuation.	Akt	NF-kappaB	11651	18033	1347	1333	0.0011207901681167	Non valid	0.03522638518800299;0.9450205633311003;0.019753051480896698	ACTIVATION	21513709	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
57513	PMID:17641044:pubtator_title_and_abstract:6516d3b77b699f39bc97fc1cba122438:7:p65:NF-kappaB:947:1114	Despite blockade of both the classical ([TF]/p50) and alternative (RelB/p52) NF-kappaB activation pathways, estrogen induced constitutive NF-kappaB activity and increased the levels of cytokines regulated by [TG] (IL-1 alpha, IL-1 beta, IL-10, and IFN-gamma).	p65	NF-kappaB	19697	18033	947	1114	0.0021159243853001	Non valid	0.9467076016981102;0.044058313786897646;0.009234084514992134	UNDEFINED	17641044	Rela	10090	Nfkb1	10090	dbTF		NFKB
57599	PMID:12716675:pubtator_title_and_abstract:27fc8148479b8d415498e0123420f589:6:NFkappaB:NFkappaB:1248:1265	RESULTS: The nuclear appearance of p50-[TF] and p65-[TG] acutely induced by TNF-alpha was not modified by resveratrol but was increased after overnight incubation with resveratrol alone or in combination with TNF-alpha.	NFkappaB	NFkappaB	Complex:NFKB	4790	1248	1265	0.0012648808744945	Non valid	0.03273822270461296;0.9642905224110837;0.0029712548843033575	ACTIVATION	12716675	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
57658	PMID:16410078:pubtator_title_and_abstract:2e574825a66496d7e731f1ea1c5c74c5:6:IkappaBbeta:NFkappaB:1002:907	However, [TG] activation occurred without degradation of inhibitory IkappaB proteins (IkappaBalpha, [TF], and IkappaBepsilon).	IkappaBbeta	NFkappaB	4793	4790	1002	907	0.0017449855820276	Non valid	0.018033415364132645;0.17819313271923642;0.803773451916631	REPRESSION	16410078	NFKBIB	9606	NFKB1	9606	coTF		NFKB
57713	PMID:12716675:pubtator_title_and_abstract:27fc8148479b8d415498e0123420f589:10:NF-kappaB:NF-kappaB:2055:2150	The increase in tyrosine phosphorylation of IkappaBalpha, p50-[TF], and p65-NF-kappaB suggests the involvement of such alterations in the modulation of [TG] transcription activity.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	2055	2150	0.2390523136435756	Non valid	0.9871324749399809;0.009999591549743872;0.0028679335102752314	UNDEFINED	12716675	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
57721	PMID:27211850:pubtator_title_and_abstract:0bb475908ce1614a615c95656173e4c4:5:NFkappaB:NFkappaB:696:808	Since disruption of NFkappaB pathway can also affect neuronal survival, we assessed the role of [TF] in bortezomib-induced neuropathy by using a transgenic mouse that selectively provides blockage of the [TG] pathway in neurons.	NFkappaB	NFkappaB	Complex:NFKB	18033	696	808	0.0010715342737312	Non valid	0.9224838593342063;0.06774277573387981;0.009773364931913922	UNDEFINED	27211850	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
57765	PMID:15893696:pubtator_title_and_abstract:e17931baafe538f1839b906dccb24a2a:5:JNK:NF-kappaB.:963:998	LPS-induced DcR3 releases in IECs appeared to be via the activation of mitogen-activated protein kinases (MAPK) such as extracellular signal-regulated kinase 1 and 2 (ERK1/2) and c-Jun NH2-terminal protein kinase ([TF]), and the transcription factor [TG] Moreover, the increased expression of DcR3 in appendix epithelia from patients with acute appendicitis was demonstrated.	JNK	NF-kappaB.	5599	4790	963	998	0.0011294157678073	Non valid	0.016843231337481595;0.9814179406221918;0.0017388280403266112	ACTIVATION	15893696	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
57769	PMID:26981881:pubtator_title_and_abstract:507dfb50ac63739ae5bc994266162321:9:hypoxia-inducible factor 1 alpha:NF-kappaB:1391:1483	Nuclear factor NF-kappaB and [TF]-activity were analysed by DNA-binding ELISA, expression of [TG]-dependent genes and TLR-4 by luciferase-assay and flow-cytometry, respectively.	hypoxia-inducible factor 1 alpha	NF-kappaB	3091	4790	1391	1483	0.0010901528738035	Non valid	0.35306944077982444;0.6435073669728346;0.003423192247340895	ACTIVATION	26981881	HIF1A	9606	NFKB1	9606	dbTF		NFKB
57810	PMID:9890939:pubtator_title_and_abstract:a71789c2a873986148f300af8e4536c6:0:CREB-binding protein:nuclear factor-kappaB:0:48	[TF] is a nuclear integrator of [TG] and p53 signaling.	CREB-binding protein	nuclear factor-kappaB	1387	4790	0	48	0.0016620211373461	Non valid	0.9531275251280439;0.04567294358342221;0.0011995312885338806	UNDEFINED	9890939	CREBBP	9606	NFKB1	9606	coTF		NFKB
57854	PMID:11413310:pubtator_title_and_abstract:8cf37e5ee50f6cfef7ba104c27acae5b:5:C/EBP:NF-kappaB:936:925	Promoter deletion and mutagenesis experiments indicate that RSV requires the presence of five different cis regulatory elements, located in the promoter fragment spanning from -220 to +55 nucleotides, corresponding to [TG], [TF], Jun/CREB/ATF, and interferon regulatory factor (IRF) binding sites.	C/EBP	NF-kappaB	1050	4790	936	925	0.0011571418372765	Non valid	0.9903869134214972;0.008871194312462116;0.0007418922660407395	UNDEFINED	11413310	CEBPA	9606	NFKB1	9606	dbTF		NFKB
57902	PMID:15048722:pubtator_title_and_abstract:8190f409ace9f039bb5bdbab60985569:5:NF-IL6:NF-kappa B:624:607	In this study, we show that the IL-4 promoter is synergistically activated by NF-kappa B, NF-AT and NF-IL6 at the [TG]/NF-AT/[TF] composite sites.	NF-IL6	NF-kappa B	1051	4790	624	607	0.0012209801490423	Non valid	0.008324152683661929;0.9908098293363664;0.0008660179799717411	ACTIVATION	15048722	CEBPB	9606	NFKB1	9606	dbTF		NFKB
57951	PMID:31841039:pubtator_title_and_abstract:b504cdd46f7b08346b3c3bc020cc0040:0:PRKAA1:NF-kappaB:64:15	Involvement of [TG] signaling pathway in the regulation of [TF]-mediated tumorigenesis in gastric cancer.	PRKAA1	NF-kappaB	5562	4790	64	15	0.0011916851371557	Non valid	0.9706062461257786;0.027965589101857393;0.001428164772364009	UNDEFINED	31841039	PRKAA1	9606	NFKB1	9606	ll_coTF		NFKB
57960	PMID:26060140:pubtator_title_and_abstract:a979173df0a7d46861514819f3b2d7be:7:COMMD7:NF-kappaB:1114:1021	Accordingly, termination of TNFalpha-induced [TG] activity on the -kappaB responsive gene, Icam1, is defective in cells silenced for [TF] expression.	COMMD7	NF-kappaB	149951	4790	1114	1021	0.0016840184316839	Non valid	0.028762610199702124;0.6654128012065519;0.3058245885937461	ACTIVATION	26060140	COMMD7	9606	NFKB1	9606	coTF		NFKB
57963	PMID:17406816:pubtator_title_and_abstract:7d86b38803c3892111cc1eb2742cdf20:10:NF-kappaB:NF-kappaB.:1213:1042	Treatment of HT-29 cells with leptin stimulated phosphorylation of ERK and p38 MAP kinase and nuclear translocation of active [TG] We conclude that leptin stimulates colon cancer proliferation via COX-independent pathways and reduces celecoxib-induced apoptosis via ERK, p38 MAP kinase, and [TF] pathways.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	1213	1042	0.0010716287018614	Non valid	0.3296636608419262;0.6105154083752269;0.059820930782846934	ACTIVATION	17406816	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
58002	PMID:29616751:pubtator_title_and_abstract:8e06c70ed067a1e429f6cf1ee2527163:10:JNK:NF-kappaB:1547:1533	CONCLUSIONS: In conclusion, this study indicated that miR-181a could improve the survival rate of TM cells after H2O2 treatment by blocking the [TG] and [TF] signaling pathways.	JNK	NF-kappaB	5599	4790	1547	1533	0.0011074608294268	Non valid	0.027377871598313484;0.8771346047865898;0.09548752361509674	ACTIVATION	29616751	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
58006	PMID:18729103:pubtator_title_and_abstract:85e7917ae9d632da5b33e362d5b69d51:9:NF-kappaB.:NF-kappaB:1656:1562	The immunoblot, ELISA and EMSA analysis demonstrated that the treatment of HCT116 cells with delphinidin resulted in the inhibition of (i) IKKalpha, (ii) phosphorylation and degradation of IkappaBalpha, (iii) phosphorylation of NF-kappaB/p65 at Ser(536), (iv) nuclear translocation of [TG]/p65, (v) NF-kappaB/p65 DNA binding activity, and (vi) transcriptional activation of [TF] Our results suggest that delphinidin treatment of HCT116 cells suppressed NF-kappaB pathway, resulting in G2/M phase arrest and apoptosis.	NF-kappaB.	NF-kappaB	Complex:NFKB	4790	1656	1562	0.0011005396517456	Non valid	0.02089192530150567;0.9737920858983328;0.005315988800161564	ACTIVATION	18729103	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
58018	PMID:12093472:pubtator_title_and_abstract:8ed61256d4ab6a2835b1a3965a8ef068:10:IkappaB-alpha:NF-kappaB:1282:1389	However, LCY-2-CHO had no effect on the degradation of [TF] or IkappaB-beta, DNA binding activity, or transcriptional activity of nuclear factor-kappaB ([TG]).	IkappaB-alpha	NF-kappaB	4792	4790	1282	1389	0.0016762443599385	Non valid	0.48624743032506584;0.404235199450279;0.10951737022465516	UNDEFINED	12093472	NFKBIA	9606	NFKB1	9606	coTF		NFKB
58107	PMID:11552314:pubtator_title_and_abstract:b142a1c11cfec21fc9ccfa943c08f919:9:NF-kappa B:nuclear factor kappa B:951:927	Through trans-repression, they inhibit the transcription factors, including [TG] ([TF]), thereby decreasing the expression of many genes encoding inflammatory mediators.	NF-kappa B	nuclear factor kappa B	Complex:NFKB	4790	951	927	0.0011827946401526	Non valid	0.008206494595658313;0.9817077571354559;0.010085748268885798	ACTIVATION	11552314	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
58240	PMID:19007749:pubtator_title_and_abstract:3582e66c5aab9b8adbe4109908c00d32:4:IkappaB alpha:NF-kappaB.:667:640	Infection of FLS with Ad-IkappaB alpha (S32A, S36A), an adenovirus-containing mutant IkappaB alpha, inhibited IL-1beta-induced nuclear translocation and DNA binding of [TG] In addition, Ad-[TF] (S32A, S36A) prevented IL-1beta-induced inflammatory responses; namely, the production of chemokines, such as ENA-78 and RANTES, and activation of MMP-1 and MMP-3.	IkappaB alpha	NF-kappaB.	4792	4790	667	640	0.0011271992131933	Non valid	0.26775269239575;0.5809179429412393;0.1513293646630107	ACTIVATION	19007749	NFKBIA	9606	NFKB1	9606	coTF		NFKB
58247	PMID:23618270:pubtator_title_and_abstract:4d64408669403c1e1e7cb7fc573d7443:8:notch1:NF-kappaB:923:972	Western-blotting results showed that S-GFB inhibited [TF] expression, IkappaB-alpha degradation and [TG]/p65 translocation from cytoplasm into nucleus.	notch1	NF-kappaB	4851	4790	923	972	0.0012348484437126	Non valid	0.04755081946657633;0.941165522232981;0.011283658300442706	ACTIVATION	23618270	NOTCH1	9606	NFKB1	9606	dbTF		NFKB
58281	PMID:28499869:pubtator_title_and_abstract:d2de797f0a01595bc86a47dd35bfa491:3:NF-kappaB:NF-kappaB:356:255	Therefore, activated [TG] needs to be terminated after induction, which highlights the physiological significance of [TF]-negative regulators.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	356	255	0.0014340376763236	Non valid	0.0021573660685311516;0.006418830596135583;0.9914238033353333	REPRESSION	28499869	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
58300	PMID:12757110:pubtator_title_and_abstract:923feea3a9d5af5841b8bfc4d38b21c3:3:AP-1:NFkappaB:707:623	"However, TNF production is a ""late"" event in the LPS-induced Mpsi inflammatory cascade, and in addition to [TG]-associated pathways, a separate transcription factor, activator protein-1 ([TF]) is an important pathway for Mpsi proinflammatory cytokine production."	AP-1	NFkappaB	16476	18033	707	623	0.0011318940758959	Non valid	0.20992828689783755;0.7843160580809484;0.0057556550212140584	ACTIVATION	12757110	Jun	10090	Nfkb1	10090	dbTF		NFKB
58354	PMID:11181531:pubtator_title_and_abstract:8898be09836134f9864cec40c39e5ffd:12:ER alpha:NF-kappa B:2045:2088	Next, we developed stable transfectants of the human osteoblastic U2-OS cell line containing [TF] or ER beta in combination with an [TG] luciferase reporter construct.	ER alpha	NF-kappa B	2099	4790	2045	2088	0.3999303496913824	Non valid	0.93166017999508;0.06450428182866494;0.003835538176255153	UNDEFINED	11181531	ESR1	9606	NFKB1	9606	dbTF		NFKB
58363	PMID:34543116:pubtator_title_and_abstract:d25b270eadf0cef10d6daf184f6a26eb:6:DYNLL1:NF-kappaB:1072:987	In contrast to previous reports that overexpressed DYNLL1 directly inhibits the phosphorylation and degradation of the [TG] inhibitor IkappaBalpha, we found here that under physiological conditions, [TF] is required for signal-specific activation of the NF-kappaB pathway upstream of IkappaBalpha.	DYNLL1	NF-kappaB	56455	18033	1072	987	0.0021169027331678	Non valid	0.006881454374193221;0.9914608407680275;0.0016577048577792496	ACTIVATION	34543116	Dynll1	10090	Nfkb1	10090	coTF		NFKB
58409	PMID:26935541:pubtator_title_and_abstract:8d6c859873dcf2198f516d09c8d038d7:7:Stat3:NFkappaB:991:894	Both plant extracts inhibited [TG]/AMPK signalling as well as their downstream signalling proteins such as p-AKT, p-ERK, p-[TF].	Stat3	NFkappaB	6774	4790	991	894	0.0011984160473513	Non valid	0.7315621370778622;0.2634196036985831;0.005018259223554677	UNDEFINED	26935541	STAT3	9606	NFKB1	9606	dbTF		NFKB
58419	PMID:11448162:pubtator_title_and_abstract:ea07a4f8f57930aff56fa8af332e676d:11:AP-1:NF-kappaB:1613:1599	These results show that TPA induces EBV reactivation via [TG] and [TF] and that PKC is an important mediator in regulating gene expression leading to EBV reactivation after TPA treatment of GT38 cells.	AP-1	NF-kappaB	3725	4790	1613	1599	0.001169421424732	Non valid	0.006822709223513311;0.992156021617664;0.0010212691588225831	ACTIVATION	11448162	JUN	9606	NFKB1	9606	dbTF		NFKB
58478	PMID:29345372:pubtator_title_and_abstract:3271e8e14e80d81a6ef18b2b55f60a80:3:ERK:NFkappaB:405:455	The interaction between SP and its receptor, neurokinin-1 receptor (NK1R), results in major downstream cellular actions, which include changes in calcium fluxes, [TF], and p21-activated kinase phosphorylation and [TG] activation.	ERK	NFkappaB	5594	4790	405	455	0.0012556010506774	Non valid	0.022202947268064023;0.9761914700059616;0.001605582725974352	ACTIVATION	29345372	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
58510	PMID:26377645:pubtator_title_and_abstract:5d0be580516ed8511ee50437a7107b88:0:AhR:NF-kappaB:4:12	The [TF] and [TG]/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region.	AhR	NF-kappaB	11622	18033	4	12	0.0011127154742714	Non valid	0.002865683990554905;0.0061837183668368885;0.9909505976426082	REPRESSION	26377645	Ahr	10090	Nfkb1	10090	dbTF		NFKB
58561	PMID:21726060:pubtator_title_and_abstract:cf24814bf01e723dd3b394e95fb6f255:8:VEGF:nuclear factor-kappa B:1406:1331	From the results of Western blotting, the expressions of [TG] (NF-kappaB) and vascular endothelial growth factor ([TF]) were found to be remarkably reduced by DSEA.	VEGF	nuclear factor-kappa B	7422	4790	1406	1331	0.001401003851815	Non valid	0.033747388118551915;0.9547413708649156;0.01151124101653246	ACTIVATION	21726060	VEGFA	9606	NFKB1	9606	ll_coTF		NFKB
58579	PMID:12500112:pubtator_title_and_abstract:589e4719e44e30566580694c07ba6567:2:NF-kappaB:NF-kappaB:325:224	BACKGROUND: Acute alcohol treatment blocks inflammatory cytokines via inhibition of [TG] in monocytes in the presence of ongoing IkappaBalpha degradation, suggesting regulation of [TF] activation downstream of IkappaBalpha degradation.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	325	224	0.0012237593741444	Non valid	0.03996010404071157;0.9436323768398935;0.016407519119394958	ACTIVATION	12500112	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
58714	PMID:12360408:pubtator_title_and_abstract:eb92a1bc2dc4343340d75340c5787a51:4:c-rel:NF-kappaB:807:656	Utilizing an electrophoretic mobility shift assay (EMSA) and a promoter/reporter assay, we show that the [TG]/rel consensus sequence in the IEX-1 promoter is specifically bound and activated by multiple NF-kappaB/rel complexes in descending order p65-[TF]-->p65-50-->p50-50.	c-rel	NF-kappaB	5966	4790	807	656	0.001159603590108	Non valid	0.051647073566513796;0.9470381419590073;0.001314784474478948	ACTIVATION	12360408	REL	9606	NFKB1	9606	dbTF		NFKB
59200	PMID:7936641:pubtator_title_and_abstract:aee7d38bc13f29c85c61a1a0294d7993:4:NF-kappa B:NF-kappa B:606:477	Viruses, cytokines, lipopolysaccharides and other stimulating agents promote the dissociation of the cytosolic [TG]/I kappa B complexes, via phosphorylation and degradation of I kappa B, resulting in the translocation of DNA binding, [TF] complexes to the nucleus.	NF-kappa B	NF-kappa B	Complex:NFKB	18033	606	477	0.0011708799268287	Non valid	0.5020984101714655;0.06518315230560767;0.43271843752292677	UNDEFINED	7936641	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
59217	PMID:21356358:pubtator_title_and_abstract:952672f863b231a464cfe0905d01fb42:7:NEMO:NF-kappaB:890:818	Therefore, we tested two novel drugs designed to specifically inhibit [TG] by targeting the IkappaB kinase (IKK) complex: Compound A and [TF] binding domain (NBD) peptide.	NEMO	NF-kappaB	16151	4790	890	818	0.066765620215356	Non valid	0.38975954253189055;0.2817990872275097;0.32844137024059983	UNDEFINED	21356358	Ikbkg	10090	NFKB1	9606	coTF		NFKB
59243	PMID:35489384:pubtator_title_and_abstract:acb72e290fe85c96d87755f12f9d4c1c:7:FOXO3A:NF-kappaB:909:986	In mechanism, KPT-8602 restored the localization of cytoplasmic [TF], p27, p21, IkappaBalpha and PP2A into the nucleus, leading to AKT and [TG] deactivation.	FOXO3A	NF-kappaB	2309	4790	909	986	0.0020017118163181	Non valid	0.02522620682250366;0.2244931356941335;0.7502806574833628	REPRESSION	35489384	FOXO3	9606	NFKB1	9606	dbTF		NFKB
59311	PMID:9890939:pubtator_title_and_abstract:a71789c2a873986148f300af8e4536c6:3:nuclear factor-kappaB:NF-kappaB:242:265	Here we show that the p65 (RelA) component of [TF] ([TG]) and p53 mutually repress each other's ability to activate transcription.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	242	265	0.0011553473722133	Non valid	0.030399113881883353;0.8293698348762742;0.1402310512418423	ACTIVATION	9890939	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
59326	PMID:32504162:pubtator_title_and_abstract:f6e3a4eb15358f6d0a540c25c531c4f3:11:nuclear factor kappa-B:NF-kappaB:1365:1389	Molecular analysis revealed that the expression of toll-like receptor 4 (TLR4), [TF] ([TG]), and cyclooxygenase-2 (COX-2) was increased in PM2.5-stimulated RAW 254.7 cells.	nuclear factor kappa-B	NF-kappaB	Complex:NFKB	4790	1365	1389	0.0013005882523179	Non valid	0.07794919943378559;0.9181375244676042;0.003913276098610225	ACTIVATION	32504162	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
59383	PMID:18164124:pubtator_title_and_abstract:7ededd46c4a439ed044b2895d280169d:11:JNK:NF-kappaB:1374:1388	Adipocyte culture medium- and palmitate-induced MIC-1 gene expression was mediated by the activation of p38 MAPK, but not by the activation of [TF], ERK, and [TG] pathway.	JNK	NF-kappaB	5599	4790	1374	1388	0.0011247132268841	Non valid	0.009183239691965826;0.9889667277006877;0.0018500326073465712	ACTIVATION	18164124	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
59478	PMID:25577342:pubtator_title_and_abstract:b6e50440eb69b84decb05a7f55690550:9:p38:NF-kappaB:1465:1474	Thus, this study demonstrates that rTB9.8 can activate RAW264.7 and trigger IL-6 and IL-12 p40 production via the ERK, [TF], and [TG] signaling pathways.	p38	NF-kappaB	26416	18033	1465	1474	0.0011006764766134	Non valid	0.008897458700162725;0.9903070978627124;0.0007954434371248402	ACTIVATION	25577342	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
59650	PMID:30033874:pubtator_title_and_abstract:87de316efdefafcce052a4b58b8be798:7:Syk:NF-kappaB:1399:1385	The highlight of this review article is to summarize the classic and novel signaling pathways involved in [TG] and [TF] signaling and then raise some possibilities for cancer therapy.	Syk	NF-kappaB	6850	4790	1399	1385	0.0011119784969354	Non valid	0.9856984941340807;0.013489867966980703;0.0008116378989386578	UNDEFINED	30033874	SYK	9606	NFKB1	9606	ll_coTF		NFKB
60010	PMID:32418902:pubtator_title_and_abstract:e22b5504e8da30c5cccdefb6e10cbd82:2:AMPK:nuclear factor kappa B:160:234	BACKGROUND: AMP-activated protein kinase ([TF]) exerts its anti-inflammatory effects by suppressing redox-sensitive [TG] (NF-kappaB) and pro-inflammatory cytokines including TNF-alpha.	AMPK	nuclear factor kappa B	5563	4790	160	234	0.0085666896842088	Non valid	0.0027286413448721976;0.002552702759526139;0.9947186558956017	REPRESSION	32418902	PRKAA2	9606	NFKB1	9606	ll_coTF		NFKB
60136	PMID:36484427:pubtator_title_and_abstract:4a7e56827662ea739337d837753e1b96:5:c-Jun N-terminal protein kinase:NFkappaB:853:980	Moreover, ISL was found to prevent the elevation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and mitigate the phosphorylation of [TF] (JNK), protein kinase B (AKT), nuclear factor kappa light-chain enhancer of activated B cells ([TG]), and inhibitor of NFkappaB protein alpha (IkappaBalpha) in the substantia nigra and striatum of MPTP-treated mice and LPS-stimulated BV-2 cells.	c-Jun N-terminal protein kinase	NFkappaB	26419	18033	853	980	0.0011126526717889	Non valid	0.6648911242717819;0.2699914124622412;0.06511746326597687	UNDEFINED	36484427	Mapk8	10090	Nfkb1	10090	ll_coTF		NFKB
60183	PMID:28356345:pubtator_title_and_abstract:cbacb9848c49f0c981b49617e1e54a19:11:mTOR:NF-kappaB:1711:1791	In conclusion, our study suggests that mTOR activity in hepatocytes decreases hepatic vulnerability to injury through a mechanism dependent on NF-kappaB proinflammatory cytokine signaling pathway in both normal and steatotic liver.-Li, Z., Zhang, J., Mulholland, M., Zhang, W. [TF] activation protects liver from ischemia/reperfusion-induced injury through [TG] pathway.	mTOR	NF-kappaB	56717	18033	1711	1791	0.0046288096078529	Non valid	0.03826478079515426;0.9511849720274719;0.010550247177373807	ACTIVATION	28356345	Mtor	10090	Nfkb1	10090	ll_coTF		NFKB
60308	PMID:24700312:pubtator_title_and_abstract:5f5c2744a7931a951a496d234590e6fb:6:ERK:NF-kappaB:1014:1070	Further studies demonstrated that the mRNA and protein expression levels of hBD-2 were attenuated by the p38 mitogen-activated protein kinase (p38 MAPK) inhibitor SB203580, the extracellular signal-regulated kinase ([TF]) inhibitor PD98059, and the nuclear factor kappa B ([TG]) inhibitor (pyrrolidine dithiocarbamate (PDTC)).	ERK	NF-kappaB	5594	4790	1014	1070	0.0011429976201024	Non valid	0.003174288487963358;0.9850582369277143;0.011767474584322387	ACTIVATION	24700312	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
60310	PMID:21118556:pubtator_title_and_abstract:f13dbb587ca6dc3827cc4b3a1015bb86:12:NFkappaB:NFkappaB:2186:2256	CONCLUSIONS: The differential regulation of IL-6 and iNOS together with the differential activation of different [TF] dimers suggest that IL-6 and iNOS are regulated by different [TG] dimers, and differentially regulated by the microenvironment of epithelial cells.	NFkappaB	NFkappaB	Complex:NFKB	18033	2186	2256	0.0010879777924247	Non valid	0.6595347081842512;0.3343394534414771;0.0061258383742716655	UNDEFINED	21118556	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
60488	PMID:11016336:pubtator_title_and_abstract:26b64985a1163ba40b966f6cead69109:4:NF-kappaB:NF-kappaB:471:405	The purpose of this study was to determine if chemotherapy induces nuclear factor-kappa B ([TG]) activation in NSCLC in vitro and whether inhibition of [TF] would sensitize tumor cells to undergo chemotherapy-induced apoptosis.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	471	405	0.0011281284059118	Non valid	0.05902014365798225;0.8379842631919161;0.10299559315010161	ACTIVATION	11016336	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
60503	PMID:31473900:pubtator_title_and_abstract:29e9cd46d33e8848301565718c8c5d9b:8:HO-1:NF-kappaB:1286:1241	In addition, we found that PF suppressed nuclear factor kappa B ([TG]) signaling via activating the Nrf2/[TF] signaling pathways in ILPS-stimulated Caco-2 cells.	HO-1	NF-kappaB	3162	4790	1286	1241	0.001673863752185	Non valid	0.06685237729002759;0.06699896398448978;0.8661486587254826	REPRESSION	31473900	HMOX1	9606	NFKB1	9606	ll_coTF		NFKB
60536	PMID:23747852:pubtator_title_and_abstract:5f16812b05aeb30c93579fa4b310ad15:5:Erk1/2:NF-kappa B:665:739	Intriguingly, the angiogenic signaling mechanisms mediated by LPA have been linked to specific G-protein coupled receptors and down stream MAPK including [TF], p38 and JNK, protein kinase D (PKD-1), Rho kinase (ROCK), and the [TG] signaling pathways.	Erk1/2	NF-kappa B	5595;5594	4790	665	739	0.0011095387254345	Non valid	0.03281949053661166;0.011848235005075794;0.9553322744583125	REPRESSION	23747852	MAPK3;MAPK1	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
60779	PMID:17707233:pubtator_title_and_abstract:7cfe3d1265549293b494352054e5ed93:3:E2F1:NF-kappaB:403:244	Here, we mapped the genome-wide loci bound by the RELA subunit of [TG] in lipopolysaccharide (LPS)-stimulated human monocytic cells, and together with global gene expression profiling, found an overrepresentation of the [TF]-binding motif among RELA-bound loci associated with NF-kappaB target genes.	E2F1	NF-kappaB	1869	4790	403	244	0.0010937080448288	Non valid	0.9962531454830869;0.002859307495077253;0.0008875470218358857	UNDEFINED	17707233	E2F1	9606	NFKB1	9606	dbTF		NFKB
60792	PMID:28334808:pubtator_title_and_abstract:da61932791e1e287ed9bd6e59d386f87:7:STAT3:NFkappaB:1204:1214	Consistently, in AAV-NT mice, hepatic levels of active [TF] and [TG]-p65 were reduced as were expression of mesenchymal markers, STAT3 targets, NFkappaB targets and beta-catenin targets, all of which were consistent with the promotion of tumorigenesis.	STAT3	NFkappaB	20848	18033	1204	1214	0.0011938043091869	Non valid	0.0206099121681824;0.9675738763043753;0.011816211527442357	ACTIVATION	28334808	Stat3	10090	Nfkb1	10090	dbTF		NFKB
60837	PMID:20691245:pubtator_title_and_abstract:d898e8364c1e0a7b506500c940a4b397:6:p65:NF-kappaB:1050:934	To evaluate the action mode of BDB and its ability to inhibit iNOS and COX-2 protein expression, we assessed the effects of BDB on nuclear factor-kappaB (NF-kappaB) DNA-binding activity, [TG]-dependent reporter gene activity, inhibitory factor-kappaB (IkappaB) phosphorylation and degradation, and [TF] nuclear translocation.	p65	NF-kappaB	19697	18033	1050	934	0.0011373029782907	Non valid	0.4245222764994686;0.569420627020593;0.006057096479938492	ACTIVATION	20691245	Rela	10090	Nfkb1	10090	dbTF		NFKB
60849	PMID:35944463:pubtator_title_and_abstract:98ca79d3a54fabfd75fdf7df06525d6c:12:NF-kappaB:NF-kappaB:1436:1523	Phosphorylated p38 and nuclear factor-kappa B ([TF]) were markedly decreased by FTS B. Additionally, FTS B-induced inhibition of [TG] and p38-MAPK signaling pathways was reversed by Nrf2 downregulation.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1436	1523	0.0012398987001352	Non valid	0.02262251427274801;0.9518059153177727;0.025571570409479334	ACTIVATION	35944463	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
60853	PMID:21673042:pubtator_title_and_abstract:8e7d3778c40aadc04aba76f6c77354d1:0:AP-1:NF{kappa}B:152:137	Endometrial epithelial cell responses to coinfecting viral and bacterial pathogens in the genital tract can activate the HIV-1 LTR in an [TG]-and [TF]-dependent manner.	AP-1	NF{kappa}B	3726	4790	152	137	0.0011677183318727	Non valid	0.00469718073497709;0.9945025337165948;0.0008002855484281604	ACTIVATION	21673042	JUNB	9606	NFKB1	9606	dbTF		NFKB
60926	PMID:30355931:pubtator_title_and_abstract:ad1cf3f9ddd872a8674d5ca5050cab11:13:NF-kappaB p65:NF-kappaB:1850:1797	CONCLUSION: The paclitaxel+hirudin compound promotes MyD88 degradation in the TLR4/MyD88/[TG] pathway to reduce the activity of TLR4 and [TF] and to weaken the LPS-initiated inflammatory reactions of IL-1beta, IL-6, and TNF-alpha.	NF-kappaB p65	NF-kappaB	5970	4790	1850	1797	0.0011608425092876	Non valid	0.02180390360452615;0.9424024129940112;0.03579368340146268	ACTIVATION	30355931	RELA	9606	NFKB1	9606	dbTF		NFKB
61064	PMID:26663017:pubtator_title_and_abstract:be0978272af9b92c5620d6848da773b1:9:p38:NF-kappaB:1621:1533	Furthermore, these pathways were activated downstream of the MAPK and [TG] signaling molecules, as demonstrated by the inhibitory effects of ERK-, JNK-, [TF]- and NF-kappaB-specific inhibitors on cytokine/chemokine production.	p38	NF-kappaB	1432	4790	1621	1533	0.0011314752584403	Non valid	0.008662696700393876;0.9882728522747737;0.003064451024832345	ACTIVATION	26663017	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
61295	PMID:19184477:pubtator_title_and_abstract:4b1764c62cd5dd837f4ea78369898919:10:NRF2:NF-kappaB:1246:1255	On the other hand, [TF] and [TG] transcription factors were not activated.	NRF2	NF-kappaB	4780	4790	1246	1255	0.001193936224864	Non valid	0.023364887306028877;0.973688415656744;0.002946697037227079	ACTIVATION	19184477	NFE2L2	9606	NFKB1	9606	dbTF		NFKB
61321	PMID:11813576:pubtator_title_and_abstract:85c9b4e7c8dbd7284f288eed34d88a6f:3:NF-kappa B.:NF-kappa B:298:375	RAGE induces neurite outgrowth and regulate gene expression through [TF] Because the pancreatic cancer shows the constitutively activated [TG], the involvement of RAGE could be possible as a determinant for the metastatic ability.	NF-kappa B.	NF-kappa B	Complex:NFKB	4790	298	375	0.0011272703526464	Non valid	0.8665973341411649;0.12879213013334367;0.004610535725491426	UNDEFINED	11813576	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
61432	PMID:11372550:pubtator_title_and_abstract:5875e24ab272ddad64caad78e20b96c2:6:transforming growth factor (TGF)-beta 1:nuclear factor kappa B:863:1081	The following growth factors, their receptors and transcription factors were examined by reverse transcription polymerase chain reaction (RT-PCR): [TF], basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), kinase insert domain-containing receptor (KDR/flk-1), hypoxia-inducible factor (HIF)-1, ETS-1, [TG] (NF-kappa B), interleukin-8 (IL-8).	transforming growth factor (TGF)-beta 1	nuclear factor kappa B	7040	4790	863	1081	0.0011877711326126	Non valid	0.9931364663582156;0.005575599180322898;0.001287934461461515	UNDEFINED	11372550	TGFB1	9606	NFKB1	9606	ll_coTF		NFKB
61503	PMID:17194723:pubtator_title_and_abstract:1a6f7ba1e6078c5f0ef9cddcc29d23c1:9:ERbeta:NF-kappaB:1055:1147	Using chromatin immunoprecipitation assay, we confirmed that ERalpha and [TF] associated with NF-kappaB and steroid hormone coactivators at the promoter region of [TG] regulated gene.	ERbeta	NF-kappaB	2100	4790	1055	1147	0.0049881805894851	Non valid	0.9980601505386706;0.0011877172190600796;0.0007521322422693456	UNDEFINED	17194723	ESR2	9606	NFKB1	9606	dbTF		NFKB
61525	PMID:18617548:pubtator_title_and_abstract:dcebb52c104e3f70b9eca6df9ecf9442:8:ERK:NF-kappaB:1083:1026	To evaluate which signal transduction pathways were stimulated by the TCDD-AhR interaction, we used inhibitors of nuclear factor-kappaB ([TG]) and extra-cellular stimulus-activated kinase ([TF]).	ERK	NF-kappaB	5594	4790	1083	1026	0.0011768834579307	Non valid	0.08994407952651667;0.8972789518665442;0.012776968606939124	ACTIVATION	18617548	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
61541	PMID:11707390:pubtator_title_and_abstract:143e0ba195ce47b3da865468b92be20d:5:IkappaBalpha:NF-kappaB:979:1123	Differences between the two structures suggest why Bcl-3 differs from IkappaBalpha in selectivity towards various NF-kappaB species, why Bcl-3 but not [TF] can associate with its NF-kappaB partner bound to DNA, and why two molecules of Bcl-3 but only one of IkappaBalpha can bind to its [TG] partner.	IkappaBalpha	NF-kappaB	4792	4790	979	1123	0.0013973315299143	Non valid	0.9946088104414669;0.0045145285688676885;0.0008766609896654823	UNDEFINED	11707390	NFKBIA	9606	NFKB1	9606	coTF		NFKB
61549	PMID:35714925:pubtator_title_and_abstract:a92aaea0b7df16632f4acefc34ba1f88:9:nuclear receptor-related 1:NF-kappaB:1412:1380	Mechanistically, gamma-GC inhibited activation of nuclear factor kappa B ([TG]), and upregulated the [TF] (Nurr1) protein expression to suppress the transcriptional effect of NF-kappaB on the inflammatory genes.	nuclear receptor-related 1	NF-kappaB	18227	18033	1412	1380	0.0011679255203111	Non valid	0.05255662504918626;0.046095602271245574;0.9013477726795682	REPRESSION	35714925	Nr4a2	10090	Nfkb1	10090	dbTF		NFKB
61568	PMID:14627128:pubtator_title_and_abstract:4d2afa506ef7cc73ed9125955a5fd4ab:12:NF-kappaB:NF-kappaB:1528:1741	Both secretion of IL-12 p70 and IFN-gamma and activation of [TF] induced by OK-432 were suppressed when imMo-DCs were pretreated with cytochalasin B. These results indicate that uptake of OK-432 by imMo-DCs is an early critical event for IL-12 p70 production and that [TG] activation induced by OK-432 also contributes partially to IL-12 p70 production.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1528	1741	0.0012040925579241	Non valid	0.005102105174470881;0.9938065428596041;0.0010913519659250357	ACTIVATION	14627128	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
61629	PMID:21146504:pubtator_title_and_abstract:4c01335b8932faeceeeb13e031c43832:6:IkappaBalpha:NF-kappaB:1062:946	The reduction in [TG] activity following GW501516 treatment in cells stimulated with TNF-alpha did not involve either increased [TF] protein levels or a reduction in the translocation of the p65 subunit of NF-kappaB. In contrast, GW501516 treatment decreased TNF-alpha-induced p65 acetylation.	IkappaBalpha	NF-kappaB	4792	4790	1062	946	0.0015920610008966	Non valid	0.0864245397436491;0.6345096767824184;0.27906578347393246	ACTIVATION	21146504	NFKBIA	9606	NFKB1	9606	coTF		NFKB
61810	PMID:37517765:pubtator_title_and_abstract:340526bb373054693a89befa6576fd42:7:HIF-1alpha:NF-kappaB:1194:1114	The Western blot results confirmed that PCA decreased the inflammation by inhibiting the IKBalpha/[TG] signaling pathway and enhanced angiogenesis by adjusting the level of [TF].	HIF-1alpha	NF-kappaB	3091	4790	1194	1114	0.0011156664059086	Non valid	0.8057937392059021;0.1756410715551792;0.018565189238918627	UNDEFINED	37517765	HIF1A	9606	NFKB1	9606	dbTF		NFKB
61826	PMID:9572494:pubtator_title_and_abstract:c763f0d0f239145020352727ce7f78de:2:IkappaBalpha:NF-kappaB:674:1174	In three Hodgkin cell lines examined each had abnormalities in expression of IkappaBalpha which could account for the deregulated NF-kappaB. Although all three cell lines had greater than normal levels of IkappaBalpha mRNA no [TF] protein could be detected in the KM-H2 cells, while the L428 cell line contains a C-terminally truncated IkappaBalpha species that fails to associate with NF-kappaB. The HDLM-2 cell line contains a more slowly migrating form of IkappaBalpha that can associate with NF-kappaB, but increasing the level of this protein within the cell fails to inhibit nuclear NF-kappaB. Addition of recombinant IkappaBalpha to nuclear extracts from all three cell lines resulted in complete inhibition of [TG] DNA binding activity and introduction of a plasmid expressing IkappaBalpha into the cells inhibited the transcriptional activity of an NF-kappaB dependent reporter plasmid.	IkappaBalpha	NF-kappaB	4792	4790	674	1174	0.0011310991554419	Non valid	0.1651995574557539;0.24683456092538436;0.5879658816188617	REPRESSION	9572494	NFKBIA	9606	NFKB1	9606	coTF		NFKB
62046	PMID:28461486:pubtator_title_and_abstract:b194d6fa8a1cffcd7e514369368c1c19:7:IkappaBalpha:NF-kappaB:1129:1165	The enhanced newly synthesized [TF] reduced the binding of [TG] to the promoters of inflammatory genes, resulting in reduced inflammatory gene expression and cytokine production.	IkappaBalpha	NF-kappaB	18035	18033	1129	1165	0.0011611082034327	Non valid	0.3386558327619944;0.013766224738163092;0.6475779424998426	REPRESSION	28461486	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
62123	PMID:27041079:pubtator_title_and_abstract:f2264668308c9aaef33043a262a2a195:8:Bcl2:NF-kappaB:1030:978	Further, we evaluated the effect Nef on hypoxia induced inflammatory and apoptotic responses by FACS and analyzing the expression patterns of [TG], COX-2, HIF-1alpha, caspase-3, caspase-9, [TF], and Bax.	Bcl2	NF-kappaB	596	4790	1030	978	0.0012077806918009	Non valid	0.9926238669613527;0.0053097271526910675;0.002066405885956245	UNDEFINED	27041079	BCL2	9606	NFKB1	9606	coTF		NFKB
62145	PMID:25520508:pubtator_title_and_abstract:076fa9422e65b6d865ffad857dd000c0:7:JNK:NF-kappaB:1012:998	G3BP1-induced SGs are linked to activation of innate immune transcriptional responses through [TG] and [TF].	JNK	NF-kappaB	5599	4790	1012	998	0.0011740959248504	Non valid	0.04019060758213368;0.9582163472844504;0.0015930451334159833	ACTIVATION	25520508	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
62312	PMID:30604633:pubtator_title_and_abstract:7a490291e5caf359f576ae7a275537a3:10:p65:NF-kappaB:1509:1455	Additionally, we found that Nec-1 treatment abolished AGE-induced activation of the transcriptional factor [TG] by suppressing the nuclear translocation of [TF].	p65	NF-kappaB	5970	4790	1509	1455	0.0776231616940215	Non valid	0.0025178190450209333;0.9946384773102628;0.0028437036447162374	ACTIVATION	30604633	RELA	9606	NFKB1	9606	dbTF		NFKB
62469	PMID:22327045:pubtator_title_and_abstract:6b0db884864db0a2ca3653463452748f:3:Bcl-2:NF-kappaB:730:584	The objective of this study was to investigate the effect of nimbolide, a neem derived tetranortriterpenoid on NF-kappaB signaling and its downstream events - Wnt/beta-catenin activation and apoptosis evasion in human hepatocarcinoma (HepG2) cells by evaluating NF-kappaB family members ([TG]-p50, p65, IkappaB-alpha, p-IkappaB-alpha, and IKKbeta), members of Wnt signaling (GSK-3beta and beta-catenin), and intrinsic apoptosis ([TF], Bax, cytochrome c, Smac/DIABLO, caspase-3, and caspase-9).	Bcl-2	NF-kappaB	596	4790	730	584	0.0011336513451268	Non valid	0.9193652813668639;0.07161019080009497;0.00902452783304113	UNDEFINED	22327045	BCL2	9606	NFKB1	9606	coTF		NFKB
62613	PMID:23851146:pubtator_title_and_abstract:622a46d05e6ad506295cbdc8d5e5b85b:4:activator protein-1:nuclear factor-kappaB:585:613	To identify the molecular mechanisms responsible for these suppressions, we examined the effect of SF on three important transcription factors; [TF] (AP-1), [TG] (NF-kappaB), and STAT5.	activator protein-1	nuclear factor-kappaB	16476	18033	585	613	0.0011597844827398	Non valid	0.9600510479192828;0.035300090031333255;0.004648862049384008	UNDEFINED	23851146	Jun	10090	Nfkb1	10090	dbTF		NFKB
62676	PMID:26853849:pubtator_title_and_abstract:05a81ae17142571e5b91dff8a4e912e4:8:signal transducers and activator of transcription 3:NF-kappaB:951:936	We discovered an inflammation-induction machinery, the inflammation amplifier, which is activated by the simultaneous stimulation of nuclear factor-kappa B ([TG]) and [TF] (STAT3) via various cytokines like IL-17 and IL-6 in non-immune cells.	signal transducers and activator of transcription 3	NF-kappaB	6774	4790	951	936	0.001160503360596	Non valid	0.004259738888734083;0.9947483037501244;0.0009919573611416258	ACTIVATION	26853849	STAT3	9606	NFKB1	9606	dbTF		NFKB
62717	PMID:29555853:pubtator_title_and_abstract:7b88c1d8f631765b7f402eae9e0743c0:7:NF-kappaB:NF-kappaB:1255:1159	We used the setting of excitatory synaptic activity during development that produces [TG]-dependent growth of dendritic spines to test physiological function of spine-enriched [TF] in an activity-dependent response.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1255	1159	0.0010677754000756	Non valid	0.4915752360419117;0.5058286886558596;0.0025960753022285458	ACTIVATION	29555853	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
62730	PMID:22339951:pubtator_title_and_abstract:0a7fa6370c89b0da028974ae5f5b3ff9:13:Bcl-2:NF-kappaB:2116:2062	CONCLUSIONS: The results suggest that NCTD can potentialize the chemosensitivity of multiple myeloma cells to ADR through regulating NF-kappaB/IkappaBalpha signaling pathway and [TG]-regulated gene products including survivin, [TF], Bax and VEGF.	Bcl-2	NF-kappaB	596	4790	2116	2062	0.0011356988065003	Non valid	0.993652558114604;0.005487750888080242;0.0008596909973157968	UNDEFINED	22339951	BCL2	9606	NFKB1	9606	coTF		NFKB
62734	PMID:36527481:pubtator_title_and_abstract:e990965c81f6dc66a2876ce419983476:9:transforming growth factor (TGF)-beta:nuclear factor kappa B:1072:1114	Immunofluorescence was performed to detect [TF] and [TG] (NFkB).	transforming growth factor (TGF)-beta	nuclear factor kappa B	59086	81736	1072	1114	0.0011868267876174	Non valid	0.9814478309049899;0.01546757935587011;0.0030845897391400677	UNDEFINED	36527481	Tgfb1	10116	Nfkb1	10116	ll_coTF		NFKB
62794	PMID:37046028:pubtator_title_and_abstract:f03da87ac6eeb6eb0bd95f1c82b2504c:8:HO-1:NF-kappaB:1688:1599	The hepatoprotective mechanisms of Lut are involved in inhibiting TLR4/[TG] and P2X7R/NLRP3 inflammatory signaling pathways, as well as enhancing the Nrf2/[TF] antioxidant pathway.	HO-1	NF-kappaB	15368	18033	1688	1599	0.0011348347314795	Non valid	0.3119336152574238;0.09315140560257457;0.5949149791400017	REPRESSION	37046028	Hmox1	10090	Nfkb1	10090	ll_coTF		NFKB
62840	PMID:12851413:pubtator_title_and_abstract:cdb10e3ddfefe7cf3718a0d904ddeb6a:4:NF kappa B:NF kappa B:500:1034	However, it remains unclear whether these oncoproteins activate a full spectrum of [TF]-dependent gene expression or whether they may augment or interfere with other stimuli that activate NF kappa B. The data presented here indicate that BCR-ABL expression in 32D myeloid cells or oncogenic Ras expression in murine fibroblasts blocks the ability of tumor necrosis factor (TNF) to activate NF kappa B. This suppression of NF kappa B is manifested by an inhibition of TNF-induced inhibitor of NF kappa B (IKK) activity and NF kappa B DNA binding potential but not by blocking TNF-induced nuclear accumulation of [TG]/p65.	NF kappa B	NF kappa B	Complex:NFKB	18033	500	1034	0.001301045731654	Non valid	0.01571817005280419;0.9827279100506021;0.0015539198965936855	ACTIVATION	12851413	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
62949	PMID:16330870:pubtator_title_and_abstract:4182c14274d051c735cbeb66d886a54f:4:IkappaBalpha:NF-kappaB:375:332	[TG] is activated when its inhibitor, [TF], is phosphorylated and degraded.	IkappaBalpha	NF-kappaB	4792	4790	375	332	0.0072083188416917	Non valid	0.004382871452709666;0.016508826216418974;0.9791083023308713	REPRESSION	16330870	NFKBIA	9606	NFKB1	9606	coTF		NFKB
63031	PMID:24972581:pubtator_title_and_abstract:1df629cf4c9965ca6043abbf9c229835:8:interferon regulatory factor (IRF)-7:NF-kappaB:1309:1394	RESULTS: The optimal concentration of AD for anti-virus effect was 250 mug/mL. IL-4 and IFN-gamma in the supernatant and mRNA levels in RLRs pathway increased when cells was infected by virus, RIG-I, IFN-beta promoter stimulator-1 (IPS-1), [TF], IRF-3 and nuclear transcription factor kappaB ([TG]) mRNA levels increased significantly (P<0.05).	interferon regulatory factor (IRF)-7	NF-kappaB	3665	4790	1309	1394	0.001498964610981	Non valid	0.01741351691095785;0.9784089954915245;0.0041774875975176705	ACTIVATION	24972581	IRF7	9606	NFKB1	9606	dbTF		NFKB
63041	PMID:18055541:pubtator_title_and_abstract:cb07af86d1669a155faf8d7b2112c148:8:AP1:NF-kappaB:1184:1192	This down-regulation was, at least in part, attributable to direct effects of EGb 761 on the interactions of the [TF] and [TG] transcription factors with the GFAP promoter.	AP1	NF-kappaB	16476	18033	1184	1192	0.0011313545470204	Non valid	0.9971029618597049;0.0020601639544314005;0.0008368741858637776	UNDEFINED	18055541	Jun	10090	Nfkb1	10090	dbTF		NFKB
63061	PMID:11460313:pubtator_title_and_abstract:7d21cddf8ea861615f752d81d1acf946:4:extracellular signal-regulated kinase 1:NF-kappa B:1068:1014	The specific p38 inhibitor SB203580 abrogated the angelan-induced [TG]/Rel activation, whereas the selective MAPK/[TF] (MEK-1) inhibitor PD98059 did not affect the NF-kappa B/Rel induction.	extracellular signal-regulated kinase 1	NF-kappa B	26417	18033	1068	1014	0.00115501477816	Non valid	0.003657523675832274;0.9938230108296697;0.0025194654944980417	ACTIVATION	11460313	Mapk3	10090	Nfkb1	10090	ll_coTF		NFKB
63119	PMID:14679069:pubtator_title_and_abstract:a7c7d2fd420a87c492f0f27acad5d24f:4:NF-kappaB:NF-kappaB:521:657	In this study, we aimed to evaluate the role of IL-6 in making a beta cell resistant to cytokine-induced apoptosis by decreasing the [TF]-dependent NO production and compared the result with that of the expression of a dominant negative inhibitor of NF-kappaB (DN [TG]).	NF-kappaB	NF-kappaB	Complex:NFKB	18033	521	657	0.0011129015175924	Non valid	0.012704739205170087;0.9841213492479292;0.003173911546900729	ACTIVATION	14679069	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
63133	PMID:16254192:pubtator_title_and_abstract:b23444c599b3d22c895d66f6d4583fe8:10:Bcl-2:NF-kappaB:1603:1569	These findings suggest that C/EBPalpha or its mutant variants tether to a subset of [TG] target genes, including [TF], via p50 to facilitate gene activation and offer an explanation for preferential in-frame rather than out-of-frame mutation of the leucine zipper with sparing of the basic region in C/EBPalphaLZ oncoproteins.	Bcl-2	NF-kappaB	12043	18033	1603	1569	0.0011671439583997	Non valid	0.2506275352591883;0.7428580501571471;0.006514414583664499	ACTIVATION	16254192	Bcl2	10090	Nfkb1	10090	coTF		NFKB
63243	PMID:14684387:pubtator_title_and_abstract:a0a4528c9a0be96cf23be55e796432bc:4:ERK1/2:NF-kappa B:625:677	Because P2X(7) has been reported to stimulate certain members of the MAP kinase family ([TF]) and can enhance the DNA-binding activity of [TG], we tested the hypothesis that LPS and nucleotides regulate NF-kappa B-dependent inflammatory events via cross talk with MAPK-associated pathways.	ERK1/2	NF-kappa B	26417;26413	18033	625	677	0.0011763681712852	Non valid	0.8789139295787316;0.11748239504493126;0.003603675376337098	UNDEFINED	14684387	Mapk3;Mapk1	10090;10090	Nfkb1	10090	ll_coTF;ll_coTF		NFKB
63285	PMID:14764668:pubtator_title_and_abstract:29564ab999fae53f58cdcd22caf45cfd:7:NF-kappaB:NF-kappaB.:1218:1411	Activation of the transcription factor [TF] appeared not to occur in wild-type macrophages after engulfment, and the rate of apoptotic cell degradation in wild-type macrophages remained the same regardless of the activation of [TG] Finally, immunohistochemical analyses showed that ectopically expressed TLR4 was associated with phagosomes in a macrophage-derived cell line.	NF-kappaB	NF-kappaB.	Complex:NFKB	18033	1218	1411	0.001410491808136	Non valid	0.16310707313250908;0.8300792444645587;0.00681368240293219	ACTIVATION	14764668	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
63406	PMID:29448097:pubtator_title_and_abstract:21c9411678b3931e4a49c50cca790794:5:BRD4:nuclear factor-kappaB:893:757	Because BET proteins are the gatekeepers of [TG] (NF-kappaB)-dependent gene transcription, we hypothesized that degradation of BET proteins, particularly BRD2 and [TF], with the proteolysis-targeting chimera (PROTAC) dBET1 would dampen the pro-inflammatory response in microglia subjected to lipopolysaccharide (LPS) challenge.	BRD4	nuclear factor-kappaB	23476	4790	893	757	0.0011590892358067	Non valid	0.0428624932327786;0.9543901593450217;0.0027473474221996986	ACTIVATION	29448097	BRD4	9606	NFKB1	9606	coTF		NFKB
63505	PMID:11385114:pubtator_title_and_abstract:9cae0ed4ee8c523f160f4a037737cc06:8:PR:NF-kappaB:1252:1052	Using transient transfections and assays for transcriptional activation and promoter binding, we have shown that there is constitutive activity of [TG] in amnion cells at the time of labour, and that COX-2 expression depends upon NF-kappaB. In cells obtained before labour, in which NF-kappaB activity is low, increasing the concentration of [TF] represses NF-kappaB dependent transcription, while stimulation with IL-1beta both increases NF-kappaB activity and represses PR activity.	PR	NF-kappaB	5241	4790	1252	1052	0.0010693929895752	Non valid	0.02732651452259406;0.05057668544082331;0.9220968000365826	REPRESSION	11385114	PGR	9606	NFKB1	9606	dbTF		NFKB
63507	PMID:20351696:pubtator_title_and_abstract:568e7b67ad500e09679157a3eabeaae0:12:Cdx2:NF-kappaB:1466:1594	Functional analysis of human [TF] promoter also revealed its upregulation by HB-EGF stimulation, showing the role of potential responsive elements (AP-1 and [TG]) for its transcriptional activation.	Cdx2	NF-kappaB	1045	4790	1466	1594	0.0013066603463255	Non valid	0.007461394698032413;0.9917757334345174;0.0007628718674501667	ACTIVATION	20351696	CDX2	9606	NFKB1	9606	dbTF		NFKB
63546	PMID:28934155:pubtator_title_and_abstract:2c9a0bca454cab83a44bbdd8c753fe01:9:p65:nuclear factor-kappa B:1378:1343	In addition, treatment of compounds 1-3 reduced LPS-induced increases of [TG] (NF-kappaB) [TF], iNOS and COX-2 protein expressions.	p65	nuclear factor-kappa B	19697	18033	1378	1343	0.0013061539327967	Non valid	0.0037592532133502677;0.9843420030668835;0.011898743719766314	ACTIVATION	28934155	Rela	10090	Nfkb1	10090	dbTF		NFKB
63589	PMID:16364464:pubtator_title_and_abstract:1d40f51f7a2f8d22a997656dbae56a8a:7:AP-1:NF-kappaB:704:713	Our findings indicate that transcription of the CCL15 gene is regulated by [TF] and [TG] through MEK and JNK MAPK pathways in monocytoid cells.	AP-1	NF-kappaB	3726	4790	704	713	0.0011455818099312	Non valid	0.997415387889394;0.0019224025997215206;0.00066220951088448	UNDEFINED	16364464	JUNB	9606	NFKB1	9606	dbTF		NFKB
63657	PMID:21882225:pubtator_title_and_abstract:f49ba833278b68987ae020b2798e4fd2:8:NF-kappaB:NF-kappaB:1003:1060	LPS elevated the expression of the protein activator of PKR (PACT) mRNA and protein, followed by the enhanced association between PACT and PKR within 3 h. In addition, LPS treatment induced the translocation of [TF] to the nucleus after 30 min, and inhibition of [TG] decreased the PACT-PKR interaction induced by LPS.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1003	1060	0.0012807232267022	Non valid	0.3044116763099895;0.6880924505905018;0.007495873099508604	ACTIVATION	21882225	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
63688	PMID:34414236:pubtator_title_and_abstract:b2cdede2a445fd89216f8b1a22760cec:9:RhoA:NF-kappaB:1414:1380	Mechanistically, BE-BJO repressed phosphorylation of [TG] subunit p65, suppressed [TF] activation, downregulated ROCK, and prevented phosphorylation of myosin light chain (MLC) in DSS-treated mice, indicating that the protective effect of BE-BJO is attributed to suppression of NF-kappaB and RhoA/ROCK signaling pathways.	RhoA	NF-kappaB	11848	18033	1414	1380	0.0011408978897041	Non valid	0.0031582863661177357;0.9943425641469598;0.002499149486922601	ACTIVATION	34414236	Rhoa	10090	Nfkb1	10090	ll_coTF		NFKB
63733	PMID:18556347:pubtator_title_and_abstract:d9294ab16991a1ab5f5a1e6ebb488a0d:7:p65:nuclear factor-kappaB:755:713	IL-1beta- and IL-1beta plus leptin-induced hBD-2 production both were suppressed by antisense oligonucleotides against [TG] (NF-kappaB) p50 and [TF]; the latter was also suppressed by antisense signal transducer and activator of transcription (STAT)1 and STAT3.	p65	nuclear factor-kappaB	5970	4790	755	713	0.0011587254877978	Non valid	0.0018924916903527971;0.9939240970905129;0.004183411219134371	ACTIVATION	18556347	RELA	9606	NFKB1	9606	dbTF		NFKB
63767	PMID:22906259:pubtator_title_and_abstract:1f2661365501bd7cf983d01e336f8b7a:7:Akt:NF-kappaB:1146:1167	RESULTS: Wortmannin inhibited the phosphorylation of [TF], upregulation of [TG], MMP-9, IL-8, and in vitro cell invasion and angiogenesis, in a dose-dependent manner.	Akt	NF-kappaB	207	4790	1146	1167	0.0085472961543578	Non valid	0.0027069642480348067;0.9944903463497443;0.002802689402220821	ACTIVATION	22906259	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
63792	PMID:26398661:pubtator_title_and_abstract:574d927b7454688fbad7b3900b28bc0c:5:IkappaBzeta:NFkappaB:620:687	Here we report that [TF] is upregulated in a glioma cell line resistant towards [TG]-dependent non-apoptotic cell death.	IkappaBzeta	NFkappaB	64332	4790	620	687	0.0011722121092006	Non valid	0.08517944624326018;0.6177322022385838;0.297088351518156	ACTIVATION	26398661	NFKBIZ	9606	NFKB1	9606	coTF		NFKB
63908	PMID:26024894:pubtator_title_and_abstract:85478d027c9839dc3f04d0dab9c89bb4:9:PPARgamma:NF-kappaB:1527:1501	Regulation of NF-kappaB activity involved direct PPARgamma-[TG] interaction and [TF]-mediated effects on IKK activation, IkappaBalpha degradation, and nuclear translocation of p65.	PPARgamma	NF-kappaB	19016	18033	1527	1501	0.0011201097343672	Non valid	0.9714666138081459;0.024867145682899765;0.003666240508954361	UNDEFINED	26024894	Pparg	10090	Nfkb1	10090	dbTF		NFKB
63951	PMID:12446019:pubtator_title_and_abstract:2fd8f64f044ea97dadfb142623aa4974:4:NF-kappaB:NF-kappaB.:1299:1187	A mechanistic analysis revealed that the cAMP analog, dibutyryl cyclic AMP (dbcAMP), or the adenyl cyclase activator, forskolin, effectively suppressed the stimulant-induced TNF-alpha production by reducing the nuclear translocation and DNA binding activity of [TG] The inhibitory mechanisms manifested by dbcAMP included the decreased phosphorylation/degradation of [TF] inhibitor (IkappaB) followed by its increased synthesis/stability.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	1299	1187	0.0010917237223133	Non valid	0.036288822277311734;0.10052373413614578;0.8631874435865424	REPRESSION	12446019	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
63974	PMID:23002344:pubtator_title_and_abstract:3b22003db5632de1f0e6d2803ec1755f:11:RelA:NF-kappaB:1354:1344	CONCLUSION: Increased expression of [TG] [TF] and high levels of serum SAA were associated with poor OS in gastric cancer patients.	RelA	NF-kappaB	5970	4790	1354	1344	0.0013584680043266	Non valid	0.006680469907948198;0.9902066172466655;0.00311291284538627	ACTIVATION	23002344	RELA	9606	NFKB1	9606	dbTF		NFKB
64100	PMID:14561184:pubtator_title_and_abstract:f8c2404f165b175123f42b3f0f9d7083:11:p38:NF-kappaB:1398:1468	The inhibition of the TNFalpha signaling cascade is under study using blockers of the [TF], JNK, and ERK kinases, and by antagonists of transcription factor [TG] activation.	p38	NF-kappaB	1432	4790	1398	1468	0.0011558991555348	Non valid	0.00787521273551566;0.9840589615784726;0.008065825686011722	ACTIVATION	14561184	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
64179	PMID:25529441:pubtator_title_and_abstract:7773015331a2ba8d9a47032f7db0b39e:10:JNK1/2:NF-kappaB:1569:1508	However, the activation of [TG] was inhibited by the inhibitors of ERK1/2, p38 and [TF], indicating that a cross-talk may exist between MAPK and NF-kappaB pathways in EV71-infected intestinal epithelial cells.	JNK1/2	NF-kappaB	5599;5601	4790	1569	1508	0.0441842431969043	Non valid	0.001759837712844032;0.9957962674734807;0.002443894813675235	ACTIVATION	25529441	MAPK8;MAPK9	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
64257	PMID:21325072:pubtator_title_and_abstract:36d5dca80e66a61a0c80f8b703993da1:9:Akt:NF-kappaB:1609:1558	Moreover, we demonstrated that upregulation of SPHK1 activated the PI3K/Akt/[TG] pathway, and that inhibition of the PI3K/[TF]/NF-kappaB pathway abrogated the antiapoptotic effect of SPHK1 on NSCLC cells.	Akt	NF-kappaB	207	4790	1609	1558	0.0011229296823099	Non valid	0.06416079963356189;0.9013676955539942;0.03447150481244387	ACTIVATION	21325072	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
64307	PMID:11113112:pubtator_title_and_abstract:5ae8b987bcb3dd65afa3b523b6844374:3:Bcl10:NF-kappaB:396:513	vCLAP has a cellular counterpart, [TF]/cCLAP, which is also an activator of apoptosis and NF-kappaB. Recent studies demonstrated that vCLAP activates [TG] through an IkappaB kinase (IKK)-dependent pathway, but the underlying mechanism remains unknown.	Bcl10	NF-kappaB	8915	4790	396	513	0.002009488952903	Non valid	0.006286189350774774;0.9921934273482158;0.0015203833010094575	ACTIVATION	11113112	BCL10	9606	NFKB1	9606	coTF		NFKB
64384	PMID:21810613:pubtator_title_and_abstract:1038b6ce9710f8f8920b2b1892888311:9:IkappaB kinase (IKK)alpha:NF-kappaB:1118:1259	Furthermore, overexpression of TNFR-associated factor 2-, MEK kinase 1-, [TF]-, or IKKbeta-induced NF-kappaB activation, but not constitutively active mutant of IKKbeta (IKKbeta SS/EE)-induced [TG] activation, was inhibited by 2C protein.	IkappaB kinase (IKK)alpha	NF-kappaB	1147	4790	1118	1259	0.001589913294844	Non valid	0.004806550779806952;0.9940372794955251;0.001156169724667971	ACTIVATION	21810613	CHUK	9606	NFKB1	9606	coTF		NFKB
64388	PMID:24901054:pubtator_title_and_abstract:13d917897aa7fe0c8843e133ab086783:8:IKKalpha/beta:NF-kappaB:1578:1533	Further mechanism research revealed that wogonin inhibited the nuclear translocation of [TG] and phosphorylation of IkappaB and [TF], and promoted Nrf2 signaling pathway in HCT116 cells and THP-1 cells.	IKKalpha/beta	NF-kappaB	1147;3551	4790	1578	1533	0.0011831442400835	Non valid	0.2310068016313278;0.6802368984825997;0.08875629988607249	ACTIVATION	24901054	CHUK;IKBKB	9606;9606	NFKB1	9606	coTF;coTF		NFKB
64444	PMID:36075274:pubtator_title_and_abstract:b21bf8ae2e1871cac4bae132326bc3e6:4:MyD88:NF-kappaB:486:517	AIM OF THE STUDY: The present work was aimed to investigate the mechanism of XLP in dextran sulfate sodium (DSS)-induced UC via the Toll Like Receptor 4 (TLR4)/Myeloid Differentiation factor 88 ([TF])/Nuclear Factor kappa-B ([TG]) signaling in mice.	MyD88	NF-kappaB	17874	18033	486	517	0.0011009551591003	Non valid	0.9697246852070043;0.02635477540055151;0.003920539392444094	UNDEFINED	36075274	Myd88	10090	Nfkb1	10090	coTF		NFKB
64483	PMID:17189672:pubtator_title_and_abstract:e115c2e2a62a55a6bc668ee373783f79:8:NF-kappaB:nuclear factor kappa B:1252:1228	Histochemical and Western blot analyses of skin biopsies revealed a strong upregulation of COX-2, a slight decrease of COX-1 and activation of [TG] ([TF]) in the area of the freezing injury.	NF-kappaB	nuclear factor kappa B	Complex:NFKB	4790	1252	1228	0.0011692045044335	Non valid	0.007748865861213659;0.990522188745364;0.0017289453934222763	ACTIVATION	17189672	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
64494	PMID:16176802:pubtator_title_and_abstract:735bed12d261ee85a06b2990305c349c:13:p65:NF-kappaB:1594:1614	To further investigate induction of apoptosis in MCF-10A cells, we measured changes in NF-kappaB. Decreases in [TF] or p50 forms of [TG] and its upstream regulator I-kappaB were found in oridonin-treated MCF-10A and not MCF-7 cells.	p65	NF-kappaB	5970	4790	1594	1614	0.0012790872611672	Non valid	0.03451627745847786;0.8837555310025728;0.08172819153894931	ACTIVATION	16176802	RELA	9606	NFKB1	9606	dbTF		NFKB
64562	PMID:19324905:pubtator_title_and_abstract:551bd9ad9c6ad73d67d851fd69a8ab22:4:p65:NF-kappaB:727:807	This induction is caused by transcriptional activation of CCL20 gene, which is mediated by binding of the [TF], p50, and c-Rel subunits of the transcription factor nuclear factor-kappaB ([TG]) to an atypical NF-kappaB-binding site present in the CCL20 gene promoter.	p65	NF-kappaB	5970	4790	727	807	0.0012374676466282	Non valid	0.023476021422991537;0.9753478511618843;0.0011761274151242795	ACTIVATION	19324905	RELA	9606	NFKB1	9606	dbTF		NFKB
64693	PMID:28515292:pubtator_title_and_abstract:0ff8ecd47ac25b9c9d05b21a337c302b:11:cIAP1:NF-kappaB:1318:1375	MC159 also diminished [TF]-mediated NEMO polyubiquitination and cIAP1-induced [TG] activation.	cIAP1	NF-kappaB	329	4790	1318	1375	0.1348164305383546	Non valid	0.018694738341633974;0.977955197450375;0.003350064207991011	ACTIVATION	28515292	BIRC2	9606	NFKB1	9606	coTF		NFKB
64696	PMID:20858459:pubtator_title_and_abstract:5c113d57ad915af9382097be592ac1c4:4:p50:NF-kappaB.:773:644	Silencing Bag-1 expression only marginally affects the transrepression action of the GR but decreased the action of the transcription factor [TG] Furthermore phosphorylation and degradation of the inhibitor protein IkappaBalpha and nuclear accumulation of p65 and [TF] NF-kappaB proteins in response to phorbol ester was attenuated following Bag-1 depletion in HeLa cells.	p50	NF-kappaB.	4790	4790	773	644	0.0011183047181067	Non valid	0.024820360723349266;0.9707914383935626;0.004388200883088151	ACTIVATION	20858459	NFKB1	9606	NFKB1	9606	dbTF		NFKB
64753	PMID:23786838:pubtator_title_and_abstract:4ea8a0a7c4126f719cba9d3a9214cab3:6:extracellular signal-related kinase (ERK)1/2:nuclear factor kappa B:753:808	Expression levels of cyclo-oxygenase 2 (COX-2), VEGF, AKT/p-AKT, [TF]/p-ERK1/2, [TG] (NF-kappaB) P65/p-P65, and caspase-3 were measured.	extracellular signal-related kinase (ERK)1/2	nuclear factor kappa B	5595;5594	4790	753	808	0.0011724778896525	Non valid	0.8759880822923125;0.11977093345136627;0.004240984256321149	UNDEFINED	23786838	MAPK3;MAPK1	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
64768	PMID:17082483:pubtator_title_and_abstract:d58c5b8370e8743229df5d3fb42d5b8a:4:Akt:NF-kappaB:568:697	METHODS AND RESULTS: In cultured rat aortic smooth muscle cells, treatment with atorvastatin significantly increased nNOS expression, associated with activation of [TF] and NF-kappaB. Inhibition of Akt by dominant-negative Akt suppressed atorvastatin-induced nNOS expression as well as Akt and [TG] activation.	Akt	NF-kappaB	24185	18033	568	697	0.0030404061717995	Non valid	0.0030170785675311435;0.9958535040575169;0.00112941737495185	ACTIVATION	17082483	Akt1	10116	Nfkb1	10090	ll_coTF		NFKB
64778	PMID:11886269:pubtator_title_and_abstract:c5e1fc2dd45daf5b1a42f4f8702f31e1:13:TRADD:NF-kappaB:1624:1666	Furthermore, NS5A prevented the association between [TF] and FADD and blocked TRADD-mediated [TG] activation.	TRADD	NF-kappaB	71609	18033	1624	1666	0.0658579002512433	Non valid	0.010036321440072155;0.9887166044920921;0.0012470740678357693	ACTIVATION	11886269	Tradd	10090	Nfkb1	10090	coTF		NFKB
64824	PMID:16552961:pubtator_title_and_abstract:b9b342524c583b16a717c86cf89fc15e:11:NF-kappaB:NF-kappaB:1742:1640	CONCLUSION: The high expression of [TG] and Bcl-2 and the low expression of I-kappaB may be related to cervical carcinogenesis, and [TF] expression may be related to HPV infection.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1742	1640	0.0011590345835307	Non valid	0.5718711800346675;0.3835928294951135;0.0445359904702191	UNDEFINED	16552961	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
64979	PMID:17041092:pubtator_title_and_abstract:aacbb68868c5ebf4daa884b883a940ab:8:NF-kappaB:nuclear factor-kappaB:913:890	Using several different transcription elements coupled with a reporter gene, it was found that the [TG] ([TF]) signaling pathway is the most sensitive pathway mediator affected by DCB-3503.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	913	890	0.0012238400973509	Non valid	0.979233365324154;0.01938196600243721;0.0013846686734088258	UNDEFINED	17041092	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
65111	PMID:30789669:pubtator_title_and_abstract:4e7fa7f3b34f03e32a3d956fa8ad4039:11:IkB alpha:NF-kappaB:2488:2558	On the other hand, LH administration prevented LPS-induced activation of the p38, extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) and attenuated [TF] (IkappaBalpha) phosphorylation and nuclear translocation of [TG] (p65) in the jejunal mucosa.	IkB alpha	NF-kappaB	4792	4790	2488	2558	0.0011249224378978	Non valid	0.030733561397145642;0.9671110818339674;0.0021553567688868762	ACTIVATION	30789669	NFKBIA	9606	NFKB1	9606	coTF		NFKB
65121	PMID:11705740:pubtator_title_and_abstract:8ce7cb472611c5e365a82a61b68f22ee:9:Akt:NF-kappa B:1141:1197	Active [TF] induces NF-kappa B transcriptional activity but not [TG] binding activity or I kappa B degradation.	Akt	NF-kappa B	11651	18033	1141	1197	0.0011420578260896	Non valid	0.07152959816179666;0.9258514315451086;0.002618970293094702	ACTIVATION	11705740	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
65279	PMID:10722693:pubtator_title_and_abstract:b53e06b8465ab356334eb60769e0d03a:11:IkappaBalpha:NF-kappaB:1432:1473	N-Acetylleucylleucylnorlucinal, a proteasome inhibitor, blocked both IkappaBalpha degradation and NF-kappaB activation, suggesting that the [TF] degradation is required for [TG] activation.	IkappaBalpha	NF-kappaB	4792	4790	1432	1473	0.1187767295623953	Non valid	0.012305440877217674;0.9564359412066681;0.031258617916114284	ACTIVATION	10722693	NFKBIA	9606	NFKB1	9606	coTF		NFKB
65339	PMID:11046018:pubtator_title_and_abstract:312053d259071c6eb1d604f414300361:2:NF-kappaB:NF-kappaB:514:309	We and others have reported that IFN-alpha potentiates the apoptotic effects of TNF through a mechanism that is not understood. Because the nuclear transcription factors [TG] and AP-1 have recently been reported to mediate anti-apoptosis and cell survival, we hypothesized that IFN-alpha potentiates the cytotoxic effects of TNF by suppressing TNF-induced activation of [TF] and AP-1.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	514	309	0.0011558526359611	Non valid	0.005075613949714701;0.9909101379853854;0.004014248064899985	ACTIVATION	11046018	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
65452	PMID:11495725:pubtator_title_and_abstract:55f847b83f57b1a2e58b30cec15e01cf:5:JAK2:NF-kappaB:944:789	The induction of an [TG]-triggered reporter gene construct was inhibited by cotransfection of dominant negative forms of the src kinase Lyn, but not by dominant negative [TF].	JAK2	NF-kappaB	3717	4790	944	789	0.0053231552454137	Non valid	0.0014275588942872807;0.9965949177050563;0.001977523400656419	ACTIVATION	11495725	JAK2	9606	NFKB1	9606	coTF		NFKB
65472	PMID:33385711:pubtator_title_and_abstract:e22f68d7ccc613d8b6f6103db8565e62:12:LSD1:nuclear factor kappa-B:1420:1443	Furthermore, GSK-LSD1 inhibition of [TF] further inhibited [TG] (NF-kappaB) signaling cascades, and subsequently inhibited the production of cytokines (TNF-alpha, IL-6 and IL-1beta) in mammary gland.	LSD1	nuclear factor kappa-B	99982	18033	1420	1443	0.0016218560058786	Non valid	0.005210318249526019;0.9924725820618902;0.0023170996885837703	ACTIVATION	33385711	Kdm1a	10090	Nfkb1	10090	coTF		NFKB
65504	PMID:32334386:pubtator_title_and_abstract:f60e6b1b7fa5092e8320a2db3ed8c6ca:7:p38:nuclear factor kappa B:1102:1066	BISA pretreatment suppressed the AGE-induced inflammatory reaction and extracellular matrix (ECM) degeneration by blocking [TG] (NF-kappaB), [TF] and c-Jun N-terminal kinase (JNK) signaling.	p38	nuclear factor kappa B	1432	4790	1102	1066	0.001184766820597	Non valid	0.011457237932596058;0.9853389813733969;0.003203780694007027	ACTIVATION	32334386	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
65536	PMID:15465599:pubtator_title_and_abstract:d6f4146d9b31b79ab4415fe9dfc0a622:7:signal transducer and activator of transcription 1:NF-kappaB:1240:1177	In addition, ethanol pretreatment selectively regulated LPS-induced [TG] signaling pathway without affecting IFNgamma-induced [TF] (STAT1) phosphorylation, interferon regulatory factor-1 (IRF-1) induction or IFNgamma-inducible IP-10 expression.	signal transducer and activator of transcription 1	NF-kappaB	20846	18033	1240	1177	0.0011112578860665	Non valid	0.5654464274516653;0.4189177053312963;0.0156358672170384	UNDEFINED	15465599	Stat1	10090	Nfkb1	10090	dbTF		NFKB
65614	PMID:31754081:pubtator_title_and_abstract:b64c74823701207a656e128410b7ed56:6:NF-kappaB:nuclear factor-kappa B:1256:1232	Erianin strongly affected the serum levels of cytokines, and regulated the activation of [TG] ([TF]), and the expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream proteins in spleen.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	4790	1256	1232	0.0011500162399588	Non valid	0.09497339422306358;0.9004186661209388;0.004607939655997612	ACTIVATION	31754081	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
65753	PMID:14576442:pubtator_title_and_abstract:53fa6b1a22f2ccb6b4006463a4536b46:0:paracaspase:NF-kappaB:75:14	Regulation of [TG]-dependent lymphocyte activation and development by [TF].	paracaspase	NF-kappaB	240354	18033	75	14	0.0017205512051007	Non valid	0.8166100406982166;0.17980335097280312;0.0035866083289802257	UNDEFINED	14576442	Malt1	10090	Nfkb1	10090	coTF		NFKB
65772	PMID:20449947:pubtator_title_and_abstract:08f3ffd3adc9e2e2f2441f2b8b65fc76:2:nuclear factor-kappaB:NF-kappaB:197:220	OBJECTIVE: To investigate the role of TNF receptor-associated factor 2 (TRAF-2) and TRAF6 in CD40-induced [TF] ([TG]) signaling pathway and whether CD40 signaling requires TRAF2.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	197	220	0.0010974958991737	Non valid	0.5445448780653442;0.45217465341646795;0.003280468518187883	UNDEFINED	20449947	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
65837	PMID:17334646:pubtator_title_and_abstract:99ac66b4a7a6764e7e1135d29e5a3bbd:11:NF-kappaB:NF-kappaB.:1722:1575	Chromatin immunoprecipitation and the electrophoretic mobility shift assay confirmed that H. pylori increased the DNA binding activity of [TG] With the aid of NAC and H2O2, it was determined that reactive oxygen species (ROS) is an upstream signaling molecule for activating the [TF] induced by H. pylori.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	1722	1575	0.0011157158269857	Non valid	0.168435807767301;0.8288334810909596;0.002730711141739322	ACTIVATION	17334646	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
65842	PMID:23333920:pubtator_title_and_abstract:70e0235bf47eacb9b29e0d4f162a5bd5:10:IkappaBalpha:NF-kappaB.:1429:1302	This synergistic CXCL10 production was dependent on the transcriptional regulation of CXCL10 gene promoter activity and the enhanced stability of CXCL10 mRNA because of IL-27 and TNF-alpha, and this synergism was regulated by the activation of p38 mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-OH kinase (PI3K)-Akt dominantly, and in small part via [TG] Interestingly, IL-27 promoted the basal and enhanced TNF-alpha-induced phosphorylation of p38 MAPK and Akt, but not [TF].	IkappaBalpha	NF-kappaB.	4792	4790	1429	1302	0.0011090227823604	Non valid	0.32230662868902216;0.6696521576691832;0.008041213641794711	ACTIVATION	23333920	NFKBIA	9606	NFKB1	9606	coTF		NFKB
65877	PMID:33582384:pubtator_title_and_abstract:9c4b21c81ebc189ac09bfaeed2ceed80:7:ERK1/2:NF-kappaB:1189:1178	Effector pathways were STAT 1, JAK2/STAT3, Ras-Raf-MEK-ERK, Wnt/beta-catenin, [TG], [TF], PI3K/ Akt/mTOR, MAPK/ERK.	ERK1/2	NF-kappaB	5595;5594	4790	1189	1178	0.0011899482422114	Non valid	0.9118451358930943;0.0857572577244502;0.0023976063824554493	UNDEFINED	33582384	MAPK3;MAPK1	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
65887	PMID:29656318:pubtator_title_and_abstract:9a67970d39cefe55ae0ae8b3d4215ff8:6:nuclear factor kappa B:NF-kappaB:763:787	We also analyzed whether the effects were caused by inhibition of [TF] ([TG]) transcription factor transmigration.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	18033	763	787	0.0013390674549261	Non valid	0.13224081423841422;0.8540034130360725;0.013755772725513263	ACTIVATION	29656318	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
66021	PMID:21048983:pubtator_title_and_abstract:067a3f5179e1e48bf1b2a04dff95ba0e:6:NF-kappaB:NF-kappaB.:1156:1016	Here we show that in addition to canonical activation, the fusion protein stabilizes NIK and activates non-canonical NF-kappaB. Canonical but not non-canonical activation depended on MALT1 paracaspase activity, and expression of E3-inactive c-IAP2 activated non-canonical [TG] Mice in which endogenous c-IAP2 was replaced with an E3-inactive mutant accumulated abnormal B cells with elevated non-canonical [TF] and had increased numbers of B cells with a marginal zone phenotype, gut-associated lymphoid hyperplasia, and other features of MALT lymphoma.	NF-kappaB	NF-kappaB.	Complex:NFKB	18033	1156	1016	0.0011299807450314	Non valid	0.06018059723372145;0.8830884143174915;0.05673098844878702	ACTIVATION	21048983	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
66046	PMID:19774508:pubtator_title_and_abstract:3b64ccf948baf706c15bd8441aba2215:6:p65:NF-kappaB:1028:1018	PGE(2) production in culture supernatants was detected by competitive ELISA, while expression of [TG]/[TF], COX-2, caspase-3 and caspase-9 proteins were analyzed by Western blot.	p65	NF-kappaB	5970	4790	1028	1018	0.0011491024250022	Non valid	0.9740635377703684;0.023001194783685598;0.0029352674459460996	UNDEFINED	19774508	RELA	9606	NFKB1	9606	dbTF		NFKB
66049	PMID:36779599:pubtator_title_and_abstract:bbbfb9e71693e4356ffdab66fedae359:11:SQSTM1:NF-kappaB:2679:2492	Our study reveals a novel mechanism by which PRRSV escapes host antiviral innate immunity through selective autophagy, providing a new target for developing anti-PRRSV drugs.Abbreviations: ACTB: actin beta; ATG: autophagy related; co-IP: co-immunoprecipitation; CQ: chloroquine; DDX10: DEAD-box helicase 10; E: envelope; EGFP: enhanced green fluorescent protein; hpi: hours post infection; hpt: hours post transfection; IFA: indirect immunofluorescence assay; IFN-I: type I IFN; IFNB/IFN-beta: interferon beta; IRF3: interferon regulatory factor 3; ISGs: interferon-stimulated genes; KO: knockout; MAP1LC3B/LC3: microtubule associated protein 1 light chain 3 beta; mAb: monoclonal antibody; MOI: multiplicity of infection; NBR1: NBR1 autophagy cargo receptor; NFKB/[TG]: nuclear factor kappa B; OPTN: optineurin; ORF: open reading frame; PRRSV: porcine reproductive and respiratory syndrome virus; SeV: sendai virus; siRNA: small interfering RNA; [TF]/p62: sequestosome 1; TCID50: 50% tissue culture infective dose; WT: wild type.	SQSTM1	NF-kappaB	8878	4790	2679	2492	0.0011275042048597	Non valid	0.7485389454264024;0.2001335010559842;0.05132755351761343	UNDEFINED	36779599	SQSTM1	9606	NFKB1	9606	coTF		NFKB
66111	PMID:37088753:pubtator_title_and_abstract:1e93fbdb4a7b15313408f6a4639f6198:12:p38MAPK:NF-kappaB:2754:2762	CONCLUSION: Obesity induces oxidative stress in the testis of mice, up-regulates the level of [TF]-[TG], and reduces the level of blood testosterone; exercise, diet and exercise*diet interventions can reduce testicular oxidative stress and down-regulate testicular p38MAPK-NF-kappaB levels by reducing body fat.	p38MAPK	NF-kappaB	26416	18033	2754	2762	0.0016102431448919	Non valid	0.04480916840873512;0.16943824092515966;0.7857525906661051	REPRESSION	37088753	Mapk14	10090	Nfkb1	10090	ll_coTF		NFKB
66141	PMID:20600004:pubtator_title_and_abstract:ed50c46c981e1db04fd18542d3853ec9:3:nuclear factor kappa-B:NF-kappaB:347:371	Here, we investigate the effects of wild-type and mutant p53, and [TF] ([TG]) (p50) on BCRP promoter activity in MCF-7 cells.	nuclear factor kappa-B	NF-kappaB	Complex:NFKB	4790	347	371	0.0012219455256801	Non valid	0.9847955976090259;0.011985653495941165;0.0032187488950329813	UNDEFINED	20600004	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
66195	PMID:26383520:pubtator_title_and_abstract:c0957ee8e1786a81d72e8ed20ba95202:7:neu:NF-kappaB:1230:1040	Among them, PPA participates in several bioprocesses in the development of breast cancer, including inhibiting hypoxia-inducible factor (HIF) activity, elevating serum concentration of nitric oxide index (NOx), depression of the neuroepithelial cell transforming gene 1 (NET1) signal pathway, blocking the nuclear factor kappa B ([TG]) pathway following an decreased expression of matrix metalloproteinase (MMP), increasing NK cytotoxicity, and affecting transforming growth factor (TGF)-beta-targeted ras and HER2/[TF] gene pathways.	neu	NF-kappaB	2064	4790	1230	1040	0.0010995632367379	Non valid	0.9677392636434904;0.02238486306955144;0.009875873286958096	UNDEFINED	26383520	ERBB2	9606	NFKB1	9606	ll_coTF		NFKB
66215	PMID:25944909:pubtator_title_and_abstract:16cc26beaf0d635784f80b321318e6a2:6:astrocyte elevated gene-1:NF-kappaB.:631:716	The oncogene [TF] (AEG-1) inhibits RXR-dependent transcription and activates [TG] Here, we interrogated the role of AEG-1 in NTIS in the context of hepatocellular carcinoma (HCC).	astrocyte elevated gene-1	NF-kappaB.	67154	4790	631	716	0.2658808875653418	Non valid	0.07772749166310784;0.8424203554163517;0.07985215292054043	ACTIVATION	25944909	Mtdh	10090	NFKB1	9606	coTF		NFKB
66481	PMID:32482710:pubtator_title_and_abstract:1d55cb040df6b9555fcc36a1adcb1890:0:NLRP3:NF-kappaB:75:65	IgA Nephropathy Benefits from Compound K Treatment by Inhibiting [TG]/[TF] Inflammasome and Enhancing Autophagy and SIRT1.	NLRP3	NF-kappaB	216799	18033	75	65	0.0011386957058248	Non valid	0.019993353480892755;0.9379488923797812;0.0420577541393261	ACTIVATION	32482710	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
66487	PMID:21040711:pubtator_title_and_abstract:60df94adf5cb9d6b7e4d0b1a55d9dc8f:5:JNK:NFkappaB:864:642	Treatment of a panel of established GBM cell lines (U138MG, U87, U373 and C6) with pharmacological [TG] inhibitors (BAY117082, parthenolide, MG132, curcumin and arsenic trioxide) and NFkappaB-p65 siRNA markedly decreased the viability of GBMs as compared to inhibitors of other signaling pathways such as MAPKs (ERK, [TF] and p38), PKC, EGFR and PI3K/Akt.	JNK	NFkappaB	5599	4790	864	642	0.0010841354784738	Non valid	0.010027586611399988;0.9775262709920753;0.012446142396524553	ACTIVATION	21040711	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
66794	PMID:12403772:pubtator_title_and_abstract:8b28563fbb4dfdedbd8a519fadd7c9a1:2:I kappa B alpha:NF-kappa B:317:354	The signal-inducible phosphorylation of serines 32 and 36 of I kappa B alpha is critical in regulating the subsequent ubiquitination and proteolysis of [TF], which then releases [TG] to promote gene transcription.	I kappa B alpha	NF-kappa B	18035	18033	317	354	0.0011156600291548	Non valid	0.02627850480240436;0.8746184817243292;0.09910301347326643	ACTIVATION	12403772	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
66820	PMID:36721171:pubtator_title_and_abstract:b79e233e4d3d62b4107e6f8a806dbfdb:0:IRAK1:NF-kappaB:121:133	Study on the regulatory effect of Panax notoginseng saponins combined with bone mesenchymal stem cell transplantation on [TF]/TRAF6-[TG] pathway in patients with diabetic cutaneous ulcers.	IRAK1	NF-kappaB	3654	4790	121	133	0.0011570693659811	Non valid	0.9976113217057192;0.0013952366247809787;0.000993441669499815	UNDEFINED	36721171	IRAK1	9606	NFKB1	9606	coTF		NFKB
66822	PMID:15982329:pubtator_title_and_abstract:1cf8a0656eee977826a79e4c620d79c5:7:NF-(kappa)B:NF-(kappa)B:933:1080	The majority of tumours had immunohistochemical features consistent with activation of the [TF] pathway, including nuclear location of the c-REL/p65 subunit, overexpression of phosphorylated I(kappa)B(alpha), and overexpression of [TG] targets.	NF-(kappa)B	NF-(kappa)B	Complex:NFKB	4790	933	1080	0.001558920054576	Non valid	0.7398643209939083;0.2573824897391454;0.0027531892669462087	UNDEFINED	15982329	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
66944	PMID:28232127:pubtator_title_and_abstract:bf414bb1851e4ab29139acf6ebebd13e:10:nuclear factor kappa-B:NF-kappaB:1467:1491	The protein expression of mitogen activated protein kinase (MAPK) and [TF] ([TG]) signaling pathway were detected by western blotting.	nuclear factor kappa-B	NF-kappaB	Complex:NFKB	4790	1467	1491	0.0011352766902906	Non valid	0.9867999433727828;0.012243034616575672;0.000957022010641443	UNDEFINED	28232127	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
67083	PMID:31894333:pubtator_title_and_abstract:2ee62d6389aa3dc118eaaf5533ccf251:7:AKT:NF-kappaB:1099:1126	Notably, ahpatinins C, E, and G led to the downregulation of VEGF-induced activation of VEGF receptor 2 (VEGFR2) and its downstream signaling mediators, including [TF], ERK1/2, JNK, p38, and [TG], in HUVECs.	AKT	NF-kappaB	207	4790	1099	1126	0.001230692030743	Non valid	0.007001853893658059;0.9911295890374329;0.0018685570689090944	ACTIVATION	31894333	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
67285	PMID:10843690:pubtator_title_and_abstract:bc4c41bc7d770bcf852f4e666b774974:11:NF-kappa B:NF-kappa B:1529:1626	Furthermore, EMSA analysis of the activation of the [TF] involved in iNOS induction demonstrated that pyrrolidinedithiocarbamate prevented the [TG] binding by sPLA2 plus LPS.	NF-kappa B	NF-kappa B	Complex:NFKB	18033	1529	1626	0.0011224134000156	Non valid	0.48503315142286185;0.5114002157323452;0.003566632844793043	ACTIVATION	10843690	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
67302	PMID:37506402:pubtator_title_and_abstract:8517cbe8d8f08bad74e7c6ebf9264cf7:8:AKT:NF-kappaB:1786:1699	RESULTS: Targeting macrophages through different signaling pathways has become a key mechanism for the treatment of inflammatory bone and joint diseases, including HIF-1alpha, [TG], AKT/mTOR, JAK1/2-STAT1, NF-kappaB, JNK, ERK, p-38alpha/beta, p38/MAPK, PI3K/[TF], AMPK, AMPK/Sirt1, STAT TLR4/NF-kappaB, TLR4/NLRP3, NAMPT pathway, as well as the programmed cell death autophagy, pyroptosis and ERS.	AKT	NF-kappaB	207	4790	1786	1699	0.0011305233887559	Non valid	0.9736060685260307;0.021843435663551052;0.004550495810418211	UNDEFINED	37506402	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
67304	PMID:11387332:pubtator_title_and_abstract:4661fc066c188f13d58db06b94e7a292:12:BCL-3:NF-kappa B:1786:1775	Together, these data suggest the presence of an [TG]-[TF] autoregulatory loop important in terminating NF-kappa B1 action and that individual NF-kappa B isoforms are actively terminated through coordinate induction of inhibitory I kappa B molecules to restore cellular homeostasis.	BCL-3	NF-kappa B	602	4790	1786	1775	0.0013629485980624	Non valid	0.7774265940609547;0.04938309662034153;0.1731903093187037	UNDEFINED	11387332	BCL3	9606	NFKB1	9606	dbTF		NFKB
67515	PMID:17513759:pubtator_title_and_abstract:777fc27229258d3581345c69e966521d:8:c-Rel:NF-kappaB:1236:1345	A transcriptional module comprised of two closely spaced c-Rel consensus sites is found with higher frequency in the [TF]-affected gene sets and may represent an important control module for genes regulated by c-Rel or other [TG] family members.	c-Rel	NF-kappaB	5966	4790	1236	1345	0.0010852362171781	Non valid	0.9976866496596437;0.0013546908073854974;0.0009586595329707368	UNDEFINED	17513759	REL	9606	NFKB1	9606	dbTF		NFKB
67560	PMID:22033934:pubtator_title_and_abstract:3f40d87ecfa2f836787fd52687c1fb2d:8:ERK:NF-kappaB:927:913	Tlr2(-/-) and Nod2(-/-) cells showed perturbed [TG] and [TF] signaling.	ERK	NF-kappaB	26413	18033	927	913	0.0011329647310711	Non valid	0.9768625377317779;0.020957552037268734;0.0021799102309534137	UNDEFINED	22033934	Mapk1	10090	Nfkb1	10090	ll_coTF		NFKB
67642	PMID:11519724:pubtator_title_and_abstract:ac66cf5e447777c9f43fc096b3b9c48f:8:NF-kappaB:NF-kappaB:937:1229	Also [TF] overexpression, coupled with bcl-x promoter/reporter assays using a series of murine bcl-x promoter and deletion mutants, has identified the downstream 1.1kb of the bcl-x promoter as necessary for basal promoter activity and induction by NF-kappaB in support of the hypothesis that [TG] can act to enhance BCl-XL expression via highly selective interactions with the bcl-x promoter, where NF-kappaB binding and promoter activation are dependent on specific DNA binding site sequences and NF-kappaB protein dimer composition.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	937	1229	0.0010582148137589	Non valid	0.0058778225281917165;0.9931551707976282;0.0009670066741801006	ACTIVATION	11519724	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
67842	PMID:31838061:pubtator_title_and_abstract:e1897f351f88eea6bfea7de8c495cd15:16:myocardin:NF-kappaB:1983:2012	CONCLUSION: NKILA enhanced the expression of [TF] via inhibiting the [TG] signalling pathway and preventing cell apoptosis and the inflammatory response of cardiomyocytes, thus ameliorating myocardial I/R injury.	myocardin	NF-kappaB	246297	4790	1983	2012	0.0012043770299915	Non valid	0.041419919225738934;0.09517175013360862;0.8634083306406525	REPRESSION	31838061	Myocd	10116	NFKB1	9606	coTF		NFKB
67850	PMID:9920937:pubtator_title_and_abstract:c6785e47c9e0b3286951c73eb44a1273:5:IkappaB-alpha:NF-kappaB:672:601	We find that LPA causes a marked activation of [TG] in Swiss 3T3 fibroblasts as determined by the degradation of [TF] in the cytosol and the emergence of kappaB binding activity in nuclear extracts.	IkappaB-alpha	NF-kappaB	4792	4790	672	601	0.0015938245770225	Non valid	0.0120197492167077;0.9597147035671898;0.02826554721610245	ACTIVATION	9920937	NFKBIA	9606	NFKB1	9606	coTF		NFKB
67854	PMID:23886618:pubtator_title_and_abstract:549e3340191eb6586de25095722e8fc9:10:NF-kappaB:NF-kappaB:2327:2345	Our observations (1) confirm the previous data on proliferation, P4 and IGF-I release in ovarian cells and their up-regulation by FSH, (2) demonstrate the presence of SIRT1, [TF]/p50 and [TG]/p65 in these cells, (3) show for the first time the involvement of SIRT1 and NF-kappaB in direct control of proliferation and secretory activity of ovarian cells, (4) represent the first data on interrelationships between FSH, SIRT1 and NF-kappaB within the ovary.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	2327	2345	0.0012154052866799	Non valid	0.6696156053408459;0.32688707256101335;0.0034973220981408286	UNDEFINED	23886618	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
68017	PMID:16179556:pubtator_title_and_abstract:903a4910d9b0ed14459bdf306cb6dbba:5:c-fos:NF-kbeta:981:1005	Cocaine (50-500 microM) resulted in significant induction of the expression of [TF], c-jun, SP-1, and [TG].	c-fos	NF-kbeta	314322	309165	981	1005	0.0012371983473529	Non valid	0.0027466014371459574;0.9958088149690157;0.0014445835938382637	ACTIVATION	16179556	Fos	10116	Rela	10116	dbTF		NFKB
68108	PMID:18196928:pubtator_title_and_abstract:7e2daa56c348f213459dae776a9d7c22:4:activated protein-1:nuclear factor-kappaB:502:534	The aim of this study was to investigate the significance of Etk/Bmx expression in hepatocellular carcinoma (HCC) and the relationship between Etk/Bmx and [TF] (AP-1)- and [TG] (NF-kappaB)-associated proteins.	activated protein-1	nuclear factor-kappaB	3725	4790	502	534	0.0011441823046105	Non valid	0.9971271852154722;0.002045524438558587;0.0008272903459691341	UNDEFINED	18196928	JUN	9606	NFKB1	9606	dbTF		NFKB
68158	PMID:23735076:pubtator_title_and_abstract:e1cc36d70114af190640e2db35c77711:4:nuclear factor kappaB:NFkappaB:587:610	Immunoblotting detected [TF] ([TG]) as a measure of functional receptor response.	nuclear factor kappaB	NFkappaB	Complex:NFKB	4790	587	610	0.0019696404328259	Non valid	0.9720607172155982;0.022509925540873426;0.0054293572435284475	UNDEFINED	23735076	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
68213	PMID:20089511:pubtator_title_and_abstract:b233107f1dcf50941d91ab51e7b48a6f:11:TXN:NF-kappaB:1293:1326	Six genes were selected for validation as follows: thioredoxin-interacting protein (TXNIP), thioredoxin ([TF]), nuclear factor of kappa B ([TG]), interleukin 6 (IL6), interleukin 8 (IL8) and receptor of advanced glycation end-products (RAGE).	TXN	NF-kappaB	7295	4790	1293	1326	0.0011826760644219	Non valid	0.9670249786577126;0.028626591093467678;0.004348430248819689	UNDEFINED	20089511	TXN	9606	NFKB1	9606	ll_coTF		NFKB
68295	PMID:14691250:pubtator_title_and_abstract:bc63a9b4e18c229e27c122f14080349a:13:IKKbeta:NF-kappaB:1812:1938	Thus, LMP1 induces typical canonical IKKbeta/IKKgamma-dependent, atypical canonical [TF]-dependent/IKKgamma-independent, and noncanonical NIK/IKKalpha-dependent NF-kappaB activations; NIK/IKKalpha-dependent [TG] activation is principally mediated by the LMP1 TRAF-binding site.	IKKbeta	NF-kappaB	3551	4790	1812	1938	0.0020544141162202	Non valid	0.021539066478466526;0.9723150951718731;0.006145838349660309	ACTIVATION	14691250	IKBKB	9606	NFKB1	9606	coTF		NFKB
68314	PMID:27667278:pubtator_title_and_abstract:5f7d11e54223b540496d6dbd221d4d6e:12:Notch1:NF-kappaB:2666:2591	(3) The fluorescence intensity of [TG]/p52 was significantly lower both in the nucleus and cytoplasm in [TF]-siRNA group, Notch2-siRNA group and Notch3-siRNA group compared with NC group and control group (all P<0.01), and the decrease was more obviously in the nucleus than in cytoplasm in Notch1-siRNA group, Notch2-siRNA group and Notch3-siRNA group (P<0.05 or 0.01).	Notch1	NF-kappaB	4851	4790	2666	2591	0.0055458063814015	Non valid	0.016783858020853026;0.9714117184337524;0.011804423545394705	ACTIVATION	27667278	NOTCH1	9606	NFKB1	9606	dbTF		NFKB
68319	PMID:15240729:pubtator_title_and_abstract:c963a1086f807cc16ed760ece46ca834:2:IkappaB kinase alpha:NF-kappaB:266:213	It has been shown that peptides corresponding to the [TG] essential modifier-binding domain (NBD) of [TF] or IkappaB kinase beta specifically inhibit the induction of NF-kappaB activation without inhibiting the basal NF-kappaB activity.	IkappaB kinase alpha	NF-kappaB	12675	18033	266	213	0.0011347571698983	Non valid	0.019659647336284822;0.9618857013461973;0.01845465131751782	ACTIVATION	15240729	Chuk	10090	Nfkb1	10090	coTF		NFKB
68387	PMID:31284759:pubtator_title_and_abstract:28f7ebbaf877573bf93644e1a87e51ec:8:AhR.:NF-kappaB:1467:1815	Lastly, we confirmed decreased AhR and increased SOCS2 expression in monocytes of patients with end-stage renal disease, indicating the activation of [TF] Taken together, our results suggest that IS-induced TNF-alpha production in macrophages is regulated through a complicated mechanism involving interaction of AhR, NF-kappaB, and SOCS2.-Kim, H. Y., Yoo, T.-H., Cho, J.-Y., Kim, H. C., Lee, W.-W. Indoxyl sulfate-induced TNF-alpha is regulated by crosstalk between the aryl hydrocarbon receptor, [TG], and SOCS2 in human macrophages.	AhR.	NF-kappaB	196	4790	1467	1815	0.0013329376348368	Non valid	0.8034203001144009;0.1904488657272653;0.006130834158333813	UNDEFINED	31284759	AHR	9606	NFKB1	9606	dbTF		NFKB
68481	PMID:31874343:pubtator_title_and_abstract:c58d770548231646c3cfa64a5e5e75cd:0:ERK1/2:NFkappaB:83:70	miRNA-20a suppressed lipopolysaccharide-induced HK-2 cells injury via [TG] and [TF] signaling by targeting CXCL12.	ERK1/2	NFkappaB	5595;5594	4790	83	70	0.0011818863320038	Non valid	0.3595964043689788;0.25415313778417203;0.38625045784684914	REPRESSION	31874343	MAPK3;MAPK1	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
68552	PMID:32856219:pubtator_title_and_abstract:c594c58267ed31a2fcadf842e7be6a56:8:FGFR2:NF-kappaB:1027:1113	The expression of CyclinD1, B cell lymphoma/leukemia-2 (Bcl-2), Bcl-2-associated X protein (Bax), [TF], P65, phosphorylated P65 (p-P65), alpha inhibitor of nuclear factor kappa beta ([TG]) (IkappaB-alpha), and phosphorylated IkappaB-alpha (p-IkappaB-alpha) at the protein level was quantified by western blot.	FGFR2	NF-kappaB	2263	4790	1027	1113	0.0011770348084063	Non valid	0.8971755116829908;0.02742425996357903;0.07540022835343006	UNDEFINED	32856219	FGFR2	9606	NFKB1	9606	ll_coTF		NFKB
68591	PMID:37139806:pubtator_title_and_abstract:d1601c283010a8ad367fea5f3e3eb149:13:STING:nuclear factor kappa B:2460:2232	Our study provides evidence of the protective effect of NLRC3 in sepsis-induced ALI by inhibiting excessive inflammatory response of the lung tissue.AbbreviationsAcute lung injury: ALI; intensive care units: ICU; lipopolysaccharide: LPS; acute respiratory distress syndrome: ARDS; bronchoalveolar lavage fluid: BALF; nucleotide-binding oligomerization domain-like receptors: NLRs; NLR family CARD domain containing 3: NLRC3; [TG]: NF-kappaB; tumor necrosis factor receptor-associated factor 6: TRAF6; Phosphatidylinositol 3'-kinase: PI3K; protein kinase B: Akt; mammalian target of the rapamycin: mTOR; stimulator of interferon genes: [TF]; TANK-binding kinase 1: TBK1; type I interferon: IFN-I; toll-like receptors: TLRs; tumor necrosis factor: TNF; interleukin: IL; NOD-like receptor protein 3: NLRP3; enhanced green fluorescent protein: EGFP; lentivirus: LV; phosphate-buffered saline: PBS; intrabronchial: i.t.; cecum ligation and puncture: CLP; wet/dry: W/D; Real time polymerase chain reaction: RT-PCR; enzyme-linked immunosorbent assay: ELISA; hematoxylin and eosin: H&E; radio immunoprecipitation assay: RIPA; sodium dodecyl sulfate polyacrylamide gel electrophoresis: SDS-PAGE; polyvinylidene fluoride: PVDF; glyceraldehyde 3-phosphate dehydrogenase: GAPDH; bovine serum albumin: BSA; Tris buffered saline containing Tween 20: TBST; standard deviation: SD; one-way analysis of variance: ANOVA; janus kinase 2: JAK2; activators of transcription 3: STAT3; pathogen associated molecular patterns: PAMPs; danger associated molecular patterns: DAMPs.	STING	nuclear factor kappa B	72512	18033	2460	2232	0.0011576655288716	Non valid	0.7817443615968632;0.1789142586287644;0.03934137977437227	UNDEFINED	37139806	Sting1	10090	Nfkb1	10090	coTF		NFKB
68609	PMID:35151924:pubtator_title_and_abstract:9f24c9b033fc6c244e8ae1a480c29c74:5:KLF4:NF-kappaB:769:803	Mechanically, Neat1 facilitates Bruton's tyrosine kinase (BTK) transcription by reducing the transcriptional factor [TF], which further activates the [TG] pathway, NLRP3 inflammation, and M1 polarization in BMDMs.	KLF4	NF-kappaB	16600	18033	769	803	0.0054523987654774	Non valid	0.031141662606039934;0.1659447446753981;0.802913592718562	REPRESSION	35151924	Klf4	10090	Nfkb1	10090	dbTF		NFKB
68660	PMID:16776680:pubtator_title_and_abstract:39cffb4c2ccda6f6aaded92965161b7a:14:Rel A:NF-kappaB:1780:1841	In activated HMC-1 cells, the expression level of nuclear factor (NF)-kappaB/[TF] protein increased in the nucleus, whereas the level of [TG]/Rel A in the nucleus was decreased by alginic acid treatment.	Rel A	NF-kappaB	5970	4790	1780	1841	0.0013369428556407	Non valid	0.3626685341925532;0.23755810383777798;0.3997733619696689	REPRESSION	16776680	RELA	9606	NFKB1	9606	dbTF		NFKB
68669	PMID:12404274:pubtator_title_and_abstract:0f942c4d225ba532af9e35d7737b4ebd:9:NF-kappaB:NF-kappaB:1848:1813	RESULTS: The results showed that TNF-alpha can induce activation of NF-kappaB and that the activation and translocation of NF-kappaB into the nucleus is responsible for promoting the 3-D cytomorphologic differentiation of anaplastic thyroid carcinoma cells, which was inhibited by the [TG] translocation inhibitor, [TF] SN50.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1848	1813	0.0020424483942315	Non valid	0.00844414131571306;0.9832675361043601;0.008288322579926895	ACTIVATION	12404274	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
68691	PMID:19688069:pubtator_title_and_abstract:81b76fbcf42cc4a42c304908c2fa93f4:2:nuclear factor-kappaB:NFkappaB:115:138	PURPOSE: Osteopontin (OPN) binds to CD44 and [TF] ([TG]) and OPN mediates tumorigenesis, invasion and metastasis, but the interrelationships between OPN, CD44 and NFkappaB are not fully understood, and especially in gastric carcinogenesis.	nuclear factor-kappaB	NFkappaB	Complex:NFKB	4790	115	138	0.0011417779961743	Non valid	0.9524568906505566;0.04513622376028897;0.0024068855891544007	UNDEFINED	19688069	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
68771	PMID:7541794:pubtator_title_and_abstract:379eab870da4d71257f3a2bcadb961cd:5:p50:NF-kappa B:581:707	In addition, integrin ligation leads to nuclear translocation of the [TF] and p65 subunits of the NF-kappa B transcription factor, to activation of a reporter gene driven by a promoter containing [TG] sites, and to increased levels of mRNAs for immediate-early genes, including the cytokine interleukin (IL)-1 beta.	p50	NF-kappa B	4790	4790	581	707	0.0010865305783293	Non valid	0.008184385062073042;0.9907420640295154;0.0010735509084115456	ACTIVATION	7541794	NFKB1	9606	NFKB1	9606	dbTF		NFKB
68802	PMID:24825463:pubtator_title_and_abstract:f9ef467193457e8e6090a99542fb2779:6:Akt:NFkappaB.:726:779	Further, BK was found to elicit the BK receptors (BDKR1 and BDKR2) mediated activation of ERK1/2 and [TF] pathways, which finally led to the activation of [TG] BK also promoted the osteoclast differentiation of bone marrow derived preosteoclast cells by upregulating the expression of c-fos, NFATC1, TRAP, clcn7, cathK, and OSCAR genes and increasing TRAP activity through NFkappaB pathway.	Akt	NFkappaB.	207	4790	726	779	0.0015486350103278	Non valid	0.005101167677410113;0.9939360964589985;0.00096273586359147	ACTIVATION	24825463	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
68854	PMID:12600818:pubtator_title_and_abstract:3c564b8324ff98a8f9abd10b627493b6:5:JNK:NF-kappaB.:1337:1276	Ras was required for maximal activation of extracellular signal-regulated kinase (ERK) and Jun amino terminal kinase (JNK) as well as AP-1 and NF-kappaB transcriptional activities, but not for activation of IkappaB kinase (IKK)-beta, an upstream activator of [TG] MEKK1 was required for maximal activation of ERK, [TF], and IKK, as well as for maximal AP-1 and NF-kappaB transcriptional activities.	JNK	NF-kappaB.	5599	4790	1337	1276	0.0010797254072006	Non valid	0.0027554453248516543;0.9964451130194767;0.0007994416556716333	ACTIVATION	12600818	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
68906	PMID:34118341:pubtator_title_and_abstract:75dfb6056ccd1e4a00adbfde7cc673a7:10:PARP-1:NFkappa-B:1360:1349	Apoptosis was analyzed by microscopy and expression of selected apoptosis-related genes (Bcl-2, Bcl-xL, [TG], [TF], p53, Bax, caspase-3 and -8) using RT-PCR.	PARP-1	NFkappa-B	11545	18033	1360	1349	0.0012436060486674	Non valid	0.9837385715038935;0.014197978782266528;0.002063449713839945	UNDEFINED	34118341	Parp1	10090	Nfkb1	10090	coTF		NFKB
68946	PMID:16266460:pubtator_title_and_abstract:cd1c61fa200d8564a6bd6a556c5f05ab:3:NF-kappaB.:NF-kappaB:359:539	TLR4 activation mediates the expression of chemokines and cytokines through activation of [TF] We investigated the expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), intercellular adhesion molecule-1 (CAM-1), E-selectin induced by TLR4/[TG] in human umbilical vein endothelial cells (HUVECs), and their effects on adhesion of monocyte to HUVECs.	NF-kappaB.	NF-kappaB	Complex:NFKB	4790	359	539	0.0011266852632504	Non valid	0.0058572872983497165;0.993501303695218;0.0006414090064322417	ACTIVATION	16266460	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
68980	PMID:28550734:pubtator_title_and_abstract:feab107bca225df8242bbf01f21e11ec:15:SIRT1:NF-kappaB:1587:1727	Moreover, Pte increased the expression of sirtuin-1 ([TF]) and reduced the expression of acetylated forkhead box O1 (Ac-FoxO1), acetylated Ac-p53, and acetylated nuclear factor-kappa beta (Ac-[TG]).	SIRT1	NF-kappaB	93759	18033	1587	1727	0.001282935767564	Non valid	0.285227176911925;0.0814791956080705;0.6332936274800046	REPRESSION	28550734	Sirt1	10090	Nfkb1	10090	coTF		NFKB
69151	PMID:36907479:pubtator_title_and_abstract:8924567f78c1447ff242ca1fc0510256:9:AKT:NF-kappaB:953:958	Inducible NO synthase (iNOS), COX-2, MAPKs, [TF], [TG], HO-1, Nrf-2 were examined by western blotting.	AKT	NF-kappaB	11651	18033	953	958	0.0011908945007657	Non valid	0.9735544753434805;0.02450239951736412;0.0019431251391553354	UNDEFINED	36907479	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
69218	PMID:14654787:pubtator_title_and_abstract:29cd3f91a79486f63365f85a1251281d:7:NEMO:NF-kappaB:848:1072	Second, using NEMO knockout mouse fibroblasts and 10 [TF] mutants, we found that different regions function in trans either to complement or to inhibit dominantly TNFalpha, IL-1beta, or Tax activation of NF-kappaB. For instance, NEMO (1-245 amino acids) supported Tax-mediated [TG] activation, but did not serve TNFalpha- or IL-1beta signaling.	NEMO	NF-kappaB	16151	18033	848	1072	0.0019656059989211	Non valid	0.016218878991462383;0.979077180291764;0.0047039407167736	ACTIVATION	14654787	Ikbkg	10090	Nfkb1	10090	coTF		NFKB
69233	PMID:23886618:pubtator_title_and_abstract:549e3340191eb6586de25095722e8fc9:3:p65,:NFkappaB:498:382	The aim of our in vitro experiments was to examine the involvement of SIRT1 and the p65 and p50 subunits of [TG] in control of porcine ovarian granulosa cell functions and the interrelationships between SIRT1, NFkappaB ([TF] p50) 30 and FSH in the ovary.	p65,	NFkappaB	5970	4790	498	382	0.0010970613164598	Non valid	0.9945755976452485;0.004528733835115649;0.0008956685196358517	UNDEFINED	23886618	RELA	9606	NFKB1	9606	dbTF		NFKB
69263	PMID:1459457:pubtator_title_and_abstract:eb331642c26d38a00a42efb7d40942c2:3:bcl-3:NF-kappa B:214:297	The [TF] protein is able to inhibit the DNA binding and trans-activation of authentic [TG] heterodimers p50-p65 and p49-p65, as well as p50 and p49 homodimers.	bcl-3	NF-kappa B	602	4790	214	297	0.0016469964871091	Non valid	0.0023686629990260872;0.00264118331476054;0.9949901536862134	REPRESSION	1459457	BCL3	9606	NFKB1	9606	dbTF		NFKB
69293	PMID:33629560:pubtator_title_and_abstract:ef70f1024ccc8b64c8f61c51d8a8be54:8:NLRP3:NF-kappaB:1399:1384	Compared with the IR group, [TG], the [TF] inflammasome proteins, their downstream pyroptosis-related proteins GSDMD-N and GSDMD as well as inflammation factors IL-1beta and IL-18 in hippocampus of RT group were significantly decreased (P<0.05), and the expression levels of SIRT1 and p-AMPK protein were significantly increased (P<0.01).	NLRP3	NF-kappaB	216799	18033	1399	1384	0.0015234247231297	Non valid	0.39594472318155965;0.5836789206241082;0.020376356194332194	ACTIVATION	33629560	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
69531	PMID:17965022:pubtator_title_and_abstract:e0280796295e48c1119044d42d5a8539:6:TAK1:NF-kappaB:582:651	We found that [TF] deletion completely abolished MDP-NOD2 signaling, activation of [TG] and MAPKs, and subsequent induction of cytokines/chemokines in keratinocytes.	TAK1	NF-kappaB	26409	18033	582	651	0.1798941609968995	Non valid	0.0015959167964980047;0.9962246220684323;0.002179461135069749	ACTIVATION	17965022	Map3k7	10090	Nfkb1	10090	ll_coTF		NFKB
69544	PMID:30309296:pubtator_title_and_abstract:a0463867a9b79d2e254c0715ee9f7650:8:NF-kappaB:nuclear factor-kappa B:1042:1075	To identify the mechanisms, we investigated the [TF] pathway and found that [TG] (NF-kappaB), B-cell lymphoma-2 (Bcl-2), and vascular endothelial growth factor (VEGF) were suppressed, whereas IkappaBalpha was promoted in miR-181-overexpressing cells.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	4790	1042	1075	0.0139287313338341	Non valid	0.02119679787353837;0.06533524602828804;0.9134679560981737	REPRESSION	30309296	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
69551	PMID:27501752:pubtator_title_and_abstract:040a421f7f0ad9bf957cc950176697f6:0:BAT3:NF-kappaB:0:53	[TF] negatively regulates lipopolysaccharide-induced [TG] signaling through TRAF6.	BAT3	NF-kappaB	7917	4790	0	53	0.0039653369187538	Non valid	0.0012887113033000998;0.002915730491179668;0.9957955582055202	REPRESSION	27501752	BAG6	9606	NFKB1	9606	coTF		NFKB
69688	PMID:32964982:pubtator_title_and_abstract:7396f670c90b6197e6649d584749d014:5:IKKalpha:NF-kappaB:1002:1071	However, FKBP51-overexpressed BT325 cells showed enhanced migration and invasion, which was supported by corresponding increase in phosphorylated [TF] (p-IKKalpha), MMP-2, and MMP-9 levels, as well as increased [TG] p65 nuclear translocation.	IKKalpha	NF-kappaB	1147	4790	1002	1071	0.0013011969178967	Non valid	0.04124719796365855;0.9548505442433847;0.003902257792956807	ACTIVATION	32964982	CHUK	9606	NFKB1	9606	coTF		NFKB
69743	PMID:15572357:pubtator_title_and_abstract:b312fdfa48a68256358be06900e0b019:6:cIAP1:NF-kappaB:1106:1002	A diminished induction of [TG]-dependent target genes conveying either anti-apoptotic or pro-inflammatory functions, such as [TF], TRAF1, IL-6, or IL-8 is observed.	cIAP1	NF-kappaB	329	4790	1106	1002	0.0016704568097501	Non valid	0.10127199484993193;0.8956949040024381;0.003033101147629988	ACTIVATION	15572357	BIRC2	9606	NFKB1	9606	coTF		NFKB
69752	PMID:26111727:pubtator_title_and_abstract:4b0781a410939d5f6484546c47631538:3:NF-kappaB:nuclear factor-kappaB:395:259	Although constitutive activation of the [TG] (NF-kappaB) pathway has been documented, knowledge about the genetic alterations leading to the impairment of the [TF] pathway in PCNSLs is still limited.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	395	259	0.0011065881710571	Non valid	0.13241358401086684;0.6929451799924846;0.1746412359966486	ACTIVATION	26111727	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
69776	PMID:12239622:pubtator_title_and_abstract:9fe479b4c29d762b6228429715644ce0:7:AR:NF-kappaB:1241:1269	The results obtained here demonstrate that curcumin has a potential therapeutic effect on prostate cancer cells through down-regulation of AR and [TF]-related cofactors (AP-1, [TG] and CBP).	AR	NF-kappaB	367	4790	1241	1269	0.0132579896522984	Non valid	0.7085917336995274;0.27981801228787495;0.011590254012597577	UNDEFINED	12239622	AR	9606	NFKB1	9606	dbTF		NFKB
69857	PMID:12432072:pubtator_title_and_abstract:9af17472e8166a6a50cc0cd38f0ddcff:7:IkappaBalpha:NFkappaB:1146:1105	We hypothesized that activation of [TG] prior to injury using antisense [TF] mRNA would reduce apoptosis.	IkappaBalpha	NFkappaB	4792	4790	1146	1105	0.0053978006678465	Non valid	0.008252482828104566;0.019423676724992532;0.9723238404469028	REPRESSION	12432072	NFKBIA	9606	NFKB1	9606	coTF		NFKB
69858	PMID:10544088:pubtator_title_and_abstract:5f7b52b78cad365a98788e920f4c7df1:7:IkappaBalpha:NF-kappaB:1185:1280	High levels of CAT activity were seen with HIV-LTR-derived reporters that contained kappaB and TAR elements in response to transfected Tat in the absence of either transfected Rel A or exogenous TNF-alpha, and overexpression of [TF] with Tat inhibited CAT activity by 60% to 80%, suggesting that some activation of [TG] by Tat was occurring.	IkappaBalpha	NF-kappaB	4792	4790	1185	1280	0.0019848585334023	Non valid	0.04754550667787579;0.3471739335636928;0.6052805597584314	REPRESSION	10544088	NFKBIA	9606	NFKB1	9606	coTF		NFKB
69915	PMID:17213804:pubtator_title_and_abstract:349432be90a6974244a1bcd89e59ffa9:2:NF-kappaB:nuclear factor-kappaB:323:300	CD34(+) bone marrow blasts from high-risk myelodysplastic syndrome (MDS) patients as well as MDS patient-derived cell lines (P39 and MOLM13) constitutively activate the [TG] ([TF]) pathway and undergo apoptosis when NF-kappaB is inhibited.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	323	300	0.0011347579806192	Non valid	0.0052993227872205;0.9931306223189202;0.0015700548938593537	ACTIVATION	17213804	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
69963	PMID:9738011:pubtator_title_and_abstract:e1ffa029df4847c167f4c947640c4d25:2:p50:NF-kappaB:568:432	We show that although a common mode of interaction exists between the Rel/[TG] dimers and Ikappa Balpha, IkappaB alpha binds the NF-kappaB p50/p65 heterodimer with 60- and 27-fold higher affinity than the [TF] and p65 homodimers, respectively.	p50	NF-kappaB	4790	4790	568	432	0.0011301258013744	Non valid	0.9835759853985224;0.012076251214932844;0.004347763386544696	UNDEFINED	9738011	NFKB1	9606	NFKB1	9606	dbTF		NFKB
70098	PMID:30879680:pubtator_title_and_abstract:20e83cf65e441af00f71863724c0fab5:4:p65:NF-kappaB:698:974	DAPI staining and Flow cytometric analysis revealed that AAP suppressed cells proliferation, not most at least via inducing [TF]-dependent mitochondrial signaling pathway, as evidenced by more activation of caspase-3 and -9, down-regulation of Bcl-2 protein, up-regulation of Bax protein and release of cytochrome c from mitochondria into cytosol, as well as suppression of the nuclear factor-kappaB ([TG]) p65.	p65	NF-kappaB	5970	4790	698	974	0.0025967985095409	Non valid	0.042989458248919234;0.5970232773005727;0.35998726445050816	ACTIVATION	30879680	RELA	9606	NFKB1	9606	dbTF		NFKB
70149	PMID:31068381:pubtator_title_and_abstract:49c85525e3e9fadab752fe6ae907bb7f:7:nuclear factor-kappaB:NF-kappaB:1552:1612	In addition, JFNE and fraction D downregulated the protein expression of iNOS, [TF] (NF-kappaB) (p50), and phosphorylated [TG] (p65).	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	1552	1612	0.0014462858341398	Non valid	0.5048354556476352;0.4665345823058883;0.028629962046476408	UNDEFINED	31068381	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
70208	PMID:22015193:pubtator_title_and_abstract:57938b49ef2a9bd9e8cc3dc3bdc01940:8:TGF-beta1:NF-kappaB:1295:1334	Furthermore, [TF], Smad2, Smad3, Smad4, Smad7, [TG] and RANK mRNA expressions of the optimal combination group were significantly lower than those of the weak combination group (P<0.01).	TGF-beta1	NF-kappaB	7040	4790	1295	1334	0.0012930222004127	Non valid	0.05703787657401047;0.19250855545015058;0.750453567975839	REPRESSION	22015193	TGFB1	9606	NFKB1	9606	ll_coTF		NFKB
70228	PMID:24302009:pubtator_title_and_abstract:7538801b28c71a9e619a31d69b438ec1:6:PPARgamma:NF-kappaB:1166:1225	Furthermore, 25HC3S increases nuclear [TF] and cytosolic IkappaBalpha and decreases nuclear [TG] levels and proinflammatory cytokine expression and secretion when cells are challenged with LPS and TNFalpha.	PPARgamma	NF-kappaB	5468	4790	1166	1225	0.0012704578978172	Non valid	0.06579442762999205;0.10805927829487127;0.8261462940751367	REPRESSION	24302009	PPARG	9606	NFKB1	9606	dbTF		NFKB
70242	PMID:8394446:pubtator_title_and_abstract:64a5aeb1dff9e3fcc03fd7668a0c2ffc:8:p65:NF-kappa B:1384:1577	Virus infection does not appear to alter the amount of RelA ([TF]) or NFKB1 (p50) but rather affects the capacity of I kappa B alpha to sequester RelA (p65), therefore leading to constitutive levels of RelA DNA binding activity and to increased levels of [TG]-dependent gene activity.	p65	NF-kappa B	5970	4790	1384	1577	0.0011251102519492	Non valid	0.12736323657687984;0.8409302845132992;0.03170647890982096	ACTIVATION	8394446	RELA	9606	NFKB1	9606	dbTF		NFKB
70255	PMID:10358154:pubtator_title_and_abstract:1ae1f7a176e1d51d2e61201262e6ae5f:9:I kappa B-beta:NF-kappa B:1228:1139	PNU156804 inhibition of [TG] activation is due to the inhibition of the degradation of I kappa B-alpha and [TF].	I kappa B-beta	NF-kappa B	4793	4790	1228	1139	0.3363325546733954	Non valid	0.005949366711009297;0.9679923923263827;0.026058240962608014	ACTIVATION	10358154	NFKBIB	9606	NFKB1	9606	coTF		NFKB
70261	PMID:17588735:pubtator_title_and_abstract:582d7e7612ef4ac087854d89bd88c9ae:5:NF-kappaB:NF-kappaB:892:1021	In nuclear factor-kappa B ([TF])-mediated apoptosis pathway, the results showed that SNL glycoprotein dose-dependently blocked DNA binding activity of [TG], activity of inducible nitric oxide synthase (iNOS) and production of inducible nitric oxide (NO).	NF-kappaB	NF-kappaB	Complex:NFKB	4790	892	1021	0.0011569594276911	Non valid	0.32569626910345806;0.6689280868938455;0.005375644002696504	ACTIVATION	17588735	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
70329	PMID:19824995:pubtator_title_and_abstract:5dd060b96efbb21efc9aebaa4b350d46:5:NF-kappaB:nuclear factor-kappa B:599:575	Cell viability, flow cytometric analysis, and [TG] ([TF]) activity were analyzed.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	4790	599	575	0.0011652346548029	Non valid	0.8590428762905035;0.1324307682970941;0.008526355412402363	UNDEFINED	19824995	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
70380	PMID:15650774:pubtator_title_and_abstract:54ad8fc4a8ceb7bf8bc0f36569ed6ce4:5:MyD88:NF-kappaB.:634:576	THP triggers typical TLR signaling, culminating in activation of [TG] Bone marrow-derived macrophages from TLR4- and [TF]-deficient mice were nonresponsive to THP in contrast to those from TLR2- and TLR9-deficient mice.	MyD88	NF-kappaB.	17874	18033	634	576	0.0049457044264996	Non valid	0.013485074336702747;0.9700558590626512;0.016459066600646027	ACTIVATION	15650774	Myd88	10090	Nfkb1	10090	coTF		NFKB
70500	PMID:12531797:pubtator_title_and_abstract:6166da1a145caed040bbcae3ffa28a0d:9:ERK:NF-kappaB:2023:2039	Thus, our study demonstrates that beta(2)M at high concentrations retards the generation of MoDCs, which may involve down-regulation of major histocompatibility complex class I molecules, inactivation of Raf/MEK/[TF] cascade and [TG], and activation of STAT3, and it merits further study to elucidate the underlying mechanisms.	ERK	NF-kappaB	5594	4790	2023	2039	0.0011610404608636	Non valid	0.015363563225232036;0.9661027099908992;0.018533726783868755	ACTIVATION	12531797	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
70521	PMID:22777360:pubtator_title_and_abstract:67e02e796b88b801f697c918cc66954c:2:RelB:NF-kappaB:229:129	The alternative nuclear factor-kappaB ([TG]) -activation pathway proceeds via inducible p100 processing, leading to the activation of [TF]-containing dimers.	RelB	NF-kappaB	19698	18033	229	129	0.0015289303737921	Non valid	0.021356818218253148;0.976566146526243;0.002077035255503918	ACTIVATION	22777360	Relb	10090	Nfkb1	10090	dbTF		NFKB
70535	PMID:11847220:pubtator_title_and_abstract:7898813ffc1affc2c1272cab8640ccdf:0:Akt:NFkappa B:90:133	The RasGAP N-terminal fragment generated by caspase cleavage protects cells in a Ras/PI3K/[TF]-dependent manner that does not rely on [TG] activation.	Akt	NFkappa B	207	4790	90	133	0.0012647366128694	Non valid	0.04940123259417586;0.947503120478053;0.003095646927771113	ACTIVATION	11847220	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
70653	PMID:20705611:pubtator_title_and_abstract:d856c1a9f7a9c32056761144af96cc6e:7:p65:NFkappaB:1182:1159	ER allows the [TG] family member [TF] to access a latent NFkappaB response element located near the ERE in the gene promoter.	p65	NFkappaB	5970	4790	1182	1159	0.0011744214215398	Non valid	0.9939188434881212;0.004626641132338192;0.001454515379540681	UNDEFINED	20705611	RELA	9606	NFKB1	9606	dbTF		NFKB
70727	PMID:15567061:pubtator_title_and_abstract:3789fbdf21a03b130c02f6f4933f7606:6:IkappaBalpha:NF-kappaB:1011:1090	Stimulation of cells with PMA caused [TF] phosphorylation, IkappaBalpha degradation, and the formation of a [TG]-specific DNA-protein complex.	IkappaBalpha	NF-kappaB	4792	4790	1011	1090	0.001396801996766	Non valid	0.9347157208103366;0.014366130921045422;0.050918148268617944	UNDEFINED	15567061	NFKBIA	9606	NFKB1	9606	coTF		NFKB
70756	PMID:19775294:pubtator_title_and_abstract:a82c9a17f027e8cea55b1f3aa6fd6325:2:nuclear factor-kappaB:NF-kappaB:186:209	Inhibitor of growth 4 (ING-4) is a tumor suppressor gene that interacts with [TF] ([TG]) and represses its transcriptional activity.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	186	209	0.0012071949730104	Non valid	0.004466840564612992;0.008137638736482036;0.987395520698905	REPRESSION	19775294	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
70773	PMID:36332385:pubtator_title_and_abstract:ce6045c360a5de4d202419c9b706a126:13:TAK1:NF-kappaB:1421:1449	We confirmed that Cos can interact with [TF] and inhibit downstream [TG] pathway activation by blocking the formation of the TAK1/TAB2 complex, thus inhibiting inflammatory cytokine release in cardiomyocytes.	TAK1	NF-kappaB	26409	18033	1421	1449	0.0032769765480675	Non valid	0.010114423410631276;0.959193709426147;0.030691867163221764	ACTIVATION	36332385	Map3k7	10090	Nfkb1	10090	ll_coTF		NFKB
70816	PMID:17426454:pubtator_title_and_abstract:2509e5f6ccb5685b17840648f91e06c7:0:cyclin D1:NFkappaB:38:0	[TG]-independent signaling to the [TF] gene by Rac.	cyclin D1	NFkappaB	12443	18033	38	0	0.0016522647184102	Non valid	0.7903346705310186;0.20678782716989255;0.002877502299088919	UNDEFINED	17426454	Ccnd1	10090	Nfkb1	10090	coTF		NFKB
70830	PMID:8831497:pubtator_title_and_abstract:f333fe2968f5cb7334179c0e7e2d0312:2:Jun N-terminal kinase:NF-kappa B:504:383	Tumor necrosis factor (TNF) activates transcription of endothelial leukocyte adhesion molecule-1 (CD62E) in endothelial cells (ECs) through the binding to the gene promoter of the p50/p65 heterodimeric form of nuclear factor-kappa B ([TG]) and of the N-terminal phosphorylated form of the ATF2/c-Jun transcription factor, which is phosphorylated by [TF] (JNK).	Jun N-terminal kinase	NF-kappa B	5599	4790	504	383	0.001094711594151	Non valid	0.012179475232844721;0.9866382466684798;0.001182278098675519	ACTIVATION	8831497	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
70975	PMID:23798555:pubtator_title_and_abstract:114456d3a09f95c029f29cf08b02c15f:7:proliferating cell nuclear antigen:NF-kappaB:949:1056	RARgamma knockdown resulted in upregulation of cell cycle inhibitor P21, as well as downregulation of cyclin D1, [TF], and matrix metallopeptidase 9, in parallel with suppression of the Akt/[TG] pathway.	proliferating cell nuclear antigen	NF-kappaB	5111	4790	949	1056	0.0012862040071412	Non valid	0.024344904990311476;0.9355877442891547;0.040067350720533905	ACTIVATION	23798555	PCNA	9606	NFKB1	9606	coTF		NFKB
70979	PMID:18718921:pubtator_title_and_abstract:b533c9507b4b74a3659855dca30b1ea0:6:NF-kappaB:NF-kappaB:1091:1155	Intracellular signaling was studied with Western blotting and phosphoELISA; this revealed that DSP induced extracellular-regulated protein kinases 1 and 2 (ERK1/2), p38, and nuclear factor-kappaB ([TF]) phosphorylation within 3 h. Blocking ERK1/2, p38, or [TG] activation by their specific inhibitors significantly attenuated the DSP-induced upregulation of ET(B) receptor-mediated contraction and both ET(B) receptor mRNA and protein expression.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1091	1155	0.0011100181622919	Non valid	0.0024674233241557837;0.9962248653931491;0.0013077112826949844	ACTIVATION	18718921	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
71099	PMID:18512729:pubtator_title_and_abstract:6bce9d5b8f9557edcbabbdce0a687843:15:IKK alpha/beta:NF-kappaB:1533:1552	CONCLUSIONS: This study suggest that the osteoblast-derived BMP-2 act through Akt and ERK, which in turn activates [TF] and [TG], resulting in the activations of beta1 and beta 3 integrins and contributing the migration of prostate cancer cells.	IKK alpha/beta	NF-kappaB	1147;3551	4790	1533	1552	0.0011313971178831	Non valid	0.010247522934360213;0.9884159476790232;0.001336529386616581	ACTIVATION	18512729	CHUK;IKBKB	9606;9606	NFKB1	9606	coTF;coTF		NFKB
71113	PMID:24760979:pubtator_title_and_abstract:1fd9fe8c105e73afa1bc52b1a1c4ffec:5:HMGB1:NF-kappaB:1110:1079	The knockdown of Akt by siRNA technology and blocking the nuclear factor-kappaB (NF-kappaB) pathway using pyrrolidine dithiocarbamate (PDTC) and SN50, inhibitors of [TG], both attenuated the [TF]-induced proliferation by counteracting the activation of the cyclin D1.	HMGB1	NF-kappaB	15289	18033	1110	1079	0.0010737593697183	Non valid	0.0027495592543203824;0.9951292961221011;0.0021211446235785717	ACTIVATION	24760979	Hmgb1	10090	Nfkb1	10090	coTF		NFKB
71173	PMID:25217163:pubtator_title_and_abstract:de4e01fcdd7b754b6df4581aba4cb8c5:8:AP-1:NF-kappaB.:1586:1596	Inhibition of T cell proliferation was associated with abrogation of proximal TCR signaling by inhibiting recruitment of TCR-associated signaling molecules to lipid rafts, followed by abrogation of protein tyrosine phosphorylation of ZAP70, phospholipase C-gamma1, and protein kinase C-theta, and impaired nuclear translocation of NFAT, [TF], and [TG] Most importantly, TRAIL-R costimulation efficiently inhibited alloantigen-induced T cell proliferation and CD3/28-induced activation and proliferation of autoreactive T cells derived from patients with Omenn syndrome, indicating that coactivation of TRAIL-R and TCR represents a mechanism to downmodulate T cell immune responses.	AP-1	NF-kappaB.	2354	4790	1586	1596	0.0011196427421569	Non valid	0.030299997125264096;0.9671989802430897;0.002501022631646207	ACTIVATION	25217163	FOSB	9606	NFKB1	9606	dbTF		NFKB
71195	PMID:20800606:pubtator_title_and_abstract:943dcf1ca0a7601530b5d87c678f75c3:14:AP-1:NF-kappaB:1671:1615	Results from a reporter gene assays using the NF-kappaB or AP-1 promoter linked to the luciferase gene in transiently transfected CHO-KI cells revealed that [TG] was activated following MWCNT exposure, while [TF] was not changed.	AP-1	NF-kappaB	3727	4790	1671	1615	0.0012977966862501	Non valid	0.05846440609273202;0.9364249532786678;0.005110640628600167	ACTIVATION	20800606	JUND	9606	NFKB1	9606	dbTF		NFKB
71221	PMID:28596424:pubtator_title_and_abstract:a2712fa7b21e75bf7d4f1cc007e2703d:10:S100-A9:NFkappaB:1531:1562	Finally, our results suggest a preponderant role for the protein [TF] as an activator of the [TG] pathway during CLL progression and suggest that the leukemic clone can generate an autoactivation loop through S100-A9 expression, NF-kappaB activation, and exosome secretion.	S100-A9	NFkappaB	6280	4790	1531	1562	0.0039173327711531	Non valid	0.0037975171785446793;0.9952775926701702;0.0009248901512851486	ACTIVATION	28596424	S100A9	9606	NFKB1	9606	ll_coTF		NFKB
71230	PMID:24307345:pubtator_title_and_abstract:c0fd700fb8e875ca2ce49e2fd7d32c01:10:IKKbeta:NF-kappaB:1586:1547	Significant positive correlations were observed between the expression of PLCE1 and [TG]-related proteins, especially [TF] (r = 0.246 and P = 0.025) and p50 (r = 0.244 and P = 0.024).	IKKbeta	NF-kappaB	3551	4790	1586	1547	0.0011590875796393	Non valid	0.07684324985564217;0.9211839764482915;0.00197277369606622	ACTIVATION	24307345	IKBKB	9606	NFKB1	9606	coTF		NFKB
71306	PMID:28000898:pubtator_title_and_abstract:f344ed6c036ad706c8c3b7b0093f7a6e:5:extracellular signal-regulated kinase:NF-kappaB:892:995	Inhibitors of various kinases including AKT, c-Jun N-terminal kinase (JNK), P38 and [TF] (ERK) were used to evaluate the mechanism of regorafenib-induced [TG] inactivation.	extracellular signal-regulated kinase	NF-kappaB	5594	4790	892	995	0.0035277772818763	Non valid	0.056666320185502383;0.645778193580897;0.2975554862336006	ACTIVATION	28000898	MAPK1	9606	NFKB1	9606	ll_coTF		NFKB
71339	PMID:22148922:pubtator_title_and_abstract:16a159e1413b95e42d70ebda0f5f5c8c:6:JNK:NF-kappaB:1105:982	Thymopentin increased activation of both [TG] and SAPK/JNK cascades in unstimulated macrophages, while thymulin significantly decreased activation of the SAPK/[TF] but not NF-kappaB cascade in LPS-stimulated macrophages.	JNK	NF-kappaB	26419	18033	1105	982	0.0011459665437341	Non valid	0.00995059697418853;0.9746959613115869;0.015353441714224618	ACTIVATION	22148922	Mapk8	10090	Nfkb1	10090	ll_coTF		NFKB
71340	PMID:34907703:pubtator_title_and_abstract:60693c5e86ecefdc101c763ccad93ef4:8:NF-kappaB:NF-kappaB:1593:1341	Molecular docking analysis found that this analog exerts its anti- [TG] activity (binding energy of -6.78 kcal/mol and Ki 10 microM) by interacting with DNA binding residues (Arg246, Lys444, and Gln606) of p50 chain NF-kappaB. This study presents a novel RESV analog that could further develop as a potential anti-[TF] mediated tumor inhibitor.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1593	1341	0.0012791280739428	Non valid	0.3546827427647991;0.5054368787585032;0.13988037847669768	ACTIVATION	34907703	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
71367	PMID:15034076:pubtator_title_and_abstract:0bca496d7661256f2bcb325a526067cf:12:NF-kappaB:NF-kappaB:1764:1598	Using the inhibitor of [TG] activity, SN50, we were able to show that NF-kappaB activity was essential for the production of Th1 cytokines, suggesting that specific down-regulation of [TF] in T cells throughout gestation is paramount to pregnancy success through specific regulation of cytokine production.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1764	1598	0.0010968063437568	Non valid	0.013415111921439583;0.9842330749720266;0.002351813106533804	ACTIVATION	15034076	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
71386	PMID:12160329:pubtator_title_and_abstract:e094780d74df3aac9d12236a85c53a06:7:VEGF:NF-kappaB:1275:1214	In MDA-MB-231 cells, inhibition of NF-KB by adenovirus-mediated expression of a dominant negative [TG] or by a proteasome inhibitor, MG132, decreased the [TF] mRNA.	VEGF	NF-kappaB	7422	4790	1275	1214	0.001294887151463	Non valid	0.002579818695113257;0.9896107792827287;0.007809402022158005	ACTIVATION	12160329	VEGFA	9606	NFKB1	9606	ll_coTF		NFKB
71546	PMID:15792944:pubtator_title_and_abstract:1703d0201cce22e56132210a946647ac:4:NFkappaB:NFkappaB:744:580	Because Akt and nuclear factor kappaB ([TG]) are intimately involved in mammary tumor cell proliferation and survival, studies were conducted to determine the effects of gamma-tocotrienol on Akt and [TF] activity in neoplastic +SA mammary epithelial cells in vitro.	NFkappaB	NFkappaB	Complex:NFKB	4790	744	580	0.001199918383035	Non valid	0.9878215137835519;0.009394334153942386;0.0027841520625057595	UNDEFINED	15792944	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
71593	PMID:15073170:pubtator_title_and_abstract:b6cf4def912d36f8a8ac0015212d6e4d:3:NF-kappaB:NF-kappaB.:838:615	Rather, p53 expression stimulates the serine/threonine kinase ribosomal S6 kinase 1 (RSK1), which in turn phosphorylates the p65 subunit of [TG] The lower affinity of RSK1-phosphorylated p65 for its negative regulator, IkappaBalpha, decreases IkappaBalpha-mediated nuclear export of shuttling forms of NF-kappaB, thereby promoting the binding and action of [TF] on cognate kappaB enhancers.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	838	615	0.0012091565352456	Non valid	0.6634763729008144;0.30388050480613116;0.0326431222930544	UNDEFINED	15073170	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
71647	PMID:10602501:pubtator_title_and_abstract:a3d9b4d8473f34d3b4dc5e87fd650f51:2:RelA:NF-kappaB:278:169	To elucidate the possible role of [TG] in mouse skin carcinogenesis we studied the expression of p50 (NF-kappaB1), p52 (NF-kappaB2), p65 ([TF]) and IkappaB-alpha inhibitor as well as kappaB-binding activity in adult SENCAR mouse skin, skin papillomas, and squamous cell carcinomas (SCC) generated by a two-stage carcinogenesis protocol.	RelA	NF-kappaB	19697	18033	278	169	0.0011376700334686	Non valid	0.9872685833210321;0.011561929310863129;0.0011694873681048236	UNDEFINED	10602501	Rela	10090	Nfkb1	10090	dbTF		NFKB
71788	PMID:12878589:pubtator_title_and_abstract:a621bc7aac7643a899f7e0c0e0e7d4a8:13:PPAR alpha:NF kappa B:1686:1625	LPL-treated LDL(-) suppressed [TG] and AP-1 activation, increasing expression of the [TF] target gene I kappa B alpha, although only in the genetic presence of PPAR alpha and with intact LPL hydrolysis.	PPAR alpha	NF kappa B	5465	4790	1686	1625	0.0012505217559358	Non valid	0.07259965661312133;0.30409027847167414;0.6233100649152046	REPRESSION	12878589	PPARA	9606	NFKB1	9606	dbTF		NFKB
71794	PMID:30736100:pubtator_title_and_abstract:fbc31dbacaceac0f0d2d232be5cec684:10:NF-kappaB:NF-kappaB:1217:1250	Colitic Sema3e-/- splenocytes and splenic CD11c+ cells produced more IL-12/23 and IFN-gamma compared to Sema3e+/+ , and rec-SEMA3E reduced their release as much as [TF] inhibitors, whereas an [TG] activator increased their production and attenuated the effect of rec-SEMA3E.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1217	1250	0.0013371252687865	Non valid	0.028471983098969592;0.7275721626037647;0.24395585429726568	ACTIVATION	30736100	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
71836	PMID:9566879:pubtator_title_and_abstract:54a67f9fb6be6b1826e113ec51f55d0e:13:NF-kappaB:NF-kappaB:1945:1903	Alternative splicing of the IkappaB beta pre-mRNA may thus provide a means to selectively control the amount of IkappaB beta-bound [TG] heteromers to be released under [TF] stimulating conditions.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1945	1903	0.0011125535729638	Non valid	0.29837060744262184;0.4289242064208748;0.27270518613650335	ACTIVATION	9566879	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
71850	PMID:30650279:pubtator_title_and_abstract:d74e7c93be44b05a8155a8ce7728031e:4:p65:NF-kappaB:451:435	The vectors of [TG] (ReIA/[TF])-PECFP and STAT3-PEYFP were constructed and transfected in SGC-7901 human gastric cancer cells.	p65	NF-kappaB	5970	4790	451	435	0.001216351488741	Non valid	0.9091402578216395;0.08852007356873769;0.00233966860962267	UNDEFINED	30650279	RELA	9606	NFKB1	9606	dbTF		NFKB
71866	PMID:16322332:pubtator_title_and_abstract:781e015c82e6f281f41bfb0f2494118c:11:cyclin D1:NF-kappaB:2161:2110	In conclusion, the study demonstrated that in parathyroid tumors: (1) p65 phosphorylation was dramatically increased by RET constitutive activation and was negatively correlated with menin expression, (2) p65 phosphorylation was increased and reduced by TNFalpha and CaR agonists respectively, and (3) blockade of the [TG] pathway caused a significant decrease in [TF] expression.	cyclin D1	NF-kappaB	595	4790	2161	2110	0.0011269090643686	Non valid	0.0021542257440196025;0.9844712962850442;0.013374477970936138	ACTIVATION	16322332	CCND1	9606	NFKB1	9606	coTF		NFKB
71894	PMID:17244613:pubtator_title_and_abstract:a4bc04e1e6da9ba3ee386276927900b8:8:IKKbeta:NF-kappaB:1358:1483	Finally, we have shown that incubation of [TF]-deficient MEFs with a cell-permeable peptide that blocks the interaction of NEMO with the IKKs inhibits IL-1-induced [TG] activation.	IKKbeta	NF-kappaB	16150	18033	1358	1483	0.4033873872216112	Non valid	0.0020628557370401565;0.9944238428644743;0.0035133013984856927	ACTIVATION	17244613	Ikbkb	10090	Nfkb1	10090	coTF		NFKB
71916	PMID:16154093:pubtator_title_and_abstract:d698289b5a9d6147b14e5ac1e1c8c0f4:0:RelB:NF-kappaB:10:0	[TG] [TF] forms an intertwined homodimer.	RelB	NF-kappaB	5971	4790	10	0	0.0012167324354966	Non valid	0.9276693453612391;0.06775729285330931;0.00457336178545152	UNDEFINED	16154093	RELB	9606	NFKB1	9606	dbTF		NFKB
71974	PMID:37611142:pubtator_title_and_abstract:91ac71308c2dc5d8af724a7bfe58b170:7:AKT:NF-kappaB:1188:1198	Additionally, G-EMP markedly enhanced immunomodulation via the activation of PI3K/[TF]-MAPKs/[TG] signal pathways.	AKT	NF-kappaB	11651	18033	1188	1198	0.0011135261294561	Non valid	0.10608496054181141;0.889203859645492;0.004711179812696599	ACTIVATION	37611142	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
72027	PMID:20974955:pubtator_title_and_abstract:986b630c61a34e2c4874bdc1995875d7:7:CCAAT/enhancer-binding protein beta:NF-kappaB:995:981	Instead, IFN-gamma blocked tolerance-associated down-regulation of IL6 and TNF transcription, RNA polymerase II recruitment, and [TG] and [TF] transcription factor binding to the IL6 and TNF promoters in tolerized monocytes.	CCAAT/enhancer-binding protein beta	NF-kappaB	1051	4790	995	981	0.0011376854767594	Non valid	0.38234302709396617;0.31672062146390634;0.30093635144212755	UNDEFINED	20974955	CEBPB	9606	NFKB1	9606	dbTF		NFKB
72123	PMID:22476925:pubtator_title_and_abstract:955d9af1fb69be1ff9f17da19ca83e72:12:Akt:NF-kappaB:1933:1862	CONCLUSIONS: These results indicate that the LHF-mediated inhibition of NO and PGE(2) secretion in LPS-stimulated macrophages is regulated by [TG] inactivation through inhibition of IkappaB-alpha, MAPKs, and [TF] phosphorylation.	Akt	NF-kappaB	11651	18033	1933	1862	0.0012063880260209	Non valid	0.06697352913664888;0.8887371378509974;0.044289333012353785	ACTIVATION	22476925	Akt1	10090	Nfkb1	10090	ll_coTF		NFKB
72158	PMID:26157065:pubtator_title_and_abstract:b4bd44f00359086699ab5fbc70b5a0a7:6:JNK:NF-kappaB:1206:1176	Our present study demonstrates that Chi IVa suppresses the production of iNOS, COX-2, IL-1beta, IL-6, and TNF-alpha in LPS-stimulated THP-1 cells likely by inhibiting [TG] activation and ERK, [TF], and p38 signal pathway phosphorylation.	JNK	NF-kappaB	5599	4790	1206	1176	0.0011354962468746	Non valid	0.0029940231554764335;0.9947756977572579;0.0022302790872656183	ACTIVATION	26157065	MAPK8	9606	NFKB1	9606	ll_coTF		NFKB
72173	PMID:32682044:pubtator_title_and_abstract:e5af54e4e1dccb4a42507f638763bc13:9:nuclear factor erythroid 2-related factor 2:nuclear factor (NF)-kappaB:1272:1175	The above therapeutic effects of SCFC4 could be attributed to suppression of [TG] and mitogen-activated protein kinase (MAPK) pathways while activating [TF] (Nrf2) mediated production of antioxidant enzymes.	nuclear factor erythroid 2-related factor 2	nuclear factor (NF)-kappaB	4780	4790	1272	1175	0.0011214873067236	Non valid	0.08989378204945708;0.7373528056616847;0.1727534122888582	ACTIVATION	32682044	NFE2L2	9606	NFKB1	9606	dbTF		NFKB
72178	PMID:34731782:pubtator_title_and_abstract:10ff77a3f03b8a7cf6783070c4a4cb99:5:NF-kappaB:nuclear factor kappa B:594:570	Cell viability, apoptosis and inflammatory molecules interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha) and cyclooxygenase-2 (Cox-2) expressions, along with [TG] ([TF]) and c-Jun N-terminal kinase (JNK) pathways activities were tested by MTT assay, Guava Nexin assay, ELISA and western blotting, respectively.	NF-kappaB	nuclear factor kappa B	Complex:NFKB	4790	594	570	0.0011133370652396	Non valid	0.7280620422346985;0.2614099655156489;0.010527992249652698	UNDEFINED	34731782	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
72267	PMID:22199285:pubtator_title_and_abstract:6ce70ac8ef5f85dd4509138dfe6e3e2c:8:NF-kappaB:nuclear factor kappa B:920:896	In addition, resveratrol repressed [TG] ([TF]) activation and down-regulated mRNA expression of urokinase plasminogen activator (uPA) and its receptor in TNF-alpha-treated glioma cells.	NF-kappaB	nuclear factor kappa B	Complex:NFKB	4790	920	896	0.001151544077593	Non valid	0.0024679016905822778;0.9943947066739066;0.0031373916355110294	ACTIVATION	22199285	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
72444	PMID:22199297:pubtator_title_and_abstract:fe3f02068b4f9494d58f4f1c44962203:4:BCL2:nuclear factor kappa-light-chain-enhancer of activated B-cells:790:797	Levels of telomerase and RT activity, and the expression of protein 53 (p53), B-cell lymphoma 2 ([TF]), [TG] (NFkappaB), transforming growth factor beta (TGFbeta) and vascular endothelial growth factor (VEGF) were significantly lower in cancer cells following sodium meta-arsenite treatment, whereas the effect was absent or marginally detected in DPSCs and somatic cells.	BCL2	nuclear factor kappa-light-chain-enhancer of activated B-cells	596	4790	790	797	0.0011911032436627	Non valid	0.6124855339454258;0.3586131611464166;0.028901304908157538	UNDEFINED	22199297	BCL2	9606	NFKB1	9606	coTF		NFKB
72455	PMID:37502894:pubtator_title_and_abstract:bac12b6983e5d35a3faa2cb75ee960a6:8:IKK2:NFkappaB:1182:1187	In addition, increased calcifying extracellular vesicles through the inhibition of the [TF]-[TG] pathway induced mineralization of VSMCs, which was significantly reduced by blocking cell death.	IKK2	NFkappaB	3551	4790	1182	1187	0.0012053269988873	Non valid	0.007361555838929917;0.015817833582413697;0.9768206105786563	REPRESSION	37502894	IKBKB	9606	NFKB1	9606	coTF		NFKB
72471	PMID:29155481:pubtator_title_and_abstract:1823a15dfb2901e59749597d5ab67d4d:9:NF-kappaB:nuclear factor-kappa B:1070:1046	The RGZ inhibited the 5-FU-induced increase of transforming growth factor-beta (TGF-beta) and [TG] ([TF]) proteins and restored collagen protein levels.	NF-kappaB	nuclear factor-kappa B	Complex:NFKB	18033	1070	1046	0.0011604160327063	Non valid	0.014631480960315836;0.8670842234865624;0.11828429555312164	ACTIVATION	29155481	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
72477	PMID:18485515:pubtator_title_and_abstract:ab267986f585e1c69f6b4cc769dacf7b:3:activator protein-1:nuclear factor-kappa B:765:726	Stimulated ROS was significantly higher in Group III compared to Group II (increment of H(2)O(2)-induced ROS production: 21.8+/-2.2% vs. 11.1+/-2.0%; increment of PMA-induced ROS production 23.5+/-4.5% vs. 21.6+/-2.2%; both respectively), and the activity of [TG] (NF-kappaB) and [TF] (AP-1), but not specificity protein 1 (Sp1) was significantly higher in Group III than in Group II (2.53-fold vs. 2.0-fold vs. 1.43-fold, respectively).	activator protein-1	nuclear factor-kappa B	3726	4790	765	726	0.0011654286363498	Non valid	0.040368259843851784;0.9545995096383381;0.005032230517810108	ACTIVATION	18485515	JUNB	9606	NFKB1	9606	dbTF		NFKB
72590	PMID:7796813:pubtator_title_and_abstract:b3c436eb41b10e06441c5de4e041457d:0:I kappa B-alpha:NF-kappa B:71:103	Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls [TF] proteolysis and [TG] activation in response to diverse stimuli.	I kappa B-alpha	NF-kappa B	4792	4790	71	103	0.0023878430818446	Non valid	0.31073127667472383;0.625622700850456;0.06364602247482021	ACTIVATION	7796813	NFKBIA	9606	NFKB1	9606	coTF		NFKB
72615	PMID:30255981:pubtator_title_and_abstract:d4bc51a032d7da0ca3a7081f7cb4ef99:9:PCNA:NF-kB:903:934	RESULTS: Glycyrrhizic acid treatment reduced the expression of Ki-67, proliferating cell nuclear antigen ([TF]), nuclear factor-kappa B ([TG]), cyclooxygenase-2 (COX-2), induced nitric oxide synthase (iNOS), and vascular endothelial growth factor (VEGF) while enhanced the expression of p53, connexin-43, b-cell lymphoma-2 (Bcl-2), survivin, and cleaved caspase-3.	PCNA	NF-kB	25737	81736	903	934	0.0012237273194727	Non valid	0.022582828154606025;0.8082366439885433;0.16918052785685053	ACTIVATION	30255981	Pcna	10116	Nfkb1	10116	coTF		NFKB
72617	PMID:30149369:pubtator_title_and_abstract:64222945591db8d138a2876485c13f79:8:HO-1:nuclear factor-kappaB:1534:1415	Oligonol pretreatment significantly decreased the levels of interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha (TNF-alpha) as well as [TG] (NF-kappaB), c-Fos, and c-Jun in affected colon tissues, but the expression of heme oxygenase-1 ([TF]) and NADH: quinone oxidoreductase-1(NQO-1) as well as total antioxidant concentration (P < 0.005) was significantly increased with oligonol.	HO-1	nuclear factor-kappaB	15368	18033	1534	1415	0.0011729325360435	Non valid	0.3859252780868983;0.35704331908964604;0.2570314028234557	UNDEFINED	30149369	Hmox1	10090	Nfkb1	10090	ll_coTF		NFKB
72637	PMID:20621584:pubtator_title_and_abstract:3466e74679b87a3cc16aa51e2eff5c76:2:NF-kappaB:nuclear factor-kappaB:364:341	In an earlier study, we found that Antrodia camphorata inhibited the production of lipopolysaccharide (LPS)-induced cytokines, inducible nitric oxide synthase, and cyclooxygenase-2 by blocking [TG] ([TF]) activation in cultured RAW 264.7 macrophages.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	18033	364	341	0.0011490143122553	Non valid	0.0021255135697559194;0.9948489382392592;0.00302554819098494	ACTIVATION	20621584	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
72670	PMID:11149512:pubtator_title_and_abstract:27da9f0813b258a9560b3ea490e12821:10:NF-kappaB:NF-kappaB:1649:1717	In addition, the data obtained indicate that the same NF-kappaB binding proteins recognize both the NF-kappaB DNA/PNA and DNA/DNA hybrids, but the molecular complexes generated with [TF] DNA/PNA hybrids are less stable than those generated with [TG] target DNA/DNA molecules.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	1649	1717	0.0014587745829861	Non valid	0.9912411325415448;0.007046822000376761;0.001712045458078594	UNDEFINED	11149512	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
72879	PMID:35553640:pubtator_title_and_abstract:ee1cbb363085f13e29a136be36296b21:6:NLRP3:NF-kappaB:725:711	We sought to demonstrate that both [TG] and [TF] contribute to development of MS and EAE, and NF-kappaB pathway is positively correlated with NLRP3 activation in EAE.	NLRP3	NF-kappaB	216799	18033	725	711	0.0012732334801067	Non valid	0.013567204657823143;0.9853238569615772;0.001108938380599588	ACTIVATION	35553640	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
72934	PMID:18038451:pubtator_title_and_abstract:f7f75553e07c29a6c14d29f4394af999:8:nuclear factor kappa B:NF-kappaB:1244:1268	Significant differences in the expression of genes reflecting enhanced [TF] ([TG]) activity were noted in PPARbeta/delta-null mice.	nuclear factor kappa B	NF-kappaB	Complex:NFKB	18033	1244	1268	0.0013924592213128	Non valid	0.269033046068404;0.7132098607615948;0.01775709317000114	ACTIVATION	18038451	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
72974	PMID:17312168:pubtator_title_and_abstract:c18f3d1a7888b9b064bc471f344d34e5:5:IKK2:NF-kappaB:696:701	The bulk of those genes were identified as targets of two distinct signaling cascades, the [TF]/[TG] pathway and a proangiogenic pathway mediated by HIF-1alpha, which accumulates upon exposure to nickel.	IKK2	NF-kappaB	3551	4790	696	701	0.0011031847932874	Non valid	0.8864395423209723;0.11096512753456428;0.002595330144463466	UNDEFINED	17312168	IKBKB	9606	NFKB1	9606	coTF		NFKB
73022	PMID:23870533:pubtator_title_and_abstract:1b3d2f606a2db8c10e3238c3a6a19ce0:4:nuclear factor-kappaB:NF-kappaB:701:724	In this review, we focus on effectors that subvert signaling pathways that impact on endosomal trafficking, cell survival, and innate immunity, particularly phagocytosis, [TF] ([TG]), and mitogen-activated protein (MAP) kinase pathways and the inflammasome.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	701	724	0.0011077684008791	Non valid	0.9908348413092442;0.0065380185247276915;0.002627140166028115	UNDEFINED	23870533	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
73107	PMID:12641655:pubtator_title_and_abstract:db22d5e9427da7a36616e5139e4d617c:8:NF-kappaB:NF-kappaB.:1417:1318	Similar findings were observed using a proteasome inhibitor to block [TG] The effective downregulation of antigen-specific T-cell responses following blockade of [TF] in DCs could be a useful approach for immunomodulating inflammatory T-cell responses.	NF-kappaB	NF-kappaB.	Complex:NFKB	4790	1417	1318	0.0012032464210514	Non valid	0.013564672762077299;0.8992833514182899;0.08715197581963288	ACTIVATION	12641655	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
73201	PMID:19351910:pubtator_title_and_abstract:eec40d3d71d99b125a2842531042b07a:3:NFATc1:NF-kappaB:347:361	Here we show that PAR-1 activation induces binding of both p65/RelA and [TF] to the [TG] binding site localized in intron-1 of the ICAM-1 gene to initiate transcription in endothelial cells.	NFATc1	NF-kappaB	4772	4790	347	361	0.0011731624396456	Non valid	0.07492626833141185;0.9233445200908492;0.0017292115777388928	ACTIVATION	19351910	NFATC1	9606	NFKB1	9606	dbTF		NFKB
73203	PMID:10891389:pubtator_title_and_abstract:eafd4015465a4a43015697641be136a7:7:IRAK:NF-kappaB:1018:1048	P. gingivalis LPS treatment of HGFs activated several intracellular proteins including protein tyrosine kinases, and upregulated the expression of IL-1 receptor-associated kinase ([TF]), nuclear factor-kappaB ([TG]), and activating protein-1 (AP-1), and these events were suppressed by anti-TLR4 monoclonal antibody.	IRAK	NF-kappaB	3654	4790	1018	1048	0.0012576783031233	Non valid	0.009253053820380512;0.9880489805228674;0.002697965656752108	ACTIVATION	10891389	IRAK1	9606	NFKB1	9606	coTF		NFKB
73217	PMID:19398040:pubtator_title_and_abstract:1aee65cf39995db0ba5996a66b23bab4:6:NF-kappaB:NF-kappaB:1441:1273	Moreover, molecular data revealed that zedoarondiol inhibited LPS-stimulated DNA binding activity and the transcription activity of nuclear factor-kappa B ([TG]), and this effect was accompanied by decreases in the degradation and phosphorylation of inhibitory kappaB (IkappaB)-alpha, and in the subsequent blocking of [TF] translocations to the nucleus.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1441	1273	0.0011298069172185	Non valid	0.04140966961439991;0.9550424024562041;0.0035479279293960477	ACTIVATION	19398040	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
73230	PMID:37121296:pubtator_title_and_abstract:f107c6a81fdece0857efb575a9538691:0:AMPK:NF-kappaB:81:92	Solasodine suppresses the metastasis of gastric cancer through claudin-2 via the [TF]/STAT3/[TG] pathway.	AMPK	NF-kappaB	5563	4790	81	92	0.0010829334591808	Non valid	0.6615178874873118;0.11531514495285804;0.22316696755983023	UNDEFINED	37121296	PRKAA2	9606	NFKB1	9606	ll_coTF		NFKB
73241	PMID:28692879:pubtator_title_and_abstract:9f4a79d3ddfa648210e8ee95b2809acd:7:NF-kappaB:nuclear factor-kappaB:996:973	These findings suggest that the mechanism underlying the inhibitory effects of pitavastatin on IL-1beta-induced IL-6 and IL-8 release might be mediated by the suppression of mitogen-activated protein kinase (MAPK), Akt, and [TG] ([TF]) signaling pathways.	NF-kappaB	nuclear factor-kappaB	Complex:NFKB	4790	996	973	0.0011322925543194	Non valid	0.02264113321530865;0.9731776457827281;0.0041812210019631126	ACTIVATION	28692879	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
73284	PMID:35929489:pubtator_title_and_abstract:0a0dd8fe7c82b302eb9adc7306e4a5bf:6:NLRP3:NF-kappaB:980:970	Furthermore, mRNA and immunohistochemistry (IHC) analysis revealed that STR ameliorates UA (uric acid)-associated renal inflammation, fibrosis, and EMT (epithelial-mesenchymal transition) via MMPS (matrix metalloproteinases), inhibiting [TG]/[TF] activation by the AMPK/SIRT1 pathway and modulating the JAK2-STAT3 and Nrf2 signaling pathways.	NLRP3	NF-kappaB	216799	18033	980	970	0.0011400241622046	Non valid	0.005978141638464168;0.9841776907478732;0.009844167613662557	ACTIVATION	35929489	Nlrp3	10090	Nfkb1	10090	coTF		NFKB
73310	PMID:29113952:pubtator_title_and_abstract:29dd98aa4e49198844de1a6d4ccfa0cd:3:Nrf2:nuclear factor kappa B:306:313	Oxidative stress can trigger variable transcription factors, such as nuclear factor erythroid-2-related factor ([TF]), [TG] (NF-kappaB), protein-53 (p-53), activating protein-1 (AP-1), hypoxia-inducible factor-1alpha (HIF-1alpha), beta-catenin/Wnt and peroxisome proliferator-activated receptor-gamma (PPAR-gamma).	Nrf2	nuclear factor kappa B	4780	4790	306	313	0.0011881159771729	Non valid	0.9375415100553145;0.06070788761130131;0.0017506023333841295	UNDEFINED	29113952	NFE2L2	9606	NFKB1	9606	dbTF		NFKB
73473	PMID:11035059:pubtator_title_and_abstract:f85e52cd6d3898c1c061148f8846547b:11:TGF-beta:NF-kappaB:1579:1436	Translocation of [TG] into nuclei induced by sRANKL in TGF-beta-pretreated M/Mphi-like hemopoietic cells was greater than that in untreated cells, whereas [TF] did not up-regulate the expression of RANK, the receptor of RANKL.	TGF-beta	NF-kappaB	21803	18033	1579	1436	0.0010905610874754	Non valid	0.41960968503587703;0.5672141625825861;0.013176152381536925	ACTIVATION	11035059	Tgfb1	10090	Nfkb1	10090	ll_coTF		NFKB
73478	PMID:11358840:pubtator_title_and_abstract:473b0daefa3e46cdf9803082965499c9:12:p65:NF-kappaB:1696:1745	Stable expression of [TF] in P- JB6 cells conferred not only inducible [TG] and AP-1 activation but also transformation response to tumor promoters.	p65	NF-kappaB	5970	4790	1696	1745	0.2097078565006125	Non valid	0.003522259972212703;0.9955905193796056;0.0008872206481816498	ACTIVATION	11358840	RELA	9606	NFKB1	9606	dbTF		NFKB
73493	PMID:30735837:pubtator_title_and_abstract:888183eaac474374469a100046ae5e8f:9:cyclinD1:NF-kappaB:1218:1231	We also found that hydrogen decreased the expression of the DNA damage-related protein ATM, [TF] and [TG] but increased the expression of the DNA repair-related protein HMGB1, suggesting that hydrogen inhibits senescence in retinas of NaIO3 mice.	cyclinD1	NF-kappaB	12443	18033	1218	1231	0.0013192752899992	Non valid	0.04335485773613823;0.8784382287540153;0.07820691350984646	ACTIVATION	30735837	Ccnd1	10090	Nfkb1	10090	coTF		NFKB
73593	PMID:10573060:pubtator_title_and_abstract:0f82506e48857b74fd443fb525076d92:3:transforming growth factor (TGF)-beta:NF-kappaB.:863:703	Here, we investigated the influence of cyclosporine A (CsA) on the in vitro maturation of DC, and on the nuclear translocation and DNA binding of [TG] METHODS: DC progenitors were propagated from mouse bone marrow in granulocyte-macrophage colony-stimulating factor (GM-CSF) or in GM-CSF plus either [TF] or interleukin (IL)-4, in the presence or absence of CsA (1 microg/ml).	transforming growth factor (TGF)-beta	NF-kappaB.	21803	18033	863	703	0.001089650087597	Non valid	0.9261279108209596;0.07122972679636543;0.0026423623826749712	UNDEFINED	10573060	Tgfb1	10090	Nfkb1	10090	ll_coTF		NFKB
73641	PMID:23884139:pubtator_title_and_abstract:f409d15b5fb86cd67a77b933f9b1bb60:8:NF-kappaB:NF-kappaB:1312:1182	Exposure of mCCDcl1 cells to albumin induced [TG] activation as assessed by luciferase reporter gene assay, nuclear translocation of NF-kappaB p65 subunit, and increased [TF] target gene expression.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	1312	1182	0.0011284890096732	Non valid	0.0260390801730639;0.972315523898568;0.0016453959283681604	ACTIVATION	23884139	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
73666	PMID:8814256:pubtator_title_and_abstract:efc1349eccf31388e863580f8a2a943a:9:AP-1:NF-kappa B:1432:1438	Whereas [TF], [TG], Oct, CREB and SP1 displayed normal binding activities in nuclear extracts, the binding of NF-AT to its IL-2 promoter response element was barely detectable both before and after T cell stimulation.	AP-1	NF-kappa B	3726	4790	1432	1438	0.001122237795112	Non valid	0.992583166771451;0.006162043987983797;0.0012547892405652035	UNDEFINED	8814256	JUNB	9606	NFKB1	9606	dbTF		NFKB
73790	PMID:19751727:pubtator_title_and_abstract:0f807be6e0bc414901a89009683c395c:3:PKCzeta:NF-kappaB:593:554	Here, we found that small interfering RNA-mediated knockdown of DGKalpha strongly attenuated protein kinase C (PKC) zeta-dependent phosphorylation of a large subunit of [TG], p65/RelA, at Ser311 but not [TF]-independent phosphorylation at Ser468 or Ser536.	PKCzeta	NF-kappaB	5590	4790	593	554	0.0013317676744639	Non valid	0.12038450019478746;0.8716861127519377;0.007929387053274778	ACTIVATION	19751727	PRKCZ	9606	NFKB1	9606	ll_coTF		NFKB
73808	PMID:10602492:pubtator_title_and_abstract:d5ad4b4f5d54a97ef095ba053f12ab54:0:c-myb:NF-kappaB:30:52	Transcriptional elongation of [TF] is regulated by [TG] (p50/RelB).	c-myb	NF-kappaB	17863	18033	30	52	0.0014080203733484	Non valid	0.5089502313694686;0.48401120094982397;0.007038567680707477	UNDEFINED	10602492	Myb	10090	Nfkb1	10090	dbTF		NFKB
73992	PMID:34698528:pubtator_title_and_abstract:b517756e73e4d035411fecdd4ae74dfc:7:p65:NF-kappaB:1040:1083	We showed that IL-17 stimulation in vitro markedly reduced occludin and zonula occludens-1 (ZO-1) expression in bronchial mucosal epithelial cells via the nuclear factor-kappaB-[TF]/TNF-alpha signaling pathway, including [TG]-p65-triggered TNF-alpha gene transcription and expression.	p65	NF-kappaB	5970	4790	1040	1083	0.0010794888563331	Non valid	0.15224440667460215;0.5961496034284386;0.2516059898969593	ACTIVATION	34698528	RELA	9606	NFKB1	9606	dbTF		NFKB
73998	PMID:11278471:pubtator_title_and_abstract:0dd613eb63249b5ac5b65af24e8ab48e:7:nuclear factor-kappaB:NF-kappaB:940:1099	Inhibition of [TF] (NF-kappaB) activation by a trans-dominant inhibitory isoform of mutant IkappaBalpha did not affect ephrin A1 induction, suggesting that [TG] proteins are not major regulators of ephrin A1 expression.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	4790	940	1099	0.0015906757001387	Non valid	0.05222522855792395;0.9397899452622273;0.007984826179848782	ACTIVATION	11278471	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
74006	PMID:22166584:pubtator_title_and_abstract:758af8ebf97df594ad9be3f8eb03446d:4:ERK1/2:NF-kappaB.:1149:1228	Under 0.5% FBS medium, all of the cellular studies were investigated on VSMCs (A10 cells) stimulated with 10 ng/ml SDF-1alpha alone or co-treated with 0.075 mg/ml Sal B. Our results showed that SDF-1alpha markedly stimulated the cell growth and migration of A10 cells, whose effects can be significantly reversed by co-incubation of Sal B. Similarly, Sal B also obviously down-regulated the SDF-1alpha-stimulated up-regulation of CXCR4 (total and cell-surface levels), Raf-1, MEK, ERK1/2, phospho-[TF], FAK and phospho-FAK as well as an increase of the promoter activity of [TG] Besides, Sal B also effectively attenuated balloon angioplasty-induced neointimal hyperplasia.	ERK1/2	NF-kappaB.	5595;5594	4790	1149	1228	0.0012794729024296	Non valid	0.031516855496164876;0.5281873747606818;0.4402957697431533	ACTIVATION	22166584	MAPK3;MAPK1	9606;9606	NFKB1	9606	ll_coTF;ll_coTF		NFKB
74021	PMID:15073105:pubtator_title_and_abstract:1155dcff2cc86732eda93b640c43e60d:8:Akt:NF-kappa B:1400:1405	The increased activation of [TF], [TG], and MAPK(Erk) was inhibited by PKI 166.	Akt	NF-kappa B	207	4790	1400	1405	0.0012246805756121	Non valid	0.003439266521924217;0.9945818705069148;0.0019788629711608354	ACTIVATION	15073105	AKT1	9606	NFKB1	9606	ll_coTF		NFKB
74040	PMID:23140765:pubtator_title_and_abstract:831da96d9e364d8214b528493917ad81:10:p65:NF-kappaB:1594:1509	The results from immunofluorescence, immunocytochemical, and immunohistochemical analyses indicated that the nuclear expression of [TG]/p50 could be seen constitutively while the nuclear expression of NF-kappaB/[TF] could only be seen after UVB irradiation.	p65	NF-kappaB	5970	4790	1594	1509	0.0011910504872517	Non valid	0.1977358272635755;0.7763226326336415;0.025941540102782913	ACTIVATION	23140765	RELA	9606	NFKB1	9606	dbTF		NFKB
74056	PMID:19351910:pubtator_title_and_abstract:eec40d3d71d99b125a2842531042b07a:6:p65:NF-kappaB:858:894	Electrophoretic mobility shift and supershift assays confirmed the binding of [TF]/RelA and NFATc1 to the intronic [TG] site 1 in thrombin-stimulated cells.	p65	NF-kappaB	5970	4790	858	894	0.0715376956578807	Non valid	0.9981419376830434;0.001095652259734643;0.0007624100572219423	UNDEFINED	19351910	RELA	9606	NFKB1	9606	dbTF		NFKB
74175	PMID:16585588:pubtator_title_and_abstract:dee481d3d21e0e517d315691bd193ae0:4:NF-kappaB:NF-kappaB:973:749	Bacterial clearance was enhanced by up-regulation of [TG] activity following AdRelA administration and was impaired by treatment with a dominant inhibitor of NF-kappaB. The TNF-alpha concentration in lung lavage was increased by AdRelA treatment and beneficial effects of [TF] up-regulation were abrogated in TNF-alpha-deficient mice.	NF-kappaB	NF-kappaB	Complex:NFKB	18033	973	749	0.0011410761394127	Non valid	0.03590107448415361;0.9558921001125262;0.008206825403320007	ACTIVATION	16585588	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
74287	PMID:8101633:pubtator_title_and_abstract:45a600f8ca8dec7fde6459d0af46adc0:9:HoxB5:NF-kappa B:989:1117	The enhanced DNA binding of oxidized [TF] protein is the opposite of the redox regulation reported for other mammalian transcription factors such as Fos, Jun, USF, [TG], c-Myb, and v-Rel, in which oxidation of cysteine residues inhibits DNA binding.	HoxB5	NF-kappa B	3215	4790	989	1117	0.001175687632409	Non valid	0.6376736590931606;0.19357103528116684;0.16875530562567254	UNDEFINED	8101633	HOXB5	9606	NFKB1	9606	dbTF		NFKB
74405	PMID:15735738:pubtator_title_and_abstract:760ab19dc0633d0f87714fe63463b9bb:6:IkappaBalpha:NF-kappaB:1149:854	Since the transcription factor nuclear factor-kappaB ([TG]) is known to regulate COX-2 induction, we attempted to determine the effect of [6]-gingerol on TPA-induced activation of NF-kappaB. Pretreatment with [6]-gingerol resulted in a decrease in both TPA-induced DNA binding and transcriptional activities of NF-kappaB through suppression of [TF] degradation and p65 nuclear translocation.	IkappaBalpha	NF-kappaB	18035	18033	1149	854	0.0011202345830501	Non valid	0.05102729888312351;0.623452567128381;0.32552013398849555	ACTIVATION	15735738	Nfkbia	10090	Nfkb1	10090	coTF		NFKB
74433	PMID:19800042:pubtator_title_and_abstract:1493a72fbfe4eee7ff757aa7e2263b44:7:P53:NF-kappaB:626:677	[TF] can inhibit cyclin D1 promoter activity via an [TG] site-dependent manner and its binding activity increased after heat shock.	P53	NF-kappaB	7157	4790	626	677	0.0015770643933394	Non valid	0.003975056776459133;0.0016297447414107761;0.9943951984821301	REPRESSION	19800042	TP53	9606	NFKB1	9606	dbTF		NFKB
74441	PMID:33858739:pubtator_title_and_abstract:cd7c2145d09f7400bad78c284b3c96b8:7:Bcl-2:NF-kappaB:1215:1119	The molecular mechanism involved are inhibiting the PI3K/Akt/mTOR, [TG] and Nrf2-Notch1 pathways; up or down modulating the levels of p53, p62, p21, Bax, and [TF] respectively, and inhibiting the expression of matrix metalloproteinases (MMPs), vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2).	Bcl-2	NF-kappaB	596	4790	1215	1119	0.0011492009441387	Non valid	0.11571677104633878;0.6001406365802707;0.2841425923733905	ACTIVATION	33858739	BCL2	9606	NFKB1	9606	coTF		NFKB
74461	PMID:15735738:pubtator_title_and_abstract:760ab19dc0633d0f87714fe63463b9bb:6:p65:NF-kappaB:1178:854	Since the transcription factor nuclear factor-kappaB ([TG]) is known to regulate COX-2 induction, we attempted to determine the effect of [6]-gingerol on TPA-induced activation of NF-kappaB. Pretreatment with [6]-gingerol resulted in a decrease in both TPA-induced DNA binding and transcriptional activities of NF-kappaB through suppression of IkappaBalpha degradation and [TF] nuclear translocation.	p65	NF-kappaB	19697	18033	1178	854	0.0011165315905446	Non valid	0.028002365393564817;0.9622630489427205;0.00973458566371471	ACTIVATION	15735738	Rela	10090	Nfkb1	10090	dbTF		NFKB
74560	PMID:37329547:pubtator_title_and_abstract:9115da2a55f945558dd8add6c61e73c2:8:NFkappaB:Nuclear Factor kappa B:1649:1625	We found that only Pyrroloquinoline quinone and CoQ10 application caused more expression increase in the [TG] ([TF]) gene compared to combined application.	NFkappaB	Nuclear Factor kappa B	Complex:NFKB	4790	1649	1625	0.0036918093255282	Non valid	0.004445534381961594;0.9906197961327239;0.004934669485314526	ACTIVATION	37329547	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
74608	PMID:34132431:pubtator_title_and_abstract:de50006da7c6dd0da98ff794c373de22:5:B-cell lymphoma 2:NF-kappaB:1022:892	In addition, CK suppressed the phosphorylation of SGK1, [TG], and inhibitor of kappa B (IkappaB) and also NF-kappaB target genes such as X-linked inhibitor of apoptosis protein and [TF] (Bcl-2) in HeLa cells.	B-cell lymphoma 2	NF-kappaB	596	4790	1022	892	0.0011483140286215	Non valid	0.8999241815628363;0.09670705408686137;0.003368764350302253	UNDEFINED	34132431	BCL2	9606	NFKB1	9606	coTF		NFKB
74632	PMID:32011533:pubtator_title_and_abstract:f4c55dd81be8f5f5f68dba1c2341083a:10:NF-kappaB.:NF-kappaB:1209:1166	Eupatilin inhibited cerulein-induced activation of PKD1/[TG] and the nuclear translocation of [TF] CONCLUSIONS: Our data demonstrated that eupatilin is a potential therapeutic candidate for the treatment of pancreatitis through its ability to reduce cellular necrosis and inflammatory responses by inhibition of the PKD1/NF-kappaB signaling pathway.	NF-kappaB.	NF-kappaB	Complex:NFKB	18033	1209	1166	0.0011347647366488	Non valid	0.027324650678225884;0.9701069978056185;0.00256835151615561	ACTIVATION	32011533	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
74714	PMID:28089769:pubtator_title_and_abstract:a474e4cab765c24766fd4d6dd8d07483:4:NF-kappaB:NF-kappaB:543:454	During a systematic analysis of [TG]/STAT3 crosstalk we observed that appearance of the subcellular distribution of [TF] and STAT3 in immunofluorescence heavily depends on the fixation procedure.	NF-kappaB	NF-kappaB	Complex:NFKB	4790	543	454	0.0013161380874501	Non valid	0.995414455128305;0.003774236543073185;0.0008113083286218269	UNDEFINED	28089769	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
74736	PMID:27902962:pubtator_title_and_abstract:04dbd7fd88c5974717f831c69d80e376:6:NF-kappaB:nuclear factor kappa B:880:856	Additionally, SCM inhibited activation of [TG] ([TF]) induced by TNF-alpha through preventing the degradation of inhibitor kappa B. Moreover, SCM reduced the production of reactive oxygen species in TNF-alpha-treated HUVECs.	NF-kappaB	nuclear factor kappa B	Complex:NFKB	4790	880	856	0.0013501483705963	Non valid	0.0023158444345090737;0.9961121693817819;0.0015719861837089851	ACTIVATION	27902962	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
74753	PMID:20172018:pubtator_title_and_abstract:943671ba01349ee19091a485479d455f:4:p65:nuclear factor-kappaB:579:594	We first confirmed that p120 expression was significantly reduced after LPS stimulation in BECs, the [TF] subunit of [TG] (NF-kappaB) nuclear translocation was promoted and NF-kappaB activity was rapidly induced.	p65	nuclear factor-kappaB	5970	4790	579	594	0.0011790521464458	Non valid	0.028841959664738737;0.9671631119134885;0.003994928421772833	ACTIVATION	20172018	RELA	9606	NFKB1	9606	dbTF		NFKB
74770	PMID:14982987:pubtator_title_and_abstract:2a8cc89a0c8b24b8afa7e375c132d6f1:4:TAK1:NFkappaB.:595:513	TRAF6-TAK1-TAB2 are then translocated to the cytosol where TAK1 is phosphorylated and activated, leading to the activation of IkappaB kinase and [TG] The present study addressed two important questions: (i) How are TRAF6, [TF], and TAB2 recruited to TLR3? (ii) Are TRAF6, TAK1, and TAB2 also required for TLR3-mediated IRF3 activation?	TAK1	NFkappaB.	6885	4790	595	513	0.0013242304548296	Non valid	0.15978530673083163;0.8367971717990069;0.003417521470161473	ACTIVATION	14982987	MAP3K7	9606	NFKB1	9606	ll_coTF		NFKB
74791	PMID:15371500:pubtator_title_and_abstract:d2a2af7e37d67013db55aa132c3dc894:3:nuclear factor-kappaB:NF-kappaB:357:380	We find that cultured cells expressing mutant Htt and striatal cells from HD transgenic mice have elevated [TF] ([TG]) activity.	nuclear factor-kappaB	NF-kappaB	Complex:NFKB	18033	357	380	0.0011336184083942	Non valid	0.08587273053535523;0.8256806260905254;0.08844664337411942	ACTIVATION	15371500	NFKB	10090	Nfkb1	10090	dbTF	NFKB	NFKB
74821	PMID:31277685:pubtator_title_and_abstract:27d350b8dc74df227b5dc9045b80cf6b:13:p65:NF-kappaB:1702:1646	Napabucasin also disrupted the [TG] signaling pathway via downregulation of RelA ([TF]).	p65	NF-kappaB	5970	4790	1702	1646	0.0012721149484237	Non valid	0.10883025884101172;0.8828725122420767;0.008297228916911542	ACTIVATION	31277685	RELA	9606	NFKB1	9606	dbTF		NFKB
74917	PMID:11035035:pubtator_title_and_abstract:c3922b6288c06246c00b13e72370f8f4:6:NF-kappaB.:NF-kappaB:1018:745	Although DA significantly reduced [TG] binding activity, Grx2 could stimulate the binding of NF-kappaB to DNA by: (i) translocating NF-kappaB from the cytoplasm to the nucleus after promoting the phosphorylation and degradation of I-kappaBalpha, and (ii) activating the binding of pre existing nuclear [TF] The DNA binding activity of NF-kappaB itself was essential for neuronal survival.	NF-kappaB.	NF-kappaB	Complex:NFKB	4790	1018	745	0.001103869415985	Non valid	0.9298651989225583;0.06727160831034655;0.0028631927670952117	UNDEFINED	11035035	NFKB	9606	NFKB1	9606	dbTF	NFKB	NFKB
74955	PMID:34244887:pubtator_title_and_abstract:32e6fad4b79ea3624790eaf03bd4cca8:14:CHOP:NF-kappaB:1951:1983	CONCLUSION: Atiprimod induced prolonged ER stress-mediated apoptosis via both activating PERK/eIF2alpha/ATF4/[TF] axis and suppressing STAT3/[TG] transcription factors nuclear migration in TBNC cells.	CHOP	NF-kappaB	1649	4790	1951	1983	0.0011669858189517	Non valid	0.17456228350162992;0.165008152380856;0.6604295641175141	REPRESSION	34244887	DDIT3	9606	NFKB1	9606	dbTF		NFKB
74965	PMID:18234473:pubtator_title_and_abstract:4a559d3393d4c073426b98560aec73ae:10:JNK:NF-kappaB:1400:1456	It can be concluded that C1P stimulates macrophage proliferation through activation of the PI3-K/PKB, ERK and [TF] pathways, and that GSK-3beta, c-Myc, cyclin D1, and [TG] are important downstream effectors in this action.	JNK	NF-kappaB	26419	18033	1400	1456	0.3028565317245957	Non valid	0.7680389039128613;0.2287190279757422;0.0032420681113964137	UNDEFINED	18234473	Mapk8	10090	Nfkb1	10090	ll_coTF		NFKB
74985	PMID:31217852:pubtator_title_and_abstract:949d28405e5f449dcc382c40e2778d52:6:p38:NF-kappaB:1316:1353	In the present study, we investigated the involvement of the P2Y11 receptor using its specific antagonist NF157 in some key aspects of HBx-induced liver disease in human MIHA hepatocytes, including mitochondrial dysfunction due to compromised mitochondrial membrane potential (MMP), oxidative stress resulting from overproduction of reactive oxygen species (ROS) and decreased antioxidant glutathione (GSH), production of proinflammatory cytokines and chemokines such as interleukin (IL)-6, monocyte chemoattractant protein (MCP)-1, and chemokine (C-X-C motif) ligand 2 (CXCL2), as well as activation of cellular signaling pathways including the p38/mitogen-activated protein kinase ([TF]/MAPK) and nuclear factor-kappaB ([TG]) pathways.	p38	NF-kappaB	1432	4790	1316	1353	0.0010863665320352	Non valid	0.08704339977859334;0.9092612409898649;0.0036953592315417845	ACTIVATION	31217852	MAPK14	9606	NFKB1	9606	ll_coTF		NFKB
518	PMID:34542797:pubtator_title_and_abstract:53b23ed497e130548cf99ac9823aa0a6:3:EGFR:AP-1:433:442	TWEAK control of these events is via an expanding list of intracellular signalling pathways which include NF-kappaB, ERK/MAPK, Notch, [TF] and [TG].	EGFR	AP-1	1956	3726	433	442	0.0011785418051248	Non valid	0.9682912977277638;0.030138522529385467;0.001570179742850808	UNDEFINED	34542797	EGFR	9606	JUNB	9606	ll_coTF		AP1
660	PMID:33599733:pubtator_title_and_abstract:67c923ee4385d701f010f16383234b2a:10:AP-1:activator protein 1:1440:1419	Among several VEGFR1 ligands induced by hypoxia, placental growth factor (PlGF)/PGF alone upregulated galectin-1/LGALS1 expression via phosphorylation of [TG] ([TF]) subunits following AKT and p38 mitogen-activated protein kinase (MAPK) activation.	AP-1	activator protein 1	Complex:AP1	3726	1440	1419	0.0011735404956412	Non valid	0.004856503067831743;0.9937682156100328;0.001375281322135487	ACTIVATION	33599733	AP1	9606	JUNB	9606	dbTF	AP1	AP1
1494	PMID:12595493:pubtator_title_and_abstract:a9250c0b0cbaecc29cb9b62043fb1461:8:c-Jun:activator protein-1:1212:1125	The inhibition of [TG] (AP-1) in MC, by adenovirus containing dominant-negative mutant of [TF] (Ad-DN-c-Jun), inhibited PDGF-BB-induced cell proliferation and TGF-beta1, MCP-1, and PAI-1 expressions.	c-Jun	activator protein-1	3725	3725	1212	1125	0.104597076818818	Non valid	0.00671613449295135;0.9570589799871084;0.03622488551994028	ACTIVATION	12595493	JUN	9606	JUN	9606	dbTF		AP1
1541	PMID:12972619:pubtator_title_and_abstract:7f474405b83d98e223e251e061a29e9b:3:AP-1:activating protein-1:574:580	Among them, the [TF] ([TG]) family of transcription factors, including c-Fos and c-Jun family members, plays a key role, as AP-1 activity is potently activated by PDGF and is required to stimulate cell proliferation.	AP-1	activating protein-1	Complex:AP1	3725	574	580	0.0011489480953161	Non valid	0.011322990529199268;0.9878541462542628;0.0008228632165379999	ACTIVATION	12972619	AP1	9606	JUN	9606	dbTF	AP1	AP1
1693	PMID:20044277:pubtator_title_and_abstract:f746f6c3b5a63bb3ec4c0cc15e44ed4a:7:interleukin-1 receptor-associated kinase-1:AP-1:972:961	Lungs were assessed for vascular permeability, myeloperoxidase content, bronchoalveolar lavage inflammatory cell and cytokine/chemokine content, as well as nuclear translocation of nuclear factor kappaB (NFkappaB) and activator protein-1 ([TG]), and [TF] (IRAK-1) and stress-activated protein kinase (SAPK) activation.	interleukin-1 receptor-associated kinase-1	AP-1	363520	24516	972	961	0.0011298456629004	Non valid	0.0316977381020857;0.9661376426255519;0.002164619272362488	ACTIVATION	20044277	Irak1	10116	Jun	10116	coTF		AP1
2274	PMID:14617683:pubtator_title_and_abstract:664ea2d7e51eba03be4922afc3492119:5:activator protein-1:AP-1:940:961	To further characterize the inhibitory mechanisms of CAPE at the transcriptional level, we examined the DNA binding and transcriptional activities of nuclear factor (NF)-kappaB, nuclear factor of activated cells (NFAT), and [TF] ([TG]) transcription factors in Jurkat cells.	activator protein-1	AP-1	Complex:AP1	3726	940	961	0.0011614663368873	Non valid	0.9209558762798472;0.07441284858510075;0.004631275135052079	UNDEFINED	14617683	AP1	9606	JUNB	9606	dbTF	AP1	AP1
2291	PMID:26707060:pubtator_title_and_abstract:8f32236e23d62dbc21e92feba175efae:10:Bcl-2:AP-1:1209:1127	We further identified that miR-22 significantly inhibited CBP-related transcriptional factor [TG] DNA binding activity under H/R. In addition, miR-22 could efficiently change [TF]/Bax ratio, and suppress the production of pro-inflammatory cytokines (TNF-alpha and IL-6) induced by H/R. In conclusion, these results suggest that miR-22 plays an important cardioprotective role partly via regulating CBP/AP-1 pathway to reduce cell apoptosis and inflammatory damage during MI/R injury.	Bcl-2	AP-1	24224	24516	1209	1127	0.0011079132475134	Non valid	0.9294127115381803;0.06043536851703772;0.01015191994478199	UNDEFINED	26707060	Bcl2	10116	Jun	10116	coTF		AP1
2323	PMID:21733335:pubtator_title_and_abstract:5915118ec142eb2ce183f35899b2ffdc:9:AP-1:activator protein 1:1044:1023	c-Jun N-terminal kinase, extracellular signal-regulated protein kinase 1/2 and p38 were activated in a dose-dependent manner; [TG] ([TF]) transcriptional activation and cyclin D1 expression were repressed.	AP-1	activator protein 1	Complex:AP1	3726	1044	1023	0.0011796806915245	Non valid	0.030671737108172337;0.8853528690159875;0.08397539387584001	ACTIVATION	21733335	AP1	9606	JUNB	9606	dbTF	AP1	AP1
2625	PMID:24256769:pubtator_title_and_abstract:cb34a714207e37aefcd1d99a833f0703:7:NF-kappaB:AP-1:1113:1187	The activities of the inhibitor of kappaB alpha kinase-inhibitor of kappaB alpha-nuclear factor kappaB (IKK-IkappaBalpha-[TF]) and mitogen activated protein kinase-activator protein-1 (MAPK-[TG]) signaling pathways were determined via electrophoretic mobility shift assays, immunoprecipitation kinase assays, Western blots, and transfection assays.	NF-kappaB	AP-1	Complex:NFKB	3726	1113	1187	0.0011184352256754	Non valid	0.9457688833822077;0.05254412758121772;0.0016869890365746449	UNDEFINED	24256769	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
2653	PMID:17407600:pubtator_title_and_abstract:a87be6fd21f739bde3857b3c082a5b29:7:NFkappaB:AP-1:1777:1570	RESULTS: Doses of parthenolide and bortezomib capable of sensitizing the two endocrine resistant breast cancer models to tamoxifen were capable of suppressing NFkappaB and [TG] regulated gene expression in combination with tamoxifen and also increased ER recruitment of the transcriptional co-repressor, NCoR. Transcript profiles from the UCSF breast cancer cases revealed three [TF] and AP-1 upregulated genes--cyclin D1, uPA and VEGF--capable of dichotomizing node-negative ER-positive cases into early and late relapsing subsets despite adjuvant tamoxfien therapy and most prognostic for younger age cases.	NFkappaB	AP-1	Complex:NFKB	3726	1777	1570	0.0011976035539665	Non valid	0.035694783167664675;0.9593406341614344;0.004964582670900761	ACTIVATION	17407600	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
2761	PMID:22801218:pubtator_title_and_abstract:7fa801498d10374fae67f875d4658aec:7:Pdcd4:AP-1:864:845	Down-regulation of c-Myc reverses MAP4K1 expression and [TG] activation in [TF] knockdown cells.	Pdcd4	AP-1	27250	3725	864	845	0.25525518706862	Non valid	0.026447623891149644;0.2515977624198943;0.7219546136889561	REPRESSION	22801218	PDCD4	9606	JUN	9606	coTF		AP1
2799	PMID:30469316:pubtator_title_and_abstract:6630032cda7ded5a67ef526d4c0263da:7:cyclic AMP response element-binding protein:AP-1:1446:1440	Mechanistic studies showed that the suppression of microglia pro-inflammatory polarization by GMI was accompanied by the resolution of oxidative stress, the preservation of protein tyrosine phosphatase and serine/threonine phosphatase activity, and the reduction of NF-kappaB, [TG], [TF] (CREB), along with signal transducers and activators of transcription (Stat1) transcriptional activities and associated upstream activators.	cyclic AMP response element-binding protein	AP-1	1385	3726	1446	1440	0.0012217948080905	Non valid	0.016895805575231213;0.9680073327053157;0.015096861719453033	ACTIVATION	30469316	CREB1	9606	JUNB	9606	dbTF		AP1
2840	PMID:18692129:pubtator_title_and_abstract:672984ed2936fc25e9ad308699070a69:3:c-Jun N-terminal kinase:AP-1:319:458	Although activation of the NF-kappaB and [TF] (JNK)/activator protein (AP)-1 transcription pathways occurs in hyperoxia, it is unclear whether activation of the [TG] pathway has a direct impact on IL-8 production and whether overexpression of superoxide dismutase (SOD) can mitigate these proinflammatory processes.	c-Jun N-terminal kinase	AP-1	5599	3725	319	458	0.0015969314001519	Non valid	0.2643758034213069;0.7305035834220899;0.005120613156603168	ACTIVATION	18692129	MAPK8	9606	JUN	9606	ll_coTF		AP1
2941	PMID:10369466:pubtator_title_and_abstract:1b5603de29894b0c41d38c1691888b5e:6:AP-1:AP-1:962:906	These increases of [TG] family mRNA were associated with increased nuclear [TF] binding activity.	AP-1	AP-1	Complex:AP1	24516	962	906	0.1761104680567615	Non valid	0.06351603697408285;0.932374534561162;0.004109428464754985	ACTIVATION	10369466	AP1	10116	Jun	10116	dbTF	AP1	AP1
3145	PMID:36483740:pubtator_title_and_abstract:18805b8eef3b8056cca77a04c9e84fb5:9:c-Jun:AP-1:1397:1428	Moreover, knockdown of JNK1, but not JNK2, significantly abolished the phosphorylation of [TF] at Ser63 (a component of [TG]), decreased the platycodin D-induced expression of PUMA and cleaved caspase 3, indicating that platycodin D inhibits JNK1/AP-1 signaling pathway.	c-Jun	AP-1	16476	16476	1397	1428	0.0014005856332112	Non valid	0.10165883957380316;0.8939236299412442;0.00441753048495261	ACTIVATION	36483740	Jun	10090	Jun	10090	dbTF		AP1
3897	PMID:19860880:pubtator_title_and_abstract:ef30603e75814691cb180195f13e0741:9:c-Jun:AP-1:1712:1443	Mutation of the NF-kappaB or [TG] site within and downstream the iE kappa, inhibition of the NF-kappaB and AP-1 pathways by their respective chemical inhibitor Bay11-7082 and SP600125 as well as stable or transient expression of dominant-negative mutant of I kappaB alpha (DNMI kappaB alpha) or of [TF] (TAM67) indicate that both sites are functional and LMP1-enhanced iE kappa activity is partly regulated by these two sites.	c-Jun	AP-1	3725	3725	1712	1443	0.0011031067653552	Non valid	0.5677842552117087;0.39429674341224147;0.03791900137604981	UNDEFINED	19860880	JUN	9606	JUN	9606	dbTF		AP1
3940	PMID:32357262:pubtator_title_and_abstract:f538cee138c49d09318eb3d15f0df621:8:NF-kappaB:AP-1:999:1013	Furthermore, [TF] and [TG] signaling were both inhibited while lung functions were significantly improved.	NF-kappaB	AP-1	Complex:NFKB	3726	999	1013	0.0011693337050084	Non valid	0.004865011415535696;0.010677984648620754;0.9844570039358436	REPRESSION	32357262	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
4997	PMID:26077911:pubtator_title_and_abstract:07f08ef7d03831e1728ea2e48b437768:2:Akt:AP-1:210:214	BACKGROUND: Although its biological function remains poorly understood, REG4 is reported to be a potent activator of the EGFR/[TF]/[TG] signaling pathway in colon cancer cells and closely linked with the inhibition of apoptosis.	Akt	AP-1	207	3726	210	214	0.0011131459122923	Non valid	0.010989420098999888;0.9870531948145344;0.0019573850864657337	ACTIVATION	26077911	AKT1	9606	JUNB	9606	ll_coTF		AP1
5089	PMID:8700518:pubtator_title_and_abstract:d78f84860ed22775671df98f3291e972:8:I kappa B alpha:AP-1:952:1010	Mutation of either of the NF-kappa B binding sites or the AP-1 binding site dramatically decreased the response of the [TF] promoter to Rel proteins alone or Rel and [TG] factors.	I kappa B alpha	AP-1	4792	3725	952	1010	0.0023306672710263	Non valid	0.031899795613344044;0.9665625119296706;0.0015376924569854404	ACTIVATION	8700518	NFKBIA	9606	JUN	9606	coTF		AP1
5259	PMID:16213465:pubtator_title_and_abstract:8a9ec6e7cd4b777f41936d110d9ecb90:0:AP-1:AP-1:100:28	Momordin I, an inhibitor of [TG], suppressed osteoclastogenesis through inhibition of NF-kappaB and [TF] and also reduced osteoclast activity and survival.	AP-1	AP-1	Complex:AP1	16476	100	28	0.0011695720952148	Non valid	0.008362223551432265;0.9825579013674118;0.009079875081155795	ACTIVATION	16213465	AP1	10090	Jun	10090	dbTF	AP1	AP1
5723	PMID:16982923:pubtator_title_and_abstract:e0e9d0ee8f462ca405ec6cd08fca150c:5:NF-kappaB:AP-1:742:693	Compared with wild-type cells, MIF-deficient cells were hyporesponsive to IL-1- and TNF-induced MAPK activity, [TG] activity, and cellular proliferation, while [TF] function was preserved.	NF-kappaB	AP-1	Complex:NFKB	3726	742	693	0.002194947510541	Non valid	0.07229935906221498;0.8531107265738116;0.07458991436397348	ACTIVATION	16982923	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
5898	PMID:33467433:pubtator_title_and_abstract:75a94ffe01927847f97968033e8d6709:9:AP-1:activator protein 1:992:971	It is known that anti-inflammatory mechanisms involve the inhibition of other transcription factors, such as nuclear factor kB(NFkappaB), signal transducer and activator of transcription (STAT) or [TG] ([TF]), or intracellular signaling proteins such as mitogen-activated protein (MAP) kinases.	AP-1	activator protein 1	Complex:AP1	3726	992	971	0.0011592300186749	Non valid	0.27316332190859827;0.70297066372426;0.023866014367141815	ACTIVATION	33467433	AP1	9606	JUNB	9606	dbTF	AP1	AP1
6528	PMID:36171622:pubtator_title_and_abstract:3465d6eceda438e99a1033ce1435b540:18:c-Fos:AP1:2160:2166	Notably, this functional circuitry was disrupted by an inhibitor of c-Jun/[TF]/[TG] proteins (SR11302) and small interfering RNAs targeting NEAT1, leading to a preferential impairment of lymph node metastasis.	c-Fos	AP1	2353	3725	2160	2166	0.0011145903129371	Non valid	0.6024477100287335;0.38220321032965565;0.015349079641610806	UNDEFINED	36171622	FOS	9606	JUN	9606	dbTF		AP1
6936	PMID:11889018:pubtator_title_and_abstract:ec446ae94f4fc4e4cd6f45362e276378:5:AP-1:AP-1:1013:943	Gel mobility shift assay revealed that AP-1 DNA binding was activated and that the AP-1 decoy reduced [TG] DNA binding activity as a result of specific binding affinity to [TF] in vivo.	AP-1	AP-1	Complex:AP1	3726	1013	943	0.0011630329105577	Non valid	0.03203672058315509;0.9658126425920387;0.0021506368248062546	ACTIVATION	11889018	AP1	9606	JUNB	9606	dbTF	AP1	AP1
7480	PMID:8834349:pubtator_title_and_abstract:efe2383c8a25629a998d7c6b83d501d3:4:nuclear factor-kappa B:activator protein-1:607:576	Many of the effects of GRs on the synthesis of cytokines and other inflammatory mediators are due to a direct interaction with other deoxyribonucleic acid (DNA)-binding proteins belonging to the basic leucine zipper (bZIP) group of transcription factors, such as [TG] (AP-1) and [TF] (NF-kappa B).	nuclear factor-kappa B	activator protein-1	Complex:NFKB	3726	607	576	0.0012551329308766	Non valid	0.9888431502222074;0.00955943052114064;0.0015974192566519925	UNDEFINED	8834349	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
7511	PMID:26497998:pubtator_title_and_abstract:474486d7225efcc3c4b7607fdb488a19:2:JDP2:AP-1:108:183	The c-Jun Dimerization Protein 2, [TF], is a basic leucine zipper protein member of the activator protein-1 ([TG]) family of transcription factors.	JDP2	AP-1	81703	16476	108	183	0.0011276674736994	Non valid	0.9837131189934955;0.014448224276342224;0.0018386567301623313	UNDEFINED	26497998	Jdp2	10090	Jun	10090	dbTF		AP1
7609	PMID:9468519:pubtator_title_and_abstract:ce9d6a59df910509563e4ad79827a52b:10:c-Fos:AP-1:2004:2195	Consistent with the promoter studies, curcumin and NDGA, inhibitors of AP-1 activation, markedly inhibited the ability of TNF-alpha to activate the expression of VCAM-1 mRNA levels at concentrations that did not inhibit the activation of NF-kappaB. In gel mobility supershift assays, the antibodies to [TF] or c-Jun inhibited the binding of TNF-alpha-activated nuclear NF-kappaB to the kappaL-kappaR, suggesting that both c-Fos and c-Jun interacted with NF-kappaB. These results suggest that [TG] proteins may mediate the effect of TNF-alpha in the regulation of VCAM-1 expression through interaction with NF-kappaB factors in endothelial cells.	c-Fos	AP-1	2353	3725	2004	2195	0.0010888124524059	Non valid	0.660716744971611;0.33422850552663297;0.00505474950175599	UNDEFINED	9468519	FOS	9606	JUN	9606	dbTF		AP1
7634	PMID:16809336:pubtator_title_and_abstract:8ee4ae9553e51d3b7d51474b62925956:5:activator protein-1:AP-1:754:829	Exposure of the Beas-2B cells to arsenite also led to significant transactivation of nuclear factor of activated T-cells (NFAT), but not [TF] (AP-1) and NFkappaB, suggesting that NFAT, rather than [TG] or NFkappaB, is implicated in the responses of Beas-2B cells to arsenite exposure.	activator protein-1	AP-1	Complex:AP1	3726	754	829	0.0011504495837037	Non valid	0.2030176986783635;0.7932159362481913;0.0037663650734450806	ACTIVATION	16809336	AP1	9606	JUNB	9606	dbTF	AP1	AP1
8195	PMID:10208434:pubtator_title_and_abstract:f36e64cb393d84387cbd3dce2d342f43:10:c-Jun:AP-1:1197:1093	We show that [TG], which is abundant in these cells throughout the whole cell cycle, consists predominantly of Fra-1/[TF] and Fra1/JunD heterodimers.	c-Jun	AP-1	16476	16476	1197	1093	0.020094279636447	Non valid	0.8246643161484126;0.17129314621063033;0.004042537640957035	UNDEFINED	10208434	Jun	10090	Jun	10090	dbTF		AP1
8209	PMID:25294825:pubtator_title_and_abstract:3732c209440ea05d197d5ce11328f4f4:6:ERK:AP-1:755:741	Furthermore, both migration and transcriptional activation through ETS/[TG] required [TF] phosphorylation of ETS1.	ERK	AP-1	5594	3726	755	741	0.0081622472680521	Non valid	0.004973717909336993;0.9943510975869141;0.0006751845037490209	ACTIVATION	25294825	MAPK1	9606	JUNB	9606	ll_coTF		AP1
8704	PMID:9030721:pubtator_title_and_abstract:34dc1c489d4f584bc36bd481671b4e28:2:activator protein-1:AP-1:328:349	Induction of murine glutathione-S-transferase (GST) Ya gene expression by a variety of chemical agents is mediated by a regulatory element, EpRE, composed of an Ets and two adjacent [TF] ([TG])-like sites and activated by the Fos/Jun heterodimeric complex (AP-1).	activator protein-1	AP-1	Complex:AP1	16476	328	349	0.0011642253060572	Non valid	0.006413148243882805;0.9926850789256056;0.0009017728305116314	ACTIVATION	9030721	AP1	10090	Jun	10090	dbTF	AP1	AP1
9049	PMID:33467433:pubtator_title_and_abstract:75a94ffe01927847f97968033e8d6709:9:activator protein 1:AP-1:971:992	It is known that anti-inflammatory mechanisms involve the inhibition of other transcription factors, such as nuclear factor kB(NFkappaB), signal transducer and activator of transcription (STAT) or [TF] ([TG]), or intracellular signaling proteins such as mitogen-activated protein (MAP) kinases.	activator protein 1	AP-1	Complex:AP1	3726	971	992	0.0011613692566124	Non valid	0.2804044609839182;0.6882004112786305;0.03139512773745128	ACTIVATION	33467433	AP1	9606	JUNB	9606	dbTF	AP1	AP1
9645	PMID:25788572:pubtator_title_and_abstract:5ab5ed193e55b76aa6c87d8654bf0133:5:JunD:AP-1:542:638	[TF] directly interacted with the miR-29b1 promoter via AP-1-binding sites, whereas mutation of [TG] sites from the miR-29b1 promoter prevented JunD-mediated transcriptional activation of the miR-29b1 gene.	JunD	AP-1	3727	3727	542	638	0.0010874104851508	Non valid	0.001975720013293326;0.9964938903865963;0.0015303896001102584	ACTIVATION	25788572	JUND	9606	JUND	9606	dbTF		AP1
9862	PMID:11254751:pubtator_title_and_abstract:dc62751f21d908e10d42b9f0a71ffb40:11:Fra-2:AP-1:1854:2042	Incubation of the nuclear extract with the appropriate antibodies showed that the AP-1 DNA-binding complex contained Fra-1, [TF], and Jun D. Western blots demonstrated that CS treatment increased the levels of Fra-1, Fra-2, and Jun D, and Northern analyses revealed that CS increased mRNA levels for these same [TG] factors.	Fra-2	AP-1	2355	3727	1854	2042	0.001614858459233	Non valid	0.9820508777657225;0.0158204481547414;0.0021286740795360953	UNDEFINED	11254751	FOSL2	9606	JUND	9606	dbTF		AP1
10251	PMID:14594454:pubtator_title_and_abstract:faf5efda9e3dab1960137f02e4509c63:7:AP-1:activator protein-1:1122:1058	Furthermore GnRH induces activation of the c-Jun N-terminal kinase/[TG] (JNK/AP-1) pathway independent of the known [TF] activators, protein kinase (PKC) or mitogen activated protein kinase (MAPK/ERK).	AP-1	activator protein-1	Complex:AP1	3726	1122	1058	0.0012778193630475	Non valid	0.004214764291807256;0.9944340686729086;0.0013511670352839922	ACTIVATION	14594454	AP1	9606	JUNB	9606	dbTF	AP1	AP1
10683	PMID:16106402:pubtator_title_and_abstract:56de467d5c44a879904b6d2f04df64a8:14:NF-kappaB:AP-1:1681:1635	In conclusion, UDCA did not induce NF-kappaB and [TG] DNA binding but also blocked DCA-induced [TF] and AP-1 activation.	NF-kappaB	AP-1	Complex:NFKB	3726	1681	1635	0.0011723653723042	Non valid	0.03136962529571804;0.9659729116783787;0.002657463025903264	ACTIVATION	16106402	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
11029	PMID:9541239:pubtator_title_and_abstract:665b464a403efbc56ceeedba3114ca46:6:CTF:AP1:975:967	Bovine, murine and human upstream regions also have similarities, with consensus sequences for potential binding of transcription factors, such as [TG] and [TF]/NF1.	CTF	AP1	4782	3726	975	967	0.0011871623117211	Non valid	0.9956017391451496;0.0038065590939836444;0.0005917017608668175	UNDEFINED	9541239	NFIC	9606	JUNB	9606	dbTF		AP1
11314	PMID:20460455:pubtator_title_and_abstract:7022d5033b61b6ebf66ab9cd9f2353e9:8:TCF4:AP-1:1136:1145	Furthermore, 417 regions contained both [TF] and [TG] motifs.	TCF4	AP-1	6925	3725	1136	1145	0.0012221538840414	Non valid	0.9931005335102446;0.005923626622133275;0.0009758398676220683	UNDEFINED	20460455	TCF4	9606	JUN	9606	dbTF		AP1
11817	PMID:28747866:pubtator_title_and_abstract:3e4feab9e8b98c553152d2f5b145da96:8:AP-1:activator protein-1:1214:1193	Further analyses demonstrated that WBP rapidly activated phosphorylated p38 mitogen-activated protein kinase (MAPK) and the transcriptional activities of [TG] ([TF]) and nuclear factor (NF)-kappaB via toll-like receptor 4 (TLR4).	AP-1	activator protein-1	Complex:AP1	16476	1214	1193	0.0011799936845537	Non valid	0.019321302469625903;0.974873158280022;0.005805539250352157	ACTIVATION	28747866	AP1	10090	Jun	10090	dbTF	AP1	AP1
11843	PMID:33355532:pubtator_title_and_abstract:729af3830c555f49ecee9fd4cb7151ed:6:BRG1:AP-1:806:893	Gained chromatin accessibility and [TF] recruited sites were strongly enriched for transcription-factor-binding motifs of [TG] family members.	BRG1	AP-1	6597	3726	806	893	0.0101120857906255	Non valid	0.9939268481758003;0.005188387378154873;0.0008847644460448056	UNDEFINED	33355532	SMARCA4	9606	JUNB	9606	coTF		AP1
11946	PMID:20615914:pubtator_title_and_abstract:c0143dcade3fa806d0b984db38274b3d:5:AP-1:activator protein 1:931:910	Additionally, EGb761 significantly down-regulated the mRNA and protein expression of class A scavenger receptor (SR-A) by decreasing expression of [TG] ([TF]); however, EGb761 increased the protein stability of ATP-binding cassette transporter A1 (ABCA1) by reducing calpain activity without affecting ABCA1 mRNA expression.	AP-1	activator protein 1	Complex:AP1	16476	931	910	0.001849352652415	Non valid	0.00986583385170058;0.9630058752839663;0.02712829086433298	ACTIVATION	20615914	AP1	10090	Jun	10090	dbTF	AP1	AP1
13265	PMID:20627121:pubtator_title_and_abstract:04f2955f0d8d47f6ca9d3f52f0fe653f:6:myeloid zinc finger 1:activator protein 1:622:784	We have identified transcription factors MZF-1 ([TF])/RREB-1 (Ras-responsive element binding protein 1), C/EBP (CCAAT/enhancer binding protein)/HNF-3beta (hepatocyte nuclear factor 3) and AP-1([TG]) as proteins likely to be involved in this regulation with the former region primarily involved in up regulation and the latter two regions involved in suppression of TCblR expression.	myeloid zinc finger 1	activator protein 1	7593	3726	622	784	0.001179607653023	Non valid	0.8331452347577929;0.12805676286114412;0.038798002381062964	UNDEFINED	20627121	MZF1	9606	JUNB	9606	dbTF		AP1
13745	PMID:16528474:pubtator_title_and_abstract:2f783b1442713fd17636cd7b28b36671:12:JNK:AP-1:1873:1834	Differently, in Chang liver cells the different composition of [TG] complex as well as the failure of [TF] activation seemed to be responsible for the low susceptibility to apoptosis.	JNK	AP-1	5599	3725	1873	1834	0.0011261318547984	Non valid	0.014585801785637635;0.9801609765406866;0.005253221673675718	ACTIVATION	16528474	MAPK8	9606	JUN	9606	ll_coTF		AP1
15112	PMID:12200434:pubtator_title_and_abstract:90b08839947b6669734e254cfa1cea88:6:USF2:AP1:859:890	Competition and gel mobility supershift assays identify upstream stimulatory factor (USF; USF1:[TF]) and activator protein-1 ([TG]; c-Fos:c-Jun) in complexes binding the composite CCTCATGAC element.	USF2	AP1	81817	24516	859	890	0.0011509126911519	Non valid	0.9979625591408868;0.0012708116475045601;0.0007666292116085409	UNDEFINED	12200434	Usf2	10116	Jun	10116	dbTF		AP1
16069	PMID:30901906:pubtator_title_and_abstract:9a6f0c87ae9257e900205f035fd2a9df:7:beta-catenin:activator protein 1:941:1098	Treatment with WNT3a-rich exosomes inhibited activity of glycogen synthase kinase 3beta (GSK3beta), induced nuclear translocation of beta-catenin, and activated T-cell factor (TCF)/lymphoid enhancer factor (LEF) transcription factors as well as expression of WNT/[TF] responsive genes in cardiac fibroblasts, but did not coactivate extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and [TG] (AP-1) signaling pathways.	beta-catenin	activator protein 1	1499	3726	941	1098	0.001150399721697	Non valid	0.41675115479372443;0.5763247628025285;0.006924082403747114	ACTIVATION	30901906	CTNNB1	9606	JUNB	9606	coTF		AP1
16140	PMID:15569826:pubtator_title_and_abstract:a73c97c068bf62d25020a944b7624236:13:AP-1:AP-1:1734:1790	MKP-1 induction was shown to depend on activation of the transcription factor activator protein-1 ([TF]) by using electrophoretic mobility shift assay and [TG] decoys.	AP-1	AP-1	Complex:AP1	3725	1734	1790	0.0011060116972705	Non valid	0.02011898662805794;0.9781841022661559;0.0016969111057861701	ACTIVATION	15569826	AP1	9606	JUN	9606	dbTF	AP1	AP1
16833	PMID:17703138:pubtator_title_and_abstract:8810e537aee6ad9dd17e426a18cdca90:10:NF-kappaB:AP-1:1579:1615	Electromobility shift assays of protein extracts isolated from aortas did not demonstrate different binding activities of nuclear factor-kappaB ([TF]) and activator protein-1 ([TG]) after treatment with c Ado.	NF-kappaB	AP-1	Complex:NFKB	16476	1579	1615	0.0011241452583474	Non valid	0.9975510386918173;0.0015649888093756683;0.0008839724988070159	UNDEFINED	17703138	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
17214	PMID:37879938:pubtator_title_and_abstract:e2456d733ee33db1c054b3bed2e90391:10:TFAP2C:AP-1:1503:1441	MICA predicted co-localisation of the [TG] transcription factor subunit proto-oncogene JUND and the [TF] transcription factor AP-2gamma in early human embryos.	TFAP2C	AP-1	7022	3727	1503	1441	0.001206801490291	Non valid	0.989386820207696;0.009497597372201915;0.0011155824201020319	UNDEFINED	37879938	TFAP2C	9606	JUND	9606	dbTF		AP1
17395	PMID:34401407:pubtator_title_and_abstract:a8b44ecf421a6603e971b3867ad631d3:2:c-fos:AP-1:202:175	The transcription factor NFATc1 and its binding partner [TG] (a complex containing [TF] and c-Jun) play a central role in osteoclast differentiation.	c-fos	AP-1	2353	3725	202	175	0.0011475043105359	Non valid	0.9937572765887488;0.005467671999956242;0.0007750514112949954	UNDEFINED	34401407	FOS	9606	JUN	9606	dbTF		AP1
17421	PMID:10527950:pubtator_title_and_abstract:ebb98f5698bac4143ab383ae3b2abf55:4:CCAAT-enhancer binding protein:AP-1:692:751	Footprinting and gel-shift assays showed that several nuclear proteins bind to this region at conserved [TF] (C/EBP), activator protein ([TG]) and E-box sequences.	CCAAT-enhancer binding protein	AP-1	25301	24516	692	751	0.0012871065667246	Non valid	0.9962689926091235;0.002910121494463535;0.0008208858964129962	UNDEFINED	10527950	Cebpg	10116	Jun	10116	dbTF		AP1
17591	PMID:12200434:pubtator_title_and_abstract:90b08839947b6669734e254cfa1cea88:6:USF2:activator protein-1:859:869	Competition and gel mobility supershift assays identify upstream stimulatory factor (USF; USF1:[TF]) and [TG] (AP1; c-Fos:c-Jun) in complexes binding the composite CCTCATGAC element.	USF2	activator protein-1	81817	24516	859	869	0.0011570327187251	Non valid	0.9979550652053766;0.0013292590118252339;0.0007156757827982245	UNDEFINED	12200434	Usf2	10116	Jun	10116	dbTF		AP1
18035	PMID:34630778:pubtator_title_and_abstract:14e11309eb0315d32ff878afd1fa0345:8:nuclear factor kappa-B:activating protein-1:909:880	The protein expression of [TG] (AP-1), [TF] (NF-kappaB), and NF-kappaB inhibitor alpha (IkappaBalpha) was determined by western blotting.	nuclear factor kappa-B	activating protein-1	Complex:NFKB	16476	909	880	0.0012151642211957	Non valid	0.9702756989590141;0.027578176106799173;0.0021461249341867693	UNDEFINED	34630778	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
18147	PMID:8373351:pubtator_title_and_abstract:0c7a76df61cf3e2ad7138592d7aeefb3:10:AP-1:AP-1:1478:1613	In transient transfections into dedifferentiating chondrocytes, an alpha 1(I) collagen expression plasmid carrying a mutated [TF] site in the first intron resulted in three-times-lower reporter gene RNA levels than a plasmid carrying the respective functional [TG] site.	AP-1	AP-1	Complex:AP1	3726	1478	1613	0.0011063299327179	Non valid	0.060053842252945945;0.8414100818785121;0.09853607586854203	ACTIVATION	8373351	AP1	9606	JUNB	9606	dbTF	AP1	AP1
18826	PMID:24895120:pubtator_title_and_abstract:2578489da38d200d6b81c8a26386b4b2:6:specificity protein 1:AP1:802:793	Fn14 promoter also contains multiple consensus DNA sequence for transcription factors activator protein 1 ([TG]) and [TF] (SP1).	specificity protein 1	AP1	20683	16476	802	793	0.0012188760674373	Non valid	0.9908047712685115;0.008198769496811168;0.0009964592346773313	UNDEFINED	24895120	Sp1	10090	Jun	10090	dbTF		AP1
19863	PMID:35888040:pubtator_title_and_abstract:6bcf070db9eeefdba30e9e779ba091bb:10:EGFR:AP-1:1449:1466	Melatonin downregulated UV-induced activation of [TF] and the JNK/[TG] signaling pathway.	EGFR	AP-1	1956	3726	1449	1466	0.0011399348444767	Non valid	0.0028092837431026875;0.9936958941711735;0.0034948220857237674	ACTIVATION	35888040	EGFR	9606	JUNB	9606	ll_coTF		AP1
20305	PMID:10713703:pubtator_title_and_abstract:ffe0105eb6c6df9fe4357f743eaa0425:8:NF-kappaB:AP-1:1094:1085	Vav1p76 displays a diminished capacity to activate the transcription factors NF-AT, [TG] and [TF], and thus completely fails to activate IL-2 transcription.	NF-kappaB	AP-1	Complex:NFKB	2354	1094	1085	0.0011898354670162	Non valid	0.004544148892993748;0.9935150210408598;0.0019408300661465387	ACTIVATION	10713703	NFKB	9606	FOSB	9606	dbTF	NFKB	AP1
20688	PMID:19950169:pubtator_title_and_abstract:034f042d8c2fc9f7a3a2cad10a236b51:5:NF-kappaB:AP-1:748:763	Similarly, dominant negative PKC-alpha repressed Pam(3)CSK(4) induced [TF]- and [TG]-driven promoter activities in TLR2-expressing human embryonic kidney 293 T cells.	NF-kappaB	AP-1	Complex:NFKB	3726	748	763	0.0013272573453825	Non valid	0.007952022911067575;0.9847168278390611;0.007331149249871335	ACTIVATION	19950169	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
20691	PMID:15196329:pubtator_title_and_abstract:e8a1915a87c5b8e0b983f2f5aae55460:2:ERbeta:AP-1:162:179	BACKGROUND: Ligand-bound estrogen receptor alpha (ERalpha) and estrogen receptor beta ([TF]) modulate [TG]-dependent transcription via protein-protein interactions on DNA, in a manner that depends on the type of cells and the subtype of ER.	ERbeta	AP-1	2100	3726	162	179	0.0012073286540726	Non valid	0.9008161178704306;0.096289667824001;0.0028942143055685067	UNDEFINED	15196329	ESR2	9606	JUNB	9606	dbTF		AP1
22320	PMID:18320311:pubtator_title_and_abstract:06d6bb44209411b13eb2cfb0f427cb14:7:Fra-2:AP-1:1041:966	These findings suggest that each member of [TG] is expressed differently and that ATF-2 is more active than c-Jun and [TF] in physiological conditions in healthy rat jejunum.	Fra-2	AP-1	25446	24516	1041	966	0.001324526557455	Non valid	0.2014735514582632;0.7916033271308649;0.0069231214108719285	ACTIVATION	18320311	Fosl2	10116	Jun	10116	dbTF		AP1
22450	PMID:18627575:pubtator_title_and_abstract:c7e22b0d489af5194f2b983cda86be7c:2:AP-2:AP-1:388:379	The Golgi-localized, gamma-ear-containing, ADP ribosylation factor-binding family of monomeric clathrin adaptors (GGAs) is known to bind cargo molecules through short C-terminal peptide motifs conforming to the sequence DXXLL (X = any amino acid), while the heterotetrameric adaptors [TG] and [TF] utilize a similar but discrete sorting motif of the sequence [D,E]XXXL[L,I].	AP-2	AP-1	7020	3727	388	379	0.0011591201513653	Non valid	0.9644945432285977;0.033839370187686006;0.0016660865837161832	UNDEFINED	18627575	TFAP2A	9606	JUND	9606	dbTF		AP1
23915	PMID:11353137:pubtator_title_and_abstract:451d22ada1bd722be331f435ae52a3e2:5:HSP 72:AP-1:616:592	Since 0.1-100 microM arsenite did not compromise slice viability at 4 hours, effects of arsenite on the expression of c-jun/[TG], NFkappaB, HSP 32, [TF], HSP 60, and HSP 90 were studied, using these concentrations of arsenite at 4 h. Nuclear c-jun was increased by 10 and 100 microM arsenite, while NFkappaB was not affected.	HSP 72	AP-1	24472	24516	616	592	0.0012033343893166	Non valid	0.9876166600100393;0.009650475530789166;0.0027328644591715053	UNDEFINED	11353137	Hspa1a	10116	Jun	10116	coTF		AP1
24053	PMID:14755552:pubtator_title_and_abstract:e7d7020b05574fc221ef1be7d7c073cb:5:AP-1:AP-1:867:982	Western blotting and gel shift assay revealed that MC-induced gel contraction resulted in ERK activation in parallel with that of [TF] binding, peaking at 4 h and lasting at least for 24 h. Application of the MEK inhibitor, U0126, and the c-jun/[TG] inhibitor, curcumin, inhibited gel contraction and AP-1 activity, respectively, dose dependently.	AP-1	AP-1	Complex:AP1	24516	867	982	0.0015162937845975	Non valid	0.3453504390660373;0.6495888960892874;0.005060664844675402	ACTIVATION	14755552	AP1	10116	Jun	10116	dbTF	AP1	AP1
24181	PMID:27553367:pubtator_title_and_abstract:3d9da51399e5075d04452861a4eea173:2:activator protein 1:AP-1:250:271	BACKGROUND: We hypothesized that apurinic/apyrimidinic endonuclease 1 (APE1) may regulate cell activity via [TF] ([TG]) signaling pathway through its redox function in the development of ovarian cancer.	activator protein 1	AP-1	Complex:AP1	3726	250	271	0.0011510050608788	Non valid	0.99624925748025;0.003083866140304762;0.0006668763794451517	UNDEFINED	27553367	AP1	9606	JUNB	9606	dbTF	AP1	AP1
25123	PMID:11973337:pubtator_title_and_abstract:532ccccccd130e75ae4f59cf2a348bbc:9:nuclear factor-kappaB:AP-1:974:1033	The IL-8 promoter contains DNA binding sites for [TF] (NF-kappaB) and activator protein-1 ([TG]).	nuclear factor-kappaB	AP-1	Complex:NFKB	3725	974	1033	0.0011956339471681	Non valid	0.997021359981435;0.002379343333365332;0.0005992966851996759	UNDEFINED	11973337	NFKB	9606	JUN	9606	dbTF	NFKB	AP1
25645	PMID:19162185:pubtator_title_and_abstract:2cce9b8ef892405af92858e6a384f2b6:9:AP-1:AP-1:1187:1083	[TG] is a dimeric protein complex and supershift assay identified c-Jun as a component of the activated [TF] complex.	AP-1	AP-1	Complex:AP1	3725	1187	1083	0.0011553663568933	Non valid	0.33823368070285514;0.6581333258909564;0.0036329934061885088	ACTIVATION	19162185	AP1	9606	JUN	9606	dbTF	AP1	AP1
25789	PMID:8747598:pubtator_title_and_abstract:593961175a8e5f157e7b1ec18a54c5c0:10:c-Jun:AP-1:1678:1706	The findings suggest that the preferential and transient increase in [TF] dephosphorylation and [TG] transcriptional activity may contribute to the preferential apoptotic response in TNFs cells; and that the greater constitutive oxidant defense in TNFr cells may contribute to their resistance.	c-Jun	AP-1	16476	16476	1678	1706	0.051574636537079	Non valid	0.010075277082445086;0.013294154255355994;0.976630568662199	REPRESSION	8747598	Jun	10090	Jun	10090	dbTF		AP1
25847	PMID:17580135:pubtator_title_and_abstract:c4b42f68489167dd601239f047898390:9:JNK:AP-1:1298:1302	CONCLUSIONS: BV treatment alleviated ischemia-reperfusion injury at least in part via inhibition of the proinflammatory and proapoptotic [TF]/[TG] pathway.	JNK	AP-1	116554	24516	1298	1302	0.0011456320090076	Non valid	0.10426307331376512;0.8807057759502775;0.015031150735957233	ACTIVATION	17580135	Mapk8	10116	Jun	10116	ll_coTF		AP1
26160	PMID:21590707:pubtator_title_and_abstract:e7f9d6d2f387b783b0473fca6727814e:8:phosphatidylinositol 3-kinase:AP-1:727:960	Activations of [TF] (PI3K), Akt, and AP-1 pathways after IL-8 treatment were demonstrated, and IL-8-induced expression of integrin and migration activity was inhibited by the specific inhibitor and mutant of PI3K, Akt, and [TG] cascades.	phosphatidylinositol 3-kinase	AP-1	5295	3727	727	960	0.0011488247011911	Non valid	0.005704364440072577;0.9923482823232265;0.00194735323670095	ACTIVATION	21590707	PIK3R1	9606	JUND	9606	ll_coTF		AP1
27043	PMID:16627221:pubtator_title_and_abstract:bd76d71b5c5bc4409a5492a69e22e190:6:NF-kappaB:AP-1:778:792	Coculture of SKGT-4 and OE33 with live H pylori and HPE induced [TF] and [TG] DNA-binding activity, and also decreased IkappaB-alpha levels.	NF-kappaB	AP-1	Complex:NFKB	3726	778	792	0.0011654233631774	Non valid	0.9539299831376695;0.04451905839022998;0.0015509584721004103	UNDEFINED	16627221	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
27282	PMID:23524338:pubtator_title_and_abstract:01e37dc4998e7de7538d763f43f6bed3:4:JNK:AP1:652:629	We also demonstrated that RhoA and Rock kinases but not Rac were involved in ORs-induced SRE/SRF activation and that [TG] was activated, via [TF] and p38 MAPKinase.	JNK	AP1	116554	24516	652	629	0.0260754546807203	Non valid	0.0025652411214217327;0.9966127866110245;0.000821972267553854	ACTIVATION	23524338	Mapk8	10116	Jun	10116	ll_coTF		AP1
28300	PMID:24676100:pubtator_title_and_abstract:6205391eeb8288db4632c6cfca038b4c:12:AP-1:activator protein 1:2221:2200	These studies implicating rs12190287 in the miRNA-dependent regulation of TCF21, in conjunction with previous studies showing that this variant modulates transcriptional regulation through [TG] ([TF]), suggests a unique bimodal level of complexity previously unreported for disease-associated variants.	AP-1	activator protein 1	Complex:AP1	3726	2221	2200	0.0011540170200532	Non valid	0.997660463647289;0.0014541588831159964;0.0008853774695950326	UNDEFINED	24676100	AP1	9606	JUNB	9606	dbTF	AP1	AP1
28412	PMID:27367679:pubtator_title_and_abstract:100987f7fb23ab23e07ba3dfc3a677cb:8:NF-kappaB:AP1:956:948	It also prevents UV- and ROS-induced DNA damage with inhibition of [TG] and [TF] and protection of natural antioxidant enzyme systems.	NF-kappaB	AP1	Complex:NFKB	3725	956	948	0.0011876331096548	Non valid	0.030699008695779826;0.12160756238720528;0.8476934289170148	REPRESSION	27367679	NFKB	9606	JUN	9606	dbTF	NFKB	AP1
28752	PMID:19162185:pubtator_title_and_abstract:2cce9b8ef892405af92858e6a384f2b6:9:c-Jun:AP-1:1149:1187	AP-1 is a dimeric protein complex and supershift assay identified [TF] as a component of the activated [TG] complex.	c-Jun	AP-1	3725	3725	1149	1187	0.0032607838903885	Non valid	0.28465989478691844;0.7125996970391625;0.002740408173919019	ACTIVATION	19162185	JUN	9606	JUN	9606	dbTF		AP1
28758	PMID:20681653:pubtator_title_and_abstract:55451c0e0a823309bf864ff0fb0f7168:8:Src:AP1:1129:1163	Taken together, these results strongly support the hypothesis that [TF]-dependent ERK1/2 and JNK/SAPK/[TG] signaling pathways play a key role in AGE-BSA-mediated down-regulation of Cx32 and Cx43 protein expression in SKHep 1 cells.	Src	AP1	6714	2354	1129	1163	0.0014829879146936	Non valid	0.16651488417812124;0.8271769786892402;0.006308137132638508	ACTIVATION	20681653	SRC	9606	FOSB	9606	ll_coTF		AP1
29061	PMID:32535385:pubtator_title_and_abstract:eab8e8a725757baf69d5a23ee3739db2:8:nuclear factor kappa-B:activator protein (AP)-1:641:612	Activation of [TG] and [TF] (NF-kappaB) was detected with enzyme linked immunosorbent assay kits.	nuclear factor kappa-B	activator protein (AP)-1	Complex:NFKB	16476	641	612	0.0012621898971738	Non valid	0.008233257999050374;0.9903957774617842;0.0013709645391654108	ACTIVATION	32535385	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
29658	PMID:21153089:pubtator_title_and_abstract:4578c4a168bbf6de483c7ca96c00c844:4:Fos:AP-1:675:652	Electrophoretic mobility shift assays were performed using nuclear extracts from a mouse pituitary tumor cell line (AtT-20) to test the binding capability of the [TG] proteins, Jun and [TF], to the putative glucocorticoid receptor and the c-jun AP-1 sites.	Fos	AP-1	14281	16476	675	652	0.0012721512981438	Non valid	0.9977072279145303;0.001354959075160449;0.0009378130103092112	UNDEFINED	21153089	Fos	10090	Jun	10090	dbTF		AP1
30136	PMID:35660746:pubtator_title_and_abstract:b1d08f20053f2daba08473efff8317c0:4:CDK1:AP-1:914:1029	Tracking TCR clonotypes at the single cell level reveals in two patients that peptide-specific long-lasting CD8+ T cells acquire an effector memory phenotype that associates with cell cycle-related genes (CCNA2 and [TF]), and are characterized by high expression of IL7R, SELL, and NOSIP along with a later stage promotion of the [TG] transcription factor network (5 years or more past vaccination).	CDK1	AP-1	983	3727	914	1029	0.0023265009496398	Non valid	0.0608780255767971;0.9319687966468126;0.007153177776390199	ACTIVATION	35660746	CDK1	9606	JUND	9606	coTF		AP1
30262	PMID:18511434:pubtator_title_and_abstract:490de7e424ca7e9559e91c3d19a5c440:3:activator protein-1:AP-1:397:418	We have previously demonstrated that ex vivo donor allograft treatment with decoy oligodeoxynucleotides (ODN) targeting the transcription factors, [TF] ([TG]) or signal transducer and activator of transcription-1 (STAT-1), delays acute rejection and prolongs cardiac allograft survival.	activator protein-1	AP-1	Complex:AP1	24516	397	418	0.0011557794195917	Non valid	0.2874528655306172;0.618859745577363;0.09368738889201987	ACTIVATION	18511434	AP1	10116	Jun	10116	dbTF	AP1	AP1
31665	PMID:34472396:pubtator_title_and_abstract:c31266c98bcee313325b8fcb7b85ba6c:8:NF-kappaB:AP-1:990:981	IL-6, IL-8, IL-10, TNF-alpha and MCP-1 levels were higher, and [TG] and [TF] gene expressions lower in septic patients.	NF-kappaB	AP-1	Complex:NFKB	3725	990	981	0.0012338058978849	Non valid	0.0084551704916023;0.052488282283052225;0.9390565472253454	REPRESSION	34472396	NFKB	9606	JUN	9606	dbTF	NFKB	AP1
31933	PMID:33139832:pubtator_title_and_abstract:5aac118cf305dc0ca8c2454034c5f10f:5:NF-kappaB:AP-1:821:831	Employing the WASp-sufficient and WASp-deficient cell-pair model of human T and B lymphocytes, we show that WASp deficiency differentially influences hyperactivation versus inhibition of both CDC42:ERK1/2 and [TF]:[TG] pro-oncogenic signaling pathways in nonmalignant versus malignant T and B lymphocytes.	NF-kappaB	AP-1	Complex:NFKB	2354	821	831	0.0012234543059443	Non valid	0.4052178283472803;0.5594207495383714;0.0353614221143483	ACTIVATION	33139832	NFKB	9606	FOSB	9606	dbTF	NFKB	AP1
32166	PMID:23917222:pubtator_title_and_abstract:ccf2712ed707745d166887939071fa41:11:activator protein-1:AP-1:1247:1268	This effect is mediated by [TF] ([TG]) occupancy of the Notch-4 promoter.	activator protein-1	AP-1	Complex:AP1	3726	1247	1268	0.001367979956405	Non valid	0.9961590510198969;0.0030119650307122987;0.0008289839493908017	UNDEFINED	23917222	AP1	9606	JUNB	9606	dbTF	AP1	AP1
32234	PMID:10804224:pubtator_title_and_abstract:6a8e054a49c1e95c3b2cc17528953dfb:8:AP-1:AP-1:1541:1443	Assays of binding by proteins in hypothalamic extracts of similarly manipulated rats toward consensus CRE and [TG] response elements supported a role for the stress-induced plasma B increment in antagonizing [TF], but not CRE, binding.	AP-1	AP-1	Complex:AP1	24516	1541	1443	0.0011359676796821	Non valid	0.9918777521048056;0.006958834018903435;0.0011634138762909613	UNDEFINED	10804224	AP1	10116	Jun	10116	dbTF	AP1	AP1
32700	PMID:30613914:pubtator_title_and_abstract:43edb2fc805c043d666348c069858161:5:ATF-2:AP-1:675:659	Several signaling pathways, such as ERK1/2, JNK, p38, and [TG] (c-Fos and [TF]), were activated in response to IL-1beta stimulation.	ATF-2	AP-1	1386	2353	675	659	0.0011892776985174	Non valid	0.3337541447985687;0.6636679586639458;0.0025778965374854365	ACTIVATION	30613914	ATF2	9606	FOS	9606	dbTF		AP1
33043	PMID:12431383:pubtator_title_and_abstract:03620e7850560119f9c23d836ff14eb4:3:NF-kappaB:AP-1:440:405	It does so through the activation of caspases, specific kinases including mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK), transcription factors Activated protein 1 ([TG]), and nuclear factor kappa-B ([TF]).	NF-kappaB	AP-1	Complex:NFKB	3726	440	405	0.0012650387077048	Non valid	0.1152223874357685;0.8815147774348584;0.0032628351293731185	ACTIVATION	12431383	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
33184	PMID:22399296:pubtator_title_and_abstract:0278556fd12c74d33320d4d22af13bf8:2:c-Jun:AP-1:418:427	Estrogen receptor (ER) alpha promotes breast cancer growth by regulating gene expression through classical estrogen response element (ERE) binding and nonclassical (interaction with [TF] at [TG] sites) pathways.	c-Jun	AP-1	3725	3725	418	427	0.0010982337505651	Non valid	0.9966411563654263;0.0022051434297040862;0.0011537002048697597	UNDEFINED	22399296	JUN	9606	JUN	9606	dbTF		AP1
33541	PMID:19719782:pubtator_title_and_abstract:ea8f2d87a49f4ad7665d917555688dde:5:CRE-binding protein:AP1:720:711	Cx43 expression as well as activation of p38 mitogen-activated protein kinase (MAPK), p42/44 MAPK, JUN NH(2)-terminal kinase (JNK) and nuclear translocation of the transcription factors activator protein 1 ([TG]) and [TF] (CREB) were investigated.	CRE-binding protein	AP1	1385	3726	720	711	0.0012023845573581	Non valid	0.05857306967104573;0.9379189357503482;0.0035079945786059487	ACTIVATION	19719782	CREB1	9606	JUNB	9606	dbTF		AP1
33544	PMID:36840360:pubtator_title_and_abstract:95a728f3447666c30b9fd663ed6a2dde:10:Fos:AP-1:1664:1686	In sum, we showed that the aging-related transcriptional activation of Jun and [TF] family members in [TG] complex is conserved across immune tissues and long- and short-living mouse strains, possibly contributing to increased inflammation with age.	Fos	AP-1	14281	16476	1664	1686	0.0013121054442347	Non valid	0.022146957137445807;0.9751823700397518;0.002670672822802338	ACTIVATION	36840360	Fos	10090	Jun	10090	dbTF		AP1
33869	PMID:19944019:pubtator_title_and_abstract:bf5111c1cb84746467d6452fbe608167:3:fos-related antigen-1:AP-1:526:428	Akt and p38 mitogen activated protein kinase (p38 MAPK) are necessary for CAGE-mediated induction of the [TG] subunit JunB, whereas extracellular regulated kinase (ERK) is necessary for the induction of [TF] (Fra-1).	fos-related antigen-1	AP-1	8061	3726	526	428	0.0012869487416898	Non valid	0.0058586880505444566;0.9925862698056482;0.0015550421438073221	ACTIVATION	19944019	FOSL1	9606	JUNB	9606	dbTF		AP1
34432	PMID:31258824:pubtator_title_and_abstract:3fdd0e01b6914b722d94373170af5f04:11:c-Fos:AP-1:1246:1320	OUFBW triggered activation of [TF], a major component of the transcription factor activator protein 1 ([TG]), and also nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2), which possessed a high sensitivity to oxidative stress.	c-Fos	AP-1	2353	2353	1246	1320	0.01000100453655	Non valid	0.03449870661746034;0.9627779722997676;0.0027233210827720756	ACTIVATION	31258824	FOS	9606	FOS	9606	dbTF		AP1
34638	PMID:21575254:pubtator_title_and_abstract:a4c97ed54c68e463825ca8c25d4c7cb9:11:NF-kappaB:AP-1:1284:1275	OMC also inhibited LPS-dependent DNA-binding activity of [TG] and [TF] in RAW264.7 cells.	NF-kappaB	AP-1	Complex:NFKB	16476	1284	1275	0.0012481427140481	Non valid	0.50963168353821;0.48670925544603766;0.0036590610157522497	UNDEFINED	21575254	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
34946	PMID:18163434:pubtator_title_and_abstract:0a617e02572f1542ad0a71114414477b:7:NGFI-B:AP-1:1060:1194	Luciferase assays using NGFI-B/Nur77 promoter constructs and electric mobility shift assays (EMSA) showed that [TF]/Nur77 gene expression was mediated through three of the four activator protein-1 (AP-1)-like sites, namely the -233 AP-1, -213 [TG] and -69 AP-1 sites adjacent to the transcription start site of the NGFI-B/Nur77 promoter.	NGFI-B	AP-1	79240	16476	1060	1194	0.0011876712906324	Non valid	0.02937197867624615;0.9695854128510594;0.0010426084726945113	ACTIVATION	18163434	Nr4a1	10116	Jun	10090	dbTF		AP1
35080	PMID:21543584:pubtator_title_and_abstract:d07266bebc5f795c8d632610c91a9f73:0:AP-1:AP-1:56:0	[TG] protein induction during monopoiesis favors C/EBP: [TF] heterodimers over C/EBP homodimerization and stimulates FosB transcription.	AP-1	AP-1	Complex:AP1	16476	56	0	0.001240691990565	Non valid	0.008633523474486544;0.9893721292864929;0.001994347239020477	ACTIVATION	21543584	AP1	10090	Jun	10090	dbTF	AP1	AP1
35158	PMID:18541274:pubtator_title_and_abstract:7af4b4d974558722ff05ed82ec27aae7:4:AP-1:activator protein-1:502:481	Zinc significantly reduced IFN-gamma expression and [TG] ([TF]) signaling in cells activated by phorbol 12-myristate 13-acetate (PMA) and phytohemagglutinin (PHA) without affecting cell viability.	AP-1	activator protein-1	Complex:AP1	3725	502	481	0.0011742614582968	Non valid	0.05599646230190412;0.9419517130399376;0.0020518246581582144	ACTIVATION	18541274	AP1	9606	JUN	9606	dbTF	AP1	AP1
36145	PMID:32153563:pubtator_title_and_abstract:db1d0b530df70a550b984ffcf72e4458:6:FoxA1:AP-1:1240:1269	Our aim was to look at the transcription factors that regulate miRNAs and then validate some of those in vivo with cell lines that have sufficient expression of these transcription factors This analysis revealed several transcription factor families that regulate MG-specific miRNAs including the Forkhead box or the FOXO proteins ([TF], FoxA2, FoxM1, FoxP2), [TG], interferon regulatory factors (IRF1, IRF3, IRF4), and signal transducer and activator of transcription proteins (Stat1, Stat3, Stat5a).	FoxA1	AP-1	15375	16476	1240	1269	0.001138287657377	Non valid	0.9976563240557331;0.001346573299836861;0.0009971026444298798	UNDEFINED	32153563	Foxa1	10090	Jun	10090	dbTF		AP1
36748	PMID:11274169:pubtator_title_and_abstract:9ca2bd9ab58e13fba06082d9d5e7282f:0:AP-1:AP-1:0:158	[TF] and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/[TG] composite element.	AP-1	AP-1	Complex:AP1	16476	0	158	0.0030770807950037	Non valid	0.9974950981299588;0.001538063830276862;0.0009668380397641799	UNDEFINED	11274169	AP1	10090	Jun	10090	dbTF	AP1	AP1
36944	PMID:14670077:pubtator_title_and_abstract:c13db013a623e8718e4b955b6438477f:7:AP-1:AP-1:1340:1255	The [TG] inhibitors dithiothreitol and N -acetylcysteine, as well as a dominant negative [TF] mutant, significantly reduced AP-1 activation, demonstrating that this activation is oxidative stress-related.	AP-1	AP-1	Complex:AP1	3726	1340	1255	0.0043537646028646	Non valid	0.0018514969884802924;0.9964640993694577;0.0016844036420621243	ACTIVATION	14670077	AP1	9606	JUNB	9606	dbTF	AP1	AP1
37077	PMID:15492115:pubtator_title_and_abstract:2715f574e6fac4c8f21e27ef9c966af4:7:Fra-1:activator protein-1:1032:881	Resveratrol reduced both [TG] (AP-1) DNA binding and transcriptional activities, and supershift assay revealed that AP-1 composition was shifted from c-Jun/JunD/[TF] to JunD/Fra-1/Fra-2, with markedly increased JunD, Fra-1, and Fra-2 protein expression levels in the nucleus.	Fra-1	activator protein-1	8061	3725	1032	881	0.0011125244279285	Non valid	0.6329014563435961;0.34234048294176006;0.024758060714643863	UNDEFINED	15492115	FOSL1	9606	JUN	9606	dbTF		AP1
37612	PMID:23505448:pubtator_title_and_abstract:99def2e59476f02f502a5affbef62300:12:NF-kappaB:AP-1:1641:1630	Finally, we established that IL-1beta could stimulate SIRCs migration via p42/p44 MAPK-, JNK1/2-, [TG]-, and [TF]-dependent MMP-9 induction.	NF-kappaB	AP-1	Complex:NFKB	3725	1641	1630	0.0012278400650421	Non valid	0.004731904040911485;0.9943893952289423;0.0008787007301462233	ACTIVATION	23505448	NFKB	9606	JUN	9606	dbTF	NFKB	AP1
37735	PMID:21843512:pubtator_title_and_abstract:79793a8b86df0d737076a12d815a9434:4:NF-kappaB:AP-1:665:687	Though one of the terminal products of the COX-2-catalyzed reactions, this cyclopentenone prostaglandin exerts potent anti-inflammatory actions, in part, by antagonizing the activities of pro-inflammatory transcription factors, such as [TF], STAT3, and [TG], while stimulating the anti-inflammatory transcription factor Nrf2.	NF-kappaB	AP-1	Complex:NFKB	2354	665	687	0.0010980219140424	Non valid	0.05654130038799403;0.9211985572398428;0.022260142372163207	ACTIVATION	21843512	NFKB	9606	FOSB	9606	dbTF	NFKB	AP1
37746	PMID:12065759:pubtator_title_and_abstract:ac5e145f66e2c8f07994fbb1c9c16bf9:7:NF-kappaB:activator protein-1:1327:1442	ATA not only inhibited nuclear factor-kappaB ([TF]) activation through impairment of the targeting and degradation of IkappaBs but also reduced LPS-induced [TG] (AP-1) activation.	NF-kappaB	activator protein-1	Complex:NFKB	16476	1327	1442	0.001444329337873	Non valid	0.0017355327749172863;0.9963657935654329;0.0018986736596498706	ACTIVATION	12065759	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
38266	PMID:21682828:pubtator_title_and_abstract:4f5b6213b743dbfc493b3dcc30e08cb7:7:CREB:AP-1:984:978	Overexpression of AP-2alphain vivo significantly suppressed transcription factors [TG], [TF] and c-Myc, and markedly increased CBF, c-Myb, NF-1, Pax-5, RXR, Smad3/4, TR(DR-4), USF-1 and GATA.	CREB	AP-1	12912	16476	984	978	0.0012125248902133	Non valid	0.05074010112245665;0.11088324556292779;0.8383766533146155	REPRESSION	21682828	Creb1	10090	Jun	10090	dbTF		AP1
38418	PMID:36523490:pubtator_title_and_abstract:49f7a68716d90c8f229655dd91cbda38:8:JNK1:AP-1:1056:1062	During the validation stage, [TF], [TG], CCL2, and CXCL8 were poorly expressed, whereas PTGS2, CSF1, and AA were highly expressed.	JNK1	AP-1	5599	2353	1056	1062	0.0012185997821531	Non valid	0.26363496968188455;0.1885919388617571;0.5477730914563584	REPRESSION	36523490	MAPK8	9606	FOS	9606	ll_coTF		AP1
38790	PMID:8557686:pubtator_title_and_abstract:05ebe0a417d9c75e616e4dc8002b8c03:4:c-Jun:AP-1:425:475	One contains a binding site that selectively binds c-Fos and [TF] in vitro and confers a response to multiple [TG] family members in vivo.	c-Jun	AP-1	3725	3725	425	475	0.0011147618021937	Non valid	0.9779940636551917;0.02084158066821166;0.0011643556765966085	UNDEFINED	8557686	JUN	9606	JUN	9606	dbTF		AP1
38804	PMID:9726817:pubtator_title_and_abstract:fb1639641fba773ee94f05791c2e4525:4:AP-1:AP-1:827:981	Furthermore, VES treatments resulted in increased [TF] transactivation activity, as measured with an AP-1 promoter/luciferase reporter construct and by the measurement of increased mRNA expression of the [TG]-dependent endogenous gene collagenase.	AP-1	AP-1	Complex:AP1	3725	827	981	0.0015679872950147	Non valid	0.0041050429573067995;0.9947457528489874;0.0011492041937057468	ACTIVATION	9726817	AP1	9606	JUN	9606	dbTF	AP1	AP1
39655	PMID:30887599:pubtator_title_and_abstract:75130d1c306e7f05968801bfe6661db3:5:AP-1:activator protein 1:961:940	Moreover, we found that epimagnolin suppressed c-Jun phosphorylation at Ser63/73, resulting in the inhibition of [TG] ([TF]) transactivation activity.	AP-1	activator protein 1	Complex:AP1	3725	961	940	0.0011685219829547	Non valid	0.0019020452692450986;0.995044459700514;0.00305349503024076	ACTIVATION	30887599	AP1	9606	JUN	9606	dbTF	AP1	AP1
39684	PMID:8799128:pubtator_title_and_abstract:6ea97297604ae8268f4b8132b7755453:3:Fos:AP-1:339:476	This mode of regulation has been proposed to control both the transcriptional activity and the oncogenic potential of [TF] and Jun. Previous studies revealed that reduction of oxidized Fos and Jun by a cellular protein, Ref-1, stimulates sequence-specific [TG] DNA-binding activity.	Fos	AP-1	14281	16476	339	476	0.0011330478367675	Non valid	0.9660746255658897;0.029580137248604994;0.004345237185505311	UNDEFINED	8799128	Fos	10090	Jun	10090	dbTF		AP1
40061	PMID:12748173:pubtator_title_and_abstract:93353d09f7bf9c60e73cc54a43811994:7:NF-kappaB:AP-1:1424:1435	The anti-inflammatory glucocorticoid dexamethasone inhibited NF-kappaB translocation and the promoter binding of [TF], [TG], and NF-IL-6.	NF-kappaB	AP-1	Complex:NFKB	2354	1424	1435	0.0011195712836417	Non valid	0.9974838042991175;0.0018162756794294986;0.0006999200214529538	UNDEFINED	12748173	NFKB	9606	FOSB	9606	dbTF	NFKB	AP1
40332	PMID:16506021:pubtator_title_and_abstract:4471363ee1db2ce3d76fd68d2a809f2c:10:NF-kappaB:AP-1:2047:2061	Down-regulation of PPAR gamma and induction of the CBP transcriptional coactivator can augment [TF] and [TG] transcriptional activities leading to up-regulation of COX-2 expression in colon adenocarcinoma cells.	NF-kappaB	AP-1	Complex:NFKB	3725	2047	2061	0.0012274170633279	Non valid	0.007179288397016011;0.9808296624848467;0.01199104911813719	ACTIVATION	16506021	NFKB	9606	JUN	9606	dbTF	NFKB	AP1
41139	PMID:21718029:pubtator_title_and_abstract:9a03935bcecb910dddde7ec9c96911e3:5:ERK:AP1:849:811	Compounds 1 and 4 displayed strong cytotoxicity against three human tumor cell lines with GI50 values in the submicromolar range, whereas 2 showed subnanomolar activity as an inhibitor of EGFR-MAPK-AP1-mediated mitogenic signaling, causing inhibition of EGF-mediated [TG] trans-activation and EGF-mediated [TF] activation and slight inhibition of EGF-mediated JNK activation.	ERK	AP1	5594	3726	849	811	0.0011780633851818	Non valid	0.002434993645491687;0.9930149314141871;0.004550074940321339	ACTIVATION	21718029	MAPK1	9606	JUNB	9606	ll_coTF		AP1
41653	PMID:26217035:pubtator_title_and_abstract:96703b1b0077cf86c3cb6c9386ad17bf:4:c-Abl:AP-1:423:466	In the present study, we found that [TF] phosphorylates JunB, a member of the [TG] (activator protein 1) transcription factor family.	c-Abl	AP-1	25	2353	423	466	0.1604708785576212	Non valid	0.9869452298163524;0.010704631374011002;0.0023501388096366536	UNDEFINED	26217035	ABL1	9606	FOS	9606	ll_coTF		AP1
41698	PMID:12210556:pubtator_title_and_abstract:98fa381bc840427d45b722475044dc21:5:PPARgamma and delta:AP-1:879:632	Several modes of action might be relevant for the biological activity of VPA: (1) VPA increases the DNA binding of activating protein-1 (AP-1) transcription factor, and the expression of genes regulated by the extracellular-regulated kinase (ERK)-[TG] pathway; (2) VPA downregulates protein kinase C (PKC) activity; (3) VPA inhibits glycogen synthase kinase-3beta (GSK-3beta), a negative regulator of the Wnt signaling pathway; (4) VPA activates the peroxisome proliferator-activated receptors [TF]; (5) VPA blocks HDAC (histone deacetylase), causing hyperacetylation.	PPARgamma and delta	AP-1	5468;5467	3726	879	632	0.0010726247865758	Non valid	0.880650413827808;0.1090279581464301;0.010321628025761864	UNDEFINED	12210556	PPARG;PPARD	9606;9606	JUNB	9606	dbTF;dbTF		AP1
42433	PMID:15459768:pubtator_title_and_abstract:4ee1fb9e6157d93154941bd44ae49eeb:5:PARP:AP-1:1200:1215	In 11 human arteriosclerotic carotid arteries, immunohistochemical analyses supported by computer-assisted morphometry and regression analyses demonstrated a significant colocalization of GDF-15/MIC-1 immunoreactivity (IR) with oxLDL IR and manganese superoxide dismutase (MnSOD) IR in CD68 immunoreactive (ir) MPhi, which were also expressing AIF-IR (apoptosis-inducing factor), caspase-3-IR (CPP32), [TF]-IR, c-Jun/[TG]-IR and p53-IR.	PARP	AP-1	142	3725	1200	1215	0.0011690819998187	Non valid	0.9352012587896845;0.06077006740279917;0.004028673807516362	UNDEFINED	15459768	PARP1	9606	JUN	9606	coTF		AP1
42501	PMID:29154967:pubtator_title_and_abstract:ceeaf153b00adab7c8150fbafb00721a:8:activator protein 1:AP-1:1336:1357	The [TF] ([TG]) transcription factor is a heterodimer of c-Fos and c-Jun, which led us to investigate the expression of the downstream target gene cyclin-D1, a gene associated with cell cycle progression and osteogenesis.	activator protein 1	AP-1	Complex:AP1	3725	1336	1357	0.0011805667834272	Non valid	0.983363779749864;0.015020753209641588;0.0016154670404945315	UNDEFINED	29154967	AP1	9606	JUN	9606	dbTF	AP1	AP1
42509	PMID:10348347:pubtator_title_and_abstract:6a28a5c58dabe65c319c5f1041c4c860:0:p53:AP-1:20:98	Expression of human [TF] requires synergistic activation of transcription from the p53 promoter by [TG], NF-kappaB and Myc/Max.	p53	AP-1	7157	3725	20	98	0.001237218675343	Non valid	0.0021463228370177676;0.9970530957774935;0.0008005813854887742	ACTIVATION	10348347	TP53	9606	JUN	9606	dbTF		AP1
42576	PMID:27632998:pubtator_title_and_abstract:a89d5e8867679111b9b6ab80dc619c6a:3:Fra-1:AP-1:306:383	Using MEF2A, c-Jun and [TF] chromatin immunoprecipitation sequencing (ChIP-seq) data and predicted [TG] consensus motifs, we identified putative common MEF2 and AP-1 target genes, several of which are implicated in regulating the actin cytoskeleton.	Fra-1	AP-1	14283	16476	306	383	0.0011277415969527	Non valid	0.997392357800026;0.00175129027910565;0.000856351920868438	UNDEFINED	27632998	Fosl1	10090	Jun	10090	dbTF		AP1
43342	PMID:20626554:pubtator_title_and_abstract:c6e1ee9e2c148bb5d42b04c753a17134:7:NF-kappaB:AP-1:975:1019	ABCG2 inhibits [TF] activation but has less effect on [TG] activation induced by ROS.	NF-kappaB	AP-1	Complex:NFKB	16476	975	1019	0.0013345813713556	Non valid	0.02426078426415496;0.9716327792614619;0.004106436474383124	ACTIVATION	20626554	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
43647	PMID:12424250:pubtator_title_and_abstract:dbd1620fd31a41697b7f16a54a7ded94:9:ERK:AP-1:1428:1478	ATP failed to stimulate the phosphorylation of [TF] and c-Jun N-terminal kinase and activation of [TG] in the p56(lck)-deficient isogenic T cell line JCaM1, suggesting a critical role for p56(lck) kinase in downstream signaling.	ERK	AP-1	5594	3725	1428	1478	0.0023069359090502	Non valid	0.004496965536133078;0.9939766781419241;0.0015263563219427474	ACTIVATION	12424250	MAPK1	9606	JUN	9606	ll_coTF		AP1
43655	PMID:15226417:pubtator_title_and_abstract:2ec40229082d59face9a11204f6d95a5:8:Pitx-1:AP-1:985:953	Further characterization indicated that an intact [TG] site was required for full [TF] responsiveness.	Pitx-1	AP-1	18740	16476	985	953	0.0014684804900749	Non valid	0.27428316101250866;0.723901804668585;0.0018150343189062951	ACTIVATION	15226417	Pitx1	10090	Jun	10090	dbTF		AP1
44021	PMID:23213242:pubtator_title_and_abstract:88ffa832ac91ca1236add7125b840f61:5:NF-kappaB:AP-1:770:805	2ME2 treatment of lymphocytes specifically reduced the nuclear translocation and transcriptional activity of nuclear factor of activated T-cells (NFAT) c1, whereas [TF] and activator protein 1 ([TG]) activation were not adversely affected.	NF-kappaB	AP-1	Complex:NFKB	3726	770	805	0.0011563969494316	Non valid	0.011854489777956568;0.980336915463371;0.007808594758672443	ACTIVATION	23213242	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
44122	PMID:12386300:pubtator_title_and_abstract:95e7f79275ca58cf76d39336b7dc6fce:4:c-Fos:AP-1:600:435	Our data showed that: (i) H(2)O(2) induces apoptosis of mesangial cells via the [TG] pathway; (iii) activation of AP-1 by H(2)O(2) is mediated by the c-Jun N-terminal kinase (JNK)-c-Jun/AP-1 pathway and the extracellular signal-regulated kinase-[TF]/AP-1 pathway; (iii) RA inhibits H(2)O(2)-induced apoptosis via suppression of c-fos/c-jun expression and JNK activation; and (iv) the anti-apoptotic effect of RA is, at least in part, mediated by induction of mitogen-activated protein kinase phosphatase 1.	c-Fos	AP-1	2353	3725	600	435	0.0015583034146706	Non valid	0.005254169756261678;0.9934825860911397;0.0012632441525985546	ACTIVATION	12386300	FOS	9606	JUN	9606	dbTF		AP1
44212	PMID:9207200:pubtator_title_and_abstract:5ca7ee796534acde20eda66f740e686e:5:NF-IL6:AP1:614:604	The nucleotide sequence of the 1.6 kb promoter region contains two TATA boxes and a number of potential regulatory elements including Sp1, CRE, GRE, [TG], AP2, [TF] and estrogen receptor binding site.	NF-IL6	AP1	12608	16476	614	604	0.0011159300102567	Non valid	0.9980099271513262;0.0012568333344128272;0.0007332395142609039	UNDEFINED	9207200	Cebpb	10090	Jun	10090	dbTF		AP1
44270	PMID:24720751:pubtator_title_and_abstract:0a53702f4f14fb25841b325b611250a9:7:NF-kappaB:AP-1:1131:1141	Expression of extracellular matrix (ECM) proteins, TGF-beta signaling molecules and [TF]/[TG] was determined in the BMMCs, bronchoalveolar lavage (BAL) cells or lung tissues using Western blot, polymerase chain reaction (PCR) and electrophoretic mobility shift assay (EMSA), respectively.	NF-kappaB	AP-1	Complex:NFKB	16476	1131	1141	0.0015215262950806	Non valid	0.9949413875684707;0.0042935563954159366;0.0007650560361133615	UNDEFINED	24720751	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
44812	PMID:15949472:pubtator_title_and_abstract:bc13b55c2c86842cdc6ba240bf6b993c:5:JunB:AP-1:729:789	METHODS AND RESULTS: The NO donor SNAP (100 microM), which is a pro-apoptotic stimulus in cardiomyocytes, activated AP-1 within 2 h. c-Jun, [TF] and FosB are identified as the main components of this [TG] complex.	JunB	AP-1	24517	24516	729	789	0.0031076520400696	Non valid	0.2131429518635085;0.7845943072028596;0.0022627409336318928	ACTIVATION	15949472	Junb	10116	Jun	10116	dbTF		AP1
44890	PMID:19223006:pubtator_title_and_abstract:4ef1dddceb81be26cb0383d2f8c7742d:8:AP-1:AP-1:1685:1795	CONCLUSION: The endogenous natriuretic peptide/NPR-A system may inhibit renal fibrosis partly via inhibition of the angiotensin/[TF]/TGF-beta/collagen pathway and exogenous ANP pre-treatment may inhibit it partly via both the angiotensin/[TG]/TGF-beta/collagen and NF-kappaB/inflammatory pathways.	AP-1	AP-1	Complex:AP1	16476	1685	1795	0.0012577606619238	Non valid	0.2898456469658061;0.6372771114043728;0.07287724162982102	ACTIVATION	19223006	AP1	10090	Jun	10090	dbTF	AP1	AP1
44920	PMID:17187171:pubtator_title_and_abstract:824eb5c7c745464f9adf60e694208e42:4:activator protein-1:AP-1:709:730	RESULTS: The region between nucleotides -2038 and -1605 relative to the transcriptional initiation site includes two [TF] ([TG]) sites, which both provided maximal response to E + P or cAMP in decidualized cells.	activator protein-1	AP-1	Complex:AP1	3725	709	730	0.0011701055855434	Non valid	0.6864358253801673;0.3109481480946874;0.0026160265251452433	UNDEFINED	17187171	AP1	9606	JUN	9606	dbTF	AP1	AP1
44990	PMID:24139673:pubtator_title_and_abstract:4ce07fd03df7d99ebc2a050128f4fc9d:9:JNK:AP-1:1427:1497	In parallel with these immunosuppressive phenomena, DHA attenuated post-stroke oxidative stress, c-Jun N-terminal kinase ([TF]) phosphorylation, c-Jun phosphorylation and activating protein-1 ([TG]) activation but further elevated ischemia-induced NF-E2-related factor-2 (Nrf2) and heme oxygenase-1 (HO-1) expression.	JNK	AP-1	116554	24516	1427	1497	0.0015008360027087	Non valid	0.009586129845270852;0.9751600957936308;0.015253774361098421	ACTIVATION	24139673	Mapk8	10116	Jun	10116	ll_coTF		AP1
45302	PMID:19383537:pubtator_title_and_abstract:31852de8bc3af72a086afe099161abad:9:c-fos:AP-1:1146:1214	Differences between HPT and RPT responses to cisplatin reveal inter-species differences associated with induction of [TF] and c-jun mRNA and protein, which in turn form the functional [TG] complex prior to the onset of cellular toxicity.	c-fos	AP-1	314322	2353	1146	1214	0.0011711395487862	Non valid	0.38521105525365873;0.6103252714462635;0.004463673300077758	ACTIVATION	19383537	Fos	10116	FOS	9606	dbTF		AP1
46421	PMID:9731508:pubtator_title_and_abstract:144cf2443d9f338f4af169d9f208106f:9:c-jun:AP-1:1265:1131	This hypothesis was supported by showing [TG] binding to two target sequences of the MGMT promoter and transactivation of the MGMT promoter upon cotransfection with c-fos and [TF] in F9 cells.	c-jun	AP-1	3725	2353	1265	1131	0.0011592002044068	Non valid	0.0031868363491740406;0.9958807785165761;0.0009323851342499939	ACTIVATION	9731508	JUN	9606	FOS	9606	dbTF		AP1
46654	PMID:16962071:pubtator_title_and_abstract:f19fe916b215a8c42222fc9650932a99:5:c-Jun:AP-1:837:825	Our results show: (i) no difference in body weights between WT and fat-1 mice on AL or CR diets, (ii) lower n-6/n-3 FA ratio in splenocytes from fat-1 mice on both AL and CR diets, (iii) significant reduction in NF-kappaB (p65/p50) and [TG] (c-Fos/[TF]) DNA-binding activities in splenocytes from fat-1/CR mice following LPS treatment, and (iv) significant reduction in kappaB- and AP-1-responsive IL-6 and TNF-alpha secretion following LPS treatment in splenocytes from fat-1/CR mice.	c-Jun	AP-1	16476	16476	837	825	0.0011260503284724	Non valid	0.21019002345135124;0.7836974704480355;0.006112506100613247	ACTIVATION	16962071	Jun	10090	Jun	10090	dbTF		AP1
46930	PMID:30395942:pubtator_title_and_abstract:3ad6231552f346876153be578e38d092:5:WT1:AP-1:489:497	The non-cytotoxic dose (IC20 values) of curcumin ([TF] and [TG] inhibitors) was employed to examine its effect on WT1 gene-mediated WT1 and AP-1 protein expression.	WT1	AP-1	7490	3725	489	497	0.00268119921961	Non valid	0.6118529677741654;0.34480440180954736;0.04334263041628721	UNDEFINED	30395942	WT1	9606	JUN	9606	dbTF		AP1
47039	PMID:19939924:pubtator_title_and_abstract:c8665683f4b4556bec897dac1342607d:11:RTA:AP-1:1707:1676	Moreover, Tpl2 knockdown inhibited the lytic replication of wild-type MHV-68 (MHV-68-WT) but not that of the MHV-68 mutant virus, indicating that endogenous Tpl2 promotes efficient virus lytic replication through [TG]-dependent upregulation of [TF] expression.	RTA	AP-1	23543	2353	1707	1676	0.0014788158212178	Non valid	0.005639129635657914;0.9929375269944983;0.0014233433698438167	ACTIVATION	19939924	RBFOX2	9606	FOS	9606	coTF		AP1
47067	PMID:10092086:pubtator_title_and_abstract:6dc164dcb869d96ae6074b96348d16c7:3:AP-1:AP-1:487:388	We sought to identify how CTLA4 ligation exerts these anti-proliferative effects by studying its influence on the activities of the relevant nuclear transcription factors [TG], NFAT and NF-kappaB. We found that cross-linking CTLA4 on activated T cells completely blocks [TF] and NFAT transcription factor activity before any effects on T cell proliferation can be observed, with NF-kappaB activity affected to a lesser degree.	AP-1	AP-1	Complex:AP1	3726	487	388	0.0011286491955056	Non valid	0.33794505408937303;0.6478874845562387;0.01416746135438833	ACTIVATION	10092086	AP1	9606	JUNB	9606	dbTF	AP1	AP1
47069	PMID:22128168:pubtator_title_and_abstract:03eda45bb8b9bef2baf1fd312b845d49:3:activator protein 1:AP1:453:474	Here we show by reporter assay that the [TF] ([TG]) (binding site in the promoter region of MMP-13 gene is primarily responsible for its transcriptional activation by Wnt5a-Ror2 signaling in osteosarcoma cell lines SaOS-2 and U2OS.	activator protein 1	AP1	Complex:AP1	3725	453	474	0.0011977669783908	Non valid	0.004193627730596708;0.9950466947581366;0.0007596775112667035	ACTIVATION	22128168	AP1	9606	JUN	9606	dbTF	AP1	AP1
47270	PMID:8663179:pubtator_title_and_abstract:e0b73356d5b4da1739c33cf9a4c61cc4:10:c-jun:AP-1:2002:2008	Because curcumin (20 microM), an inhibitor of [TF]/[TG] and protein kinases, also blocked IL-1beta-stimulated IL-8 gene expression implicating c-JUN/AP-1 and protein phosphorylation in the induction of IL-8 gene expression by IL-1beta, we conclude that the regulation of IL-8 mRNA by IL-1beta is mediated via protein kinase-dependent signal transduction pathways.	c-jun	AP-1	3725	3725	2002	2008	0.0011218698355077	Non valid	0.008735777466398377;0.9897220668564601;0.0015421556771414884	ACTIVATION	8663179	JUN	9606	JUN	9606	dbTF		AP1
47806	PMID:22842120:pubtator_title_and_abstract:638b0c9f2f4798902f8914c921557b5e:7:AP-1:activator protein-1:918:897	The enhanced VEGF gene transcription in TAMR-MCF-7 cells was suppressed by amurensin G. Molecular analyses using reporter genes with hypoxia response elements and [TG] ([TF]) elements, and western blots revealed that the activities and the nuclear levels of hypoxia inducible factor-1 (HIF-1)alpha and AP-1 in TAMR-MCF-7 cells were decreased by amurensin G. Moreover, amurensin G concentration-dependently inhibited protein expression and gene transcription of Pin1 in TAMR-MCF-7 cells, which was dependent on E2F1 inhibition.	AP-1	activator protein-1	Complex:AP1	3726	918	897	0.0010834393423181	Non valid	0.5434503455443291;0.4318852521075438;0.024664402348127064	UNDEFINED	22842120	AP1	9606	JUNB	9606	dbTF	AP1	AP1
48039	PMID:11795593:pubtator_title_and_abstract:5f6472f66924f9dfb7e63f2ac51f57ea:5:HIF-1:AP-1:656:666	Here, we summarize the data indicating that ERK and JNK are needed for activation of [TF] and [TG], respectively.	HIF-1	AP-1	3091	3726	656	666	0.0012818245946838	Non valid	0.0037752979375095296;0.9952914950846117;0.0009332069778788092	ACTIVATION	11795593	HIF1A	9606	JUNB	9606	dbTF		AP1
48187	PMID:29580411:pubtator_title_and_abstract:9a84ba4f6cb1fda41f32972041d010b9:7:p65:AP-1:954:1042	Further, the phosphorylation analysis of [TF], IkappaB, p38 and JNK as well as the DNA binding activity analysis of NF-kappaB and [TG] implied that the anti-inflammation function of cDHP is mediated via regulating NF-kappaB and MAPK signaling.	p65	AP-1	19697	16476	954	1042	0.0011343367539785	Non valid	0.9968635241931121;0.00229758683928731;0.0008388889676005549	UNDEFINED	29580411	Rela	10090	Jun	10090	dbTF		AP1
48256	PMID:7889400:pubtator_title_and_abstract:6289d28191984101b8939b37f73277d4:6:activator protein-1:AP-1:894:967	We further showed that the relatively normal activation responses of the c-jun-/- T cells probably results from the fact that other members of the Jun family contribute to the bulk of the [TF] (AP-1) complexes in normal T cells and, as a result, [TG] complexes are found at relatively normal levels in c-jun-/- T cells.	activator protein-1	AP-1	Complex:AP1	16476	894	967	0.0011627892058456	Non valid	0.2674244759277351;0.7151507086929954;0.017424815379269595	ACTIVATION	7889400	AP1	10090	Jun	10090	dbTF	AP1	AP1
48513	PMID:12809553:pubtator_title_and_abstract:4c03c1da0b5b08ee5ba5e712d6458e77:0:BATF:AP-1:19:69	Phosphorylation of [TF] regulates DNA binding: a novel mechanism for [TG] (activator protein-1) regulation.	BATF	AP-1	10538	3725	19	69	0.067548605779785	Non valid	0.9978775722019645;0.0012016404849929468;0.0009207873130425094	UNDEFINED	12809553	BATF	9606	JUN	9606	dbTF		AP1
48697	PMID:27117051:pubtator_title_and_abstract:421eb74b0b95af706b4801d989946401:7:NF-kappaB:activator protein 1:1182:1196	Finally, co-stimulation with TNF-alpha induces DNA binding of [TF] and [TG] (AP-1) to two specific sites in the DEFB4 promoter region.	NF-kappaB	activator protein 1	Complex:NFKB	3726	1182	1196	0.0012046584136449	Non valid	0.9970919360269646;0.0022284592461259676;0.0006796047269094594	UNDEFINED	27117051	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
48743	PMID:10547001:pubtator_title_and_abstract:5b2c87bb7f77a50c7889d1ca7869720b:4:CREB:AP-1:714:697	This suggests that glucocorticoid stimulation of TRH gene expression may be regulated by the [TG] complex and [TF] pathway.	CREB	AP-1	81646	24516	714	697	0.0011599228639144	Non valid	0.247935952967732;0.7487208516898421;0.003343195342425759	ACTIVATION	10547001	Creb1	10116	Jun	10116	dbTF		AP1
48764	PMID:11401521:pubtator_title_and_abstract:596e450d45ef5f29876ebcf790d4d46f:6:c-Jun:AP-1:1244:1281	In contrast, both troglitazone (at 10 microM) and 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2), at 15 microM), a natural ligand for PPARgamma, induce c-Jun phosphorylation by activation of c-Jun N-terminal kinase (JNK) through a posttranslational regulation of [TF] activity, therefore increasing [TG]/DNA binding activity and transcriptional responses as results of increasing basal ICAM-1 gene expression.	c-Jun	AP-1	3725	3725	1244	1281	0.0010956560457786	Non valid	0.18857093329527705;0.805729602087447;0.005699464617275872	ACTIVATION	11401521	JUN	9606	JUN	9606	dbTF		AP1
48926	PMID:10506755:pubtator_title_and_abstract:9e845b499c24260004eee02f30782430:6:C/EBPbeta:AP-1:1331:1154	Supershift analysis with antibodies specific for NF-kappaB, [TG], and NF-IL6 binding proteins showed that the NF-kappaB-binding protein included p65/Rel A and p50; AP-1 activity included c-jun, junB, junD, and Fra-1; and NF-IL6 included [TF].	C/EBPbeta	AP-1	1051	3727	1331	1154	0.0011136844589453	Non valid	0.8920979492161915;0.10204841020355052;0.00585364058025806	UNDEFINED	10506755	CEBPB	9606	JUND	9606	dbTF		AP1
48955	PMID:23747343:pubtator_title_and_abstract:24c88d737858801435ca013d809ed1e1:12:ER-alpha:AP-1:1351:1458	Co-immunoprecipitation assay demonstrated that EE induces c-JUN/[TF] interaction, and chromatin immunoprecipitation assay showed that this complex is recruited to the [TG] binding consensus element present at the position (-1300/-1078 bp) of human mrp3 promoter.	ER-alpha	AP-1	2099	3725	1351	1458	0.0011700267306773	Non valid	0.9978478253403252;0.0013037080295505792;0.0008484666301241528	UNDEFINED	23747343	ESR1	9606	JUN	9606	dbTF		AP1
48986	PMID:12633740:pubtator_title_and_abstract:1be6c4e0ebd34fad8c2e676148ee9d9f:6:ERK:AP1:688:723	UVA by itself induced an activation of [TF] activity, and a stimulation of [TG], NFkappaB, and STAT1 binding activity.	ERK	AP1	5594	3726	688	723	0.0011822393237267	Non valid	0.2826959712174345;0.713672622605896;0.003631406176669453	ACTIVATION	12633740	MAPK1	9606	JUNB	9606	ll_coTF		AP1
49490	PMID:30415238:pubtator_title_and_abstract:56821a067e79ee3f22f19a32c2a7fbaa:9:NF-kappaB:AP-1:1335:1346	Pretreatment of thiol antioxidants GSH and NAC reduced ROS levels and attenuated the increase in ROS, the activation of [TF], [TG], and STAT-3, and the expression of COX-2 in LPS-treated A549 cells.	NF-kappaB	AP-1	Complex:NFKB	3726	1335	1346	0.0011716413872108	Non valid	0.006064627429114955;0.991974682020926;0.0019606905499590342	ACTIVATION	30415238	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
49746	PMID:18840457:pubtator_title_and_abstract:54ebed6c704f917058d95b55d880ab9a:8:NF-kappaB:activator protein 1:1174:1090	Transfection with human COX-2 promoter construct, electrophoretic mobility shift assays and DNA-affinity protein-binding assay experiments revealed that o,p'-DDT activated the [TG] (AP-1) and cyclic AMP response element (CRE) sites, but not the [TF] site.	NF-kappaB	activator protein 1	Complex:NFKB	16476	1174	1090	0.0011792852139434	Non valid	0.9554406363959782;0.04024096682448522;0.004318396779536578	UNDEFINED	18840457	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
49811	PMID:15541355:pubtator_title_and_abstract:26e3d527cbe59d8030c7337a1c146b8e:0:NF-kappaB:AP-1:66:57	Induction of mouse c-src in RAW264 cells is dependent on [TG] and [TF] and important for progression to multinucleated cell formation.	NF-kappaB	AP-1	Complex:NFKB	16476	66	57	0.0011450174943733	Non valid	0.0031567537717629287;0.9961159251835331;0.0007273210447040375	ACTIVATION	15541355	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
50258	PMID:16845475:pubtator_title_and_abstract:22eac316411aab000db60b5edd62953a:6:activator protein-1:AP-1:983:1004	First, the early induction of 15 genes involved in assembly and activation of the [TF] ([TG]) family of transcription factors implicates AP-1 as a dominant regulator of earliest post-ischemic molecular events.	activator protein-1	AP-1	Complex:AP1	16476	983	1004	0.0012084685618467	Non valid	0.019395248469682342;0.9793995932671149;0.0012051582632028853	ACTIVATION	16845475	AP1	10090	Jun	10090	dbTF	AP1	AP1
50819	PMID:24566933:pubtator_title_and_abstract:4d55eeab88da49bf090b7f27235681fa:11:AP-1:activator protein-1:1723:1702	Specific for the metabolic inducers was an activation of the proinflammatory transcription factor [TG] ([TF]), neutrophil infiltration, and induction of risk factors associated with human NASH, that is, dyslipidemia (by cholesterol) and insulin resistance (by carbohydrate).	AP-1	activator protein-1	Complex:AP1	16476	1723	1702	0.0019103327755178	Non valid	0.042934513654636346;0.9537877717736803;0.0032777145716832517	ACTIVATION	24566933	AP1	10090	Jun	10090	dbTF	AP1	AP1
50869	PMID:16972255:pubtator_title_and_abstract:8ce78539ffed9bd412c0c854741f851b:7:PTEN:AP-1:911:1236	Transfection of wild-type PTEN (Wt-[TF]) decreased basal and UVB-induced MMP-1 and -3 secretions, as well as activator protein-1 (AP-1) activity, while transfection of small interference RNA of PTEN (siRNA-PTEN), phosphatase-inactive PTEN (C124S-PTEN), or lipid phosphatase-inactive PTEN (G129E-PTEN) increased basal or UVB-induced MMP-1 and -3 secretions and [TG] activity.	PTEN	AP-1	5728	2354	911	1236	0.0171852378505412	Non valid	0.003903872972093896;0.005513626632649186;0.990582500395257	REPRESSION	16972255	PTEN	9606	FOSB	9606	ll_coTF		AP1
51197	PMID:9062890:pubtator_title_and_abstract:b3ee44ff8a8a57b9bd8ba247c2f3cecf:7:JunB:AP-1:1207:1159	These results therefore demonstrate that the induction of [TG] binding activity associated with c-Jun and [TF] is required for insulin- and vandate-induced mitogenesis in SV40-transformed murine 3T3T cells.	JunB	AP-1	16477	16476	1207	1159	0.0011922778196613	Non valid	0.432546484478041;0.5647195018697673;0.0027340136521917325	ACTIVATION	9062890	Junb	10090	Jun	10090	dbTF		AP1
51300	PMID:35970410:pubtator_title_and_abstract:f022d765b10cd091bdd8eb265f466187:11:activator protein 1:AP-1:1283:1304	Further, OSC suppressed the phosphorylation of c-Jun N-terminal kinase (JNK), and [TF] ([TG], Fos and Jun).	activator protein 1	AP-1	Complex:AP1	16476	1283	1304	0.0011679416519582	Non valid	0.12122948115748339;0.8702831291864374;0.008487389656079215	ACTIVATION	35970410	AP1	10090	Jun	10090	dbTF	AP1	AP1
51428	PMID:36103110:pubtator_title_and_abstract:369c1cc429d158b97ab88506f06af30c:6:activator protein 1:AP-1:820:846	The expression of aging-related markers including mitogen-activated protein kinases/[TF] (MAPK/[TG]), nuclear factor-kappaB (NF-kappaB), and nuclear factor E2-related factor 2/heme oxygenase-1 (Nrf2/HO-1) was evaluated using Western blot analysis.	activator protein 1	AP-1	Complex:AP1	3726	820	846	0.0011559910991275	Non valid	0.9326644450106598;0.05797204826876861;0.009363506720571579	UNDEFINED	36103110	AP1	9606	JUNB	9606	dbTF	AP1	AP1
51753	PMID:16481330:pubtator_title_and_abstract:ea59d81c5c334337f00462a0c6dde93d:6:NF-kappaB:AP-1:1236:1164	This region lacks apparent TATA and CAAT boxes but contains putative binding sites for transcription factors c-Ets-1, cAMP-responsive element-binding (CREB) protein, activating protein 1 ([TG]), and NF-kappaB. Base-substitution experiment showed that only the [TF]-binding site of putative binding sites is required for the maximal expression induced by Fas.	NF-kappaB	AP-1	Complex:NFKB	3725	1236	1164	0.0011315407389892	Non valid	0.004644362910765965;0.9946018023728705;0.0007538347163634655	ACTIVATION	16481330	NFKB	9606	JUN	9606	dbTF	NFKB	AP1
51810	PMID:21314641:pubtator_title_and_abstract:27d83af6cf518658f764695680dc7fb5:0:cyclin D1:AP-1:27:22	Roles of the ERK, JNK/[TG]/[TF]-CDK4 pathway in silica-induced cell cycle changes in human embryo lung fibroblast cells.	cyclin D1	AP-1	595	3727	27	22	0.001109049458639	Non valid	0.9904044746297744;0.00830433830892719;0.0012911870612982996	UNDEFINED	21314641	CCND1	9606	JUND	9606	coTF		AP1
51882	PMID:17278098:pubtator_title_and_abstract:cef05c4ede3d54945683a36aece6652a:5:c-Jun:AP1:521:527	BRCA1-IRIS alone or in complex with steroid receptor co-activators was targeted to the cyclin D1 promoter pre-bound by the [TF]/[TG] and activated its transcription, which could explain the co-overexpression of BRCA1-IRIS and Cyclin D1 in breast cancer cells coupled with their increased proliferation.	c-Jun	AP1	3725	3725	521	527	0.0011535839824122	Non valid	0.35024952440450186;0.6441091758484889;0.0056412997470092485	ACTIVATION	17278098	JUN	9606	JUN	9606	dbTF		AP1
51927	PMID:15546613:pubtator_title_and_abstract:25e3d5f6fcf3e0cf700b2678d679c295:2:c-Jun.:AP-1:256:221	The NH2-terminal Jun kinases (JNKs) function in diverse roles through phosphorylation and activation of [TG] components including ATF2 and [TF]	c-Jun.	AP-1	3725	3725	256	221	0.0015880421425777	Non valid	0.057815444379512075;0.9397418964422776;0.0024426591782103738	ACTIVATION	15546613	JUN	9606	JUN	9606	dbTF		AP1
52329	PMID:17218407:pubtator_title_and_abstract:a7aba01867d998cd7ff102b3c1ca585b:8:NF-kappaB:AP-1:901:785	EMSA studies showed that stretch increased both activator protein-1 ([TG]) and nuclear factor-kappaB (NF-kappaB) DNA binding at 1 and 6 h. In contrast, IL-1beta increased both AP-1 and [TF] DNA binding at 1 h only.	NF-kappaB	AP-1	Complex:NFKB	3726	901	785	0.0012440986103548	Non valid	0.9950393597838638;0.003182474461573465;0.0017781657545626747	UNDEFINED	17218407	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
52332	PMID:23609053:pubtator_title_and_abstract:bfd3260204882cb207176e02ef51367c:8:NF-kappaB:AP-1:1162:1176	The activation of [TF] and [TG] was determined by the electrophoretic mobility shift assay.	NF-kappaB	AP-1	Complex:NFKB	3726	1162	1176	0.0012018669910076	Non valid	0.10827239724536945;0.8889573251927524;0.002770277561878262	ACTIVATION	23609053	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
52722	PMID:16317160:pubtator_title_and_abstract:fb326a983713a385e6d287b675ecabcf:8:NF-kappaB:AP-1:1198:1234	Components of the cell signaling pathways, especially those that converge on redox-sensitive transcription factors, including nuclear factor-kappaB ([TF]) and activator protein 1 ([TG]) involved in mediating inflammatory response, have been implicated in carcinogenesis.	NF-kappaB	AP-1	Complex:NFKB	3727	1198	1234	0.0011249880754825	Non valid	0.8846388040493823;0.11372055856408933;0.0016406373865282225	UNDEFINED	16317160	NFKB	9606	JUND	9606	dbTF	NFKB	AP1
52968	PMID:14717848:pubtator_title_and_abstract:f1af45a19bac5a711a7257c49aa2026c:6:AP-1:AP-1:938:976	In w3211, c-Jun, JunD and Fra-1 were involved in [TF] binding, while in w1205, overall [TG] binding activity was decreased significantly and supershift binding was detected only with JunD antibodies.	AP-1	AP-1	Complex:AP1	3725	938	976	0.0011394465711327	Non valid	0.9150040332890262;0.07985672437448402;0.005139242336489786	UNDEFINED	14717848	AP1	9606	JUN	9606	dbTF	AP1	AP1
53143	PMID:18265671:pubtator_title_and_abstract:60819db53dc3adf653158d791b10e931:6:nuclear factor-kappaB:AP-1:765:821	We then examined whether activities of proliferation factors [TF] (NF-kappaB), activator protein-1 ([TG]), and serum response element (SRE) of human pancreatic cancer cells were increased by H. pylori infection.	nuclear factor-kappaB	AP-1	Complex:NFKB	3727	765	821	0.0011830552104853	Non valid	0.8028263036618112;0.18172221483956746;0.01545148149862132	UNDEFINED	18265671	NFKB	9606	JUND	9606	dbTF	NFKB	AP1
53184	PMID:7566966:pubtator_title_and_abstract:417fc30d948acce920a36895ed5265a3:5:Fra-2:AP-1:611:575	Treatment of cells with 8Br-cAMP results in increased DNA-binding activity of two distinct [TG] complexes; JunD/Fra-2 and JunB/[TF], and also in elevated AP-1 transactivation.	Fra-2	AP-1	2355	3726	611	575	0.0011053441742716	Non valid	0.22578097468551106;0.7709863718135989;0.0032326535008900545	ACTIVATION	7566966	FOSL2	9606	JUNB	9606	dbTF		AP1
53277	PMID:22095787:pubtator_title_and_abstract:14deb62d443574c43a799d32ae010f0f:10:c-jun:AP-1:1335:1369	The c-fos/[TF] dimer was identified as the [TG] complex regulating CXCL8 in response to UDP stimulation.	c-jun	AP-1	16476	16476	1335	1369	0.0011350331186378	Non valid	0.9975012129922679;0.001846298780670875;0.0006524882270612842	UNDEFINED	22095787	Jun	10090	Jun	10090	dbTF		AP1
54651	PMID:11200181:pubtator_title_and_abstract:ad511bbe42050be8640f23bc2e1f2b27:5:NF-kappa B p65:AP-1:651:614	Our laboratory has discovered that Fos-related antigen-2 from [TG] transcription factor family and [TF] and p50 subunits are induced long-term (days to months) in the brain after neurotoxic, excitotoxic or ischemic insult.	NF-kappa B p65	AP-1	5970	2353	651	614	0.0011554813721957	Non valid	0.03127828416406011;0.965986807662255;0.002734908173684998	ACTIVATION	11200181	RELA	9606	FOS	9606	dbTF		AP1
54724	PMID:7675040:pubtator_title_and_abstract:a773e52bd0639185c511038c7c45ff80:10:Fra-1:AP-1:1679:1720	Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced [TF] protein, thereby forming an active [TG] complex.	Fra-1	AP-1	14283	16476	1679	1720	0.0011863927537863	Non valid	0.06505864428856993;0.9330875447728281;0.0018538109386020045	ACTIVATION	7675040	Fosl1	10090	Jun	10090	dbTF		AP1
54975	PMID:11306697:pubtator_title_and_abstract:078a1a410b5346b225f080104b55a4c7:8:JNK:activator protein-1:1371:1434	Wortmannin-mediated activation of the SAPK/[TF] and p38 MAPK pathways also resulted in the mobilization of [TG] complex to the nuclear compartment.	JNK	activator protein-1	116554	24516	1371	1434	0.0011676685564967	Non valid	0.3434882063802711;0.6532019532070241;0.003309840412704736	ACTIVATION	11306697	Mapk8	10116	Jun	10116	ll_coTF		AP1
55017	PMID:15860507:pubtator_title_and_abstract:acad7773f8ce947d6098930d1aa91802:6:activator protein-1:AP-1:1226:1247	In addition, the polyphenol triggered the phosphorylation of c-JUN (Ser63 and Ser73) and induced c-JUN/c-FOS, thereby increasing the DNA binding activity of [TF] ([TG]), as shown by an AP-1 luciferase reporter assay.	activator protein-1	AP-1	Complex:AP1	3725	1226	1247	0.0011368499434605	Non valid	0.8822080207953836;0.11506212101019239;0.002729858194424017	UNDEFINED	15860507	AP1	9606	JUN	9606	dbTF	AP1	AP1
55573	PMID:19802005:pubtator_title_and_abstract:216e5c08c3555377085808edbc67b5cb:4:JNK:AP-1:520:528	Here, we reveal a novel, Gsk3b-independent function of Frat converging on the activation of [TF] and [TG].	JNK	AP-1	5599	3726	520	528	0.0011967750811238	Non valid	0.006123682627142479;0.9922689559956025;0.0016073613772550498	ACTIVATION	19802005	MAPK8	9606	JUNB	9606	ll_coTF		AP1
55664	PMID:15130773:pubtator_title_and_abstract:8019f8decc98da58905156b9f37e8572:7:NF-kappaB:AP-1:780:793	Using stable transfectants of JB6 P(+) cells expressing [TF] or [TG] luciferase reporter constructs, we demonstrated that exposure to DEP at a non-cytotoxic concentration significantly enhanced the transactivation of NF-kappaB, but not AP-1.	NF-kappaB	AP-1	Complex:NFKB	16476	780	793	0.0015021825174558	Non valid	0.025208691540458083;0.9730843891058537;0.001706919353688242	ACTIVATION	15130773	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
55877	PMID:16197369:pubtator_title_and_abstract:d2105b8ae47ed411a6e2a2c0c4ef1f1b:9:NF-kappaB:activator protein-1:1511:1555	LPA enhanced the transcriptional activity of the IL-8 gene; that effect relied on activation of the transcriptional factors [TF] (nuclear factor kappaB) and AP-1 ([TG]).	NF-kappaB	activator protein-1	Complex:NFKB	3725	1511	1555	0.0012408036707784	Non valid	0.0069823601744186;0.9917375338861274;0.0012801059394539336	ACTIVATION	16197369	NFKB	9606	JUN	9606	dbTF	NFKB	AP1
56006	PMID:27106123:pubtator_title_and_abstract:2eeb12206c30599d85bab3c4a55f9c75:7:adaptor protein complex 1:AP-1:1201:1228	We found that constitutive secretion of low-molecular-weight (LMW) VWF is targeted basolaterally, toward the subendothelial matrix, using the [TF] ([TG]), where it may provide the bulk of collagen-bound subendothelial VWF.	adaptor protein complex 1	AP-1	3726	3726	1201	1228	0.0012906315521476	Non valid	0.12843409521610424;0.862546028939522;0.009019875844373797	ACTIVATION	27106123	JUNB	9606	JUNB	9606	dbTF		AP1
56396	PMID:25935309:pubtator_title_and_abstract:ba801d33e0d907ae498ef06b13422d8b:11:p38:AP-1:1909:1914	At the molecular level, CYLD interrupts the ERK- and [TF]-/[TG] and c-Myc pathways to suppress Nrf2-operated antioxidative capacity, thereby enhancing oxidative stress in the heart.	p38	AP-1	1432	3725	1909	1914	0.0011072625095546	Non valid	0.034265432852904856;0.9490608432919517;0.016673723855143482	ACTIVATION	25935309	MAPK14	9606	JUN	9606	ll_coTF		AP1
56490	PMID:8938978:pubtator_title_and_abstract:af3b2cfdedd3031fa0e5d128ddf6cd8a:7:Jun-B:AP-1:1140:1127	The proposed cell type specific--regulatory element that harbors binding sites for NF1 as well as TEF-1 and PEA3 motifs, but neither other AP-1 sites nor the proximal enhancer region, could augment the transcriptional response of the promoter-proximal [TG] site to [TF]:c-Fos.	Jun-B	AP-1	3726	2353	1140	1127	0.0219766843828293	Non valid	0.42710316315910113;0.5695558070785883;0.00334102976231063	ACTIVATION	8938978	JUNB	9606	FOS	9606	dbTF		AP1
56617	PMID:12914529:pubtator_title_and_abstract:0ea11475a96cb11a4c43104bfcec8af4:6:activating protein-1:AP-1:759:781	The distal promoter element PGDH-DE (positions-2152/-1944 relative to the start codon) contains binding sites for Ets and [TF] ([TG]) flanked by two cAMP-responsive element-binding protein binding sites (CREB1, CREB2), whereas the proximal element PGDH-PE (-235/-153) includes an Ets and an AP-1 binding sequence.	activating protein-1	AP-1	Complex:AP1	2353	759	781	0.0011614536136548	Non valid	0.994596627027994;0.0045517311828709986;0.0008516417891350055	UNDEFINED	12914529	AP1	9606	FOS	9606	dbTF	AP1	AP1
56831	PMID:23390317:pubtator_title_and_abstract:ecb7dc975791a854e21dce230e2a9bb9:8:vegf:AP-1:1104:1185	Furthermore, by identifying the adjacent NFAT- and AP-1-binding sites within the [TF] promoter, we also found an induced interaction between NFAT3 and one of the [TG] components, c-Fos, after UVB irradiation.	vegf	AP-1	22339	16476	1104	1185	0.0041807309636376	Non valid	0.9867767154264109;0.01234948466739764;0.0008737999061913964	UNDEFINED	23390317	Vegfa	10090	Jun	10090	ll_coTF		AP1
57024	PMID:15860756:pubtator_title_and_abstract:559edac65011ca6f05f9cf710d67eae9:5:p38:AP-1:670:733	We observed that IL-18 activated Src kinase, protein kinase C, [TF] and JNK MAPKs, Akt kinase, transcription factors NF-kB and [TG], and induced expression of pro-inflammatory cytokines in VSMC.	p38	AP-1	26416	16476	670	733	0.0011495707398115	Non valid	0.028208787959575918;0.9672630133746971;0.00452819866572696	ACTIVATION	15860756	Mapk14	10090	Jun	10090	ll_coTF		AP1
57216	PMID:16049073:pubtator_title_and_abstract:3abb69012b53daa33dcb1c2004a0ff06:8:AP-1:AP-1:1183:1283	The data indicate that various [TF] components are constitutively activated in polycystic kidney disease and suggest that aberrant [TG] activity is relevant for cyst formation.	AP-1	AP-1	Complex:AP1	3725	1183	1283	0.0015977405215933	Non valid	0.657036403078454;0.3204180084689916;0.022545588452554357	UNDEFINED	16049073	AP1	9606	JUN	9606	dbTF	AP1	AP1
57255	PMID:27911090:pubtator_title_and_abstract:ef2f18f2dba99acb83b853d88a31692a:9:P65:Activator Protein-1:1280:1207	In addition, POL-P3b inhibited the protein expression levels of TLR4, MyD88, TRAF6, [TG] (AP-1) and nuclear factor-kappaB (NF-kappaB) subunit [TF] in HeLa cells.	P65	Activator Protein-1	5970	3726	1280	1207	0.0012280538137283	Non valid	0.011501814036257307;0.9786524630809896;0.009845722882753045	ACTIVATION	27911090	RELA	9606	JUNB	9606	dbTF		AP1
57747	PMID:10101602:pubtator_title_and_abstract:810aaa2743c7d51189560d386b0a31ad:7:GR:AP-1:962:1019	"Depending on the type of lymphocytes, the mechanism of apoptosis induced by glucocorticoids fall roughly in two categories: induction of ""death genes"" by the activated [TF] (I kappa B, c-jun) or repression of survival factors ([TG], c-Myc)."	GR	AP-1	2908	3725	962	1019	0.0013378433839242	Non valid	0.025777969797260776;0.11433546995693922;0.8598865602458	REPRESSION	10101602	NR3C1	9606	JUN	9606	dbTF		AP1
57889	PMID:19507277:pubtator_title_and_abstract:0e65a4483361017b37e6399dcee80372:3:AP-1:activator-protein-1:456:435	We hypothesized that UR and its major component rhynchophylline (RH), reduce epileptic seizures in rats treated with kainic acid (KA) by inhibiting nuclear factor-kappaB (NF-kappaB) and [TG] ([TF]) activity, and by eliminating superoxide anions.	AP-1	activator-protein-1	Complex:AP1	24516	456	435	0.0011429878209303	Non valid	0.021870958388944824;0.9075342334126643;0.070594808198391	ACTIVATION	19507277	AP1	10116	Jun	10116	dbTF	AP1	AP1
57949	PMID:8036012:pubtator_title_and_abstract:cc541fd9315ae219777e6e6b11a5edac:6:AP-1:AP-1:771:975	This decrease in [TF] binding activity may be mediated by an increase in the activity of an AP-1 inhibitory factor, as the steady state levels of jun protein remained constant during the onset of apoptosis, and cytosolic [TG] inhibitory activity was found to increase, concomitant with the decrease in AP-1 DNA binding activity.	AP-1	AP-1	Complex:AP1	3725	771	975	0.0014116323539175	Non valid	0.06019700864245537;0.036647582861365165;0.9031554084961795	REPRESSION	8036012	AP1	9606	JUN	9606	dbTF	AP1	AP1
58166	PMID:9593012:pubtator_title_and_abstract:9adf4897d4bba186f1a30154cd9ffc9e:2:nuclear factor (NF)-kappaB:activator protein (AP)-1:284:258	"The role of ""oxidant-sensitive"" transcription factors [TG], [TF], and NF-IL6 in respiratory syncytial virus (RSV)-induced interleukin (IL)-8 gene expression in A549 epithelial cells was evaluated."	nuclear factor (NF)-kappaB	activator protein (AP)-1	Complex:NFKB	3726	284	258	0.0013034103328126	Non valid	0.133368949817011;0.8633856542917743;0.0032453958912147187	ACTIVATION	9593012	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
58189	PMID:1400499:pubtator_title_and_abstract:2c2923ea037e8e1949c0139b8b3bde25:0:heme oxygenase-1:AP-1:89:7	Distal [TG] binding sites mediate basal level enhancement and TPA induction of the mouse [TF] gene.	heme oxygenase-1	AP-1	15368	16476	89	7	0.0014808422310732	Non valid	0.017427472625217637;0.9802211089300995;0.0023514184446829568	ACTIVATION	1400499	Hmox1	10090	Jun	10090	ll_coTF		AP1
58776	PMID:19585511:pubtator_title_and_abstract:662d268620b6f2bcc831f0fff7bcae7f:6:CREB:AP-1:844:865	Moreover, the results from gel shift analysis and chromatin immunoprecipitation indicated that c-Jun and [TF] bind to the CRE/[TG] box.	CREB	AP-1	1385	3725	844	865	0.1154862985059129	Non valid	0.9980362784589192;0.0008611336138098618;0.001102587927270977	UNDEFINED	19585511	CREB1	9606	JUN	9606	dbTF		AP1
58950	PMID:8757326:pubtator_title_and_abstract:df4087ca68c7ae6afad682cfbcc4b44f:3:AP-1:Activator Protein-1:582:561	In this work, we report that these anergic T cells are defective in their ability to up-regulate protein binding and transactivation at two critical IL-2 DNA enhancer elements: NF-AT (nuclear factor of activated T cells; a sequence that binds a heterotrimeric NFATp, Fos, and Jun protein complex) and [TG] ([TF]) (that binds Fos and Jun heterodimers).	AP-1	Activator Protein-1	Complex:AP1	2353	582	561	0.0011585756611998	Non valid	0.025348443307909314;0.9725667170695363;0.0020848396225542905	ACTIVATION	8757326	AP1	9606	FOS	9606	dbTF	AP1	AP1
58987	PMID:33132060:pubtator_title_and_abstract:a00d8cd0bf73739df1d45cb16bd7ee72:12:cAMP response element-binding:activator protein-1:1414:1480	The effect of FSH on AQP7 in adipocytes was through activation of [TF] (CREB) protein, which could bind to [TG] (AP-1) sites in the AQP7 promoter, and therefore inhibited the transcriptional activation elicited by c-Jun.	cAMP response element-binding	activator protein-1	1385	3725	1414	1480	0.0011550150532189	Non valid	0.02242959621073882;0.025085426003245957;0.9524849777860153	REPRESSION	33132060	CREB1	9606	JUN	9606	dbTF		AP1
59084	PMID:22099628:pubtator_title_and_abstract:9e9dca5b03f5d05e368695178db32253:9:ERbeta:AP-1:1629:1609	These complexes could mediate crosstalk among STATs, estrogen receptor beta (ERbeta), and [TG] regulating the [TF]-mediated transcriptional repression of the hIR gene and insulin resistance in U-937 cells.	ERbeta	AP-1	2100	3726	1629	1609	0.0011655471502461	Non valid	0.3935552520023364;0.10835106631492848;0.49809368168273516	REPRESSION	22099628	ESR2	9606	JUNB	9606	dbTF		AP1
59143	PMID:9271387:pubtator_title_and_abstract:dcc379d26f74e6be181b7d06aedd4eb1:10:NF-kappaB:AP-1:1587:1601	The induction of [TF] and [TG] binding is reduced by the addition of protein kinase C inhibitors and cyclic AMP effector, respectively.	NF-kappaB	AP-1	Complex:NFKB	3727	1587	1601	0.0014325147674159	Non valid	0.2672702058476233;0.7291705098628287;0.003559284289547951	ACTIVATION	9271387	NFKB	9606	JUND	9606	dbTF	NFKB	AP1
59547	PMID:8794887:pubtator_title_and_abstract:ce46828df329cac00f9025a49d8264a3:4:AP-1:activator protein-1:480:459	Cysteine residues in the basic DNA binding domains of Jun and Fos, members of the [TG] ([TF]) transcription factor family, have been identified as likely targets for the therapeutic action of antirheumatic gold(I) thiolates.	AP-1	activator protein-1	Complex:AP1	2353	480	459	0.0011715688458693	Non valid	0.9964858304152424;0.002723792365983745;0.0007903772187738855	UNDEFINED	8794887	AP1	9606	FOS	9606	dbTF	AP1	AP1
59619	PMID:28012964:pubtator_title_and_abstract:87e20efb7e3af45bc6ebf2e84480b504:6:Egr-1:AP-1:875:869	Here, we review the effect of resveratrol on the activation of the stimulus-responsive transcription factors CREB, [TG], [TF], Elk-1, and Nrf2.	Egr-1	AP-1	1958	2354	875	869	0.0012682058473622	Non valid	0.1756951228965086;0.8187526148717059;0.005552262231785517	ACTIVATION	28012964	EGR1	9606	FOSB	9606	dbTF		AP1
60172	PMID:15767432:pubtator_title_and_abstract:b0ecf23ef273286e5718dadaf1e762ee:0:NF-kappaB:AP-1:162:183	Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through [TF], NFAT, and [TG] transduction pathways.	NF-kappaB	AP-1	Complex:NFKB	2354	162	183	0.0011056553715919	Non valid	0.005333177460035338;0.9935874877040666;0.001079334835898096	ACTIVATION	15767432	NFKB	9606	FOSB	9606	dbTF	NFKB	AP1
60230	PMID:27721381:pubtator_title_and_abstract:73cfbf59550589d73e740bb7cf92c062:9:NF-kappaB:AP-1:1030:1092	Importantly, OEA inhibited LPS-induced [TF] activation, IkappaBalpha degradation, expression of [TG], and the phosphorylation of ERK1/2 and STAT3.	NF-kappaB	AP-1	Complex:NFKB	2354	1030	1092	0.0155421029549651	Non valid	0.0033241735555751754;0.9917649802865328;0.004910846157891968	ACTIVATION	27721381	NFKB	9606	FOSB	9606	dbTF	NFKB	AP1
60360	PMID:16421317:pubtator_title_and_abstract:0726ef78779d129ee41640f112485a8e:7:c-Jun:activator protein-1:1111:1183	Furthermore, the mGluR5-dependent JNK activation specifically activated [TF], but not activating transcription factor-2 or JunD, and increased [TG] (AP-1)-mediated endogenous transcriptional activity.	c-Jun	activator protein-1	3725	3725	1111	1183	0.0023599435737331	Non valid	0.006530982513054616;0.992236883286898;0.0012321342000474146	ACTIVATION	16421317	JUN	9606	JUN	9606	dbTF		AP1
60539	PMID:34288018:pubtator_title_and_abstract:f4788058b1fd2690bbd71e5e615518cd:8:HIF-1alpha:AP1:1956:1822	In addition to the prominent role of NF-kappaB, other transcription factors are also inhibited by artemisinins (mammalian target of rapamycin [mTOR], activating protein 1 [[TG]]/FBJ murine osteosarcoma viral oncogene homologue [FOS]/JUN oncogenic transcription factor [JUN]), hypoxia-induced factor 1alpha ([TF]), nuclear factor of activated T cells c1 (NF-ATC1), Signal transducers and activators of transcription (STAT), NF E2-related factor-2 (NRF-2), retinoic-acid-receptor-related orphan nuclear receptor gamma (ROR-gammat), and forkhead box P-3 (FOXP-3).	HIF-1alpha	AP1	15251	16476	1956	1822	0.001170937925458	Non valid	0.00882087400764972;0.03885259287378371;0.9523265331185666	REPRESSION	34288018	Hif1a	10090	Jun	10090	dbTF		AP1
60765	PMID:20826812:pubtator_title_and_abstract:d54961edf97c6ed24d6752e497482a5e:7:c-Fos:AP-1:1044:898	Consistently, both transcription factors, [TG] and Nrf2, were required for LPS-mediated Srx induction, as revealed by chromatin immunoprecipitation using antibodies specific for c-Jun and [TF] and little Srx induction in Nrf2-null bone marrow-derived macrophages.	c-Fos	AP-1	14281	16476	1044	898	0.0010986599009655	Non valid	0.021640105370033445;0.976900612304767;0.0014592823251995638	ACTIVATION	20826812	Fos	10090	Jun	10090	dbTF		AP1
61027	PMID:15591535:pubtator_title_and_abstract:ab1f5ce734f7a75036854bd51438370f:10:NFkappaB:AP-1:1574:1542	Thus, our data suggest a mechanism for transrepression between two nuclear receptors, GR and NGFI-B, that is unique, although quite similar to that proposed for transrepression between GR and activator protein 1 ([TG]) or nuclear factor-kappaB ([TF]).	NFkappaB	AP-1	Complex:NFKB	3726	1574	1542	0.0011390585984944	Non valid	0.18699999958660135;0.1373223898221038;0.6756776105912948	REPRESSION	15591535	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
61301	PMID:18304423:pubtator_title_and_abstract:acaa285fa34635f360b625ca7d1d532f:2:NF-kappa B:AP-1:365:388	OBJECTIVE: To investigate the effect of synthetic non-methylated CpG-ODN combined with recombined HBsAg on the phenotype, function and the expression level of nucleic transcription factor [TF] (NF-kB) and [TG] of monocyte-derived dendritic cells (DC) in patients with chronic hepatitis B (CHB).	NF-kappa B	AP-1	Complex:NFKB	3726	365	388	0.0013094619111875	Non valid	0.9950901637054296;0.003476394756456501;0.0014334415381138533	UNDEFINED	18304423	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
61311	PMID:9134962:pubtator_title_and_abstract:f1a5d7a1d80175f510616a4507715b54:10:c-Fos:AP-1:1683:1452	The composition of the [TG] complex activated by AMPA alone was similar to that produced by NMDA, but with an additional contribution of Fos B. In contrast, application of AMPA plus cyclothiazide induced an AP-1 transcription with contribution of Jun D, [TF], Fos B, c-Jun and Jun B proteins.	c-Fos	AP-1	314322	24516	1683	1452	0.0011576903411872	Non valid	0.062397266706027514;0.9310778747000868;0.006524858593885564	ACTIVATION	9134962	Fos	10116	Jun	10116	dbTF		AP1
61839	PMID:31970677:pubtator_title_and_abstract:8487b75566775c7a5ca2d82222b356df:7:AP-1:activator protein-1:1107:1086	In the same condition, WOE was revealed to inhibit NO production by down-regulating iNOS expression, mainly by interrupting mitogen activated protein kinases (MAPKs)/[TG] ([TF]) pathway.	AP-1	activator protein-1	Complex:AP1	16476	1107	1086	0.0011746418261294	Non valid	0.009448878424743509;0.978687877500626;0.011863244074630418	ACTIVATION	31970677	AP1	10090	Jun	10090	dbTF	AP1	AP1
62330	PMID:15170815:pubtator_title_and_abstract:0a89bdcc4e6bf4055aaa7a009ec37e57:11:AP-1:AP-1:1766:1837	Considering the important roles of [TF] and NF-kappaB in tumor promotion, we speculated the activation of [TG] and NF-kappaB by B[a]PDE and 5-MCDE may involve in their or their parent compounds' tumor promotion effects.	AP-1	AP-1	Complex:AP1	16476	1766	1837	0.0011735295965369	Non valid	0.0183060597429321;0.9797662809388704;0.001927659318197521	ACTIVATION	15170815	AP1	10090	Jun	10090	dbTF	AP1	AP1
62598	PMID:18668519:pubtator_title_and_abstract:b0a43d9b3ad49a253e0a1b3518cb1c2a:7:TGF-beta1:AP-1:1337:1415	Furthermore, transfection of a c-jun antisense expression vector significantly prevented [TF]-induced Cx43 gene expression demonstrating the involvement of c-Jun/[TG] pathway together with p38 and PI3K/AKT pathways in mediating TGF-beta1-induced Cx43 gene expression.	TGF-beta1	AP-1	21803	16476	1337	1415	0.0010909967356587	Non valid	0.0026820513157087694;0.9965476846915904;0.0007702639927009284	ACTIVATION	18668519	Tgfb1	10090	Jun	10090	ll_coTF		AP1
62711	PMID:11399048:pubtator_title_and_abstract:f6b89e830119410fe8e89245df99ac10:4:AP-1:AP-1:680:811	Mutation of either the AP-1 site or the NF-IL-6 site on the IL-8 promoter suppressed the TNF-alpha-induced activation, suggesting cooperation between these transcription factors and transcription factor NF-kappaB. Overexpression of dominant negative mutants of c-Jun suppressed [TF]-driven transcription of the IL-8 promoter following stimulation by TNF-alpha, suggesting that cooperative interaction between [TG] and NF-kappaB is essential for IL-8 transcription in the presence of TNF-alpha.	AP-1	AP-1	Complex:AP1	3725	680	811	0.0011504161594827	Non valid	0.0022360149630579547;0.9967817457981918;0.0009822392387502255	ACTIVATION	11399048	AP1	9606	JUN	9606	dbTF	AP1	AP1
62775	PMID:12857751:pubtator_title_and_abstract:dd23162400fb891383f5f4a0588583ca:9:JNK:AP-1:1323:1304	Upstream of [TG], CO decreased [TF] phosphorylation in murine macrophages and lung endothelial cells.	JNK	AP-1	26419	16476	1323	1304	0.0040594810948482	Non valid	0.05524397664960782;0.9250209397093834;0.01973508364100888	ACTIVATION	12857751	Mapk8	10090	Jun	10090	ll_coTF		AP1
63080	PMID:38199515:pubtator_title_and_abstract:29027ce3efe04d74cb9e613e417c4796:8:NOD2:AP1:1025:1035	These findings suggest that the KIAA1109-[TF]-NFkB/[TG]-CXCL1/CXCL2 regulatory axis is the molecular mechanism of IBD pathogenesis, which will provide a new perspective for the diagnosis, treatment and management of IBD patients.	NOD2	AP1	64127	3726	1025	1035	0.0012033862563526	Non valid	0.997962406490663;0.0011237324949832216;0.0009138610143537242	UNDEFINED	38199515	NOD2	9606	JUNB	9606	coTF		AP1
63108	PMID:23731386:pubtator_title_and_abstract:d7305645e88b5acdad10581c499a4fb7:5:HO-1:AP-1:806:1104	RESULTS: Treatment with hemin enhanced [TF], HO activity and cGMP, but suppressed retroperitoneal adiposity and abated the elevated levels of macrophage-chemoattractant protein-1 (MCP-1), ICAM-1, tumour necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), IL-1beta, NF-kappaB, c-Jun-NH2-terminal-kinase (JNK) and activating-protein ([TG]), with parallel reduction of adipocyte hypertrophy.	HO-1	AP-1	24451	24516	806	1104	0.00135125402202	Non valid	0.03622139146269079;0.20885842973761687;0.7549201787996923	REPRESSION	23731386	Hmox1	10116	Jun	10116	ll_coTF		AP1
63123	PMID:11912216:pubtator_title_and_abstract:c97a75cb1581dab62ddae9013d7efd5c:5:polycystin-1:AP-1:655:820	To test if [TF] can activate cellular signaling cascades via heterotrimeric G protein subunits, polycystin-1 C-terminal tail-mediated c-Jun N-terminal kinase (JNK) and [TG] activities were assayed in transiently transfected 293T cells in the presence of dominant-negative, G protein inhibiting constructs, and in the presence of cotransfected Galpha subunits.	polycystin-1	AP-1	5310	3725	655	820	0.0040808309179867	Non valid	0.05742271969850869;0.9406840494823095;0.0018932308191817783	ACTIVATION	11912216	PKD1	9606	JUN	9606	coTF		AP1
63151	PMID:16327802:pubtator_title_and_abstract:8b5c30c1648fa8b74fbfa37ee15156ed:5:c-jun:AP-1:680:656	Second, it involves IL-13 signaling through IL-13Ralpha(2) to activate an [TG] variant containing [TF] and Fra-2, which then activates the TGFB1 promoter.	c-jun	AP-1	3725	3725	680	656	0.0019096800973835	Non valid	0.12050458552699794;0.8663653993428989;0.013130015130103133	ACTIVATION	16327802	JUN	9606	JUN	9606	dbTF		AP1
63695	PMID:9115394:pubtator_title_and_abstract:97a54c5cefbfafcb19238d99eb7342bb:7:PI 3-kinase:AP1:1067:982	RESULTS: Certain aspects of TCR responses such as the induction of transcriptional activity of [TG] and serum response factor were not affected by expression of the mutant forms of [TF].	PI 3-kinase	AP1	5295	3726	1067	982	0.0084404453744837	Non valid	0.04385905487585478;0.9166589879827696;0.03948195714137555	ACTIVATION	9115394	PIK3R1	9606	JUNB	9606	ll_coTF		AP1
63847	PMID:20826812:pubtator_title_and_abstract:d54961edf97c6ed24d6752e497482a5e:10:Nrf2:AP-1:1650:1641	These results suggest that LPS-mediated Srx induction is dependent on both [TG] and [TF], which is regulated by Nox2-derived reactive oxygen species.	Nrf2	AP-1	18024	16476	1650	1641	0.0012671312521716	Non valid	0.0035898403278880695;0.9956644246554062;0.0007457350167058735	ACTIVATION	20826812	Nfe2l2	10090	Jun	10090	dbTF		AP1
64014	PMID:10800078:pubtator_title_and_abstract:8009980d01eeea0bb6b3a84f3bab7070:4:RAR:AP1:536:433	By contrast, two RXR agonists, a RARbeta agonist and an anti-[TG] retinoid have very limited activity, ATRA- and AM580-dependent effects are completely inhibited by [TF] antagonistic blockade, while 9-cis RA-induced cell-growth-inhibition and apoptosis are equally inhibited by RAR and RXR antagonists.	RAR	AP1	5914	3727	536	433	0.0018956186737539	Non valid	0.012484216087951173;0.935721660186748;0.05179412372530094	ACTIVATION	10800078	RARA	9606	JUND	9606	dbTF		AP1
64069	PMID:14561194:pubtator_title_and_abstract:50fddae25c957834d4db91edbb7f6321:5:NF-kappaB:AP-1:1129:1143	ROS, either directly or via the formation of lipid peroxidation products such as acrolein, 4-hydroxy-2-nonenal and F(2)-isoprostanes, may play a role in enhancing the inflammation through the activation of stress kinases (JNK, MAPK, p38, phosphoinositide 3 (PI-3)-kinase/PI-3K-activated serine-threonine kinase Akt) and redox sensitive transcription factors such as [TF] and [TG].	NF-kappaB	AP-1	Complex:NFKB	3726	1129	1143	0.0011167927394149	Non valid	0.4739962253064595;0.5196604633210863;0.006343311372454164	ACTIVATION	14561194	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
64197	PMID:12618755:pubtator_title_and_abstract:b9443d9367e3a50d8bb38ee4075d3d37:16:Elk1:AP1:2861:2866	Together, these results suggest that anticancer effects of GSE in PCA be mediated via impairment of EGFR-ERK1/2-[TF]-[TG]-mediated mitogenic signaling and activation of JNK causing growth inhibition and apoptosis, respectively.	Elk1	AP1	2002	3725	2861	2866	0.0011436118689792	Non valid	0.014462501995670375;0.9784781958905528;0.007059302113776855	ACTIVATION	12618755	ELK1	9606	JUN	9606	dbTF		AP1
64730	PMID:11120852:pubtator_title_and_abstract:95c0443907ac7281bcad8e36fd4af771:7:c-Jun:AP-1:1059:1065	Inhibition of [TF]/[TG] had no effect on the production of either IL-6 or IL-8.	c-Jun	AP-1	3725	3725	1059	1065	0.0011900012332384	Non valid	0.05755969709422188;0.8721758418269357;0.07026446107884238	ACTIVATION	11120852	JUN	9606	JUN	9606	dbTF		AP1
64946	PMID:21615409:pubtator_title_and_abstract:3d3117fe453b652ba253d592acbc0175:3:NF-kappaB:AP-1:537:504	We comprehensively assessed the involvement of MAPKs, activator protein-1 ([TG]) and nuclear factor-kappaB ([TF]) in IL-1beta-induced production of interleukin-6 (IL-6), interleukin-8 (IL-8), prostaglandin E(2) (PGE(2) ) and MMP-1 in human periodontal ligament cells.	NF-kappaB	AP-1	Complex:NFKB	3726	537	504	0.0011401905995965	Non valid	0.03433146406701694;0.9643135665800776;0.0013549693529054101	ACTIVATION	21615409	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
64984	PMID:27239846:pubtator_title_and_abstract:9b6cf03df155a90fc89a85fffff7ffd4:2:c-fos:AP-1:206:242	The ratio of the expression levels of the immediate early genes c-jun and [TF] that encode components of the [TG] transcription complex determines the direction of changes in the expression of genes controlled by the complex, including changes induced by glucocorticoids.	c-fos	AP-1	314322	24516	206	242	0.0013546467153672	Non valid	0.9800899469449899;0.01701815218539777;0.0028919008696124144	UNDEFINED	27239846	Fos	10116	Jun	10116	dbTF		AP1
65124	PMID:17478933:pubtator_title_and_abstract:85c55d219fa60752b31f206164aaa573:7:NF-kappaB:AP-1:1236:1227	PD98059 could inhibit the cell proliferation mediated by HCV NS3 protein, down-regulate the activities of [TG] and [TF], and suppress the expression of cyclin D1.	NF-kappaB	AP-1	Complex:NFKB	3727	1236	1227	0.0012489686334224	Non valid	0.011640051435946387;0.9636973674407596;0.024662581123294097	ACTIVATION	17478933	NFKB	9606	JUND	9606	dbTF	NFKB	AP1
65189	PMID:8404860:pubtator_title_and_abstract:92645d847c16f3b0b2b83f4a656214e8:4:fos:AP-1:593:715	The BZLF1 protein belongs to the extended [TF]/jun family of transcription factors and binds to specific BZLF1 binding motifs within oriLyt, as well as to consensus [TG] sites.	fos	AP-1	2353	3725	593	715	0.0012699382815802	Non valid	0.9927123027948668;0.0065392332649001185;0.0007484639402330546	UNDEFINED	8404860	FOS	9606	JUN	9606	dbTF		AP1
65232	PMID:21511059:pubtator_title_and_abstract:f89ee4bd9e271d6583909e0a03de0d33:8:JNK:AP-1:1245:1425	Furthermore, kob A inhibited SNP-induced phosphorylation of [TF] and c-Jun, and SNP-induced reduction in NF-kappaBeta and AP-1 activities, implicating that protective effect of kob A may occur through the regulation of JNK, NF-kappaBeta and [TG] signaling pathways.	JNK	AP-1	5599	3725	1245	1425	0.0014919206473288	Non valid	0.2837939615333706;0.5718343660562198;0.14437167241040957	ACTIVATION	21511059	MAPK8	9606	JUN	9606	ll_coTF		AP1
65234	PMID:10847592:pubtator_title_and_abstract:663bcfd6ed26e0ba48da9f0a7335eff6:5:nuclear factor-kappaB:activating protein-1:806:736	Second, ASC-2 specifically interacted with the [TG] (AP-1) components c-Jun and c-Fos as well as the [TF] (NFkappaB) components p50 and p65, as demonstrated by the glutathione S-transferase pull-down assays as well as the yeast two-hybrid tests.	nuclear factor-kappaB	activating protein-1	Complex:NFKB	3725	806	736	0.0012347325945206	Non valid	0.9708441750856354;0.027762429524472516;0.0013933953898920678	UNDEFINED	10847592	NFKB	9606	JUN	9606	dbTF	NFKB	AP1
65280	PMID:22764536:pubtator_title_and_abstract:359093e379cad92a0a0520171b290d8a:7:MyD88:AP-1:781:945	Activated PRRs deliver signals to adaptor molecules ([TF], TRIF, IRAK, IPS-1), which act as important messengers to activate downstream kinases (IKK complex, MAPKs, TBK1, RIP-1) and transcription factors (NF-kappaB, [TG], IRF3), which produce effected molecules including cytokines, chemokines, inflammatory enzymes, and type I interferons.	MyD88	AP-1	4615	3726	781	945	0.0034030490222791	Non valid	0.04503470942326104;0.9533452436488201;0.0016200469279189465	ACTIVATION	22764536	MYD88	9606	JUNB	9606	coTF		AP1
65328	PMID:35935582:pubtator_title_and_abstract:8757caccd6f1956f3245f43e292948a0:4:TGFbetaR1:AP1:703:725	Furthermore, SRPX2 exhibited excellent antifibrosis effect via the [TF]/SMAD3/SRPX2/[TG]/SMAD7 signaling pathway.	TGFbetaR1	AP1	7046	2354	703	725	0.0011988970127883	Non valid	0.8862521329292926;0.11100993091878528;0.0027379361519220924	UNDEFINED	35935582	TGFBR1	9606	FOSB	9606	ll_coTF		AP1
65602	PMID:24342046:pubtator_title_and_abstract:2eb82c295ebdb39fdb135f08209221eb:5:AP-1:AP-1:824:743	Given the binding motifs for [TG] within the first intron of the SphK1 gene, we speculated that the activated [TF] in the kidney under HG condition possibly regulates SphK1 expression in a positive feedback manner, thereby promoting the sustained activation of SphK1-S1P pathway and mediating the pathological progression of DN.	AP-1	AP-1	Complex:AP1	24516	824	743	0.0010993710423718	Non valid	0.10068376340280186;0.8955319305750289;0.0037843060221692676	ACTIVATION	24342046	AP1	10116	Jun	10116	dbTF	AP1	AP1
65653	PMID:15561798:pubtator_title_and_abstract:c40cfaea282ff79f68c0d6326f793db4:5:IkappaB-alpha:AP-1:1610:1577	In addition, apicularen A activated nuclear factor-kappaB (NF-kappaB) and activator protein-1 ([TG]) and decreased the level of [TF] and increased that of phosphorylated c-Jun N-terminal kinase (JNK).	IkappaB-alpha	AP-1	18035	16476	1610	1577	0.0011734032860891	Non valid	0.08483013602667394;0.24116077723452534;0.6740090867388007	REPRESSION	15561798	Nfkbia	10090	Jun	10090	coTF		AP1
65787	PMID:15452235:pubtator_title_and_abstract:f915043a6ca54ce16f2755cd290f24ed:7:NF-kappaB:activating protein 1:1263:1323	Many microbial products that induce proinflammatory responses are recognized via Toll-like receptor (TLR) signaling through the key adaptor protein MyD88 and activation of [TF], nuclear factor of activated T cells (NF-AT), and [TG] (AP-1).	NF-kappaB	activating protein 1	Complex:NFKB	16476	1263	1323	0.0011484414703814	Non valid	0.011296634285437864;0.9871565428283161;0.0015468228862460934	ACTIVATION	15452235	NFKB	10090	Jun	10090	dbTF	NFKB	AP1
65791	PMID:1901948:pubtator_title_and_abstract:74aaed2ef1f03abb31e645684183b711:9:AP-1:AP-1:1192:1231	Both UV and H2O2 lead to a long-lasting increase in [TF] binding activity, suggesting that [TG] may mediate the induction of other damage-inducible genes such as human collagenase.	AP-1	AP-1	Complex:AP1	3725	1192	1231	0.0016949965263454	Non valid	0.027314537675634694;0.9712028546295711;0.001482607694794118	ACTIVATION	1901948	AP1	9606	JUN	9606	dbTF	AP1	AP1
66339	PMID:16652374:pubtator_title_and_abstract:9e6854bf871803179421675d28633aed:7:JNK:AP-1:923:867	Moreover, we previously showed that in response to ITC treatment c-jun was predominantly stimulated among [TG] family members largely by c-jun N-terminal kinase ([TF]) [Food Chem Toxicol 2005; 43: 1373-1380], but neither JNK inhibition nor forced expression of c-jun altered the antiproliferative activity of PEITC.	JNK	AP-1	5599	3725	923	867	0.0148414202183084	Non valid	0.0035412519052914516;0.9956037702068136;0.0008549778878950264	ACTIVATION	16652374	MAPK8	9606	JUN	9606	ll_coTF		AP1
66592	PMID:16800774:pubtator_title_and_abstract:fab23d4ee8f91b149035ee46c499053e:5:VEGF:AP-1:731:698	Pretreatment of Cl 41 cells with methanol-extracted blackberry fraction RO-ME resulted in a dramatical inhibition of B(a)PDE-induced activation of [TG] and NFkB, and expression of [TF] and COX-2.	VEGF	AP-1	22339	16476	731	698	0.0012530828525837	Non valid	0.031573146774911444;0.7864239888649835;0.18200286436010504	ACTIVATION	16800774	Vegfa	10090	Jun	10090	ll_coTF		AP1
66703	PMID:9165057:pubtator_title_and_abstract:41d59bbfc62af2af519c8e59d8947a1a:3:activating protein-1:AP-1:446:468	Although little is known about the transcriptional regulation of the beta-subunit (the rate-limiting subunit of FSH synthesis), sequence analysis of the ovine FSHbeta promoter has revealed a number of potential [TF] ([TG]; Jun/Fos)-binding sites.	activating protein-1	AP-1	Complex:AP1	3725	446	468	0.001198347272204	Non valid	0.9977760661215518;0.0016260933010076408;0.0005978405774405568	UNDEFINED	9165057	AP1	9606	JUN	9606	dbTF	AP1	AP1
66878	PMID:15647850:pubtator_title_and_abstract:f1df22e09d2545acfdf30199cc3b26cc:5:NF-kappaB:AP-1:747:718	Electric mobility shift assay revealed increased DNA binding activity of the cellular transcription factors activator protein 1 ([TG]) and nuclear factor (B ([TF]) in SARS-CoV infected cells.	NF-kappaB	AP-1	Complex:NFKB	3726	747	718	0.0013160447038825	Non valid	0.9974577781097799;0.0016212979869741602;0.0009209239032459656	UNDEFINED	15647850	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
66939	PMID:11278891:pubtator_title_and_abstract:ab7b83f2a438e06af43d3734e69f1413:1:hypoxia-inducible factor-1:activator protein-1:75:103	Contributions of [TF], [TG], GATA-2, AND p300/CBP.	hypoxia-inducible factor-1	activator protein-1	3091	3726	75	103	0.0012431817665949	Non valid	0.9318745942215021;0.06559674088774678;0.0025286648907511273	UNDEFINED	11278891	HIF1A	9606	JUNB	9606	dbTF		AP1
66974	PMID:12137955:pubtator_title_and_abstract:d9739e77a8f9cb287cd7db7286bbe1fb:4:AP-1:AP-1:705:518	The [TG] complex formed in UVB-irradiated HaCaT cells is specifically composed of c-fos and Jun D. c-Fos expression was induced in a manner that correlated with the UVB-induced activation of [TF].	AP-1	AP-1	Complex:AP1	3727	705	518	0.001233614355586	Non valid	0.07200218000247531;0.9254714736143159;0.0025263463832087664	ACTIVATION	12137955	AP1	9606	JUND	9606	dbTF	AP1	AP1
67004	PMID:28233171:pubtator_title_and_abstract:364a29e947b71b029ec5a96d086f6256:8:GSK3alpha/beta:AP-1:1022:1003	Messenger RNA (mRNA) expression levels of bcl-2 and protein levels of bcl-2, NFkappaB, [TG], and inactive [TF] were measured by semiquantitative RT-PCR, immunohistochemistry, Western blot, and ChIP analysis.	GSK3alpha/beta	AP-1	2931	3726	1022	1003	0.0011503161665805	Non valid	0.16221974520776328;0.07228160277194513;0.7654986520202917	REPRESSION	28233171	GSK3A	9606	JUNB	9606	ll_coTF		AP1
67317	PMID:15138601:pubtator_title_and_abstract:4d64cbfb3d5c2f0cae51f66209b75306:8:PEA3:AP-1:1034:983	Results using PEA3, ETS and [TG] artificial promoters showed that EGF enhanced [TF] transcription factor activity by up to 70% in comparison to non-treated cell lines.	PEA3	AP-1	2118	3726	1034	983	0.0016719429127993	Non valid	0.021807022481565606;0.9677043516121648;0.010488625906269648	ACTIVATION	15138601	ETV4	9606	JUNB	9606	dbTF		AP1
67359	PMID:20674565:pubtator_title_and_abstract:4ef61e5440c424c26c6cd5f20ebddd7c:5:activating protein-1:AP-1:724:746	In contrast, steroidal anti-inflammatory drugs suppress the immune system mainly via inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) and the [TF] ([TG]) pathway.	activating protein-1	AP-1	Complex:AP1	16476	724	746	0.0011061734379652	Non valid	0.23585546769503357;0.7550712585677319;0.009073273737234457	ACTIVATION	20674565	AP1	10090	Jun	10090	dbTF	AP1	AP1
67584	PMID:9032267:pubtator_title_and_abstract:1291541b72e1acca6cae46558ebcddeb:8:p45:AP1:1018:1123	The region of CBP which interacts with [TF]/NF-E2 is the same interaction domain that mediates inhibition of hormone-stimulated transcription by [TG] transcription factors.	p45	AP1	4778	2354	1018	1123	0.0010860736907101	Non valid	0.0018469837562089682;0.0037240626718780057;0.994428953571913	REPRESSION	9032267	NFE2	9606	FOSB	9606	dbTF		AP1
68179	PMID:22224945:pubtator_title_and_abstract:96254db5ba1548d4bb50586e12c7dad5:10:NF-kappaB:AP-1:1436:1450	These results indicate that activation of p38, ERK1/2 MAPK, [TF] and [TG] comprises the signalling pathway responsible for IL-8 production by G. lamblia ESP.	NF-kappaB	AP-1	Complex:NFKB	3726	1436	1450	0.0011073223709905	Non valid	0.0056856410114250475;0.9934992464102891;0.0008151125782857918	ACTIVATION	22224945	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
68786	PMID:16155909:pubtator_title_and_abstract:9d062b915e987b326a1bd42c202333b6:2:AP-1:activator protein-1:125:104	We previously reported that [TG] ([TF]) DNA binding activity was increased in vascular smooth muscle cells (VSMC) from old rats when exposed to high glucose or tumor necrosis factor (TNF-alpha) (Li et al., 2003.	AP-1	activator protein-1	Complex:AP1	24516	125	104	0.0011690569436359	Non valid	0.9960307983943996;0.0028149950190392244;0.0011542065865611172	UNDEFINED	16155909	AP1	10116	Jun	10116	dbTF	AP1	AP1
68972	PMID:15034932:pubtator_title_and_abstract:2471542efb8806529deb1267646e0d10:14:c-myc:AP-1:2038:1961	The apoptosis induced by [TG] inhibition may be dependent on c-myc protein levels suggesting that the [TF] protein induces apoptosis at a low level of AP-1 binding activity.	c-myc	AP-1	4609	3725	2038	1961	0.0011122629515945	Non valid	0.006617517938966772;0.01772354864751379;0.9756589334135194	REPRESSION	15034932	MYC	9606	JUN	9606	dbTF		AP1
69114	PMID:30990796:pubtator_title_and_abstract:43f814c110a3b2b77af89eae4aaf3c3b:2:AP-1:activator protein 1:242:221	The polarization of macrophages is regulated by transcription factors such as nuclear factor kappa B (NF-kappaB) and [TG] ([TF]).	AP-1	activator protein 1	Complex:AP1	16476	242	221	0.0011719039685697	Non valid	0.9867294390234683;0.01195266871488664;0.0013178922616450327	UNDEFINED	30990796	AP1	10090	Jun	10090	dbTF	AP1	AP1
69581	PMID:22224945:pubtator_title_and_abstract:96254db5ba1548d4bb50586e12c7dad5:7:NF-kappaB:AP-1:1069:1105	Electrophoretic mobility gel shift and transfection assays using mutagenized IL-8 promoter reporter plasmids indicated that IL-8 production by G. lamblia ESP occurs through activation of two transcriptional factors, nuclear factor kappaB ([TF]) and activator protein 1 ([TG]) in HT-29 cells.	NF-kappaB	AP-1	Complex:NFKB	3726	1069	1105	0.0011236979941038	Non valid	0.038058749987928665;0.9597099030678264;0.0022313469442447956	ACTIVATION	22224945	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
69796	PMID:12441666:pubtator_title_and_abstract:b9e555b9be406d145f04804474aa5027:3:NF-kappaB:AP-1:727:718	This study shows that in these cells binding of short-term glycated albumin leads to activation of PKC, especially its isoform epsilon and this is linked to translocation of [TG] and [TF] into the nucleus.	NF-kappaB	AP-1	Complex:NFKB	3725	727	718	0.0012057604859437	Non valid	0.6307851352896136;0.36441035214832107;0.004804512562065338	UNDEFINED	12441666	NFKB	9606	JUN	9606	dbTF	NFKB	AP1
70199	PMID:9551998:pubtator_title_and_abstract:f4022678ab0c083e425b8993714ed3fd:6:NF-kappaB:AP-1:1203:1222	Immunofluorescent RelA nuclear staining was strongly inhibited in Ad5 IkappaB-infected IEC compared with control Ad5LacZ and [TF], but not [TG] binding activity, was reduced by more than 70% as measured by electrophoretic mobility shift assay (EMSA).	NF-kappaB	AP-1	Complex:NFKB	3726	1203	1222	0.0011266750671348	Non valid	0.987555107065276;0.009536254766960475;0.0029086381677635117	UNDEFINED	9551998	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
70268	PMID:21196933:pubtator_title_and_abstract:07ec0fb4b955920df3f706d616ea6bf5:2:AP-1:activator protein 1:93:99	[TF] ([TG]) activity is strongly induced in response to numerous signals, including growth factors, cytokines and extracellular stresses.	AP-1	activator protein 1	Complex:AP1	16476	93	99	0.0027441253103536	Non valid	0.004090570905405958;0.994476401641904;0.0014330274526900707	ACTIVATION	21196933	AP1	10090	Jun	10090	dbTF	AP1	AP1
70327	PMID:11295497:pubtator_title_and_abstract:a78601234570421ba51fada92dc36688:6:c-Jun:AP-1:551:616	[TF], one of the main dimerization partners of c-Fos within the [TG] transcription complex, is also an unstable protein.	c-Jun	AP-1	16476	16476	551	616	0.375989337981976	Non valid	0.9637200568839641;0.03207881068317983;0.0042011324328559635	UNDEFINED	11295497	Jun	10090	Jun	10090	dbTF		AP1
70550	PMID:11641266:pubtator_title_and_abstract:bf3c37b215de7d1d3c4ccef90e899db7:6:c-Jun amino-terminal kinase:AP-1:775:763	Activation of [TG] with a [TF] (JNK) activator (Ro318220, 10 microM) provoked apoptosis in 18.7 +/- 1.2% cardiomyocytes, which was again blocked by intracellular scavenging of AP-1.	c-Jun amino-terminal kinase	AP-1	116554	24516	775	763	0.0023489000729011	Non valid	0.0035493729880672993;0.995313200425046;0.0011374265868867015	ACTIVATION	11641266	Mapk8	10116	Jun	10116	ll_coTF		AP1
70685	PMID:12208854:pubtator_title_and_abstract:f6b87254474efc56b1ee13ee9dbfd48c:5:Akt:AP-1:1133:1240	LPS markedly activated [TF] and Erk1/2, but not p38, in a GM-CSF-dependent manner in direct temporal association with NFkappaB and [TG] activation.	Akt	AP-1	11651	16476	1133	1240	0.0011173846721321	Non valid	0.006406143313204664;0.9924995213352232;0.00109433535157215	ACTIVATION	12208854	Akt1	10090	Jun	10090	ll_coTF		AP1
70760	PMID:9187311:pubtator_title_and_abstract:ad6c50fd36cc43be88936147bbfa972f:0:activator protein-1:AP-1:58:79	Changes in glutamate receptors, c-fos mRNA expression and [TF] ([TG]) DNA binding activity in the brain of phenobarbital-dependent and -withdrawn rats.	activator protein-1	AP-1	Complex:AP1	24516	58	79	0.0012102068081391	Non valid	0.997063879300803;0.001808599917276402;0.0011275207819206588	UNDEFINED	9187311	AP1	10116	Jun	10116	dbTF	AP1	AP1
71033	PMID:12433834:pubtator_title_and_abstract:b2a76b63bbb8733953465965e9e728c2:11:Egr-1:AP-1:1635:1644	Mutations of either [TF] or [TG] binding sites partially abrogate ACE expression induced by PMA, whereas mutation of both sites totally abrogates PMA-induced ACE expression.	Egr-1	AP-1	1958	3727	1635	1644	0.0011697046789946	Non valid	0.0019363070152789155;0.9953983723316097;0.0026653206531113893	ACTIVATION	12433834	EGR1	9606	JUND	9606	dbTF		AP1
71103	PMID:33915176:pubtator_title_and_abstract:91c97d9d97a410dac4d68e7d6da6b5a0:0:NF-kappaB:AP1:115:126	Identification of IkappaBalpha in Japanese eel Anguilla japonica that impairs the IKKalpha-dependent activation of [TF], [TG], and type I IFN signaling pathways.	NF-kappaB	AP1	Complex:NFKB	3726	115	126	0.0011458216394735	Non valid	0.0441933108478888;0.7975972136175322;0.158209475534579	ACTIVATION	33915176	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
71186	PMID:10022864:pubtator_title_and_abstract:f3d74aca0dfa532978e811b43f15e738:3:c-Jun:AP-1:300:450	JNK-mediated phosphorylation of [TF] is currently understood to stimulate the transactivating potency of AP-1 (e.g., c-Jun/c-Fos; c-Jun/ATF-2), thereby increasing the expression of [TG] target genes.	c-Jun	AP-1	16476	16476	300	450	0.0015042111763129	Non valid	0.0045168714441622265;0.9943596444825096;0.001123484073328153	ACTIVATION	10022864	Jun	10090	Jun	10090	dbTF		AP1
71624	PMID:11997078:pubtator_title_and_abstract:0182966bd9cab77e3673920a7d4e2abc:9:ERK 1/2:AP-1:1291:1398	We show that inhibition of [TF] leads to the repression of MMP-1 transcription, and that both the 2G polymorphism and the adjacent [TG] site at -1602 bp are necessary for high levels of MMP-1 transcription and for the inhibition of MMP-1 expression by PD098059, a specific ERK inhibitor.	ERK 1/2	AP-1	5595;5594	3725	1291	1398	0.0010731396606098	Non valid	0.017354077397417126;0.9623932604650351;0.020252662137547707	ACTIVATION	11997078	MAPK3;MAPK1	9606;9606	JUN	9606	ll_coTF;ll_coTF		AP1
72025	PMID:9466818:pubtator_title_and_abstract:4bbaea6c33aebf69d701794b5f510170:5:c-Jun:AP-1:931:916	Nuclear extracts from TPA-treated HepG2 cells protected both the 5'AP1 and 3'AP1 sequences against digestion with DNase I. Gel mobility shift and supershift assays revealed that TPA treatment of HepG2 results in increased binding activity of the [TG] proteins, [TF], JunD, and c-Fos, to both sites.	c-Jun	AP-1	3725	3725	931	916	0.0011636756493741	Non valid	0.9975711841122791;0.001320210909060743;0.0011086049786602228	UNDEFINED	9466818	JUN	9606	JUN	9606	dbTF		AP1
72114	PMID:10374969:pubtator_title_and_abstract:f573a8be8cc5f13cec86fdad5c56769b:5:CREB:AP-1:620:625	In the present study, we localize this differentiation responsive element to the [TF]/[TG]-like binding site (TGACATCA) between -67 to -60 bp within Zp, previously designated ZII, and furthermore show that homodimers and heterodimers of CREB and ATF-1 specifically bind ZII.	CREB	AP-1	1385	3726	620	625	0.0011566820107807	Non valid	0.994483074253132;0.004561521251522295;0.0009554044953456797	UNDEFINED	10374969	CREB1	9606	JUNB	9606	dbTF		AP1
72233	PMID:19397838:pubtator_title_and_abstract:ebf19e715f86988e9b881ad956050f7d:5:USF1 and 2:activator protein 1:589:602	This review focuses on the transcription factors upstream stimulatory factors 1 and 2 ([TF]), [TG] (AP-1), nuclear factor (NF)-kappaB, cAMP-response-element-binding protein (CREB), nuclear factor of activated T cells (NFAT), and stimulating protein 1 (Sp1).	USF1 and 2	activator protein 1	7391;7392	3726	589	602	0.0012075026053298	Non valid	0.9797191311491406;0.01906012746225375;0.0012207413886057648	UNDEFINED	19397838	USF1;USF2	9606;9606	JUNB	9606	dbTF;dbTF		AP1
72272	PMID:25263558:pubtator_title_and_abstract:caab12d459af618c68f05ec836028f18:8:JNK:AP1:1058:980	Furthermore, Blm-s is a direct target gene of p53 and [TG] via the ataxia telangiectasia mutated (ATM)- and c-Jun N-terminal kinase ([TF])-signaling pathways activated by DSBs.	JNK	AP1	5599	3725	1058	980	0.0012575962491661	Non valid	0.9875774165996886;0.01154123998250595;0.000881343417805521	UNDEFINED	25263558	MAPK8	9606	JUN	9606	ll_coTF		AP1
72874	PMID:32866426:pubtator_title_and_abstract:f6851676146db6d3a2fa0418028d1a5c:12:RELA:activator protein 1:3248:1951	Our findings demonstrate a critical role of epidermal autophagy in wound healing in vivo and elucidate a critical molecular machinery coordinating keratinocyte-fibroblast interaction in skin repair.Abbreviations: ACTA2/alpha-SMA: actin alpha 2, smooth muscle; ACTB: beta-actin; ADGRE1: adhesion G protein-coupled receptor E1; AMPK: AMP-activated protein kinase; AP1: [TG]; AP1-RE: AP1 response element; ATG: autophagy-related; ATG16L1: autophagy related 16 like 1; BECN1: beclin 1; BRAF: B-Raf proto-oncogene, serine/threonine kinase; C5: complement C5; CCL2/MCP-1: C-C motif chemokine ligand 2; CCL3: C-C motif chemokine ligand 3; CK: cytokeratin; cKO: conditional knockout; CRTC1: CREB-regulated transcription coactivator 1; CXCL1: C-X-C motif chemokine ligand 1; CXCL2: C-X-C motif chemokine ligand 2; ECM: extracellular matrix; EGF: epidermal growth factor; FGF7: fibroblast growth factor 7; GABARAPL2: GABA type A receptor associated protein like 2; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; HBEGF: heparin binding EGF like growth factor; HPRT1: hypoxanthine phosphoribosyltransferase 1; IHC: immunohistochemical; IL1B: interleukin 1 beta; KRT10: keratin 10; KRT14: keratin 14; MAP1LC3B/LC3B-I/II: microtubule-associated protein 1 light chain 3 beta; MAPK1/3/ERK: mitogen-activated protein kinase 1/3; MKI67/Ki-67: marker of proliferation; MPO: myeloperoxidase; NFKB: NF-kappa B, nuclear factor kappa-light-chain-enhancer of activated B cells; NFKB-RE: NFKB response element; PDGF: platelet-derived growth factor; PECAM1: platelet and endothelial cell adhesion molecule 1; PRKAA1: protein kinase AMP-activated catalytic subunit alpha 1; [TF]/p65: RELA proto-oncogene, NFKB subunit; shCON: small hairpin negative control; siNC: negative control; siRNA: small interfering RNA; SP1: sp1 transcription factor; SQSTM1/p62: sequestosome 1; TGFA: transforming growth factor alpha; TGFB1: transforming growth factor beta 1; TIMP1: TIMP metallopeptidase inhibitor 1; TNF/TNF-alpha: tumor necrosis factor; TREM1: triggering receptor expressed on myeloid cells 1; WT: wild-type.	RELA	activator protein 1	19697	16476	3248	1951	0.0012248517737925	Non valid	0.7287147185353322;0.25823389538141844;0.013051386083249347	UNDEFINED	32866426	Rela	10090	Jun	10090	dbTF		AP1
73143	PMID:20801131:pubtator_title_and_abstract:20acd01d948eb66260611983efe5769d:4:AP2:AP1:641:666	We use a numerical procedure on the Luo-Rudy phase 1 model of the ventricular action potential (AP1) in order to find a modified set of model parameters which generates an action potential profile ([TF]) almost identical to [TG].	AP2	AP1	7020	2354	641	666	0.0016726554051611	Non valid	0.9638143825405115;0.030475271941845423;0.005710345517643052	UNDEFINED	20801131	TFAP2A	9606	FOSB	9606	dbTF		AP1
73170	PMID:19956833:pubtator_title_and_abstract:62e7173e7553657f0c72ffa387e54833:8:AP-1:AP-1:860:747	In the skin of [TG]-luciferase transgenic mice, topical treatment of the mouse with quercitrin markedly blocked the TPA-induced [TF] transactivation.	AP-1	AP-1	Complex:AP1	16476	860	747	0.0015312451387009	Non valid	0.004068797615722856;0.9946657290213163;0.001265473362960839	ACTIVATION	19956833	AP1	10090	Jun	10090	dbTF	AP1	AP1
74069	PMID:10022864:pubtator_title_and_abstract:f3d74aca0dfa532978e811b43f15e738:3:c-Jun:AP-1:399:374	JNK-mediated phosphorylation of c-Jun is currently understood to stimulate the transactivating potency of [TG] (e.g., c-Jun/c-Fos; [TF]/ATF-2), thereby increasing the expression of AP-1 target genes.	c-Jun	AP-1	16476	16476	399	374	0.0012290686764417	Non valid	0.0025720630873450976;0.9964177192675354;0.0010102176451194623	ACTIVATION	10022864	Jun	10090	Jun	10090	dbTF		AP1
74239	PMID:10573519:pubtator_title_and_abstract:30b5f9b287577f4edf5a4b917169fc05:6:c-Jun-N-terminal kinase:AP-1:785:900	HGF alone induced moderate levels of [TF] (JNK) and p44/p42 mitogen-activated protein kinase (MAPK), resulting in moderate levels of [TG]-DNA binding activity.	c-Jun-N-terminal kinase	AP-1	116554	24516	785	900	0.0011633739058194	Non valid	0.9758149143009855;0.02294129198220488;0.001243793716809563	UNDEFINED	10573519	Mapk8	10116	Jun	10116	ll_coTF		AP1
74253	PMID:9406932:pubtator_title_and_abstract:64c0990ad6a6bc55edda0536bc40d06f:5:NF-kappaB:AP-1:999:876	Besides being differentially sensitive to inhibition by lithium, activation of [TG] and NF-kappaB demonstrated different carbachol EC50 concentrations, and carbachol-induced activation of AP-1, but not [TF], was inhibited by treating cells with Ni2+, which blocks receptor-mediated calcium influx.	NF-kappaB	AP-1	Complex:NFKB	3726	999	876	0.0011948779682837	Non valid	0.021353951519159347;0.9756080125022977;0.0030380359785430132	ACTIVATION	9406932	NFKB	9606	JUNB	9606	dbTF	NFKB	AP1
74336	PMID:32866426:pubtator_title_and_abstract:f6851676146db6d3a2fa0418028d1a5c:12:CRTC1:AP1:2275:1972	Our findings demonstrate a critical role of epidermal autophagy in wound healing in vivo and elucidate a critical molecular machinery coordinating keratinocyte-fibroblast interaction in skin repair.Abbreviations: ACTA2/alpha-SMA: actin alpha 2, smooth muscle; ACTB: beta-actin; ADGRE1: adhesion G protein-coupled receptor E1; AMPK: AMP-activated protein kinase; AP1: activator protein 1; [TG]-RE: AP1 response element; ATG: autophagy-related; ATG16L1: autophagy related 16 like 1; BECN1: beclin 1; BRAF: B-Raf proto-oncogene, serine/threonine kinase; C5: complement C5; CCL2/MCP-1: C-C motif chemokine ligand 2; CCL3: C-C motif chemokine ligand 3; CK: cytokeratin; cKO: conditional knockout; [TF]: CREB-regulated transcription coactivator 1; CXCL1: C-X-C motif chemokine ligand 1; CXCL2: C-X-C motif chemokine ligand 2; ECM: extracellular matrix; EGF: epidermal growth factor; FGF7: fibroblast growth factor 7; GABARAPL2: GABA type A receptor associated protein like 2; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; HBEGF: heparin binding EGF like growth factor; HPRT1: hypoxanthine phosphoribosyltransferase 1; IHC: immunohistochemical; IL1B: interleukin 1 beta; KRT10: keratin 10; KRT14: keratin 14; MAP1LC3B/LC3B-I/II: microtubule-associated protein 1 light chain 3 beta; MAPK1/3/ERK: mitogen-activated protein kinase 1/3; MKI67/Ki-67: marker of proliferation; MPO: myeloperoxidase; NFKB: NF-kappa B, nuclear factor kappa-light-chain-enhancer of activated B cells; NFKB-RE: NFKB response element; PDGF: platelet-derived growth factor; PECAM1: platelet and endothelial cell adhesion molecule 1; PRKAA1: protein kinase AMP-activated catalytic subunit alpha 1; RELA/p65: RELA proto-oncogene, NFKB subunit; shCON: small hairpin negative control; siNC: negative control; siRNA: small interfering RNA; SP1: sp1 transcription factor; SQSTM1/p62: sequestosome 1; TGFA: transforming growth factor alpha; TGFB1: transforming growth factor beta 1; TIMP1: TIMP metallopeptidase inhibitor 1; TNF/TNF-alpha: tumor necrosis factor; TREM1: triggering receptor expressed on myeloid cells 1; WT: wild-type.	CRTC1	AP1	382056	16476	2275	1972	0.0012287971061925	Non valid	0.7486925056392445;0.23087738743960576;0.02043010692114977	UNDEFINED	32866426	Crtc1	10090	Jun	10090	coTF		AP1
74465	PMID:24269960:pubtator_title_and_abstract:985235f582bd96e1c9b74e5001d92335:7:JNK:AP-1:928:941	Further investigations reveal that these effects mainly act via suppressing [TF]-mediated [TG] rather than the NF-kappaB pathway; these effects include a decrease in the phosphorylation level of JNK and a direct inhibition of the activity of p-JNK.	JNK	AP-1	26419	16476	928	941	0.297528946670384	Non valid	0.0044337534870966845;0.9944128326864307;0.0011534138264726313	ACTIVATION	24269960	Mapk8	10090	Jun	10090	ll_coTF		AP1
74729	PMID:10022864:pubtator_title_and_abstract:f3d74aca0dfa532978e811b43f15e738:3:AP-1:AP-1:374:450	JNK-mediated phosphorylation of c-Jun is currently understood to stimulate the transactivating potency of [TF] (e.g., c-Jun/c-Fos; c-Jun/ATF-2), thereby increasing the expression of [TG] target genes.	AP-1	AP-1	Complex:AP1	16476	374	450	0.0011432461660451	Non valid	0.004056797021358496;0.9947939045212074;0.001149298457434125	ACTIVATION	10022864	AP1	10090	Jun	10090	dbTF	AP1	AP1
